<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30370561</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1360-0443</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>114</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Addiction (Abingdon, England)</Title>
          <ISOAbbreviation>Addiction</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Substance use and the objectives of current global health frameworks: measurement matters.</ArticleTitle>
        <Pagination>
          <StartPage>771</StartPage>
          <EndPage>773</EndPage>
          <MedlinePgn>771-773</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/add.14485</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shield</LastName>
            <ForeName>Kevin D</ForeName>
            <Initials>KD</Initials>
            <Identifier Source="ORCID">0000-0003-1871-8849</Identifier>
            <AffiliationInfo>
              <Affiliation>World Health Organization/Pan American Health Organization Collaborating Centre for Addiction and Mental Health, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rehm</LastName>
            <ForeName>J&#xFC;rgen</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0001-5665-0385</Identifier>
            <AffiliationInfo>
              <Affiliation>World Health Organization/Pan American Health Organization Collaborating Centre for Addiction and Mental Health, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Clinical Psychology and Psychotherapy, TU Dresden, Dresden, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Addiction</MedlineTA>
        <NlmUniqueID>9304118</NlmUniqueID>
        <ISSNLinking>0965-2140</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006040" MajorTopicYN="N">Goals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007226" MajorTopicYN="N">Infant Mortality</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061213" MajorTopicYN="Y">Mortality, Premature</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName>
          <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Frameworks</Keyword>
        <Keyword MajorTopicYN="N">goals</Keyword>
        <Keyword MajorTopicYN="N">health</Keyword>
        <Keyword MajorTopicYN="N">measurement</Keyword>
        <Keyword MajorTopicYN="N">morbidity</Keyword>
        <Keyword MajorTopicYN="N">mortality</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30370561</ArticleId>
        <ArticleId IdType="doi">10.1111/add.14485</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>United Nations. Transforming Our World: the 2030 Agenda for Sustainable Development. New York, USA: United Nations; 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. Geneva, Switzerland: World Health Organization; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen L., Evans T., Anand S., Boufford J. I., Brown H., Chowdhury M. et al. Human resources for health: overcoming the crisis. Lancet 2004; 364: 1984-1990.</Citation>
        </Reference>
        <Reference>
          <Citation>Harris J. The value of life: an introduction to medical ethics. London, UK: Routledge; 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Rehm J., Gmel G. E., Gmel G., Hasan O. S., Imtiaz S., Popova S. et al. The relationship between different dimensions of alcohol use and the burden of disease-an update. Addiction 2017; 112: 968-1001.</Citation>
        </Reference>
        <Reference>
          <Citation>Institute for Health Metrics and Evaluation. Data Visualizations: GBD Compare. Seattle, Washington: Institute for Health Metrics and Evaluation; 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Tarkiainen L., Martikainen P., Laaksonen M., Valkonen T. Trends in life expectancy by income from 1988 to 2007: decomposition by age and cause of death. J Epidemiol Community Health 2012; 66: 573-578.</Citation>
        </Reference>
        <Reference>
          <Citation>Shield K. D., Rehm J. Global risk factor rankings: the importance of age-based health loss inequities caused by alcohol and other risk factors. BMC Res Notes 2015; 8: 231.</Citation>
        </Reference>
        <Reference>
          <Citation>Peacock A., Leung J., Larney S., Colledge S., Hickman M., Rehm J. et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction 2018; 113: 1905-1926.</Citation>
        </Reference>
        <Reference>
          <Citation>Lange S., Probst C., Rehm J., Popova S. National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Glob Health 2018; 6: e769-e776.</Citation>
        </Reference>
        <Reference>
          <Citation>Popova S., Lange S., Probst C., Gmel G., Rehm J. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health 2017; 5: e290-e299.</Citation>
        </Reference>
        <Reference>
          <Citation>Rehm J., Anderson P., Fischer B., Gual A., Room R. Policy implications of marked reversals of population life expectancy caused by substance use. BMC Med 2016; 14: 42.</Citation>
        </Reference>
        <Reference>
          <Citation>Case A., Deaton A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci USA 2015; 112: 15078-15083.</Citation>
        </Reference>
        <Reference>
          <Citation>Braveman P., Gottlieb L. The social determinants of health: it's time to consider the causes of the causes. Public Health Rep 2014; 129: 19-31.</Citation>
        </Reference>
        <Reference>
          <Citation>Murray C. J., Ezzati M., Flaxman A. D., Lim S., Lozano R., Michaud C. et al. GBD 2010: design, definitions, and metrics. Lancet 2012; 380: 2063-2066.</Citation>
        </Reference>
        <Reference>
          <Citation>Norheim O. F., Jha P., Admasu K., Jamison D. T., Peto R. A premature mortality target for the SDG for health is ageist-Authors&#x2019; reply. Lancet 2015; 385: 2148-2149.</Citation>
        </Reference>
        <Reference>
          <Citation>Williams A. Intergenerational equity: an exploration of the &#x2018;fair innings&#x2019; argument. Health Econ 1997; 6: 117-132.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30367973</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-0260</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>118</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Preventive medicine</Title>
          <ISOAbbreviation>Prev Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Understanding the associations among parents teaching safety rules to children, safety behaviors and unintentional injuries in Chinese preschool children.</ArticleTitle>
        <Pagination>
          <StartPage>98</StartPage>
          <EndPage>103</EndPage>
          <MedlinePgn>98-103</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ypmed.2018.10.022</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0091-7435(18)30341-4</ELocationID>
        <Abstract>
          <AbstractText>Child unintentional injuries are one of the most prominent global health threats and parents may play a vital role in these injuries. This study thus aims to explore the associations of parents teaching safety rules with preschool children's safety behaviors and unintentional injuries. A total of 62,922 children registered at 182 kindergartens in Longhua District of Shenzhen, China during the fall semester of 2016, were included in this cross-sectional study. Their parents were invited to complete a self-administered questionnaire covering information about socio-demographics, parents teaching safety rules to children, child safety behaviors and unintentional injuries. Logistic and linear regression models were carried out to test the associations among parents teaching safety rules, child safety behaviors, and child unintentional injuries. Whether child safety behaviors mediated the relationship between parents teaching safety rules and child unintentional injuries was assessed using Hayes' PROCESS macros for SPSS. Regression analyses revealed that the higher scores of both mothers' and fathers' teaching safety rules to children were significantly associated with the reduced risks of child unintentional injuries and the modest improvements in child safety behaviors, after adjusting for potential confounders. Furthermore, mediation analysis illustrated that child safety behaviors mediated 18.1% of the association between mothers teaching safety rules and child unintentional injuries and 30.3% of the association between fathers teaching safety rules and child unintentional injuries, respectively. These findings suggest that parents teaching safety rules to children is beneficial for mitigating unintentional injury risks among Chinese preschool children through improving child safety behaviors.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Hong-Zhen</ForeName>
            <Initials>HZ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fan</LastName>
            <ForeName>Li-Jun</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Chuan-An</ForeName>
            <Initials>CA</Initials>
            <AffiliationInfo>
              <Affiliation>Women's and Children's Hospital of Longhua District of Shenzhen, Shenzhen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>An-Fei</ForeName>
            <Initials>AF</Initials>
            <AffiliationInfo>
              <Affiliation>Women's and Children's Hospital of Longhua District of Shenzhen, Shenzhen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mo</LastName>
            <ForeName>Chun-Qi</ForeName>
            <Initials>CQ</Initials>
            <AffiliationInfo>
              <Affiliation>Women's and Children's Hospital of Longhua District of Shenzhen, Shenzhen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Guan-Hao</ForeName>
            <Initials>GH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ruan</LastName>
            <ForeName>Zeng-Liang</ForeName>
            <Initials>ZL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jing</LastName>
            <ForeName>Jin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Women and Child Health, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Women and Child Health, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Wei-Qing</ForeName>
            <Initials>WQ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China. Electronic address: chenwq@mail.sysu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Prev Med</MedlineTA>
        <NlmUniqueID>0322116</NlmUniqueID>
        <ISSNLinking>0091-7435</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000056" MajorTopicYN="Y">Accident Prevention</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000081084" MajorTopicYN="N">Accidental Injuries</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002652" MajorTopicYN="Y">Child Behavior</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012449" MajorTopicYN="Y">Safety</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012574" MajorTopicYN="N">Schools</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chinese preschool children</Keyword>
        <Keyword MajorTopicYN="N">Parents teaching safety rules to children</Keyword>
        <Keyword MajorTopicYN="N">Safety behaviors</Keyword>
        <Keyword MajorTopicYN="N">Unintentional injuries</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30367973</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ypmed.2018.10.022</ArticleId>
        <ArticleId IdType="pii">S0091-7435(18)30341-4</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30366643</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1877-9603</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Ticks and tick-borne diseases</Title>
          <ISOAbbreviation>Ticks Tick Borne Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>HSC70 from Haemaphysalis flava (Acari: Ixodidae) exerts anticoagulation activity in vitro.</ArticleTitle>
        <Pagination>
          <StartPage>170</StartPage>
          <EndPage>175</EndPage>
          <MedlinePgn>170-175</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ttbdis.2018.10.005</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1877-959X(18)30258-9</ELocationID>
        <Abstract>
          <AbstractText>Ticks and tick-borne diseases are major global health threats. During blood feeding, ticks insert their hypostomes into hosts and inject an array of anticoagulant molecules to maintain fluidity of the blood-meal. These anticoagulant molecules may provide insights into understanding the feeding biology of ticks and to develop vaccines against infestations. In Haemaphysalis flava, the heat shock cognate 70 (HSC70), a member of the heat shock protein (HSP) family, is differentially expressed in salivary glands at different levels of engorgement during blood feeding. However, its function in ticks is largely not known. The present study was designed to explore the possible effects of HSC70 on the plasma. The open reading frame (ORF) of HSC70 was expressed in a prokaryotic system, and recombinant HSC70 (rHSC70) was purified and characterized. The anticoagulation activity of rHSC70 was estimated by measuring prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen (FIB) with/without its inhibitor, VER155008. The results demonstrated that rHSC70 from H. flava extended TT (P&#x2009;&lt;&#x2009;0.001) and FIB clotting times (&gt;300&#x2009;s), but showed little effect on PT and APTT. Adding an inhibitor reversed anticlotting effects of rHSC70 on TT and FIB. These data indicate that rHSC70 is an anticoagulant agent, and the anticlotting activity likely attributes to the inhibition of thrombin and the transformation of fibrinogen into fibrin.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier GmbH. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Xiao-Ming</ForeName>
            <Initials>XM</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines, Hunan Collaborative Innovation Center for Safety Production of Livestock and Poultry, Hunan Agricultural University, Changsha, 410128, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines, Hunan Collaborative Innovation Center for Safety Production of Livestock and Poultry, Hunan Agricultural University, Changsha, 410128, China. Electronic address: ll434@hunau.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Tian-Yin</ForeName>
            <Initials>TY</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines, Hunan Collaborative Innovation Center for Safety Production of Livestock and Poultry, Hunan Agricultural University, Changsha, 410128, China. Electronic address: hn5368@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Ticks Tick Borne Dis</MedlineTA>
        <NlmUniqueID>101522599</NlmUniqueID>
        <ISSNLinking>1877-959X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D050883">HSC70 Heat-Shock Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9001-32-5</RegistryNumber>
          <NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.21.5</RegistryNumber>
          <NameOfSubstance UI="D013917">Thrombin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005340" MajorTopicYN="N">Fibrinogen</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050883" MajorTopicYN="N">HSC70 Heat-Shock Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D026863" MajorTopicYN="N">Ixodidae</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011517" MajorTopicYN="N">Prothrombin Time</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013917" MajorTopicYN="N">Thrombin</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anticoagulation</Keyword>
        <Keyword MajorTopicYN="N">HSC70</Keyword>
        <Keyword MajorTopicYN="N">Heat shock protein</Keyword>
        <Keyword MajorTopicYN="N">Tick</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30366643</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ttbdis.2018.10.005</ArticleId>
        <ArticleId IdType="pii">S1877-959X(18)30258-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30366597</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1883</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>218</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>American journal of surgery</Title>
          <ISOAbbreviation>Am J Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>International surgery: How to be involved while maintaining a surgical practice.</ArticleTitle>
        <Pagination>
          <StartPage>71</StartPage>
          <EndPage>76</EndPage>
          <MedlinePgn>71-76</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjsurg.2018.10.021</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0002-9610(18)31055-9</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Surgeons can find it challenging to sustain their global involvement while maintaining a clinical practice. This study gathered advice from surgeons with global surgical experience on how to do so successfully.</AbstractText>
          <AbstractText Label="METHODS">Using a qualitative approach with thematic analysis, 14 semi-structured interviews were conducted with surgeons from different specialties involved in varying international projects.</AbstractText>
          <AbstractText Label="RESULTS">Early involvement is important to set up expectations for one's practice, and makes anticipated costs more manageable. The type of practice does not limit amount of participation, but maintaining a broader skill set can be beneficial. Hiring locums can help defray costs for community surgeons, and good collegial support is important for academic surgeons. Family support is important to maintain involvement.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Surgeons from diverse clinical practices are able to participate in international surgery. Early involvement sets up expectations and allows one to build their practice and lives around their international work instead of the other way around.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ying</LastName>
            <ForeName>Yvonne</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada; Department of Surgery, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada. Electronic address: yying@cheo.on.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rekman</LastName>
            <ForeName>Janelle</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Virginia Mason Medical Center, Seattle, WA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McCarthy</LastName>
            <ForeName>Anne</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Surg</MedlineTA>
        <NlmUniqueID>0370473</NlmUniqueID>
        <ISSNLinking>0002-9610</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001291" MajorTopicYN="Y">Attitude of Health Personnel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002983" MajorTopicYN="N">Clinical Competence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066296" MajorTopicYN="N">Grounded Theory</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D038622" MajorTopicYN="Y">Internationality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008493" MajorTopicYN="Y">Medical Missions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066231" MajorTopicYN="Y">Surgeons</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Global surgery</Keyword>
        <Keyword MajorTopicYN="N">International surgery</Keyword>
        <Keyword MajorTopicYN="N">Surgical practice</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30366597</ArticleId>
        <ArticleId IdType="doi">10.1016/j.amjsurg.2018.10.021</ArticleId>
        <ArticleId IdType="pii">S0002-9610(18)31055-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30366125</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-1208</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>126</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Microbial pathogenesis</Title>
          <ISOAbbreviation>Microb Pathog</ISOAbbreviation>
        </Journal>
        <ArticleTitle>PPE11 of Mycobacterium tuberculosis can alter host inflammatory response and trigger cell death.</ArticleTitle>
        <Pagination>
          <StartPage>45</StartPage>
          <EndPage>55</EndPage>
          <MedlinePgn>45-55</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.micpath.2018.10.031</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0882-4010(18)30092-5</ELocationID>
        <Abstract>
          <AbstractText>Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), remains a serious global health problem. The PE/PPE family, featuring unique sequences, structures and expression in Mtb, is reported to interfere with the macrophage response to the pathogen and facilitate its infection. PPE11 (Rv0453) existed in pathogenic mycobacteria and was persistently expressed in the infected guinea pig lungs. However, the role it played in the pathogenesis remains unclear. Here, to investigate the interaction and potential mechanism of PPE11 between pathogens and hosts, we heterologously expressed PPE11 in non-pathogenic, rapidly growing Mycobacterium smegmatis strains. We found that the overexpression of the cell wall-associated protein, PPE11, can improve the viability of bacteria in the presence of lysozyme, hydrogen peroxide and acid stress. Expression of PPE11 enhanced the early survival of M. smegmatis in macrophages and sustained a higher bacterial load in mouse tissues that showed exacerbated organ pathology. Macrophages infected with recombinant M. smegmatis produced significantly greater amounts of interleukin (IL)-1&#x3B2;, IL-6, tumour necrosis factor (TNF)-&#x3B1; and an early decrease in IL-10 along with higher levels of host cell death. Similar cytokines changes were observed in the sera of infected mice. Accordingly, PPE11 protein causes histopathological changes by disrupting the dynamic balance of the inflammatory factors and promoting host-cell death, indicating a potential role in the virulence of Mtb.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Xuan</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Infection and Immunity, West China School of Basic Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Infection and Immunity, West China School of Basic Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhai</LastName>
            <ForeName>Xiaoqian</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Infection and Immunity, West China School of Basic Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Chunxi</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Infection and Immunity, West China School of Basic Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suo</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Infection and Immunity, West China School of Basic Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Pengjiao</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Infection and Immunity, West China School of Basic Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Chuhan</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Infection and Immunity, West China School of Basic Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, 610041, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bao</LastName>
            <ForeName>Lang</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Infection and Immunity, West China School of Basic Sciences &amp; Forensic Medicine, Sichuan University, Chengdu, 610041, China. Electronic address: baolang@scu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Microb Pathog</MedlineTA>
        <NlmUniqueID>8606191</NlmUniqueID>
        <ISSNLinking>0882-4010</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>130068-27-8</RegistryNumber>
          <NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000942" MajorTopicYN="N">Antigens, Bacterial</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002473" MajorTopicYN="N">Cell Wall</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015964" MajorTopicYN="N">Gene Expression Regulation, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020102" MajorTopicYN="N">Mycobacterium smegmatis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013154" MajorTopicYN="N">Spleen</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074084" MajorTopicYN="N">THP-1 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Mycobacterium smegmatis</Keyword>
        <Keyword MajorTopicYN="N">Mycobacterium tuberculosis</Keyword>
        <Keyword MajorTopicYN="N">PE/PPE</Keyword>
        <Keyword MajorTopicYN="N">PPE11</Keyword>
        <Keyword MajorTopicYN="N">Pathology</Keyword>
        <Keyword MajorTopicYN="N">Virulence</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30366125</ArticleId>
        <ArticleId IdType="doi">10.1016/j.micpath.2018.10.031</ArticleId>
        <ArticleId IdType="pii">S0882-4010(18)30092-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30366118</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>27</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1095-8274</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>55</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Anaerobe</Title>
          <ISOAbbreviation>Anaerobe</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The gut microbiome of Mexican children affected by obesity.</ArticleTitle>
        <Pagination>
          <StartPage>11</StartPage>
          <EndPage>23</EndPage>
          <MedlinePgn>11-23</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anaerobe.2018.10.009</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1075-9964(18)30181-1</ELocationID>
        <Abstract>
          <AbstractText>Obesity is a metabolic disorder and global health issue. In Mexico 34.4% of children between 5 and 11 years-old are overweight or obese. Here we address this issue studying the gut microbiome in a sample of Mexican children affected by obesity. We performed metagenomic shotgun-sequencing of DNA isolated from fecal samples from a cohort of normal weight and obese Mexican children using Illumina platform with HiSeq 2500. We also examined their metabolic factors and fecal short-chain fatty acids concentration. The results show that a remarkable dysbiosis of bacteria, archaea and viruses was not observed in the obese children group compared to the normal weight group; however, the archaeal community exhibited an increase of unclassified Methanobrevibacter spp. in obese children. The bacterial communities of all participants were clustered into three different enterotypes. Most normal weight children have a gut bacterial community dominated by Ruminococcus spp. (Enterotype 3), while most obese children had a community dominated by Prevotella spp. (Enterotype 2). On the other hand, changes in the gut microbiome were correlated with clinical metadata and could be used to stratify individuals based on their phenotype. The species Megamonas spp. were over-represented in obese children, whereas members of the family Oscillospiraceae were depleted in the same individuals and negatively correlated with levels of serum cholesterol. A microbiome comparative metabolic pathway analysis showed that two KEGG pathway modules of glycolysis, Glycolysis I (from Glucose 6-Phosphate), and Glycolysis II (from Fructose 6-Phosphate) were significantly overrepresented in normal weight children. Our results establish specific alterations in the gut microbiome of Mexican children affected of obesity, along with clinical alterations, providing information on the microbiome composition that may be useful for prognosis, diagnosis, and treatment.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maya-Lucas</LastName>
            <ForeName>Otoniel</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Gen&#xE9;tica y Biolog&#xED;a Molecular, Cinvestav Unidad Zacatenco, Av IPN 2508, Ciudad de M&#xE9;xico 07360, Mexico. Electronic address: omaya@cinvestav.mx.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murugesan</LastName>
            <ForeName>Selvasankar</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Gen&#xE9;tica y Biolog&#xED;a Molecular, Cinvestav Unidad Zacatenco, Av IPN 2508, Ciudad de M&#xE9;xico 07360, Mexico. Electronic address: smurugesan@sidra.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nirmalkar</LastName>
            <ForeName>Khemlal</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Gen&#xE9;tica y Biolog&#xED;a Molecular, Cinvestav Unidad Zacatenco, Av IPN 2508, Ciudad de M&#xE9;xico 07360, Mexico; Departamento de Farmacolog&#xED;a, Cinvestav Unidad Zacatenco, Av IPN 2508, Ciudad de M&#xE9;xico 07360, Mexico. Electronic address: nirmalkar@cinvestav.mx.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alcaraz</LastName>
            <ForeName>Luis David</ForeName>
            <Initials>LD</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Biolog&#xED;a Celular, Facultad de Ciencias, UNAM, Ciudad de M&#xE9;xico, Mexico. Electronic address: lalcaraz@iecologia.unam.mx.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoyo-Vadillo</LastName>
            <ForeName>Carlos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Farmacolog&#xED;a, Cinvestav Unidad Zacatenco, Av IPN 2508, Ciudad de M&#xE9;xico 07360, Mexico. Electronic address: citocromo@cinvestav.mx.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pizano-Z&#xE1;rate</LastName>
            <ForeName>Mar&#xED;a Luisa</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Nutrici&#xF3;n y Bioprogramaci&#xF3;n, INPer, Ciudad de M&#xE9;xico, Mexico. Electronic address: pizanozarate@yahoo.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garc&#xED;a-Mena</LastName>
            <ForeName>Jaime</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Gen&#xE9;tica y Biolog&#xED;a Molecular, Cinvestav Unidad Zacatenco, Av IPN 2508, Ciudad de M&#xE9;xico 07360, Mexico. Electronic address: jgmena@cinvestav.mx.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Anaerobe</MedlineTA>
        <NlmUniqueID>9505216</NlmUniqueID>
        <ISSNLinking>1075-9964</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005232">Fatty Acids, Volatile</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001105" MajorTopicYN="N">Archaea</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005232" MajorTopicYN="N">Fatty Acids, Volatile</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055442" MajorTopicYN="N">Metabolome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014780" MajorTopicYN="N">Viruses</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cholesterol</Keyword>
        <Keyword MajorTopicYN="N">Gut microbiome</Keyword>
        <Keyword MajorTopicYN="N">High-throughput sequencing</Keyword>
        <Keyword MajorTopicYN="N">Mexican children</Keyword>
        <Keyword MajorTopicYN="N">Obesity</Keyword>
        <Keyword MajorTopicYN="N">Triglycerides</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30366118</ArticleId>
        <ArticleId IdType="doi">10.1016/j.anaerobe.2018.10.009</ArticleId>
        <ArticleId IdType="pii">S1075-9964(18)30181-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30364984</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1537-6613</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>219</Volume>
            <Issue>12</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
              <Day>24</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of infectious diseases</Title>
          <ISOAbbreviation>J Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018.</ArticleTitle>
        <Pagination>
          <StartPage>1867</StartPage>
          <EndPage>1878</EndPage>
          <MedlinePgn>1867-1878</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiy612</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Nipah Virus (NiV) is a highly fatal emerging zoonotic virus and a potential threat to global health security. Here we describe the characteristics of the NiV outbreak that occurred in Kerala, India, during May-June 2018.</AbstractText>
          <AbstractText Label="METHODS">We used real-time reverse transcription polymerase chain reaction analysis of throat swab, blood, urine, and cerebrospinal fluid specimens to detect NiV. Further, the viral genome was sequenced and subjected to phylogenetic analysis. We conducted an epidemiologic investigation to describe the outbreak and elucidate the dynamics of NiV transmission.</AbstractText>
          <AbstractText Label="RESULTS">During 2-29 May 2018, 23 cases were identified, including the index case; 18 were laboratory confirmed. The lineage of the NiV responsible for this outbreak was closer to the Bangladesh lineage. The median age of cases was 45 years; the sex of 15 (65%) was male. The median incubation period was 9.5 days (range, 6-14 days). Of the 23 cases, 20 (87%) had respiratory symptoms. The case-fatality rate was 91%; 2 cases survived. Risk factors for infection included close proximity (ie, touching, feeding, or nursing a NiV-infected person), enabling exposure to droplet infection. The public health response included isolation of cases, contact tracing, and enforcement of hospital infection control practices.</AbstractText>
          <AbstractText Label="CONCLUSION">This is the first recorded NiV outbreak in South India. Early laboratory confirmation and an immediate public health response contained the outbreak.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Arunkumar</LastName>
            <ForeName>Govindakarnavar</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Research, Ministry of Health and Family Welfare, Government of India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Manipal Centre for Virus Research, Manipal Academy of Higher Education (Deemed to be University), Manipal, Karnataka, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chandni</LastName>
            <ForeName>Radhakrishnan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health and Family Welfare, Government of Kerala, India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Government Medical College, Kozhikode, Kerala, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mourya</LastName>
            <ForeName>Devendra T</ForeName>
            <Initials>DT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Research, Ministry of Health and Family Welfare, Government of India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute of Virology, Pune, Maharashtra, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Singh</LastName>
            <ForeName>Sujeet K</ForeName>
            <Initials>SK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health and Family Welfare, Ministry of Health and Family Welfare, Government of India.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Centre for Disease Control, Delhi, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sadanandan</LastName>
            <ForeName>Rajeev</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health and Family Welfare, Government of Kerala, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sudan</LastName>
            <ForeName>Preeti</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health and Family Welfare, Ministry of Health and Family Welfare, Government of India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhargava</LastName>
            <ForeName>Balram</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Research, Ministry of Health and Family Welfare, Government of India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>Nipah Investigators People and Health Study Group</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Infect Dis</MedlineTA>
        <NlmUniqueID>0413675</NlmUniqueID>
        <ISSNLinking>0022-1899</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>J Infect Dis. 2019 May 24;219(12):1855-1857. doi: 10.1093/infdis/jiy611.</RefSource>
          <PMID Version="1">30365002</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001459" MajorTopicYN="N" Type="Geographic">Bangladesh</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045464" MajorTopicYN="N">Henipavirus Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045405" MajorTopicYN="N">Nipah Virus</DescriptorName>
          <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">India</Keyword>
        <Keyword MajorTopicYN="N">Kerala</Keyword>
        <Keyword MajorTopicYN="N">NVD</Keyword>
        <Keyword MajorTopicYN="N">NiV</Keyword>
        <Keyword MajorTopicYN="N">Nipah</Keyword>
        <Keyword MajorTopicYN="N">outbreak</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30364984</ArticleId>
        <ArticleId IdType="doi">10.1093/infdis/jiy612</ArticleId>
        <ArticleId IdType="pii">5144922</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30362646</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1524-475X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society</Title>
          <ISOAbbreviation>Wound Repair Regen</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The humanistic and economic burden of chronic wounds: A systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>114</StartPage>
          <EndPage>125</EndPage>
          <MedlinePgn>114-125</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/wrr.12683</ELocationID>
        <Abstract>
          <AbstractText>Chronic wounds are a health problem that have devastating consequences for patients and contribute major costs to healthcare systems and societies. To understand the magnitude of this health issue, a systematic review was undertaken. Searches were conducted in MEDLINE, EMBASE, EBM Reviews and Cochrane library, CINAHL, EBSCO, PsycINFO, and Global Health databases for articles published between 2000 and 2015. Included publications had to target adults (&#x2265;18 years of age), state wound chronicity (&#x2265;3 weeks) and/or label the wounds as chronic, complex, hard-to-heal, or having led to an amputation. The review excluded studies that did not present data on generic health-related quality of life and/or cost data, case studies, randomized controlled trials, economic modeling studies, abstracts, and editorials. Extracted data were summarized into a narrative synthesis, and for a few articles using the same health-related quality of life instrument, average estimates with 95% confidence intervals were calculated. Thirty articles met the inclusion criteria. Findings revealed that health-related quality of life was lowest for physical pathologies, and based on average estimates were scores most inferior in the domain physical role for both patients with chronic wounds and for those with wound-related amputations. The cost burden was mainly attributed to amputations for patients also comorbid with diabetes, where the cost for hospitalization ranged from US$12,851 to US$16,267 (median) for this patient group. Patients with chronic wounds have poor health-related quality of life in general and wound-related costs are substantial. Development and implementation of wound management strategies that focus on increasing health-related quality of life and effectively reduce costs for this patient group are urgently needed.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 by the Wound Healing Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Olsson</LastName>
            <ForeName>Maja</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-2228-5134</Identifier>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences (CePHaS), Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>J&#xE4;rbrink</LastName>
            <ForeName>Krister</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences (CePHaS), Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Divakar</LastName>
            <ForeName>Ushashree</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences (CePHaS), Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bajpai</LastName>
            <ForeName>Ram</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences (CePHaS), Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Upton</LastName>
            <ForeName>Zee</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Dermatology and Skin Biology Programme, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schmidtchen</LastName>
            <ForeName>Artur</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Dermatology and Skin Biology Programme, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Dermatology, Department of Clinical Sciences, Lund University, Lund, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Car</LastName>
            <ForeName>Josip</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences (CePHaS), Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Global eHealth Unit, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Agency for Science, Technology and Research (A*STAR)</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <Agency>BMRC Strategic Positioning Fund</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <Agency>Lee Kong Chian School of Medicine, Nanyang Technological University</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Wound Repair Regen</MedlineTA>
        <NlmUniqueID>9310939</NlmUniqueID>
        <ISSNLinking>1067-1927</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017048" MajorTopicYN="N">Health Care Costs</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>9</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30362646</ArticleId>
        <ArticleId IdType="doi">10.1111/wrr.12683</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30360637</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1535-4970</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>199</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of respiratory and critical care medicine</Title>
          <ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Wood Smoke Exposure Alters Human Inflammatory Responses to Viral Infection in a Sex-Specific Manner. A Randomized, Placebo-controlled Study.</ArticleTitle>
        <Pagination>
          <StartPage>996</StartPage>
          <EndPage>1007</EndPage>
          <MedlinePgn>996-1007</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201807-1287OC</ELocationID>
        <Abstract>
          <AbstractText Label="RATIONALE">Exposure to particulates from burning biomass is an increasing global health issue. Burning biomass, including wood smoke, is associated with increased lower respiratory infections.</AbstractText>
          <AbstractText Label="OBJECTIVES">To determine whether acute exposure to wood smoke modifies nasal inflammatory responses to influenza.</AbstractText>
          <AbstractText Label="METHODS">Healthy young adults (n&#x2009;=&#x2009;39) were randomized to a 2-hour controlled chamber exposure to wood smoke, where exposure levels were controlled to particulate number (wood smoke particles [WSP]; 500 &#x3BC;g/cm<sup>3</sup>) or filtered air, followed by nasal inoculation with a vaccine dose of live attenuated influenza virus (LAIV). Nasal lavage was performed before exposure (Day 0) and on Days 1 and 2 after exposure. Nasal lavage fluid cells were analyzed for inflammatory gene expression profiles, and cell-free fluid was assayed for cytokines.</AbstractText>
          <AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Only IP-10 protein levels were affected, suppressed, by WSP exposure in aggregate analysis. Subsequent analysis indicated an exposure&#x2009;&#xD7;&#x2009;sex interaction, prompting additional analyses of WSP- and LAIV-induced changes in males and females. Inflammation-related gene expression profiles differed between the sexes, at baseline (males greater than females), after LAIV inoculation (females greater than males), and after WSP exposure (increase in males and decrease in females), demonstrating that WSP- and LAIV-induced changes in antiviral defense responses in the nasal mucosa occur in a sex-specific manner.</AbstractText>
          <AbstractText Label="CONCLUSIONS">WSP exposure resulted in minimal modification of LAIV-induced responses in aggregate analysis. In contrast, analyzing WSP-induced modification of LAIV responses in the sexes separately unmasked sex-specific differences in response to exposure. These data highlight the need for additional studies to understand sex-specific pollutant-induced effects. Clinical trial registered with www.clinicaltrials.gov (NCT02183753).</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rebuli</LastName>
            <ForeName>Meghan E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>1 Curriculum in Toxicology &amp; Environmental Medicine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Speen</LastName>
            <ForeName>Adam M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>1 Curriculum in Toxicology &amp; Environmental Medicine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martin</LastName>
            <ForeName>Elizabeth M</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>1 Curriculum in Toxicology &amp; Environmental Medicine.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2 Department of Environmental Sciences and Engineering, Gillings School of Global Public Health.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Addo</LastName>
            <ForeName>Kezia A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>1 Curriculum in Toxicology &amp; Environmental Medicine.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pawlak</LastName>
            <ForeName>Erica A</ForeName>
            <Initials>EA</Initials>
            <AffiliationInfo>
              <Affiliation>3 Center for Environmental Medicine, Asthma, and Lung Biology.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Glista-Baker</LastName>
            <ForeName>Ellen</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>3 Center for Environmental Medicine, Asthma, and Lung Biology.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Robinette</LastName>
            <ForeName>Carole</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>3 Center for Environmental Medicine, Asthma, and Lung Biology.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Haibo</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>4 Department of Biostatistics, and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Noah</LastName>
            <ForeName>Terry L</ForeName>
            <Initials>TL</Initials>
            <AffiliationInfo>
              <Affiliation>1 Curriculum in Toxicology &amp; Environmental Medicine.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3 Center for Environmental Medicine, Asthma, and Lung Biology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>5 Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jaspers</LastName>
            <ForeName>Ilona</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>1 Curriculum in Toxicology &amp; Environmental Medicine.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3 Center for Environmental Medicine, Asthma, and Lung Biology.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>5 Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>ClinicalTrials.gov</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>NCT02183753</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 ES010126</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 ES007126</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Respir Crit Care Med</MedlineTA>
        <NlmUniqueID>9421642</NlmUniqueID>
        <ISSNLinking>1073-449X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012906">Smoke</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Am J Respir Crit Care Med. 2019 Apr 15;199(8):940-941. doi: 10.1164/rccm.201810-2030ED.</RefSource>
          <PMID Version="1">30480478</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019570" MajorTopicYN="N">Inhalation Exposure</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017817" MajorTopicYN="N">Nasal Lavage Fluid</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012906" MajorTopicYN="N">Smoke</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014934" MajorTopicYN="Y">Wood</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">air pollution</Keyword>
        <Keyword MajorTopicYN="N">nasal mucosa</Keyword>
        <Keyword MajorTopicYN="N">sex difference</Keyword>
        <Keyword MajorTopicYN="N">viral infection</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>15</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30360637</ArticleId>
        <ArticleId IdType="pmc">PMC6467301</ArticleId>
        <ArticleId IdType="doi">10.1164/rccm.201807-1287OC</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Croft DP, Cameron SJ, Morrell CN, Lowenstein CJ, Ling F, Zareba W, et al. Associations between ambient wood smoke and other particulate pollutants and biomarkers of systemic inflammation, coagulation and thrombosis in cardiac patients. Environ Res. 2017;154:352&#x2013;361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5375102</ArticleId>
            <ArticleId IdType="pubmed">28167447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezzati M, Kammen D. Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study. Lancet. 2001;358:619&#x2013;624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11530148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fullerton DG, Suseno A, Semple S, Kalambo F, Malamba R, White S, et al. Wood smoke exposure, poverty and impaired lung function in Malawian adults. Int J Tuberc Lung Dis. 2011;15:391&#x2013;398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21333109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Sancho MC, Garcia-Garcia L, Baez-Saldana R, Ponce-De-Leon A, Sifuentes-Osornio J, Bobadilla-Del-valle M, et al. Indoor pollution as an occupational risk factor for tuberculosis among women: a population-based, gender oriented, case-control study in Southern Mexico. Rev Invest Clin. 2009;61:392&#x2013;398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20184099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghio AJ, Soukup JM, Case M, Dailey LA, Richards J, Berntsen J, et al. Exposure to wood smoke particles produces inflammation in healthy volunteers. Occup Environ Med. 2012;69:170&#x2013;175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21719562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra V. Indoor air pollution from biomass combustion and acute respiratory illness in preschool age children in Zimbabwe. Int J Epidemiol. 2003;32:847&#x2013;853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14559763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moln&#xE1;r P, Gustafson P, Johannesson S, Boman J, Barreg&#xE5;rd L, S&#xE4;llsten G. Domestic wood burning and PM2.5 trace elements: personal exposures, indoor and outdoor levels. Atmos Environ. 2005;39:2643&#x2013;2653.</Citation>
        </Reference>
        <Reference>
          <Citation>Oloyede IP, Ekrikpo UE, Ekanem EE. Lung function indices of children exposed to wood smoke in a fishing port in South-South Nigeria. J Trop Pediatr. 2013;59:399&#x2013;402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23687094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Opotowsky AR, Vedanthan R, Mamlin JJ. A case report of cor pulmonale in a woman without exposure to tobacco smoke: an example of the risks of indoor wood burning. Medscape J Med. 2008;10:22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2258468</ArticleId>
            <ArticleId IdType="pubmed">18324332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perez-Padilla R, Perez-Guzman C, Baez-Saldana R, Torres-Cruz A. Cooking with biomass stoves and tuberculosis: a case control study. Int J Tuberc Lung Dis. 2001;5:441&#x2013;447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11336275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reed MD, Campen MJ, Gigliotti AP, Harrod KS, McDonald JD, Seagrave JC, et al. Health effects of subchronic exposure to environmental levels of hardwood smoke. Inhal Toxicol. 2006;18:523&#x2013;539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16717024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riojas-Rodr&#xED;guez H, Romano-Riquer P, Santos-Burgoa C, Smith KR. Household firewood use and the health of children and women of Indian communities in Chiapas, Mexico. Int J Occup Environ Health. 2001;7:44&#x2013;53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11210012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samuelsen M, Cecilie Nygaard U, L&#xF8;vik M. Particles from wood smoke and road traffic differently affect the innate immune system of the lung. Inhal Toxicol. 2009;21:943&#x2013;951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19552530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith KR, Samet JM, Romieu I, Bruce N. Indoor air pollution in developing countries and acute lower respiratory infections in children. Thorax. 2000;55:518&#x2013;532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1745777</ArticleId>
            <ArticleId IdType="pubmed">10817802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu JC, Mickley LJ, Sulprizio MP, Dominici F, Yue X, Ebisu K, et al. particulate air pollution from wildfires in the western US under climate change. Clim Change. 2016;138:655&#x2013;666.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5476308</ArticleId>
            <ArticleId IdType="pubmed">28642628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barregard L, S&#xE4;llsten G, Gustafson P, Andersson L, Johansson L, Basu S, et al. Experimental exposure to wood-smoke particles in healthy humans: effects on markers of inflammation, coagulation, and lipid peroxidation. Inhal Toxicol. 2006;18:845&#x2013;853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16864402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>S&#xE4;llsten G, Gustafson P, Johansson L, Johannesson S, Moln&#xE1;r P, Strandberg B, et al. Experimental wood smoke exposure in humans. Inhal Toxicol. 2006;18:855&#x2013;864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16864403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sehlstedt M, Dove R, Boman C, Pagels J, Swietlicki E, L&#xF6;ndahl J, et al. Antioxidant airway responses following experimental exposure to wood smoke in man. Part Fibre Toxicol. 2010;7:21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2936868</ArticleId>
            <ArticleId IdType="pubmed">20727160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flanagan KL, Fink AL, Plebanski M, Klein SL. Sex and gender differences in the outcomes of vaccination over the life course. Annu Rev Cell Dev Biol. 2017;33:577&#x2013;599.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28992436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626&#x2013;638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27546235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>vom Steeg LG, Klein SL. SeXX matters in infectious disease pathogenesis. PLoS Pathog. 2016;12:e1005374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4759457</ArticleId>
            <ArticleId IdType="pubmed">26891052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomoda S, Programme ILOSA. Public emergency services: social dialogue in a changing environment: report for discussion at the joint meeting on public emergency services: social dialogue in a changing environment. Geneva: International Labour Office; 2003.</Citation>
        </Reference>
        <Reference>
          <Citation>Black C, Gerriets JE, Fontaine JH, Harper RW, Kenyon NJ, Tablin F, et al. Early life wildfire smoke exposure is associated with immune dysregulation and lung function decrements in adolescence. Am J Respir Cell Mol Biol. 2017;56:657&#x2013;666.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5449494</ArticleId>
            <ArticleId IdType="pubmed">28208028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noah TL, Zhou H, Zhang H, Horvath K, Robinette C, Kesic M, et al. Diesel exhaust exposure and nasal response to attenuated influenza in normal and allergic volunteers. Am J Respir Crit Care Med. 2012;185:179&#x2013;185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3297091</ArticleId>
            <ArticleId IdType="pubmed">22071326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaspers I, Pawlak EA, Addo K, Diamond C, Speen AM, Robinette C, et al. Effects of wood smoke exposure on nasal mucosal host defense responses after infection with live-attenuated influenza virus [abstract] Am J Respir Crit Care Med. 2016;193:A2872.</Citation>
        </Reference>
        <Reference>
          <Citation>Noah TL, Rebuli ME, Speen AM, Robinette C, Jaspers I. Effect of woodsmoke particle exposure on antiviral host defense in human volunteers: nasal inflammatory mediators and influence of gender on responses [abstract] Am J Respir Crit Care Med. 2018;197:A4165.</Citation>
        </Reference>
        <Reference>
          <Citation>Noah TL, Zhang H, Zhou H, Glista-Baker E, M&#xFC;ller L, Bauer RN, et al. Effect of broccoli sprouts on nasal response to live attenuated influenza virus in smokers: a randomized, double-blind study. PLoS One. 2014;9:e98671.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4049587</ArticleId>
            <ArticleId IdType="pubmed">24910991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J Infect Dis. 2014;209:S114&#x2013;S119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4157517</ArticleId>
            <ArticleId IdType="pubmed">24966191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forero A, Fenstermacher K, Wohlgemuth N, Nishida A, Carter V, Smith EA, et al. Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells. Vaccine. 2017;35:6112&#x2013;6121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5647870</ArticleId>
            <ArticleId IdType="pubmed">28967519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sue K. The science behind &#x201C;man flu&#x201D;. BMJ. 2017;359:j5560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29229663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghosh S, Klein RS. Sex drives dimorphic immune responses to viral infections. J Immunol. 2017;198:1782&#x2013;1790.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5325721</ArticleId>
            <ArticleId IdType="pubmed">28223406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rebuli ME, Speen AM, Clapp PW, Jaspers I. Novel applications for a noninvasive sampling method of the nasal mucosa. Am J Physiol Lung Cell Mol Physiol. 2017;312:L288&#x2013;L296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5336583</ArticleId>
            <ArticleId IdType="pubmed">28011618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447&#x2013;D452.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4383874</ArticleId>
            <ArticleId IdType="pubmed">25352553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clayton JA. Applying the new SABV (sex as a biological variable) policy to research and clinical care. Physiol Behav. 2018;187:2&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28823546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thi&#xE9;baut R, et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci USA. 2014;111:869&#x2013;874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3896147</ArticleId>
            <ArticleId IdType="pubmed">24367114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zivkovic I, Petrovic R, Arsenovic-Ranin N, Petrusic V, Minic R, Bufan B, et al. Sex bias in mouse humoral immune response to influenza vaccine depends on the vaccine type. Biologicals. 2018;52:18&#x2013;24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29426673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun K, Torres L, Metzger DW. A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J Virol. 2010;84:5007&#x2013;5014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2863832</ArticleId>
            <ArticleId IdType="pubmed">20200252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh EE, Peterson DR, Kalkanoglu AE, Lee FE, Falsey AR. Viral shedding and immune responses to respiratory syncytial virus infection in older adults. J Infect Dis. 2013;207:1424&#x2013;1432.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3610422</ArticleId>
            <ArticleId IdType="pubmed">23382572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casimir GJ, Lef&#xE8;vre N, Corazza F, Duchateau J. Sex and inflammation in respiratory diseases: a clinical viewpoint. Biol Sex Differ. 2013;4:16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3765878</ArticleId>
            <ArticleId IdType="pubmed">24128344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen T, Liu HX, Yan HY, Wu DM, Ping J. Developmental origins of inflammatory and immune diseases. Mol Hum Reprod. 2016;22:858&#x2013;865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4986419</ArticleId>
            <ArticleId IdType="pubmed">27226490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roved J, Westerdahl H, Hasselquist D. Sex differences in immune responses: Hormonal effects, antagonistic selection, and evolutionary consequences. Horm Behav. 2017;88:95&#x2013;105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27956226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gottschalk RA, Martins AJ, Angermann BR, Dutta B, Ng CE, Uderhardt S, et al. Distinct NF-&#x3BA;B and MAPK activation thresholds uncouple steady-state microbe sensing from anti-pathogen inflammatory responses. Cell Syst. 2016;2:378&#x2013;390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4919147</ArticleId>
            <ArticleId IdType="pubmed">27237739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller-Jensen K. Distinct signaling thresholds distinguish friend from foe. Cell Syst. 2016;2:360&#x2013;361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27336965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarabichi Y, Li K, Hu S, Nguyen C, Wang X, Elashoff D, et al. The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles. Microbiome. 2015;3:74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4678663</ArticleId>
            <ArticleId IdType="pubmed">26667497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Fire Protection Association. Firefighting occupations by women and race. 2017 [accessed 2017 Dec 21]. Available from:  http://www.nfpa.org/News-and-Research/Fire-statistics-and-reports/Fire-statistics/The-fire-service/Administration/Firefighting-occupations-by-women-and-race.</Citation>
        </Reference>
        <Reference>
          <Citation>B&#xF8;nl&#xF8;kke JH, Riddervold IS, Gr&#xF8;nborg TK, Skogstrand K, Hougaard DM, Barregard L, et al. Systemic effects of wood smoke in a short-term experimental exposure study of atopic volunteers. J Occup Environ Med. 2014;56:177&#x2013;183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3921260</ArticleId>
            <ArticleId IdType="pubmed">24451613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forchhammer L, M&#xF8;ller P, Riddervold IS, B&#xF8;nl&#xF8;kke J, Massling A, Sigsgaard T, et al. Controlled human wood smoke exposure: oxidative stress, inflammation and microvascular function. Part Fibre Toxicol. 2012;9:7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3369202</ArticleId>
            <ArticleId IdType="pubmed">22452928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riddervold IS, B&#xF8;nl&#xF8;kke JH, M&#xF8;lhave L, Massling A, Jensen B, Gr&#xF8;nborg TK, et al. Wood smoke in a controlled exposure experiment with human volunteers. Inhal Toxicol. 2011;23:277&#x2013;288.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21506878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stockfelt L, Sallsten G, Olin AC, Almerud P, Samuelsson L, Johannesson S, et al. Effects on airways of short-term exposure to two kinds of wood smoke in a chamber study of healthy humans. Inhal Toxicol. 2012;24:47&#x2013;59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22220980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unosson J, Blomberg A, Sandstr&#xF6;m T, Muala A, Boman C, Nystr&#xF6;m R, et al. Exposure to wood smoke increases arterial stiffness and decreases heart rate variability in humans. Part Fibre Toxicol. 2013;10:20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3685524</ArticleId>
            <ArticleId IdType="pubmed">23742058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Awji EG, Chand H, Bruse S, Smith KR, Colby JK, Mebratu Y, et al. Wood smoke enhances cigarette smoke-induced inflammation by inducing the aryl hydrocarbon receptor repressor in airway epithelial cells. Am J Respir Cell Mol Biol. 2015;52:377&#x2013;386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4370262</ArticleId>
            <ArticleId IdType="pubmed">25137396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barrett EG, Henson RD, Seilkop SK, McDonald JD, Reed MD. Effects of hardwood smoke exposure on allergic airway inflammation in mice. Inhal Toxicol. 2006;18:33&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16326399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danielsen PH, Loft S, Jacobsen NR, Jensen KA, Autrup H, Ravanat JL, et al. Oxidative stress, inflammation, and DNA damage in rats after intratracheal instillation or oral exposure to ambient air and wood smoke particulate matter. Toxicol Sci. 2010;118:574&#x2013;585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20864625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perng DW, Chang TM, Wang JY, Lee CC, Lu SH, Shyue SK, et al. Inflammatory role of AMP-activated protein kinase signaling in an experimental model of toxic smoke inhalation injury. Crit Care Med. 2013;41:120&#x2013;132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23222262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seilkop SK, Campen MJ, Lund AK, McDonald JD, Mauderly JL. Identification of chemical components of combustion emissions that affect pro-atherosclerotic vascular responses in mice. Inhal Toxicol. 2012;24:270&#x2013;287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3606057</ArticleId>
            <ArticleId IdType="pubmed">22486345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burchiel SW, Lauer FT, Dunaway SL, Zawadzki J, McDonald JD, Reed MD. Hardwood smoke alters murine splenic T cell responses to mitogens following a 6-month whole body inhalation exposure. Toxicol Appl Pharmacol. 2005;202:229&#x2013;236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15667828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matthew E, Warden G, Dedman J. A murine model of smoke inhalation. Am J Physiol Lung Cell Mol Physiol. 2001;280:L716&#x2013;L723.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11238012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim YH, Warren SH, Krantz QT, King C, Jaskot R, Preston WT, et al. Mutagenicity and lung toxicity of smoldering vs. flaming emissions from various biomass fuels: implications for health effects from wildland fires. Environ Health Perspect. 2018;126:017011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6039157</ArticleId>
            <ArticleId IdType="pubmed">29373863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Migliaccio CT, Bergauff MA, Palmer CP, Jessop F, Noonan CW, Ward TJ. Urinary levoglucosan as a biomarker of wood smoke exposure: observations in a mouse model and in children. Environ Health Perspect. 2009;117:74&#x2013;79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2627869</ArticleId>
            <ArticleId IdType="pubmed">19165390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Migliaccio CT, Kobos E, King QO, Porter V, Jessop F, Ward T. Adverse effects of wood smoke PM(2.5) exposure on macrophage functions. Inhal Toxicol. 2013;25:67&#x2013;76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4757468</ArticleId>
            <ArticleId IdType="pubmed">23363038</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30359758</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-4596</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>130</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Free radical biology &amp; medicine</Title>
          <ISOAbbreviation>Free Radic Biol Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.</ArticleTitle>
        <Pagination>
          <StartPage>23</StartPage>
          <EndPage>34</EndPage>
          <MedlinePgn>23-34</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2018.10.436</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0891-5849(18)32247-0</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Chagas cardiomyopathy, caused by Trypanosoma cruzi infection, continues to be a neglected illness, and has a major impact on global health. The parasite undergoes several stages of morphological and biochemical changes during its life cycle, and utilizes an elaborated antioxidant network to overcome the oxidants barrier and establish infection in vector and mammalian hosts. Trypanothione synthetase (TryS) catalyzes the biosynthesis of glutathione-spermidine adduct trypanothione (T(SH)<sub>2</sub>) that is the principal intracellular thiol-redox metabolite in trypanosomatids.</AbstractText>
          <AbstractText Label="METHODS AND RESULTS">We utilized genetic overexpression (TryS<sup>hi</sup>) and pharmacological inhibition approaches to examine the role of TryS in T. cruzi proliferation, tolerance to oxidative stress and resistance to anti-protozoal drugs. Our data showed the expression and activity of TryS was increased in all morphological stages of TryS<sup>hi</sup> (vs. control) parasites. In comparison to controls, the TryS<sup>hi</sup> epimastigotes (insect stage) recorded shorter doubling time, and both epimastigotes and infective trypomastigotes of TryS<sup>hi</sup> exhibited 36-71% higher resistance to H<sub>2</sub>O<sub>2</sub> (50-1000&#x202F;&#x3BC;M) and heavy metal (1-500&#x202F;&#x3BC;M) toxicity. Treatment with TryS inhibitors (5-30&#x202F;&#x3BC;M) abolished the proliferation and survival advantages against H<sub>2</sub>O<sub>2</sub> pressure in a dose-dependent manner in both TryS<sup>hi</sup> and control parasites. Further, epimastigote and trypomastigote forms of TryS<sup>hi</sup> (vs. control) T. cruzi tolerated higher doses of benznidazole and nifurtimox, the drugs currently administered for acute Chagas disease treatment.</AbstractText>
          <AbstractText Label="CONCLUSIONS">TryS is essential for proliferation and survival of T. cruzi under normal and oxidant stress conditions, and provides an advantage to the parasite to develop resistance against currently used anti-trypanosomal drugs. TryS indispensability has been chemically validated with inhibitors that may be useful for drug combination therapy against Chagas disease.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mes&#xED;as</LastName>
            <ForeName>Andrea C</ForeName>
            <Initials>AC</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Patolog&#xED;a Experimental, Universidad Nacional de Salta - Consejo Nacional de Investigaciones Cient&#xED;ficas y T&#xE9;cnicas (CONICET), Salta, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sasoni</LastName>
            <ForeName>Natalia</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Agrobiotecnolog&#xED;a del Litoral, Universidad Nacional del Litoral - CONICET, Santa Fe, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arias</LastName>
            <ForeName>Diego G</ForeName>
            <Initials>DG</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Agrobiotecnolog&#xED;a del Litoral, Universidad Nacional del Litoral - CONICET, Santa Fe, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>P&#xE9;rez Brand&#xE1;n</LastName>
            <ForeName>Cecilia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Patolog&#xED;a Experimental, Universidad Nacional de Salta - Consejo Nacional de Investigaciones Cient&#xED;ficas y T&#xE9;cnicas (CONICET), Salta, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Orban</LastName>
            <ForeName>Oliver C F</ForeName>
            <Initials>OCF</Initials>
            <AffiliationInfo>
              <Affiliation>Technische Universit&#xE4;t Braunschweig, Institut f&#xFC;r Medizinische und Pharmazeutische Chemie, Beethovenstra&#xDF;e 55, D-38106 Braunschweig, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kunick</LastName>
            <ForeName>Conrad</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Technische Universit&#xE4;t Braunschweig, Institut f&#xFC;r Medizinische und Pharmazeutische Chemie, Beethovenstra&#xDF;e 55, D-38106 Braunschweig, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Robello</LastName>
            <ForeName>Carlos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Unidad de Biolog&#xED;a Molecular, Institut Pasteur de Montevideo, and Departamento de Bioqu&#xED;mica, Facultad de Medicina, Uruguay.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Comini</LastName>
            <ForeName>Marcelo A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Redox Biology of Trypanosomes - Institut Pasteur de Montevideo, Montevideo, Uruguay.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garg</LastName>
            <ForeName>Nisha J</ForeName>
            <Initials>NJ</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Microbiology and Immunology and Pathology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: nigarg@utmb.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zago</LastName>
            <ForeName>M Paola</ForeName>
            <Initials>MP</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Patolog&#xED;a Experimental, Universidad Nacional de Salta - Consejo Nacional de Investigaciones Cient&#xED;ficas y T&#xE9;cnicas (CONICET), Salta, Argentina. Electronic address: mpzago@conicet.gov.ar.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 AI054578</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AI136031</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Free Radic Biol Med</MedlineTA>
        <NlmUniqueID>8709159</NlmUniqueID>
        <ISSNLinking>0891-5849</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000981">Antiprotozoal Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015800">Protozoan Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 6.3.1.-</RegistryNumber>
          <NameOfSubstance UI="D019732">Amide Synthases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 6.3.1.9</RegistryNumber>
          <NameOfSubstance UI="C064407">trypanothione synthetase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D019732" MajorTopicYN="N">Amide Synthases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000981" MajorTopicYN="N">Antiprotozoal Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002598" MajorTopicYN="N">Chagas Cardiomyopathy</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000469" MajorTopicYN="Y">parasitology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004351" MajorTopicYN="N">Drug Resistance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015800" MajorTopicYN="N">Protozoan Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019076" MajorTopicYN="N">Transgenes</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014349" MajorTopicYN="N">Trypanosoma cruzi</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anti-parasite drugs</Keyword>
        <Keyword MajorTopicYN="N">Chagas disease</Keyword>
        <Keyword MajorTopicYN="N">Paullones</Keyword>
        <Keyword MajorTopicYN="N">Small molecule inhibitors</Keyword>
        <Keyword MajorTopicYN="N">Trypanosoma cruzi</Keyword>
        <Keyword MajorTopicYN="N">Trypanothione synthetase</Keyword>
      </KeywordList>
      <CoiStatement>Conflict of interest: The authors declare no financial conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30359758</ArticleId>
        <ArticleId IdType="mid">NIHMS1511258</ArticleId>
        <ArticleId IdType="pmc">PMC6331241</ArticleId>
        <ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.10.436</ArticleId>
        <ArticleId IdType="pii">S0891-5849(18)32247-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Schmunis GA, Epidemiology of Chagas disease in non-endemic countries: the role of international migration, Mem. Inst. Oswaldo Cruz 102 (2007) 75&#x2013;85. doi:10.1590/S007402762007005000093.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S007402762007005000093</ArticleId>
            <ArticleId IdType="pubmed">17891282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO | Chagas disease (American trypanosomiasis), (2017). http://www.who.int/mediacentre/factsheets/fs340/en/ (accessed April 15, 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Coura JR, De Castro SL, A critical review on chagas disease chemotherapy, Mem. Inst. Oswaldo Cruz 97 (2002) 3&#x2013;24. doi:10.1590/S0074-02762002000100001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0074-02762002000100001</ArticleId>
            <ArticleId IdType="pubmed">11992141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauria-Pires L, Braga MS, Vexenat AC, Nitz N, Sim&#xF5;es-Barbosa A, Tinoco DL, Teixeira ARL, Progressive chronic chagas heart disease ten years after treatment with antiTrypanosoma cruzi nitroderivatives, Am. J. Trop. Med. Hyg 63 (2000) 111&#x2013;118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11388500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velazquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, Randomized trial of benznidazole for chronic Chagas&#x2019; cardiomyopathy, N. Engl. J. Med 373 (2015) 1295&#x2013;1306. doi:10.1056/NEJMoa1507574.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1507574</ArticleId>
            <ArticleId IdType="pubmed">26323937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oza SL, Tetaud E, Ariyanayagam MR, Warnon SS, Fairlamb AH, A Single Enzyme Catalyses Formation of Trypanothione from Glutathione and Spermidine in Trypanosoma cruzi, J. Biol. Chem 277 (2002) 35853&#x2013;35861. doi:10.1074/jbc.M204403200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M204403200</ArticleId>
            <ArticleId IdType="pubmed">12121990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krauth-Siegel RL, Comini MA, Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism, Biochim. Biophys. Acta - Gen. Subj 1780 (2008) 1236&#x2013; 1248. doi:10.1016/J.BBAGEN.2008.03.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/J.BBAGEN.2008.03.006</ArticleId>
            <ArticleId IdType="pubmed">18395526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wyllie S, Oza SL, Patterson S, Spinks D, Thompson S, Fairlamb AH, Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods, Mol. Microbiol 74 (2009) 529&#x2013;540. doi:10.1111/j.13652958.2009.06761.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.13652958.2009.06761.x</ArticleId>
            <ArticleId IdType="pmc">PMC2784880</ArticleId>
            <ArticleId IdType="pubmed">19558432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sousa AF, Gomes-Alves AG, Ben&#xED;tez D, Comini MA, Floh&#xE9; L, Jaeger T, Passos J, Stuhlmann F, Tom&#xE1;s AM, Castro H, Genetic and chemical analyses reveal that trypanothione synthetase but not glutathionylspermidine synthetase is essential for Leishmania infantum, Free Radic. Biol. Med 73 (2014) 229&#x2013;238. doi:10.1016/j.freeradbiomed.2014.05.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.05.007</ArticleId>
            <ArticleId IdType="pubmed">24853758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orban OCF, Korn RS, Ben&#xED;tez D, Medeiros A, Preu L, Loa&#xEB;c N, Meijer L, Koch O, Comini MA, Kunick C, 5-Substituted 3-chlorokenpaullone derivatives are potent inhibitors of Trypanosoma brucei bloodstream forms, Bioorganic Med. Chem 24 (2016) 3790&#x2013;3800. doi:10.1016/j.bmc.2016.06.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmc.2016.06.023</ArticleId>
            <ArticleId IdType="pubmed">27349574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Contreras VT, Araujo-Jorge TC, Bonaldo MC, Thomaz N, Barbosa HS, Meirelles MN, Goldenberg S, Biological aspects of the Dm 28c clone of Trypanosoma cruzi after metacyclogenesis in chemically defined media, Mem. Inst. Oswaldo Cruz 83 (1988) 123&#x2013;133. doi:S0074-02761988000100016 [pii].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3074237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isola EL, Lammel EM, Gonz&#xE1;lez Cappa SM, Trypanosoma cruzi: differentiation after interaction of epimastigotes and Triatoma infestans intestinal homogenate., Exp. Parasitol
62 (1986) 329&#x2013;35. http://www.ncbi.nlm.nih.gov/pubmed/3023131 (accessed September 17, 2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3023131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vazquez MP, Levin MJ, Functional analysis of the intergenic regions of TcP2&#x3B2; gene loci allowed the construction of an improved Trypanosoma cruzi expression vector, Gene 239 (1999) 217&#x2013;225. doi:10.1016/S0378-1119(99)00386-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0378-1119(99)00386-8</ArticleId>
            <ArticleId IdType="pubmed">10548722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans DB, odfrey D, Lanham S, Lanotte F, enevi ve, Modabber, Handboo on isolation, characterization and cryopreservation of Leishmania geneva :
World Health Organization, 1989. 
http://www.who.int/iris/handle/10665/60795.</Citation>
        </Reference>
        <Reference>
          <Citation>Lorenzi HA, Vazquez MP, Levin MJ, Integration of expression vectors into the ribosomal locus of Trypanosoma cruzi, Gene 310 (2003) 91&#x2013;99. doi:10.1016/S0378-1119(03)00502-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0378-1119(03)00502-X</ArticleId>
            <ArticleId IdType="pubmed">12801636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fusari C, Demonte AM, Figueroa CM, Aleanzi M, Iglesias AA, A colorimetric method for the assay of ADP-glucose pyrophosphorylase, Anal. Biochem 352 (2006) 11&#x2013;13. doi:10.1016/j.ab.2006.01.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ab.2006.01.024</ArticleId>
            <ArticleId IdType="pubmed">16574055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arias DG, Marquez VE, Chiribao ML, Gadelha FR, Robello C, Iglesias AA, Guerrero SA, Redox metabolism in Trypanosoma cruzi: functional characterization of tryparedoxins revisited, Free Radic. Biol. Med 63 (2013) 65&#x2013;77. doi:10.1016/j.freeradbiomed.2013.04.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.04.036</ArticleId>
            <ArticleId IdType="pubmed">23665397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dormeyer M, Reckenfelderb&#xE4;umer N, L&#xFC;demann H, Krauth-Siegel RL, Trypanothionedependent synthesis of deoxyribonucleotides by Trypanosoma brucei ribonucleotide reductase, J. Biol. Chem 276 (2001) 10602&#x2013;10606. doi:10.1074/jbc.M010352200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M010352200</ArticleId>
            <ArticleId IdType="pubmed">11150302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parodi-Talice A, Monteiro-Goes V, Arrambide N, Avila AR, Duran R, Correa A, Dallagiovanna B, Cayota A, Krieger M, Goldenberg S, Robello C, Proteomic analysis of metacyclic trypomastigotes undergoing Trypanosoma cruzi metacyclogenesis., J. Mass Spectrom 42 (2007) 1422&#x2013;32. doi:10.1002/jms.1267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jms.1267</ArticleId>
            <ArticleId IdType="pubmed">17960573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atwood JA, Weatherly DB, Minning TA, Bundy B, Cavola C, Opperdoes FR, Orlando R, Tarleton RL, The Trypanosoma cruzi proteome, Science 309 (2005) 473&#x2013;6. doi:10.1126/science.1110289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1110289</ArticleId>
            <ArticleId IdType="pubmed">16020736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azambuja P, Garcia ES, Waniek PJ, Vieira CS, Figueiredo MB, Gonzalez MS, Mello CB, Castro DP, Ratcliffe NA, Rhodnius prolixus: from physiology by Wigglesworth to recent studies of immune system modulation by Trypanosoma cruzi and Trypanosoma rangeli, J. Insect Physiol (2016). doi:10.1016/j.jinsphys.2016.11.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinsphys.2016.11.006</ArticleId>
            <ArticleId IdType="pubmed">27866813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zumaya-Estrada FA, Mart&#xED;nez-Barnetche J, Lavore A, Rivera-Pomar R, Rodr&#xED;guez MH, Comparative genomics analysis of triatomines reveals common first line and inducible immunity-related genes and the absence of Imd canonical components among hemimetabolous arthropods, Parasit. Vectors 11 (2018) 48. doi:10.1186/s13071-017-2561-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13071-017-2561-2</ArticleId>
            <ArticleId IdType="pmc">PMC5778769</ArticleId>
            <ArticleId IdType="pubmed">29357911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piacenza L, Alvarez M, Peluffo G, Radi R, Fighting the oxidative assault: the Trypanosoma cruzi journey to infection, Curr Opin Microbiol 12 (2009) 415&#x2013;421. doi:10.1016/j.mib.2009.06.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mib.2009.06.011</ArticleId>
            <ArticleId IdType="pubmed">19616990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Carvalho LP, de Melo EJT, Life and death of Trypanosoma cruzi in presence of metals, BioMetals 30 (2017) 955&#x2013;974. doi:10.1007/s10534-017-0064-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10534-017-0064-4</ArticleId>
            <ArticleId IdType="pubmed">29081021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall BS, Bot C, Wilkinson SR, Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites, J. Biol. Chem 286 (2011) 13088&#x2013;13095. doi:10.1074/jbc.M111.230847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.230847</ArticleId>
            <ArticleId IdType="pmc">PMC3075655</ArticleId>
            <ArticleId IdType="pubmed">21345801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boiani M, Piacenza L, Hern&#xE1;ndez P, Boiani L, Cerecetto H, Gonz&#xE1;lez M, Denicola A, Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved?, Biochem. Pharmacol 79 (2010) 1736&#x2013;45. doi:10.1016/j.bcp.2010.02.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bcp.2010.02.009</ArticleId>
            <ArticleId IdType="pubmed">20178775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trochine A, Creek DJ, Faral-Tello P, Barrett MP, Robello C, Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics, PLoS Negl. Trop. Dis 8 (2014). doi:10.1371/journal.pntd.0002844.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0002844</ArticleId>
            <ArticleId IdType="pmc">PMC4031082</ArticleId>
            <ArticleId IdType="pubmed">24853684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Comini MA, Guerrero SA, Haile S, Menge U, L&#xFC;nsdorf H, Floh&#xE9; L, Validation of Trypanosoma brucei trypanothione synthetase as drug target, Free Radic. Biol. Med 36 (2004) 1289&#x2013;1302. doi:10.1016/j.freeradbiomed.2004.02.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2004.02.008</ArticleId>
            <ArticleId IdType="pubmed">15110394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mukhopadhyay R, Dey S, Xut N, Gaget D, Lightbody J, Ouellette M, Rosen BP, Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania, Proc. Natl. Acad. Sci. U. S. A 93 (1996) 10383&#x2013;10387. doi:10.1073/pnas.93.19.10383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.93.19.10383</ArticleId>
            <ArticleId IdType="pmc">PMC38393</ArticleId>
            <ArticleId IdType="pubmed">8816809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irigo&#xED;n F, Cibils L, Comini MA, Wilkinson SR, Floh&#xE9; L, Radi R, Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification, Free Radic. Biol. Med 45 (2008) 733&#x2013;742. doi:10.1016/j.freeradbiomed.2008.05.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2008.05.028</ArticleId>
            <ArticleId IdType="pubmed">18588970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonz&#xE1;lez-Ch&#xE1;vez Z, Olin-Sandoval V, Rod&#xED;guez-Zavala JS, Moreno-S&#xE1;nchez R, Saavedra E, Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target, Biochim. Biophys. Acta - Gen. Subj 1850 (2015) 263&#x2013;273. doi:10.1016/j.bbagen.2014.10.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbagen.2014.10.029</ArticleId>
            <ArticleId IdType="pubmed">25450181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zago MP, Hosakote YM, jie Koo S, Dhiman M, Pi&#xF1;eyro MD, Parodi-Talice A, Basombrio MA, Robello C, Garg NJ, TcI isolates of Trypanosoma cruzi exploit the antioxidant network for enhanced intracellular survival in macrophages and virulence in mice, Infect. Immun 84 (2016) 1842&#x2013;1856. doi:10.1128/IAI.00193-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00193-16</ArticleId>
            <ArticleId IdType="pmc">PMC4907148</ArticleId>
            <ArticleId IdType="pubmed">27068090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piacenza L, Zago MP, Peluffo G, Alvarez MN, Basombrio MA, Radi R, Enzymes of the antioxidant network as novel determiners of Trypanosoma cruzi virulence, Int. J. Parasitol 39 (2009) 1455&#x2013;1464. doi:10.1016/j.ijpara.2009.05.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpara.2009.05.010</ArticleId>
            <ArticleId IdType="pmc">PMC3909716</ArticleId>
            <ArticleId IdType="pubmed">19505468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onn I, Milman-shtepel N, Shlomai J, Redox potential regulates binding of universal minicircle sequence binding protein at the kinetoplast DNA replication origin, Eukaryot Cell 3 (2004) 277&#x2013; 287. doi:10.1128/EC.3.2.277.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/EC.3.2.277</ArticleId>
            <ArticleId IdType="pmc">PMC387648</ArticleId>
            <ArticleId IdType="pubmed">15075258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh R, Purkait B, Abhishek K, Saini S, Das S, Verma S, Mandal A, Ghosh AK, Ansari Y, Kumar A, Sardar AH, Kumar A, Parrack P, Universal minicircle sequence binding protein of Leishmania donovani regulates pathogenicity by controlling expression of cytochrome - b, Cell Biosci (2016) 1&#x2013;17. doi:10.1186/s13578-016-0072-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13578-016-0072-z</ArticleId>
            <ArticleId IdType="pmc">PMC4756535</ArticleId>
            <ArticleId IdType="pubmed">26889377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamedi A, Botelho L, Britto C, Fragoso SP, Umaki ACS, Goldenberg S, Bottu G, Salmon D, In vitro metacyclogenesis of Trypanosoma cruzi induced by starvation correlates with a transient adenylyl cyclase stimulation as well as with a constitutive upregulation of adenylyl cyclase expression, Mol. Biochem. Parasitol 200 (2015) 9&#x2013;18. doi:10.1016/j.molbiopara.2015.04.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molbiopara.2015.04.002</ArticleId>
            <ArticleId IdType="pubmed">25912925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Figueiredo RC, Rosa DS, Soares MJ, Differentiation of Trypanosoma cruzi epimastigotes: metacyclogenesis and adhesion to substrate are triggered by nutritional stress., J. Parasitol 86 (2000) 1213&#x2013;8. doi:10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2</ArticleId>
            <ArticleId IdType="pubmed">11191893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carnieri EGS, Moreno SNJ, Docampo R, Trypanothione-dependent peroxide metabolism in Trypanosoma cruzi different stages, Mol. Biochem. Parasitol 61 (1993) 79&#x2013;86. doi:10.1016/0166-6851(93)90160-Y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0166-6851(93)90160-Y</ArticleId>
            <ArticleId IdType="pubmed">8259135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piacenza L, Peluffo G, Alvarez MN, Mart&#xED;nez A, Radi R, Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease, Antioxid. Redox Signal 19 (2013) 723&#x2013;734. doi:10.1089/ars.2012.4618.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2012.4618</ArticleId>
            <ArticleId IdType="pmc">PMC3739954</ArticleId>
            <ArticleId IdType="pubmed">22458250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finzi JK, Chiavegatto CWM, Corat KF, Lopez JA, Cabrera OG, Mielniczki-Pereira AA, Colli W, Alves MJM, Gadelha FR, Trypanosoma cruzi response to the oxidative stress generated by hydrogen peroxide, Mol. Biochem. Parasitol 133 (2004) 37&#x2013;43. doi:10.1016/j.molbiopara.2003.08.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molbiopara.2003.08.011</ArticleId>
            <ArticleId IdType="pubmed">14668010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Comini MA, Krauth-Siegel RL, Floh&#xE9; L, Depletion of the thioredoxin homologue tryparedoxin impairs antioxidative defence in African trypanosomes., Biochem. J 402 (2007) 43&#x2013;9. doi:10.1042/BJ20061341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20061341</ArticleId>
            <ArticleId IdType="pmc">PMC1783994</ArticleId>
            <ArticleId IdType="pubmed">17040206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maya JD, Repetto Y, Agosin M, Ojeda JM, Tellez R, Gaule C, Morello A, Effects of Nifurtimox and benzonidazole upon glutathione and trypanothione content in epimastigote, tripomastigote and amastigote forms of Trypanosoma cruzi, Mol. Biochem. Parasitol 86 (1997) 101&#x2013;106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9178272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ariyanayagam MR, Oza SL, Guther MLS, Fairlamb AH, Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome, Biochem. J 391 (2005) 425&#x2013; 432. doi:10.1042/BJ20050911.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20050911</ArticleId>
            <ArticleId IdType="pmc">PMC1276942</ArticleId>
            <ArticleId IdType="pubmed">16008527</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30359630</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1872-8294</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>140</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Advanced drug delivery reviews</Title>
          <ISOAbbreviation>Adv Drug Deliv Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Stem-cell based organ-on-a-chip models for diabetes research.</ArticleTitle>
        <Pagination>
          <StartPage>101</StartPage>
          <EndPage>128</EndPage>
          <MedlinePgn>101-128</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.addr.2018.10.010</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0169-409X(18)30260-6</ELocationID>
        <Abstract>
          <AbstractText>Diabetes mellitus (DM) ranks among the severest global health concerns of the 21st century. It encompasses a group of chronic disorders characterized by a dysregulated glucose metabolism, which arises as a consequence of progressive autoimmune destruction of pancreatic beta-cells (type 1 DM), or as a result of beta-cell dysfunction combined with systemic insulin resistance (type 2 DM). Human cohort studies have provided evidence of genetic and environmental contributions to DM; yet, these studies are mostly restricted to investigating statistical correlations between DM and certain risk factors. Mechanistic studies, on the other hand, aimed at re-creating the clinical picture of human DM in animal models. A translation to human biology is, however, often inadequate owing to significant differences between animal and human physiology, including the species-specific glucose regulation. Thus, there is an urgent need for the development of advanced human in vitro models with the potential to identify novel treatment options for DM. This review provides an overview of the technological advances in research on DM-relevant stem cells and their integration into microphysiological environments as provided by the organ-on-a-chip technology.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rogal</LastName>
            <ForeName>Julia</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Women's Health, Research Institute for Women's Health, Eberhard Karls University, Silcherstrasse 7/1, 72076 T&#xFC;bingen, Germany; Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Nobelstrasse 12, 70569 Stuttgart, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zbinden</LastName>
            <ForeName>Aline</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Women's Health, Research Institute for Women's Health, Eberhard Karls University, Silcherstrasse 7/1, 72076 T&#xFC;bingen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schenke-Layland</LastName>
            <ForeName>Katja</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Women's Health, Research Institute for Women's Health, Eberhard Karls University, Silcherstrasse 7/1, 72076 T&#xFC;bingen, Germany; The Natural and Medical Sciences Institute (NMI) at the University of T&#xFC;bingen, Markwiesenstr. 55, 72770 Reutlingen, Germany; Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, 675 Charles E. Young Drive South, MRL 3645, Los Angeles, CA, USA. Electronic address: katja.schenke-layland@med.uni-tuebingen.de.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Loskill</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Women's Health, Research Institute for Women's Health, Eberhard Karls University, Silcherstrasse 7/1, 72076 T&#xFC;bingen, Germany; Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Nobelstrasse 12, 70569 Stuttgart, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Adv Drug Deliv Rev</MedlineTA>
        <NlmUniqueID>8710523</NlmUniqueID>
        <ISSNLinking>0169-409X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013234" MajorTopicYN="Y">Stem Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023822" MajorTopicYN="N">Tissue Engineering</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HiPSCs</Keyword>
        <Keyword MajorTopicYN="N">Human in vitro model</Keyword>
        <Keyword MajorTopicYN="N">Microfluidics</Keyword>
        <Keyword MajorTopicYN="N">Multi-organ chips</Keyword>
        <Keyword MajorTopicYN="N">Organ-on-a-chip</Keyword>
        <Keyword MajorTopicYN="N">Type 1 diabetes</Keyword>
        <Keyword MajorTopicYN="N">Type 2 diabetes</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30359630</ArticleId>
        <ArticleId IdType="doi">10.1016/j.addr.2018.10.010</ArticleId>
        <ArticleId IdType="pii">S0169-409X(18)30260-6</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30357854</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-9071</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>91</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of medical virology</Title>
          <ISOAbbreviation>J Med Virol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Use of induced pluripotent stem cells (iPSCs) and cerebral organoids in modeling the congenital infection and neuropathogenesis induced by Zika virus.</ArticleTitle>
        <Pagination>
          <StartPage>525</StartPage>
          <EndPage>532</EndPage>
          <MedlinePgn>525-532</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.25345</ELocationID>
        <Abstract>
          <AbstractText>Infection with Zika virus (ZIKV) was recently demonstrated to be associated with damage to the central nervous system, especially microcephaly and the Guillain-Barr&#xE9; syndrome. This finding had alarmed public health agencies and mobilized institutions around the world to search for more information about the virus, its effects, pathophysiological mechanisms, and potential immunizations and treatments. Given the increasing interest in using iPSCs and cerebral organoids to model the congenital infection and neuropathogenesis induced by ZIKV, the aim of this review was to present an up-to-date summary of the publications on the association of ZIKV with microcephaly, using iPSCs and organoids. According to our review, the number of studies has decreased concomitantly with a decrease in the number of cases. The presence of subclinical lesions at birth, which may eventually present cognitive or behavioral problems in the future, suggests that persistent research efforts on the virus should be undertaken by the global health community till the threat is completely wiped out.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Majolo</LastName>
            <ForeName>Fernanda</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0002-7955-078X</Identifier>
            <AffiliationInfo>
              <Affiliation>Neuroscience Laboratory, Brain Institute of Rio Grande do Sul (BraIns) from Pontif&#xED;cia Universidade Cat&#xF3;lica do Rio Grande do Sul, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marinowic</LastName>
            <ForeName>Daniel Rodrigo</ForeName>
            <Initials>DR</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Laboratory, Brain Institute of Rio Grande do Sul (BraIns) from Pontif&#xED;cia Universidade Cat&#xF3;lica do Rio Grande do Sul, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moura</LastName>
            <ForeName>Adriana &#xC1;vila</ForeName>
            <Initials>A&#xC1;</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Universidade Federal de Alagoas, Macei&#xF3;, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Machado</LastName>
            <ForeName>Denise Cantarelli</ForeName>
            <Initials>DC</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Laboratory, Brain Institute of Rio Grande do Sul (BraIns) from Pontif&#xED;cia Universidade Cat&#xF3;lica do Rio Grande do Sul, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>da Costa</LastName>
            <ForeName>Jaderson Costa</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Laboratory, Brain Institute of Rio Grande do Sul (BraIns) from Pontif&#xED;cia Universidade Cat&#xF3;lica do Rio Grande do Sul, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Med Virol</MedlineTA>
        <NlmUniqueID>7705876</NlmUniqueID>
        <ISSNLinking>0146-6615</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName>
          <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008831" MajorTopicYN="N">Microcephaly</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009940" MajorTopicYN="N">Organoids</DescriptorName>
          <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName>
          <QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071243" MajorTopicYN="N">Zika Virus Infection</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Zika virus</Keyword>
        <Keyword MajorTopicYN="N">iPSCs</Keyword>
        <Keyword MajorTopicYN="N">microcephaly</Keyword>
        <Keyword MajorTopicYN="N">organoids</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30357854</ArticleId>
        <ArticleId IdType="doi">10.1002/jmv.25345</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30357851</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2025</Year>
        <Month>01</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-9071</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>91</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of medical virology</Title>
          <ISOAbbreviation>J Med Virol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria.</ArticleTitle>
        <Pagination>
          <StartPage>533</StartPage>
          <EndPage>540</EndPage>
          <MedlinePgn>533-540</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.25348</ELocationID>
        <Abstract>
          <AbstractText>Since the eradication of smallpox approximately 39 years ago, monkeypox virus remains the most pathogenic poxvirus, being mainly restricted to Central and West Africa. Before 1970, there were no reports of human monkeypox in Nigeria, while between 1971 and 1978 there were three cases, with none having been reported thereafter. However, in September 2017, a case of contagious skin rash disease, typical of monkeypox, was observed in an 11-year-old boy from the southern part of the country and confirmed to be associated with the monkeypox virus. This large outbreak consisted of 262 suspected, 115 confirmed cases, and 7 mortalities across 26 states and the Federal Capital Territory (FCT), Abuja. The aim of this manuscript is to provide an updated, comprehensive, and timely review of monkeypox, an important emerging infection in Nigeria. Monkeypox is now a major threat to global health security, requiring an urgent multidisciplinary approach involving veterinarians, physicians, virologists, and public health experts to fast-track the development of diagnostic assays, vaccines, antivirals, and other control strategies.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kabuga</LastName>
            <ForeName>Auwal I</ForeName>
            <Initials>AI</Initials>
            <Identifier Source="ORCID">0000-0002-9317-3407</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medical Microbiology and Parasitology, College of Health Sciences, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El Zowalaty</LastName>
            <ForeName>Mohamed E</ForeName>
            <Initials>ME</Initials>
            <Identifier Source="ORCID">0000-0002-1056-4761</Identifier>
            <AffiliationInfo>
              <Affiliation>Virology, Microbiology and Infectious Diseases Research Group, School of Health Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Med Virol</MedlineTA>
        <NlmUniqueID>7705876</NlmUniqueID>
        <ISSNLinking>0146-6615</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005076" MajorTopicYN="N">Exanthema</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045908" MajorTopicYN="N">Mpox, Monkeypox</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008993" MajorTopicYN="N">Monkeypox virus</DescriptorName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Africa</Keyword>
        <Keyword MajorTopicYN="N">Nigeria</Keyword>
        <Keyword MajorTopicYN="N">antipoxvirus agents</Keyword>
        <Keyword MajorTopicYN="N">epidemiology</Keyword>
        <Keyword MajorTopicYN="N">infectious diseases</Keyword>
        <Keyword MajorTopicYN="N">monkeypox</Keyword>
        <Keyword MajorTopicYN="N">outbreak</Keyword>
        <Keyword MajorTopicYN="N">poxviruses</Keyword>
        <Keyword MajorTopicYN="N">re-emerging infection</Keyword>
        <Keyword MajorTopicYN="N">zoonotic</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30357851</ArticleId>
        <ArticleId IdType="doi">10.1002/jmv.25348</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30347486</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-3156</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tropical medicine &amp; international health : TM &amp; IH</Title>
          <ISOAbbreviation>Trop Med Int Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Packed red cells versus whole blood transfusion for severe paediatric anaemia, pregnancy-related anaemia and obstetric bleeding: an analysis of clinical practice guidelines from sub-Saharan Africa and evidence underpinning recommendations.</ArticleTitle>
        <Pagination>
          <StartPage>11</StartPage>
          <EndPage>22</EndPage>
          <MedlinePgn>11-22</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/tmi.13173</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">Blood component transfusion is increasingly promoted in sub-Saharan Africa (SSA), but is resource-intensive so whole blood is often used. We examined SSA recommendations about whole blood and packed red cell transfusions for pregnancy-related bleeding or anaemia, and paediatric anaemia, and evaluated the evidence underpinning these recommendations.</AbstractText>
          <AbstractText Label="METHOD">Relevant SSA guidelines were identified using five electronic databases, websites for SSA Ministries of Health, blood transfusion services and WHO. To facilitate comparisons, indications for transfusing packed red cells or whole blood within these guidelines and reasons given for these recommendations were recorded on a pre-designed matrix. The AGREE II tool was used to appraise guidelines that gave a reason for recommending either packed red cells or whole blood. We systematically searched MEDLINE, CINAHL, Global Health, Cochrane library and NHSBT Transfusion Evidence Library, using PRISMA guidelines, for clinical studies comparing whole blood with packed red cells or combined blood components in obstetric bleeding or anaemia, or paediatric anaemia. Characteristics and findings of included studies were extracted in a standardised format and narratively summarised.</AbstractText>
          <AbstractText Label="RESULTS">32 English language guidelines from 15 SSA countries mentioned packed red cell or whole blood use for our conditions of interest. Only seven guidelines justified their recommendation for using packed red cells or whole blood. No recommendations or justifications had supporting citations to research evidence. 33 full-text papers, from 11&#xA0;234 citations, were reviewed but only one study met our inclusion criteria. This was a single-centre study in post-partum haemorrhage.</AbstractText>
          <AbstractText Label="CONCLUSION">Evidence comparing whole blood and packed red cell transfusion for common paediatric and maternal indications is virtually absent in SSA. Therefore, it is unclear whether policies promoting red cells over whole blood transfusion are clinically appropriate. Building a relevant evidence base will help develop effective policies promoting the most appropriate use of blood in African settings.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kohli</LastName>
            <ForeName>Neeraj</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhaumik</LastName>
            <ForeName>Soumyadeep</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jagadesh</LastName>
            <ForeName>Soushieta</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sales</LastName>
            <ForeName>Reneepearl Kim</ForeName>
            <Initials>RK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bates</LastName>
            <ForeName>Imelda</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Trop Med Int Health</MedlineTA>
        <NlmUniqueID>9610576</NlmUniqueID>
        <ISSNLinking>1360-2276</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017954" MajorTopicYN="N" Type="Geographic">Africa South of the Sahara</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001793" MajorTopicYN="N">Blood Preservation</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007744" MajorTopicYN="N">Obstetric Labor Complications</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006473" MajorTopicYN="N">Postpartum Hemorrhage</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AGREE II</Keyword>
        <Keyword MajorTopicYN="N">Chine</Keyword>
        <Keyword MajorTopicYN="N">Sub-Saharan Africa</Keyword>
        <Keyword MajorTopicYN="N">caract&#xE8;re abordable</Keyword>
        <Keyword MajorTopicYN="N">clinical guideline quality</Keyword>
        <Keyword MajorTopicYN="N">composantes des prix</Keyword>
        <Keyword MajorTopicYN="N">disponibilit&#xE9;</Keyword>
        <Keyword MajorTopicYN="N">evidence-based medicine</Keyword>
        <Keyword MajorTopicYN="N">insuline</Keyword>
        <Keyword MajorTopicYN="N">obstetric haemorrhage</Keyword>
        <Keyword MajorTopicYN="N">packed red cells</Keyword>
        <Keyword MajorTopicYN="N">paediatric anaemia</Keyword>
        <Keyword MajorTopicYN="N">pregnancy-related anaemia</Keyword>
        <Keyword MajorTopicYN="N">systematic review</Keyword>
        <Keyword MajorTopicYN="N">transfusion medicine</Keyword>
        <Keyword MajorTopicYN="N">whole blood</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30347486</ArticleId>
        <ArticleId IdType="doi">10.1111/tmi.13173</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30346068</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-1573</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>33</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Phytotherapy research : PTR</Title>
          <ISOAbbreviation>Phytother Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antibacterial activity of flavonoids and their structure-activity relationship: An update review.</ArticleTitle>
        <Pagination>
          <StartPage>13</StartPage>
          <EndPage>40</EndPage>
          <MedlinePgn>13-40</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ptr.6208</ELocationID>
        <Abstract>
          <AbstractText>Based on World Health Organization reports, resistance of bacteria to well-known antibiotics is a major global health challenge now and in the future. Different strategies have been proposed to tackle this problem including inhibition of multidrug resistance pumps and biofilm formation in bacteria and development of new antibiotics with novel mechanism of action. Flavonoids are a large class of natural compounds, have been extensively studied for their antibacterial activity, and more than 150 articles have been published on this topic since 2005. Over the past decade, some promising results were obtained with the antibacterial activity of flavonoids. In some cases, flavonoids (especially chalcones) showed up to sixfold stronger antibacterial activities than standard drugs in the market. Some synthetic derivatives of flavonoids also exhibited remarkable antibacterial activities with 20- to 80-fold more potent activity than the standard drug against multidrug-resistant Gram-negative and Gram-positive bacteria (including Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus). This review summarizes the ever changing information on antibacterial activity of flavonoids since 2005, with a special focus on the structure-activity relationship and mechanisms of actions of this broad class of natural compounds.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Farhadi</LastName>
            <ForeName>Faegheh</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khameneh</LastName>
            <ForeName>Bahman</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutical Control, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iranshahi</LastName>
            <ForeName>Mehrdad</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-3018-5750</Identifier>
            <AffiliationInfo>
              <Affiliation>Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iranshahy</LastName>
            <ForeName>Milad</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-5339-6294</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>Mashhad University of Medical Sciences</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Phytother Res</MedlineTA>
        <NlmUniqueID>8904486</NlmUniqueID>
        <ISSNLinking>0951-418X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005419">Flavonoids</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005419" MajorTopicYN="N">Flavonoids</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013329" MajorTopicYN="Y">Structure-Activity Relationship</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antibacterial</Keyword>
        <Keyword MajorTopicYN="N">biofilm</Keyword>
        <Keyword MajorTopicYN="N">chalcones</Keyword>
        <Keyword MajorTopicYN="N">flavonoids</Keyword>
        <Keyword MajorTopicYN="N">multidrug resistance</Keyword>
        <Keyword MajorTopicYN="N">natural compounds</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30346068</ArticleId>
        <ArticleId IdType="doi">10.1002/ptr.6208</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30343625</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2025</Year>
        <Month>01</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1557-9042</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>36</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neurotrauma</Title>
          <ISOAbbreviation>J Neurotrauma</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Autonomic Dysfunction and Associations with Functional and Neurophysiological Outcome in Moderate/Severe Traumatic Brain Injury: A Scoping Review.</ArticleTitle>
        <Pagination>
          <StartPage>1491</StartPage>
          <EndPage>1504</EndPage>
          <MedlinePgn>1491-1504</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/neu.2018.6073</ELocationID>
        <Abstract>
          <AbstractText>The quantification and objective documentation of autonomic dysfunction in traumatic brain injury (TBI) is neither well studied nor extensively validated. Most of the descriptions of autonomic dysfunction in the literature are in the form of vague non-specific clinical manifestations. Few studies propose the use of objective measures of assessing the extent of autonomic dysfunction to link them to the outcome of TBI. Our goal was to perform a scoping systematic review of the literature on the objective documentation of autonomic dysfunction in terms of functional and physiological variables to be linked to outcome of TBI. PubMed/MEDLINE<sup>&#xAE;</sup>, BIOSIS, Scopus, Embase, Cochrane Libraries, and Global Health databases were searched. Two reviewers independently screened the results. Full texts for citations passing this initial screen were obtained. Inclusion and exclusion criteria were applied to each article to obtain final articles for review. The initial search yielded 2619 citations. Of 69 articles selected for final review, 14 were chosen based on the inclusion and exclusion criteria and are included in the results of this article. 9 of these articles assessed autonomic dysfunction using functional variables and 7 assessed autonomic dysfunction using physiological variables. Some studies included both functional and physiological variables. Of the nine studies linking autonomic dysfunction to functional variables, nine included heart rate variability (HRV), three included baroreflex sensitivity (BRS), and two included blood pressure variability (BPV). A total of 2714 adult patients were studied. Although the nature of association between autonomic dysfunction and outcome is unclear, the objective quantification of autonomic dysfunction seems to be associated with global patient outcome and other neurophysiological measures. Further studies are needed to validate its use and explore the underlying molecular mechanisms of the described associations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hasen</LastName>
            <ForeName>Mohammed</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>1 Section of Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2 Department of Neurosurgery, King Fahad University Hospital, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Almojuela</LastName>
            <ForeName>Alysa</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>1 Section of Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeiler</LastName>
            <ForeName>Frederick A</ForeName>
            <Initials>FA</Initials>
            <AffiliationInfo>
              <Affiliation>1 Section of Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3 Clinician Investigator Program, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>4 Division of Anaesthesia, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D000098583">Scoping Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>01</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Neurotrauma</MedlineTA>
        <NlmUniqueID>8811626</NlmUniqueID>
        <ISSNLinking>0897-7151</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001342" MajorTopicYN="N">Autonomic Nervous System Diseases</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000070642" MajorTopicYN="N">Brain Injuries, Traumatic</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">BPV</Keyword>
        <Keyword MajorTopicYN="N">BRS</Keyword>
        <Keyword MajorTopicYN="N">HRV</Keyword>
        <Keyword MajorTopicYN="N">TBI</Keyword>
        <Keyword MajorTopicYN="N">autonomic dysfunction</Keyword>
        <Keyword MajorTopicYN="N">outcome</Keyword>
        <Keyword MajorTopicYN="N">paroxysmal sympathetic hyperactivity</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30343625</ArticleId>
        <ArticleId IdType="doi">10.1089/neu.2018.6073</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30342323</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-0953</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>168</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Environmental research</Title>
          <ISOAbbreviation>Environ Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Preparing the next generation of health professionals to tackle climate change: Are China's medical students ready?</ArticleTitle>
        <Pagination>
          <StartPage>270</StartPage>
          <EndPage>277</EndPage>
          <MedlinePgn>270-277</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.envres.2018.10.006</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0013-9351(18)30537-1</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Climate change is the biggest global health threat of the 21st century. Medical students will lead the health sector responses and adaptation efforts in the near future, yet little is known in China about their knowledge, perceptions and preparedness to meet these challenges.</AbstractText>
          <AbstractText Label="METHODS">A nationwide study was conducted at five medical universities across different regions of China using a two-stage stratified cluster sampling design. A self-administered questionnaire was applied to collect the information including perception, preparedness and educational needs in response to climate change. The data were first analyzed descriptively, then chi-square tests and kruskal wallis tests were applied to determined differences among subgroups, and logistic regression analysis were deployed to detect the socio-demographic factors influencing student's perception.</AbstractText>
          <AbstractText Label="RESULTS">A total of 1436 medical students were approached and 1387 participated in the study (96.6% response rate). Most students were aware of the health impacts because of climate change, with over 90% perceived air quality-related and heat-related illness, while only a small part identified undernutrition and mental health. Approximately 90% embraced their role in tackling climate change, but 50% reported themselves and the health sectors were not adequately prepared. Compared to clinical students, preventive medicine students were more likely to perceive their responsibility to address climate change (OR:1.36, 95% CI: 1.04, 1.78). Also, 80% students admitted insufficient information and knowledge on climate change and health. Most students agreed that climate change and its health impacts should be included into their current curriculum.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Medical students in China were aware of climate change and felt responsible, but were not ready to make responses to its health impacts. Educational efforts should reinforce eco-medical literacy development and capacity building in the era of climate change.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liao</LastName>
            <ForeName>Wenmin</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Lianping</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhong</LastName>
            <ForeName>Shuang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Chinese Public Administration Research, School of Government, Sun Yat-Sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hess</LastName>
            <ForeName>Jeremy J</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Emergency Medicine, Environmental and Occupational Health Sciences, and Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Qiong</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bao</LastName>
            <ForeName>Junzhe</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Cunrui</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Sun Yat-sen University, Guangzhou, China. Electronic address: huangcr@mail.sysu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Environ Res</MedlineTA>
        <NlmUniqueID>0147621</NlmUniqueID>
        <ISSNLinking>0013-9351</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057231" MajorTopicYN="Y">Climate Change</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013337" MajorTopicYN="Y">Students, Medical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014495" MajorTopicYN="N">Universities</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Climate change</Keyword>
        <Keyword MajorTopicYN="N">Education</Keyword>
        <Keyword MajorTopicYN="N">Health impact</Keyword>
        <Keyword MajorTopicYN="N">Medical student</Keyword>
        <Keyword MajorTopicYN="N">Perception</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30342323</ArticleId>
        <ArticleId IdType="doi">10.1016/j.envres.2018.10.006</ArticleId>
        <ArticleId IdType="pii">S0013-9351(18)30537-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30336741</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>09</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0036-9330</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Scottish medical journal</Title>
          <ISOAbbreviation>Scott Med J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Surgery, obstetrics and anaesthesia: a Cambrian explosion for global health.</ArticleTitle>
        <Pagination>
          <StartPage>22</StartPage>
          <EndPage>24</EndPage>
          <MedlinePgn>22-24</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/0036933018804125</ELocationID>
        <Abstract>
          <AbstractText>Our current global health structure has not yet evolved to do what the world needs of it. Despite significant advances in some areas of public health over the past few decades, disparities in health have worsened in many areas. The historical approach of global health governance to health issues has been overwhelmingly led by vertical, single disease efforts. Yet, this structure cannot effectively implement broad-reaching international development goals set forth by the United Nations. The solution requires a rapid evolution of the present health system conceptualisation. As the Cambrian period brought skeletal infrastructure to life on our planet with vertebrates, allowing life to take on new capabilities never before witnessed on earth, so will surgery, obstetrics and anaesthesia provide the much needed healthcare delivery infrastructure that will allow health system strengthening to take global healthcare along a new path. Surgery, anaesthesia and obstetrics form the core foundation upon which the whole of global health is built and serve as the skeletal structure and indicator of robust health systems. Integrating these domains as the backbone of health system strengthening will finally allow global health to stand and support all sectors of healthcare delivery as an equal partner in health.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vaughan</LastName>
            <ForeName>Kerry A</ForeName>
            <Initials>KA</Initials>
            <Identifier Source="ORCID">0000-0002-5467-3097</Identifier>
            <AffiliationInfo>
              <Affiliation>1 Paul Farmer Research Fellow (KAV) and Kletjian Professor of Global Surgery (JGM), Program in Global Surgery and Social Change, Harvard Medical School, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2 Senior Resident, Department of Neurosurgery, University of Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McKirdy</LastName>
            <ForeName>Michael J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>3 Consultant General Surgeon, General Surgery, Royal Alexandra Hospital, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meara</LastName>
            <ForeName>John G</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>1 Paul Farmer Research Fellow (KAV) and Kletjian Professor of Global Surgery (JGM), Program in Global Surgery and Social Change, Harvard Medical School, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>4 Plastic Surgeon-in-Chief, Boston Children's Hospital, Plastic &amp; Oral Surgery, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D019531">Lecture</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Scotland</Country>
        <MedlineTA>Scott Med J</MedlineTA>
        <NlmUniqueID>2983335R</NlmUniqueID>
        <ISSNLinking>0036-9330</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013513" MajorTopicYN="N">Obstetric Surgical Procedures</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009774" MajorTopicYN="N">Obstetrics</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Global surgery</Keyword>
        <Keyword MajorTopicYN="N">anaesthesia</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">health systems</Keyword>
        <Keyword MajorTopicYN="N">obstetrics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30336741</ArticleId>
        <ArticleId IdType="doi">10.1177/0036933018804125</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30329052</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>12</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1460-2245</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>34</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Health promotion international</Title>
          <ISOAbbreviation>Health Promot Int</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Community-based interventions for prevention of Type 2 diabetes in low- and middle-income countries: a systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>1218</StartPage>
          <EndPage>1230</EndPage>
          <MedlinePgn>1218-1230</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/heapro/day081</ELocationID>
        <Abstract>
          <AbstractText>Type 2 diabetes is an increasing burden in low- and middle-income countries (LMICs). Knowledge of effective prevention programs in LMICs is thus important. The aim of this review was to establish an overview of studies evaluating the effectiveness of community-based interventions for prevention of Type 2 diabetes in LMICs. A literature review with searches in the databases using MEDLINE in Ovid (Ovid MEDLINE&#xAE; In-Process &amp; Other Non-Indexed Citations, Ovid MEDLINE(R) Daily, Ovid MEDLINE and Version (R); Embase; PsycINFO; Global Health; and Google Scholar) between 1 January 2000 and 31 December 2015 was conducted. Only 10 studies that met our selection criteria were included; 3 were randomized controlled trials, 2 non-randomized controlled trials and 5 were pre-and post-intervention studies. About 9 of 10 studies reported significant reduction in both the glycated hemoglobin (HbA1c) and fasting blood glucose (FBG) levels as a result of the intervention. A majority of the studies included multicomponent interventions such as education and behavioral encompassing both individual and group work, and included health education, nutrition education, nutrition counseling, exercise and promoting physical activity, psychosocial approaches and lifestyle modification. The interventions were delivered by community health workers, volunteers, social workers, community nutritionists and community nurses. Comparisons between studies, however, was not possible due to substantial heterogeneity in study design. This review contributes to the current literature on community-based interventions for prevention of Type 2 diabetes in LMICs, acknowledging the community-based approach can be effective in prevention and control of Type 2 diabetes. Due to the heterogeneity across study designs, outcomes and in terms of variation and duration of interventions, only limited conclusions can be drawn about the effectiveness of interventions. More evidence from randomized controlled trials on culturally tailored, community-based interventions is needed to compare findings and test implementation in practice.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gyawali</LastName>
            <ForeName>Bishal</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Public Health, Aarhus University, Bartholins All&#xE9; 2, 8000 Aarhus C, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bloch</LastName>
            <ForeName>Joakim</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, University of Copenhagen, St. Kannikestraede 2, 1160 Copenhagen C, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vaidya</LastName>
            <ForeName>Abhinav</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Community Medicine, Kathmandu Medical College, Kathmandu PO Box: 21266, Nepal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kallestrup</LastName>
            <ForeName>Per</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Public Health, Aarhus University, Bartholins All&#xE9; 2, 8000 Aarhus C, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Health Promot Int</MedlineTA>
        <NlmUniqueID>9008939</NlmUniqueID>
        <ISSNLinking>0957-4824</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003153" MajorTopicYN="N">Community Health Services</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003150" MajorTopicYN="N">Community Health Workers</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003376" MajorTopicYN="N">Counseling</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054521" MajorTopicYN="N">Cultural Competency</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015438" MajorTopicYN="N">Health Behavior</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006266" MajorTopicYN="N">Health Education</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011322" MajorTopicYN="N">Primary Prevention</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000068217" MajorTopicYN="N">Social Workers</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Type 2 diabetes</Keyword>
        <Keyword MajorTopicYN="N">intervention</Keyword>
        <Keyword MajorTopicYN="N">literature review</Keyword>
        <Keyword MajorTopicYN="N">low- and middle-income countries</Keyword>
        <Keyword MajorTopicYN="N">prevention</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30329052</ArticleId>
        <ArticleId IdType="doi">10.1093/heapro/day081</ArticleId>
        <ArticleId IdType="pii">5133273</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30327188</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-7361</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>165</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Surgery</Title>
          <ISOAbbreviation>Surgery</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Assessing the impact of HIV status on injury outcomes: A multicenter study of trauma patients in Rwanda.</ArticleTitle>
        <Pagination>
          <StartPage>444</StartPage>
          <EndPage>449</EndPage>
          <MedlinePgn>444-449</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surg.2018.07.037</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0039-6060(18)30497-5</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">There is conflicting evidence regarding the impact of human immunodeficiency virus serostatus on trauma outcomes in low-resource settings. This study sought to evaluate the impact of human immunodeficiency virus serostatus on mortality outcomes for Rwandan patients presenting after trauma.</AbstractText>
          <AbstractText Label="METHODS">This retrospective review of the University of Rwanda trauma registry captured all adult trauma patients with known human immunodeficiency virus status presenting between March 2011 and July 2015. Confirmed human immunodeficiency virus-positive cases were matched 1:2 with known human immunodeficiency virus-negative controls using a modified Kampala Trauma Score, sex, and district of residence or primary hospital. All-cause mortality was compared using multivariable logistic regression.</AbstractText>
          <AbstractText Label="RESULTS">In total, 11,280 patients were recorded prospectively in the registry (169 human immunodeficiency virus positive; 334 human immunodeficiency virus negative matches). There was no difference in delay of hospital presentation or time until operation (P&#x202F;=&#x202F;.50 and P&#x202F;=&#x202F;.57, respectively). Less than 30% of all patients underwent operation during admission (n&#x202F;=&#x202F;133), and the rate of operative intervention was independent of human immunodeficiency virus serostatus (P&#x202F;=&#x202F;.946). There was no association between development of any complication and human immunodeficiency virus status (P&#x202F;=&#x202F;.837). The overall mortality rate was 8.9% and 3.3% for human immunodeficiency virus-positive and human immunodeficiency virus-negative patients, respectively (P&#x202F;=&#x202F;.010). Human immunodeficiency virus positivity was associated with increased 30-day mortality when controlling for potential confounders (P&#x202F;=&#x202F;.016; odds ratio 3.60, 95% confidence interval: 1.27-10.2, C statistic 0.88).</AbstractText>
          <AbstractText Label="CONCLUSION">Both human immunodeficiency virus and trauma pose substantial public health threats in sub-Saharan Africa. Known human immunodeficiency virus seropositivity in Rwandan trauma patients is associated with early mortality. Further investigation regarding testing, treatment, and outcomes in human immunodeficiency virus-positive trauma patients is warranted and provides an opportunity for leveraging human immunodeficiency virus global health efforts in trauma outcomes assessment.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018. Published by Elsevier Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Martin</LastName>
            <ForeName>Allison N</ForeName>
            <Initials>AN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Virginia, Charlottesville, VA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Byiringiro</LastName>
            <ForeName>Jean Claude</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Clinical Education and Research, University Teaching Hospital of Kigali, Kigali, Rwanda; College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda. Electronic address: jcbyiringiro@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Petroze</LastName>
            <ForeName>Robin T</ForeName>
            <Initials>RT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatric Surgery, Montreal&#xA0;Children's Hospital, Montreal, Quebec, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nkeshimana</LastName>
            <ForeName>Menelas</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Accident and Emergency, University Teaching Hospital of Kigali, Rwanda.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Byiringiro</LastName>
            <ForeName>Fidele</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University Teaching Hospital of Kigali, Rwanda.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Calland</LastName>
            <ForeName>James F</ForeName>
            <Initials>JF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Virginia, Charlottesville, VA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R24 TW007988</GrantID>
            <Acronym>TW</Acronym>
            <Agency>FIC NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016448">Multicenter Study</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Surgery</MedlineTA>
        <NlmUniqueID>0417347</NlmUniqueID>
        <ISSNLinking>0039-6060</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012432" MajorTopicYN="N" Type="Geographic">Rwanda</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName>
          <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30327188</ArticleId>
        <ArticleId IdType="doi">10.1016/j.surg.2018.07.037</ArticleId>
        <ArticleId IdType="pii">S0039-6060(18)30497-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30326281</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1567-7257</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>72</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</Title>
          <ISOAbbreviation>Infect Genet Evol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Improving diagnosis and case management of patients with tuberculosis: A review of gaps, needs and potential solutions in accessing laboratory diagnostics.</ArticleTitle>
        <Pagination>
          <StartPage>131</StartPage>
          <EndPage>140</EndPage>
          <MedlinePgn>131-140</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.meegid.2018.08.030</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1567-1348(18)30629-4</ELocationID>
        <Abstract>
          <AbstractText>Tuberculosis (TB) recently surpassed HIV/AIDS as the deadliest infectious disease. Despite some advancements in technologies and programs, TB remains a global health epidemic that, without significant gains in better diagnostic and management, will not abate. This review describes the molecular diagnostic gaps, needs, and potential solutions for improving access to diagnosis and management of patients with drug susceptible and drug resistant TB. The ultimate goal is to improve laboratory diagnostics and better individualized managementof detected TB, and make an important contribution toward eliminating this global epidemic. RATIONALE: Tuberculosis persists as one of the world's most deadly infectious disease. To make substantive progress toward TB elimination and end the global tuberculosis epidemic by 2035, innovative approaches and technologies are essential. Among the various related and complementary scientific and clinical milestones toward elimination, including vaccine development and new therapeutic regimens, one of the greatest challenges is to address the gaps in existing diagnostics. Current diagnostic technologies fall short in meeting the complex nature of the disease and its epidemiologic profile. This review concentrates and outlines the priorities for development of laboratory diagnostic tools for screening and diagnosing TB. APPROACH: The approaches and priorities described in this manuscript are based on identified gaps of current laboratory diagnosis of different clinical forms of TB. Closing these gaps will enable national programs to more efficiently diagnose TB, monitor treatment efficacy, and control drug resistance. Prioritization is based on technologies that address facilitate a more patient-centered approach, and are appropriate for low-resource and high-burden TB settings. New diagnostics must complement current or anticipated developments elsewhere and accelerate increased coverage, quality, and impact at the lower levels of the healthcare system.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Andama</LastName>
            <ForeName>Alfred</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>College of Health Sciences, Makerere University, Kampala, Uganda. Electronic address: andama.alf@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Somoskovi</LastName>
            <ForeName>Akos</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Global Good Fund, Intellectual Ventures Laboratory, Bellevue, USA. Electronic address: asomoskovi@intven.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mandel</LastName>
            <ForeName>Brinnon</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Global Good Fund, Intellectual Ventures Laboratory, Bellevue, USA. Electronic address: bmandel@intven.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bell</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Global Good Fund, Intellectual Ventures Laboratory, Bellevue, USA. Electronic address: dbell@intven.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gutierrez</LastName>
            <ForeName>Cristina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Independent Consultant, Vigo, Spain. Electronic address: crisgupe1@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Infect Genet Evol</MedlineTA>
        <NlmUniqueID>101084138</NlmUniqueID>
        <ISSNLinking>1567-1348</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019090" MajorTopicYN="N">Case Management</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019411" MajorTopicYN="Y">Clinical Laboratory Techniques</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056990" MajorTopicYN="N">Post-Exposure Prophylaxis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
          <QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018088" MajorTopicYN="N">Tuberculosis, Multidrug-Resistant</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Diagnostics</Keyword>
        <Keyword MajorTopicYN="N">Molecular</Keyword>
        <Keyword MajorTopicYN="N">Novel</Keyword>
        <Keyword MajorTopicYN="N">Tuberculosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30326281</ArticleId>
        <ArticleId IdType="doi">10.1016/j.meegid.2018.08.030</ArticleId>
        <ArticleId IdType="pii">S1567-1348(18)30629-4</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30325704</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-1706</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global public health</Title>
          <ISOAbbreviation>Glob Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Prevalence of traditional, complementary, and alternative medicine use by cancer patients in low income and lower-middle income countries.</ArticleTitle>
        <Pagination>
          <StartPage>418</StartPage>
          <EndPage>430</EndPage>
          <MedlinePgn>418-430</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2018.1534254</ELocationID>
        <Abstract>
          <AbstractText>The use of traditional, complementary, and alternative medicine (TCAM) for cancer may influence the delivery or effectiveness of conventional cancer treatment. In this systematic review, we aimed to (1) summarise the available prevalence data on traditional medicine use by cancer patients in less developed countries (LDCs), and (2) stratify the prevalence data by world region and country income level. A literature search for cancer, TCAM, and low income (LI) and lower-middle income (LMI) countries was conducted across 5 databases. A total of 2,365 publications were reviewed for eligibility, of which 25 studies met inclusion criteria. The combined sample size was 6,878 cancer patients, with a median of 54.5% reporting the use of TCAM for cancer care. Of the studies providing data on the concomitant use of TCAM and conventional cancer treatment (<i>n</i>&#x2009;=&#x2009;4,872 cancer patients), a median of 26.7% of participants reported combining the two systems of medicine. From the data available, it is apparent that TCAM use among cancer patients in less developed countries is common; however, additional studies are needed to support the safe and effective management of cancer for patients in LI and LMI countries.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hill</LastName>
            <ForeName>Jacob</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-9695-2166</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physical Medicine and Rehabilitation, Program on Integrative Medicine, University of North Carolina, Chapel Hill, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mills</LastName>
            <ForeName>Coleman</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Quefeng</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Jennifer S</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>T32 AT003378</GrantID>
            <Acronym>AT</Acronym>
            <Agency>NCCIH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Public Health</MedlineTA>
        <NlmUniqueID>101256323</NlmUniqueID>
        <ISSNLinking>1744-1692</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000529" MajorTopicYN="Y">Complementary Therapies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008519" MajorTopicYN="Y">Medicine, Traditional</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011203" MajorTopicYN="Y">Poverty</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Traditional medicine</Keyword>
        <Keyword MajorTopicYN="N">cancer</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">less developed countries</Keyword>
        <Keyword MajorTopicYN="N">public health</Keyword>
      </KeywordList>
      <CoiStatement>Disclaimer/Conflict of Interest. The authors have no conflict of interest to disclose regarding this
systematic review.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>16</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30325704</ArticleId>
        <ArticleId IdType="mid">NIHMS1510258</ArticleId>
        <ArticleId IdType="pmc">PMC6467694</ArticleId>
        <ArticleId IdType="doi">10.1080/17441692.2018.1534254</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abdullahi AA (2011). Trends and challenges of traditional medicine in Africa. African Journal of Traditional, Complementary, and Alternative Medicines&#x202F;: AJTCAM, 8(5 Suppl), 115&#x2013;23. 10.4314/ajtcam.v8i5S.5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4314/ajtcam.v8i5S.5</ArticleId>
            <ArticleId IdType="pmc">PMC3252714</ArticleId>
            <ArticleId IdType="pubmed">22754064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Afungchwi GM, Hesseling PB, &amp; Ladas EJ (2017). The role of traditional healers in the diagnosis and management of Burkitt lymphoma in Cameroon: understanding the challenges and moving forward. BMC Complementary and Alternative Medicine, 17(1), 209 10.1186/s12906-017-1719-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12906-017-1719-y</ArticleId>
            <ArticleId IdType="pmc">PMC5387296</ArticleId>
            <ArticleId IdType="pubmed">28399870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alexander GA (1985). A survey of traditional medical
practices used for the treatment of malignant tumors in an East African
population. Social Science &amp; Medicine
(1982), 20(1),
53&#x2013;9. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3975670</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3975670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American Cancer Society. (2015). Global Cancer Facts &amp; Figures 3rd Edition. American Cancer Society, (800), 1&#x2013;64. 10.1002/ijc.27711</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.27711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asuzu CC, Elumelu-Kupoluyi T, Asuzu MC, Campbell OB, Akin-Odanye EO, &amp; Lounsbury D (2017). A pilot study of cancer patients&#x2019; use of traditional healers in the Radiotherapy Department, University College Hospital, Ibadan, Nigeria. Psycho-Oncology, 26(3), 369&#x2013;376. 10.1002/pon.4033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pon.4033</ArticleId>
            <ArticleId IdType="pubmed">26577066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blaes AH, Kreitzer MJ, Torkelson C, &amp; Haddad T (2011). Nonpharmacologic Complementary Therapies in Symptom Management for Breast Cancer Survivors. Seminars in Oncology, 38(3), 394&#x2013;402. 10.1053/j.seminoncol.2011.03.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.seminoncol.2011.03.009</ArticleId>
            <ArticleId IdType="pubmed">21600369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Block KI, &amp; Gyllenhaal C (2002). Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes. Integr Cancer Ther, 1(1), 83&#x2013;89. 10.1177/1534735402001001007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1534735402001001007</ArticleId>
            <ArticleId IdType="pubmed">14664751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bodeker G, &amp; Kronenberg F (2002). A public health agenda for
traditional, complementary, and alternative medicine.
American Journal of Public Health,
92(10),
1582&#x2013;91. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/12356597</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3221447</ArticleId>
            <ArticleId IdType="pubmed">12356597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brahmi SA, El M&#x2019;rabet FZ, Benbrahim Z, Akesbi Y, Amine B, Nejjari C, &amp; El Mesbahi O (2011). Complementary medicine use among
Moroccan patients with cancer: a descriptive study.
The Pan African Medical Journal, 10,
36
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22187618</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3240925</ArticleId>
            <ArticleId IdType="pubmed">22187618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Broom A, Wijewardena K, Sibbritt D, Adams J, &amp; Nayar KR (2010). The use of traditional, complementary and alternative medicine in Sri Lankan cancer care: Results from a survey of 500 cancer patients. Public Health, 124(4), 232&#x2013;237. 10.1016/j.puhe.2010.02.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.puhe.2010.02.012</ArticleId>
            <ArticleId IdType="pubmed">20363486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaturvedi P, Chaturvedi U, &amp; Sanyal B (2002). Alternative medicine and cancer patients in less developed countries. The Lancet Oncology. 10.1016/S1470-2045(01)00615-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1470-2045(01)00615-5</ArticleId>
            <ArticleId IdType="pubmed">11905597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clegg-Lamptey JNA, Dakuboandy JCB, &amp; Attobra YN (2009). Psychosocial aspects of breast cancer treatment in Accra, Ghana. East African Medical Journal, 86(7). 10.4314/eamj.v86i7.54152</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4314/eamj.v86i7.54152</ArticleId>
            <ArticleId IdType="pubmed">20499785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis EL, Oh B, Butow PN, Mullan BA, &amp; Clarke S (2012). Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. The Oncologist, 17(11), 1475&#x2013;81. 10.1634/theoncologist.2012-0223</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1634/theoncologist.2012-0223</ArticleId>
            <ArticleId IdType="pmc">PMC3500370</ArticleId>
            <ArticleId IdType="pubmed">22933591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Ver Dye T, Bogale S, Hobden C, Tilahun Y, Hechter V, Deressa T, &#x2026; Reeler A. (2011). A mixed-method assessment of beliefs and practice around breast cancer in Ethiopia: implications for public health programming and cancer control. Global Public Health, 6(7), 719&#x2013;31. 10.1080/17441692.2010.510479</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17441692.2010.510479</ArticleId>
            <ArticleId IdType="pubmed">20865612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erku DA (2016). Complementary and Alternative Medicine Use and Its Association with Quality of Life among Cancer Patients Receiving Chemotherapy in Ethiopia: A Cross-Sectional Study. Evidence-Based Complementary and Alternative Medicine, 2016, 1&#x2013;8. 10.1155/2016/2809875</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/2809875</ArticleId>
            <ArticleId IdType="pmc">PMC4940514</ArticleId>
            <ArticleId IdType="pubmed">27433182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezeome ER, &amp; Anarado AN (2007). Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria. BMC Complementary and Alternative Medicine, 7(1), 28 10.1186/1472-6882-7-28</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1472-6882-7-28</ArticleId>
            <ArticleId IdType="pmc">PMC2034592</ArticleId>
            <ArticleId IdType="pubmed">17850665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta M, Shafiq N, Kumari S, &amp; Pandhi P (2002). Patterns and perceptions of complementary and alternative medicine ( CAM ) among leukaemia patients visiting haematology clinic of a north Indian tertiary care hospital. Pharmacoepidemiology and Drug Safety, 11, 671&#x2013;676.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12512243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>INCTR Strategies-INCTR &#x2013;
International Network for Cancer Treatment and Research.
(2016). Retrieved December 20, 2016, from http://www.inctr.org/about-inctr/inctr-strategies/</Citation>
        </Reference>
        <Reference>
          <Citation>Jaradat NA, Shawahna R, Eid AM, Al-Ramahi R, Asma MK, &amp; Zaid AN (2016). Herbal remedies use by breast cancer patients in the West Bank of Palestine. Journal of Ethnopharmacology, 178, 1&#x2013;8. 10.1016/j.jep.2015.11.050</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jep.2015.11.050</ArticleId>
            <ArticleId IdType="pubmed">26656536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kazaura R
Kombe, D. Yuma, safina. Mtiro, Hussein. Mlawa, G.
(2007). Health Seeking Behaviour Among Cancer
Patients attending Ocean Road Cancer Institute, Tanzania.
East African Journal of Public Health,
4(1),
19&#x2013;22. Retrieved from
http://www.bioline.org.br/request?lp07004</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17907756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar D, Goel NK, &amp; Pandey AK (2016). Complementary and alternative medicine use among the cancer patients in Northern India. South Asian Journal of Cancer, 5(1), 8&#x2013;11. 10.4103/2278-330X.179689</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/2278-330X.179689</ArticleId>
            <ArticleId IdType="pmc">PMC4845611</ArticleId>
            <ArticleId IdType="pubmed">27169110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ladas E, Ricas S, Ndao D, Damoulakis D, Yuan Yuan B, Cheng B, &#x2026; Antillon F. (2014). Use of Traditional and Complementary/Alternative Medicine (TCAM) in Children with Cancer in Guatelama. Pediatric Blood and Cancer, 61, 687&#x2013;692.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24504792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ly M, Diop S, Sacko M, Baby M, Diop CT, &amp; Diallo D (2002). Cancer du sein&#x202F;: Facteurs influencant l&#x2019;itineraire therapeurtique des usagers d&#x2019;un service d&#x2019;oncologie medicale a Bamako (Mali). Bulletin Du Cancer, 89(3), 323&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11940471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malik IA, &amp; Gopalan S (2003). Use of CAM results in delay in seeking medical advice for breast cancer. European Journal of Epidemiology, 18(8), 817&#x2013;822. 10.1023/A:1025343720564</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1025343720564</ArticleId>
            <ArticleId IdType="pubmed">12974558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malik IA, Khan NA, &amp; Khan W (2000). Use of unconventional methods of therapy by cancer patients in Pakistan. European Journal of Epidemiology, 16(2), 155&#x2013;160. 10.1023/A:1007621104789</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1007621104789</ArticleId>
            <ArticleId IdType="pubmed">10845265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malik I, &amp; Qureshi A (1997). Communication with Cancer Patients. Annals of the New York Academy of Sciences, 809(1 Communication), 300&#x2013;308. 10.1111/j.1749-6632.1997.tb48093.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1749-6632.1997.tb48093.x</ArticleId>
            <ArticleId IdType="pubmed">9103581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obrist M, Osei-Bonsu E, Awuah B, Watanabe-Galloway S, Merajver SD, Schmid K, &amp; Soliman AS (2014). Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. The Breast, 23(6), 821&#x2013;828. 10.1016/j.breast.2014.08.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.breast.2014.08.014</ArticleId>
            <ArticleId IdType="pmc">PMC4274250</ArticleId>
            <ArticleId IdType="pubmed">25282667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oyunchimeg B, Hwang JH, Ahmed M, Choi S, &amp; Han D (2017). Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey. BMC Complement Altern Med, 17(1), 58 10.1186/s12906-017-1576-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12906-017-1576-8</ArticleId>
            <ArticleId IdType="pmc">PMC5244576</ArticleId>
            <ArticleId IdType="pubmed">28103860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruff P, Al-Sukhun S, Blanchard C, &amp; Shulman LN (2016). Access to Cancer Therapeutics in Low- and Middle-Income Countries. American Society of Clinical Oncology Educational Book, 36, 58&#x2013;65. 10.14694/EDBK_155975</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14694/EDBK_155975</ArticleId>
            <ArticleId IdType="pubmed">27249686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandar K, Win L, Han W, Aye Aye K, Than Than L, Kyu Kyu S, &#x2026; Khin M. (2013). Use of Complementary and Alternative Medicine (CAM) in Children with Cancer at Yangon Children&#x2019;s Hospital. The Mayanmar Health Sciences Research Journal, 25(3), 183&#x2013;188.</Citation>
        </Reference>
        <Reference>
          <Citation>Stewart B, &amp; Wild C (2014). World Health Organization World Cancer Report 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Tazi I, Nafil H, Mahmal L, Harif M, Khouchani M, Saadi Z, &#x2026; Tahri A. (2013). Les m&#xE9;decines alternatives et compl&#xE9;mentaires chez les patients canc&#xE9;reux en cours de traitement &#xE0; Marrakech, Maroc: &#xE9;tude prospective. Bulletin de La Societe de Pathologie Exotique, 106(4), 278&#x2013;285. 10.1007/s13149-013-0308-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13149-013-0308-7</ArticleId>
            <ArticleId IdType="pubmed">24057644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tovey P, Broom A, Chatwin J, Ahmad S, &amp; Hafeez M (2005). Use of traditional, complementary and allopathic medicines in Pakistan by cancer patients. Rural and Remote Health, 5, 447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16351496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villa S, Compagni A, &amp; Reich MR (2009). Orphan drug legislation: lessons for neglected tropical diseases. The International Journal of Health Planning and Management, 24(1), 27&#x2013;42. 10.1002/hpm.930</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hpm.930</ArticleId>
            <ArticleId IdType="pubmed">18435430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Bank list of economies
(September 2016). (2016). Retrieved from
http://www.ispo2017.org/wp-content/uploads/2016/11/World-Bank-List-of-Economies.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization.
(2002). WHO Traditional Medicine Strategy
2002&#x2013;2005. WHO Traditional Medicine Strategy World Health
Organization Geneva. Retrieved from http://www.wpro.who.int/health_technology/book_who_traditional_medicine_strategy_2002_2005.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization.
(2013). WHO Traditional Medicine Strategy
2014&#x2013;2023. https://doi.org/2013</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization.
(2018). WHO Cancer Factsheet.
Retrieved December 20, 2016, from http://www.who.int/mediacentre/factsheets/fs297/en/</Citation>
        </Reference>
        <Reference>
          <Citation>Yarney J, Donkor A, Opoku SY, Yarney L, Agyeman-Duah I, Abakah AC, &amp; Asampong E (2013). Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study. BMC Complementary and Alternative Medicine, 13, 16 10.1186/1472-6882-13-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1472-6882-13-16</ArticleId>
            <ArticleId IdType="pmc">PMC3565863</ArticleId>
            <ArticleId IdType="pubmed">23331546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yomi J, &amp; Gonsu F (1995). Causes sociales, economiques et educationnelles du diagnositic et du traitement tardif des cancers au Cameroun. Bulletin Du Cancer, 82, 724&#x2013;727.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8535031</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30325010</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>12</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2249</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>195</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical and experimental immunology</Title>
          <ISOAbbreviation>Clin Exp Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Th17 responses to pneumococcus in blood and adenoidal cells in children.</ArticleTitle>
        <Pagination>
          <StartPage>213</StartPage>
          <EndPage>225</EndPage>
          <MedlinePgn>213-225</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cei.13225</ELocationID>
        <Abstract>
          <AbstractText>Pneumococcal infections cause a large global health burden, and the search for serotype-independent vaccines continues. Existing conjugate vaccines reduce nasopharyngeal colonization by target serotypes. Such mucosal effects of novel antigens may similarly be important. CD4<sup>+</sup> Th17 cell-dependent, antibody-independent reductions in colonization and enhanced clearance have been described in mice. Here we describe the evaluation of T helper type 17 (Th17) cytokine responses to candidate pneumococcal protein vaccine antigens in human cell culture, using adenoidal and peripheral blood mononuclear cells. Optimal detection of interleukin (IL)-17A was at day 7, and of IL-22 at day 11, in these primary cell cultures. Removal of CD45RO<sup>+</sup> memory T cells abolished these responses. Age-associated increases in magnitude of responses were evident for IL-17A, but not IL-22, in adenoidal cells. There was a strong correlation between individual IL-17A and IL-22 responses after pneumococcal antigen stimulation (P&#xA0;&lt;&#xA0;0&#xB7;015). Intracellular cytokine staining following phorbol myristate acetate (PMA)/ionomycin stimulation demonstrated that &#xA0;&gt;&#xA0;30% CD4<sup>+</sup> T cells positive for IL-22 express the innate markers &#x3B3;&#x3B4;T cell receptor and/or CD56, with much lower proportions for IL-17A<sup>+</sup> cells (P&#xA0;&lt;&#xA0;0&#xB7;001). Responses to several vaccine candidate antigens were observed but were consistently absent, particularly in blood, to PhtD (P&#xA0;&lt;&#xA0;0&#xB7;0001), an antigen recently shown not to impact colonization in a clinical trial of a PhtD-containing conjugate vaccine in infants. The data presented and approach discussed have the potential to assist in the identification of novel vaccine antigens aimed at reducing pneumococcal carriage and transmission, thus improving the design of empirical clinical trials.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 British Society for Immunology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Oliver</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0002-1211-1942</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pope</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Clarke</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Vaccines and Immunity Theme, MRC Unit The Gambia, Fajara, The Gambia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Langton Hewer</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Bristol Royal Hospital for Children, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ogunniyi</LastName>
            <ForeName>A D</ForeName>
            <Initials>AD</Initials>
            <AffiliationInfo>
              <Affiliation>Australian Centre for Antimicrobial Resistance Ecology, School of Animal and Veterinary Sciences, The University of Adelaide, Adelaide, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paton</LastName>
            <ForeName>J C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Research Centre for Infectious Diseases, Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mitchell</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Malley</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Medicine, Children's Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Finn</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>School of Cellular and Molecular Medicine, Biomedical Sciences Building, University of Bristol, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MC_EX_MR/M007529/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MC_EX_MR/R006148/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MC_UP_A900_1115</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Clin Exp Immunol</MedlineTA>
        <NlmUniqueID>0057202</NlmUniqueID>
        <ISSNLinking>0009-9104</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C508717">IL17A protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D020381">Interleukin-17</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007378">Interleukins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018074">Vaccines, Conjugate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000234" MajorTopicYN="N">Adenoids</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007156" MajorTopicYN="N">Immunologic Memory</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020381" MajorTopicYN="N">Interleukin-17</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011008" MajorTopicYN="N">Pneumococcal Infections</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058504" MajorTopicYN="N">Th17 Cells</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018074" MajorTopicYN="N">Vaccines, Conjugate</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000097043" MajorTopicYN="N">Interleukin-22</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">T cells</Keyword>
        <Keyword MajorTopicYN="N">cytokines</Keyword>
        <Keyword MajorTopicYN="N">human</Keyword>
        <Keyword MajorTopicYN="N">vaccination</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30325010</ArticleId>
        <ArticleId IdType="pmc">PMC6330644</ArticleId>
        <ArticleId IdType="doi">10.1111/cei.13225</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>O&#x2019;Brien KL, Wolfson LJ, Watt JP et al Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009;374:893&#x2013;902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19748398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pneumococcal conjugate vaccine for childhood immunization&#xA0;&#x2013;&#xA0;WHO position paper. Wkly Epidemiol Rec 2007;82:93&#x2013;104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17380597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reinert RR. The antimicrobial resistance profile of Streptococcus pneumoniae . Clin Microbiol Infect 2009;15(Suppl 3):7&#x2013;11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19366363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim L, McGee L, Tomczyk S, Beall B. Biological and epidemiological features of antibiotic&#x2010;resistant streptococcus pneumoniae in pre&#x2010; and post&#x2010;conjugate vaccine eras: a United States perspective. Clin Microbiol Rev 2016;29:525&#x2013;52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4861989</ArticleId>
            <ArticleId IdType="pubmed">27076637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Bernatoniene J, Bagrade L et al Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status. Eur J Immunol 2006;36:46&#x2013;57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16342325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hogberg L, Geli P, Ringberg H, Melander E, Lipsitch M, Ekdahl K. Age&#x2010; and serogroup&#x2010;related differences in observed durations of nasopharyngeal carriage of penicillin&#x2010;resistant pneumococci. J Clin Microbiol 2007;45:948&#x2013;52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1829115</ArticleId>
            <ArticleId IdType="pubmed">17202280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipsitch M, Whitney CG, Zell E, Kaijalainen T, Dagan R, Malley R. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLOS Med 2005;2:e15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC545206</ArticleId>
            <ArticleId IdType="pubmed">15696204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004;4:144&#x2013;54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14998500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waight PA, Andrews NJ, Ladhani NJ, Sheppard CL, Slack MP, Miller E. Effect of the 13&#x2010;valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis 2015;15:535&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25801458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
PHE
. Pneumococcal disease infections caused by serotypes not in Prevenar 13 vaccine 2017 [updated 27th March 2017]. Available at: https://www.gov.uk/government/publications/pneumococcal-disease-caused-by-strains-not-covered-by-prevenar-13-vaccine/pneumococcal-disease-infections-caused-by-serotypes-not-in-prevenar-13-vaccine (accessed 19 October 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011;378:1962&#x2013;73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3256741</ArticleId>
            <ArticleId IdType="pubmed">21492929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M. CD4+ T cells mediate antibody&#x2010;independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci USA 2005;102:4848&#x2013;53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC555733</ArticleId>
            <ArticleId IdType="pubmed">15781870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malley R, Srivastava A, Lipsitch M et al Antibody&#x2010;independent, interleukin&#x2010;17A&#x2010;mediated, cross&#x2010;serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 2006;74:2187&#x2013;95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1418935</ArticleId>
            <ArticleId IdType="pubmed">16552049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Basset A, Thompson CM, Hollingshead SK et al Antibody&#x2010;independent, CD4+ T&#x2010;cell&#x2010;dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun 2007;75:5460&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2168310</ArticleId>
            <ArticleId IdType="pubmed">17698570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu YJ, Gross J, Bogaert D et al Interleukin&#x2010;17A mediates acquired immunity to pneumococcal colonization. PLOS Pathog 2008;4:e1000159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2528945</ArticleId>
            <ArticleId IdType="pubmed">18802458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17&#x2010;dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009;119:1899&#x2013;909.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2701860</ArticleId>
            <ArticleId IdType="pubmed">19509469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harrington LE, Hatton RD, Mangan PR et al Interleukin 17&#x2010;producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123&#x2013;32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16200070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang SC, Tan XY, Luxenberg DP et al Interleukin (IL)&#x2010;22 and IL&#x2010;17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203:2271&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2118116</ArticleId>
            <ArticleId IdType="pubmed">16982811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malley R, Lipsitch M, Stack A et al Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun 2001;69:4870&#x2013;3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC98576</ArticleId>
            <ArticleId IdType="pubmed">11447162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogunniyi AD, Folland RL, Briles DE, Hollingshead SK, Paton JC. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae . Infect Immun 2000;68:3028&#x2013;33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC97524</ArticleId>
            <ArticleId IdType="pubmed">10769009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogunniyi AD, Woodrow MC, Poolman JT, Paton JC. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect Immun 2001;69:5997&#x2013;6003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC98727</ArticleId>
            <ArticleId IdType="pubmed">11553536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rioux S, Neyt C, Di Paolo E et al Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae . Microbiology 2011;157:336&#x2013;48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20966093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Choo S, Finn A. Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children. Infect Immun 2002;70:5363&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC128328</ArticleId>
            <ArticleId IdType="pubmed">12228260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Bagrade L, Bernatoniene J et al Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children. J Infect Dis 2007;195:1194&#x2013;202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17357058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pope C, Oliver EH, Ma J, Langton Hewer C, Mitchell TJ, Finn A. Genetic conjugation of components in two pneumococcal fusion protein vaccines enhances paediatric mucosal immune responses. Vaccine 2015;33:1711&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25698489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rapola S, Jantti V, Haikala R et al Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis 2000;182:1146&#x2013;52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10979911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundgren A, Bhuiyan TR, Novak D et al Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country. Vaccine 2012;30:3897&#x2013;907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3369217</ArticleId>
            <ArticleId IdType="pubmed">22504663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fossiez F, Djossou O, Chomarat P et al T cell interleukin&#x2010;17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996;183:2593&#x2013;603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2192621</ArticleId>
            <ArticleId IdType="pubmed">8676080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mangan PR, Harrington LE, O&#x2019;Quinn DB et al Transforming growth factor&#x2010;beta induces development of the T(H)17 lineage. Nature 2006;441:231&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16648837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bettelli E, Carrier Y, Gao W et al Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16648838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klugman KP, Madhi SA, Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis 2007;20:11&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17197876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rachitskaya AV, Hansen AM, Horai R et al Cutting edge: NKT cells constitutively express IL&#x2010;23 receptor and RORgammat and rapidly produce IL&#x2010;17 upon receptor ligation in an IL&#x2010;6&#x2010;independent fashion. J Immunol 2008;180:5167&#x2013;71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2442579</ArticleId>
            <ArticleId IdType="pubmed">18390697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goto M, Murakawa M, Kadoshima&#x2010;Yamaoka K et al. Murine NKT cells produce Th17 cytokine interleukin&#x2010;22. Cell Immunol 2009;254:81&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19010461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lockhart E, Green AM, Flynn JL. IL&#x2010;17 production is dominated by &#x3B3;&#x3B4; T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006;177:4662&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16982905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ness&#x2010;Schwickerath KJ, Jin C, Morita CT. Cytokine requirements for the differentiation and expansion of IL&#x2010;17A&#x2010; and IL&#x2010;22&#x2010;producing human Vgamma2Vdelta2 T cells. J Immunol 2010;184:7268&#x2013;80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2965829</ArticleId>
            <ArticleId IdType="pubmed">20483730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakasone C, Yamamoto N, Nakamatsu M et al Accumulation of gamma/delta T cells in the lungs and their roles in neutrophil&#x2010;mediated host defense against pneumococcal infection. Microbes Infect 2007;9:251&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17306586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawakami K, Yamamoto N, Kinjo Y et al Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 2003;33:3322&#x2013;30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14635040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Bernatoniene J, Bagrade L et al Regulation of production of mucosal antibody to pneumococcal protein antigens by T&#x2010;cell&#x2010;derived gamma interferon and interleukin&#x2010;10 in children. Infect Immun 2006;74:4735&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1539627</ArticleId>
            <ArticleId IdType="pubmed">16861661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briles DE, Hollingshead SK, Nabors GS, Paton JC, Brooks&#x2010;Walter A. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 2000;19(Suppl 1):S87&#x2013;95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11163470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briles DE, Ades E, Paton JC et al Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae . Infect Immun 2000;68:796&#x2013;800.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC97207</ArticleId>
            <ArticleId IdType="pubmed">10639448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trzcinski K, Thompson C, Malley R, Lipsitch M. Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun 2005;73:7043&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1230924</ArticleId>
            <ArticleId IdType="pubmed">16177389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pido&#x2010;Lopez J, Kwok WW, Mitchell TJ, Heyderman RS, Williams NA. Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory&#x2010;tract mucosal lymphoid tissue. PLOS Pathog 2011;7:e1002396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3228808</ArticleId>
            <ArticleId IdType="pubmed">22144893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Leong SC, McNamara PS, Mubarak A, Malley R, Finn A. Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. PLOS Pathog 2011;7:e1002175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3154846</ArticleId>
            <ArticleId IdType="pubmed">21852948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Odutola A, Ota MO, Antonio M et al Efficacy of a novel, protein&#x2010;based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: a phase 2, randomized, controlled, observer&#x2010;blind study. Vaccine 2017;35:2531&#x2013;42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28389097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plumptre CD, Ogunniyi AD, Paton JC. Surface association of Pht proteins of Streptococcus pneumoniae . Infect Immun 2013;81:3644&#x2013;51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3811752</ArticleId>
            <ArticleId IdType="pubmed">23876799</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30324863</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>07</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1747-0927</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Social neuroscience</Title>
          <ISOAbbreviation>Soc Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Gray matter volume covariance networks associated with social networks in older adults.</ArticleTitle>
        <Pagination>
          <StartPage>559</StartPage>
          <EndPage>570</EndPage>
          <MedlinePgn>559-570</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17470919.2018.1535999</ELocationID>
        <Abstract>
          <AbstractText>Extensive social networks are associated with better physical, mental, and cognitive health in aging, but the underlying brain substrates remain largely unexplored. Voxel-based morphometry and multivariate statistics were used to identify gray matter volume covariance networks associated with social networks in 86 older adults without dementia (<i>M</i> Age&#xA0;=&#xA0;75.20&#xA0;years, 53% women). Gray matter networks associated with the number of high-contact social roles and the total number of network members were identified after adjusting for age, sex, education, global health, and total intracranial volume - and shared nodes included medial, lateral and orbital prefrontal, hippocampal, precuneus, insular, and cingulate regions. Greater expression of these gray matter networks was associated with better memory scores on the Free and Cued Selective Reminding Test. A more distributed network was associated with high-contact social roles than total number of networks members - also extending into amygdala and entorhinal cortex. Thus, high-contact social roles and total number of network members in older adults are associated with gray matter networks composed of regions previously linked to memory and affected by both healthy aging and Alzheimer disease - and high-contact social roles are more strongly associated with brain structures than the total number of network members.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Blumen</LastName>
            <ForeName>Helena M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Medicine, Albert Einstein College of Medicine , Bronx , NY , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verghese</LastName>
            <ForeName>Joe</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Neurology, Albert Einstein College of Medicine , Bronx , NY , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K01 AG049829</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AG036921</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AG044007</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UL1 TR002556</GrantID>
            <Acronym>TR</Acronym>
            <Agency>NCATS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Soc Neurosci</MedlineTA>
        <NlmUniqueID>101279009</NlmUniqueID>
        <ISSNLinking>1747-0919</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066128" MajorTopicYN="Y">Gray Matter</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009415" MajorTopicYN="Y">Nerve Net</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060756" MajorTopicYN="Y">Social Networking</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Social networks</Keyword>
        <Keyword MajorTopicYN="N">aging</Keyword>
        <Keyword MajorTopicYN="N">multivariate statistics</Keyword>
        <Keyword MajorTopicYN="N">neuroimaging</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30324863</ArticleId>
        <ArticleId IdType="mid">NIHMS1520301</ArticleId>
        <ArticleId IdType="pmc">PMC6467743</ArticleId>
        <ArticleId IdType="doi">10.1080/17470919.2018.1535999</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Alvarez JA, &amp; Emory E (2006). Executive function and the frontal lobes: a meta-analytic review. Neuropsychology review, 16(1), 17&#x2013;42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16794878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antonucci T (1990). Social support and social relationships Handbook of aging and the social sciences. Edited by: Binstock RH, George LK. 1990: San Diego, CA: Academic Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Arias-Carri&#xF3;n O, Stamelou M, Murillo-Rodr&#xED;guez E, Men&#xE9;ndez-Gonz&#xE1;lez M, &amp; P&#xF6;ppel E (2010). Dopaminergic reward system: a short integrative review. International archives of medicine, 3(1), 24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2958859</ArticleId>
            <ArticleId IdType="pubmed">20925949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashburner J (2007). A fast diffeomorphic image registration algorithm. Neuroimage, 38(1), 95&#x2013;113. doi: 10.1016/j.neuroimage.2007.07.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroimage.2007.07.007</ArticleId>
            <ArticleId IdType="pubmed">17761438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashburner J, &amp; Friston KJ (2005). Unified segmentation. Neuroimage, 26(3), 839&#x2013;851. doi: 10.1016/j.neuroimage.2005.02.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroimage.2005.02.018</ArticleId>
            <ArticleId IdType="pubmed">15955494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashby FG (2011). Statistical analysis of fMRI data: MIT press.</Citation>
        </Reference>
        <Reference>
          <Citation>Association AP (2000). Diagnostic and statistical manual of mental disorders (revised 4th ed.). Washington, DC: American Psychiatric Association.</Citation>
        </Reference>
        <Reference>
          <Citation>Barnes LL, De Leon CM, Wilson RS, Bienias JL, &amp; Evans DA (2004). Social resources and cognitive decline in a population of older African Americans and whites. Neurology, 63(12), 2322&#x2013;2326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15623694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bassuk SS, Glass TA, &amp; Berkman LF (1999). Social disengagement and incident cognitive decline in community-dwelling elderly persons. Annals of internal medicine, 131(3), 165&#x2013;173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10428732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergfield KL, Hanson KD, Chen K, Teipel SJ, Hampel H, Rapoport SI, &#x2026; Alexander GE (2010). Age-related networks of regional covariance in MRI gray matter: reproducible multivariate patterns in healthy aging. Neuroimage, 49(2), 1750&#x2013;1759.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2789892</ArticleId>
            <ArticleId IdType="pubmed">19796692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berkman LF (1984). Assessing the physical health effects of social networks and social support. Annual review of public health, 5(1), 413&#x2013;432.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6372817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bherer L, Erickson KI, &amp; Liu-Ambrose T (2013). A review of the effects of physical activity and exercise on cognitive and brain functions in older adults. Journal of aging research, 2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3786463</ArticleId>
            <ArticleId IdType="pubmed">24102028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickart KC, Hollenbeck MC, Barrett LF, &amp; Dickerson BC (2012). Intrinsic amygdala&#x2013;cortical functional connectivity predicts social network size in humans. Journal of Neuroscience, 32(42), 14729&#x2013;14741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3569519</ArticleId>
            <ArticleId IdType="pubmed">23077058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickart KC, Hollenbeck MC, Barrett LF, &amp; Dickerson BC (2012). Intrinsic Amygdala&#x2013;Cortical Functional Connectivity Predicts Social Network Size in Humans. The Journal of Neuroscience, 32(42), 14729.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3569519</ArticleId>
            <ArticleId IdType="pubmed">23077058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickart KC, Wright CI, Dautoff RJ, Dickerson BC, &amp; Barrett LF (2011). Amygdala Volume and Social Network Size in Humans. Nature neuroscience, 14(2), 163&#x2013;164. doi: 10.1038/nn.2724</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn.2724</ArticleId>
            <ArticleId IdType="pmc">PMC3079404</ArticleId>
            <ArticleId IdType="pubmed">21186358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Botvinick MM, Cohen JD, &amp; Carter CS (2004). Conflict monitoring and anterior cingulate cortex: an update. Trends in cognitive sciences, 8(12), 539&#x2013;546. doi: 10.1016/j.tics.2004.10.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tics.2004.10.003</ArticleId>
            <ArticleId IdType="pubmed">15556023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bowie CR, &amp; Harvey PD (2006). Administration and interpretation of the Trail Making Test. Nature Protocols, 1, 2277. doi: 10.1038/nprot.2006.390</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nprot.2006.390</ArticleId>
            <ArticleId IdType="pubmed">17406468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burgess N, Maguire EA, &amp; O&#x2019;Keefe J (2002). The human hippocampus and spatial and episodic memory. Neuron, 35(4), 625&#x2013;641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12194864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burnham KP, &amp; Anderson DR (2002). Model selection and multimodel inference: a practical information-theoretic approach: Springer Science &amp; Business Media.</Citation>
        </Reference>
        <Reference>
          <Citation>Burns J, Galvin J, Roe C, Morris J, &amp; McKeel D (2005). The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology, 64(8), 1397&#x2013;1403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15851730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buschke H (1973). Selective reminding for analysis of memory and learning. Journal of Verbal Learning and Verbal Behavior, 12(5), 543&#x2013;550. doi: 10.1016/S0022-5371(73)80034-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-5371(73)80034-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bush G, Luu P, &amp; Posner MI (2000). Cognitive and emotional influences in anterior cingulate cortex. Trends in cognitive sciences, 4(6), 215&#x2013;222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10827444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cavanna AE, &amp; Trimble MR (2006). The precuneus: a review of its functional anatomy and behavioural correlates. Brain, 129(3), 564&#x2013;583. doi: 10.1093/brain/awl004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awl004</ArticleId>
            <ArticleId IdType="pubmed">16399806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen S, Doyle WJ, Skoner DP, Rabin BS, &amp; Gwaltney JM (1997). Social ties and susceptibility to the common cold. Jama, 277(24), 1940&#x2013;1944.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9200634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cosentino S, Brickman AM, Griffith E, Habeck C, Cines S, Farrell M, &#x2026; Stern Y (2015). The right insula contributes to memory awareness in cognitively diverse older adults. Neuropsychologia, 75, 163&#x2013;169. doi: 10.1016/j.neuropsychologia.2015.05.032</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuropsychologia.2015.05.032</ArticleId>
            <ArticleId IdType="pmc">PMC4546518</ArticleId>
            <ArticleId IdType="pubmed">26049091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demakis GJ (2004). Frontal lobe damage and tests of executive processing: a meta-analysis of the category test, stroop test, and trail-making test. J Clin Exp Neuropsychol, 26(3), 441&#x2013;450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15512932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du A, Schuff N, Zhu X, Jagust W, Miller B, Reed B, &#x2026; Chui H (2003). Atrophy rates of entorhinal cortex in AD and normal aging. Neurology, 60(3), 481&#x2013;486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1851672</ArticleId>
            <ArticleId IdType="pubmed">12578931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eckert M, Keren N, Roberts D, Calhoun V, &amp; Harris K (2010). Age-related changes in processing speed: unique contributions of cerebellar and prefrontal cortex. Front Hum Neurosci, 4(10). doi: 10.3389/neuro.09.010.2010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/neuro.09.010.2010</ArticleId>
            <ArticleId IdType="pmc">PMC2839847</ArticleId>
            <ArticleId IdType="pubmed">20300463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Efron B, &amp; Tibshirani RJ (1994). An introduction to the bootstrap: CRC press.</Citation>
        </Reference>
        <Reference>
          <Citation>Elderkin-Thompson V, Ballmaier M, Hellemann G, Pham D, &amp; Kumar A (2008). Executive function and MRI prefrontal volumes among healthy older adults. Neuropsychology, 22(5), 626&#x2013;637. doi: 10.1037/0894-4105.22.5.626</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1037/0894-4105.22.5.626</ArticleId>
            <ArticleId IdType="pubmed">18763882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ertel KA, Glymour MM, &amp; Berkman LF (2008). Effects of social integration on preserving memory function in a nationally representative US elderly population. American journal of public health, 98(7), 1215&#x2013;1220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2424091</ArticleId>
            <ArticleId IdType="pubmed">18511736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fratiglioni L, Paillard-Borg S, &amp; Winblad B (2004). An active and socially integrated lifestyle in late life might protect against dementia. The Lancet Neurology, 3(6), 343&#x2013;353. doi: 10.1016/S1474-4422(04)00767-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(04)00767-7</ArticleId>
            <ArticleId IdType="pubmed">15157849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friston KJ, Holmes AP, Poline JB, Grasby PJ, Williams SC, Frackowiak RS, &amp; Turner R (1995). Analysis of fMRI time-series revisited. Neuroimage, 2(1), 45&#x2013;53. doi: 10.1006/nimg.1995.1007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/nimg.1995.1007</ArticleId>
            <ArticleId IdType="pubmed">9343589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, &#x2026; Morris JC (2005). The AD8: a brief informant interview to detect dementia. Neurology, 65(4), 559&#x2013;564. doi: 10.1212/01.wnl.0000172958.95282.2a</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/01.wnl.0000172958.95282.2a</ArticleId>
            <ArticleId IdType="pubmed">16116116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibb W, Mountjoy C, Mann D, &amp; Lees A (1989). The substantia nigra and ventral tegmental area in Alzheimer&#x2019;s disease and Down&#x2019;s syndrome. Journal of Neurology, Neurosurgery &amp; Psychiatry, 52(2), 193&#x2013;200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1032505</ArticleId>
            <ArticleId IdType="pubmed">2539435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grober E, Lipton RB, Hall C, &amp; Crystal H (2000). Memory impairment on free and cued selective reminding predicts dementia. Neurology, 54(4), 827&#x2013;832.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10690971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grober E, Sanders AE, Hall C, &amp; Lipton RB (2010). Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer disease and associated disorders, 24(3), 284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2929322</ArticleId>
            <ArticleId IdType="pubmed">20683186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gutchess AH, Kensinger EA, &amp; Schacter DL (2007). Aging, self-referencing, and medial prefrontal cortex. Social Neuroscience, 2(2), 117&#x2013;133. doi: 10.1080/17470910701399029</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17470910701399029</ArticleId>
            <ArticleId IdType="pubmed">18633811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habeck C, Foster NL, Perneczky R, Kurz A, Alexopoulos P, Koeppe RA, &#x2026; Stern Y (2008). Multivariate and univariate neuroimaging biomarkers of Alzheimer&#x2019;s disease. NeuroImage, 40(4), 1503&#x2013;1515. doi: 10.1016/j.neuroimage.2008.01.056</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroimage.2008.01.056</ArticleId>
            <ArticleId IdType="pmc">PMC2441445</ArticleId>
            <ArticleId IdType="pubmed">18343688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habeck C, Krakauer JW, Ghez C, Sackeim HA, Eidelberg D, Stern Y, &amp; Moeller JR (2005). A New Approach to Spatial Covariance Modeling of Functional Brain Imaging Data: Ordinal Trend Analysis. Neural Computation, 17(7), 1602&#x2013;1645. doi: 10.1162/0899766053723023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1162/0899766053723023</ArticleId>
            <ArticleId IdType="pubmed">15901409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habeck C, Rakitin BC, Moeller J, Scarmeas N, Zarahn E, Brown T, &amp; Stern Y (2005). An event-related fMRI study of the neural networks underlying the encoding, maintenance, and retrieval phase in a delayed-match-to-sample task. Brain Res Cogn Brain Res, 23(2&#x2013;3), 207&#x2013;220. doi: 10.1016/j.cogbrainres.2004.10.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cogbrainres.2004.10.010</ArticleId>
            <ArticleId IdType="pubmed">15820629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habeck C, &amp; Stern Y (2007). Neural network approaches and their reproducibility in the study of verbal working memory and Alzheimer&#x2019;s disease. Clin Neurosci Res, 6(6), 381&#x2013;390. doi: 10.1016/j.cnr.2007.05.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cnr.2007.05.004</ArticleId>
            <ArticleId IdType="pmc">PMC2329589</ArticleId>
            <ArticleId IdType="pubmed">18978933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habeck C, &amp; Stern Y (2010). Multivariate Data Analysis for Neuroimaging Data: Overview and Application to Alzheimer&#x2019;s Disease. Cell Biochemistry and Biophysics, 58(2), 53&#x2013;67. doi: 10.1007/s12013-010-9093-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12013-010-9093-0</ArticleId>
            <ArticleId IdType="pmc">PMC3001346</ArticleId>
            <ArticleId IdType="pubmed">20658269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holt-Lunstad J, Smith TB, &amp; Layton JB (2010). Social relationships and mortality risk: a meta-analytic review. PLoS medicine, 7(7), e1000316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2910600</ArticleId>
            <ArticleId IdType="pubmed">20668659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holtzer R, Wang C, &amp; Verghese J (2014). Performance variance on walking while talking tasks: theory, findings, and clinical implications. AGE, 36(1), 373&#x2013;381. doi: 10.1007/s11357-013-9570-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11357-013-9570-7</ArticleId>
            <ArticleId IdType="pmc">PMC3889876</ArticleId>
            <ArticleId IdType="pubmed">23943111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>House JS, Landis KR, &amp; Umberson D (1988). Social relationships and health. Science, 241(4865), 540.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3399889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalpouzos G, Ch&#xE9;telat G, Baron J-C, Landeau B, Mevel K, Godeau C, &#x2026; Desgranges B (2009). Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging, 30(1), 112&#x2013;124. doi: 10.1016/j.neurobiolaging.2007.05.019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2007.05.019</ArticleId>
            <ArticleId IdType="pubmed">17630048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawachi I, &amp; Berkman LF (2001). Social ties and mental health. Journal of Urban health, 78(3), 458&#x2013;467.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3455910</ArticleId>
            <ArticleId IdType="pubmed">11564849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khondoker M, Rafnsson SB, Morris S, Orrell M, &amp; Steptoe A (2017). Positive and negative experiences of social support and risk of dementia in later life: An investigation using the English Longitudinal Study of Ageing. Journal of Alzheimer&#x2019;s Disease, 58(1), 99&#x2013;108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5438469</ArticleId>
            <ArticleId IdType="pubmed">28387667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koechlin E, Ody C, &amp; Kouneiher F (2003). The Architecture of Cognitive Control in the Human Prefrontal Cortex. Science, 302(5648), 1181&#x2013;1185. doi: 10.1126/science.1088545</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1088545</ArticleId>
            <ArticleId IdType="pubmed">14615530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopell NJ, Gritton HJ, Whittington MA, &amp; Kramer MA (2014). Beyond the connectome: the dynome. Neuron, 83(6), 1319&#x2013;1328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4169213</ArticleId>
            <ArticleId IdType="pubmed">25233314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S, Habeck C, Razlighi Q, Salthouse T, &amp; Stern Y (2016). Selective association between cortical thickness and reference abilities in normal aging. Neuroimage, 142, 293&#x2013;300. doi: 10.1016/j.neuroimage.2016.06.041</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroimage.2016.06.041</ArticleId>
            <ArticleId IdType="pmc">PMC5159226</ArticleId>
            <ArticleId IdType="pubmed">27353567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis PA, Rezaie R, Brown R, Roberts N, &amp; Dunbar RIM (2011). Ventromedial prefrontal volume predicts understanding of others and social network size. NeuroImage, 57(4), 1624&#x2013;1629. doi: 10.1016/j.neuroimage.2011.05.030</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroimage.2011.05.030</ArticleId>
            <ArticleId IdType="pmc">PMC7614375</ArticleId>
            <ArticleId IdType="pubmed">21616156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipton RB, Katz MJ, Kuslansky G, Sliwinski MJ, Stewart WF, Verghese J, &#x2026; Buschke H (2003). Screening for dementia by telephone using the memory impairment screen. Journal of the American Geriatrics Society, 51(10), 1382&#x2013;1390. doi: DOI 10.1046/j.1532-5415.2003.51455.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1532-5415.2003.51455.x</ArticleId>
            <ArticleId IdType="pubmed">14511157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luong G, Charles ST, &amp; Fingerman KL (2011). Better with age: Social relationships across adulthood. Journal of social and personal relationships, 28(1), 9&#x2013;23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3291125</ArticleId>
            <ArticleId IdType="pubmed">22389547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNeill LH, Kreuter MW, &amp; Subramanian S (2006). Social environment and physical activity: a review of concepts and evidence. Social science &amp; medicine, 63(4), 1011&#x2013;1022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16650513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menon V, &amp; Uddin LQ (2010). Saliency, switching, attention and control: a network model of insula function. Brain structure &amp; function, 214(5&#x2013;6), 655&#x2013;667. doi: 10.1007/s00429-010-0262-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00429-010-0262-0</ArticleId>
            <ArticleId IdType="pmc">PMC2899886</ArticleId>
            <ArticleId IdType="pubmed">20512370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller EK, &amp; Cohen JD (2001). An integrative theory of prefrontal cortex function. Annual review of neuroscience, 24(1), 167&#x2013;202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11283309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moeller J, &amp; Strother S (1991). A regional covariance approach to the analysis of functional patterns in positron emission tomographic data. Journal of Cerebral Blood Flow &amp; Metabolism, 11(1_suppl), A121&#x2013;A135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1997480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molesworth T, Sheu LK, Cohen S, Gianaros PJ, &amp; Verstynen TD (2015). Social network diversity and white matter microstructural integrity in humans. Social cognitive and affective neuroscience, 10(9), 1169&#x2013;1176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4560936</ArticleId>
            <ArticleId IdType="pubmed">25605966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nobili A, Latagliata EC, Viscomi MT, Cavallucci V, Cutuli D, Giacovazzo G, &#x2026; Federici M (2017). Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer&#x2019;s disease. Nature communications, 8, 14727.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5382255</ArticleId>
            <ArticleId IdType="pubmed">28367951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park H-J, &amp; Friston K (2013). Structural and functional brain networks: from connections to cognition. Science, 342(6158), 1238411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24179229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, H&#xE4;nninen T, Laakso MP, &#x2026; Soininen H (2004). Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiology of Aging, 25(3), 303&#x2013;310. doi: 10.1016/S0197-4580(03)00084-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0197-4580(03)00084-8</ArticleId>
            <ArticleId IdType="pubmed">15123335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pillemer S, &amp; Holtzer R (2016). The differential relationships of dimensions of perceived social support with cognitive function among older adults. Aging &amp; mental health, 20(7), 727&#x2013;735.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4618790</ArticleId>
            <ArticleId IdType="pubmed">25902848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pillemer S, Holtzer R, &amp; Blumen HM (2017). Functional connectivity associated with social networks in older adults: A resting-state fMRI study. Social Neuroscience, 12(3), 242&#x2013;252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5293673</ArticleId>
            <ArticleId IdType="pubmed">27072369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Powell J, Lewis PA, Roberts N, Garc&#xED;a-Fi&#xF1;ana M, &amp; Dunbar RI (2012). Orbital prefrontal cortex volume predicts social network size: an imaging study of individual differences in humans. Proceedings of the Royal Society of London B: Biological Sciences, 279(1736), 2157&#x2013;2162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3321718</ArticleId>
            <ArticleId IdType="pubmed">22298855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Randolph C, Tierney MC, Mohr E, &amp; Chase TN (1998). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. Journal of clinical and experimental neuropsychology, 20(3), 310&#x2013;319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9845158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raz N, Gunning FM, Head D, Dupuis JH, McQuain J, Briggs SD, &#x2026; Acker JD (1997). Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cerebral Cortex, 7(3), 268&#x2013;282. doi: 10.1093/cercor/7.3.268</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cercor/7.3.268</ArticleId>
            <ArticleId IdType="pubmed">9143446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reitan R (1978). Manual for Administration of Neuropsychological Test Batteries for Adults and Children: Tucson, AZ: Reitan Neuropsychology Laboratories.</Citation>
        </Reference>
        <Reference>
          <Citation>Rodrigue KM, &amp; Raz N (2004). Shrinkage of the entorhinal cortex over five years predicts memory performance in healthy adults. Journal of Neuroscience, 24(4), 956&#x2013;963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6729806</ArticleId>
            <ArticleId IdType="pubmed">14749440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seeman TE, Lusignolo TM, Albert M, &amp; Berkman L (2001). Social relationships, social support, and patterns of cognitive aging in healthy, high-functioning older adults: MacArthur Studies of Successful Aging. Health Psychology, 20(4), 243&#x2013;255. doi: 10.1037/0278-6133.20.4.243</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1037/0278-6133.20.4.243</ArticleId>
            <ArticleId IdType="pubmed">11515736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shackman AJ, Salomons TV, Slagter HA, Fox AS, Winter JJ, &amp; Davidson RJ (2011). The integration of negative affect, pain and cognitive control in the cingulate cortex. Nature Reviews Neuroscience, 12(3), 154&#x2013;167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3044650</ArticleId>
            <ArticleId IdType="pubmed">21331082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spaniol J, Davidson PS, Kim AS, Han H, Moscovitch M, &amp; Grady CL (2009). Event-related fMRI studies of episodic encoding and retrieval: meta-analyses using activation likelihood estimation. Neuropsychologia, 47(8), 1765&#x2013;1779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19428409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spetsieris PG, &amp; Eidelberg D (2011). Scaled subprofile modeling of resting state imaging data in Parkinson&#x2019;s disease: Methodological issues. NeuroImage, 54(4), 2899&#x2013;2914. doi: 10.1016/j.neuroimage.2010.10.025</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroimage.2010.10.025</ArticleId>
            <ArticleId IdType="pmc">PMC3020239</ArticleId>
            <ArticleId IdType="pubmed">20969965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>St. Jacques P, Dolcos F, &amp; Cabeza R (2010). Effects of aging on functional connectivity of the amygdala during negative evaluation: A network analysis of fMRI data. Neurobiol Aging, 31(2), 315&#x2013;327. doi: 10.1016/j.neurobiolaging.2008.03.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.03.012</ArticleId>
            <ArticleId IdType="pmc">PMC3541693</ArticleId>
            <ArticleId IdType="pubmed">18455837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steffener J, Brickman AM, Habeck C, Salthouse TA, &amp; Stern Y (2013). Cerebral blood flow and gray matter volume covariance patterns of cognition in aging. Human brain mapping, 34(12), 3267&#x2013;3279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3812339</ArticleId>
            <ArticleId IdType="pubmed">22806997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thompson PM, Hayashi KM, De Zubicaray G, Janke AL, Rose SE, Semple J, &#x2026; Doddrell DM (2003). Dynamics of gray matter loss in Alzheimer&#x2019;s disease. Journal of Neuroscience, 23(3), 994&#x2013;1005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6741905</ArticleId>
            <ArticleId IdType="pubmed">12574429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verghese J, Holtzer R, Lipton RB, &amp; Wang C (2009). Quantitative Gait Markers and Incident Fall Risk in Older Adults. Journals of Gerontology Series A: Biological Sciences &amp; Medical Sciences, 64A(8), 896&#x2013;901. doi: 10.1093/gerona/glp033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/gerona/glp033</ArticleId>
            <ArticleId IdType="pmc">PMC2709543</ArticleId>
            <ArticleId IdType="pubmed">19349593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Von Der Heide R, Vyas G, &amp; Olson IR (2014). The social network-network: size is predicted by brain structure and function in the amygdala and paralimbic regions. Social Cognitive and Affective Neuroscience, 9(12), 1962&#x2013;1972. doi: 10.1093/scan/nsu009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/scan/nsu009</ArticleId>
            <ArticleId IdType="pmc">PMC4249478</ArticleId>
            <ArticleId IdType="pubmed">24493846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wagner AD, Shannon BJ, Kahn I, &amp; Buckner RL (2005). Parietal lobe contributions to episodic memory retrieval. Trends Cogn Sci, 9(9), 445&#x2013;453. doi: 10.1016/j.tics.2005.07.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tics.2005.07.001</ArticleId>
            <ArticleId IdType="pubmed">16054861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whalen P, Shin LM, Somerville LH, McLean AA, &amp; Kim H (2002). Functional neuroimaging studies of the amygdala in depression. Paper presented at the Seminars in clinical neuropsychiatry.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12382206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yeh S-CJ, &amp; Liu Y-Y (2003). Influence of social support on cognitive function in the elderly. BMC Health Services Research, 3, 9&#x2013;9. doi: 10.1186/1472-6963-3-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1472-6963-3-9</ArticleId>
            <ArticleId IdType="pmc">PMC161808</ArticleId>
            <ArticleId IdType="pubmed">12775218</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30321716</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1556-3871</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Heart rhythm</Title>
          <ISOAbbreviation>Heart Rhythm</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Global disparities in cardiac pacemaker therapy: Problem statement, potential solution, and call to action.</ArticleTitle>
        <Pagination>
          <StartPage>153</StartPage>
          <EndPage>155</EndPage>
          <MedlinePgn>153-155</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2018.10.006</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1547-5271(18)31022-1</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Marine</LastName>
            <ForeName>Joseph E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: jmarine2@jhmi.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crawford</LastName>
            <ForeName>Thomas C</ForeName>
            <Initials>TC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan Health System, Ann Arbor, Michigan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sinha</LastName>
            <ForeName>Sunil K</ForeName>
            <Initials>SK</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pavri</LastName>
            <ForeName>Behzad B</ForeName>
            <Initials>BB</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sundaram</LastName>
            <ForeName>Sri</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Cardiac Electrophysiology, South Denver Cardiology Associates, Littleton, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eagle</LastName>
            <ForeName>Kim A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan Health System, Ann Arbor, Michigan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vlay</LastName>
            <ForeName>Stephen C</ForeName>
            <Initials>SC</Initials>
            <AffiliationInfo>
              <Affiliation>Stony Brook Heart Institute, Stony Brook University, Stony Brook, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deering</LastName>
            <ForeName>Thomas F</ForeName>
            <Initials>TF</Initials>
            <AffiliationInfo>
              <Affiliation>Arrhythmia Center, Piedmont Heart Institute, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Heart Rhythm</MedlineTA>
        <NlmUniqueID>101200317</NlmUniqueID>
        <ISSNLinking>1547-5271</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001919" MajorTopicYN="N">Bradycardia</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002304" MajorTopicYN="N">Cardiac Pacing, Artificial</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010138" MajorTopicYN="Y">Pacemaker, Artificial</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bradycardia</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Humanitarian</Keyword>
        <Keyword MajorTopicYN="N">Pacemaker</Keyword>
        <Keyword MajorTopicYN="N">Resterilization</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30321716</ArticleId>
        <ArticleId IdType="doi">10.1016/j.hrthm.2018.10.006</ArticleId>
        <ArticleId IdType="pii">S1547-5271(18)31022-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30318975</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1557-9891</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Jan-Feb</Season>
            </PubDate>
          </JournalIssue>
          <Title>American journal of men's health</Title>
          <ISOAbbreviation>Am J Mens Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Electronic Cigarettes: Impact on Lung Function and Fractional Exhaled Nitric Oxide Among Healthy Adults.</ArticleTitle>
        <Pagination>
          <StartPage>1557988318806073</StartPage>
          <MedlinePgn>1557988318806073</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">1557988318806073</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1557988318806073</ELocationID>
        <Abstract>
          <AbstractText>Electronic cigarettes (e-cigarettes) are rapidly becoming an alternative form of nicotine consumption worldwide and a disruptive element in the global health diplomacy. This study aimed to investigate the impact of e-cigarettes on lung function and fractional exhaled nitric oxide (FeNO) among young healthy male adults. Sixty apparently healthy male volunteers were recruited and divided into two groups. Group 1 (e-cigarette-exposed group) consisted of 30 males who were daily e-cigarette users (age 27.07 &#xB1; 6.00 [mean &#xB1; SD] years). Group 2 (control group) consisted of 30 males who were not e-cigarette users (age 25.90 &#xB1; 7.72 [mean &#xB1; SD] years). Both groups were neither current nor former traditional tobacco users. Age, ethnicity, height, weight, and socioeconomic status were considered using a matched design to investigate the impact of e-cigarette use on lung function and FeNO. The lung function test parameters that were found to be significantly decreased in e-cigarette users compared to their control group were forced expiratory volume in the first second (FEV<sub>1</sub>), forced expiratory ratio (FEV<sub>1</sub>/FVC), forced expiratory flow-25% (FEF<sub>25%</sub>), forced expiratory flow-50% (FEF<sub>50%</sub>), forced expiratory flow-75% (FEF<sub>75%</sub>), forced expiratory flow-25%-75% (FEF<sub>25%-75%</sub>), and forced expiratory flow-75%-85% (FEF<sub>75%-85%</sub>). FeNO was also decreased in e-cigarette users, but it did not reach the level of significance. The use of e-cigarettes significantly impaired various lung function parameters and the pattern of impairment exhibited a peripheral obstructive airway involvement. These findings have a general message for the global health community on the potential harm of e-cigarettes on lung function.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Meo</LastName>
            <ForeName>Sultan Ayoub</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ansary</LastName>
            <ForeName>Muhammad Abdullah</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barayan</LastName>
            <ForeName>Fahad Rayan</ForeName>
            <Initials>FR</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Almusallam</LastName>
            <ForeName>Abdulaziz Sulaiman</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Almehaid</LastName>
            <ForeName>Abdulrahman Muteb</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alarifi</LastName>
            <ForeName>Nawaf Saad</ForeName>
            <Initials>NS</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alsohaibani</LastName>
            <ForeName>Thamer Abdulnasir</ForeName>
            <Initials>TA</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zia</LastName>
            <ForeName>Inam</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Mens Health</MedlineTA>
        <NlmUniqueID>101287723</NlmUniqueID>
        <ISSNLinking>1557-9883</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>31C4KY9ESH</RegistryNumber>
          <NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001944" MajorTopicYN="N">Breath Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066300" MajorTopicYN="N">Electronic Nicotine Delivery Systems</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045853" MajorTopicYN="N">Exhalation</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005541" MajorTopicYN="N">Forced Expiratory Volume</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015656" MajorTopicYN="N">Respiratory Mechanics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012309" MajorTopicYN="N">Risk-Taking</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">FeNO</Keyword>
        <Keyword MajorTopicYN="N">e-cigarette</Keyword>
        <Keyword MajorTopicYN="N">lung physiology</Keyword>
        <Keyword MajorTopicYN="N">pulmonary function</Keyword>
      </KeywordList>
      <CoiStatement><b>Declaration of Conflicting Interests:</b> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30318975</ArticleId>
        <ArticleId IdType="pmc">PMC6771130</ArticleId>
        <ArticleId IdType="doi">10.1177/1557988318806073</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Allen J. G., Flanigan S. S., LeBlanc M., Vallarino J., MacNaughton P., Stewart J. H., Christiani D. C. (2016). Flavoring chemicals in E-cigarettes: Diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored E-cigarettes. Environmental Health Perspectives, 124(6), 733&#x2013;739. doi:10.1289/ehp.1510185</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1289/ehp.1510185</ArticleId>
            <ArticleId IdType="pmc">PMC4892929</ArticleId>
            <ArticleId IdType="pubmed">26642857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Besaratinia A., Tommasi S. (2014). Electronic cigarettes: The road ahead. Preventive Medicine, 66, 65&#x2013;67. doi:10.1016/j.ypmed.2014.06.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ypmed.2014.06.014</ArticleId>
            <ArticleId IdType="pubmed">24952095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camenga D., Kong G., Cavallo D., Krishnan-Sarin S. (2017). Current and former smokers use of electronic cigarettes for quitting smoking: An exploratory study of adolescents and young adults. Nicotine &amp; Tobacco Research, 19(12), 1531&#x2013;1535. doi:10.1093/ntr/ntw248</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntw248</ArticleId>
            <ArticleId IdType="pmc">PMC5896554</ArticleId>
            <ArticleId IdType="pubmed">27663781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chorti M., Poulianiti K., Jamurtas A., Kostikas K., Tzatzarakis M., Vynias D., &#x2026; Tsatsakis A. (2012). Effects of active and passive electronic and tobacco cigarette smoking on lung function. Toxicology Letters, 211, S64. doi:10.1016/j.toxlet.2012.03.250</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.toxlet.2012.03.250</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dweik R. A., Boggs P. B., Erzurum S. C., Irvin C. G., Leigh M. W., &#x2026; Lundberg J. O. (2011). An official ATS clinical practice guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for clinical applications. American Journal of Respiratory and Critical Care Medicine, 184(5), 602&#x2013;615. doi:10.1164/rccm.9120-11st</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.9120-11st</ArticleId>
            <ArticleId IdType="pmc">PMC4408724</ArticleId>
            <ArticleId IdType="pubmed">21885636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farsalinos K., Romagna G., Tsiapras D., Kyrzopoulos S., Voudris V. (2013). Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of &#x201C;vapers&#x201D; who had achieved complete substitution of smoking. Substance Abuse: Research and Treatment, 7, SART.S12756. doi:10.4137/sart.s12756</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4137/sart.s12756</ArticleId>
            <ArticleId IdType="pmc">PMC3772898</ArticleId>
            <ArticleId IdType="pubmed">24049448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farsalinos K., Tomaselli V., Polosa R. (2018). Frequency of use and smoking status of U.S. adolescent E-cigarette users in 2015. American Journal of Preventive Medicine, 54(6), 814&#x2013;820. doi:10.1016/j.amepre.2018.03.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amepre.2018.03.003</ArticleId>
            <ArticleId IdType="pubmed">29631871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flouris A. D., Chorti M. S., Poulianiti K. P., Jamurtas A. Z., Kostikas K., Tzatzarakis M. N., &#x2026; Koutedakis Y. (2013). Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhalation Toxicology, 25(2), 91&#x2013;101. doi:10.3109/08958378.2012.758197</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08958378.2012.758197</ArticleId>
            <ArticleId IdType="pubmed">23363041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gennimata S., Palamidas A., Kaltsakas G., Tsikrika S., Vakali S., Gratziou C., Koulouris N. (2012). Acute effect of e-cigarette on pulmonary function in healthy subjects and smokers. European Respiratory Journal, 40(56), 1053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hahn J., Monakhova Y. B., Hengen J., Kohl-Himmelseher M., Sch&#xFC;ssler J., Hahn H., &#x2026; Lachenmeier D. W. (2014). Electronic cigarettes: Overview of chemical composition and exposure estimation. Tobacco Induced Diseases, 12(1), 23. doi:10.1186/s12971-014-0023-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12971-014-0023-6</ArticleId>
            <ArticleId IdType="pmc">PMC4304610</ArticleId>
            <ArticleId IdType="pubmed">25620905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henningfield J., Zaatari G. (2010). Electronic nicotine delivery systems: Emerging science foundation for policy. Tobacco Control, 19(2), 89&#x2013;90. doi:10.1136/tc.2009.035279</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2009.035279</ArticleId>
            <ArticleId IdType="pubmed">20378582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim H., Shin H. (2013). Measurement of aldehydes in replacement liquids of electronic cigarettes by headspace gas chromatography-mass spectrometry. Bulletin of the Korean Chemical Society, 34(9), 2691&#x2013;2696. doi:10.5012/bkcs.2013.34.9.2691</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5012/bkcs.2013.34.9.2691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez A. A., Hiler M. M., Soule E. K., Ram&#xF4;a C. P., Karaoghlanian N. V., Lipato T., &#x2026; Eissenberg T. (2015). Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: A preliminary report. Nicotine &amp; Tobacco Research, 18(5), 720&#x2013;723. doi:10.1093/ntr/ntv182</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntv182</ArticleId>
            <ArticleId IdType="pmc">PMC5896822</ArticleId>
            <ArticleId IdType="pubmed">26377515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marini S., Buonanno G., Stabile L., Ficco G. (2014). Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicology and Applied Pharmacology, 278(1), 9&#x2013;15. doi:10.1016/j.taap.2014.04.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.taap.2014.04.004</ArticleId>
            <ArticleId IdType="pubmed">24732441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meo S. A. (2006). Lung function in Pakistani wood workers. International Journal of Environmental Health Research, 16(3), 193&#x2013;203. doi:10.1080/09603120600641375</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09603120600641375</ArticleId>
            <ArticleId IdType="pubmed">16611564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meo S. A., AL-Asiri S. (2014). Effects of electronic cigarette smoking on human health. European Review for Medical and Pharmacological Sciences, 18(21), 3315&#x2013;3319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25487945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meo S. A., Al-Drees A., Al Masri A., Al Rouq F., Azeem M. A. (2013). Effect of duration of exposure to cement dust on respiratory function of non-smoking cement mill workers. International Journal of Environmental Research and Public Health, 10(1), 390&#x2013;398. doi:10.3390/ijerph10010390</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijerph10010390</ArticleId>
            <ArticleId IdType="pmc">PMC3564149</ArticleId>
            <ArticleId IdType="pubmed">23325026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller M. (2005). Standardisation of spirometry. European Respiratory Journal, 26(2), 319&#x2013;338. doi:10.1183/09031936.05.00034805</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.05.00034805</ArticleId>
            <ArticleId IdType="pubmed">16055882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palamidas A., Gennimata S. A., Kaltsakas G., Tsikrika S., Vakali S., Gratziou C., Koulouris N. (2014). Acute effect of an e-cigarette with and without nicotine on lung function. Tobacco Induced Diseases, 12(Suppl 1), A34. doi:10.1186/1617-9625-12-S1-A34</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1617-9625-12-S1-A34</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polosa R. (2015). Electronic cigarette use and harm reversal: Emerging evidence in the lung. BMC Medicine, 13, 54. doi:10.1186/s12916-015-0298-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12916-015-0298-3</ArticleId>
            <ArticleId IdType="pmc">PMC4365531</ArticleId>
            <ArticleId IdType="pubmed">25857426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohde J., Noar S., Horvitz C., Lazard A., Cornacchione Ross J., Sutfin E. (2018). The role of knowledge and risk beliefs in adolescent e-cigarette use: A pilot study. International Journal of Environmental Research and Public Health, 15(4), 830. doi:10.3390/ijerph15040830</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijerph15040830</ArticleId>
            <ArticleId IdType="pmc">PMC5923872</ArticleId>
            <ArticleId IdType="pubmed">29690606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schober W., Szendrei K., Matzen W., Osiander-Fuchs H., Heitmann D., Schettgen T., &#x2026; Fromme H. (2014). Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. International Journal of Hygiene and Environmental Health, 217(6), 628&#x2013;637. doi:10.1016/j.ijheh.2013.11.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijheh.2013.11.003</ArticleId>
            <ArticleId IdType="pubmed">24373737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stark H., Purokivi M., Kiviranta J., Randell J., Tukiainen H. (2007). Short-term and seasonal variations of exhaled and nasal NO in healthy subjects. Respiratory Medicine, 101(2), 265&#x2013;271. doi:10.1016/j.rmed.2006.05.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2006.05.009</ArticleId>
            <ArticleId IdType="pubmed">16797173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vardavas C., Anagnostopoulos N., Kougias M., Evangelopoulou V., Connolly G., Behrakis P. (2012). Short-term pulmonary effects of using an electronic cigarette. Chest, 141(6), 1400&#x2013;1406. doi:10.1378/chest.11-2443</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.11-2443</ArticleId>
            <ArticleId IdType="pubmed">22194587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y., Guo Y., Liu K., Liu Z., Wang X. (2016). E-cigarette awareness, use, and harm perception among adults: A meta-analysis of observational studies. PLOS ONE, 11(11), e0165938. doi:10.1371/journal.pone.0165938</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0165938</ArticleId>
            <ArticleId IdType="pmc">PMC5115669</ArticleId>
            <ArticleId IdType="pubmed">27861501</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30318821</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2025</Year>
        <Month>01</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1466-7657</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>66</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>International nursing review</Title>
          <ISOAbbreviation>Int Nurs Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neonatal abstinence syndrome in countries with no to low medical opioid consumption: a scoping review.</ArticleTitle>
        <Pagination>
          <StartPage>224</StartPage>
          <EndPage>233</EndPage>
          <MedlinePgn>224-233</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/inr.12489</ELocationID>
        <Abstract>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To describe the current state of evidence on the care of neonates with neonatal abstinence syndrome in countries with low to virtually no medical opioid analgesic consumption.</AbstractText>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">While access to opioids for medical use improves globally, misuse grows as a health concern. One unintended consequence has been an increase in the incidence of neonatal abstinence syndrome. Because most evidence is generated in countries with adequate opioid analgesic consumption, a picture of evidence in lower opioid-consuming countries is not available.</AbstractText>
          <AbstractText Label="DESIGN" NlmCategory="METHODS">A scoping review methodology was employed and augmented with principles of international development literature review. Electronic database searches (PubMed and CINAHL) located 1106 articles. Google was employed to access an additional 17 non-indexed articles. From the total of 1123 articles located, 27 articles from 15 countries were included.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Minimal evidence was produced in low to virtually no medical opioid-consuming countries. Sources were primarily review articles, descriptive, comparative or case reports. Seventy-one per cent of the articles identified at least one specific clinical practice related to the care of infants with neonatal abstinence syndrome.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">As opioid analgesic use increases globally, a subsequent increase in neonatal abstinence syndrome is likely. It will be beneficial for providers and policymakers to be proactive in considering implications for neonatal and maternal populations and collaborate with providers who have been gaining experience in this area. A number of these countries are heroin-growing regions and already experiencing issues.</AbstractText>
          <AbstractText Label="IMPLICATIONS FOR NURSING PRACTICE AND HEALTH POLICY" NlmCategory="CONCLUSIONS">Policymakers may use these findings to support data collection and reporting, context and resource relevant guideline development, and advocacy for inclusion of the maternal-infant population in global opioid research priority setting. International collaboration for establishing gender and culturally appropriate practices globally is critical.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 International Council of Nurses.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Marcellus</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Nursing, University of Victoria, Victoria, BC, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000098583">Scoping Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int Nurs Rev</MedlineTA>
        <NlmUniqueID>7808754</NlmUniqueID>
        <ISSNLinking>0020-8132</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055318" MajorTopicYN="Y">Evidence-Based Nursing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007363" MajorTopicYN="N">Intensive Care Units, Neonatal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009357" MajorTopicYN="N">Neonatal Abstinence Syndrome</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058850" MajorTopicYN="N">Opiate Substitution Treatment</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Drugs</Keyword>
        <Keyword MajorTopicYN="N">Global Health Policy</Keyword>
        <Keyword MajorTopicYN="N">Maternity</Keyword>
        <Keyword MajorTopicYN="N">Neonatal Nursing</Keyword>
        <Keyword MajorTopicYN="N">Opioids</Keyword>
        <Keyword MajorTopicYN="N">Special Care Baby Nursing</Keyword>
        <Keyword MajorTopicYN="N">Systematic Reviews</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30318821</ArticleId>
        <ArticleId IdType="doi">10.1111/inr.12489</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30317217</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2052-0468</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>165</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the Royal Army Medical Corps</Title>
          <ISOAbbreviation>J R Army Med Corps</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Global health diplomacy and humanitarian assistance: understanding the intentional divide between military and non-military actors.</ArticleTitle>
        <Pagination>
          <StartPage>244</StartPage>
          <EndPage>247</EndPage>
          <MedlinePgn>244-247</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/jramc-2018-001030</ELocationID>
        <Abstract>
          <AbstractText>Often known as <i>'</i> <i>global</i> <i>health diplomacy</i> <i>'</i>, the provision of medical care to accomplish strategic objectives, advance public diplomacy goals and enhance soft power is increasingly emphasised in international affairs and military policies. Despite this emergent trend, there has been little critical analysis and examination of the ethics of military actors engaging in this type of work. This type of mission represents the most common form of military medical deployment within the International Security Assistance Force in Afghanistan and is now explicitly emphasised in many militaries' defence doctrine. The growth of these programmes has occurred with little analysis, examination or critique. This paper examines the history of global health diplomacy as directly related to humanitarian assistance, focusing on the difference in intention to highlight ethical dilemmas related to military involvement in the humanitarian sphere. The relationship between non-military humanitarian actors and military actors will be a focal point of discussion, as this relationship has been historically complicated and continues to shift. Relevant differences between these two groups of actors, their motivations and work will be highlighted. In order to examine the morally important differences between these groups, analysis will draw on relevant international doctrine and codes that attempt to provide ethical guidance within the humanitarian sphere.</AbstractText>
          <CopyrightInformation>&#xA9; Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Eagan</LastName>
            <ForeName>Sheena M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Bioethics and Interdisciplinary Studies, Brody School of Medicine, East Carolina University, Greenville, NC 27858, USA eagansh17@ecu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J R Army Med Corps</MedlineTA>
        <NlmUniqueID>7505627</NlmUniqueID>
        <ISSNLinking>0035-8665</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055826" MajorTopicYN="N">Afghan Campaign 2001-</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000533" MajorTopicYN="N">Altruism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067551" MajorTopicYN="Y">Diplomacy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008889" MajorTopicYN="Y">Military Personnel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024382" MajorTopicYN="N">Professional Role</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012066" MajorTopicYN="Y">Relief Work</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">civic action</Keyword>
        <Keyword MajorTopicYN="N">health diplomacy</Keyword>
        <Keyword MajorTopicYN="N">humanitarian assistance</Keyword>
        <Keyword MajorTopicYN="N">medical ethics</Keyword>
        <Keyword MajorTopicYN="N">military ethics</Keyword>
        <Keyword MajorTopicYN="N">military medicine</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30317217</ArticleId>
        <ArticleId IdType="doi">10.1136/jramc-2018-001030</ArticleId>
        <ArticleId IdType="pii">jramc-2018-001030</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30316687</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-7541</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Mar-Apr</Season>
            </PubDate>
          </JournalIssue>
          <Title>Explore (New York, N.Y.)</Title>
          <ISOAbbreviation>Explore (NY)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Planetary Health: From the Wellspring of Holistic Medicine to Personal and Public Health Imperative.</ArticleTitle>
        <Pagination>
          <StartPage>98</StartPage>
          <EndPage>106</EndPage>
          <MedlinePgn>98-106</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.explore.2018.09.002</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1550-8307(18)30182-4</ELocationID>
        <Abstract>
          <AbstractText>The term planetary health - denoting the interconnections between the health of person and place at all scales - emerged from the environmental and holistic health movements of the 1970-80s; in 1980, Friends of the Earth expanded the World Health Organization definition of health, stating: "health is a state of complete physical, mental, social and ecological well-being and not merely the absence of disease - personal health involves&#xA0;planetary health". By the 1990s, the concept of planetary health was part of the fabric of integrative medicine; more recently, after the 2015 Lancet Commission on Planetary Health report, the concept has penetrated mainstream academic and medical discourse. Here, we explore this history and describe its relevance to contemporary healthcare; integrative medicine is uniquely positioned to educate and advocate on behalf of patients and communities (current and future generations), helping to safeguard health of person, place and planet. We use the emerging microbiome science as a way to illustrate the interconnectivity and health implications of ecosystems (including social/political/economic systems) at all scales. As highlighted in the Canmore Declaration, mainstream planetary health discourse will be strengthened by inter-professional healthcare perspectives, and a more sophisticated understanding of the ways in which social dominance orientation and medical authoritarianism compromise the World Health Organization's broad vision of global health. Planetary health isn't a "new discipline"; it is merely an extension of a concept that was understood by our ancestors, and remains the vocation of all healthcare providers. Discourse on the topic requires cultural competency, critical consciousness and a greater appreciation of marginalized voices.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Prescott</LastName>
            <ForeName>Susan L</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>University of Western Australia, School of Medicine, Princess Margaret Hospital, 15 Hospital Ave., Nedlands, WA, 6009, Australia; in-VIVO Global Initiative, Research Group of the Worldwide Universities Network (WUN), 6010 Park Ave, Suite #4081, West New York, NJ, 07093, United States. Electronic address: susan.prescott@uwa.edu.au.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Logan</LastName>
            <ForeName>Alan C</ForeName>
            <Initials>AC</Initials>
            <AffiliationInfo>
              <Affiliation>in-VIVO Global Initiative, Research Group of the Worldwide Universities Network (WUN), 6010 Park Ave, Suite #4081, West New York, NJ, 07093, United States. Electronic address: aclnd@cfs-fm.org.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016456">Historical Article</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Explore (NY)</MedlineTA>
        <NlmUniqueID>101233160</NlmUniqueID>
        <ISSNLinking>1550-8307</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017753" MajorTopicYN="N">Ecosystem</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006694" MajorTopicYN="N">Holistic Health</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055048" MajorTopicYN="N">Integrative Medicine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064307" MajorTopicYN="N">Microbiota</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019222" MajorTopicYN="N">Mind-Body Relations, Metaphysical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Dysbiosis</Keyword>
        <Keyword MajorTopicYN="N">Ecology</Keyword>
        <Keyword MajorTopicYN="N">Health disparities</Keyword>
        <Keyword MajorTopicYN="N">Microbiome</Keyword>
        <Keyword MajorTopicYN="N">Natural environments</Keyword>
        <Keyword MajorTopicYN="N">Non-communicable diseases</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30316687</ArticleId>
        <ArticleId IdType="doi">10.1016/j.explore.2018.09.002</ArticleId>
        <ArticleId IdType="pii">S1550-8307(18)30182-4</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30316576</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-7361</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>165</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Surgery</Title>
          <ISOAbbreviation>Surgery</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Bill &amp; Melinda Gates Foundation: An opportunity to lead innovation in global surgery.</ArticleTitle>
        <Pagination>
          <StartPage>273</StartPage>
          <EndPage>280</EndPage>
          <MedlinePgn>273-280</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surg.2018.08.002</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0039-6060(18)30501-4</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">The Bill and Melinda Gates Foundation has made unparalleled contributions to global health and human development by bringing together generous funding, strategic partnerships, and innovative leadership. For the last twenty years, the Gates Foundation has supported the expansion of programs that directly address the fundamental barriers to the advancement of marginalized communities around the globe, with a transformative focus on innovations to combat communicable diseases and to ensure maternal and child health. Despite the wide spectrum of programs, the Gates Foundation has not, as of yet, explicitly supported the development of surgical care.</AbstractText>
          <AbstractText Label="METHODS">This article explores the pivotal role that the Gates Foundation could play in advancing the emerging global surgery agenda. First, we demonstrate the importance of the Gates Foundation's contributions by reviewing its history, growth, and evolution as a pioneering supporter of global health and human development. Recognizing the Foundation's use of metrics and data in strategic planning and action, we align the priorities of the Foundation with the growing recognition of surgical care as a critical component of efforts to ensure universal health care.</AbstractText>
          <AbstractText Label="RESULTS">To promote healthy lives and well-being for all, development of quality and affordable capacity for surgery, obstetrics and anesthesia is more important than ever. We present the unique opportunity for the Gates Foundation to bring its transformative vision and programing to the effort to ensure equitable, timely, and quality surgical care around the world.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Koch</LastName>
            <ForeName>Rachel</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Global Surgery and Social Change, Harvard Medical School, Boston, MA; Department of Surgery, Vanderbilt University Medical Center, Nashville, TN. Electronic address: Rachel.a.koch@vumc.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roa</LastName>
            <ForeName>Lina</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Global Surgery and Social Change, Harvard Medical School, Boston, MA; Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pyda</LastName>
            <ForeName>Jordan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Global Surgery and Social Change, Harvard Medical School, Boston, MA; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kerrigan</LastName>
            <ForeName>Monica</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Vice President, Jhpiego, Baltimore, MD; Family Planning Strategy, Bill &amp; Melinda Gates Foundation, Seattle, WA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barth&#xE9;lemy</LastName>
            <ForeName>Ernest</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Global Surgery and Social Change, Harvard Medical School, Boston, MA; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meara</LastName>
            <ForeName>John G</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Global Surgery and Social Change, Harvard Medical School, Boston, MA; Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, MA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Surgery</MedlineTA>
        <NlmUniqueID>0417347</NlmUniqueID>
        <ISSNLinking>0039-6060</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005582" MajorTopicYN="Y">Foundations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006289" MajorTopicYN="N">Health Planning Support</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30316576</ArticleId>
        <ArticleId IdType="doi">10.1016/j.surg.2018.08.002</ArticleId>
        <ArticleId IdType="pii">S0039-6060(18)30501-4</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30311768</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>01</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>01</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1369-1619</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of environmental health research</Title>
          <ISOAbbreviation>Int J Environ Health Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Demand for improved sanitation in an urban informal settlement in India: role of the local built environment.</ArticleTitle>
        <Pagination>
          <StartPage>194</StartPage>
          <EndPage>208</EndPage>
          <MedlinePgn>194-208</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09603123.2018.1533530</ELocationID>
        <Abstract>
          <AbstractText>Sanitation uptake is a pressing challenge, especially in India, and sanitation demand in urban informal settlements and slums has been understudied relative to rural areas. Given the spatial and socioeconomic disadvantage of these settings, research suggests that the built environment may relate to sanitation demand, but this has not been tested. This study utilizes data on a large urban informal settlement in Maharashtra, India, examining built environment predictors including housing security, water access, and proximity to existing common sanitation, in association with sanitation demand. Results indicate that household size, home ownership, individual household water sources, and open defecation avoidance are significantly associated with interest in a toilet. Further, interactions between (1) water source and home ownership, and (2) open defecation and distance to shared sanitation, are associated with interest in a toilet. These findings support the role of the built environment in shaping sanitation demand in urban informal settlements.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vijay Panchang</LastName>
            <ForeName>Sarita</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Global Health , University of South Florida , Tampa , FL , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Environ Health Res</MedlineTA>
        <NlmUniqueID>9106628</NlmUniqueID>
        <ISSNLinking>0960-3123</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076624" MajorTopicYN="Y">Built Environment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002947" MajorTopicYN="N" Type="Geographic">Cities</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011204" MajorTopicYN="Y">Poverty Areas</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012499" MajorTopicYN="Y">Sanitation</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Urban</Keyword>
        <Keyword MajorTopicYN="N">environmental health</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">sanitation</Keyword>
        <Keyword MajorTopicYN="N">spatial</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30311768</ArticleId>
        <ArticleId IdType="doi">10.1080/09603123.2018.1533530</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30311050</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2366-0058</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>44</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Abdominal radiology (New York)</Title>
          <ISOAbbreviation>Abdom Radiol (NY)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma.</ArticleTitle>
        <Pagination>
          <StartPage>1554</StartPage>
          <EndPage>1561</EndPage>
          <MedlinePgn>1554-1561</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00261-018-1802-y</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE">The purpose of this study was to compare quality of life (QoL) after two different transarterial therapies [transarterial chemoembolization (TACE) and transarterial radioembolization (TARE)] for patients with unresectable hepatocellular carcinoma (HCC) to assess tumor therapy in palliative situation additional to traditional aims like survival or image response.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS">QoL was evaluated with two validated questionnaires (EORTC QLQ-30 and EORTC HCC18) before and 14d after treatment in 94 initial therapies (TACE n&#xA0;=&#xA0;67; TARE n&#xA0;=&#xA0;27). QoL changes after treatment were analyzed. Tumor response was evaluated using RECIST/WHO/mRECIST/EASL criteria. A multivariate linear regression was undertaken to identify potential influence factors on change of QoL.</AbstractText>
          <AbstractText Label="RESULTS">Mean return rate of questionnaires was 71.3% allowing analysis of 67 therapies (TACE n&#xA0;=&#xA0;46; TARE n&#xA0;=&#xA0;21). Initial global health status/QoL was significantly higher in TACE (62.5%) compared to TARE with 50.8%. Absolute global health decrease was higher in TACE (-&#x2009;10.5%) compared to TARE (-&#x2009;4.8%, p = 0.396). Also relative global health decrease was higher in TACE (-&#x2009;16.82%) compared to TARE (-&#x2009;9.37%). Findings for other items were corresponding, as less impairment was found for TARE compared to TACE for physical/social functioning, fatigue and pain. Objective mRECIST response rate was 22.8% in TACE and 21.1% in TARE.</AbstractText>
          <AbstractText Label="CONCLUSION">Neither TACE nor TARE showed a major decrease in QoL after first treatment. TACE showed a slightly but not significantly higher decrease, so this study is not clearly in favor for one treatment. But with the addition that TARE showed less decrease even in patients with higher tumor burden and lower baseline.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kirchner</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marquardt</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Werncke</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kirstein</LastName>
            <ForeName>M M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brunkhorst</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Clinic for Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wacker</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vogel</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rodt</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Diagnostic and Interventional Radiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. rodt.thomas@mh-hannover.de.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Abdom Radiol (NY)</MedlineTA>
        <NlmUniqueID>101674571</NlmUniqueID>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015021">Yttrium Radioisotopes</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016461" MajorTopicYN="N">Chemoembolization, Therapeutic</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066066" MajorTopicYN="N">Response Evaluation Criteria in Solid Tumors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015021" MajorTopicYN="N">Yttrium Radioisotopes</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Hepatocellular carcinoma</Keyword>
        <Keyword MajorTopicYN="N">Palliative therapy</Keyword>
        <Keyword MajorTopicYN="N">Quality of life</Keyword>
        <Keyword MajorTopicYN="N">Transarterial chemoembolization</Keyword>
        <Keyword MajorTopicYN="N">Transarterial radioembolization</Keyword>
        <Keyword MajorTopicYN="N">Transarterial therapies</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30311050</ArticleId>
        <ArticleId IdType="doi">10.1007/s00261-018-1802-y</ArticleId>
        <ArticleId IdType="pii">10.1007/s00261-018-1802-y</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30309290</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1541-4469</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of health services : planning, administration, evaluation</Title>
          <ISOAbbreviation>Int J Health Serv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hard Currency, Solidarity, and Soft Power: The Motives, Implications, and Lessons of Cuban Health Internationalism.</ArticleTitle>
        <Pagination>
          <StartPage>165</StartPage>
          <EndPage>185</EndPage>
          <MedlinePgn>165-185</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/0020731418805378</ELocationID>
        <Abstract>
          <AbstractText>This article explores Cuba's health assistance and support for other countries. It explores the rationale and motivations for Cuba's internationalism in health. It then details the various aspects of its health interventions, including emergency relief, strengthening of health systems, treatment programs, training of health professionals, engagement in multilateral cooperation, and biotechnology. The article analyzes the benefits of Cuba's health internationalism for Cuba and for others. It also explores potential adverse consequences and criticisms of Cuba's approach. The article concludes by noting that Cuba has been ahead of the game in integrating foreign policy and health policy and that its experience may hold lessons for other countries seeking to develop global health strategies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Baggott</LastName>
            <ForeName>Rob</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-8947-0214</Identifier>
            <AffiliationInfo>
              <Affiliation>1 Department of Politics &amp; Public Policy, De Montfort University, Leicester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lambie</LastName>
            <ForeName>George</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>2 Department of Politics and Public Administration, University of Hong Kong, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Int J Health Serv</MedlineTA>
        <NlmUniqueID>1305035</NlmUniqueID>
        <ISSNLinking>0020-7314</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003462" MajorTopicYN="N" Type="Geographic">Cuba</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004190" MajorTopicYN="N">Disasters</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009042" MajorTopicYN="N">Motivation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011640" MajorTopicYN="Y">Public Policy</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cuba</Keyword>
        <Keyword MajorTopicYN="N">health systems strengthening</Keyword>
        <Keyword MajorTopicYN="N">international health</Keyword>
        <Keyword MajorTopicYN="N">soft power</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30309290</ArticleId>
        <ArticleId IdType="doi">10.1177/0020731418805378</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30307509</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>04</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1460-2369</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>25</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human reproduction update</Title>
          <ISOAbbreviation>Hum Reprod Update</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Exposure to non-persistent chemicals in consumer products and fecundability: a systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>51</StartPage>
          <EndPage>71</EndPage>
          <MedlinePgn>51-71</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/humupd/dmy032</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Exposure to non-persistent chemicals in consumer products is ubiquitous and associated with endocrine-disrupting effects. These effects have been linked to infertility and adverse pregnancy outcomes in some studies and could affect couple fecundability, i.e. the capacity to conceive a pregnancy, quantified as time to pregnancy (TTP).</AbstractText>
          <AbstractText Label="OBJECTIVE AND RATIONALE">Few epidemiologic studies have examined the impact of non-persistent chemicals specifically on TTP, and the results of these studies have not been synthesized. We undertook a systematic review to summarize the strength of evidence for associations of common non-persistent chemicals with couple fecundability and to identify gaps and limitations in the literature, with the aim of informing policy decisions and future research.</AbstractText>
          <AbstractText Label="SEARCH METHODS">We performed an electronic search of English language literature published between 1 January 2007 and 25 August 2017 in MEDLINE, EMBASE.com, Global Health, DART/TOXLINE, POPLINE and DESTAF. We included human retrospective and prospective cohort, cross-sectional and case-control studies that examined phthalates, bisphenol A, triclosan, triclocarban, benzophenones, parabens and glycol ethers in consumer products, and considered TTP or fecundability as an outcome among women, men and couples conceiving without medical assistance. We excluded editorials, opinion pieces, introductions to special sections, articles that described only lifestyle (e.g. caffeine, stress) or clinical factors (e.g. semen parameters, IVF success). Standardized forms for screening, data extraction and study quality were developed using DistillerSR software and completed in duplicate. We used the Newcastle-Ottawa Scale to assess risk of bias and devised additional quality metrics based on specific methodological features of fecundability studies.</AbstractText>
          <AbstractText Label="OUTCOMES">The search returned 3456 articles. There were 15 papers from 12 studies which met inclusion criteria, of which eight included biomarkers of chemical exposure. Studies varied widely in terms of exposure characterization, precluding a meta-analytic approach. Among the studies that measured exposure using biospecimens, results were equivocal for associations between either male or female phthalate exposure and TTP. There was preliminary support for associations of female exposure to some parabens and glycol ethers and of male exposure to benzophenone with longer TTP, but further research and replication of these results are needed. The results provided little to no indication that bisphenol A, triclocarban or triclosan exposure was associated with TTP.</AbstractText>
          <AbstractText Label="WIDER IMPLICATIONS">Despite a growing literature on couple exposure to non-persistent endocrine-disrupting chemicals and fecundability, evidence for associations between biologically measured exposures and TTP is limited. Equivocal results with different non-persistent chemical compounds and metabolites complicate the interpretation of our findings with respect to TTP, but do not preclude action, given the documented endocrine disrupting effects on other reproductive outcomes as well as fetal development. We therefore advocate for common-sense lifestyle changes in which both females and males seeking to conceive minimize their exposure to non-persistent chemicals.</AbstractText>
          <AbstractText Label="SYSTEMATIC REVIEW REGISTRATION NUMBER">CRD42018084304.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hipwell</LastName>
            <ForeName>Alison E</ForeName>
            <Initials>AE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Pittsburgh, 3811 O'Hara Street, Pittsburgh, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kahn</LastName>
            <ForeName>Linda G</ForeName>
            <Initials>LG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, New York University School of Medicine, 403 East 34th Street, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Factor-Litvak</LastName>
            <ForeName>Pam</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168 Street, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Porucznik</LastName>
            <ForeName>Christina A</ForeName>
            <Initials>CA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Family and Preventive Medicine, School of Medicine, University of Utah, 375 Chipeta Way, Salt Lake City, UT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siegel</LastName>
            <ForeName>Eva L</ForeName>
            <Initials>EL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168 Street, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fichorova</LastName>
            <ForeName>Raina N</ForeName>
            <Initials>RN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hamman</LastName>
            <ForeName>Richard F</ForeName>
            <Initials>RF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, Colorado School of Public Health, University of Colorado, 13001 East 17th Place, Denver, CO, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Klein-Fedyshin</LastName>
            <ForeName>Michele</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Health Sciences Library System, School of Medicine, University of Pittsburgh, 3550 Terrace Street, Pittsburgh, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harley</LastName>
            <ForeName>Kim G</ForeName>
            <Initials>KG</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Environmental Research and Children's Health, University of California Berkeley, 1995 University Avenue, Berkley CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>program collaborators for Environmental influences on Child Health Outcomes</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>UH3 OD023249</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>U2C OD023375</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UH3 OD023285</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UG3 OD023248</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 ES013543</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UH3 OD023305</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 ES023772</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UG3 OD023305</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UH3 OD023244</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UG3 OD023244</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UG3 OD023356</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 ES014393</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UH3 OD023248</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UG3 OD023249</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 ES009089</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Hum Reprod Update</MedlineTA>
        <NlmUniqueID>9507614</NlmUniqueID>
        <ISSNLinking>1355-4786</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D052244">Endocrine Disruptors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004785">Environmental Pollutants</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D052244" MajorTopicYN="N">Endocrine Disruptors</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005191" MajorTopicYN="N">Family Characteristics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005298" MajorTopicYN="N">Fertility</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012661" MajorTopicYN="N">Semen</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055101" MajorTopicYN="N">Semen Analysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061685" MajorTopicYN="N">Time-to-Pregnancy</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30307509</ArticleId>
        <ArticleId IdType="pmc">PMC6295794</ArticleId>
        <ArticleId IdType="doi">10.1093/humupd/dmy032</ArticleId>
        <ArticleId IdType="pii">5126877</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Acconcia F, Pallottini V, Marino M. Molecular mechanisms of action of BPA. Dose Response 2015;13:1&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4679188</ArticleId>
            <ArticleId IdType="pubmed">26740804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahn KC, Zhao B, Chen J, Cherednichenko G, Sanmarti E, Denison MS, Lasley B, Pessah IN, K&#xFC;ltz D, Chang DP. In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. Environ Health Perspect 2008;116:1203&#x2013;1210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2535623</ArticleId>
            <ArticleId IdType="pubmed">18795164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aker AM, Watkins DJ, Johns LE, Ferguson KK, Soldin OP, Del Toro LVA, Alshawabkeh AN, Cordero JF, Meeker JD. Phenols and parabens in relation to reproductive and thyroid hormones in pregnant women. Environ Res 2016;151:30&#x2013;37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5071140</ArticleId>
            <ArticleId IdType="pubmed">27448730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alur S, Wang H, Hoeger K, Swan SH, Sathyanarayana S, Redmon BJ, Nguyen R, Barrett ES. Urinary phthalate metabolite concentrations in relation to history of infertility and use of assisted reproductive technology. Fertil Steril 2015;104:1227&#x2013;1235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4630141</ArticleId>
            <ArticleId IdType="pubmed">26275821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen FA. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products. Int J Toxicol 2008;27:1&#x2013;82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19101832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attarchi MS, Ashouri M, Labbafinejad Y, Mohammadi S. Assessment of time to pregnancy and spontaneous abortion status following occupational exposure to organic solvents mixture. Int Arch Occup Environ Health 2012;85:295&#x2013;303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21681482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baird DD, Saldana TM, Nepomnaschy PA, Hoppin JA, Longnecker MP, Weinberg CR, Wilcox AJ. Within-person variability in urinary phthalate metabolite concentrations: measurements from specimens after long-term frozen storage. J Expo Sci Environ Epidemiol 2010;20:169&#x2013;175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5377909</ArticleId>
            <ArticleId IdType="pubmed">19277068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baird DD, Wilcox AJ, Weinberg CR. Use of time to pregnancy to study environmental exposures. Am J Epidemiol 1986;124:470&#x2013;480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3740046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005;113:192&#x2013;200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1277864</ArticleId>
            <ArticleId IdType="pubmed">15687057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barr L, Metaxas G, Harbach CA, Savoy LA, Darbre PD. Measurement of paraben concentrations in human breast tissue at serial locations across the breast from axilla to sternum. J Appl Toxicol 2012;32:219&#x2013;232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22237600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baste V, Moen BE, Riise T, Hollund BE, &#xD8;yen N. Infertility and spontaneous abortion among female hairdressers: the Hordaland Health Study. J Occup Environ Med 2008;50:1371&#x2013;1377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19092492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bello B, Heederik D, Kielkowski D, Wilson K. Increased time-to-pregnancy is associated with domestic work in South Africa. Reprod Health 2016;13:1&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5011794</ArticleId>
            <ArticleId IdType="pubmed">27600296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boberg J, Taxvig C, Christiansen S, Hass U. Possible endocrine disrupting effects of parabens and their metabolites. Reprod Toxicol 2010;30:301&#x2013;312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20381602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007;22:1506&#x2013;1512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17376819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braun J, Just A, Williams PM, Smith K, Calafat AM, Hauser R. Personal care product use and urinary phthalate metabolite and paraben concentrations during pregnancy among women from a fertility clinic. J Expo Sci Environ Epidemiol 2014;24:459&#x2013;466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4016195</ArticleId>
            <ArticleId IdType="pubmed">24149971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braun JM, Smith KW, Williams PL, Calafat AM, Berry K, Ehrlich S, Hauser R. Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect 2012;120:739&#x2013;745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3346778</ArticleId>
            <ArticleId IdType="pubmed">22262702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buck Louis GM, Kannan K, Sapra KJ, Maisog J, Sundaram R. Urinary concentrations of benzophenone-type ultraviolet radiation filters and couples&#x2019; fecundity. Am J Epidemiol 2014. a;180:1168&#x2013;1175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4262441</ArticleId>
            <ArticleId IdType="pubmed">25395025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buck Louis GM, Sundaram R, Sweeney AM, Schisterman EF, Maisog J, Kannan K. Urinary bisphenol A, phthalates, and couple fecundity: the Longitudinal Investigation of Fertility and the Environment (LIFE) Study. Fertil Steril 2014. b;101:1359&#x2013;1366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4008721</ArticleId>
            <ArticleId IdType="pubmed">24534276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burdorf A, Brand T, Jaddoe VW, Hofman A, Mackenbach JP, Steegers EA. The effects of work-related maternal risk factors on time to pregnancy, preterm birth and birth weight: the Generation R Study. Occup Environ Med 2011;68:197&#x2013;204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21172792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calafat AM, Longnecker MP, Koch HM, Swan SH, Hauser R, Goldman LR, Lanphear BP, Rudel RA, Engel SM, Teitelbaum SL. Optimal exposure biomarkers for nonpersistent chemicals in environmental epidemiology. Environ Health Perspect 2015;123:A166&#x2013;A168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4492274</ArticleId>
            <ArticleId IdType="pubmed">26132373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calafat AM, Needham LL. What additional factors beyond state-of-the-art analytical methods are needed for optimal generation and interpretation of biomonitoring data? Environ Health Perspect 2009;117:1481&#x2013;1485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2790499</ArticleId>
            <ArticleId IdType="pubmed">20019895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calafat AM, Wong L-Y, Ye X, Reidy JA, Needham LL. Concentrations of the sunscreen agent benzophenone-3 in residents of the United States: National Health and Nutrition Examination Survey 2003&#x2013;2004. Environ Health Perspect 2008;116:893&#x2013;897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2453157</ArticleId>
            <ArticleId IdType="pubmed">18629311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calafat AM, Ye X, Wong LY, Bishop AM, Needham LL. Urinary concentrations of four parabens in the U.S. population: NHANES 2005&#x2013;2006. Environ Health Perspect 2010;118:679&#x2013;685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2866685</ArticleId>
            <ArticleId IdType="pubmed">20056562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carwile JL, Ye X, Zhou X, Calafat AM, Michels KB. Canned soup consumption and urinary bisphenol A: a randomized crossover trial. JAMA 2011;306:2218&#x2013;2220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3367259</ArticleId>
            <ArticleId IdType="pubmed">22110104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caserta D, Bordi G, Ciardo F, Marci R, La Rocca C, Tait S, Bergamasco B, Stecca L, Mantovani A, Guerranti C et al. . The influence of endocrine disruptors in a selected population of infertile women. Gynecol Endocrinol 2013;29:444&#x2013;447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23347089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandra A, Copen C, Stephen E. Infertility service use in the United States: data from the National Survey of Family Growth, 1982&#x2013;2010. Natl Health Stat Report 2014;73:1&#x2013;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24467919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Ahn KC, Gee NA, Gee SJ, Hammock BD, Lasley BL. Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. Toxicol Appl Pharmacol 2007;221:278&#x2013;284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1978490</ArticleId>
            <ArticleId IdType="pubmed">17481686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Correa A, Gray RH, Cohen R, Rothman N, Shah F, Seacat H, Com M. Ethylene glycol ethers and risks of spontaneous abortion and subfertility. Am J Epidemiol 1996;143:707&#x2013;717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8651233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dann AB, Hontela A. Triclosan: environmental exposure, toxicity and mechanisms of action. J Appl Toxicol 2011;31:285&#x2013;311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21462230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS. Concentrations of parabens in human breast tumours. J Appl Toxicol 2004;24:5&#x2013;13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14745841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Renzo GC, Conry JA, Blake J, DeFrancesco MS, DeNicola N, Martin JN, McCue KA, Richmond D, Shah A, Sutton P. International Federation of Gynecology and Obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals. Int J Gynecol Obstet 2015;131:219&#x2013;225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6663094</ArticleId>
            <ArticleId IdType="pubmed">26433469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diop H, Gopal D, Cabral H, Belanoff C, Declercq ER, Kotelchuck M, Luke B, Stern JE. Assisted reproductive technology and early intervention program enrollment. Pediatrics 2016;137:e20122007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4766754</ArticleId>
            <ArticleId IdType="pubmed">26908668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dodge L, Williams P, Williams M, Missmer S, Souter I, Calafat A, Hauser R, Team ES. Associations between paternal urinary phthalate metabolite concentrations and reproductive outcomes among couples seeking fertility treatment. Reprod Toxicol 2015;58:184&#x2013;193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4690752</ArticleId>
            <ArticleId IdType="pubmed">26456810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ehrlich S, Calafat AM, Humblet O, Smith T, Hauser R. Handling of thermal receipts as a source of exposure to bisphenol A. J Am Med Assoc 2014;311:859&#x2013;860.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4685668</ArticleId>
            <ArticleId IdType="pubmed">24570250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eisenberg ML, Li S, Behr B, Cullen MR, Galusha D, Lamb DJ, Lipshultz LI. Semen quality, infertility and mortality in the USA. Hum Reprod 2014;29:1567&#x2013;1574.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4059337</ArticleId>
            <ArticleId IdType="pubmed">24838701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eisenberg ML, Li S, Cullen MR, Baker LC. Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data. Fertil Steril 2016;105:629&#x2013;636.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26674559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Hussein S, Muret P, Berard M, Makki S, Humbert P. Assessment of principal parabens used in cosmetics after their passage through human epidermis-dermis layers (ex-vivo study). Exp Dermatol 2007;16:830&#x2013;836.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17845215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eladak S, Grisin T, Moison D, Guerquin M-J, N&#x2019;Tumba-Byn T, Pozzi-Gaudin S, Benachi A, Livera G, Rouiller-Fabre V, Habert R. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. Fertil Steril 2015;103:11&#x2013;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25475787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008&#x2013;2011. N Engl J Med 2016;374:843&#x2013;852.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4861155</ArticleId>
            <ArticleId IdType="pubmed">26962904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster PM, Lloyd SC, Blackburn DM. Comparison of the in vivo and in vitro testicular effects produced by methoxy-, ethoxy-and N-butoxy acetic acids in the rat. Toxicology 1987;43:17&#x2013;30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3810650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galhardo A, Pinto-Gouveia J, Cunha M, Matos M. The impact of shame and self-judgment on psychopathology in infertile patients. Hum Reprod 2011;26:2408&#x2013;2414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21727160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galloway T, Cipelli R, Guralnik J, Ferrucci L, Bandinelli S, Corsi AM, Money C, McCormack P, Melzer D. Daily bisphenol A excretion and associations with sex hormone concentrations: results from the InCHIANTI adult population study. Environ Health Perspect 2010;118:1603&#x2013;1608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2974700</ArticleId>
            <ArticleId IdType="pubmed">20797929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garlant&#xE9;zec R, Warembourg C, Monfort C, Labat L, Pulkkinen J, Bonvallot N, Multigner L, Chevrier C, Cordier S. Urinary glycol ether metabolites in women and time to pregnancy: the PELAGIE cohort. Environ Health Perspect 2013;121:1167&#x2013;1173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3801453</ArticleId>
            <ArticleId IdType="pubmed">23838187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gee R, Charles A, Taylor N, Darbre P. Oestrogenic and androgenic activity of triclosan in breast cancer cells. J Appl Toxicol 2008;28:78&#x2013;91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17992702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonzalez H, Farbrot A, Larko O, Wennberg AM. Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol 2006;154:337&#x2013;340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16433806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gore AC, Chappell V, Fenton S, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller R. EDC-2: the endocrine society&#x2019;s second scientific statement on endocrine-disrupting chemicals. Endocr Rev 2015;36:593&#x2013;602.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4702494</ArticleId>
            <ArticleId IdType="pubmed">26544531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hannon PR, Peretz J, Flaws JA. Daily exposure to Di (2-ethylhexyl) phthalate alters estrous cyclicity and accelerates primordial follicle recruitment potentially via dysregulation of the phosphatidylinositol 3-kinase signaling pathway in adult mice. Biol Reprod 2014;90:136, 131-111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4435463</ArticleId>
            <ArticleId IdType="pubmed">24804967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanson BM, Eisenberg ML, Hotaling JM. Male infertility: a biomarker of individual and familial cancer risk. Fertil Steril 2018;109:6&#x2013;19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29307404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harley KG, Kogut K, Madrigal DS, Cardenas M, Vera IA, Meza-Alfaro G, She J, Gavin Q, Zahedi R, Bradman A. Reducing phthalate, paraben, and phenol exposure from personal care products in adolescent girls: findings from the hermosa intervention study. Environ Health Perspect 2016;124:1600&#x2013;1607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5047791</ArticleId>
            <ArticleId IdType="pubmed">26947464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart RJ. Physiological aspects of female fertility: role of the environment, modern lifestyle, and genetics. Physiol Rev 2016;96:873&#x2013;909.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27252278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hauser R. Urinary phthalate metabolites and semen quality: a review of a potential biomarker of susceptibility. Int J Androl 2008;31:112&#x2013;117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18067563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hauser R, Gaskins AJ, Souter I, Smith KW, Dodge LE, Ehrlich S, Meeker JD, Calafat AM, Williams PL, Team ES. Urinary phthalate metabolite concentrations and reproductive outcomes among women undergoing in vitro fertilization: results from the EARTH study. Environ Health Perspect 2016;124:831&#x2013;839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4892919</ArticleId>
            <ArticleId IdType="pubmed">26545148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsieh G, Wang J, Cheng T, Chen P. Prolonged menstrual cycles in female workers exposed to ethylene glycol ethers in the semiconductor manufacturing industry. Occup Environ Med 2005;62:510&#x2013;516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1741062</ArticleId>
            <ArticleId IdType="pubmed">16046602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua R, Zhou Y, Wu B, Huang Z, Zhu Y, Song Y, Yu Y, Li H, Quan S. Urinary triclosan concentrations and early outcomes of in vitro fertilization-embryo transfer. Reproduction 2017;153:319&#x2013;325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28073982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huo X, Chen D, He Y, Zhu W, Zhou W, Zhang J. Bisphenol-A and female infertility: a possible role of gene-environment interactions. Int J Environ Res Public Health 2015;12:11101&#x2013;11116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4586663</ArticleId>
            <ArticleId IdType="pubmed">26371021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>James MO, Li W, Summerlot DP, Rowland-Faux L, Wood CE. Triclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta. Environ Int 2010;36:942&#x2013;949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4789100</ArticleId>
            <ArticleId IdType="pubmed">19299018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jensen TK, Jacobsen R, Christensen K, Nielsen NC, Bostofte E. Good semen quality and life expectancy: a cohort study of 43,277 men. Am J Epidemiol 2009;170:559&#x2013;565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19635736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeon HK, Sarma SN, Kim YJ, Ryu JC. Toxicokinetics and metabolisms of benzophenone-type UV filters in rats. Toxicology 2008;248:89&#x2013;95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18448226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang R, Roberts MS, Collins DM, Benson HA. Absorption of sunscreens across human skin: an evaluation of commercial products for children and adults. Br J Clin Pharmacol 1999;48:635&#x2013;637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2014387</ArticleId>
            <ArticleId IdType="pubmed">10583038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joffe M. Time to pregnancy: a measure of reproductive function in either sex. Occup Environ Med 1997;54:289&#x2013;295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1128774</ArticleId>
            <ArticleId IdType="pubmed">9196448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jukic AM, Calafat AM, McConnaughey DR, Longnecker MP, Hoppin JA, Weinberg CR, Wilcox AJ, Baird DD, Calafat AM, McConnaughey DR. Urinary concentrations of phthalate metabolites and bisphenol A and associations with follicular-phase length, luteal-phase length, fecundability, and early pregnancy loss. Environ Health Perspect 2016;124:321&#x2013;328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4786975</ArticleId>
            <ArticleId IdType="pubmed">26161573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jurewicz J, Hanke W. Exposure to phthalates: reproductive outcome and children health. A review of epidemiological studies. Int J Occup Med Environ Health 2011;24:115&#x2013;141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21594692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawamura Y, Mutsuga M, Kato T, Iida M, Tanamoto K. Estrogenic and anti-androgenic activities of benzophenones in human estrogen and androgen receptor mediated mammalian reporter gene assays. J Health Sci 2005;51:48&#x2013;54.</Citation>
        </Reference>
        <Reference>
          <Citation>Kay VR, Bloom MS, Foster WG. Reproductive and developmental effects of phthalate diesters in males. Crit Rev Toxicol 2014;44:467&#x2013;498.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24903855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kessler LM, Craig BM, Plosker SM, Reed DR, Quinn GP. Infertility evaluation and treatment among women in the United States. Fertil Steril 2013;100:1025&#x2013;1032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3814221</ArticleId>
            <ArticleId IdType="pubmed">23849845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S, Choi K. Occurrences, toxicities, and ecological risks of benzophenone-3, a common component of organic sunscreen products: a mini-review. Environ Int 2014;70:143&#x2013;157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24934855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobrosly RW, Parlett LE, Stahlhut RW, Barrett ES, Swan SH. Socioeconomic factors and phthalate metabolite concentrations among United States women of reproductive age. Environ Res 2012;115:11&#x2013;17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22472009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koch HM, Aylward LL, Hays SM, Smolders R, Moos RK, Cocker J, Jones K, Warren N, Levy L, Bevan R. Inter-and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: personal care product ingredients. Toxicol Lett 2014;231:261&#x2013;269.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24956590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krause M, Klit A, Blomberg Jensen M, S&#xF8;eborg T, Frederiksen H, Schlumpf M, Lichtensteiger W, Skakkebaek N, Drzewiecki K. Sunscreens: are they beneficial for health? An overview of endocrine disrupting properties of UV&#x2010;filters. Int J Androl 2012;35:424&#x2013;436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22612478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar V, Chakraborty A, Kural MR, Roy P. Alteration of testicular steroidogenesis and histopathology of reproductive system in male rats treated with triclosan. Reprod Toxicol 2009;27:177&#x2013;185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19118620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kunisue T, Chen Z, Buck Louis GM, Sundaram R, Hediger ML, Sun L, Kannan K. Urinary concentrations of benzophenone-type UV filters in US women and their association with endometriosis. Environ Sci Technol 2012;46:4624&#x2013;4632.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3352028</ArticleId>
            <ArticleId IdType="pubmed">22417702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langer S, Bek&#xF6; G, Weschler CJ, Brive LM, Toftum J, Callesen M, Clausen G. Phthalate metabolites in urine samples from Danish children and correlations with phthalates in dust samples from their homes and daycare centers. Int J Hyg Environ Health 2014;217:78&#x2013;87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23623597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Latif T, Kold Jensen T, Mehlsen J, Holmboe SA, Brinth L, Pors K, Skouby SO, J&#xF8;rgensen N, Lindahl-Jacobsen R. Semen quality as a predictor of subsequent morbidity: a Danish cohort study of 4,712 men with long-term follow-up. Am J Epidemiol 2017;186:910&#x2013;917.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28498890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luk BH, Loke AY. The impact of infertility on the psychological well-being, marital relationships, sexual relationships, and quality of life of couples: a systematic review. J Sex Marital Ther 2015;41:610&#x2013;625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25211377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Machtinger R, Orvieto R. Bisphenol A, oocyte maturation, implantation, and IVF outcome: review of animal and human data. Reprod Biomed Online 2014;29:404&#x2013;410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25154017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manfo FPT, Jubendradass R, Nantia EA, Moundipa PF, Mathur PP. Adverse effects of bisphenol A on male reproductive function In: Whitacre DM (ed). Reviews of Environmental Contamination and Toxicology; Vol. 228 Basel, Switzerland: Springer International Publishing, 2014;57&#x2013;82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24162092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mariana M, Feiteiro J, Verde I, Cairrao E. The effects of phthalates in the cardiovascular and reproductive systems: a review. Environ Int 2016;94:758&#x2013;776.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27424259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meeker JD, Calafat AM, Hauser R. Di (2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels in men. Environ Health Perspect 2007;115:1029&#x2013;1034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1913587</ArticleId>
            <ArticleId IdType="pubmed">17637918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meeker JD, Calafat AM, Hauser R. Urinary bisphenol A concentrations in relation to serum thyroid and reproductive hormone levels in men from an infertility clinic. Environ Sci Technol 2009;44:1458&#x2013;1463.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2823133</ArticleId>
            <ArticleId IdType="pubmed">20030380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meeker JD, Ferguson KK. Relationship between urinary phthalate and bisphenol A concentrations and serum thyroid measures in US adults and adolescents from the National Health and Nutrition Examination Survey (NHANES) 2007&#x2013;2008. Environ Health Perspect 2011;119:1396&#x2013;1402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3230451</ArticleId>
            <ArticleId IdType="pubmed">21749963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mendiola J, J&#xF8;rgensen N, Andersson A-M, Calafat AM, Ye X, Redmon JB, Drobnis EZ, Wang C, Sparks A, Thurston SW. Are environmental levels of bisphenol A associated with reproductive function in fertile men? Environ Health Perspect 2010;118:1286&#x2013;1291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2944091</ArticleId>
            <ArticleId IdType="pubmed">20494855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Messerlian C, Maclagan L, Basso O. Infertility and the risk of adverse pregnancy outcomes: a systematic review and meta-analysis. Hum Reprod 2012;28:125&#x2013;137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23042798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Messerlian C, Souter I, Gaskins AJ, Williams PL, Ford JB, Chiu Y-H, Calafat AM, Hauser R. Urinary phthalate metabolites and ovarian reserve among women seeking infertility care. Hum Reprod 2015;31:75&#x2013;83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4677966</ArticleId>
            <ArticleId IdType="pubmed">26573529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Minguez-Alarcon L, Hauser R, Gaskins AJ. Effects of bisphenol A on male and couple reproductive health: a review. Fertil Steril 2016;106:864&#x2013;870.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5242098</ArticleId>
            <ArticleId IdType="pubmed">27498136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mocanu E, Redmond ML, Hennelly B, Collins C, Harrison R. Odds of ovarian hyperstimulation syndrome (OHSS)&#x2014;time for reassessment. Hum Fertil 2007;10:175&#x2013;181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17786650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:1&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3090117</ArticleId>
            <ArticleId IdType="pubmed">21603045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4320440</ArticleId>
            <ArticleId IdType="pubmed">25554246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molina-Molina J-M, Escande A, Pillon A, Gomez E, Pakdel F, Cavaill&#xE8;s V, Olea N, A&#xEF;t-A&#xEF;ssa S, Balaguer P. Profiling of benzophenone derivatives using fish and human estrogen receptor-specific in vitro bioassays. Toxicol Appl Pharmacol 2008;232:384&#x2013;395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18706922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morgenstern R, Whyatt RM, Insel BJ, Calafat AM, Liu X, Rauh VA, Herbstman J, Bradwin G, Factor-Litvak P. Phthalates and thyroid function in preschool age children: sex specific associations. Environ Int 2017;106:11&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5533628</ArticleId>
            <ArticleId IdType="pubmed">28554096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moss T, Howes D, Williams FM. Percutaneous penetration and dermal metabolism of triclosan (2,4, 4&#x2019;-trichloro-2&#x2019;-hydroxydiphenyl ether). Food Chem Toxicol 2000;38:361&#x2013;370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10722890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Multigner L, Catala M, Cordier S, Delaforge M, Fenaux P, Garnier R, Rico-Lattes I, Vasseur P. The INSERM expert review on glycol ethers: findings and recommendations. Toxicol Lett 2005;156:29&#x2013;37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15705485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nargund VH. Effects of psychological stress on male fertility. Nat Rev Urol 2015;12:373&#x2013;382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26057063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson JW, Scammell MK, Hatch EE, Webster TF. Social disparities in exposures to bisphenol A and polyfluoroalkyl chemicals: a cross-sectional study within NHANES 2003&#x2013;2006. Environ Health 2012;11:10&#x2013;25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3312862</ArticleId>
            <ArticleId IdType="pubmed">22394520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen J, Ramlau-Hansen CH. Epidemiologic methods for investigating male fecundity. Asian J Androl 2014;16:17&#x2013;22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3901876</ArticleId>
            <ArticleId IdType="pubmed">24369129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paul KB, Hedge JM, DeVito MJ, Crofton KM. Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in Young Long-Evans rats. Toxicol Sci 2010;113:367&#x2013;379.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2902919</ArticleId>
            <ArticleId IdType="pubmed">19910387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peretz J, Gallicchio L, Miller S, Greene T, Zacur H, Flaws JA. Infertility among cosmetologists. Reprod Toxicol 2009;28:359&#x2013;364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19481600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perrier F, Giorgis-Allemand L, Slama R, Philippat C. Within-subject pooling of biological samples to reduce exposure misclassification in biomarker-based studies. Epidemiology 2016;27:378&#x2013;388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4820663</ArticleId>
            <ArticleId IdType="pubmed">27035688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phillips KP, Tanphaichitr N. Human exposure to endocrine disrupters and semen quality. J Toxicol Environ Health B Crit Rev 2008;11:188&#x2013;220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18368553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajapakse N, Silva E, Kortenkamp A. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 2002;110:917&#x2013;921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1240992</ArticleId>
            <ArticleId IdType="pubmed">12204827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rattan S, Zhou C, Chiang C, Mahalingam S, Brehm E, Flaws JA. Exposure to endocrine disruptors during adulthood: consequences for female fertility. J Endocrinol 2017;233:R109&#x2013;R129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5479690</ArticleId>
            <ArticleId IdType="pubmed">28356401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robinson O, Basaga&#xF1;a X, Agier L, de Castro M, Hernandez-Ferrer C, Gonzalez JR, Grimalt JO, Nieuwenhuijsen M, Sunyer J, Slama RM. The pregnancy exposome: multiple environmental exposures in the INMA-Sabadell birth cohort. Environ Sci Technol 2015;49:10632&#x2013;10641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26168307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rochester JR, Bolden AL, Pelch KE, Kwiatkowski CF. Potential developmental and reproductive impacts of triclocarban: a scoping review. J Toxicol 2017;2017:9679738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5733165</ArticleId>
            <ArticleId IdType="pubmed">29333157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodricks JV, Swenberg JA, Borzelleca JF, Maronpot RR, Shipp AM. Triclosan: a critical review of the experimental data and development of margins of safety for consumer products. Crit Rev Toxicol 2010;40:422&#x2013;484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20377306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rogers JA, Metz L, Yong VW. endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. Mol Immunol 2013;53:421&#x2013;430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23123408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ronda E, Garc&#xED;a AM, S&#xE1;nchez-Paya J, Moen BE. Menstrual disorders and subfertility in Spanish hairdressers. Eur J Obstet Gynecol Reprod Biol 2009;147:61&#x2013;64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19713029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol Appl Pharmacol 1998;153:12&#x2013;19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9875295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudel RA, Gray JM, Engel CL, Rawsthorne TW, Dodson RE, Ackerman JM, Rizzo J, Nudelman JL, Brody JG. Food packaging and bisphenol A and bis (2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ Health Perspect 2011;119:914&#x2013;920.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3223004</ArticleId>
            <ArticleId IdType="pubmed">21450549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>S&#xE1;nchez BN, Hu H, Litman HJ, T&#xE9;llez-Rojo MM. Statistical methods to study timing of vulnerability with sparsely sampled data on environmental toxicants. Environ Health Perspect 2011;119:409&#x2013;415.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3060007</ArticleId>
            <ArticleId IdType="pubmed">21362588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandborgh-Englund G, Adolfsson-Erici M, Odham G, Ekstrand J. Pharmacokinetics of triclosan following oral ingestion in humans. J Toxicol Environ Health A 2006;69:1861&#x2013;1873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16952905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W. In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect 2001;109:239&#x2013;244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1240241</ArticleId>
            <ArticleId IdType="pubmed">11333184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sedha S, Kumar S, Shukla S. Role of oxidative stress in male reproductive dysfunctions with reference to phthalate compounds. Urology 2015;12:2304&#x2013;2316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26571312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seggers J, Pontesilli M, Ravelli AC, Painter RC, Hadders-Algra M, Heineman MJ, Repping S, Mol BWJ, Roseboom TJ, Ensing S. Effects of in vitro fertilization and maternal characteristics on perinatal outcomes: a population-based study using siblings. Fertil Steril 2016;105:590&#x2013;598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26658132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Br Med J 2015;350:1&#x2013;25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25555855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma R, Biedenharn KR, Fedor JM, Agarwal A. Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol 2013;11:66. ; 61-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3717046</ArticleId>
            <ArticleId IdType="pubmed">23870423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva MJ, Samandar E, Preau JL Jr, Reidy JA, Needham LL, Calafat AM. Quantification of 22 phthalate metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 2007;860:106&#x2013;112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17997365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh M, Kaur J, Singh S, Thumburu K, Jaiswal N, Chauhan A, Agarwal A, Paul N, Sagwal S Comparison of Newcastle Ottawa scale (NOS) and Agency for Health Research and Quality (AHRQ) as risk of bias assessment tools for cohort studies. Filtering the information overload for better decisions. Abstracts of the 23rd Cochrane Colloquium. 2015. John Wiley and Sons, Vienna, Austria.</Citation>
        </Reference>
        <Reference>
          <Citation>Smarr MM, Sapra KJ, Gemmill A, Kahn LG, Wise LA, Lynch CD, Factor-Litvak P, Mumford SL, Skakkebaek NE, Slama R. Is human fecundity changing? A discussion of research and data gaps precluding us from having an answer. Hum Reprod 2017. a;32:499&#x2013;504.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5850610</ArticleId>
            <ArticleId IdType="pubmed">28137753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smarr MM, Sundaram R, Honda M, Kannan K, Buck Louis GM. Urinary concentrations of parabens and other antimicrobial chemicals and their association with couples&#x2019; fecundity. Environ Health Perspect 2017. b;125:730&#x2013;736.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5381974</ArticleId>
            <ArticleId IdType="pubmed">27286252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Snijder CA, Brouwers MM, Jaddoe VW, Hofman A, Roeleveld N, Burdorf A. Occupational exposure to endocrine disruptors and time to pregnancy among couples in a large birth cohort study: the Generation R Study. Fertil Steril 2011;95:2067&#x2013;2072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21392747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soni MG, Carabin IG, Burdock GA. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol 2005;43:985&#x2013;1015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15833376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Specht IO, Bonde JP, Toft G, Lindh CH, J&#xF6;nsson BA, J&#xF8;rgensen KT. Serum phthalate levels and time to pregnancy in couples from Greenland, Poland and Ukraine. PLoS One 2015;10:1&#x2013;15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4364890</ArticleId>
            <ArticleId IdType="pubmed">25786246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603&#x2013;605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20652370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steiner AZ (ed).. Biomarkers of Ovarian Reserve as Predictors of Reproductive Potential. Stuttgart, Germany: Thieme Medical Publishers, 2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24101224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoker TE, Gibson EK, Zorrilla LM. Triclosan exposure modulates estrogen-dependent responses in the female wistar rat. Toxicol Sci 2010;117:45&#x2013;53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20562219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sumpter JP, Johnson AC. Lessons from endocrine disruption and their application to other issues concerning trace organics in the aquatic environment. Environ Sci Technol 2005;39:4321&#x2013;4332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16047764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki T, Kitamura S, Khota R, Sugihara K, Fujimoto N, Ohta S. Estrogenic and antiandrogenic activities of 17 benzophenone derivatives used as UV stabilizers and sunscreens. Toxicol Appl Pharmacol 2005;203:9&#x2013;17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15694459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talmor A, Dunphy B. Female obesity and infertility. Best Pract Res Clin Obstet Gynaecol 2015;29:498&#x2013;506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25619586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tavares RS, Martins FC, Oliveira PJ, Ramalho-Santos J, Peixoto FP. Parabens in male infertility&#x2014;is there a mitochondrial connection? Reprod Toxicol 2009;27:1&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19007877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thayer KA, Doerge DR, Hunt D, Schurman SH, Twaddle NC, Churchwell MI, Garantziotis S, Kissling GE, Easterling MR, Bucher JR. Pharmacokinetics of bisphenol A in humans following a single oral administration. Environ Int 2015;83:107&#x2013;115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4545316</ArticleId>
            <ArticleId IdType="pubmed">26115537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomsen AML, Riis AH, Olsen J, J&#xF6;nsson BA, Lindh CH, Hjollund NH, Jensen TK, Bonde JP, Toft G. Female exposure to phthalates and time to pregnancy: a first pregnancy planner study. Hum Reprod 2017;32:232&#x2013;238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27852689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Townsend MK, Franke AA, Li X, Hu FB, Eliassen AH. Within-person reproducibility of urinary bisphenol A and phthalate metabolites over a 1 to 3 year period among women in the Nurses&#x2019; Health Studies: a prospective cohort study. Environ Health 2013;12:1&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3847616</ArticleId>
            <ArticleId IdType="pubmed">24034517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>US Food and Drug Administration Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Reopening of Administrative Record, 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Vabre P, Gatimel N, Moreau J, Gayrard V, Picard-Hagen N, Parinaud J, Leandri RD. Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data. Environ Health 2017;16:37; 31-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5384040</ArticleId>
            <ArticleId IdType="pubmed">28388912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>V&#xE9;lez MP, Arbuckle TE, Fraser WD. Female exposure to phenols and phthalates and time to pregnancy: the Maternal-Infant Research on Environmental Chemicals (MIREC) Study. Fertil Steril 2015;103:1011&#x2013;1020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25681860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veulemans H, Steeno O, Masschelein R, Groeseneken D. Exposure to ethylene glycol ethers and spermatogenic disorders in man: a case-control study. Occup Environ Med 1993;50:71&#x2013;78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1061237</ArticleId>
            <ArticleId IdType="pubmed">8431394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vo TT, Yoo YM, Choi KC, Jeung EB. Potential estrogenic effect(s) of parabens at the prepubertal stage of a postnatal female rat model. Reprod Toxicol 2010;29:306&#x2013;316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20132880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, Yang L, Wang S, Zhang Z, Yu Y, Wang M, Cromie M, Gao W, Wang SL. The classic EDCs, phthalate esters and organochlorines, in relation to abnormal sperm quality: a systematic review with meta-analysis. Sci Rep 2016;6:1&#x2013;11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4726156</ArticleId>
            <ArticleId IdType="pubmed">26804707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang L, Kannan K. Characteristic profiles of benzonphenone-3 and its derivatives in urine of children and adults from the United States and China. Environ Sci Technol 2013;47:12532&#x2013;12538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24073792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webster TF. Mixtures of endocrine disruptors: how similar must mechanisms be for concentration addition to apply? Toxicology 2013;313:129&#x2013;133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23357612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wellings K, Jones KG, Mercer CH, Tanton C, Clifton S, Datta J, Copas AJ, Erens B, Gibson LJ, Macdowall W. The prevalence of unplanned pregnancy and associated factors in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Lancet 2013;382:1807&#x2013;1816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3898922</ArticleId>
            <ArticleId IdType="pubmed">24286786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wells G, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analysis. Ottawa, Ontario: The Ottawa Health Research Institute, 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Wesselink AK, Rothman KJ, Hatch EE, Mikkelsen EM, S&#xF8;rensen HT, Wise LA. Age and fecundability in a North American preconception cohort study. Am J Obstet Gynecol 2017;217:e1&#x2013;e8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5712257</ArticleId>
            <ArticleId IdType="pubmed">28917614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT, Belcher SM. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 2007;24:178&#x2013;198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17628395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999;340:1796&#x2013;1799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10362823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wise LA, Mikkelsen EM, S&#xF8;rensen HT, Rothman KJ, Hahn KA, Riis AH, Hatch EE. Prospective study of time to pregnancy and adverse birth outcomes. Fertil Steril 2015;103:1065&#x2013;1073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4394049</ArticleId>
            <ArticleId IdType="pubmed">25707334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Witorsch RJ, Thomas JA. Personal care products and endocrine disruption: a critical review of the literature. Crit Rev Toxicol 2010;40:1&#x2013;30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20932229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolff MS, Engel SM, Berkowitz GS, Ye X, Silva MJ, Zhu C, Wetmur J, Calafat AM. Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect 2008;116:1092&#x2013;1097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2516577</ArticleId>
            <ArticleId IdType="pubmed">18709157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wood JW, Weinstein M. A model of age-specific fecundability. Popul Stud 1988;42:85&#x2013;113.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu AK, Elliott P, Katz PP, Smith JF. Time costs of fertility care: the hidden hardship of building a family. Fertil Steril 2013;99:2025&#x2013;2030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3736984</ArticleId>
            <ArticleId IdType="pubmed">23454007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye X, Kuklenyik Z, Bishop AM, Needham LL, Calafat AM. Quantification of the urinary concentrations of parabens in humans by on-line solid phase extraction-high performance liquid chromatography&#x2013;isotope dilution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006;844:53&#x2013;59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16893688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye X, Kuklenyik Z, Needham LL, Calafat AM. Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem 2005;77:5407&#x2013;5413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16097788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye X, Zhou X, Furr J, Ahn KC, Hammock BD, Gray EL, Calafat AM. Biomarkers of exposure to triclocarban in urine and serum. Toxicology 2011;286:69&#x2013;74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3534749</ArticleId>
            <ArticleId IdType="pubmed">21635932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, Van der Poel S. The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on ART terminology, 2009. Hum Reprod 2009;24:2683&#x2013;2687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19801627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y, Du L. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta&#x2010;analysis, and clinical practice guideline: a systematic review. J Evid Based Med 2015;8:2&#x2013;10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25594108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Chang H, Wiseman S, He Y, Higley E, Jones P, Wong CK, Al-Khedhairy A, Giesy JP, Hecker M. Bisphenol A disrupts steroidogenesis in human H295R cells. Toxicol Sci 2011;121:320&#x2013;327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21427057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu W, Zhang H, Tong C, Xie C, Fan G, Zhao S, Yu X, Tian Y, Zhang J. Environmental exposure to triclosan and semen quality. Int J Environ Res Public Health 2016;13:1&#x2013;12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4772244</ArticleId>
            <ArticleId IdType="pubmed">26901211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zoeller RT, Brown T, Doan L, Gore A, Skakkebaek N, Soto A, Woodruff T, Vom Saal F. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 2012;153:4097&#x2013;4110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3423612</ArticleId>
            <ArticleId IdType="pubmed">22733974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zota AR, Shamasunder B. The environmental injustice of beauty: framing chemical exposures from beauty products as a health disparities concern. Am J Obstet Gynecol 2017;217:418&#x2013;422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5614862</ArticleId>
            <ArticleId IdType="pubmed">28822238</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">30302954</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">1738-3536</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>82</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tuberculosis and respiratory diseases</Title>
          <ISOAbbreviation>Tuberc Respir Dis (Seoul)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sepsis: Early Recognition and Optimized Treatment.</ArticleTitle>
        <Pagination>
          <StartPage>6</StartPage>
          <EndPage>14</EndPage>
          <MedlinePgn>6-14</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4046/trd.2018.0041</ELocationID>
        <Abstract>
          <AbstractText>Sepsis is a life-threatening condition caused by infection and represents a substantial global health burden. Recent epidemiological studies showed that sepsis mortality rates have decreased, but that the incidence has continued to increase. Although a mortality benefit from early-goal directed therapy (EGDT) in patients with severe sepsis or septic shock was reported in 2001, three subsequent multicenter randomized studies showed no benefits of EGDT versus usual care. Nonetheless, the early administration of antibiotics and intravenous fluids is considered crucial for the treatment of sepsis. In 2016, new sepsis definitions (Sepsis-3) were issued, in which organ failure was emphasized and use of the terms "systemic inflammatory response syndrome" and "severe sepsis" was discouraged. However, early detection of sepsis with timely, appropriate interventions increases the likelihood of survival for patients with sepsis. Also, performance improvement programs have been associated with a significant increase in compliance with the sepsis bundles and a reduction in mortality. To improve sepsis management and reduce its burden, in 2017, the World Health Assembly and World Health Organization adopted a resolution that urged governments and healthcare workers to implement appropriate measures to address sepsis. Sepsis should be considered a medical emergency, and increasing the level of awareness of sepsis is essential.</AbstractText>
          <CopyrightInformation>Copyright&#xA9;2019. The Korean Academy of Tuberculosis and Respiratory Diseases.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Hwan Il</ForeName>
            <Initials>HI</Initials>
            <Identifier Source="ORCID">0000-0002-0165-5506</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Sunghoon</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-7004-6985</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea. f2000tj@naver.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Korea (South)</Country>
        <MedlineTA>Tuberc Respir Dis (Seoul)</MedlineTA>
        <NlmUniqueID>101479418</NlmUniqueID>
        <ISSNLinking>1738-3536</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Compliance</Keyword>
        <Keyword MajorTopicYN="N">Mortality</Keyword>
        <Keyword MajorTopicYN="N">Sepsis</Keyword>
        <Keyword MajorTopicYN="N">Treatment</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30302954</ArticleId>
        <ArticleId IdType="pmc">PMC6304323</ArticleId>
        <ArticleId IdType="doi">10.4046/trd.2018.0041</ArticleId>
        <ArticleId IdType="pii">81.e39</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Torio CM, Moore BJ.  National inpatient hospital costs: the most expensive conditions by payer, 2013. Statistical Brief #204. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet] Rockville, MD: Agency for Healthcare Research and Quality; 2006.  [cited 2018 Apr 29].  Available from:  https://www.ncbi.nlm.nih.gov/books/NBK368492/</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27359025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303&#x2013;1310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11445675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311:1308&#x2013;1316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24638143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546&#x2013;1554.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12700374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376:2235&#x2013;2244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5538258</ArticleId>
            <ArticleId IdType="pubmed">28528569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osborn TM. Severe sepsis and septic shock trials (ProCESS, ARISE, ProMISe): what is optimal resuscitation? Crit Care Clin. 2017;33:323&#x2013;344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28284298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pruinelli L, Westra BL, Yadav P, Hoff A, Steinbach M, Kumar V, et al. Delay within the 3-hour surviving sepsis campaign guideline on mortality for patients with severe sepsis and septic shock. Crit Care Med. 2018;46:500&#x2013;505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5851815</ArticleId>
            <ArticleId IdType="pubmed">29298189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304&#x2013;377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28101605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;1377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11794169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lilly CM. The ProCESS trial: a new era of sepsis management. N Engl J Med. 2014;370:1750&#x2013;1751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24635774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ARISE Investigators; ANZICS Clinical Trials Group. Peake SL, Delaney A, Bailey M, Bellomo R, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496&#x2013;1506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25272316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ProCESS Investigators. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683&#x2013;1693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4101700</ArticleId>
            <ArticleId IdType="pubmed">24635773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:762&#x2013;774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5433435</ArticleId>
            <ArticleId IdType="pubmed">26903335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:775&#x2013;787.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4910392</ArticleId>
            <ArticleId IdType="pubmed">26903336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsi. Crit Care Med. 1992;20:864&#x2013;874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1597042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31:1250&#x2013;1256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12682500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4968574</ArticleId>
            <ArticleId IdType="pubmed">26903338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gatewood MO, Wemple M, Greco S, Kritek PA, Durvasula R. A quality improvement project to improve early sepsis care in the emergency department. BMJ Qual Saf. 2015;24:787&#x2013;795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26251506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayden GE, Tuuri RE, Scott R, Losek JD, Blackshaw AM, Schoenling AJ, et al. Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED. Am J Emerg Med. 2016;34:1&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4905767</ArticleId>
            <ArticleId IdType="pubmed">26386734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644&#x2013;1655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1303622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beesley SJ, Lanspa MJ. Why we need a new definition of sepsis. Ann Transl Med. 2015;3:296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4671881</ArticleId>
            <ArticleId IdType="pubmed">26697456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams JM, Greenslade JH, McKenzie JV, Chu K, Brown AFT, Lipman J. Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection. Chest. 2017;151:586&#x2013;596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27876592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gardner-Thorpe J, Love N, Wrightson J, Walsh S, Keeling N. The value of Modified Early Warning Score (MEWS) in surgical in-patients: a prospective observational study. Ann R Coll Surg Engl. 2006;88:571&#x2013;575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1963767</ArticleId>
            <ArticleId IdType="pubmed">17059720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith GB, Prytherch DR, Meredith P, Schmidt PE, Featherstone PI. The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation. 2013;84:465&#x2013;470.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23295778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roney JK, Whitley BE, Maples JC, Futrell LS, Stunkard KA, Long JD. Modified early warning scoring (MEWS): evaluating the evidence for tool inclusion of sepsis screening criteria and impact on mortality and failure to rescue. J Clin Nurs. 2015;24:3343&#x2013;3354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26780181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stark AP, Maciel RC, Sheppard W, Sacks G, Hines OJ. An early warning score predicts risk of death after in-hospital cardiopulmonary arrest in surgical patients. Am Surg. 2015;81:916&#x2013;921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26463280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Qahtani S, Al-Dorzi HM, Tamim HM, Hussain S, Fong L, Taher S, et al. Impact of an intensivist-led multidisciplinary extended rapid response team on hospital-wide cardiopulmonary arrests and mortality. Crit Care Med. 2013;41:506&#x2013;517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23263618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huh JW, Lim CM, Koh Y, Lee J, Jung YK, Seo HS, et al. Activation of a medical emergency team using an electronic medical recording-based screening system*. Crit Care Med. 2014;42:801&#x2013;808.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24335439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Churpek MM, Snyder A, Han X, Sokol S, Pettit N, Howell MD, et al. Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit. Am J Respir Crit Care Med. 2017;195:906&#x2013;911.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5387705</ArticleId>
            <ArticleId IdType="pubmed">27649072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301&#x2013;1311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25776532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PRISM Investigators. Rowan KM, Angus DC, Bailey M, Barnato AE, Bellomo R, et al. Early, goal-directed therapy for septic shock: a patient-level meta-analysis. N Engl J Med. 2017;376:2223&#x2013;2234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28320242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378:829&#x2013;839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5846085</ArticleId>
            <ArticleId IdType="pubmed">29485925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitchell KH, Carlbom D, Caldwell E, Leary PJ, Himmelfarb J, Hough CL. Volume overload: prevalence, risk factors, and functional outcome in survivors of septic shock. Ann Am Thorac Soc. 2015;12:1837&#x2013;1844.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4722831</ArticleId>
            <ArticleId IdType="pubmed">26394090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walkey AJ, Wiener RS, Lindenauer PK. Utilization patterns and outcomes associated with central venous catheter in septic shock: a population-based study. Crit Care Med. 2013;41:1450&#x2013;1457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3780984</ArticleId>
            <ArticleId IdType="pubmed">23507718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osman D, Ridel C, Ray P, Monnet X, Anguel N, Richard C, et al. Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med. 2007;35:64&#x2013;68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17080001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid therapy. Ann Intensive Care. 2011;1:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3159904</ArticleId>
            <ArticleId IdType="pubmed">21906322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739&#x2013;746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2918907</ArticleId>
            <ArticleId IdType="pubmed">20179283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feissel M, Michard F, Faller JP, Teboul JL. The respiratory variation in inferior vena cava diameter as a guide to fluid therapy. Intensive Care Med. 2004;30:1834&#x2013;1837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15045170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, et al. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med. 2017;196:856&#x2013;863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5649973</ArticleId>
            <ArticleId IdType="pubmed">28345952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai X, Yu W, Ji W, Lin Z, Tan S, Duan K, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care. 2014;18:532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4194405</ArticleId>
            <ArticleId IdType="pubmed">25277635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583&#x2013;1593.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24635770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40:1795&#x2013;1815.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4239778</ArticleId>
            <ArticleId IdType="pubmed">25392034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DellaVolpe JD, Moore JE, Pinsky MR. Arterial blood pressure and heart rate regulation in shock state. Curr Opin Crit Care. 2015;21:376&#x2013;380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26263297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293&#x2013;316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19703817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310:1683&#x2013;1691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24108526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morelli A, Singer M, Ranieri VM, D'Egidio A, Mascia L, Orecchioni A, et al. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study. Intensive Care Med. 2016;42:1528&#x2013;1534.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27101380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Majno G. The ancient riddle of sigma eta psi iota sigma (sepsis) J Infect Dis. 1991;163:937&#x2013;945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2019770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority: a WHO resolution. N Engl J Med. 2017;377:414&#x2013;417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28658587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Just say sepsis! A review of the process of care received by patients with sepsis [Internet] London: National Confidential Enquiry into Patient Outcome and Death; 2015.  [cited 2018 Apr 3].  Available from:  http://www.ncepod.org.uk/2015report2/downloads/JustSaySepsis_FullReport.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Rubulotta FM, Ramsay G, Parker MM, Dellinger RP, Levy MM, Poeze M, et al. An international survey: public awareness and perception of sepsis. Crit Care Med. 2009;37:167&#x2013;170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19123265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vincent JL. Increasing awareness of sepsis: World Sepsis Day. Crit Care. 2012;16:152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3682256</ArticleId>
            <ArticleId IdType="pubmed">22971299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thwaites CL, Lundeg G, Dondorp AM sepsis in resourcelimited settings-expert consensus recommendations group of the European Society of Intensive Care Medicine (ESCICM), the Mahidol-Oxford Research Unit (MORU) in Bangkok, Thailand. Infection management in patients with sepsis and septic shock in resource-limited settings. Intensive Care Med. 2016;42:2117&#x2013;2118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27738708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schultz MJ, Dunser MW, Dondorp AM, Adhikari NK, Iyer S, Kwizera A, et al. Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future. Intensive Care Med. 2017;43:612&#x2013;624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28349179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Sepsis Day [Internet] Seoul: Korean Society of Critical Care Medicine; 2018.  [cited 2018 Apr 3].  Available from:  http://www.ksccm.org/#%2Fboard%2Flist.kin%3Fmenu_main%3D6%26menu_sub%3D29%261522741514642.</Citation>
        </Reference>
        <Reference>
          <Citation>Phua J, Koh Y, Du B, Tang YQ, Divatia JV, Tan CC, et al. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ. 2011;342:d3245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3113333</ArticleId>
            <ArticleId IdType="pubmed">21669950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Center for Outcome and Resource Evaluation. ANZICS [Internet] Camberwell: Australian and New Zealand Intensive Care Society; 2018.  [cited 2018 Apr 3].  Available from:  http://www.anzics.com.au/Pages/CORE/About-CORE.aspx.</Citation>
        </Reference>
        <Reference>
          <Citation>Blot K, Bergs J, Vogelaers D, Blot S, Vandijck D. Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis. Clin Infect Dis. 2014;59:96&#x2013;105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4305144</ArticleId>
            <ArticleId IdType="pubmed">24723276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eom JS, Lee MS, Chun HK, Choi HJ, Jung SY, Kim YS, et al. The impact of a ventilator bundle on preventing ventilator-associated pneumonia: a multicenter study. Am J Infect Control. 2014;42:34&#x2013;37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24189326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy MM, Pronovost PJ, Dellinger RP, Townsend S, Resar RK, Clemmer TP, et al. Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med. 2004;32(11 Suppl):S595&#x2013;S597.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15542969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580&#x2013;637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23353941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Crit Care Med. 2018;46:997&#x2013;1000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29767636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy MM, Rhodes A, Phillips GS, Townsend SR, Schorr CA, Beale R, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med. 2014;40:1623&#x2013;1633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25270221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen YC, Chang SC, Pu C, Tang GJ. The impact of nationwide education program on clinical practice in sepsis care and mortality of severe sepsis: a population-based study in Taiwan. PLoS One. 2013;8:e77414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3790748</ArticleId>
            <ArticleId IdType="pubmed">24124616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coba V, Whitmill M, Mooney R, Horst HM, Brandt MM, Digiovine B, et al. Resuscitation bundle compliance in severe sepsis and septic shock: improves survival, is better late than never. J Intensive Care Med. 2011;26:304&#x2013;313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21220270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, Ortiz F, Llorca J, Delgado-Rodriguez M. Late compliance with the sepsis resuscitation bundle: impact on mortality. Shock. 2011;36:542&#x2013;547.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21937951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim JH, Hong SK, Kim KC, Lee MG, Lee KM, Jung SS, et al. Influence of full-time intensivist and the nurse-to-patient ratio on the implementation of severe sepsis bundles in Korean intensive care units. J Crit Care. 2012;27:414.e11&#x2013;414.e21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22591568</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">30300645</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>10</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>10</Month>
        <Day>31</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-6259</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>107</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Annals of thoracic surgery</Title>
          <ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Low- and Middle-Income Countries and US Trainees Benefit From the Global Health Educator.</ArticleTitle>
        <Pagination>
          <StartPage>689</StartPage>
          <MedlinePgn>689</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.athoracsur.2018.08.025</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0003-4975(18)31420-6</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Martin</LastName>
            <ForeName>Allison N</ForeName>
            <Initials>AN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Virginia, 1215 Lee St, Charlottesville, VA 22908. Electronic address: anm7p@virginia.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Costas-Chavarri</LastName>
            <ForeName>Ainhoa</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Human Resources for Health, Rwanda, Rwanda Military Hospital, Kigali, Rwanda.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Ann Thorac Surg</MedlineTA>
        <NlmUniqueID>15030100R</NlmUniqueID>
        <ISSNLinking>0003-4975</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Ann Thorac Surg. 2018 Nov;106(5):1271-1273. doi: 10.1016/j.athoracsur.2018.04.076.</RefSource>
          <PMID Version="1">29856971</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040441" MajorTopicYN="Y">Health Educators</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066231" MajorTopicYN="Y">Surgeons</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30300645</ArticleId>
        <ArticleId IdType="doi">10.1016/j.athoracsur.2018.08.025</ArticleId>
        <ArticleId IdType="pii">S0003-4975(18)31420-6</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">30299486</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>02</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1537-6613</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>219</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
              <Day>23</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of infectious diseases</Title>
          <ISOAbbreviation>J Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Global Health and the Infectious Diseases Physician-Scientist Workforce.</ArticleTitle>
        <Pagination>
          <StartPage>1007</StartPage>
          <EndPage>1008</EndPage>
          <MedlinePgn>1007-1008</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiy593</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kempker</LastName>
            <ForeName>Russell R</ForeName>
            <Initials>RR</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blumberg</LastName>
            <ForeName>Henry M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Departments of Epidemiology and Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>D43 TW007124</GrantID>
            <Acronym>TW</Acronym>
            <Agency>FIC NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21 AI122001</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UL1 TR002378</GrantID>
            <Acronym>TR</Acronym>
            <Agency>NCATS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>K23 AI103044</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Infect Dis</MedlineTA>
        <NlmUniqueID>0413675</NlmUniqueID>
        <ISSNLinking>0022-1899</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>J Infect Dis. 2018 Aug 14;218(suppl_1):S49-S54. doi: 10.1093/infdis/jiy246.</RefSource>
          <PMID Version="1">30124981</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>J Infect Dis. 2019 Feb 23;219(6):1008-1009. doi: 10.1093/infdis/jiy594.</RefSource>
          <PMID Version="1">30299514</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010820" MajorTopicYN="Y">Physicians</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000078329" MajorTopicYN="N">Workforce</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>23</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30299486</ArticleId>
        <ArticleId IdType="pmc">PMC6386802</ArticleId>
        <ArticleId IdType="doi">10.1093/infdis/jiy593</ArticleId>
        <ArticleId IdType="pii">5123691</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Singh UV. Policy recommendations for optimizing the infectious diseases physician-scientist workforce. J Infect Dis 2018; 218:S49&#x2013;54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30124981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kerry VB, Ndung&#x2019;u T, Walensky RP, Lee PT, Kayanja VF, Bangsberg DR. Managing the demand for global health education. PLoS Med 2011; 8:e1001118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3210750</ArticleId>
            <ArticleId IdType="pubmed">22087076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vermund SH. The vital case for global health investments by the United States government. Clin Infect Dis 2017. doi:10.1093/cid/cix048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix048</ArticleId>
            <ArticleId IdType="pmc">PMC10941300</ArticleId>
            <ArticleId IdType="pubmed">28158519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glass RI. What the United States has to gain from global health research. JAMA 2013; 310:903&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24002270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonura EM, Lee ES, Ramsey K, Armstrong WS. Factors influencing internal medicine resident choice of infectious diseases or other specialties: a national cross-sectional study. Clin Infect Dis 2016; 63:155&#x2013;63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4928385</ArticleId>
            <ArticleId IdType="pubmed">27126345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heimburger DC, Carothers CL, Blevins M, Warner TL, Vermund SH. Impact of global health research training on career trajectories: the Fogarty International Clinical Research Scholars and Fellows Program. Am J Trop Med Hyg 2015; 93:655&#x2013;61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4559713</ArticleId>
            <ArticleId IdType="pubmed">26195466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tucker JD, Hughes MA, Durvasula RV, et al. . Measuring success in global health training: data from 14 years of a postdoctoral fellowship in infectious diseases and tropical medicine. Clin Infect Dis 2017; 64:1768&#x2013;72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6248731</ArticleId>
            <ArticleId IdType="pubmed">28369324</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30298418</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>02</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-4626</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract</Title>
          <ISOAbbreviation>J Gastrointest Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparison of Long-term Quality of Life in Patients with Esophageal Cancer after Ivor-Lewis, Mckeown, or Sweet Esophagectomy.</ArticleTitle>
        <Pagination>
          <StartPage>225</StartPage>
          <EndPage>231</EndPage>
          <MedlinePgn>225-231</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11605-018-3999-z</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">The aim of this study was to compare the long-term quality of life (QoL) in patients after Sweet, Ivor-Lewis, or Mckeown esophagectomy.</AbstractText>
          <AbstractText Label="METHODS">Esophageal cancer patients after Sweet, Ivor-Lewis, or Mckeown esophagectomy from 2010 to 2012 were included. QoL was assessed according to the European Organization for Research and Treatment of Cancer general questionnaire: QLQ-C30 and esophagus-specific questionnaire: QLQ-OES18.</AbstractText>
          <AbstractText Label="RESULTS">A total of 126 qualified patients who have been alive for more than 3&#xA0;years without tumor recurrence were divided into three groups: the Sweet group (n&#x2009;=&#x2009;40), Ivor-Lewis group (n&#x2009;=&#x2009;38), and Mckeown group (n&#x2009;=&#x2009;48). Among these three groups, the QLQ-C30 mean scores of global health status, functional and symptom scales, and general QoL were similar. The symptom scales of QLQ-OSE18 showed that patients who had a Mckeown operation experienced more problem of eating (P&#x2009;=&#x2009;0.029), choking when swallowing (P&#x2009;=&#x2009;0.010) and coughing (P&#x2009;=&#x2009;0.016), while patients undergoing Sweet operation complained more symptom of reflux (P&#x2009;=&#x2009;0.003) and pain (P&#x2009;=&#x2009;0.000).</AbstractText>
          <AbstractText Label="CONCLUSIONS">All three types of esophagectomy provided a generally good long-term QoL. However, patients in Sweet and Mckeown group tend to suffer from a higher symptomatic burden as compared to Ivor-Lewis approach.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Yu-Shang</ForeName>
            <Initials>YS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shang</LastName>
            <ForeName>Qi-Xin</ForeName>
            <Initials>QX</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yuan</LastName>
            <ForeName>Yong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan, China. yongyuan@scu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Xiao-Ying</ForeName>
            <Initials>XY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Wei-Peng</ForeName>
            <Initials>WP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Long-Qi</ForeName>
            <Initials>LQ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Gastrointest Surg</MedlineTA>
        <NlmUniqueID>9706084</NlmUniqueID>
        <ISSNLinking>1091-255X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016629" MajorTopicYN="N">Esophagectomy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006304" MajorTopicYN="Y">Health Status</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Esophageal cancer</Keyword>
        <Keyword MajorTopicYN="N">Esophagectomy</Keyword>
        <Keyword MajorTopicYN="N">QLQ-C30</Keyword>
        <Keyword MajorTopicYN="N">QLQ-OES18</Keyword>
        <Keyword MajorTopicYN="N">Quality of life (QoL)</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30298418</ArticleId>
        <ArticleId IdType="doi">10.1007/s11605-018-3999-z</ArticleId>
        <ArticleId IdType="pii">S1091-255X(23)03202-X</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lancet. 2017 Nov 25;390(10110):2383-2396</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28648400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Thorac Surg. 2004 Oct;78(4):1170-6; discussion 1170-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15464465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Thorac Surg. 1997 Jun;63(6):1568-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9205149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Cancer. 2003 Jul;39(10):1384-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12826041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Surg. 2004 Apr;28(4):355-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14994144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langenbecks Arch Surg. 2013 Feb;398(2):231-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22661100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Surg. 2011 Aug;35(8):1853-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21553202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Surg. 2010 Jun;251(6):1064-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20485137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dis Esophagus. 2016 Oct;29(7):773-779</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26382935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Surg. 2016 Jan;40(1):129-36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26464155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Surg. 2015 Aug;262(2):286-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25607756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Cancer. 1996 Oct;32A(11):1912-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8943674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surg Clin North Am. 2005 Jun;85(3):649-56, xi</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15927658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2012 Feb 1;30(4):413-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22215745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 2000 Apr 15;88(8):1781-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10760752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thorac Cardiovasc Surg. 2015 Jun;63(4):328-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24715527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Surg Oncol. 2008 Feb;15(2):566-75</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17929101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Cancer. 2006 Jul;42(10):1407-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16737812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Surg. 2009 Feb;33(2):284-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19083053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Thorac Surg. 2016 Jul;102(1):207-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27240449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Thorac Surg. 2014 May;97(5):1728-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24650587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Gastroenterol. 2007 May;42(5):342-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17530357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Surg Oncol. 2010 Jun;17(6):1471-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20180029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Surg. 2014 Sep;38(9):2345-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24756548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Surg. 2007 Nov;94(11):1369-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17665422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Thorac Surg. 2010 Jun;89(6):S2163-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20494003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thorac Cardiovasc Surg. 2010 Oct;140(4):777-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20554296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dis Esophagus. 2016 Jan;29(1):93-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25515370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thorac Dis. 2016 Nov;8(11):3187-3196</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28066598</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30296194</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Introduction of universal infant hepatitis B immunisation in the UK- paving the way to elimination.</ArticleTitle>
        <Pagination>
          <StartPage>440</StartPage>
          <EndPage>443</EndPage>
          <MedlinePgn>440-443</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2018.1528837</ELocationID>
        <Abstract>
          <AbstractText>In May 2016, the World Health Assembly ratified the first ever Global Health Sector Strategy (GHSS) on Viral Hepatitis to eliminate viral hepatitis as a public health threat by 2030. In pursuit of this elimination goal and recognising that hepatitis control through immunisation is an essential foundation of a hepatitis B prevention programme, the World Health Organization set out vaccine coverage targets for both universal and selective childhood immunisation programmes, focusing on preventing mother to child transmission. In August 2017 the UK introduced a hexavalent (DTaP/IPV/Hib/HepB) combination vaccine into the routine childhood immunisation programme, replacing the pentavalent vaccine given to all infants at 8, 12 and 16&#xA0;weeks. With the addition of the 6th component to protect against hepatitis B the UK finally introduced universal hepatitis B immunisation. Prior to that, the UK had a selective immunisation policy targeting high risk groups for hepatitis B - including infants born to hepatitis B infected mothers. We tell the story of hepatitis B vaccination in the UK, and how we have evolved from selective to a universal infant immunisation programme, the factors considered in hepatitis B vaccine policy decision-making, and the progress towards elimination of viral hepatitis as a public health threat.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mandal</LastName>
            <ForeName>Sema</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>a Immunisation and Countermeasures Division, National Infection Service , Public Health England , London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D017325">Hepatitis B Vaccines</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
          <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017325" MajorTopicYN="N">Hepatitis B Vaccines</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017589" MajorTopicYN="Y">Immunization Programs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007115" MajorTopicYN="N">Immunization Schedule</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018445" MajorTopicYN="N">Infectious Disease Transmission, Vertical</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Hepatitis B</Keyword>
        <Keyword MajorTopicYN="N">elimination</Keyword>
        <Keyword MajorTopicYN="N">selective immunisation</Keyword>
        <Keyword MajorTopicYN="N">universal immunisation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30296194</ArticleId>
        <ArticleId IdType="pmc">PMC6422463</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2018.1528837</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>World Health Organization 
Hepatitis B fact sheet; 2017. 
accessed
2018
March
16
http://www.who.int/mediacentre/factsheets/fs204/en/.</Citation>
        </Reference>
        <Reference>
          <Citation>Health Protection Surveillance Centre 
Hepatitis B virus: epidemiology and transmission risks; 2016. 
May
http://www.hpsc.ie/a-z/EMIToolkit/appendices/app21-26.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP.. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112&#x2013;125. doi:10.1093/epirev/mxj009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/epirev/mxj009</ArticleId>
            <ArticleId IdType="pubmed">16754644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gentile I, Borgia G. Vertical transmission of hepatitis B virus: challenges and solutions. Int J Womens Health. 2014;6:605&#x2013;611. doi:10.2147/IJWH.S51138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJWH.S51138</ArticleId>
            <ArticleId IdType="pmc">PMC4062549</ArticleId>
            <ArticleId IdType="pubmed">24966696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yi P, Chen R, Huang Y, Zhou RR, Fan XG. Management of mother-to-child transmission of hepatitis B virus: propositions and challenges. J Clin Virol. 2016;77:32&#x2013;39. doi:10.1016/j.jcv.2016.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcv.2016.02.003</ArticleId>
            <ArticleId IdType="pubmed">26895227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Institute for Health and Care Excellence 
The guidelines manual, Chapter 7 Assessing cost effectiveness; 2012. 
https://www.nice.org.uk/process/pmg6/chapter/assessing-cost-effectiveness.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27905714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siddiqui MR, Gay N, Edmunds WJ, Ramsay M. Economic evaluation of infant and adolescent hepatitis B vaccination in the UK. Vaccine. 2011;29(3):466&#x2013;475. doi:10.1016/j.vaccine.2010.10.075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2010.10.075</ArticleId>
            <ArticleId IdType="pubmed">21073988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The Joint Committee on Vaccination and Immunisation 
Minute of the meeting; 2014. 
October
1
https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation#minutes.</Citation>
        </Reference>
        <Reference>
          <Citation>GlaxoSmithKline UK 
Summary of product characteristics&#x2014;infanrix hexa, powder and suspension for suspension for injection. Electronic Medicines Compendium
2017. 
accessed
2018
April
10
https://www.medicines.org.uk/emc/medicine/33313.</Citation>
        </Reference>
        <Reference>
          <Citation>The Joint Committee on Vaccination and Immunisation 
Minute of the meeting; 2016. 
October
5
https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation#minutes.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30292994</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1026</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>650</Volume>
            <Issue>Pt 2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
              <Day>10</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Science of the total environment</Title>
          <ISOAbbreviation>Sci Total Environ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pollution and children's health.</ArticleTitle>
        <Pagination>
          <StartPage>2389</StartPage>
          <EndPage>2394</EndPage>
          <MedlinePgn>2389-2394</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scitotenv.2018.09.375</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0048-9697(18)33854-3</ELocationID>
        <Abstract>
          <AbstractText Label="FINDINGS" NlmCategory="RESULTS">The Lancet Commission on Pollution and Health found that pollution - air, water, soil, and chemical pollution - was responsible in 2016 for 940,000 deaths in children worldwide, two-thirds of them in children under the age of 5. Pollution is inequitably distributed, and the overwhelming majority of pollution-related deaths in children occurred in low- and middle-income countries (LMICs). Most were due to respiratory and gastrointestinal diseases caused by polluted air and water. Pollution is linked also to multiple non-communicable diseases (NCDs) in children including low birth weight, asthma, cancer and neurodevelopmental disorders, and these diseases are on the rise. The full impact of pollution, especially chemical pollution on the global burden of pediatric disease is not yet known, but almost certainly is undercounted because patterns of chemical exposure are not well charted and the potential toxicity of many chemical pollutants has not been characterized. The list of pediatric NCDs attributed to pollution will likely expand as the health effects of newer chemical pollutants are better defined and additional associations between pollution and disease are discovered.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pollution prevention presents a major, largely unexploited opportunity to improve children's health and prevent NCDs, especially in LMICs. Failure to incorporate pollution prevention into NCD control programs is a major missed opportunity for disease prevention.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Landrigan</LastName>
            <ForeName>Philip J</ForeName>
            <Initials>PJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Boston College, Chestnut Hill, MA 02467, USA. Electronic address: phil.landrigan@bc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fuller</LastName>
            <ForeName>Richard</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Pure Earth, 475 Riverside Drive, 860, New York, NY 10115, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fisher</LastName>
            <ForeName>Samantha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Pure Earth, 475 Riverside Drive, 860, New York, NY 10115, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suk</LastName>
            <ForeName>William A</ForeName>
            <Initials>WA</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute of Environmental Health Sciences, 111 T.W. Alexander Drive, Durham, NC 27709, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sly</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Child Health Research Center, Faculty of Medicine, University of Queensland, Brisbane, St. Lucia, 4072, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chiles</LastName>
            <ForeName>Thomas C</ForeName>
            <Initials>TC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology, Boston College, Chestnut Hill, MA 02467, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bose-O'Reilly</LastName>
            <ForeName>Stephan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University Hospital Munich, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, WHO Collaborating Centre for Occupational Health, Unit Global Environmental Health, Ziemssenstr. 1, D-80336 Munich, Germany; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT (University for Health Sciences, Medical Informatics and Technology), Hall i.T., Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Sci Total Environ</MedlineTA>
        <NlmUniqueID>0330500</NlmUniqueID>
        <ISSNLinking>0048-9697</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000067576" MajorTopicYN="Y">Child Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004787" MajorTopicYN="N">Environmental Pollution</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Children's environmental health;</Keyword>
        <Keyword MajorTopicYN="N">Global health;</Keyword>
        <Keyword MajorTopicYN="N">Non-communicable diseases;</Keyword>
        <Keyword MajorTopicYN="N">Pollution;</Keyword>
        <Keyword MajorTopicYN="N">Prevention</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30292994</ArticleId>
        <ArticleId IdType="doi">10.1016/j.scitotenv.2018.09.375</ArticleId>
        <ArticleId IdType="pii">S0048-9697(18)33854-3</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30292907</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-3557</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>208</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy</Title>
          <ISOAbbreviation>Spectrochim Acta A Mol Biomol Spectrosc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Fourier transform infrared spectroscopy based spectral biomarkers of metastasized breast cancer progression.</ArticleTitle>
        <Pagination>
          <StartPage>85</StartPage>
          <EndPage>96</EndPage>
          <MedlinePgn>85-96</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.saa.2018.09.052</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1386-1425(18)30906-5</ELocationID>
        <Abstract>
          <AbstractText>Breast cancer is a global health issue and the second leading cause of cancer death in women. Breast cancer tends to migrate to bone and causes bone metastases which is ultimately the cause of death. Here, we report the use of FTIR to identify spectral biomarkers of cancer progression on 3D in vitro model of breast cancer bone metastasis. Our results indicate that the following spectral biomarkers can monitor cancer progression, for example, lipids (CH2 asymmetric/CH2 symmetric stretch), Amide I/Amide II, and RNA/DNA. Principal component analysis also confirmed the involvement of protein, lipids and nucleic acids in cancer progression on sequential culture. The collective observations from this study suggest successful application of FTIR as a non-invasive and accurate method to identify biochemical changes in cancer cells during the progression of breast cancer bone metastasis.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018. Published by Elsevier B.V.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kar</LastName>
            <ForeName>Sumanta</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Civil and Environmental Engineering, CIE 201, NDSU, Fargo, ND 58104, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Katti</LastName>
            <ForeName>Dinesh R</ForeName>
            <Initials>DR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Civil and Environmental Engineering, CIE 201, NDSU, Fargo, ND 58104, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Katti</LastName>
            <ForeName>Kalpana S</ForeName>
            <Initials>KS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Civil and Environmental Engineering, CIE 201, NDSU, Fargo, ND 58104, United States of America. Electronic address: Kalpana.katti@ndsu.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Spectrochim Acta A Mol Biomol Spectrosc</MedlineTA>
        <NlmUniqueID>9602533</NlmUniqueID>
        <ISSNLinking>1386-1425</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D048430" MajorTopicYN="N">Cell Shape</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059630" MajorTopicYN="N">Mesenchymal Stem Cells</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017550" MajorTopicYN="N">Spectroscopy, Fourier Transform Infrared</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014732" MajorTopicYN="N">Vibration</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">3D in vitro model</Keyword>
        <Keyword MajorTopicYN="N">Bone metastases</Keyword>
        <Keyword MajorTopicYN="N">Breast cancer</Keyword>
        <Keyword MajorTopicYN="N">FTIR spectroscopy</Keyword>
        <Keyword MajorTopicYN="N">Principal component analysis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30292907</ArticleId>
        <ArticleId IdType="doi">10.1016/j.saa.2018.09.052</ArticleId>
        <ArticleId IdType="pii">S1386-1425(18)30906-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30292736</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2152-2669</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical lymphoma, myeloma &amp; leukemia</Title>
          <ISOAbbreviation>Clin Lymphoma Myeloma Leuk</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France.</ArticleTitle>
        <Pagination>
          <StartPage>e13</StartPage>
          <EndPage>e28</EndPage>
          <MedlinePgn>e13-e28</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clml.2018.08.019</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S2152-2650(18)30428-2</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">New therapies for multiple myeloma (MM) have improved life expectancy, but health-related quality of life (HRQoL) data from patients with MM in the real-world setting are lacking. This study, conducted in France, explored the associations between treatment outcomes and HRQoL in patients with MM.</AbstractText>
          <AbstractText Label="PATIENTS AND METHODS">This observational, cross-sectional, multicenter study enrolled patients (&#x2265; 18 years old) with symptomatic MM who had consulted a physician at least once between February and March 2016. HRQoL was assessed using the European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life questionnaire (QLQ-C30) and the Quality of Life Multiple Myeloma module (QLQ-MY20).</AbstractText>
          <AbstractText Label="RESULTS">In total, 445 patients were included in the study; 402 (90%) completed the EORTC QLQ-C30 and QLQ-MY20 questionnaires. HRQoL decreased significantly with treatment line. Patients in the first treatment-free interval had relatively high scores. At later lines, patients receiving active treatment had better scores than those whose treatment had ended. High EORTC QLQ-C30 global health status scores were associated with good treatment response, few adverse events, and long duration of treatment, and were strongly influenced by the Eastern Cooperative Oncology Group performance status. Global health status scores correlated well with the 4 items of the QLQ-MY20 (future perspective, 0.46; body image, 0.41; disease symptoms,&#xA0;-0.57; side effects of treatment,&#xA0;-0.53).</AbstractText>
          <AbstractText Label="CONCLUSION">Effective treatment options in MM can help maintain HRQoL by influencing treatment response levels and delaying disease progression.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Despi&#xE9;gel</LastName>
            <ForeName>Nicolas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Amgen France, Value Access and Policy, Paris, France. Electronic address: nicolasd@amgen.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Touboul</LastName>
            <ForeName>Chantal</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Kantar Health, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flinois</LastName>
            <ForeName>Alain</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Kantar Health, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saba</LastName>
            <ForeName>Gr&#xE8;ce</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Kantar Health, Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suzan</LastName>
            <ForeName>Florence</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Amgen (Europe) GmbH, Zug, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gonzalez-McQuire</LastName>
            <ForeName>Sebastian</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Amgen (Europe) GmbH, Zug, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bonnetain</LastName>
            <ForeName>Franck</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>University Hospital of Besan&#xE7;on (INSERM 1098), Methodological and Quality of Life Unit in Oncology, Besan&#xE7;on, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016448">Multicenter Study</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Lymphoma Myeloma Leuk</MedlineTA>
        <NlmUniqueID>101525386</NlmUniqueID>
        <ISSNLinking>2152-2669</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009101" MajorTopicYN="N">Multiple Myeloma</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Global health status</Keyword>
        <Keyword MajorTopicYN="N">Observational</Keyword>
        <Keyword MajorTopicYN="N">Real world</Keyword>
        <Keyword MajorTopicYN="N">Toxicity</Keyword>
        <Keyword MajorTopicYN="N">Treatment optimization</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30292736</ArticleId>
        <ArticleId IdType="doi">10.1016/j.clml.2018.08.019</ArticleId>
        <ArticleId IdType="pii">S2152-2650(18)30428-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30291200</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>12</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Towards 'a balanced delegation' or enhancing global health governance? Analysis of parties' participation in the Conference of the Parties to WHO Framework Convention on Tobacco Control.</ArticleTitle>
        <Pagination>
          <StartPage>636</StartPage>
          <EndPage>642</EndPage>
          <MedlinePgn>636-642</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054710</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">The success of the WHO Framework Convention on Tobacco Control (FCTC) depends on parties' active participation in its governance and implementation, particularly via biennial Conference of the Parties (COP) meetings. The COP's efficacy is threatened by declining attendance and reductions in travel support for low-income and middle-income countries, and there are growing concerns about transparency and representation in country delegations amid industry efforts to shape their composition.</AbstractText>
          <AbstractText Label="METHODS">We examined parties' participation in the COP based on official meeting records, and the relationship between attendance and strength of tobacco control based on national global tobacco control reports.</AbstractText>
          <AbstractText Label="RESULTS">Attendance at the COP has decreased over time, and at several meetings would have fallen below 66% (the threshold for decision-making) if it was not for high levels of participation among low-income and lower-middle-income countries. Despite their higher attendance at COP meetings, these countries represent a smaller share of meeting attendees due to the smaller size of their delegations. Additionally, there has been a decline in the proportion of delegates from ministries of health and tobacco control focal points. Nationally, COP participation is correlated with stronger tobacco control policies; attendance by low-income countries has a strong correlation with implementation of advertising bans, while attendance among high-income and lower-middle-income countries shows a moderate correlation with implementation of tobacco taxes.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Supporting states to actively engage in the COP is crucial for ongoing FCTC implementation, strengthening national capacity for tobacco control, and protecting the legitimacy and efficacy of global health governance.</AbstractText>
          <CopyrightInformation>&#xA9; Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Plotnikova</LastName>
            <ForeName>Evgeniya</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Global Health Policy Unit, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hill</LastName>
            <ForeName>Sarah E</ForeName>
            <Initials>SE</Initials>
            <AffiliationInfo>
              <Affiliation>Global Health Policy Unit, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wright</LastName>
            <ForeName>Alex</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Global Health Policy Unit, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Collin</LastName>
            <ForeName>Jeff</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Global Health Policy Unit, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MR/P027946/2</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000329" MajorTopicYN="N">Advertising</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011640" MajorTopicYN="Y">Public Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013660" MajorTopicYN="N">Taxes</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019460" MajorTopicYN="N">Tobacco Industry</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="N">Tobacco Products</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064424" MajorTopicYN="N">Tobacco Use</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">low/middle income country</Keyword>
        <Keyword MajorTopicYN="N">tobacco industry</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30291200</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054710</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054710</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30284234</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1699-3055</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical &amp; translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</Title>
          <ISOAbbreviation>Clin Transl Oncol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Risk of malnutrition and emotional distress as factors affecting health-related quality of life in patients with resected cancer.</ArticleTitle>
        <Pagination>
          <StartPage>687</StartPage>
          <EndPage>691</EndPage>
          <MedlinePgn>687-691</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12094-018-1954-9</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">This study analyzes the prevalence of malnutrition, depression, anxiety, and somatization and which factor has the biggest effect on quality of life (QoL) in individuals with resected cancer.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A prospective study was conducted among 747 participants. Participants completed the EORTC-QLQ30, MST, and BSI-18 questionnaires.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Prevalence for risk of malnutrition, depression, anxiety, and somatization were 36.4%, 35.5%, 35.2%, and 48.8%, respectively. Hierarchical multiple regression analyses revealed that malnutrition risk, somatization, depression, and anxiety accounted for 50.8% of the variance in functional scale, 45.3% in symptom scale, and 52.2% in global health. Malnutrition, somatization, depression, and anxiety displayed high explanatory power on all health-related QoL (HRQoL) scales.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The risk of malnutrition and psychological symptoms is strongly associated with HRQoL in cancer patients; thus, medical oncologists should develop effective interventions that contribute to lowering the risk of malnutrition and psychological distress, thereby improving subjects' HRQoL before initiating adjuvant chemotherapy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Calderon</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carmona-Bayonas</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beato</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Hospital Universitario Virgen de la Macarena, Sevilla, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghanem</LastName>
            <ForeName>I</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hernandez</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Majem</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Hospital Universitari Santa Creu i Sant Pau, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rosa Diaz</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Higuera</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mut Lloret</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Hospital Universitario Son Espases, Mallorca, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jimenez-Fonseca</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-4592-3813</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. palucaji@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016448">Multicenter Study</PublicationType>
          <PublicationType UI="D064888">Observational Study</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Clin Transl Oncol</MedlineTA>
        <NlmUniqueID>101247119</NlmUniqueID>
        <ISSNLinking>1699-048X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044342" MajorTopicYN="N">Malnutrition</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">BSI18</Keyword>
        <Keyword MajorTopicYN="N">Cancer</Keyword>
        <Keyword MajorTopicYN="N">EORTC-QLQ30</Keyword>
        <Keyword MajorTopicYN="N">Health-related quality of life</Keyword>
        <Keyword MajorTopicYN="N">MST</Keyword>
        <Keyword MajorTopicYN="N">Malnutrition</Keyword>
        <Keyword MajorTopicYN="N">Psychological symptoms</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30284234</ArticleId>
        <ArticleId IdType="doi">10.1007/s12094-018-1954-9</ArticleId>
        <ArticleId IdType="pii">10.1007/s12094-018-1954-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Australas Radiol. 1999 Aug;43(3):325-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10901927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pediatrics. 2002 Jul;110(1 Pt 1):42-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12093945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Cancer. 2004 Jun 14;90(12):2297-304</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15162149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Support Care Cancer. 2006 Nov;14(11):1152-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16622648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer. 2008 Mar 15;112(6):1363-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18318044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psicothema. 2008 Nov;20(4):844-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18940093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Oncol. 2010 Apr;21(4):877-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19822532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Intern Med. 2010 Oct 11;170(18):1686-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20937930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1838-49</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21844244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2011 Nov 20;29(33):4387-93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22010012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Natl Cancer Inst. 2012 Mar 7;104(5):386-405</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22271773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Support Care Cancer. 2013 Mar;21(3):765-73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22941116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Oncol. 2013 Nov 1;31(31):3869-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24062405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Support Care Cancer. 2014 Feb;22(2):453-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24091720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychooncology. 2014 Feb;23(2):121-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24105788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Support Care Cancer. 2015 Jan;23(1):47-54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24947056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychooncology. 2015 Jun;24(6):712-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25099337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World J Gastroenterol. 2014 Sep 7;20(33):11567-73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25206264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Nurs. 2015 Sep-Oct;38(5):335-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25226516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Cardiothorac Surg. 2016 Jan;49(1):e16-21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26410631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychooncology. 2017 Jan;26(1):22-28</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26490953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychooncology. 2017 Jul;26(7):917-926</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27440317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Cancer. 2016 Aug 18;16:651</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27538465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychol Assess. 2017 Oct;29(10):1189-1200</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28080106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychooncology. 2018 Jan;27(1):333-338</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28557067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JPRAS Open. 2017 Mar;11:1-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28713853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychooncology. 2018 Mar;27(3):900-907</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29239060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Acad Nutr Diet. 2018 Jun;118(6):1065-1071</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29398570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Transl Oncol. 2018 Nov;20(11):1408-1415</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29651672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Nutr. 2019 Jun;38(3):1274-1279</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29853223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychol Med. 1983 Aug;13(3):595-605</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6622612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8433390</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30282775</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Basic economic gap related to smoking: reconciling tobacco tax receipts and economic costs of smoking-attributable diseases.</ArticleTitle>
        <Pagination>
          <StartPage>558</StartPage>
          <EndPage>561</EndPage>
          <MedlinePgn>558-561</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054307</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Tobacco tax rates set by various governments are not based on the idea that tax receipts should cover the costs incurred by smoking. It can be assumed that tobacco tax receipts (TTR) differ from the costs of smoking. The aim is to determine the global basic economic gap (BEG) between TTR and the economic costs of smoking-attributable diseases (ECS).</AbstractText>
          <AbstractText Label="METHODS">BEG is described as the difference between the ECS and TTR. A total of 124 countries representing 94% of global tobacco consumption were included in the research by means of the creation of a database, the adjustment of input data and the identification of their intersection.</AbstractText>
          <AbstractText Label="RESULTS">The global BEG reaches US$1438 billion per year. The global ECS are US$1911 billion per year. The global TTR are US$473 billion per year and compensate for only one quarter of the ECS. Within countries with the highest consumption of cigarettes, especially the USA but also Russia and Germany, the proportion of the ECS covered by the TTR is even lower, although private health expenditures have been taken into account.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Our findings suggest that tobacco taxes would have to be globally increased by more than four times on average in order to cover the ECS or between two and two-and-a-half times if we take private health expenditures into account. The informational pressure concerning health risks associated with smoking aimed at reducing harmful consumption and improving global health can also be supported with these economic facts.</AbstractText>
          <CopyrightInformation>&#xA9; Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>David</LastName>
            <ForeName>Petr</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0002-5055-0989</Identifier>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005102" MajorTopicYN="N">Health Expenditures</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013660" MajorTopicYN="N">Taxes</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="N">Tobacco Products</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073869" MajorTopicYN="N">Tobacco Smoking</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">economics</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">taxation</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30282775</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054307</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054307</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30282710</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>09</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">1098-5514</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>93</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of virology</Title>
          <ISOAbbreviation>J Virol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Engineered Small-Molecule Control of Influenza A Virus Replication.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e01677-18</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01677-18</ELocationID>
        <Abstract>
          <AbstractText>Influenza A virus (IAV) remains a global health concern despite the availability of a seasonal vaccine. It is difficult to predict which strains will circulate during influenza season, and therefore, it is extremely challenging to test novel vaccines in the human population. To overcome this obstacle, new vaccines must be tested in challenge studies. This approach poses significant safety problems, since current pharmacological interventions for IAV are poorly efficacious. New methods are needed to enhance the safety of these challenge studies. In this study, we have generated a virus expressing a small-molecule-assisted shutoff (SMASh) tag as a safety switch for IAV replication. The addition of the SMASh tag to an essential IAV protein allows for small-molecule-mediated inhibition of replication. Treatment with this drug controls the replication of a SMASh-tagged virus <i>in vitro</i> and <i>in vivo</i> This model for restriction of viral replication has potential for broad applications in vaccine studies, virotherapy, and basic virus research.<b>IMPORTANCE</b> Influenza A virus (IAV) causes significant morbidity and mortality annually worldwide, despite the availability of new formulations of the vaccine each season. There is a critical need to develop more-efficacious vaccines. However, testing novel vaccines in the human population in controlled studies is difficult due to the limited availability and efficacy of intervention strategies should the vaccine fail. There are also significant safety concerns for work with highly pathogenic IAV strains in the laboratory. Therefore, novel strategies are needed to improve the safety of vaccine studies and of research on highly pathogenic IAV. In this study, we developed an IAV strain engineered to contain a small-molecule-mediated safety switch. This tag, when attached to an essential viral protein, allows for the regulation of IAV replication <i>in vitro</i> and <i>in vivo</i> This strategy provides a platform for the regulation of virus replication without targeting viral proteins directly.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 American Society for Microbiology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fay</LastName>
            <ForeName>Elizabeth J</ForeName>
            <Initials>EJ</Initials>
            <AffiliationInfo>
              <Affiliation>Biochemistry, Molecular Biology, and Biophysics Graduate Program, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Immunology, University of Minnesota Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Aron</LastName>
            <ForeName>Stephanie L</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Immunology, University of Minnesota Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stone</LastName>
            <ForeName>Ian A</ForeName>
            <Initials>IA</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Immunology, University of Minnesota Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Waring</LastName>
            <ForeName>Barbara M</ForeName>
            <Initials>BM</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Immunology, University of Minnesota Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Plemper</LastName>
            <ForeName>Richard K</ForeName>
            <Initials>RK</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Langlois</LastName>
            <ForeName>Ryan A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Biochemistry, Molecular Biology, and Biophysics Graduate Program, University of Minnesota, Minneapolis, Minnesota, USA langlois@umn.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Immunology, University of Minnesota Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K22 AI110581</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AI071002</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AI132962</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 AI007313</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 CA077598</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Virol</MedlineTA>
        <NlmUniqueID>0113724</NlmUniqueID>
        <ISSNLinking>0022-538X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007546">Isoquinolines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D054852">Small Molecule Libraries</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>20O93L6F9H</RegistryNumber>
          <NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>S9X0KRJ00S</RegistryNumber>
          <NameOfSubstance UI="C571889">asunaprevir</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007546" MajorTopicYN="N">Isoquinolines</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061985" MajorTopicYN="N">Madin Darby Canine Kidney Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015202" MajorTopicYN="N">Protein Engineering</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054852" MajorTopicYN="N">Small Molecule Libraries</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">biotechnology</Keyword>
        <Keyword MajorTopicYN="N">influenza vaccines</Keyword>
        <Keyword MajorTopicYN="N">virus engineering</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>10</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30282710</ArticleId>
        <ArticleId IdType="pmc">PMC6288343</ArticleId>
        <ArticleId IdType="doi">10.1128/JVI.01677-18</ArticleId>
        <ArticleId IdType="pii">JVI.01677-18</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kash JC, Taubenberger JK. 2015. The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am J Pathol 185:1528&#x2013;1536. doi:10.1016/j.ajpath.2014.08.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2014.08.030</ArticleId>
            <ArticleId IdType="pmc">PMC4450310</ArticleId>
            <ArticleId IdType="pubmed">25747532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tao H, Li L, White MC, Steel J, Lowen AC. 2015. Influenza A virus coinfection through transmission can support high levels of reassortment. J Virol 89:8453&#x2013;8461. doi:10.1128/JVI.01162-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.01162-15</ArticleId>
            <ArticleId IdType="pmc">PMC4524221</ArticleId>
            <ArticleId IdType="pubmed">26041285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schrauwen EJ, de Graaf M, Herfst S, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2014. Determinants of virulence of influenza A virus. Eur J Clin Microbiol Infect Dis 33:479&#x2013;490. doi:10.1007/s10096-013-1984-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-013-1984-8</ArticleId>
            <ArticleId IdType="pmc">PMC3969785</ArticleId>
            <ArticleId IdType="pubmed">24078062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marjuki H, Mishin VP, Chesnokov AP, De La Cruz JA, Davis CT, Villanueva JM, Fry AM, Gubareva LV. 2015. Neuraminidase mutations conferring resistance to oseltamivir in influenza A(H7N9) viruses. J Virol 89:5419&#x2013;5426. doi:10.1128/JVI.03513-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.03513-14</ArticleId>
            <ArticleId IdType="pmc">PMC4442539</ArticleId>
            <ArticleId IdType="pubmed">25740997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A, Baloxavir Marboxil Investigators Group . 2018. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med 379:913&#x2013;923. doi:10.1056/NEJMoa1716197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1716197</ArticleId>
            <ArticleId IdType="pubmed">30184455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, Stockmann CR, McCullers J, Arnold SR, Wunderink RG, Anderson EJ, Lindstrom S, Fry AM, Foppa IM, Finelli L, Bramley AM, Jain S, Griffin MR, Edwards KM. 2015. Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination. JAMA 314:1488&#x2013;1497. doi:10.1001/jama.2015.12160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2015.12160</ArticleId>
            <ArticleId IdType="pmc">PMC4688454</ArticleId>
            <ArticleId IdType="pubmed">26436611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, Tashkandi M, Bauch CT, Loeb M. 2013. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 11:153. doi:10.1186/1741-7015-11-153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1741-7015-11-153</ArticleId>
            <ArticleId IdType="pmc">PMC3706345</ArticleId>
            <ArticleId IdType="pubmed">23800265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. 2011. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis 204:1879&#x2013;1885. doi:10.1093/infdis/jir661.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jir661</ArticleId>
            <ArticleId IdType="pubmed">21998477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, Tsai T, Clemens R, Rappuoli R. 2011. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 30:1081&#x2013;1085. doi:10.1097/INF.0b013e3182367662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0b013e3182367662</ArticleId>
            <ArticleId IdType="pubmed">21983214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobhanie M, Matsuoka Y, Jegaskanda S, Fitzgerald T, Mallory R, Chen Z, Luke C, Treanor J, Subbarao K. 2016. Evaluation of the safety and immunogenicity of a candidate pandemic live attenuated influenza vaccine (pLAIV) against influenza A(H7N9). J Infect Dis 213:922&#x2013;929. doi:10.1093/infdis/jiv526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiv526</ArticleId>
            <ArticleId IdType="pmc">PMC4760421</ArticleId>
            <ArticleId IdType="pubmed">26655841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jegaskanda S, Luke C, Hickman HD, Sangster MY, Wieland-Alter WF, McBride JM, Yewdell JW, Wright PF, Treanor J, Rosenberger CM, Subbarao K. 2016. Generation and protective ability of influenza virus-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection, and experimental challenge. J Infect Dis 214:945&#x2013;952. doi:10.1093/infdis/jiw262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiw262</ArticleId>
            <ArticleId IdType="pmc">PMC4996149</ArticleId>
            <ArticleId IdType="pubmed">27354365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Memoli MJ, Shaw PA, Han A, Czajkowski L, Reed S, Athota R, Bristol T, Fargis S, Risos K, Powers JH, Davey RT Jr, Taubenberger JK. 2016. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model. mBio 7:e00417-16. doi:10.1128/mBio.00417-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00417-16</ArticleId>
            <ArticleId IdType="pmc">PMC4959521</ArticleId>
            <ArticleId IdType="pubmed">27094330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. 2008. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167:775&#x2013;785. doi:10.1093/aje/kwm375.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/aje/kwm375</ArticleId>
            <ArticleId IdType="pubmed">18230677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Killingley B, Enstone J, Booy R, Hayward A, Oxford J, Ferguson N, Nguyen Van-Tam J, Influenza Transmission Strategy Development Group . 2011. Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect Dis 11:879&#x2013;886. doi:10.1016/S1473-3099(11)70142-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(11)70142-6</ArticleId>
            <ArticleId IdType="pubmed">21798808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langlois RA, Albrecht RA, Kimble B, Sutton T, Shapiro JS, Finch C, Angel M, Chua MA, Gonzalez-Reiche AS, Xu K, Perez D, Garcia-Sastre A, tenOever BR. 2013. microRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nat Biotechnol 31:844&#x2013;847. doi:10.1038/nbt.2666.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nbt.2666</ArticleId>
            <ArticleId IdType="pmc">PMC3808852</ArticleId>
            <ArticleId IdType="pubmed">23934176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung HK, Jacobs CL, Huo Y, Yang J, Krumm SA, Plemper RK, Tsien RY, Lin MZ. 2015. Tunable and reversible drug control of protein production via a self-excising degron. Nat Chem Biol 11:713&#x2013;720. doi:10.1038/nchembio.1869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.1869</ArticleId>
            <ArticleId IdType="pmc">PMC4543534</ArticleId>
            <ArticleId IdType="pubmed">26214256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McPhee F, Sheaffer AK, Friborg J, Hernandez D, Falk P, Zhai G, Levine S, Chaniewski S, Yu F, Barry D, Chen C, Lee MS, Mosure K, Sun LQ, Sinz M, Meanwell NA, Colonno RJ, Knipe J, Scola P. 2012. Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032). Antimicrob Agents Chemother 56:5387&#x2013;5396. doi:10.1128/AAC.01186-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01186-12</ArticleId>
            <ArticleId IdType="pmc">PMC3457370</ArticleId>
            <ArticleId IdType="pubmed">22869577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muir AJ, Poordad F, Lalezari J, Everson G, Dore GJ, Herring R, Sheikh A, Kwo P, Hezode C, Pockros PJ, Tran A, Yozviak J, Reau N, Ramji A, Stuart K, Thompson AJ, Vierling J, Freilich B, Cooper J, Ghesquiere W, Yang R, McPhee F, Hughes EA, Swenson ES, Yin PD. 2015. Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis. JAMA 313:1736&#x2013;1744. doi:10.1001/jama.2015.3868.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2015.3868</ArticleId>
            <ArticleId IdType="pubmed">25942724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poordad F, Sievert W, Mollison L, Bennett M, Tse E, Brau N, Levin J, Sepe T, Lee SS, Angus P, Conway B, Pol S, Boyer N, Bronowicki JP, Jacobson I, Muir AJ, Reddy KR, Tam E, Ortiz-Lasanta G, de Ledinghen V, Sulkowski M, Boparai N, McPhee F, Hughes E, Swenson ES, Yin PD, UNITY-1 Study Group . 2015. Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection. JAMA 313:1728&#x2013;1735. doi:10.1001/jama.2015.3860.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2015.3860</ArticleId>
            <ArticleId IdType="pubmed">25942723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toyoda H, Kumada T, Tada T, Takaguchi K, Ishikawa T, Tsuji K, Zeniya M, Iio E, Tanaka Y. 2016. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis. J Gastroenterol 51:741&#x2013;747. doi:10.1007/s00535-016-1174-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00535-016-1174-4</ArticleId>
            <ArticleId IdType="pubmed">26872889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan D, Weisshaar M, Lamb K, Chung HK, Lin MZ, Plemper RK. 2015. Replication-competent influenza virus and respiratory syncytial virus luciferase reporter strains engineered for co-infections identify antiviral compounds in combination screens. Biochemistry 54:5589&#x2013;5604. doi:10.1021/acs.biochem.5b00623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.biochem.5b00623</ArticleId>
            <ArticleId IdType="pmc">PMC4719150</ArticleId>
            <ArticleId IdType="pubmed">26307636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. 2014. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ 348:g2545. doi:10.1136/bmj.g2545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.g2545</ArticleId>
            <ArticleId IdType="pmc">PMC3981975</ArticleId>
            <ArticleId IdType="pubmed">24811411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heaton NS, Langlois RA, Sachs D, Lim JK, Palese P, tenOever BR. 2014. Long-term survival of influenza virus infected club cells drives immunopathology. J Exp Med 211:1707&#x2013;1714. doi:10.1084/jem.20140488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20140488</ArticleId>
            <ArticleId IdType="pmc">PMC4144728</ArticleId>
            <ArticleId IdType="pubmed">25135297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dias A, Bouvier D, Crepin T, McCarthy AA, Hart DJ, Baudin F, Cusack S, Ruigrok RW. 2009. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458:914&#x2013;918. doi:10.1038/nature07745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature07745</ArticleId>
            <ArticleId IdType="pubmed">19194459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langlois RA, Varble A, Chua MA, Garcia-Sastre A, tenOever BR. 2012. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc Natl Acad Sci U S A 109:12117&#x2013;12122. doi:10.1073/pnas.1206039109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1206039109</ArticleId>
            <ArticleId IdType="pmc">PMC3409765</ArticleId>
            <ArticleId IdType="pubmed">22778433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waring BM, Sjaastad LE, Fiege JK, Fay EJ, Reyes I, Moriarity B, Langlois RA. 2018. microRNA-based attenuation of influenza virus across susceptible hosts. J Virol 92:e01741-17. doi:10.1128/JVI.01741-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.01741-17</ArticleId>
            <ArticleId IdType="pmc">PMC5752925</ArticleId>
            <ArticleId IdType="pubmed">29093096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiege JK, Langlois RA. 2015. Investigating influenza A virus infection: tools to track infection and limit tropism. J Virol 89:6167&#x2013;6170. doi:10.1128/JVI.00462-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.00462-15</ArticleId>
            <ArticleId IdType="pmc">PMC4474293</ArticleId>
            <ArticleId IdType="pubmed">25855737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferreira AR, Magalhaes AC, Camoes F, Gouveia A, Vieira M, Kagan JC, Ribeiro D. 2016. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response. J Cell Mol Med 20:750&#x2013;757. doi:10.1111/jcmm.12801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jcmm.12801</ArticleId>
            <ArticleId IdType="pmc">PMC5125814</ArticleId>
            <ArticleId IdType="pubmed">26865163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukuyama S, Katsura H, Zhao D, Ozawa M, Ando T, Shoemaker JE, Ishikawa I, Yamada S, Neumann G, Watanabe S, Kitano H, Kawaoka Y. 2015. Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies. Nat Commun 6:6600. doi:10.1038/ncomms7600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms7600</ArticleId>
            <ArticleId IdType="pmc">PMC4389232</ArticleId>
            <ArticleId IdType="pubmed">25807527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hai R, Martinez-Sobrido L, Fraser KA, Ayllon J, Garcia-Sastre A, Palese P. 2008. Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol 82:10580&#x2013;10590. doi:10.1128/JVI.01213-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.01213-08</ArticleId>
            <ArticleId IdType="pmc">PMC2573209</ArticleId>
            <ArticleId IdType="pubmed">18768976</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30274731</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-7361</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>165</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Surgery</Title>
          <ISOAbbreviation>Surgery</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The World Bank Group: Innovative financing for health and opportunities for global surgery.</ArticleTitle>
        <Pagination>
          <StartPage>263</StartPage>
          <EndPage>272</EndPage>
          <MedlinePgn>263-272</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surg.2018.07.040</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0039-6060(18)30500-2</ELocationID>
        <Abstract>
          <AbstractText>The World Bank Group is the largest global development organization working to end poverty and promote shared prosperity. Its 5 institutions play an essential role in the advancement of global health through innovative health financing, data collection and management, policy reform, and advocacy. Previously, the World Bank Group has supported global surgery through data collection and advocacy. As it grows, it must continue to focus on the importance of surgical care in promoting health and avoiding poverty in low- and middle-income countries. The house of surgery and its community should play an active role in advocating for the many ways in which the World Bank Group could facilitate the strengthening of surgical systems to improve access to surgical care worldwide.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peters</LastName>
            <ForeName>Alexander W</ForeName>
            <Initials>AW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Weill Cornell Medical College, New York, New York; Program in Global Surgery and Social Change, Harvard Medical School, Boston, Massachusetts; Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, Massachusetts. Electronic address: awp9003@nyp.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pyda</LastName>
            <ForeName>Jordan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Global Surgery and Social Change, Harvard Medical School, Boston, Massachusetts; Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, Massachusetts; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Menon</LastName>
            <ForeName>Gopal</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Global Surgery and Social Change, Harvard Medical School, Boston, Massachusetts; Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, Massachusetts; Department of Surgery, New York Presbyterian Hospital-Queens, Queens, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suzuki</LastName>
            <ForeName>Emi</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Development Data Group, World Bank Group, Washington, DC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meara</LastName>
            <ForeName>John G</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Global Surgery and Social Change, Harvard Medical School, Boston, Massachusetts; Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Surgery</MedlineTA>
        <NlmUniqueID>0417347</NlmUniqueID>
        <ISSNLinking>0039-6060</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018166" MajorTopicYN="N">Health Care Reform</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006293" MajorTopicYN="N">Health Promotion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061889" MajorTopicYN="Y">Healthcare Financing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014480" MajorTopicYN="N">United Nations</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30274731</ArticleId>
        <ArticleId IdType="doi">10.1016/j.surg.2018.07.040</ArticleId>
        <ArticleId IdType="pii">S0039-6060(18)30500-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30269628</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2025</Year>
        <Month>01</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1360-0567</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of mental health (Abingdon, England)</Title>
          <ISOAbbreviation>J Ment Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Paramedic management of mental health related presentations: a scoping review.</ArticleTitle>
        <Pagination>
          <StartPage>89</StartPage>
          <EndPage>96</EndPage>
          <MedlinePgn>89-96</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09638237.2018.1487534</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mental illness is a recognised global health issue and is a major burden of disease that health systems have failed to adequately address. National reforms in Australia to improve mental health service delivery propose building the knowledge and skills of service providers, such as paramedics, to ensure that they appropriately respond to the needs of people experiencing mental health issues. There is a paucity of literature on the role of paramedics in managing mental health presentations despite becoming an increasingly significant part of mental health care in the pre-hospital context.</AbstractText>
          <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This scoping review examined the available literature on the paramedic management of mental health related presentations.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The five stages of Arksey and O'Malley's methodological framework was used: (1) identifying the research question; (2) identifying relevant studies; (3) study section; (4) charting the data; and (5) collating, summarizing and reporting of results. Relevant databases were searched.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Fourteen peer-reviewed articles met the inclusion criteria. Three themes were identified and structured the findings. These were education and training, organizational factors, and clinical decision making.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The authors recommend that future research address these areas, as high quality evidence will support planning in this complex area of health care delivery.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Emond</LastName>
            <ForeName>Kate</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-4968-4007</Identifier>
            <AffiliationInfo>
              <Affiliation>a La Trobe Rural Health School La Trobe University , Bendigo , Victoria , Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Meara</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>a La Trobe Rural Health School La Trobe University , Bendigo , Victoria , Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bish</LastName>
            <ForeName>Melanie</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-4305-6760</Identifier>
            <AffiliationInfo>
              <Affiliation>a La Trobe Rural Health School La Trobe University , Bendigo , Victoria , Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000098583">Scoping Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Ment Health</MedlineTA>
        <NlmUniqueID>9212352</NlmUniqueID>
        <ISSNLinking>0963-8237</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000488" MajorTopicYN="N">Allied Health Personnel</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002983" MajorTopicYN="N">Clinical Competence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008605" MajorTopicYN="Y">Mental Health Services</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071836" MajorTopicYN="N">Professional Practice Gaps</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Mental health</Keyword>
        <Keyword MajorTopicYN="N">mental illness</Keyword>
        <Keyword MajorTopicYN="N">paramedic</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30269628</ArticleId>
        <ArticleId IdType="doi">10.1080/09638237.2018.1487534</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30269375</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-4644</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>120</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cellular biochemistry</Title>
          <ISOAbbreviation>J Cell Biochem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>In utero exposure to PM2.5 during gestation caused adult cardiac hypertrophy through histone acetylation modification.</ArticleTitle>
        <Pagination>
          <StartPage>4375</StartPage>
          <EndPage>4384</EndPage>
          <MedlinePgn>4375-4384</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jcb.27723</ELocationID>
        <Abstract>
          <AbstractText>Ambient particles with a diameter of &lt;2.5 &#x3BC;m (PM2.5) is a global health concern, and exposure to PM2.5 contributes to the progression of cardiovascular morbidity and mortality. In this study, pregnant c57 mice were exposed to PM2.5 during the whole gestation (approximately 300 &#xB5;g/m <sup>3</sup> PM2.5 for 2&#x2009;hours/d). A significantly low birth weight was found after in utero PM2.5 exposure, and low body weight continued for 12 weeks after birth. In the offspring, remarkable destructions of cardiac ultrastructures were determined both in newborn and adult hearts. In adulthood, hearts of mice in the PM2.5 exposed group showed cardiac hypertrophy. Protein levels of p300, CBP (histone acetyltransferase), and acetylated histone3 lysine 9 (H3K9ac) increased in the trial group; messenger RNA (mRNA) levels of GATA binding protein 4 (GATA4) and myocyte enhancer factor 2C (Mef2c) (prohypertrophic transcription factors), and mRNA levels of the classic hypertrophic genes, such as &#x3B1;-MHC and &#x3B2;-MHC, increased significantly in the hearts of the PM2.5 exposed group. H3K9ac levels near the promoter region of GATA4 and Mef2c went up in the PM2.5 group. The binding affinities of p300/CBP with promoters of GATA4 and Mef2c increased notably. Taken together, out data indicated that maternal exposure to PM2.5 during gestation may cause a series of cardiovascular events in the offspring; histone acetylation modification may play an important role in the programming of cardiac hypertrophy.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Xiaoqi</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Heart Centre, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Developmental Disease in Childhood (Chongqing Medical University), Ministry of Education, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pediatrics, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Bo</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Heart Centre, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Developmental Disease in Childhood (Chongqing Medical University), Ministry of Education, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pediatrics, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Lingjuan</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Developmental Disease in Childhood (Chongqing Medical University), Ministry of Education, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pediatrics, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Weian</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Heart Centre, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Developmental Disease in Childhood (Chongqing Medical University), Ministry of Education, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pediatrics, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Developmental Disease in Childhood (Chongqing Medical University), Ministry of Education, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pediatrics, Chongqing, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Xupei</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Science, Charlie E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tian</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-9006-6710</Identifier>
            <AffiliationInfo>
              <Affiliation>Heart Centre, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Cell Biochem</MedlineTA>
        <NlmUniqueID>8205768</NlmUniqueID>
        <ISSNLinking>0730-2312</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009124">Muscle Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D052638">Particulate Matter</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006332" MajorTopicYN="Y">Cardiomegaly</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018811" MajorTopicYN="N">Maternal Exposure</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009124" MajorTopicYN="N">Muscle Proteins</DescriptorName>
          <QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009206" MajorTopicYN="Y">Myocardium</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D032383" MajorTopicYN="Y">Myocytes, Cardiac</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D052638" MajorTopicYN="N">Particulate Matter</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011297" MajorTopicYN="Y">Prenatal Exposure Delayed Effects</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">PM2.5</Keyword>
        <Keyword MajorTopicYN="N">cardiac hypertrophy</Keyword>
        <Keyword MajorTopicYN="N">histone acetylation</Keyword>
        <Keyword MajorTopicYN="N">maternal exposure</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30269375</ArticleId>
        <ArticleId IdType="doi">10.1002/jcb.27723</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30264137</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>10</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2168-6238</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>76</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>JAMA psychiatry</Title>
          <ISOAbbreviation>JAMA Psychiatry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life: A Randomized Clinical Trial.</ArticleTitle>
        <Pagination>
          <StartPage>21</StartPage>
          <EndPage>30</EndPage>
          <MedlinePgn>21-30</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamapsychiatry.2018.2745</ELocationID>
        <Abstract>
          <AbstractText Label="IMPORTANCE">Digital cognitive behavioral therapy (dCBT) is a scalable and effective intervention for treating insomnia. Most people with insomnia, however, seek help because of the daytime consequences of poor sleep, which adversely affects quality of life.</AbstractText>
          <AbstractText Label="OBJECTIVES">To investigate the effect of dCBT for insomnia on functional health, psychological well-being, and sleep-related quality of life and to determine whether a reduction in insomnia symptoms was a mediating factor.</AbstractText>
          <AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This online, 2-arm, parallel-group randomized trial comparing dCBT for insomnia with sleep hygiene education (SHE) evaluated 1711 participants with self-reported symptoms of insomnia. Participants were recruited between December 1, 2015, and December 1, 2016, and dCBT was delivered using web and/or mobile channels plus treatment as usual; SHE comprised a website and a downloadable booklet plus treatment as usual. Online assessments took place at 0 (baseline), 4 (midtreatment), 8 (posttreatment), and 24 (follow-up) weeks. Programs were completed within 12 weeks after inclusion.</AbstractText>
          <AbstractText Label="MAIN OUTCOMES AND MEASURES">Primary outcomes were scores on self-reported measures of functional health (Patient-Reported Outcomes Measurement Information System: Global Health Scale; range, 10-50; higher scores indicate better health); psychological well-being (Warwick-Edinburgh Mental Well-being Scale; range, 14-70; higher scores indicate greater well-being); and sleep-related quality of life (Glasgow Sleep Impact Index; range, 1-100; higher scores indicate greater impairment). Secondary outcomes comprised mood, fatigue, sleepiness, cognitive failures, work productivity, and relationship satisfaction. Insomnia was assessed with the Sleep Condition Indicator (range: 0-32; higher scores indicate better sleep).</AbstractText>
          <AbstractText Label="RESULTS">Of the 1711 participants included in the intention-to-treat analysis, 1329 (77.7%) were female, mean (SD) age was 48.0 (13.8) years, and 1558 (91.1%) were white. Use of dCBT was associated with a small improvement in functional health compared with SHE (adjusted difference [95% CI] at week 4, 0.90 [0.40-1.40]; week 8, 1.76 [1.24-2.28]; week 24, 1.76 [1.22-2.30]) and psychological well-being (adjusted difference [95% CI] at week 4, 1.04 [0.28-1.80]; week 8, 2.68 [1.89-3.47]; week 24, 2.95 [2.13-3.76]), and with a large improvement in sleep-related quality of life (at week 4, -8.76 [-11.83 to -5.69]; week 8, -17.60 [-20.81 to -14.39]; week 24, -18.72 [-22.04 to -15.41]) (all P&#x2009;&lt;&#x2009;.01). A large improvement in insomnia mediated these outcomes (range mediated, 45.5%-84.0%).</AbstractText>
          <AbstractText Label="CONCLUSIONS AND RELEVANCE">Use of dCBT is effective in improving functional health, psychological well-being, and sleep-related quality of life in people reporting insomnia symptoms. A reduction in insomnia symptoms mediates these improvements. These results confirm that dCBT improves both daytime and nighttime aspects of insomnia, strengthening existing recommendations of CBT as the treatment of choice for insomnia.</AbstractText>
          <AbstractText Label="TRIAL REGISTRATION">isrctn.org identifier: ISRCTN60530898.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Espie</LastName>
            <ForeName>Colin A</ForeName>
            <Initials>CA</Initials>
            <AffiliationInfo>
              <Affiliation>Sleep &amp; Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Big Health Ltd, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Emsley</LastName>
            <ForeName>Richard</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Biostatistics &amp; Health Informatics Department, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kyle</LastName>
            <ForeName>Simon D</ForeName>
            <Initials>SD</Initials>
            <AffiliationInfo>
              <Affiliation>Sleep &amp; Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gordon</LastName>
            <ForeName>Christopher</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Susan Wakil School of Nursing and Midwifery, The University of Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>CIRUS Centre for Integrated Research and Understanding of Sleep, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Drake</LastName>
            <ForeName>Christopher L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sleep Disorders and Research Center, Henry Ford Health System, Detroit, Michigan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siriwardena</LastName>
            <ForeName>A Niroshan</ForeName>
            <Initials>AN</Initials>
            <AffiliationInfo>
              <Affiliation>School of Health and Social Care, University of Lincoln, Lincoln, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cape</LastName>
            <ForeName>John</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Big Health Ltd, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Psychology and Language Sciences, Faculty of Brain Sciences, University College London, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ong</LastName>
            <ForeName>Jason C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Feinberg School of Medicine, Northwestern University, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sheaves</LastName>
            <ForeName>Bryony</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Sleep &amp; Circadian Neuroscience Institute, Department of Psychiatry, University of Oxford, Oxford, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Foster</LastName>
            <ForeName>Russell</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Sleep &amp; Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Freeman</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Sleep &amp; Circadian Neuroscience Institute, Department of Psychiatry, University of Oxford, Oxford, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Costa-Font</LastName>
            <ForeName>Joan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Policy, The London School of Economics and Political Science, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marsden</LastName>
            <ForeName>Antonia</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Biostatistics, School of Health Sciences, The University of Manchester, Manchester, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luik</LastName>
            <ForeName>Annemarie I</ForeName>
            <Initials>AI</Initials>
            <AffiliationInfo>
              <Affiliation>Sleep &amp; Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Big Health Ltd, London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>RP-2014-05-003</GrantID>
            <Acronym>DH_</Acronym>
            <Agency>Department of Health</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>JAMA Psychiatry</MedlineTA>
        <NlmUniqueID>101589550</NlmUniqueID>
        <ISSNLinking>2168-622X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Behavioral Therapy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007319" MajorTopicYN="N">Sleep Initiation and Maintenance Disorders</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013813" MajorTopicYN="N">Therapy, Computer-Assisted</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Espie reports being a cofounder, chief medical officer, and shareholder of and receiving salary from Big Health Ltd and being a developer of Sleepio. Drs Kyle and Drake report receiving nonfinancial support from Big Health Ltd (provision of Sleepio for use in clinical trials). Dr Cape reports providing clinical advice and support to Sleepio and receiving payment from Big Health Ltd. Dr Ong reports receiving nonfinancial support from Big Health Ltd (provision of Sleepio for use in clinical trials), providing consultancy support for Sleepio, and receiving payment from Big Health Ltd. Dr Sheaves reports providing monthly support for an online discussion forum run by Sleepio and receiving payment from Big Health Ltd. Dr Freeman reports being a cofounder of the University of Oxford spinout company, Oxford VR; receiving nonfinancial support from Big Health Ltd (provision of Sleepio for use in clinical trials); and being supported by an NIHR Research Professorship. Dr Luik held a research position at the University of Oxford during the conduct of the study that was funded by Big Health Ltd. No other conflicts were reported.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>25</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30264137</ArticleId>
        <ArticleId IdType="pmc">PMC6583463</ArticleId>
        <ArticleId IdType="doi">10.1001/jamapsychiatry.2018.2745</ArticleId>
        <ArticleId IdType="pii">2704019</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 5th ed Arlington, VA: American Psychiatric Association; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97-111. doi:10.1053/smrv.2002.0186</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/smrv.2002.0186</ArticleId>
            <ArticleId IdType="pubmed">12531146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lichstein KL. Epidemiology of Sleep: Age, Gender, and Ethnicity. Mahwah, NJ: Lawrence Erlbaum Assoc; 2004.</Citation>
        </Reference>
        <Reference>
          <Citation>Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep. 2007;30(3):274-280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17425223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pigeon WR, Bishop TM, Krueger KM. Insomnia as a precipitating factor in new onset mental illness: a systematic review of recent findings. Curr Psychiatry Rep. 2017;19(8):44. doi:10.1007/s11920-017-0802-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11920-017-0802-x</ArticleId>
            <ArticleId IdType="pubmed">28616860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan MS, Aouad R. The effects of insomnia and sleep loss on cardiovascular disease. Sleep Med Clin. 2017;12(2):167-177. doi:10.1016/j.jsmc.2017.01.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsmc.2017.01.005</ArticleId>
            <ArticleId IdType="pubmed">28477772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care. 2009;32(11):1980-1985. doi:10.2337/dc09-0284</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc09-0284</ArticleId>
            <ArticleId IdType="pmc">PMC2768214</ArticleId>
            <ArticleId IdType="pubmed">19641160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cappuccio FP, D&#x2019;Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414-420. doi:10.2337/dc09-1124</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/dc09-1124</ArticleId>
            <ArticleId IdType="pmc">PMC2809295</ArticleId>
            <ArticleId IdType="pubmed">19910503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kyle SD, Morgan K, Espie CA. Insomnia and health-related quality of life. Sleep Med Rev. 2010;14(1):69-82. doi:10.1016/j.smrv.2009.07.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.smrv.2009.07.004</ArticleId>
            <ArticleId IdType="pubmed">19962922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espie CA, Kyle SD, Hames P, Cyhlarova E, Benzeval M. The daytime impact of DSM-5 insomnia disorder: comparative analysis of insomnia subtypes from the Great British Sleep Survey. J Clin Psychiatry. 2012;73(12):e1478-e1484. doi:10.4088/JCP.12m07954</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4088/JCP.12m07954</ArticleId>
            <ArticleId IdType="pubmed">23290331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey: II. Sleep. 1999;22(suppl 2):S354-S358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10394607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morin CM, LeBlanc M, Daley M, Gregoire JP, M&#xE9;rette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7(2):123-130. doi:10.1016/j.sleep.2005.08.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sleep.2005.08.008</ArticleId>
            <ArticleId IdType="pubmed">16459140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians . Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. doi:10.7326/M15-2175</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/M15-2175</ArticleId>
            <ArticleId IdType="pubmed">27136449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riemann D, Baglioni C, Bassetti C, et al. . European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700. doi:10.1111/jsr.12594</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jsr.12594</ArticleId>
            <ArticleId IdType="pubmed">28875581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson SJ, Nutt DJ, Alford C, et al. . British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24(11):1577-1601. doi:10.1177/0269881110379307</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0269881110379307</ArticleId>
            <ArticleId IdType="pubmed">20813762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Institutes of Health NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements. 2005;22(2):1-30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17308547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis. Sleep Med Rev. 2018;38:3-16. doi:10.1016/j.smrv.2017.02.001 doi:10.1016/j.smrv.2017.02.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.smrv.2017.02.001</ArticleId>
            <ArticleId IdType="doi">10.1016/j.smrv.2017.02.001</ArticleId>
            <ArticleId IdType="pubmed">28392168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitchell MD, Gehrman P, Perlis M, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40. doi:10.1186/1471-2296-13-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2296-13-40</ArticleId>
            <ArticleId IdType="pmc">PMC3481424</ArticleId>
            <ArticleId IdType="pubmed">22631616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009;13(3):205-214. doi:10.1016/j.smrv.2008.06.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.smrv.2008.06.001</ArticleId>
            <ArticleId IdType="pubmed">19201632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luik AI, Kyle SD, Espie CA. Digital cognitive behavioral therapy (dCBT) for insomnia: a state-of-the-science review. Curr Sleep Med Rep. 2017;3(2):48-56. doi:10.1007/s40675-017-0065-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40675-017-0065-4</ArticleId>
            <ArticleId IdType="pmc">PMC5427093</ArticleId>
            <ArticleId IdType="pubmed">28553574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seyffert M, Lagisetty P, Landgraf J, et al. . Internet-delivered cognitive behavioral therapy to treat insomnia: a systematic review and meta-analysis. PLoS One. 2016;11(2):e0149139. doi:10.1371/journal.pone.0149139</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0149139</ArticleId>
            <ArticleId IdType="pmc">PMC4750912</ArticleId>
            <ArticleId IdType="pubmed">26867139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zachariae R, Lyby MS, Ritterband LM, O&#x2019;Toole MS. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia&#x2014;a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2016;30:1-10. doi:10.1016/j.smrv.2015.10.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.smrv.2015.10.004</ArticleId>
            <ArticleId IdType="pubmed">26615572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peoples AR, Garland SN, Perlis ML, et al. . Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial. J Cancer Surviv. 2017;11(3):401-409. doi:10.1007/s11764-017-0597-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11764-017-0597-0</ArticleId>
            <ArticleId IdType="pmc">PMC5437869</ArticleId>
            <ArticleId IdType="pubmed">28105576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morin CM, Beaulieu-Bonneau S, B&#xE9;langer L, et al. . Cognitive-behavior therapy singly and combined with medication for persistent insomnia: impact on psychological and daytime functioning. Behav Res Ther. 2016;87:109-116. doi:10.1016/j.brat.2016.09.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brat.2016.09.002</ArticleId>
            <ArticleId IdType="pmc">PMC5127752</ArticleId>
            <ArticleId IdType="pubmed">27658218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Houdenhove L, Buyse B, Gabri&#xEB;ls L, Van den Bergh O. Treating primary insomnia: clinical effectiveness and predictors of outcomes on sleep, daytime function and health-related quality of life. J Clin Psychol Med Settings. 2011;18(3):312-321. doi:10.1007/s10880-011-9250-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10880-011-9250-7</ArticleId>
            <ArticleId IdType="pubmed">21629999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palermo TM, Beals-Erickson S, Bromberg M, Law E, Chen M. A single arm pilot trial of brief cognitive behavioral therapy for insomnia in adolescents with physical and psychiatric comorbidities. J Clin Sleep Med. 2017;13(3):401-410. doi:10.5664/jcsm.6490</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5664/jcsm.6490</ArticleId>
            <ArticleId IdType="pmc">PMC5337587</ArticleId>
            <ArticleId IdType="pubmed">27923435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conley S, Redeker NS. Cognitive behavioral therapy for insomnia in the context of cardiovascular conditions. Curr Sleep Med Rep. 2015;1(3):157-165. doi:10.1007/s40675-015-0019-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40675-015-0019-7</ArticleId>
            <ArticleId IdType="pmc">PMC4612490</ArticleId>
            <ArticleId IdType="pubmed">26500835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dixon S, Morgan K, Mathers N, Thompson J, Tomeny M. Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia. Behav Sleep Med. 2006;4(2):71-84. doi:10.1207/s15402010bsm0402_1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1207/s15402010bsm0402_1</ArticleId>
            <ArticleId IdType="pubmed">16579717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espie CA, Fleming L, Cassidy J, et al. . Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008;26(28):4651-4658. doi:10.1200/JCO.2007.13.9006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.2007.13.9006</ArticleId>
            <ArticleId IdType="pubmed">18591549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espie CA, Kyle SD, Miller CB, Ong J, Hames P, Fleming L. Attribution, cognition and psychopathology in persistent insomnia disorder: outcome and mediation analysis from a randomized placebo-controlled trial of online cognitive behavioural therapy. Sleep Med. 2014;15(8):913-917. doi:10.1016/j.sleep.2014.03.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sleep.2014.03.001</ArticleId>
            <ArticleId IdType="pubmed">24791643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pillai V, Anderson JR, Cheng P, et al. . The anxiolytic effects of cognitive behavior therapy for insomnia: preliminary results from a web-delivered protocol. J Sleep Med Disord. 2015;2(2):1017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7081886</ArticleId>
            <ArticleId IdType="pubmed">32195356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4):489-495. doi:10.1093/sleep/31.4.489</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/sleep/31.4.489</ArticleId>
            <ArticleId IdType="pmc">PMC2279754</ArticleId>
            <ArticleId IdType="pubmed">18457236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freeman D, Sheaves B, Goodwin GM, et al. . The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis. Lancet Psychiatry. 2017;4(10):749-758. doi:10.1016/S2215-0366(17)30328-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2215-0366(17)30328-0</ArticleId>
            <ArticleId IdType="pmc">PMC5614772</ArticleId>
            <ArticleId IdType="pubmed">28888927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christensen H, Batterham PJ, Gosling JA, et al. . Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial. Lancet Psychiatry. 2016;3(4):333-341. doi:10.1016/S2215-0366(15)00536-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2215-0366(15)00536-2</ArticleId>
            <ArticleId IdType="pubmed">26827250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alessi C, Martin JL, Fiorentino L, et al. . Cognitive behavioral therapy for insomnia in older veterans using nonclinician sleep coaches: randomized controlled trial. J Am Geriatr Soc. 2016;64(9):1830-1838. doi:10.1111/jgs.14304</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jgs.14304</ArticleId>
            <ArticleId IdType="pmc">PMC5351772</ArticleId>
            <ArticleId IdType="pubmed">27550552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Omvik S, Sivertsen B, Pallesen S, Bjorvatn B, Havik OE, Nordhus IH. Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with zopiclone. Behav Res Ther. 2008;46(5):623-641. doi:10.1016/j.brat.2008.02.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brat.2008.02.013</ArticleId>
            <ArticleId IdType="pubmed">18417099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hewitt CE, Torgerson DJ. Is restricted randomisation necessary? BMJ. 2006;332(7556):1506-1508. doi:10.1136/bmj.332.7556.1506</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.332.7556.1506</ArticleId>
            <ArticleId IdType="pmc">PMC1482349</ArticleId>
            <ArticleId IdType="pubmed">16793819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espie CA, Luik AI, Cape J, et al. . Digital cognitive behavioural therapy for insomnia versus sleep hygiene education: the impact of improved sleep on functional health, quality of life and psychological well-being: study protocol for a randomised controlled trial. Trials. 2016;17(1):257. doi:10.1186/s13063-016-1364-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13063-016-1364-7</ArticleId>
            <ArticleId IdType="pmc">PMC4877942</ArticleId>
            <ArticleId IdType="pubmed">27216112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espie CA, Kyle SD, Hames P, Gardani M, Fleming L, Cape J. The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder. BMJ Open. 2014;4(3):e004183. doi:10.1136/bmjopen-2013-004183</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2013-004183</ArticleId>
            <ArticleId IdType="pmc">PMC3964344</ArticleId>
            <ArticleId IdType="pubmed">24643168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The Great British Sleep Survey 
http://www.greatbritishsleepsurvey.com. Accessed September 12, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>The World Sleep Survey 
http://www.worldsleepsurvey.com. Accessed September 12, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Sleepio 
https://www.sleepio.com. Accessed September 12, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Espie CA, Kyle SD, Williams C, et al. . A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012;35(6):769-781. doi:10.5665/sleep.1872</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5665/sleep.1872</ArticleId>
            <ArticleId IdType="pmc">PMC3353040</ArticleId>
            <ArticleId IdType="pubmed">22654196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espie CA, Inglis SJ, Tessier S, Harvey L. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther. 2001;39(1):45-60. doi:10.1016/S0005-7967(99)00157-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0005-7967(99)00157-6</ArticleId>
            <ArticleId IdType="pubmed">11125723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espie CA, MacMahon KM, Kelly HL, et al. . Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep. 2007;30(5):574-584. doi:10.1093/sleep/30.5.574</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/sleep/30.5.574</ArticleId>
            <ArticleId IdType="pubmed">17552372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espie CA. Overcoming Insomnia and Sleep Problems: A Self-help Guide Using Cognitive Behavioral Techniques. London, UK: Constable &amp; Robinson Ltd; 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>McGrath ER, Espie CA, Power A, et al. . Sleep to lower elevated blood pressure: a randomized controlled trial (SLEPT). Am J Hypertens. 2017;30(3):319-327. doi:10.1093/ajh/hpw132</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ajh/hpw132</ArticleId>
            <ArticleId IdType="pubmed">28391289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bostock S, Luik AI, Espie CA. Sleep and productivity benefits of digital cognitive behavioral therapy for insomnia: a randomized controlled trial conducted in the workplace environment. J Occup Environ Med. 2016;58(7):683-689. doi:10.1097/JOM.0000000000000778</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/JOM.0000000000000778</ArticleId>
            <ArticleId IdType="pubmed">27257747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barnes CM, Miller JA, Bostock S. Helping employees sleep well: effects of cognitive behavioral therapy for insomnia on work outcomes. J Appl Psychol. 2017; 102(1):104-113. doi:10.1037/apl0000154</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1037/apl0000154</ArticleId>
            <ArticleId IdType="pubmed">27690480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng P, Luik AI, Fellman-Couture C, et al. . The efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized controlled trial [published online May 24, 2018]. Psychol Med. doi:10.1017/S0033291718001113</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0033291718001113</ArticleId>
            <ArticleId IdType="pmc">PMC7050476</ArticleId>
            <ArticleId IdType="pubmed">29792241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American Academy of Sleep Medicine How to Sleep Better. Darien, IL: American Academy of Sleep Medicine; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) global items. Qual Life Res. 2009;18(7):873-880. doi:10.1007/s11136-009-9496-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11136-009-9496-9</ArticleId>
            <ArticleId IdType="pmc">PMC2724630</ArticleId>
            <ArticleId IdType="pubmed">19543809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tennant R, Hiller L, Fishwick R, et al. . The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5:63. doi:10.1186/1477-7525-5-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1477-7525-5-63</ArticleId>
            <ArticleId IdType="pmc">PMC2222612</ArticleId>
            <ArticleId IdType="pubmed">18042300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kyle SD, Crawford MR, Morgan K, Spiegelhalder K, Clark AA, Espie CA. The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in insomnia disorder. Sleep Med. 2013;14(6):493-501. doi:10.1016/j.sleep.2012.10.023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sleep.2012.10.023</ArticleId>
            <ArticleId IdType="pubmed">23347908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.2001.016009606.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId>
            <ArticleId IdType="pmc">PMC1495268</ArticleId>
            <ArticleId IdType="pubmed">11556941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spitzer RL, Kroenke K, Williams JB, L&#xF6;we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. doi:10.1001/archinte.166.10.1092</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId>
            <ArticleId IdType="pubmed">16717171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gradisar M, Lack L, Richards H, et al. . The Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomnia. J Clin Sleep Med. 2007;3(7):722-728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2556916</ArticleId>
            <ArticleId IdType="pubmed">18198807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hendrick SS, Dicke A, Hendrick C. The Relationship Assessment Scale. J Soc Pers Relat. 1998;15:137-142. doi:10.1177/0265407598151009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0265407598151009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(pt 1):1-16. doi:10.1111/j.2044-8260.1982.tb01421.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.2044-8260.1982.tb01421.x</ArticleId>
            <ArticleId IdType="pubmed">7126941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353-365. doi:10.2165/00019053-199304050-00006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00019053-199304050-00006</ArticleId>
            <ArticleId IdType="pubmed">10146874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dolbier CL, Webster JA, McCalister KT, Mallon MW, Steinhardt MA. Reliability and validity of a single-item measure of job satisfaction. Am J Health Promot. 2005;19(3):194-198. doi:10.4278/0890-1171-19.3.194</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4278/0890-1171-19.3.194</ArticleId>
            <ArticleId IdType="pubmed">15693347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540-545. doi:10.1093/sleep/14.6.540</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/sleep/14.6.540</ArticleId>
            <ArticleId IdType="pubmed">1798888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheung F, Lucas RE. Assessing the validity of single-item life satisfaction measures: results from three large samples. Qual Life Res. 2014;23(10):2809-2818. doi:10.1007/s11136-014-0726-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11136-014-0726-4</ArticleId>
            <ArticleId IdType="pmc">PMC4221492</ArticleId>
            <ArticleId IdType="pubmed">24890827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kyle SD, Morgan K, Spiegelhalder K, Espie CA. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med. 2011;12(8):735-747. doi:10.1016/j.sleep.2011.03.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sleep.2011.03.016</ArticleId>
            <ArticleId IdType="pubmed">21907616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004;61(3):310-317. doi:10.1001/archpsyc.61.3.310</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archpsyc.61.3.310</ArticleId>
            <ArticleId IdType="pubmed">14993119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173-1182. doi:10.1037/0022-3514.51.6.1173</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1037/0022-3514.51.6.1173</ArticleId>
            <ArticleId IdType="pubmed">3806354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunn G, Emsley R, Liu H, et al. . Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme. Health Technol Assess. 2015;19(93):1-115, v-vi. doi:10.3310/hta19930</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3310/hta19930</ArticleId>
            <ArticleId IdType="pmc">PMC4781463</ArticleId>
            <ArticleId IdType="pubmed">26560448</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30261831</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1607-8454</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Hematology (Amsterdam, Netherlands)</Title>
          <ISOAbbreviation>Hematology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Differences in pulmonary and extra-pulmonary characteristics in severely versus non-severely fatigued recipients of allogeneic hematopoietic stem cell transplantation: a cross-sectional, comparative study.</ArticleTitle>
        <Pagination>
          <StartPage>112</StartPage>
          <EndPage>122</EndPage>
          <MedlinePgn>112-122</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10245332.2018.1526441</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Fatigue is a common symptom in allogeneic-hematopoietic stem cell transplantation (allogeneic-HSCT) recipients. However, effects of severe fatigue on pulmonary functions, blood cells, dyspnea, muscle strength, exercise capacity, depression and quality of life (QOL) in allogeneic-HSCT recipients are still unknown. Therefore, to compare pulmonary functions, blood levels, dyspnea, muscle strength, exercise capacity, depression, and QOL between allogeneic-HSCT recipients according to fatigue severity and to determine predictors of severe fatigue were aimed in the current study.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-four severe-fatigued (Fatigue Severity Scale score &#x2265;36) (40.08&#x2009;&#xB1;&#x2009;12.44years) and 25 non-severe-fatigued (36.20&#x2009;&#xB1;&#x2009;13.73years) allogeneic-HSCT recipients were compared. Blood levels, pulmonary functions (spirometer), dyspnea (Modified Medical Research Council Dyspnea scale), exercise capacity (6-minute walk test), depression (Beck Depression Inventory-II), QOL (European Organization for Research and Treatment of Cancer QOL Questionnaire), respiratory (mouth pressure device) and peripheral muscle strength (dynamometer) were evaluated.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Symptom QOL-subscale and depression scores were significantly higher; peripheral muscle strength, global health status, and functional QOL-subscales scores were lower in severe-fatigued recipients (p&#x2009;&lt;&#x2009;0.05) whose exercise capacity was clinically (28.85&#x2005;m) decreased. Blood levels, pulmonary functions, dyspnea, and respiratory muscle strength were similar in groups (p&#x2009;&gt;&#x2009;0.05). 42.4% of the variance in severe fatigue was explained by symptom QOL-subscale score and corticosteroid use after HSCT (p&#x2009;&lt;&#x2009;0.001).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Impairments in peripheral muscle strength, QOL, exercise capacity, and depression are more prevalent among severe-fatigued recipients. Moreover, poorer QOL and corticosteroid use after HSCT are most important predictors of severe fatigue. Effects of comprehensive exercise programs and psychosocial support for severe-fatigued recipients in late post-engraftment period should be investigated.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bar&#x11F;&#x131;</LastName>
            <ForeName>G&#xFC;l&#x15F;ah</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0002-5243-3997</Identifier>
            <AffiliationInfo>
              <Affiliation>a Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation , Gazi University , Ankara , Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bo&#x15F;nak G&#xFC;&#xE7;l&#xFC;</LastName>
            <ForeName>Meral</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>a Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation , Gazi University , Ankara , Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>T&#xFC;rk&#xF6;z Sucak</LastName>
            <ForeName>Ayhan G&#xFC;lsan</ForeName>
            <Initials>AG</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Hematology , Bah&#xE7;e&#x15F;ehir University, Hospital of MedicalPark , Istanbul , Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016430">Clinical Trial</PublicationType>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Hematology</MedlineTA>
        <NlmUniqueID>9708388</NlmUniqueID>
        <ISSNLinking>1024-5332</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018380" MajorTopicYN="Y">Hematopoietic Stem Cell Transplantation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053580" MajorTopicYN="Y">Muscle Strength</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012132" MajorTopicYN="N">Respiratory Muscles</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Depression</Keyword>
        <Keyword MajorTopicYN="N">fatigue</Keyword>
        <Keyword MajorTopicYN="N">hematopoietic stem cell transplantation</Keyword>
        <Keyword MajorTopicYN="N">muscle strength</Keyword>
        <Keyword MajorTopicYN="N">pulmonary function</Keyword>
        <Keyword MajorTopicYN="N">quality of life</Keyword>
        <Keyword MajorTopicYN="N">respiratory muscles</Keyword>
        <Keyword MajorTopicYN="N">walk test</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30261831</ArticleId>
        <ArticleId IdType="doi">10.1080/10245332.2018.1526441</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30260702</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>09</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1530-6860</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>33</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>
          <ISOAbbreviation>FASEB J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Self-derived structure-disrupting peptides targeting methionine aminopeptidase in pathogenic bacteria: a new strategy to generate antimicrobial peptides.</ArticleTitle>
        <Pagination>
          <StartPage>2095</StartPage>
          <EndPage>2104</EndPage>
          <MedlinePgn>2095-2104</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201700613RR</ELocationID>
        <Abstract>
          <AbstractText>Bacterial infection is one of the leading causes of death in young, elderly, and immune-compromised patients. The rapid spread of multi-drug-resistant (MDR) bacteria is a global health emergency and there is a lack of new drugs to control MDR pathogens. We describe a heretofore-unexplored discovery pathway for novel antibiotics that is based on self-targeting, structure-disrupting peptides. We show that a helical peptide, KFF- EcH3, derived from the Escherichia coli methionine aminopeptidase can disrupt secondary and tertiary structure of this essential enzyme, thereby killing the bacterium (including MDR strains). Significantly, no detectable resistance developed against this peptide. Based on a computational analysis, our study predicted that peptide KFF- EcH3 has the strongest interaction with the structural core of the methionine aminopeptidase. We further used our approach to identify peptide KFF- NgH1 to target the same enzyme from Neisseria gonorrhoeae. This peptide inhibited bacterial growth and was able to treat a gonococcal infection in a human cervical epithelial cell model. These findings present an exciting new paradigm in antibiotic discovery using self-derived peptides that can be developed to target the structures of any essential bacterial proteins.-Zhan, J., Jia, H., Semchenko, E. A., Bian, Y., Zhou, A. M., Li, Z., Yang, Y., Wang, J., Sarkar, S., Totsika, M., Blanchard, H., Jen, F. E.-C., Ye, Q., Haselhorst, T., Jennings, M. P., Seib, K. L., Zhou, Y. Self-derived structure-disrupting peptides targeting methionine aminopeptidase in pathogenic bacteria: a new strategy to generate antimicrobial peptides.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhan</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jia</LastName>
            <ForeName>Husen</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Semchenko</LastName>
            <ForeName>Evgeny A</ForeName>
            <Initials>EA</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bian</LastName>
            <ForeName>Yunqiang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Amy M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Queensland Academies-Health Sciences, Southport, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhixiu</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Indiana University School of Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Yuedong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jihua</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarkar</LastName>
            <ForeName>Sohinee</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Totsika</LastName>
            <ForeName>Makrina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blanchard</LastName>
            <ForeName>Helen</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jen</LastName>
            <ForeName>Freda E-C</ForeName>
            <Initials>FE</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ye</LastName>
            <ForeName>Qizhuang</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Shenzhen University, Shenzhen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haselhorst</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jennings</LastName>
            <ForeName>Michael P</ForeName>
            <Initials>MP</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seib</LastName>
            <ForeName>Kate L</ForeName>
            <Initials>KL</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Yaoqi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Glycomics, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Indiana University School of Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 GM085003</GrantID>
            <Acronym>GM</Acronym>
            <Agency>NIGMS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>FASEB J</MedlineTA>
        <NlmUniqueID>8804484</NlmUniqueID>
        <ISSNLinking>0892-6638</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D023181">Antimicrobial Cationic Peptides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>AE28F7PNPL</RegistryNumber>
          <NameOfSubstance UI="D008715">Methionine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.11.-</RegistryNumber>
          <NameOfSubstance UI="D000626">Aminopeptidases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000626" MajorTopicYN="N">Aminopeptidases</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023181" MajorTopicYN="N">Antimicrobial Cationic Peptides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002584" MajorTopicYN="N">Cervix Uteri</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024901" MajorTopicYN="N">Drug Resistance, Multiple, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006069" MajorTopicYN="N">Gonorrhea</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008715" MajorTopicYN="N">Methionine</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009344" MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antibiotic resistance</Keyword>
        <Keyword MajorTopicYN="N">protein-specific denaturation</Keyword>
      </KeywordList>
      <CoiStatement>The authors acknowledge support from the National Institute of General Medical Sciences of the U.S. National Institutes of Health under award number R01GM085003 and National Health and Medical Research Council of Australia Grants 1059775 (to Y.Z.), 1121629 (to Y.Z., K.L.S., T.H., H.B., and Y.Y), 1069370 (to M.T.), and 1071659 (to M.P.J.), and Fellowships 1045235 (to K.L.S.) and 1138466 (to M.P.J.); National Natural Science Foundation of China Grants 61271378, 61671107, and 61540025 (to J.W.); and the Taishan Scholars Program of the Shandong Province of China. The authors also gratefully acknowledge the use of the High Performance Computing Cluster &#x201C;Gowonda&#x201D; to complete this research. This research/project was undertaken with the aid of the research cloud resources provided by the Queensland Cyber Infrastructure Foundation (QCIF). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>27</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30260702</ArticleId>
        <ArticleId IdType="pmc">PMC6338635</ArticleId>
        <ArticleId IdType="doi">10.1096/fj.201700613RR</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lushniak, B. D. (2014) Antibiotic resistance: a public health crisis. Public Health Rep. 129, 314&#x2013;316</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4037453</ArticleId>
            <ArticleId IdType="pubmed">24982528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis, K. (2013) Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12, 371&#x2013;387</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23629505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davies, J., Davies, D. (2010) Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417&#x2013;433</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2937522</ArticleId>
            <ArticleId IdType="pubmed">20805405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Sch&#xE4;berle, T. F., Hughes, D. E., Epstein, S., Jones, M., Lazarides, L., Steadman, V. A., Cohen, D. R., Felix, C. R., Fetterman, K. A., Millett, W. P., Nitti, A. G., Zullo, A. M., Chen, C., Lewis, K. (2015) A new antibiotic kills pathogens without detectable resistance. Nature 517, 455&#x2013;459; erratum: 520, 388</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7414797</ArticleId>
            <ArticleId IdType="pubmed">25561178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Croxen, M. A., Finlay, B. B. (2010) Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8, 26&#x2013;38; erratum: 11, 141</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19966814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edwards, J. L., Jennings, M. P., Apicella, M. A., Seib, K. L. (2016) Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development. Crit. Rev. Microbiol. 42, 928&#x2013;941</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4958600</ArticleId>
            <ArticleId IdType="pubmed">26805040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. (2013) Antibiotic Resistance Threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA, USA.</Citation>
        </Reference>
        <Reference>
          <Citation>Otvos, L., Jr., Wade, J. D. (2014) Current challenges in peptide-based drug discovery. Front Chem. 2, 62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4126357</ArticleId>
            <ArticleId IdType="pubmed">25152873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee, T. T., Garcia, J. R., Paez, J. I., Singh, A., Phelps, E. A., Weis, S., Shafiq, Z., Shekaran, A., Del Campo, A., Garcia, A. J. (2015) Light-triggered in vivo activation of adhesive peptides regulates cell adhesion, inflammation and vascularization of biomaterials. Nat. Mater. 14:352&#x2013;360</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4336636</ArticleId>
            <ArticleId IdType="pubmed">25502097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simon, M. D., Heider, P. L., Adamo, A., Vinogradov, A. A., Mong, S. K., Li, X., Berger, T., Policarpo, R. L., Zhang, C., Zou, Y., Liao, X., Spokoyny, A. M., Jensen, K. F., Pentelute, B. L. (2014) Rapid flow-based peptide synthesis. ChemBioChem 15, 713&#x2013;720</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4045704</ArticleId>
            <ArticleId IdType="pubmed">24616230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White, T. R., Renzelman, C. M., Rand, A. C., Rezai, T., McEwen, C. M., Gelev, V. M., Turner, R. A., Linington, R. G., Leung, S. S., Kalgutkar, A. S., Bauman, J. N., Zhang, Y., Liras, S., Price, D. A., Mathiowetz, A. M., Jacobson, M. P., Lokey, R. S. (2011) On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds. Nat. Chem. Biol. 7, 810&#x2013;817</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3210067</ArticleId>
            <ArticleId IdType="pubmed">21946276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>London, N., Raveh, B., Movshovitz-Attias, D., Schueler-Furman, O. (2010) Can self-inhibitory peptides be derived from the interfaces of globular protein-protein interactions? Proteins 78, 3140&#x2013;3149</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2952690</ArticleId>
            <ArticleId IdType="pubmed">20607702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hrobowski, Y. M., Garry, R. F., Michael, S. F. (2005) Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol. J. 2, 49</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1177995</ArticleId>
            <ArticleId IdType="pubmed">15927084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caldarini, M., Vasile, F., Provasi, D., Longhi, R., Tiana, G., Broglia, R. A. (2009) Identification and characterization of folding inhibitors of hen egg lysozyme: an example of a new paradigm of drug design. Proteins 74, 390&#x2013;399</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18623063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Broglia, R., Levy, Y., Tiana, G. (2008) HIV-1 protease folding and the design of drugs which do not create resistance. Curr. Opin. Struct. Biol. 18, 60&#x2013;66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18160276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerdes, S. Y., Scholle, M. D., Campbell, J. W., Bal&#xE1;zsi, G., Ravasz, E., Daugherty, M. D., Somera, A. L., Kyrpides, N. C., Anderson, I., Gelfand, M. S., Bhattacharya, A., Kapatral, V., D&#x2019;Souza, M., Baev, M. V., Grechkin, Y., Mseeh, F., Fonstein, M. Y., Overbeek, R., Barab&#xE1;si, A. L., Oltvai, Z. N., Osterman, A. L. (2003) Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J. Bacteriol. 185, 5673&#x2013;5684</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC193955</ArticleId>
            <ArticleId IdType="pubmed">13129938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashimoto, M., Ichimura, T., Mizoguchi, H., Tanaka, K., Fujimitsu, K., Keyamura, K., Ote, T., Yamakawa, T., Yamazaki, Y., Mori, H., Katayama, T., Kato, J. (2005) Cell size and nucleoid organization of engineered Escherichia coli cells with a reduced genome. Mol. Microbiol. 55, 137&#x2013;149</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15612923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu, J. P., Chai, S. C., Ye, Q. Z. (2010) Catalysis and inhibition of Mycobacterium tuberculosis methionine aminopeptidase. J. Med. Chem. 53, 1329&#x2013;1337</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2820511</ArticleId>
            <ArticleId IdType="pubmed">20038112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Totsika, M., Beatson, S. A., Sarkar, S., Phan, M. D., Petty, N. K., Bachmann, N., Szubert, M., Sidjabat, H. E., Paterson, D. L., Upton, M., Schembri, M. A. (2011) Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 6, e26578</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3203889</ArticleId>
            <ArticleId IdType="pubmed">22053197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clinical and Laboratory Standards Institute . (2015) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement (M100-S25), Clinical and Laboratory Standards Institute, Wayne, PA, USA</Citation>
        </Reference>
        <Reference>
          <Citation>French, G. L. (2006) Bactericidal agents in the treatment of MRSA infections: the potential role of daptomycin. J. Antimicrob. Chemother. 58, 1107&#x2013;1117</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17040922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herring, C. D., Blattner, F. R. (2004) Conditional lethal amber mutations in essential Escherichia coli genes. J. Bacteriol. 186, 2673&#x2013;2681</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC387789</ArticleId>
            <ArticleId IdType="pubmed">15090508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Louis-Jeune, C., Andrade-Navarro, M. A., Perez-Iratxeta, C. (2012) Prediction of protein secondary structure from circular dichroism using theoretically derived spectra. Proteins 80, 374&#x2013;381; erratum: 80, 2818</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22095872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darden, T., York, D., Pedersen, L. (1993) Particle mesh Ewald: An N&#xB7;log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089&#x2013;10092</Citation>
        </Reference>
        <Reference>
          <Citation>Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., Pedersen, L. G. (1995) A smooth particle mesh ewald potential. J. Chem. Phys. 103, 8577&#x2013;8592</Citation>
        </Reference>
        <Reference>
          <Citation>Berendsen, H. J. C., Postma, J. P. M., DiNola, A., Haak, J. R. (1984) Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684&#x2013;3690</Citation>
        </Reference>
        <Reference>
          <Citation>Hess, B., Kutzner, C., van der Spoel, D., Lindahl, E. (2008) GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 4, 435&#x2013;447</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26620784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., Shaw, D. E. (2010) Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950&#x2013;1958</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2970904</ArticleId>
            <ArticleId IdType="pubmed">20408171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laio, A., Gervasio, F. L. (2008) Metadynamics: a method to simulate rare events and reconstruct the free energy in biophysics, chemistry and material science. Rep. Prog. Phys. 71, 126601</Citation>
        </Reference>
        <Reference>
          <Citation>Bonomi, M., Branduardi, D., Bussi, G., Camilloni, C., Provasi, D., Raiteri, P., Donadio, D., Marinelli, F., Pietrucci, F., Broglia, R. A., Parrinello, M. (2009) PLUMED: a portable plugin for free-energy calculations with molecular dynamics. Comput. Phys. Commun. 180, 1961&#x2013;1972</Citation>
        </Reference>
        <Reference>
          <Citation>Unemo, M., Fasth, O., Fredlund, H., Limnios, A., Tapsall, J. (2009) Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J. Antimicrob. Chemother. 63, 1142&#x2013;1151</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19318360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzarito, V., Long, K., Murphy, N. S., Wilson, A. J. (2013) Inhibition of &#x3B1;-helix-mediated protein-protein interactions using designed molecules. Nat. Chem. 5, 161&#x2013;173</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23422557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obrecht, D., Chevalier, E., Moehle, K., Robinson, J. A. (2012) &#x3B2;-Hairpin protein epitope mimetic technology in drug discovery. Drug Discov. Today. Technol. 9, e1&#x2013;e70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24064246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roderick, S. L., Matthews, B. W. (1993) Structure of the cobalt-dependent methionine aminopeptidase from Escherichia coli: a new type of proteolytic enzyme. Biochemistry 32, 3907&#x2013;3912</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8471602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan, X. X., Actor, J. K., Chen, Y. (2005) Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrob. Agents Chemother. 49, 3203&#x2013;3207</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1196239</ArticleId>
            <ArticleId IdType="pubmed">16048926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holm, T., Johansson, H., Lundberg, P., Pooga, M., Lindgren, M., Langel, U. (2006) Studying the uptake of cell-penetrating peptides. Nat. Protoc. 1, 1001&#x2013;1005</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17406337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matulis, D., Kranz, J. K., Salemme, F. R., Todd, M. J. (2005) Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry 44, 5258&#x2013;5266</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15794662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao, J., Dyson, H. J., Wright, P. E. (1997) Chemical shift dispersion and secondary structure prediction in unfolded and partly folded proteins. FEBS Lett. 419, 285&#x2013;289</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9428652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kabsch, W., Sander, C. (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577&#x2013;2637</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6667333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou, H., Zhou, Y. (2002) Distance-scaled, finite ideal-gas reference state improves structure-derived potentials of mean force for structure selection and stability prediction. Protein Sci. 11, 2714&#x2013;2726</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2373736</ArticleId>
            <ArticleId IdType="pubmed">12381853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang, Y., Zhou, Y. (2008) Ab initio folding of terminal segments with secondary structures reveals the fine difference between two closely related all-atom statistical energy functions. Protein Sci. 17, 1212&#x2013;1219</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2442011</ArticleId>
            <ArticleId IdType="pubmed">18469178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arya, T., Reddi, R., Kishor, C., Ganji, R. J., Bhukya, S., Gumpena, R., McGowan, S., Drag, M., Addlagatta, A. (2015) Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases. J. Med. Chem. 58, 2350&#x2013;2357</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25699713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cresci, G. A., Bawden, E. (2015) Gut microbiome: what we do and don&#x2019;t know. Nutr. Clin. Pract. 30, 734&#x2013;746</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4838018</ArticleId>
            <ArticleId IdType="pubmed">26449893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski, L. S., Silva-Pereira, I., Kyaw, C. M. (2013) Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front. Microbiol. 4, 353</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3856679</ArticleId>
            <ArticleId IdType="pubmed">24367355</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30260538</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2893</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of viral hepatitis</Title>
          <ISOAbbreviation>J Viral Hepat</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Recombinant identification, molecular classification and proposed reference genomes for hepatitis delta virus.</ArticleTitle>
        <Pagination>
          <StartPage>183</StartPage>
          <EndPage>190</EndPage>
          <MedlinePgn>183-190</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jvh.13010</ELocationID>
        <Abstract>
          <AbstractText>Hepatitis delta virus (HDV), as a defective sub-virus that co-infects with hepatitis B virus, imposes an emerging global health burden. However, genetic characteristics and molecular classification of HDV remain under investigated. In this study, we have systematically retrieved and analysed a large set of HDV full-length genome sequences and identified novel recombinants. Based on phylogenetic and genetic analyses, we have established an updated classification system for HDV when recombinants were excluded. Furthermore, we have mapped the global distribution of different genotypes and subtypes. Finally, we have compiled a complete set of reference genomes for each subtype and proposed criteria for future identification of novel genotypes and subtypes. Of note, the global distribution map indicates that currently available HDV genetic data remain limited, and thus our proposed classification will likely evolve as future epidemiological data will accumulate. These results will facilitate the future research on the diagnosis, screening, epidemiology, evolution, prevention and clinical management of HDV infection.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 The Authors. Journal of Viral Hepatitis Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Miao</LastName>
            <ForeName>Zhijiang</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0001-7778-2010</Identifier>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Center, Northwest Minzu University, Lanzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Shaoshi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Center, Northwest Minzu University, Lanzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Zhongren</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Center, Northwest Minzu University, Lanzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hakim</LastName>
            <ForeName>Mohamad S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Wenshi</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peppelenbosch</LastName>
            <ForeName>Maikel P</ForeName>
            <Initials>MP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Qiuwei</ForeName>
            <Initials>Q</Initials>
            <Identifier Source="ORCID">0000-0001-9982-6184</Identifier>
            <AffiliationInfo>
              <Affiliation>Biomedical Research Center, Northwest Minzu University, Lanzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>GENBANK</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>KF786305</AccessionNumber>
              <AccessionNumber>KF786352</AccessionNumber>
              <AccessionNumber>HQ005364</AccessionNumber>
              <AccessionNumber>HQ005372</AccessionNumber>
              <AccessionNumber>KY463677</AccessionNumber>
              <AccessionNumber>JX888100</AccessionNumber>
              <AccessionNumber>JX888098</AccessionNumber>
              <AccessionNumber>KJ744242</AccessionNumber>
              <AccessionNumber>KJ744255</AccessionNumber>
              <AccessionNumber>X60193</AccessionNumber>
              <AccessionNumber>AJ309879</AccessionNumber>
              <AccessionNumber>LT604954</AccessionNumber>
              <AccessionNumber>AB037947</AccessionNumber>
              <AccessionNumber>KC590319</AccessionNumber>
              <AccessionNumber>AF018077</AccessionNumber>
              <AccessionNumber>AB118818</AccessionNumber>
              <AccessionNumber>JX888103</AccessionNumber>
              <AccessionNumber>AM183331</AccessionNumber>
              <AccessionNumber>AJ584847</AccessionNumber>
              <AccessionNumber>JX888102</AccessionNumber>
              <AccessionNumber>AM183332</AccessionNumber>
              <AccessionNumber>AJ584844</AccessionNumber>
              <AccessionNumber>AM183333</AccessionNumber>
              <AccessionNumber>AJ584849</AccessionNumber>
              <AccessionNumber>LT594488</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Viral Hepat</MedlineTA>
        <NlmUniqueID>9435672</NlmUniqueID>
        <ISSNLinking>1352-0504</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016679" MajorTopicYN="Y">Genome, Viral</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003698" MajorTopicYN="N">Hepatitis Delta Virus</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011995" MajorTopicYN="Y">Recombination, Genetic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cRNA</Keyword>
        <Keyword MajorTopicYN="N">genetic recombination</Keyword>
        <Keyword MajorTopicYN="N">genotype</Keyword>
        <Keyword MajorTopicYN="N">hepatitis delta virus</Keyword>
        <Keyword MajorTopicYN="N">viral RNA</Keyword>
        <Keyword MajorTopicYN="N">viral genome</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>24</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30260538</ArticleId>
        <ArticleId IdType="pmc">PMC7379554</ArticleId>
        <ArticleId IdType="doi">10.1111/jvh.13010</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011;378(9785):73&#x2010;85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21511329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luan BS, Santos ADOD, Salcedo JMV, Vieira DS. Hepatitis delta: virological and clinical aspects. Virol J. 2017;14(1):177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5597996</ArticleId>
            <ArticleId IdType="pubmed">28903779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pascarella S, Negro F. Hepatitis D virus: an update. Liver Int. 2011;31(1):7&#x2010;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20880077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuo MY, Goldberg J, Coates L, Mason W, Gerin J, Taylor J. Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol. 1988;62(6):1855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC253266</ArticleId>
            <ArticleId IdType="pubmed">3367426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahn J, Gish RG. Hepatitis D virus: a call to screening. Gastroenterol Hepatol. 2014;10(10):647&#x2010;686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4988222</ArticleId>
            <ArticleId IdType="pubmed">27540336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rizzetto M, Canese MG, Aric&#xF2; S, et&#xA0;al. Immunofluorescence detection of new antigen&#x2010;antibody system (delta/anti&#x2010;delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18(12):997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1411847</ArticleId>
            <ArticleId IdType="pubmed">75123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stockdale AJ, Chaponda M, Beloukas A, et&#xA0;al. Prevalence of hepatitis D virus infection in sub&#x2010;Saharan Africa: a systematic review and meta&#x2010;analysis. Lancet Glob Health. 2017;5(10):e992&#x2010;e1003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5599428</ArticleId>
            <ArticleId IdType="pubmed">28911765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taghavi SA, Sedighi S, Mehrabani D, Khademolhosseini F. Hepatitis D in chronic active hepatitis B: prevalence, liver enzyme levels and histopathology &#x2013; an Epidemiological Study in Shiraz, Southern Iran, 2003&#x2013;2004. Hepat Monthly. 2008;8(4):248&#x2010;251.</Citation>
        </Reference>
        <Reference>
          <Citation>Yamaguchi Y, Del&#xE9;houz&#xE9;e S, Handa H. HIV and hepatitis delta virus: evolution takes different paths to relieve blocks in transcriptional elongation. Microbes Infect. 2002;4(11):1169&#x2010;1175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12361917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsu SC, Syu WJ, Sheen IJ, Liu HT, Jeng KS, Wu JC. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications. Hepatology. 2002;35(3):665&#x2010;672.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11870382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delfino CM, Cerrudo CS, Biglione M, Oubi&#xF1;a JR, Ghiringhelli PD, Mathet VL. A comprehensive bioinformatic analysis of hepatitis D virus (HDV) full&#x2010;length genomes. J Viral Hepat. 2018;25:860&#x2010;869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29406571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gal FL, Brichler S, Drugan T, et&#xA0;al. Genetic diversity and worldwide distribution of the deltavirus genus: a study of 2,152 clinical strains. Hepatology. 2017;66:1826&#x2010;1841.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28992360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radjef N, Gordien E, Ivaniushina V, et&#xA0;al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Hepatol. 2004;78(5):2537&#x2010;2544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC369207</ArticleId>
            <ArticleId IdType="pubmed">14963156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol. 2016;33(7):1870.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8210823</ArticleId>
            <ArticleId IdType="pubmed">27004904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nei M, Kumar S. Molecular evolution and phylogenetics. Heredity. 2013;86(86):385.</Citation>
        </Reference>
        <Reference>
          <Citation>Hung CC, Wu SM, Lin PH, et&#xA0;al. Increasing incidence of recent hepatitis D virus infection in HIV&#x2010;infected patients in an area hyperendemic for hepatitis B virus infection. Clin Infect Dis. 2014;58(11):1625&#x2010;1633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4072904</ArticleId>
            <ArticleId IdType="pubmed">24599769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cicero MF, Pena NM, Santana LC, et&#xA0;al. Is hepatitis delta infections important in Brazil? BMC Infect Dis. 2016;16(1):525.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5041555</ArticleId>
            <ArticleId IdType="pubmed">27686363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Celik I, Karatayli E, Cevik E, et&#xA0;al. Complete genome sequences and phylogenetic analysis of hepatitis delta viruses isolated from nine Turkish patients. Adv Virol. 2011;156(12):2215&#x2010;2220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21984217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sy BT, Nguyen HM, Toan NL, et&#xA0;al. Identification of a natural intergenotypic recombinant hepatitis delta virus genotype 1 and 2 in Vietnamese HBsAg&#x2010;positive patients. J Viral Hepat. 2015;22(1):55&#x2010;63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24548489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin CC, Lee CC, Lin SH, et&#xA0;al. RNA recombination in Hepatitis delta virus: Identification of a novel naturally occurring recombinant. J Microbiol Immunol Infect. 2015;50(6):771&#x2010;780.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26757847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simmonds P, Bukh J, Combet C, et&#xA0;al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962&#x2010;973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16149085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wranke A, Pinheiro Borzacov LM, Parana R, et&#xA0;al. Clinical and virological heterogeneity of hepatitis delta in different regions world&#x2010;wide: the Hepatitis Delta International Network (HDIN). Liver Int. 2017;38(5):842&#x2010;850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28963781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han M, Littlejohn M, Yuen L, et&#xA0;al. Molecular epidemiology of hepatitis delta virus in the Western Pacific region. J Clin Virol. 2014;61(1):34&#x2010;39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24973283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>B&#xE9;guelin C, Moradpour D, Sahli R, et&#xA0;al. Hepatitis delta&#x2010;associated mortality in HIV/HBV&#x2010;coinfected patients. J Hepatol. 2017;66:297&#x2010;303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27746337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chao M, Wang TC, Lee SE. Detection of hepatitis delta virus recombinants in cultured cells co&#x2010;transfected with cloned genotypes I and IIb DNA sequences. J Virol Methods. 2006;137(2):252&#x2010;258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16860882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang TC, Chao M. RNA recombination of hepatitis delta virus in natural mixed&#x2010;genotype infection and transfected cultured cells. J Virol. 2005;79(4):2221&#x2010;2229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC546541</ArticleId>
            <ArticleId IdType="pubmed">15681424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu JC, Chiang TY, Shiue WK, et&#xA0;al. Recombination of hepatitis D virus RNA sequences and its implications. Mol Biol Evol. 1999;16(11):1622&#x2010;1632.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10555293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chao M, Wang TC, Lin CC, et&#xA0;al. Analyses of a whole&#x2010;genome inter&#x2010;clade recombination map of hepatitis delta virus suggest a host polymerase&#x2010;driven and viral RNA structure&#x2010;promoted template&#x2010;switching mechanism for viral RNA recombination. Oncotarget. 2017;8(37):60841&#x2010;60859.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5617389</ArticleId>
            <ArticleId IdType="pubmed">28977829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chao M. RNA recombination in hepatitis delta virus: implications regarding the abilities of mammalian RNA polymerases. Virus Res. 2007;127(2):208&#x2010;215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17296240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Gal F, Badur S, Hawajri NA, et&#xA0;al. Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins. Arch Virol. 2012;157(4):647&#x2010;659.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22241621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith DB, Simmonds P, Izopet J, et&#xA0;al. Proposed reference sequences for Hepatitis E virus subtypes. J Gen Virol. 2016;97(3):537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5588893</ArticleId>
            <ArticleId IdType="pubmed">26743685</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">30260391</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1873-734X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>55</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</Title>
          <ISOAbbreviation>Eur J Cardiothorac Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Global cardiac surgery: a wake-up call.</ArticleTitle>
        <Pagination>
          <StartPage>1022</StartPage>
          <EndPage>1023</EndPage>
          <MedlinePgn>1022-1023</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ejcts/ezy319</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vervoort</LastName>
            <ForeName>Dominique</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Cardiothorac Surg</MedlineTA>
        <NlmUniqueID>8804069</NlmUniqueID>
        <ISSNLinking>1010-7940</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Eur J Cardiothorac Surg. 2018 Sep 1;54(3):407-410. doi: 10.1093/ejcts/ezy272.</RefSource>
          <PMID Version="1">30113630</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Eur J Cardiothorac Surg. 2019 May 1;55(5):1023. doi: 10.1093/ejcts/ezy320.</RefSource>
          <PMID Version="1">30260379</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012214" MajorTopicYN="Y">Rheumatic Heart Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013019" MajorTopicYN="N" Type="Geographic">South Africa</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Education</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Global surgery</Keyword>
        <Keyword MajorTopicYN="N">Rheumatic heart disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30260391</ArticleId>
        <ArticleId IdType="doi">10.1093/ejcts/ezy319</ArticleId>
        <ArticleId IdType="pii">5107796</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30257277</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1467-789X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>20</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Obesity reviews : an official journal of the International Association for the Study of Obesity</Title>
          <ISOAbbreviation>Obes Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Interventions to increase physical activity in children 0-5&#xA0;years old: a systematic review, meta-analysis and realist synthesis.</ArticleTitle>
        <Pagination>
          <StartPage>75</StartPage>
          <EndPage>87</EndPage>
          <MedlinePgn>75-87</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/obr.12763</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">The objective of the study is to evaluate the effectiveness of interventions to increase physical activity (PA) in 0-5&#xA0;year olds and to determine what works, for whom, in what circumstances.</AbstractText>
          <AbstractText Label="DESIGN">Systematic review, meta-analysis and realist synthesis.</AbstractText>
          <AbstractText Label="DATA SOURCES">Embase and EBSCOhost (Academic Search Complete, CINAHL Complete, Global Health, MEDLINE Complete, PsycINFO, SPORTDiscus with full text), up to and including April 2017.</AbstractText>
          <AbstractText Label="ELIGIBILITY CRITERIA">Published in a peer-reviewed English language journal; randomized or controlled trial design; aimed to increase children's PA levels; reported on objectively assessed PA in children between 0 and 5.9&#xA0;years at baseline and post-intervention.</AbstractText>
          <AbstractText Label="RESULTS">Thirty-four studies were included in the review, mostly conducted in the preschool/childcare setting. Meta-analyses showed an overall non-significant (Z&#xA0;=&#xA0;0.04, p&#xA0;=&#xA0;0.97) mean difference of 0.03 (95% CI&#xA0;=&#xA0;-1.57, 1.63) minutes/day for light-intensity PA (n&#xA0;=&#xA0;11). The overall mean difference for moderate-intensity to vigorous-intensity PA (n&#xA0;=&#xA0;21) was 2.88 (95% CI&#xA0;=&#xA0;1.54, 4.23) minutes/day, indicating a small but significant overall positive effect (Z&#xA0;=&#xA0;4.20, p&#xA0;&lt;&#xA0;0.001). The realist synthesis provided insights into the key contexts and mechanisms that appeared to be effective at changing children's PA.</AbstractText>
          <AbstractText Label="CONCLUSION">Based on a quantitative and qualitative examination of the evidence, this review provides specific recommendations for effective early childhood PA interventions for practitioners and policymakers.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 World Obesity Federation.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hnatiuk</LastName>
            <ForeName>J A</ForeName>
            <Initials>JA</Initials>
            <Identifier Source="ORCID">0000-0002-5754-7176</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Science, Deakin University, Geelong, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brown</LastName>
            <ForeName>H E</ForeName>
            <Initials>HE</Initials>
            <AffiliationInfo>
              <Affiliation>MRC Epidemiology Unit and UKCRC Centre for Diet and Activity Research (CEDAR), University of Cambridge, Cambridge, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Downing</LastName>
            <ForeName>K L</ForeName>
            <Initials>KL</Initials>
            <Identifier Source="ORCID">0000-0002-6552-8506</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Science, Deakin University, Geelong, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hinkley</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Science, Deakin University, Geelong, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salmon</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Science, Deakin University, Geelong, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hesketh</LastName>
            <ForeName>K D</ForeName>
            <Initials>KD</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Science, Deakin University, Geelong, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>APP1026216</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>APP1070571</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>MC_UU_12015/7</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MR/K023187/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>GNT1092876</GrantID>
            <Agency>National Health and Medical Research Council</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>100370</GrantID>
            <Agency>Honorary Heart Foundation</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>FT130100637</GrantID>
            <Agency>Australian Research Council</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D017418">Meta-Analysis</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Obes Rev</MedlineTA>
        <NlmUniqueID>100897395</NlmUniqueID>
        <ISSNLinking>1467-7881</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006293" MajorTopicYN="N">Health Promotion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012574" MajorTopicYN="N">Schools</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">early childhood</Keyword>
        <Keyword MajorTopicYN="N">meta-analysis</Keyword>
        <Keyword MajorTopicYN="N">physical activity</Keyword>
        <Keyword MajorTopicYN="N">realist review</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30257277</ArticleId>
        <ArticleId IdType="doi">10.1111/obr.12763</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30257229</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1026</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>651</Volume>
            <Issue>Pt 1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Science of the total environment</Title>
          <ISOAbbreviation>Sci Total Environ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Di(2-ethylhexyl) phthalate induced hepatotoxicity in quail (Coturnix japonica) via modulating the mitochondrial unfolded protein response and NRF2 mediated antioxidant defense.</ArticleTitle>
        <Pagination>
          <StartPage>885</StartPage>
          <EndPage>894</EndPage>
          <MedlinePgn>885-894</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scitotenv.2018.09.211</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0048-9697(18)33656-8</ELocationID>
        <Abstract>
          <AbstractText>Among ubiquitously found environmental contaminants in the ecosystem, di(2-ethylhexyl) phthalate (DEHP) is an important environmental contaminant used as plasticizer in medical and consumer goods. The bioaccumulation and environmental persistence of DEHP cause serious global health effects in wildlife animals and human, especially hepatotoxicity. Herein, to explore the mechanisms of DEHP induced hepatotoxicity, quail were exposed with 0, 250, 500 and 1000&#x202F;mg/kg BW/day DEHP by gavage administration daily for 45&#x202F;days. Notably, the adipose tissue degeneration was observed in the liver of DEHP-exposed quail under the histopathological analysis. DEHP exposure increased the peroxidation product (MDA), GSH and GST, but decreased antioxidant function (T-AOC, SOD and GPX). DEHP induced the oxidative stress and pulsed on NRF2 signal pathway through activating downstream genes. Furthermore, DEHP induced mitochondrial ultrastructural abnormalities and mitochondrial dysfunctions. Mitochondrial unfolded protein response (mtUPR) was activated to relieve mitochondrial dysfunctions and mitigated oxidative stress. These findings showed that mitochondrial functions and redox homeostasis were affected by DEHP and resulted in irreversible hepatic injury. In Conclusion, this study suggested that DEHP-induced hepatotoxicity in quail was associated with activating the NRF2 mediated antioxidant defense and mtUPR. These results provided new evidence on molecular mechanism of DEHP induced hepatotoxicity.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Qi</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Talukder</LastName>
            <ForeName>Milton</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China; Department of Physiology and Pharmacology, Faculty of Animal Science and Veterinary Medicine, Patuakhali Science and Technology University, Barishal 8210, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of gastrointestinal oncology, Harbin Medical University Cancer Hospital, Harbin 150081, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Cong</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xue-Nan</ForeName>
            <Initials>XN</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Jin-Long</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China; Key Laboratory of the Provincial Education Department of Heilongjiang for Common Animal Disease Prevention and Treatment, Northeast Agricultural University, Harbin 150030, PR China; Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, Northeast Agricultural University, Harbin 150030, PR China. Electronic address: Jinlongli@neau.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Sci Total Environ</MedlineTA>
        <NlmUniqueID>0330500</NlmUniqueID>
        <ISSNLinking>0048-9697</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004785">Environmental Pollutants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>C42K0PH13C</RegistryNumber>
          <NameOfSubstance UI="D004051">Diethylhexyl Phthalate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056486" MajorTopicYN="N">Chemical and Drug Induced Liver Injury</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003370" MajorTopicYN="N">Coturnix</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056811" MajorTopicYN="Y">Unfolded Protein Response</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Di (2-ethylhexyl) phthalate</Keyword>
        <Keyword MajorTopicYN="N">Hepatotoxicity</Keyword>
        <Keyword MajorTopicYN="N">NRF2 mediated antioxidant defense</Keyword>
        <Keyword MajorTopicYN="N">Quail</Keyword>
        <Keyword MajorTopicYN="N">mtUPR</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30257229</ArticleId>
        <ArticleId IdType="doi">10.1016/j.scitotenv.2018.09.211</ArticleId>
        <ArticleId IdType="pii">S0048-9697(18)33656-8</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30256927</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1537-6591</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>68</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title>
          <ISOAbbreviation>Clin Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ensuring Antibiotic Development, Equitable Availability, and Responsible Use of Effective Antibiotics: Recommendations for Multisectoral Action.</ArticleTitle>
        <Pagination>
          <StartPage>1952</StartPage>
          <EndPage>1959</EndPage>
          <MedlinePgn>1952-1959</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciy824</ELocationID>
        <Abstract>
          <AbstractText>Antibiotic resistance is a growing threat to global public health. The World Health Organization's Global Action Plan on Antimicrobial Resistance recommends engaging multisectoral stakeholders to tackle the issue. However, so far, few studies have addressed barriers to antibiotic development, equitable availability, and responsible antibiotic use from the perspective of stakeholders outside healthcare facilities or patient communities: the so-called third-party stakeholders. Third-party stakeholders include, inter alia, governments, regulatory agencies, and professionals working in antibiotic research and development and medical ethics. This viewpoint provides an overview of barriers to antibiotic development, equitable availability of effective antibiotics, and the responsible use of antibiotics. The barriers were identified in an exploratory, qualitative interview study with an illustrative sample of 12 third-party stakeholders. Recommendations to lift these barriers are presented, together with examples of recently-made progress. The recommendations should guide future antibiotic policies and multisectoral policy action.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Monnier</LastName>
            <ForeName>Annelie A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Research Group of Immunology and Biochemistry, Hasselt University, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schouten</LastName>
            <ForeName>Jeroen</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tebano</LastName>
            <ForeName>Gianpiero</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Universit&#xE9; de Lorraine, APEMAC, Nancy, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zanichelli</LastName>
            <ForeName>Veronica</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huttner</LastName>
            <ForeName>Benedikt D</ForeName>
            <Initials>BD</Initials>
            <AffiliationInfo>
              <Affiliation>Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pulcini</LastName>
            <ForeName>C&#xE9;line</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Universit&#xE9; de Lorraine, APEMAC, Nancy, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Universit&#xE9; de Lorraine, CHRU-Nancy (Centre Hospitalier R&#xE9;gional Universitaire de Nancy), Infectious Diseases Department, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>&#xC5;rdal</LastName>
            <ForeName>Christine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harbarth</LastName>
            <ForeName>Stephan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hulscher</LastName>
            <ForeName>Marlies E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gyssens</LastName>
            <ForeName>Inge C</ForeName>
            <Initials>IC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Research Group of Immunology and Biochemistry, Hasselt University, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Infect Dis</MedlineTA>
        <NlmUniqueID>9203213</NlmUniqueID>
        <ISSNLinking>1058-4838</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>Clin Infect Dis. 2019 Mar 5;68(6):1070. doi: 10.1093/cid/ciy1027.</RefSource>
          <PMID Version="1">30753361</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
          <QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073602" MajorTopicYN="Y">Antimicrobial Stewardship</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004352" MajorTopicYN="Y">Drug Resistance, Microbial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073597" MajorTopicYN="N">Stakeholder Participation</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antibiotic access</Keyword>
        <Keyword MajorTopicYN="N">antibiotic discovery</Keyword>
        <Keyword MajorTopicYN="N">antimicrobial resistance</Keyword>
        <Keyword MajorTopicYN="N">barriers and facilitators</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">multisectoral stakeholders</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30256927</ArticleId>
        <ArticleId IdType="doi">10.1093/cid/ciy824</ArticleId>
        <ArticleId IdType="pii">5106995</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30255943</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1098-2299</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>80</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug development research</Title>
          <ISOAbbreviation>Drug Dev Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Harnessing snake venom phospholipases A<sub>2</sub> to novel approaches for overcoming antibiotic resistance.</ArticleTitle>
        <Pagination>
          <StartPage>68</StartPage>
          <EndPage>85</EndPage>
          <MedlinePgn>68-85</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ddr.21456</ELocationID>
        <Abstract>
          <AbstractText>The emergence of antibiotic resistance drives an essential race against time to reveal new molecular structures capable of addressing this alarming global health problem. Snake venoms are natural catalogs of multifunctional toxins and privileged frameworks, which serve as potential templates for the inspiration of novel treatment strategies for combating antibiotic resistant bacteria. Phospholipases A<sub>2</sub> (PLA<sub>2</sub> s) are one of the main classes of antibacterial biomolecules, with recognized therapeutic value, found in these valuable secretions. Recently, a number of biomimetic oligopeptides based on small fragments of primary structure from PLA<sub>2</sub> toxins has emerged as a meaningful opportunity to overcome multidrug-resistant clinical isolates. Thus, this review will highlight the biochemical and structural properties of antibacterial PLA<sub>2</sub> s and peptides thereof, as well as their possible molecular mechanisms of action and key roles in development of effective therapeutic strategies. Chemical strategies possibly useful to convert antibacterial peptides from PLA<sub>2</sub> s to efficient drugs will be equally addressed.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Almeida</LastName>
            <ForeName>Jos&#xE9; R</ForeName>
            <Initials>JR</Initials>
            <Identifier Source="ORCID">0000-0002-4637-4468</Identifier>
            <AffiliationInfo>
              <Affiliation>Ikiam - Universidad Regional Amaz&#xF3;nica, Tena, Ecuador.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Palacios</LastName>
            <ForeName>Antonio L V</ForeName>
            <Initials>ALV</Initials>
            <AffiliationInfo>
              <Affiliation>Ikiam - Universidad Regional Amaz&#xF3;nica, Tena, Ecuador.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pati&#xF1;o</LastName>
            <ForeName>Ricardo S P</ForeName>
            <Initials>RSP</Initials>
            <AffiliationInfo>
              <Affiliation>Ikiam - Universidad Regional Amaz&#xF3;nica, Tena, Ecuador.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mendes</LastName>
            <ForeName>Bruno</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Biologia Animal, Instituto de Biologia, Universidade de Campinas (UNICAMP), Campinas, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Teixeira</LastName>
            <ForeName>C&#xE1;tia A S</ForeName>
            <Initials>CAS</Initials>
            <AffiliationInfo>
              <Affiliation>LAQV/REQUIMTE, Departamento de Qu&#xED;mica e Bioqu&#xED;mica, Faculdade de Ci&#xEA;ncias, Universidade do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gomes</LastName>
            <ForeName>Paula</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>LAQV/REQUIMTE, Departamento de Qu&#xED;mica e Bioqu&#xED;mica, Faculdade de Ci&#xEA;ncias, Universidade do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>da Silva</LastName>
            <ForeName>Saulo L</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>Facultad de Ciencias Qu&#xED;mica, Universidad de Cuenca - Cuenca/Azuay - Ecuador.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Drug Dev Res</MedlineTA>
        <NlmUniqueID>8204468</NlmUniqueID>
        <ISSNLinking>0272-4391</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D023181">Antimicrobial Cationic Peptides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012910">Snake Venoms</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.1.4</RegistryNumber>
          <NameOfSubstance UI="D054467">Phospholipases A2</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023181" MajorTopicYN="N">Antimicrobial Cationic Peptides</DescriptorName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004352" MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054467" MajorTopicYN="N">Phospholipases A2</DescriptorName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012910" MajorTopicYN="N">Snake Venoms</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antibacterial peptides</Keyword>
        <Keyword MajorTopicYN="N">antibiotic-resistant bacteria</Keyword>
        <Keyword MajorTopicYN="N">peptidomimetics</Keyword>
        <Keyword MajorTopicYN="N">phospholipase A2</Keyword>
        <Keyword MajorTopicYN="N">snake venom</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30255943</ArticleId>
        <ArticleId IdType="doi">10.1002/ddr.21456</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30252591</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Update on Campylobacter vaccine development.</ArticleTitle>
        <Pagination>
          <StartPage>1389</StartPage>
          <EndPage>1400</EndPage>
          <MedlinePgn>1389-1400</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2018.1528410</ELocationID>
        <Abstract>
          <AbstractText><b><i>Background</i></b>: Acute diarrheal disease caused by viral, bacterial and parasitic infections are a major global health problem with substantial mortality and morbidity in children under five years of age in lower and middle income countries. However, a number of these infections also impact large segments of populations in upper income countries, as well as individuals who travel overseas for work, business or pleasure. <i>Campylobacter</i> has been and continues to be a leading cause of disease burden globally across all income countries. <b><i>Aims</i></b>: The aim of this review is to describe recent understanding in burden of disease, consider the current landscape of <i>Campylobacter</i> vaccine development, and address the challenges that need to be overcome. <b><i>Sources</i></b>: Relevant data from the literature as well as clinical trials described in European and US registries were used to conduct this review. <b><i>Content</i></b>: Despite advances in population health, food security, improved sanitation, water quality and the reduction of poverty, <i>Campylobacter</i> infections continue to plague global populations. The emerging recognition of chronic health consequences attributed to this pathogen is changing the potential valuation of preventive interventions. Advancing development of new vaccines is a present opportunity and holds promise.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Poly</LastName>
            <ForeName>Fr&#xE9;d&#xE9;ric</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>a Enteric Diseases Department , Naval Medical Research Center , Silver Spring , MD , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Noll</LastName>
            <ForeName>Alexander J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>a Enteric Diseases Department , Naval Medical Research Center , Silver Spring , MD , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Riddle</LastName>
            <ForeName>Mark S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>b F. Edward H&#xE9;bert School of Medicine , Uniformed Services University , Bethesda , MD , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Porter</LastName>
            <ForeName>Chad K</ForeName>
            <Initials>CK</Initials>
            <AffiliationInfo>
              <Affiliation>a Enteric Diseases Department , Naval Medical Research Center , Silver Spring , MD , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001428">Bacterial Vaccines</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001428" MajorTopicYN="N">Bacterial Vaccines</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002167" MajorTopicYN="N">Campylobacter</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002169" MajorTopicYN="N">Campylobacter Infections</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016123" MajorTopicYN="N">Campylobacter jejuni</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003967" MajorTopicYN="N">Diarrhea</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014195" MajorTopicYN="N">Travel</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Campylobacter</Keyword>
        <Keyword MajorTopicYN="N">capsule</Keyword>
        <Keyword MajorTopicYN="N">diarrhea</Keyword>
        <Keyword MajorTopicYN="N">jejuni</Keyword>
        <Keyword MajorTopicYN="N">traveler</Keyword>
        <Keyword MajorTopicYN="N">vaccine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>17</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30252591</ArticleId>
        <ArticleId IdType="pmc">PMC6663129</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2018.1528410</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>GBD Diarrhoeal Diseases Collaborators. Estimates of Global, Regional, and National Morbidity, Mortality, and Aetiologies of Diarrhoeal Diseases: A&#xA0;Systematic Analysis for The Global Burden of Disease Study 2015. Lancet Infect Dis 2017;17(9):909&#x2013;&#x2013;948..</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5589208</ArticleId>
            <ArticleId IdType="pubmed">28579426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nataro JP, Guerrant RL.. Chronic consequences on human health induced by microbial pathogens: growth faltering among children in developing countries. Vaccine. 2017;35(49Pt A):6807&#x2013;6812. doi:10.1016/j.vaccine.2017.05.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2017.05.035</ArticleId>
            <ArticleId IdType="pubmed">28549806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scallan E, Hoekstra RM, Mahon BE, Jones TF, Griffin PM. An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years. Epidemiol Infect. 2015;143(13):2795&#x2013;2804. doi:10.1017/S0950268814003185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268814003185</ArticleId>
            <ArticleId IdType="pmc">PMC9151020</ArticleId>
            <ArticleId IdType="pubmed">25633631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verdu EF, Riddle MS. Chronic gastrointestinal consequences of acute infectious diarrhea: evolving concepts in epidemiology and pathogenesis. Am J Gastroenterol. 2012;107(7):981&#x2013;989. doi:10.1038/ajg.2012.65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2012.65</ArticleId>
            <ArticleId IdType="pubmed">22508147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; (9859):2197&#x2013;2223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23245608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209&#x2013;222. doi:10.1016/S0140-6736(13)60844-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(13)60844-2</ArticleId>
            <ArticleId IdType="pubmed">23680352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A, McCormick BJ, McGrath M, Olortegui MP, Samie A, et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). The Lancet Global Health. 2015;3(9):e564&#x2013;75. doi:10.1016/S2214-109X(15)00151-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2214-109X(15)00151-5</ArticleId>
            <ArticleId IdType="pmc">PMC7328884</ArticleId>
            <ArticleId IdType="pubmed">26202075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Havelaar AH, Swart A. Impact of waning acquired immunity and asymptomatic infections on case-control studies for enteric pathogens. Epidemics. 2016;17:56&#x2013;63. doi:10.1016/j.epidem.2016.11.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.epidem.2016.11.004</ArticleId>
            <ArticleId IdType="pubmed">27915211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, Operario DJ, Uddin J, Ahmed S, Alonso PL, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016;388(10051):1291&#x2013;1301. doi:10.1016/S0140-6736(16)31529-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)31529-X</ArticleId>
            <ArticleId IdType="pmc">PMC5471845</ArticleId>
            <ArticleId IdType="pubmed">27673470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amour C, Gratz J, Mduma E, Svensen E, Rogawski ET, McGrath M, Seidman JC, McCormick BJ, Shrestha S, Samie A, et al. Epidemiology and impact of campylobacter infection in children in 8 low-resource settings: results from the MAL-ED study. Clin Infect Dis. 2016;63(9):1171&#x2013;1179. doi:10.1093/cid/ciw542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciw542</ArticleId>
            <ArticleId IdType="pmc">PMC5064165</ArticleId>
            <ArticleId IdType="pubmed">27501842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Investigators M-EN. Relationship between growth and illness, enteropathogens and dietary intakes in the first 2 years of life: findings from the MAL-ED birth cohort study. BMJ Glob Health. 2017;2(4):e000370. doi:10.1136/bmjgh-2017-000306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjgh-2017-000306</ArticleId>
            <ArticleId IdType="pmc">PMC5759708</ArticleId>
            <ArticleId IdType="pubmed">29333282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schnee AE, Petri WA Jr.. Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries. Curr Opin Infect Dis. 2017;30(3):322&#x2013;328. doi:10.1097/QCO.0000000000000364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QCO.0000000000000364</ArticleId>
            <ArticleId IdType="pmc">PMC5560167</ArticleId>
            <ArticleId IdType="pubmed">28157786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marder EP, Griffin PM, Cieslak PR, Dunn J, Hurd S, Jervis R, Lathrop S, Muse A, Ryan P, Smith K, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food - foodborne diseases active surveillance network, 10 U.S. Sites, 2006-2017. MMWR Morb Mortal Wkly Rep. 2018;67(11):324&#x2013;328. doi:10.15585/mmwr.mm6711a3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15585/mmwr.mm6711a3</ArticleId>
            <ArticleId IdType="pmc">PMC5868202</ArticleId>
            <ArticleId IdType="pubmed">29565841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jorgensen K. [Prevalence of Campylobacter fetus ssp. jejuni in Danish dogs (author&#x2019;s transl)]. NordVetMed. 1981;33(1):42&#x2013;48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7220268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>OzFoodNet Working G Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet network, 2011. Commun Dis Intell Q Rep. 2015;39(2):E236&#x2013;64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26234259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. Foodborne illness acquired in the United States&#x2013;major pathogens. Emerg Infect Dis. 2011;17(1):7&#x2013;15. doi:10.3201/eid1701.091101p1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1701.091101p1</ArticleId>
            <ArticleId IdType="pmc">PMC3375761</ArticleId>
            <ArticleId IdType="pubmed">21192848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riddle MS, Sanders JW, Putnam SD, Tribble DR. Incidence, etiology, and impact of diarrhea among long-term travelers (U.S. military and similar populations): A systematic review. Am J Trop Med Hyg. 2006;74(5):891&#x2013;900.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16687698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers&#x2019; diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009;80(4):609&#x2013;614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19346386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Porter CK, Olson S, Hall A, Riddle MS. Travelers&#x2019; Diarrhea: an update on the incidence, etiology, and risk in military deployments and similar travel populations. Mil Med. 2017;182(S2):4&#x2013;10. doi:10.7205/MILMED-D-17-00064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7205/MILMED-D-17-00064</ArticleId>
            <ArticleId IdType="pubmed">28885918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Porter CK, Riddle MS, Tribble DR, Putnam SD, Rockabrand DM, Frenck RW, Rozmajzl P, Kilbane E, Fox A, Ruck R, et al. The epidemiology of travelers&#x2019; diarrhea in Incirlik, Turkey: a region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coli. Diagn Microbiol Infect Dis. 2010;66(3):241&#x2013;247. doi:10.1016/j.diagmicrobio.2009.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diagmicrobio.2009.10.002</ArticleId>
            <ArticleId IdType="pubmed">19903582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanders JW, Isenbarger DW, Walz SE, Pang LW, Scott DA, Tamminga C, Oyofo BA, Hewitson WC, Sanchez JL, Pitarangsi C, et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67(5):533&#x2013;538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12479558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keithlin J, Sargeant J, Thomas MK, Fazil A. Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC Public Health. 2014;14:1203. doi:10.1186/1471-2458-14-1203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2458-14-1203</ArticleId>
            <ArticleId IdType="pmc">PMC4391665</ArticleId>
            <ArticleId IdType="pubmed">25416162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodfellow JA, Willison HJ. Guillain-Barre syndrome: a century of progress. Nat Rev Neurol. 2016;12(12):723&#x2013;731. doi:10.1038/nrneurol.2016.172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneurol.2016.172</ArticleId>
            <ArticleId IdType="pubmed">27857121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome. Lancet. 2016;388(10045):717&#x2013;727. doi:10.1016/S0140-6736(16)00339-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)00339-1</ArticleId>
            <ArticleId IdType="pubmed">26948435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riddle MS, Gutierrez RL, Verdu EF, Porter CK. The chronic gastrointestinal consequences associated with campylobacter. Curr Gastroenterol Rep. 2012;14(5):395&#x2013;405. doi:10.1007/s11894-012-0278-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11894-012-0278-0</ArticleId>
            <ArticleId IdType="pubmed">22864805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ajene AN, Fischer Walker CL, Black RE. Enteric pathogens and reactive arthritis: a systematic review of Campylobacter, salmonella and Shigella-associated reactive arthritis. J Health Popul Nutr. 2013;31(3):299&#x2013;307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3805878</ArticleId>
            <ArticleId IdType="pubmed">24288942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stavropoulos PG, Soura E, Kanelleas A, Katsambas A, Antoniou C. Reactive arthritis. J Eur Acad Dermatol Venereol. 2015;29(3):415&#x2013;424. doi:10.1111/jdv.12741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.12741</ArticleId>
            <ArticleId IdType="pubmed">25199646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Post A, Martiny D, van Waterschoot N, Hallin M, Maniewski U, Bottieau E, Van Esbroeck M, Vlieghe E, Ombelet S, Vandenberg O, et al. Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014. Eur J Clin Microbiol Infect Dis. 2017;36(11):2101&#x2013;2107. doi:10.1007/s10096-017-3032-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-017-3032-6</ArticleId>
            <ArticleId IdType="pmc">PMC5653722</ArticleId>
            <ArticleId IdType="pubmed">28623550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosunen TU, Ponka A, Kauranen O, Martio J, Pitkanen T, Hortling L, Aittoniemi S, Penttila O, Koskimies S. Arthritis associated with Campylobacter jejuni enteritis. ScandJRheumatol. 1981;10(2):77&#x2013;80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7244582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ponka A, Kosunen TU. Pancreas affection in association with enteritis due to Campylobacter fetus ssp. jejuni. Acta MedScand. 1981;209(3):239&#x2013;240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7223520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol. 2007;5(9):665&#x2013;679. doi:10.1038/nrmicro1718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro1718</ArticleId>
            <ArticleId IdType="pubmed">17703225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poly F, Guerry P. Pathogenesis of Campylobacter. Curr Opin Gastroenterol. 2008;24(1):27&#x2013;31. doi:10.1097/MOG.0b013e3282f1dcb1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MOG.0b013e3282f1dcb1</ArticleId>
            <ArticleId IdType="pubmed">18043229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010;300(4):205&#x2013;211. doi:10.1016/j.ijmm.2009.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2009.07.002</ArticleId>
            <ArticleId IdType="pubmed">19665925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerry P, Poly F, Riddle M, Maue AC, Chen YH, Monteiro MA. Campylobacter polysaccharide capsules: virulence and vaccines. Front Cell Infect Microbiol. 2012;2:7. doi:10.3389/fcimb.2012.00007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2012.00007</ArticleId>
            <ArticleId IdType="pmc">PMC3417588</ArticleId>
            <ArticleId IdType="pubmed">22919599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lertpiriyapong K, Gamazon ER, Feng Y, Park DS, Pang J, Botka G, Graffam ME, Ge Z, Fox JG. Campylobacter jejuni type VI secretion system: roles in adaptation to deoxycholic acid, host cell adherence, invasion, and in vivo colonization. PLoS One. 2012;7(8):e42842. doi:10.1371/journal.pone.0042842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0042842</ArticleId>
            <ArticleId IdType="pmc">PMC3428339</ArticleId>
            <ArticleId IdType="pubmed">22952616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babakhani FK, Bradley GA, Joens LA. Newborn piglet model for campylobacteriosis. InfectImmun. 1993;61(8):3466&#x2013;3475.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC281024</ArticleId>
            <ArticleId IdType="pubmed">8335377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fox JG, Ackerman JI, Taylor N, Claps M, Murphy JC. Campylobacter jejuni infection in the ferret: an animal model of human campylobacteriosis. AmJVetRes. 1987;48(1):85&#x2013;90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3826848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mansfield LS, Bell JA, Wilson DL, Murphy AJ, Elsheikha HM, Rathinam VA, Fierro BR, Linz JE, Young VB. C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis. InfectImmun. 2007;75(3):1099&#x2013;1115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1828563</ArticleId>
            <ArticleId IdType="pubmed">17130251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stahl M, Graef FA, Vallance BA. Mouse Models for Campylobacter jejuni Colonization and Infection. Methods Mol Biol. 2017;1512:171&#x2013;188. doi:10.1007/978-1-4939-6536-6_15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-6536-6_15</ArticleId>
            <ArticleId IdType="pubmed">27885607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fox JG, Rogers AB, Whary MT, Ge Z, Taylor NS, Xu S, Horwitz BH, Erdman SE. Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect Immun. 2004;72(2):1116&#x2013;1125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC321575</ArticleId>
            <ArticleId IdType="pubmed">14742559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Champion OL, Karlyshev AV, Senior NJ, Woodward M, La Ragione R, Howard SL, Wren BW, Titball RW. Insect infection model for Campylobacter jejuni reveals that O-methyl phosphoramidate has insecticidal activity. J Infect Dis. 2010;201(5):776&#x2013;782. doi:10.1086/650494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/650494</ArticleId>
            <ArticleId IdType="pubmed">20113177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giallourou N, Medlock GL, Bolick DT, Medeiros PH, Ledwaba SE, Kolling GL, Tung K, Guerry P, Swann JR, Guerrant RL.&#xA0;A novel mouse model of Campylobacter jejuni enteropathy and diarrhea. PLoS Pathog. 2018;14(3):e1007083. doi:10.1371/journal.ppat.1006797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1006797</ArticleId>
            <ArticleId IdType="pmc">PMC5988333</ArticleId>
            <ArticleId IdType="pubmed">29791507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltwell T, Holroyd S, et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature. 2000;403(6770):665&#x2013;668. doi:10.1038/35001088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35001088</ArticleId>
            <ArticleId IdType="pubmed">10688204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlyshev AV, Linton D, Gregson NA, Lastovica AJ, Wren BW. Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol Microbiol. 2000;35(3):529&#x2013;541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10672176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penner JL, Hennessy JN. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol. 1980;12(6):732&#x2013;737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC273687</ArticleId>
            <ArticleId IdType="pubmed">6796598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, Guerry P. A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol Microbiol. 2001;40(3):769&#x2013;777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11359581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahin&#xA0;O,&#xA0;Terhorst&#xA0;SA,&#xA0;Burrough&#xA0;ER,&#xA0;Shen&#xA0;Z,&#xA0;Wu&#xA0;Z,&#xA0;Dai&#xA0;L, et&#xA0;al. Key role of capsular polysaccharide in the induction of systemic infection and abortion by hypervirulent campylobacter jejuni. Infect Immun. 2017;85(6). doi:10.1128/IAI.00001-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00001-17</ArticleId>
            <ArticleId IdType="pmc">PMC5442617</ArticleId>
            <ArticleId IdType="pubmed">28373351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Alphen LB, Wenzel CQ, Richards MR, Fodor C, Ashmus RA, Stahl M, Karlyshev AV, Wren BW, Stintzi A, Miller WG, et al. Biological roles of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni. PloS one. 2014;9(1):e87051. doi:10.1371/journal.pone.0087051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0087051</ArticleId>
            <ArticleId IdType="pmc">PMC3907429</ArticleId>
            <ArticleId IdType="pubmed">24498018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grant AJ, Coward C, Jones MA, Woodall CA, Barrow PA, Maskell DJ. Signature-tagged transposon mutagenesis studies demonstrate the dynamic nature of cecal colonization of 2-week-old chickens by Campylobacter jejuni. Appl Environ Microbiol. 2005;71(12):8031&#x2013;8041. doi:10.1128/AEM.71.12.8031-8041.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.71.12.8031-8041.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1317333</ArticleId>
            <ArticleId IdType="pubmed">16332783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bachtiar BM, Coloe PJ, Fry BN. Knockout mutagenesis of the kpsE gene of Campylobacter jejuni 81116 and its involvement in bacterium-host interactions. FEMS Immunol Med Microbiol. 2007;49(1):149&#x2013;154. doi:10.1111/j.1574-695X.2006.00182.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-695X.2006.00182.x</ArticleId>
            <ArticleId IdType="pubmed">17266722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong A, Lange D, Houle S, Arbatsky NP, Valvano MA, Knirel YA, Dozois CM, Creuzenet C.&#xA0;Role of capsular modified heptose in the virulence of Campylobacter jejuni. Mol Microbiol. 2015;96(6):1136&#x2013;1158. doi:10.1111/mmi.12995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/mmi.12995</ArticleId>
            <ArticleId IdType="pubmed">25766665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maue AC, Mohawk KL, Giles DK, Poly F, Ewing CP, Jiao Y, Lee G, Ma Z, Monteiro MA, Hill CL, et al. The polysaccharide capsule of Campylobacter jejuni modulates the host immune response. Infect Immun. 2013;81(3):665&#x2013;672. doi:10.1128/IAI.01008-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01008-12</ArticleId>
            <ArticleId IdType="pmc">PMC3584872</ArticleId>
            <ArticleId IdType="pubmed">23250948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pequegnat B, Laird RM, Ewing CP, Hill CL, Omari E, Poly F, Monteiro MA, Guerry P. Phase-variable changes in the position of O-methyl phosphoramidate modifications on the polysaccharide capsule of campylobacter jejuni modulate serum resistance. J Bacteriol. 2017;199(14). doi:10.1128/JB.00027-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00027-17</ArticleId>
            <ArticleId IdType="pmc">PMC5494740</ArticleId>
            <ArticleId IdType="pubmed">28461446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerry P, Szymanski CM. Campylobacter sugars sticking out. Trends Microbiol. 2008;16(9):428&#x2013;435. doi:10.1016/j.tim.2008.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2008.07.002</ArticleId>
            <ArticleId IdType="pubmed">18707886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prendergast MM, Moran AP. Lipopolysaccharides in the development of the Guillain-Barre syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. J Endotoxin Res. 2000;6(5):341&#x2013;359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11521055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Penner JL, Aspinall GO. Diversity of lipopolysaccharide structures in Campylobacter jejuni. J Infect Dis. 1997;176(Suppl 2):S135&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9396697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Houliston RS, Vinogradov E, Dzieciatkowska M, Li J, St Michael F, Karwaski MF, Brochu D, Jarrell HC, Parker CT, Yuki N, et al. Lipooligosaccharide of Campylobacter jejuni: similarity with multiple types of mammalian glycans beyond gangliosides. J Biol Chem. 2011;286(14):12361&#x2013;12370. doi:10.1074/jbc.M110.181750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M110.181750</ArticleId>
            <ArticleId IdType="pmc">PMC3069439</ArticleId>
            <ArticleId IdType="pubmed">21257763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Linton D, Gilbert M, Hitchen PG, Dell A, Morris HR, Wakarchuk WW, Gregson NA, Wren BW.&#xA0;Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni. Mol Microbiol. 2000;37(3):501&#x2013;514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10931344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, Pattarini DL, Moran AP.&#xA0;Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect Immun. 2002;70(2):787&#x2013;793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC127662</ArticleId>
            <ArticleId IdType="pubmed">11796612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Godschalk PC, Kuijf ML, Li J, St Michael F, Ang CW, Jacobs BC, Karwaski MF, Brochu D, Moterassed A, Endtz HP, et al. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun. 2007;75(3):1245&#x2013;1254. doi:10.1128/IAI.00872-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00872-06</ArticleId>
            <ArticleId IdType="pmc">PMC1828588</ArticleId>
            <ArticleId IdType="pubmed">17261613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young NM, Brisson JR, Kelly J, Watson DC, Tessier L, Lanthier PH, Jarrell HC, Cadotte N, St Michael F, Aberg E, et al. Structure of the N-linked glycan present on multiple glycoproteins in the Gram-negative bacterium, Campylobacter jejuni. J Biol Chem. 2002;277(45):42530&#x2013;42539. doi:10.1074/jbc.M206114200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M206114200</ArticleId>
            <ArticleId IdType="pubmed">12186869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott NE, Nothaft H, Edwards AV, Labbate M, Djordjevic SP, Larsen MR, Szymanski CM, Cordwell SJ. Modification of the Campylobacter jejuni N-linked glycan by EptC protein-mediated addition of phosphoethanolamine. J Biol Chem. 2012;287(35):29384&#x2013;29396. doi:10.1074/jbc.M112.380212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.380212</ArticleId>
            <ArticleId IdType="pmc">PMC3436159</ArticleId>
            <ArticleId IdType="pubmed">22761430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cullen TW, O'Brien JP, Hendrixson DR, Giles DK, Hobb RI, Thompson SA, Brodbelt JS, Trent MS. EptC of Campylobacter jejuni mediates phenotypes involved in host interactions and virulence. Infect Immun. 2013;81(2):430&#x2013;440. doi:10.1128/IAI.01046-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01046-12</ArticleId>
            <ArticleId IdType="pmc">PMC3553815</ArticleId>
            <ArticleId IdType="pubmed">23184526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cullen TW, Trent MS. A link between the assembly of flagella and lipooligosaccharide of the Gram-negative bacterium Campylobacter jejuni. Proc Natl Acad Sci U S A. 2010;107(11):5160&#x2013;5165. doi:10.1073/pnas.0913451107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0913451107</ArticleId>
            <ArticleId IdType="pmc">PMC2841920</ArticleId>
            <ArticleId IdType="pubmed">20194750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alemka A, Nothaft H, Zheng J, Szymanski CM. N-glycosylation of Campylobacter jejuni surface proteins promotes bacterial fitness. Infect Immun. 2013;81(5):1674&#x2013;1682. doi:10.1128/IAI.01370-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01370-12</ArticleId>
            <ArticleId IdType="pmc">PMC3648013</ArticleId>
            <ArticleId IdType="pubmed">23460522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Sorge NM, Bleumink NM, van Vliet SJ, Saeland E, van der Pol WL, van Kooyk Y, van Putten JP.&#xA0;N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL. Cell Microbiol. 2009;11(12):1768&#x2013;1781. doi:10.1111/j.1462-5822.2009.01370.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-5822.2009.01370.x</ArticleId>
            <ArticleId IdType="pubmed">19681908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szymanski CM, Burr DH, Guerry P. Campylobacter protein glycosylation affects host cell interactions. Infect Immun. 2002;70(4):2242&#x2013;2244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC127875</ArticleId>
            <ArticleId IdType="pubmed">11895996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlyshev AV, Everest P, Linton D, Cawthraw S, Newell DG, Wren BW. The Campylobacter jejuni general glycosylation system is important for attachment to human epithelial cells and in the colonization of chicks. Microbiology. 2004;150(Pt 6):1957&#x2013;1964. doi:10.1099/mic.0.26721-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.26721-0</ArticleId>
            <ArticleId IdType="pubmed">15184581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morooka T, Umeda A, Amako K. Motility as an intestinal colonization factor for Campylobacter jejuni. J Gen Microbiol. 1985;131(8):1973&#x2013;1980. doi:10.1099/00221287-131-8-1973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/00221287-131-8-1973</ArticleId>
            <ArticleId IdType="pubmed">4056739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerry P. Campylobacter flagella: not just for motility. Trends Microbiol. 2007;15(10):456&#x2013;461. doi:10.1016/j.tim.2007.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2007.09.006</ArticleId>
            <ArticleId IdType="pubmed">17920274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Merino S, Tomas JM. Gram-negative flagella glycosylation. Int J Mol Sci. 2014;15(2):2840&#x2013;2857. doi:10.3390/ijms15022840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms15022840</ArticleId>
            <ArticleId IdType="pmc">PMC3958885</ArticleId>
            <ArticleId IdType="pubmed">24557579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerry P, Ewing CP, Schirm M, Lorenzo M, Kelly J, Pattarini D, Majam G, Thibault P, Logan S.&#xA0;Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol Microbiol. 2006;60(2):299&#x2013;311. doi:10.1111/j.1365-2958.2006.05100.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2006.05100.x</ArticleId>
            <ArticleId IdType="pmc">PMC1424674</ArticleId>
            <ArticleId IdType="pubmed">16573682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stephenson HN, Mills DC, Jones H, Milioris E, Copland A, Dorrell N, Wren BW, Crocker PR, Escors D, Bajaj-Elliott M. Pseudaminic acid on Campylobacter jejuni flagella modulates dendritic cell IL-10 expression via Siglec-10 receptor: a novel flagellin-host interaction. J Infect Dis. 2014;210(9):1487&#x2013;1498. doi:10.1093/infdis/jiu287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiu287</ArticleId>
            <ArticleId IdType="pmc">PMC4195440</ArticleId>
            <ArticleId IdType="pubmed">24823621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howard SL, Jagannathan A, Soo EC, Hui JP, Aubry AJ, Ahmed I, Karlyshev A, Kelly JF, Jones MA, Stevens MP, et al. Campylobacter jejuni glycosylation island important in cell charge, legionaminic acid biosynthesis, and colonization of chickens. Infect Immun. 2009;77(6):2544&#x2013;2556. doi:10.1128/IAI.01425-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01425-08</ArticleId>
            <ArticleId IdType="pmc">PMC2687346</ArticleId>
            <ArticleId IdType="pubmed">19307210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ewing CP, Andreishcheva E, Guerry P. Functional characterization of flagellin glycosylation in Campylobacter jejuni 81-176. J Bacteriol. 2009;191(22):7086&#x2013;7093. doi:10.1128/JB.00378-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00378-09</ArticleId>
            <ArticleId IdType="pmc">PMC2772469</ArticleId>
            <ArticleId IdType="pubmed">19749047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nachamkin I, Hart AM. Western blot analysis of the human antibody response to Campylobacter jejuni cellular antigens during gastrointestinal infection. J Clin Microbiol. 1985;21(1):33&#x2013;38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC271575</ArticleId>
            <ArticleId IdType="pubmed">2578479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin PM, Mathiot J, Ipero J, Kirimat M, Georges AJ, Georges-Courbot MC. Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children from birth to 2 years of age. Infect Immun. 1989;57(8):2542&#x2013;2546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC313483</ArticleId>
            <ArticleId IdType="pubmed">2744860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Logan SM, Trust TJ, Guerry P. Evidence for posttranslational modification and gene duplication of Campylobacter flagellin. J Bacteriol. 1989;171(6):3031&#x2013;3038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC210011</ArticleId>
            <ArticleId IdType="pubmed">2722741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alm RA, Guerry P, Power ME, Trust TJ. Variation in antigenicity and molecular weight of Campylobacter coli VC167 flagellin in different genetic backgrounds. J Bacteriol. 1992;174(13):4230&#x2013;4238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC206204</ArticleId>
            <ArticleId IdType="pubmed">1624417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Power ME, Guerry P, McCubbin WD, Kay CM, Trust TJ. Structural and antigenic characteristics of Campylobacter coli FlaA flagellin. J Bacteriol. 1994;176(11):3303&#x2013;3313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC205501</ArticleId>
            <ArticleId IdType="pubmed">7515043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doig P, Kinsella N, Guerry P, Trust TJ. Characterization of a post-translational modification of Campylobacter flagellin: identification of a sero-specific glycosyl moiety. Mol Microbiol. 1996;19(2):379&#x2013;387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8825782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerry P, Doig P, Alm RA, Burr DH, Kinsella N, Trust TJ. Identification and characterization of genes required for post-translational modification of Campylobacter coli VC167 flagellin. Mol Microbiol. 1996;19(2):369&#x2013;378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8825781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watson RO, Galan JE. Signal transduction in Campylobacter jejuni-induced cytokine production. Cell Microbiol. 2005;7(5):655&#x2013;665. doi:10.1111/j.1462-5822.2004.00498.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-5822.2004.00498.x</ArticleId>
            <ArticleId IdType="pubmed">15839895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Zoete MR, Keestra AM, Wagenaar JA, van Putten JP. Reconstitution of a functional Toll-like receptor 5 binding site in Campylobacter jejuni flagellin. J Biol Chem. 2010;285(16):12149&#x2013;12158. doi:10.1074/jbc.M109.070227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M109.070227</ArticleId>
            <ArticleId IdType="pmc">PMC2852954</ArticleId>
            <ArticleId IdType="pubmed">20164175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hermans D, Pasmans F, Messens W, Martel A, Van Immerseel F, Rasschaert G, Heyndrickx M, Van Deun K, Haesebrouck F.&#xA0;Poultry as a host for the zoonotic pathogen Campylobacter jejuni. Vector Borne Zoonotic Dis. 2012;12(2):89&#x2013;98. doi:10.1089/vbz.2011.0676.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/vbz.2011.0676</ArticleId>
            <ArticleId IdType="pubmed">22133236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Zoete MR, van Putten JP, Wagenaar JA. Vaccination of chickens against Campylobacter. Vaccine. 2007;25(30):5548&#x2013;5557. doi:10.1016/j.vaccine.2006.12.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2006.12.002</ArticleId>
            <ArticleId IdType="pubmed">17224215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neal-McKinney JM, Samuelson DR, Eucker TP, Nissen MS, Crespo R, Konkel ME. Reducing Campylobacter jejuni colonization of poultry via vaccination. PLoS One. 2014;9(12):e114254. doi:10.1371/journal.pone.0114254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0114254</ArticleId>
            <ArticleId IdType="pmc">PMC4256221</ArticleId>
            <ArticleId IdType="pubmed">25474206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nothaft H, Perez-Munoz ME, Gouveia GJ, Duar RM, Wanford JJ, Lango-Scholey L, Panagos CG, Srithayakumar V, Plastow GS, Coros C, et al. Co-administration of the Campylobacter jejuni N-glycan based vaccine with probiotics improves vaccine performance in broiler chickens. Appl Environ Microbiol. 2017. doi:10.1128/AEM.01523-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.01523-17</ArticleId>
            <ArticleId IdType="pmc">PMC5691412</ArticleId>
            <ArticleId IdType="pubmed">28939610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korlath JA, Osterholm MT, Judy LA, Forfang JC, Robinson RA. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. JInfectDis. 1985;152(3):592&#x2013;596. doi:10.1093/infdis/152.3.592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/152.3.592</ArticleId>
            <ArticleId IdType="pubmed">4031557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baqar S, Applebee LA, Bourgeois AL. Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice. InfectImmun. 1995;63(9):3731&#x2013;3735.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC173521</ArticleId>
            <ArticleId IdType="pubmed">7642317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baqar S, Bourgeois AL, Schultheiss PJ, Walker RI, Rollins DM, Haberberger RL, Pavlovskis OR. Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates. Vaccine. 1995;13(1):22&#x2013;28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7539199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>David R, Tribble SB, Thompson SA. Development of a Human Vaccine In: editor. Campylobacter. Irving Nachamkin CMSaMJB. 3rd Washington D.C.: ASM press; 2008. p. 429.</Citation>
        </Reference>
        <Reference>
          <Citation>Burr DH, Rollins D, Lee LH, Pattarini DL, Walz SS, Tian JH, Pace JL, Bourgeois AL, Walker RI. Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine. Vaccine. 2005;23(34):4315&#x2013;4321. doi:10.1016/j.vaccine.2005.03.038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2005.03.038</ArticleId>
            <ArticleId IdType="pubmed">16005742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee LH, Burg E, Baqar S, Bourgeois AL, Burr DH, Ewing CP, Trust TJ, Guerry P.&#xA0;Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni. InfectImmun. 1999;67(11):5799&#x2013;5805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC96957</ArticleId>
            <ArticleId IdType="pubmed">10531231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blaser MJ, Duncan DJ. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. InfectImmun. 1984;44(2):292&#x2013;298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC263516</ArticleId>
            <ArticleId IdType="pubmed">6715034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schrotz-King P, Prokhorova TA, Nielsen PN, Crawford JS, Morsczeck C. Campylobacter jejuni proteomics for new travellers&#x2019; diarrhoea vaccines. TravelMedInfectDis. 2007;5(2):106&#x2013;109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17298916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poly F, Read TD, Chen YH, Monteiro MA, Serichantalergs O, Pootong P, Bodhidatta L, Mason CJ, Rockabrand D, Baqar S, et al. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies. Infect Immun. 2008;76(12):5655&#x2013;5667. doi:10.1128/IAI.00780-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00780-08</ArticleId>
            <ArticleId IdType="pmc">PMC2583572</ArticleId>
            <ArticleId IdType="pubmed">18809665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rijkers GT, Sanders EA, Breukels MA, Zegers BJ. Infant B cell responses to polysaccharide determinants. Vaccine. 1998;16(14&#x2013;15):1396&#x2013;1400.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9711778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lesinski GB, Westerink MA. Novel vaccine strategies to T-independent antigens. J Microbiol Methods. 2001;47(2):135&#x2013;149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11576678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aspinall GO, McDonald AG, Pang H. Structures of the O chains from lipopolysaccharides of Campylobacter jejuni serotypes O:23 and O:36. Carbohydr Res. 1992;231:13&#x2013;30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1394309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlyshev AV, Champion OL, Churcher C, Brisson JR, Jarrell HC, Gilbert M, Brochu D, St Michael F, Li J, Wakarchuk WW, et al. Analysis of Campylobacter jejuni capsular loci reveals multiple mechanisms for the generation of structural diversity and the ability to form complex heptoses. Mol Microbiol. 2005;55(1):90&#x2013;103. doi:10.1111/j.1365-2958.2004.04374.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2004.04374.x</ArticleId>
            <ArticleId IdType="pubmed">15612919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monteiro MA, Baqar S, Hall ER, Chen YH, Porter CK, Bentzel DE, Applebee L, Guerry P. Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni. InfectImmun. 2009;77(3):1128&#x2013;1136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2643618</ArticleId>
            <ArticleId IdType="pubmed">19114545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rimmer JE, Harro C, Sack DA, Talaat KR, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Poly F, Maue AC, et al. Rifaximin fails to prevent campylobacteriosis in the human challenge model: A randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2018;66(9):1435&#x2013;1441. doi:10.1093/cid/cix1014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix1014</ArticleId>
            <ArticleId IdType="pubmed">29145631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirkpatrick BD, Lyon CE, Porter CK, Maue AC, Guerry P, Pierce KK, Carmolli MP, Riddle MS, Larsson CJ, Hawk D, et al. Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model. Clin Infect Dis. 2013;57(8):1106&#x2013;1113. doi:10.1093/cid/cit454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cit454</ArticleId>
            <ArticleId IdType="pmc">PMC3888245</ArticleId>
            <ArticleId IdType="pubmed">23840001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tribble DR, Baqar S, Carmolli MP, Porter C, Pierce KK, Sadigh K, Guerry P, Larsson CJ, Rockabrand D, Ventone CH, et al. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clin Infect Dis. 2009;49(10):1512&#x2013;1519. doi:10.1086/644622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/644622</ArticleId>
            <ArticleId IdType="pubmed">19842970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindow JC, Poly F, Tribble DR, Guerry P, Carmolli MP, Baqar S, Porter CK, Pierce KK, Darsley MJ, Sadigh KS, et al. Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infection. J Clin Microbiol. 2010;48(8):3012&#x2013;3015. doi:10.1128/JCM.00768-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00768-10</ArticleId>
            <ArticleId IdType="pmc">PMC2916616</ArticleId>
            <ArticleId IdType="pubmed">20554818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baqar S, Tribble DR, Carmolli M, Sadigh K, Poly F, Porter C, Larsson CJ, Pierce KK, Guerry P, Campylobacter Study Team, et al. Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism. ClinVaccine Immunol. 2010;17(1):80&#x2013;86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2812103</ArticleId>
            <ArticleId IdType="pubmed">19923572</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30252094</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1930-613X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>184</Volume>
            <Issue>1-2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Military medicine</Title>
          <ISOAbbreviation>Mil Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Formal Training for Ethical Dilemmas in Global Health.</ArticleTitle>
        <Pagination>
          <StartPage>8</StartPage>
          <EndPage>10</EndPage>
          <MedlinePgn>8-10</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/milmed/usy246</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Berkley</LastName>
            <ForeName>Holly</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, Naval Medical Center, 345120 Bob Wilson Drive, San Diego, CA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zitzman</LastName>
            <ForeName>Elena</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>USU-Walter Reed Department of Surgery, Uniformed Services University, 4301 Jones Bridge Road, Bethesda, MD.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jindal</LastName>
            <ForeName>Rahul M</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>USU-Walter Reed Department of Surgery, Uniformed Services University, 4301 Jones Bridge Road, Bethesda, MD.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Mil Med</MedlineTA>
        <NlmUniqueID>2984771R</NlmUniqueID>
        <ISSNLinking>0026-4075</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004992" MajorTopicYN="N">Ethics, Medical</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D028681" MajorTopicYN="Y">Moral Obligations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013663" MajorTopicYN="N">Teaching</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30252094</ArticleId>
        <ArticleId IdType="doi">10.1093/milmed/usy246</ArticleId>
        <ArticleId IdType="pii">5106700</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30251443</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-1166</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>34</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of geriatric psychiatry</Title>
          <ISOAbbreviation>Int J Geriatr Psychiatry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Understanding the quality of life of family carers of people with dementia: Development of a new conceptual framework.</ArticleTitle>
        <Pagination>
          <StartPage>79</StartPage>
          <EndPage>86</EndPage>
          <MedlinePgn>79-86</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/gps.4990</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Dementia is a major global health and social care challenge, and family carers are a vital determinant of positive outcomes for people with dementia. This study's aim was to develop a conceptual framework for the Quality of Life (QOL) of family carers of people with dementia.</AbstractText>
          <AbstractText Label="METHODS">We studied family carers of people with dementia and staff working in dementia services iteratively using in-depth individual qualitative interviews and focus groups discussions. Analysis used constant comparison techniques underpinned by a collaborative approach with a study-specific advisory group of family carers.</AbstractText>
          <AbstractText Label="RESULTS">We completed 41 individual interviews with 32 family carers and nine staff and two focus groups with six family carers and five staff. From the analysis, we identified 12 themes that influenced carer QOL. These were organised into three categories focussing on person with dementia, carer, and external environment.</AbstractText>
          <AbstractText Label="CONCLUSIONS">For carers of people with dementia, the QOL construct was found to include condition-specific domains which are not routinely considered in generic assessment of QOL. This has implications for researchers, policy makers, and service providers in addressing and measuring QOL in family carers of people with dementia.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 The Authors. International Journal of Geriatric Psychiatry Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Daley</LastName>
            <ForeName>Stephanie</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-5842-0492</Identifier>
            <AffiliationInfo>
              <Affiliation>Centre for Dementia Studies, Brighton and Sussex Medical School and Sussex Partnership NHS Foundation Trust, Brighton, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murray</LastName>
            <ForeName>Joanna</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Health Services and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, Kings' College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Farina</LastName>
            <ForeName>Nicolas</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-0635-2547</Identifier>
            <AffiliationInfo>
              <Affiliation>Centre for Dementia Studies, Brighton and Sussex Medical School and Sussex Partnership NHS Foundation Trust, Brighton, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Page</LastName>
            <ForeName>Thomas E</ForeName>
            <Initials>TE</Initials>
            <AffiliationInfo>
              <Affiliation>School of Psychology, University of Kent, Canterbury, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brown</LastName>
            <ForeName>Anna</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>School of Psychology, University of Kent, Canterbury, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Basset</LastName>
            <ForeName>Thurstine</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Lived Experience Advisory Panel, Sussex Partnership NHS Foundation Trust, Brighton, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Livingston</LastName>
            <ForeName>Gill</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Psychiatry, University College London, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bowling</LastName>
            <ForeName>Ann</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Health Sciences, University of Southampton, Southampton, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Knapp</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Social Policy, London School of Economics, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Banerjee</LastName>
            <ForeName>Sube</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Dementia Studies, Brighton and Sussex Medical School and Sussex Partnership NHS Foundation Trust, Brighton, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Geriatr Psychiatry</MedlineTA>
        <NlmUniqueID>8710629</NlmUniqueID>
        <ISSNLinking>0885-6230</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Alzheimer's disease (AD)</Keyword>
        <Keyword MajorTopicYN="N">Quality of Life (QOL)</Keyword>
        <Keyword MajorTopicYN="N">carers</Keyword>
        <Keyword MajorTopicYN="N">dementia</Keyword>
        <Keyword MajorTopicYN="N">family carers</Keyword>
        <Keyword MajorTopicYN="N">informal carers</Keyword>
      </KeywordList>
      <CoiStatement>None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>20</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30251443</ArticleId>
        <ArticleId IdType="pmc">PMC6586036</ArticleId>
        <ArticleId IdType="doi">10.1002/gps.4990</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Wimo A, J&#xF6;nsson L, Bond J, et al. The worldwide economic impact of dementia 2010. Alzheimers Dement. 2013;9:1, e13&#x2010;11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23305821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chari AV, Engberg J, Ray KN, Mehrotra A. The opportunity costs of informal elder&#x2010;care in the United States: new estimates from the American time use survey. Health Serv Res. 2015;50(3):871&#x2010;882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4450934</ArticleId>
            <ArticleId IdType="pubmed">25294306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knapp M, Chua K&#x2010;C, Broadbent M, et al. Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register. BMJ Open. 2016;6(11):e013591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5128896</ArticleId>
            <ArticleId IdType="pubmed">27864252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banerjee S, Murray J, Foley B, Atkins L, Schneider J, Mann A. Predictors of institutionalisation in people with dementia. J Neurol Neurosurg Psychiatry. 2003;74(9):1315&#x2010;1316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1738636</ArticleId>
            <ArticleId IdType="pubmed">12933944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alzheimers Society . Dementia 2012: A National Challenge. London: Alzheimers Soceity; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Mo&#xEF;se P, Schwarzinger M, Um M. Dementia Care in 9 OECD Countries. OECD Publishing; 2004.</Citation>
        </Reference>
        <Reference>
          <Citation>Farina N, Page T, Daley S, et al. Factors associated with carer quality of life of people with dementia: a systematic review. Alzheimers Dement. 2017;13(5):572&#x2010;581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28167069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones C, Edwards RT, Hounsome B. Qualitative exploration of the suitability of capability based instruments to measure quality of life in family carers of people with dementia. ISRN Fam Med. 2014;2014:919613&#x2010;919613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4041269</ArticleId>
            <ArticleId IdType="pubmed">24967332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vellone E, Piras G, Talucci C, Cohen MZ. Quality of life for caregivers of people with Alzheimer's disease. J Adv Nurs. 2008;61(2):222&#x2010;231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18186913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vellone E, Piras G, Venturini G, Alvaro R, Cohen MZ. Quality of life for caregivers of people with Alzheimer's disease living in Sardinia, Italy. J Transcult Nurs. 2012;23(1):46&#x2010;55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21807960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manthorpe J, Bowling A. Quality of life measures for carers for people with dementia: measurement issues, gaps in research and promising paths. Res Policy Plann. 2016;31:163&#x2010;178.</Citation>
        </Reference>
        <Reference>
          <Citation>Page T, Farina N, Brown A, et al. Instruments measuring the disease&#x2010;specific quality of life of family carers of people with neurodegenerative diseases: a systematic review. BMJ Open. 2017;7(3):e013611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5372121</ArticleId>
            <ArticleId IdType="pubmed">28360239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pearlin LI, Mullan JT, Semple SJ, Skaff MM. Caregiving and the stress process: an overview of concepts and their measures. Gerontologist. 1990;30(5):583&#x2010;594.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2276631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glaser B, Strauss A. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago: Aldine; 1967.</Citation>
        </Reference>
        <Reference>
          <Citation>Farina N, Page TE, Daley S, et al. Factors associated with the quality of life of family carers of people with dementia: A systematic review. Alzheimer's &amp; Dementia. 2017;13(5):572&#x2010;581. http://dx.doi.org/10.1016/j.jalz.2016.12.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28167069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fauth E, Hess K, Piercy K, et al. Caregivers' relationship closeness with the person with dementia predicts both positive and negative outcomes for caregivers' physical health and psychological well&#x2010;being. Aging Ment Health. 2012;16(6):699&#x2010;711.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3430821</ArticleId>
            <ArticleId IdType="pubmed">22548375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bell CM, Araki SS, Neumann PJ. The association between caregiver burden and caregiver health&#x2010;related quality of life in Alzheimer disease. Alzheimer Dis Assoc Disord. 2001;15(3):129&#x2010;136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11522930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papastavrou E, Andreou P, Middleton N, Papacostas S, Georgiou IK. Factors associated with quality of life among family members of patients with dementia in Cyprus. Int Psychogeriatr. 2014;26(03):443&#x2010;452.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24308651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perrin PB, Morgan M, Aretouli E, et al. Connecting health&#x2010;related quality of life and mental health in dementia caregivers from Colombia, South America. J Alzheimers Dis. 2014;39(3):499&#x2010;509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24240638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruce DG, Paley GA, Nichols P, Roberts D, Underwood PJ, Schaper F. Physical disability contributes to caregiver stress in dementia caregivers. J Gerontol A Biol Sci Med Sci. 2005;60(3):345&#x2010;349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15860472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruvik FK, Ulstein ID, Ranhoff AH, Engedal K. The quality of life of people with dementia and their family carers. Dement Geriatr Cogn Disord. 2012;34(1):7&#x2010;14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22854507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLennon SM, Habermann B, Rice M. Finding meaning as a mediator of burden on the health of caregivers of spouses with dementia. Aging Ment Health. 2011;15(4):522&#x2010;530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21500019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coen RF, O'Boyle CA, Coakley D, Lawlor BA. Dementia carer education and patient behaviour disturbance. Int J Geriatr Psychiatry. 1999;14(4):302&#x2010;306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10340192</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30247787</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-1166</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>34</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of geriatric psychiatry</Title>
          <ISOAbbreviation>Int J Geriatr Psychiatry</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Current approaches to dementia screening and case finding in low- and middle-income countries: Research update and recommendations.</ArticleTitle>
        <Pagination>
          <StartPage>3</StartPage>
          <EndPage>7</EndPage>
          <MedlinePgn>3-7</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/gps.4969</ELocationID>
        <Abstract>
          <AbstractText>Approximately 47 million people have dementia worldwide, with this figure, it is expected to almost triple by 2050. Most people with dementia (approximately two-thirds) live in low- and middle-income countries (LMICs). This presents a significant challenge for such countries that often have limited financial resources and less well-developed health and social care systems. In the absence of a cure, reducing the future costs of dementia care and burden of disease may be best achieved by a greater emphasis on (1) more timely diagnosis with earlier intervention to maintain functional independence and (2) undertaking "screening" in groups at high risk of developing dementia, case finding, and using brief cognitive assessment instruments. In clinical settings, a wide range of instruments for dementia screening and diagnosis are currently available; however, few cognitive assessment tools have been developed specifically for clinical use within LMIC settings. Screening for dementia and cognitive impairment in LMICs largely relies on tools adapted from high-income countries (HICs); these often lack validation in these settings leading to education, literacy, and cultural biases. Research is urgently needed to develop cognitive assessment tools and dementia diagnostic approaches that are appropriate and feasible for clinical use in LMIC settings.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Magklara</LastName>
            <ForeName>Eleni</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0002-1900-7144</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Health &amp; Society, Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stephan</LastName>
            <ForeName>Blossom C M</ForeName>
            <Initials>BCM</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Health &amp; Society, Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Newcastle Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Robinson</LastName>
            <ForeName>Louise</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0003-0209-2503</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute of Health &amp; Society, Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Newcastle Institute for Ageing, Newcastle University, Newcastle upon Tyne, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>16/137/62</GrantID>
            <Agency>Department of Health</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Geriatr Psychiatry</MedlineTA>
        <NlmUniqueID>8710629</NlmUniqueID>
        <ISSNLinking>0885-6230</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cognitive assessment</Keyword>
        <Keyword MajorTopicYN="N">dementia</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">low- and middle-income countries</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30247787</ArticleId>
        <ArticleId IdType="doi">10.1002/gps.4969</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30246676</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>12</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1475-2727</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Public health nutrition</Title>
          <ISOAbbreviation>Public Health Nutr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Co-morbid anaemia and stunting among children of pre-school age in low- and middle-income countries: a syndemic.</ArticleTitle>
        <Pagination>
          <StartPage>35</StartPage>
          <EndPage>43</EndPage>
          <MedlinePgn>35-43</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1017/S136898001800232X</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">To determine the prevalence of co-morbidity of two important global health challenges, anaemia and stunting, among children aged 6-59 months in low- and middle-income countries.</AbstractText>
          <AbstractText Label="DESIGN">Secondary analysis of data from Demographic and Health Surveys (DHS) conducted 2005-2015. Child stunting and anaemia were defined using current WHO classifications. Sociodemographic characteristics of children with anaemia, stunting and co-morbidity of these conditions were compared with those of 'healthy' children in the sample (children who were not stunted and not anaemic) using multiple logistic models.</AbstractText>
          <AbstractText Label="SETTING">Low- and middle-income countries.</AbstractText>
          <AbstractText Label="SUBJECTS">Children aged 6-59 months.</AbstractText>
          <AbstractText Label="RESULTS">Data from 193 065 children from forty-three countries were included. The pooled proportion of co-morbid anaemia and stunting was 21&#xB7;5 (95 % CI 21&#xB7;2, 21&#xB7;9) %, ranging from the lowest in Albania (2&#xB7;6 %; 95 % CI 1&#xB7;8, 3&#xB7;7 %) to the highest in Yemen (43&#xB7;3; 95 % CI 40&#xB7;6, 46&#xB7;1 %). Compared with the healthy group, children with co-morbidity were more likely to be living in rural areas, have mothers or main carers with lower educational levels and to live in poorer households. Inequality in children who had both anaemia and stunting was apparent in all countries.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Co-morbid anaemia and stunting among young children is highly prevalent in low- and middle-income countries, especially among more disadvantaged children. It is suggested that they be considered under a syndemic framework, the Childhood Anaemia and Stunting (CHAS) Syndemic, which acknowledges the interacting nature of these diseases and the social and environmental factors that promote their negative interaction.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tran</LastName>
            <ForeName>Thach Duc</ForeName>
            <Initials>TD</Initials>
            <AffiliationInfo>
              <Affiliation>Jean Hailes Research Unit, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC3004, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Biggs</LastName>
            <ForeName>Beverley-Ann</ForeName>
            <Initials>BA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine (Royal Melbourne Hospital) at the Doherty Institute, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Holton</LastName>
            <ForeName>Sara</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Jean Hailes Research Unit, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC3004, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nguyen</LastName>
            <ForeName>Hau Thi Minh</ForeName>
            <Initials>HTM</Initials>
            <AffiliationInfo>
              <Affiliation>Jean Hailes Research Unit, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC3004, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hanieh</LastName>
            <ForeName>Sarah</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine (Royal Melbourne Hospital) at the Doherty Institute, The University of Melbourne, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fisher</LastName>
            <ForeName>Jane</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Jean Hailes Research Unit, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC3004, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Public Health Nutr</MedlineTA>
        <NlmUniqueID>9808463</NlmUniqueID>
        <ISSNLinking>1368-9800</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006130" MajorTopicYN="N">Growth Disorders</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007182" MajorTopicYN="N">Income</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anaemia</Keyword>
        <Keyword MajorTopicYN="N">Child</Keyword>
        <Keyword MajorTopicYN="N">Low- and middle-income countries</Keyword>
        <Keyword MajorTopicYN="N">Stunting</Keyword>
        <Keyword MajorTopicYN="N">Syndemic</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>24</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30246676</ArticleId>
        <ArticleId IdType="pmc">PMC10260636</ArticleId>
        <ArticleId IdType="doi">10.1017/S136898001800232X</ArticleId>
        <ArticleId IdType="pii">S136898001800232X</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Black RE, Allen LH, Bhutta ZA et al.. (2008) Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 371, 243&#x2013;260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18207566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balarajan Y, Ramakrishnan U, Ozaltin E et al.. (2011) Anaemia in low-income and middle-income countries. Lancet 378, 2123&#x2013;2135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21813172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dewey KG &amp; Begum K (2011) Long-term consequences of stunting in early life. Matern Child Nutr 7, Suppl. 3, 5&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6860846</ArticleId>
            <ArticleId IdType="pubmed">21929633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singer M (2000) A dose of drugs, a touch of violence, a case of AIDS: conceptualizing the SAVA syndemic. Free Inq Creat Sociol 28, 13&#x2013;24.</Citation>
        </Reference>
        <Reference>
          <Citation>Singer M, Bulled N, Ostrach B et al.. (2017) Syndemics and the biosocial conception of health. Lancet 389, 941&#x2013;950.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28271845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Victora CG, Adair L, Fall C et al.. (2008) Maternal and child undernutrition: consequences for adult health and human capital. Lancet 371, 340&#x2013;357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2258311</ArticleId>
            <ArticleId IdType="pubmed">18206223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grantham-McGregor S &amp; Ani C (2001) A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 131, 2S-2, 649S&#x2013;666S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11160596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haas JD &amp; Brownlie T 4th (2001) Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 131, 2S-2, 676S&#x2013;688S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11160598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corsi DJ, Neuman M, Finlay JE et al.. (2012) Demographic and health surveys: a profile. Int J Epidemiol 41, 1602&#x2013;1613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23148108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization, UNICEF &amp; United Nations University (2001) Iron Deficiency Anaemia, Assessment, Prevention and Control: A Guide for Programme Managers. Geneva: WHO.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization (2010) WHO Anthro for Personal Computers, Version 3.1, 2010: Software for Assessing Growth and Development of the World&#x2019;s Children. Geneva: WHO.</Citation>
        </Reference>
        <Reference>
          <Citation>O&#x2019;Donnell O, Doorslaer EV, Wagstaff A et al.. (2008) Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation . Washington, DC: The World Bank.</Citation>
        </Reference>
        <Reference>
          <Citation>World Bank (2016) World Development Report 2016: Digital Dividends. Washington, DC: World Bank Publications.</Citation>
        </Reference>
        <Reference>
          <Citation>Stata Corp (2015) Stata Survey Data Reference Manual: Release 14. College Station, TX: StataCorp LP.</Citation>
        </Reference>
        <Reference>
          <Citation>Stevens GA, Finucane MM, De-Regil LM et al.. (2013) Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995&#x2013;2011: a systematic analysis of population-representative data. Lancet Glob Health 1, e16&#x2013;e25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4547326</ArticleId>
            <ArticleId IdType="pubmed">25103581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Onis M, Blossner M &amp; Borghi E (2012) Prevalence and trends of stunting among pre-school children, 1990&#x2013;2020. Public Health Nutr 15, 142&#x2013;148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21752311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van de Poel E, Hosseinpoor AR, Speybroeck N et al.. (2008) Socioeconomic inequality in malnutrition in developing countries. Bull World Health Organ 86, 282&#x2013;291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2647414</ArticleId>
            <ArticleId IdType="pubmed">18438517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tran TD, Hetzel B &amp; Fisher J (2016) Access to iodized salt in 11 low- and lower-middle-income countries: 2000 and 2010. Bull World Health Organ 94, 122&#x2013;129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4750437</ArticleId>
            <ArticleId IdType="pubmed">26908961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tran TD, Luchters S &amp; Fisher J (2017) Early childhood development: impact of national human development, family poverty, parenting practices and access to early childhood education. Child Care Health Dev 43, 415&#x2013;426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27535624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Powe CE, Knott CD &amp; Conklin-Brittain N (2010) Infant sex predicts breast milk energy content. Am J Hum Biol 22, 50&#x2013;54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19533619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obermann-Borst SA, Eilers PH, Tobi EW et al.. (2013) Duration of breastfeeding and gender are associated with methylation of the LEPTIN gene in very young children. Pediatr Res 74, 344&#x2013;349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23884163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mosha T, Laswai H &amp; Dakiyo S (1998) Breastfeeding, weaning practices and anthropometric status of children in Morogoro district, Tanzania. Ecol Food Nutr 37, 309&#x2013;338.</Citation>
        </Reference>
        <Reference>
          <Citation>Victora CG, de Onis M, Hallal PC et al.. (2010) Worldwide timing of growth faltering: revisiting implications for interventions. Pediatrics 125, e473&#x2013;e480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20156903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kassebaum NJ, Jasrasaria R, Naghavi M et al.. (2014) A systematic analysis of global anemia burden from 1990 to 2010. Blood 123, 615&#x2013;624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3907750</ArticleId>
            <ArticleId IdType="pubmed">24297872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walker SP, Wachs TD, Grantham-McGregor S et al.. (2011) Inequality in early childhood: risk and protective factors for early child development. Lancet 378, 1325&#x2013;1338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21944375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prendergast AJ &amp; Humphrey JH (2014) The stunting syndrome in developing countries. Paediatr Int Child Health 34, 250&#x2013;265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4232245</ArticleId>
            <ArticleId IdType="pubmed">25310000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanieh S, Ha TT, De Livera AM et al.. (2015) Antenatal and early infant predictors of postnatal growth in rural Vietnam: a prospective cohort study. Arch Dis Child 100, 165&#x2013;173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4316936</ArticleId>
            <ArticleId IdType="pubmed">25246090</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30244014</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1520-6017</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>108</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of pharmaceutical sciences</Title>
          <ISOAbbreviation>J Pharm Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Drug Repurposing for Ebola Virus Disease: Principles of Consideration and the Animal Rule.</ArticleTitle>
        <Pagination>
          <StartPage>798</StartPage>
          <EndPage>806</EndPage>
          <MedlinePgn>798-806</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xphs.2018.09.010</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0022-3549(18)30537-9</ELocationID>
        <Abstract>
          <AbstractText>There are no approved drugs or biologics to treat Ebola virus disease (EVD). Literature reviews identified a list of 141 drugs with reports of preliminary in&#xA0;vitro potency and in&#xA0;vivo effectiveness in animals or with reports of clinical use/trials in EVD patients. The majority of these drugs have been individually approved by the U.S. Food and Drug Administration for treating various non-EVD diseases. The anti-Ebola potency data of these drugs were curated from literature and publicly accessible databases, along with their individual biopharmaceutical and pharmacokinetic characteristics. To facilitate the development of antiviral drugs including anti-EVD drugs, highlights include optimization of the exposure-response relationship, design of a safe and effective clinical dosing regimen to achieve an adequate high ratio of clinical C<sub>min</sub> to a plasma protein binding-adjusted EC<sub>95</sub>, and the pharmacokinetic studies needed in animal models (healthy and affected) and in healthy volunteers. The exposure/response relationship for human dose selection is summarized, as described in the U.S. Food and Drug Administration "Animal Rule'' guidance when human efficacy studies are not ethical or feasible.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2019 American Pharmacists Association&#xAE;. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bai</LastName>
            <ForeName>Jane P F</ForeName>
            <Initials>JPF</Initials>
            <AffiliationInfo>
              <Affiliation>Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993. Electronic address: jane.bai@fda.hhs.gov.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hsu</LastName>
            <ForeName>Chia-Wen</ForeName>
            <Initials>CW</Initials>
            <AffiliationInfo>
              <Affiliation>Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Pharm Sci</MedlineTA>
        <NlmUniqueID>2985195R</NlmUniqueID>
        <ISSNLinking>0022-3549</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
          <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017277" MajorTopicYN="N">Drug Approval</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019142" MajorTopicYN="N">Hemorrhagic Fever, Ebola</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014486" MajorTopicYN="N">United States Food and Drug Administration</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">anti-infective(s)</Keyword>
        <Keyword MajorTopicYN="N">bioavailability</Keyword>
        <Keyword MajorTopicYN="N">clinical pharmacokinetics</Keyword>
        <Keyword MajorTopicYN="N">dose-response</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">regulatory science</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30244014</ArticleId>
        <ArticleId IdType="doi">10.1016/j.xphs.2018.09.010</ArticleId>
        <ArticleId IdType="pii">S0022-3549(18)30537-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30239798</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1460-2245</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>34</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Health promotion international</Title>
          <ISOAbbreviation>Health Promot Int</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comprehending practitioners' assessments of community-led total sanitation.</ArticleTitle>
        <Pagination>
          <StartPage>e129</StartPage>
          <EndPage>e138</EndPage>
          <MedlinePgn>e129-e138</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/heapro/day070</ELocationID>
        <Abstract>
          <AbstractText>Around 2.3 billion people in developing countries still lack access to improved sanitation facilities and almost one billion practice open defecation (OD). The Community-Led Total Sanitation (CLTS) has recently become a particularly popular approach used in more than 60 countries. CLTS is a behavior-change approach that aims to ignite community action and make OD socially unacceptable without providing any external financial or material support to individual households. CLTS is sometimes perceived as a revolutionary approach that has proven to be highly cost-effective in abolishing OD. However, it has been criticized for its use of unethical practices and questioned with respect to the sustainability of its outcomes and the limited health benefits it can generate. Based on semi-structured interviews with development workers experienced in the implementation of CLTS in 14 different countries, this paper seeks to examine practical views on the issues surrounding this approach. We found that despite acknowledging some of the controversies and the possibly limited sustainability of results, CLTS is generally considered an effective and satisfactory tool for improving sanitation conditions. Practitioners first of all accentuate the normative importance of the elimination of OD attained through CLTS without weighting on (the absence of) evidence on the longer term effects or impacts on health. However, a need for various modifications of CLTS according to local social and natural environments was strongly expressed, including changes that go against the core principles of CLTS like no subsidies and no technical assistance principles.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ficek</LastName>
            <ForeName>Franti&#x161;ek</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Social Geography and Regional Development, Faculty of Science, Charles University, Albertov 6, 128 43 Praha 2, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Novotn&#xFD;</LastName>
            <ForeName>Josef</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Social Geography and Regional Development, Faculty of Science, Charles University, Albertov 6, 128 43 Praha 2, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Health Promot Int</MedlineTA>
        <NlmUniqueID>9008939</NlmUniqueID>
        <ISSNLinking>0957-4824</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003256" MajorTopicYN="N">Community Participation</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003672" MajorTopicYN="Y">Defecation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012499" MajorTopicYN="N">Sanitation</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012922" MajorTopicYN="Y">Social Change</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">community based intervention</Keyword>
        <Keyword MajorTopicYN="N">community health promotion</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">health behaviour</Keyword>
        <Keyword MajorTopicYN="N">sustainable development goals</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30239798</ArticleId>
        <ArticleId IdType="doi">10.1093/heapro/day070</ArticleId>
        <ArticleId IdType="pii">5103433</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30239262</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1538-0254</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>14</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biomolecular structure &amp; dynamics</Title>
          <ISOAbbreviation>J Biomol Struct Dyn</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Inhibitor binding studies of <i>Mycobacterium tuberculosis</i> MraY (Rv21 56c): Insights from molecular modeling, docking, and simulation studies.</ArticleTitle>
        <Pagination>
          <StartPage>3751</StartPage>
          <EndPage>3763</EndPage>
          <MedlinePgn>3751-3763</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07391102.2018.1526715</ELocationID>
        <Abstract>
          <AbstractText>Tuberculosis (TB) is a contagious disease caused by <i>Mycobacterium tuberculosis (M.tb)</i> or tubercule bacillus, and H37Rv is the most studied clinical strain. The recent development of resistance to existing drugs is a global health-care challenge to control and cure TB. Hence, there is a critical need to discover new drug targets in <i>M.tb.</i> The members of peptidoglycan biosynthesis pathway are attractive target proteins for antibacterial drug development. We have performed <i>in silico</i> analysis of <i>M</i>.<i>tb</i> MraY (Rv2156c) integral membrane protein and constructed the three-dimensional (3D) structure model of <i>M</i>.<i>tb</i> MraY based on homology modeling method. The validated model was complexed with antibiotic muraymycin D2 (MD2) and was used to generate structure-based pharmacophore model (e-pharmacophore). High-throughput virtual screening (HTVS) of Asinex database and molecular docking of hits was performed to identify the potential inhibitors based on their mode of interactions with the key residues involved in <i>M</i>.<i>tb</i> MraY-MD2 binding. The validation of these molecules was performed using molecular dynamics (MD) simulations for two best identified hit molecules complexed with <i>M</i>.<i>tb</i> MraY in the lipid bilayer, dipalmitoylphosphatidyl-choline (DPPC) membrane. The results indicated the stability of the complexes formed and retained non-bonding interactions similar to MD2. These findings may help in the design of new inhibitors to <i>M</i>.<i>tb</i> MraY involved in peptidoglycan biosynthesis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mallavarapu</LastName>
            <ForeName>Bala Divya</ForeName>
            <Initials>BD</Initials>
            <AffiliationInfo>
              <Affiliation>a School of Chemistry , University of Hyderabad , Hyderabad , India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdullah</LastName>
            <ForeName>Maaged</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>a School of Chemistry , University of Hyderabad , Hyderabad , India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saxena</LastName>
            <ForeName>Shalini</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>a School of Chemistry , University of Hyderabad , Hyderabad , India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guruprasad</LastName>
            <ForeName>Lalitha</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>a School of Chemistry , University of Hyderabad , Hyderabad , India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Biomol Struct Dyn</MedlineTA>
        <NlmUniqueID>8404176</NlmUniqueID>
        <ISSNLinking>0739-1102</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008051">Lipid Bilayers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>2644-64-6</RegistryNumber>
          <NameOfSubstance UI="D015060">1,2-Dipalmitoylphosphatidylcholine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015060" MajorTopicYN="N">1,2-Dipalmitoylphosphatidylcholine</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008051" MajorTopicYN="N">Lipid Bilayers</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062105" MajorTopicYN="Y">Molecular Docking Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056004" MajorTopicYN="Y">Molecular Dynamics Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013816" MajorTopicYN="N">Thermodynamics</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Integral membrane protein MraY</Keyword>
        <Keyword MajorTopicYN="N">e-pharmacophore-based virtual screening</Keyword>
        <Keyword MajorTopicYN="N">lipid bilayer</Keyword>
        <Keyword MajorTopicYN="N">molecular dynamics simulations</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30239262</ArticleId>
        <ArticleId IdType="doi">10.1080/07391102.2018.1526715</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30238696</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1099-0801</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>33</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Biomedical chromatography : BMC</Title>
          <ISOAbbreviation>Biomed Chromatogr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Bioanalytical method development and validation of moxidectin in plasma by LC-MS/MS: Application to in vitro metabolism.</ArticleTitle>
        <Pagination>
          <StartPage>e4389</StartPage>
          <MedlinePgn>e4389</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/bmc.4389</ELocationID>
        <Abstract>
          <AbstractText>Moxidectin (MOX) has recently been approved by the US Food and Drug Administration for the treatment of river blindness in select populations. It is also being evaluated as an alternative for the use of ivermectin, widespread resistance to which is becoming a global health issue. Moreover, MOX is becoming increasingly used as a prophylactic antiparasitic in the cattle industry. In this study, we developed and validated an LC-MS/MS method of MOX in human, monkey and mouse plasma. The separation was achieved on an ACE C<sub>18</sub> (50&#x2009;&#xD7; 3.0&#x2009;mm, 3&#x2009;&#x3BC;m) column with isocratic elution using 0.1% acetic acid and methanol-acetonitrile (1:1, v/v) as mobile phase. MOX was quantitated using MS/MS with an electrospray ionization source operating in negative multiple reaction monitoring mode. The multiple reaction monitoring precursor ion &#x2192; product ion transitions for MOX and abamectin (IS) were m/z 638.40&#xA0;&#x2192;&#xA0;236.30 and m/z 871.50&#xA0;&#x2192;&#xA0;565.35 respectively. The MS/MS response was linear over the concentration range 0.1-1000&#x2009;ng/mL in plasma with a correlation coefficient (r<sup>2</sup> ) of 0.997 or better. The within- and between-day precision (relative standard deviation, RSD) and accuracy were within the acceptable limits per US Food and Drug Administration guidelines. The method was successfully applied to an in vitro metabolic stability study of MOX.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chhonker</LastName>
            <ForeName>Yashpal S</ForeName>
            <Initials>YS</Initials>
            <Identifier Source="ORCID">0000-0001-6455-5388</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sleightholm</LastName>
            <ForeName>Richard L</ForeName>
            <Initials>RL</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murry</LastName>
            <ForeName>Daryl J</ForeName>
            <Initials>DJ</Initials>
            <Identifier Source="ORCID">0000-0002-4169-5027</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 CA036727 and F31 CA224942-01A1</GrantID>
            <Agency>Fred &amp; Pamela Buffett Cancer Center Support Grant from the National Cancer Institute</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Biomed Chromatogr</MedlineTA>
        <NlmUniqueID>8610241</NlmUniqueID>
        <ISSNLinking>0269-3879</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018942">Macrolides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>NGU5H31YO9</RegistryNumber>
          <NameOfSubstance UI="C027837">moxidectin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004355" MajorTopicYN="N">Drug Stability</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000882" MajorTopicYN="N">Haplorhini</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057230" MajorTopicYN="N">Limit of Detection</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018942" MajorTopicYN="N">Macrolides</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">LC-MS/MS</Keyword>
        <Keyword MajorTopicYN="N">in-vitro metabolism</Keyword>
        <Keyword MajorTopicYN="N">moxidectin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30238696</ArticleId>
        <ArticleId IdType="doi">10.1002/bmc.4389</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30230960</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1545-4304</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>59</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Annual review of pharmacology and toxicology</Title>
          <ISOAbbreviation>Annu Rev Pharmacol Toxicol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Novel Clinical Toxicology and Pharmacology of Organophosphorus Insecticide Self-Poisoning.</ArticleTitle>
        <Pagination>
          <StartPage>341</StartPage>
          <EndPage>360</EndPage>
          <MedlinePgn>341-360</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1146/annurev-pharmtox-010818-021842</ELocationID>
        <Abstract>
          <AbstractText>Organophosphorus insecticide self-poisoning is a major global health problem, killing over 100,000 people annually. It is a complex multi-organ condition, involving the inhibition of cholinesterases, and perhaps other enzymes, and the effects of large doses of ingested solvents. Variability between organophosphorus insecticides-in lipophilicity, speed of activation, speed and potency of acetylcholinesterase inhibition, and in the chemical groups attached to the phosphorus-results in variable speed of poisoning onset, severity, clinical toxidrome, and case fatality. Current treatment is modestly effective, aiming only to reactivate acetylcholinesterase and counter the effects of excess acetylcholine at muscarinic receptors. Rapid titration of atropine during resuscitation is lifesaving and can be performed in the absence of oxygen. The role of oximes in therapy remains unclear. Novel antidotes have been tested in small trials, but the great variability in poisoning makes interpretation of such trials difficult. More effort is required to test treatments in adequately powered studies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Eddleston</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Pharmacology, Toxicology, and Therapeutics Unit, Centre for Cardiovascular Science, and Centre for Pesticide Suicide Prevention, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom; email: m.eddleston@ed.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MR/M024075/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Annu Rev Pharmacol Toxicol</MedlineTA>
        <NlmUniqueID>7607088</NlmUniqueID>
        <ISSNLinking>0362-1642</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000931">Antidotes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007306">Insecticides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009943">Organophosphorus Compounds</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000931" MajorTopicYN="N">Antidotes</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007306" MajorTopicYN="N">Insecticides</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062025" MajorTopicYN="N">Organophosphate Poisoning</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009943" MajorTopicYN="N">Organophosphorus Compounds</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">highly hazardous pesticides</Keyword>
        <Keyword MajorTopicYN="N">insecticide</Keyword>
        <Keyword MajorTopicYN="N">organophosphate</Keyword>
        <Keyword MajorTopicYN="N">suicide</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30230960</ArticleId>
        <ArticleId IdType="doi">10.1146/annurev-pharmtox-010818-021842</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30230944</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>10</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>IgY antibodies for the immunoprophylaxis and therapy of respiratory infections.</ArticleTitle>
        <Pagination>
          <StartPage>264</StartPage>
          <EndPage>275</EndPage>
          <MedlinePgn>264-275</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2018.1514224</ELocationID>
        <Abstract>
          <AbstractText>Emergence of drug resistance among the causative organisms for respiratory tract infections represents a critical challenge to the global health care community. Further, although vaccination can prevent disease, vaccine development is impeded by several factors. Therefore, novel approaches to treat and manage respiratory infections are urgently needed. Passive immunization represents a possible alternative to meet this need. Immunoglobulin Y antibodies (IgYs) from the yolk of chicken eggs have previously been used against bacterial and viral infections in human and animals. Their advantages include lack of reaction with mammalian Fc receptors, low production cost, and ease of extraction. Compared to mammalian IgGs, they have higher target specificity and greater binding avidity. They also possess remarkable pathogen-neutralizing activity in the respiratory tract and lungs. In this review, we provide an overview of avian IgYs and describe their potential therapeutic applications for the prevention and treatment of respiratory infections.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abbas</LastName>
            <ForeName>Aymn Talat</ForeName>
            <Initials>AT</Initials>
            <Identifier Source="ORCID">0000-0001-7372-370X</Identifier>
            <AffiliationInfo>
              <Affiliation>a King Fahd Medical Research Center , King Abdulaziz University , Jeddah , Saudi Arabia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Biotechnology Research Laboratories, Gastroeneterology, Surgery Centre , Mansoura University , Mansoura , Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El-Kafrawy</LastName>
            <ForeName>Sherif Aly</ForeName>
            <Initials>SA</Initials>
            <Identifier Source="ORCID">0000-0002-3667-7529</Identifier>
            <AffiliationInfo>
              <Affiliation>c Special Infectious Agents Unit, King Fahd Medical Research Center , King Abdulaziz University , Jeddah , Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sohrab</LastName>
            <ForeName>Sayed Sartaj</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>c Special Infectious Agents Unit, King Fahd Medical Research Center , King Abdulaziz University , Jeddah , Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Azhar</LastName>
            <ForeName>Esam Ibraheem Ahmed</ForeName>
            <Initials>EIA</Initials>
            <AffiliationInfo>
              <Affiliation>c Special Infectious Agents Unit, King Fahd Medical Research Center , King Abdulaziz University , Jeddah , Saudi Arabia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>d Medical Laboratory Technology Department, Faculty of Applied Medical Sciences , King Abdulaziz University , Jeddah , Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C016512">IgY</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004530" MajorTopicYN="N">Egg Yolk</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007116" MajorTopicYN="Y">Immunization, Passive</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007136" MajorTopicYN="N">Immunoglobulins</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065129" MajorTopicYN="Y">Pre-Exposure Prophylaxis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">IgY</Keyword>
        <Keyword MajorTopicYN="N">immunotherapy</Keyword>
        <Keyword MajorTopicYN="N">passive immunization</Keyword>
        <Keyword MajorTopicYN="N">respiratory infection</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>19</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30230944</ArticleId>
        <ArticleId IdType="pmc">PMC6363154</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2018.1514224</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bryce J, Boschi-Pinto C, Shibuya K, Black RE.. WHO estimates of the causes of death in children. Lancet (London, England). 2005;365:1147&#x2013;1152. doi:10.1016/S0140-6736(05)71877-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(05)71877-8</ArticleId>
            <ArticleId IdType="pubmed">15794969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qazi S, Aboubaker S, MacLean R, Fontaine O, Mantel C, Goodman T, Young M, Henderson P, Cherian T. Ending preventable child deaths from pneumonia and diarrhoea by 2025. Development of the integrated global action plan for the prevention and control of pneumonia and diarrhoea. Arch Dis Child. 2015;100(Suppl 1):S23&#x2013;8. doi:10.1136/archdischild-2013-305429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/archdischild-2013-305429</ArticleId>
            <ArticleId IdType="pubmed">25613963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ujunwa F, Ezeonu C. Risk factors for acute respiratory tract infections in under-five children in enugu Southeast Nigeria. Ann Med Health Sci Res. 2014;4:95&#x2013;99. doi:10.4103/2141-9248.126610.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/2141-9248.126610</ArticleId>
            <ArticleId IdType="pmc">PMC3952306</ArticleId>
            <ArticleId IdType="pubmed">24669339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mogayzel PJ Jr., Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann CM, Ratjen F, et al. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann Am Thorac Soc. 2014;11:1640&#x2013;1650. doi:10.1513/AnnalsATS.201404-166OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1513/AnnalsATS.201404-166OC</ArticleId>
            <ArticleId IdType="pubmed">25549030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flume PA, Mogayzel PJ Jr., Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med. 2009;180:802&#x2013;808. doi:10.1164/rccm.200812-1845PP.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.200812-1845PP</ArticleId>
            <ArticleId IdType="pubmed">19729669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367&#x2013;416. doi:10.1164/rccm.200604-571ST.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.200604-571ST</ArticleId>
            <ArticleId IdType="pubmed">17277290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mogayzel PJ Jr., Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187:680&#x2013;689.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23540878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasteur MC, Bilton D, At H. British thoracic Soc B. British thoracic society guideline for non-CF bronchiectasis. Thorax. 2010;65:I1&#x2013;I58. doi:10.1136/thx.2010.136119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thx.2010.136119</ArticleId>
            <ArticleId IdType="pubmed">20627931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCaskill JL, Ressel S, Alber A, Redford J, Power UF, Schwarze J, Dutia BM, Buck AH. Broad-spectrum inhibition of respiratory virus infection by MicroRNA mimics targeting p38 MAPK signaling. Mol Ther Nucl Acids. 2017;7:256&#x2013;266. doi:10.1016/j.omtn.2017.03.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.omtn.2017.03.008</ArticleId>
            <ArticleId IdType="pmc">PMC5415959</ArticleId>
            <ArticleId IdType="pubmed">28624201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corti D, Passini N, Lanzavecchia A, Zambon M. Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome. J Infect Public Health. 2016;9:231&#x2013;235. doi:10.1016/j.jiph.2016.04.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiph.2016.04.003</ArticleId>
            <ArticleId IdType="pmc">PMC7102728</ArticleId>
            <ArticleId IdType="pubmed">27102927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sparrow E, Friede M, Sheikh M, Torvaldsen S. Therapeutic antibodies for infectious diseases. Bull World Health Organ. 2017;95:235&#x2013;237. doi:10.2471/BLT.16.178061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2471/BLT.16.178061</ArticleId>
            <ArticleId IdType="pmc">PMC5328111</ArticleId>
            <ArticleId IdType="pubmed">28250538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev. 2000;13:602&#x2013;614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC88952</ArticleId>
            <ArticleId IdType="pubmed">11023960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graham BS, Ambrosino DM. History of passive antibody administration for prevention and treatment of infectious diseases. Curr Opin HIV AIDS. 2015;10:129&#x2013;134. doi:10.1097/COH.0000000000000154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/COH.0000000000000154</ArticleId>
            <ArticleId IdType="pmc">PMC4437582</ArticleId>
            <ArticleId IdType="pubmed">25760933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelley B. Industrialization of mAb production technology: the bioprocessing industry at a crossroads. mAbs. 2009;1:443&#x2013;452.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2759494</ArticleId>
            <ArticleId IdType="pubmed">20065641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casadevall A, Dadachova E, Pirofski LA. Passive antibody therapy for infectious diseases. Nat Rev Microbiol. 2004;2:695&#x2013;703. doi:10.1038/nrmicro974.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro974</ArticleId>
            <ArticleId IdType="pubmed">15372080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warr GW, Magor KE, Higgins DA. IgY: clues to the origins of modern antibodies. Immunol Today. 1995;16:392&#x2013;398. doi:10.1016/0167-5699(95)80008-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0167-5699(95)80008-5</ArticleId>
            <ArticleId IdType="pubmed">7546196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlander D, Stalberg J, Larsson A. Chicken antibodies: a clinical chemistry perspective. Ups J Med Sci. 1999;104:179&#x2013;189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10680951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomsen K, Christophersen L, Bjarnsholt T, Jensen PO, Moser C, Hoiby N. Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model. J Cyst Fibr. 2016;15:171&#x2013;178. doi:10.1016/j.jcf.2015.08.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcf.2015.08.002</ArticleId>
            <ArticleId IdType="pubmed">26303991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen HH, Tumpey TM, Park HJ, Byun Y-H, Tran LD, Nguyen VD, Kilgore PE, Czerkinsky C, Katz JM, Seong BL, et al. Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS One. 2010;5:e10152. doi:10.1371/journal.pone.0010152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0010152</ArticleId>
            <ArticleId IdType="pmc">PMC2854139</ArticleId>
            <ArticleId IdType="pubmed">20405007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahman S, Van Nguyen S, Icatlo FC Jr., Umeda K, Kodama Y. Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases. Hum Vaccin Immunother. 2013;9:1039&#x2013;1048. doi:10.4161/hv.23383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/hv.23383</ArticleId>
            <ArticleId IdType="pmc">PMC3899138</ArticleId>
            <ArticleId IdType="pubmed">23319156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vega CG, Bok M, Vlasova AN, Chattha KS, Fern&#xE1;ndez FM, Wigdorovitz A, Parre&#xF1;o VG, Saif LJ, Salmon H. IgY antibodies protect against human Rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model. PLoS One. 2012;7:e42788. doi:10.1371/journal.pone.0042788.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0042788</ArticleId>
            <ArticleId IdType="pmc">PMC3411843</ArticleId>
            <ArticleId IdType="pubmed">22880110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torche AM, Le Dimna M, Le Corre P, Mesplede A, Le Gal S, Cariolet R, Le Potier MF. Immune responses after local administration of IgY loaded-PLGA microspheres in gut-associated lymphoid tissue in pigs. Vet Immunol Immunopathol. 2006;109:209&#x2013;217. doi:10.1016/j.vetimm.2005.08.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetimm.2005.08.016</ArticleId>
            <ArticleId IdType="pubmed">16219363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akita E, Jang C, Kitts D, Nakai S. Evaluation of allergenicity of egg yolk immunoglobulin Y and other egg proteins by passive cutaneous anaphylaxis. Food Agric Immunol. 1999;11:191&#x2013;201. doi:10.1080/09540109999861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09540109999861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovacs-Nolan J, Mine Y. Egg yolk antibodies for passive immunity. Annu Rev Food Sci Technol. 2012;3:163&#x2013;182. doi:10.1146/annurev-food-022811-101137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-food-022811-101137</ArticleId>
            <ArticleId IdType="pubmed">22136128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y, Li X, Jin L, Zhen Y, Lu Y, Li S, You J, Wang L. Application of chicken egg yolk immunoglobulins in the control of terrestrial and aquatic animal diseases: a review. Biotechnol Adv. 2011;29:860&#x2013;868. doi:10.1016/j.biotechadv.2011.07.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biotechadv.2011.07.003</ArticleId>
            <ArticleId IdType="pmc">PMC7126572</ArticleId>
            <ArticleId IdType="pubmed">21787857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Calvert RA, Sutton BJ, Dore KA. IgY: a key isotype in antibody evolution. Biol Rev Camb Philos Soc. 2017;92:2144&#x2013;2156. doi:10.1111/brv.12325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/brv.12325</ArticleId>
            <ArticleId IdType="pubmed">28299878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller S, Schubert A, Zajac J, Dyck T, Oelkrug C. IgY antibodies in human nutrition for disease prevention. Nutr J. 2015;14:109. doi:10.1186/s12937-015-0067-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12937-015-0067-3</ArticleId>
            <ArticleId IdType="pmc">PMC4617726</ArticleId>
            <ArticleId IdType="pubmed">26487372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gilgunn S, Millan Martin S, Wormald MR, Zapatero-Rodr&#xED;guez J, Conroy PJ, O&#x2019;Kennedy RJ, Rudd PM, Saldova R, Mondelli MU. Comprehensive N-Glycan profiling of avian immunoglobulin Y. PLoS One. 2016;11:e0159859. doi:10.1371/journal.pone.0159859.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0159859</ArticleId>
            <ArticleId IdType="pmc">PMC4961449</ArticleId>
            <ArticleId IdType="pubmed">27459092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu L. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins. J Pharm Sci. 2015;104:1866&#x2013;1884. doi:10.1002/jps.24444.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jps.24444</ArticleId>
            <ArticleId IdType="pubmed">25872915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casadevall A, Scharff MD. Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis. 1995;21:150&#x2013;161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7197598</ArticleId>
            <ArticleId IdType="pubmed">7578724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baxter D. Active and passive immunity, vaccine types, excipients and licensing. Occup Med (Lond). 2007;57:552&#x2013;556. doi:10.1093/occmed/kqm110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/occmed/kqm110</ArticleId>
            <ArticleId IdType="pubmed">18045976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patterson R, Youngner JS, Weigle WO, Dixon FJ. The metabolism of serum proteins in the hen and chick and secretion of serum proteins by the ovary of the hen. J Gen Physiol. 1962;45:501&#x2013;513.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2195174</ArticleId>
            <ArticleId IdType="pubmed">14484408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rose ME, Orlans E, Buttress N. Immunoglobulin classes in the hen&#x2019;s egg: their segregation in yolk and white. Eur J Immunol. 1974;4:521&#x2013;523. doi:10.1002/eji.1830040715.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/eji.1830040715</ArticleId>
            <ArticleId IdType="pubmed">4213170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamal KR, Burgess SC, Pevzner IY, Erf GF. Maternal antibody transfer from dams to their egg yolks, egg whites, and chicks in meat lines of chickens. Poult Sci. 2006;85:1364&#x2013;1372. doi:10.1093/ps/85.8.1364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ps/85.8.1364</ArticleId>
            <ArticleId IdType="pubmed">16903465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chalghoumi R, Marcq C, Thewis A, Portetelle D, Beckers Y. Effects of feed supplementation with specific hen egg yolk antibody (immunoglobin Y) on Salmonella species cecal colonization and growth performances of challenged broiler chickens. Poult Sci. 2009;88:2081&#x2013;2092. doi:10.3382/ps.2009-00173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3382/ps.2009-00173</ArticleId>
            <ArticleId IdType="pubmed">19762860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gadde U, Rathinam T, Lillehoj HS. Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases&#x2013;A review. Animal Health Res Rev. 2015;16:163&#x2013;176. doi:10.1017/S1466252315000195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1466252315000195</ArticleId>
            <ArticleId IdType="pubmed">26568433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calmette A. The treatment of animals poisoned with snake venom by the injection of antivenomous serum. Br Med J. 1896;2:399&#x2013;400.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2509956</ArticleId>
            <ArticleId IdType="pubmed">20756388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eibl MM. History of immunoglobulin replacement. Immunol Allergy Clin North Am. 2008;28:737&#x2013;64, viii. doi:10.1016/j.iac.2008.06.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.iac.2008.06.004</ArticleId>
            <ArticleId IdType="pubmed">18940572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsu JL, Safdar N. Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases. Infect Dis Clin North Am. 2011;25:773&#x2013;788. doi:10.1016/j.idc.2011.07.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idc.2011.07.005</ArticleId>
            <ArticleId IdType="pubmed">22054755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casadevall A, Dadachova E, Pirofski L. Passive antibody therapy for infectious diseases. Nat Rev Microbiol. 2004;2:695&#x2013;703. doi:10.1038/nrmicro974.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro974</ArticleId>
            <ArticleId IdType="pubmed">15372080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weltzin R, Monath TP. Intranasal antibody prophylaxis for protection against viral disease. Clin Microbiol Rev. 1999;12:383-+.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC100244</ArticleId>
            <ArticleId IdType="pubmed">10398671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klemperer F. Ueber nat&#xFC;rliche Immunit&#xE4;tund ihre Verwerthung f&#xFC;r die immunisirungstherapie. Archiv F&#xFC;r Experimentelle Pathologie Und Pharmakologie. 1893;31:356&#x2013;382.</Citation>
        </Reference>
        <Reference>
          <Citation>Wen JL, Zhao SQ, He DG, Yang YN, Li YM, Zhu SS. Preparation and characterization of egg yolk immunoglobulin Y specific to influenza B virus. Antiviral Res. 2012;93:154&#x2013;159. doi:10.1016/j.antiviral.2011.11.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.antiviral.2011.11.005</ArticleId>
            <ArticleId IdType="pubmed">22127067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallach MG, Webby RJ, Islam F, Walkden-Brown S, Emmoth E, Feinstein R, Gronvik K-O. Cross-protection of chicken immunoglobulin Y antibodies against H5N1 and H1N1 viruses passively administered in mice. Clin Vaccine Immunol. 2011;18:1083&#x2013;1090. doi:10.1128/CVI.05075-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CVI.05075-11</ArticleId>
            <ArticleId IdType="pmc">PMC3147324</ArticleId>
            <ArticleId IdType="pubmed">21613458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schade R, Hlinak A. Egg yolk antibodies, state of the art and future prospects. Altex. 1996;13:5&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11178463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Selvan K, Sentila R, Michael A. Generation and characterization of chicken egg yolk antibodies against propionibacterium acnes for the prevention of acne vulgaris. Indian J Dermatol. 2012;57:15&#x2013;19. doi:10.4103/0019-5154.92669.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0019-5154.92669</ArticleId>
            <ArticleId IdType="pmc">PMC3312649</ArticleId>
            <ArticleId IdType="pubmed">22470202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ibrahim El SM, Rahman AK, Isoda R, Umeda K, Van Sa N, Kodama Y. vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY). Vaccine. 2008;26:2073&#x2013;2080. doi:10.1016/j.vaccine.2008.02.046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2008.02.046</ArticleId>
            <ArticleId IdType="pubmed">18375022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen SV, Icatlo FC Jr., Nakano T, Isogai E, Hirose K, Mizugai H, Kobayashi-Sakamoto M, Isogai H, Chiba I. Anti-cell-associated glucosyltransferase immunoglobulin Y suppression of salivary mutans streptococci in healthy young adults. J Am Dent Assoc. 2011;142:943&#x2013;949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21804061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoyama K, Sugano N, Shimada T, Shofiqur RAKM, Ibrahim E-SM, Isoda R, Umeda K, Sa NV, Kodama Y, Ito K. Effects of egg yolk antibody against Porphyromonas gingivalis gingipains in periodontitis patients. J Oral Sci. 2007;49:201&#x2013;206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17928726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki H, Nomura S, Masaoka T, Goshima H, Kamata N, Kodama Y, Ishii H, Kitajima M, Nomoto K, Hibi T. Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection. Aliment Pharmacol Ther. 2004;20(Suppl 1):185&#x2013;192. doi:10.1111/apt.2004.20.issue-s1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apt.2004.20.issue-s1</ArticleId>
            <ArticleId IdType="pubmed">15298626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong KS, Ki MR, Ullah HMA, Lee E-J, Kim YD, Chung M-J, Elfadl AK, Park J-K, Jeong K-S. Preventive effect of anti-VacA egg yolk immunoglobulin (IgY) on Helicobacter pylori-infected mice. Vaccine. 2018;36:371&#x2013;380. doi:10.1016/j.vaccine.2017.11.082.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2017.11.082</ArticleId>
            <ArticleId IdType="pubmed">29223485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gujral N, Lobenberg R, Suresh M, Sunwoo H. In-vitro and in-vivo binding activity of chicken egg yolk immunoglobulin Y (IgY) against gliadin in food matrix. J Agric Food Chem. 2012;60:3166&#x2013;3172. doi:10.1021/jf205319s.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf205319s</ArticleId>
            <ArticleId IdType="pubmed">22400905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirai K, Arimitsu H, Umeda K, Yokota K, Shen L, Ayada K, Kodama Y, Tsuji T, Hirai Y, Oguma K. Passive oral immunization by egg yolk immunoglobulin (IgY) to Vibrio cholerae effectively prevents cholera. Acta Med Okayama. 2010;64:163&#x2013;170. doi:10.18926/AMO/40008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18926/AMO/40008</ArticleId>
            <ArticleId IdType="pubmed">20596127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahman S, Higo-Moriguchi K, Htun KW, Taniguchi K, Icatlo FC, Tsuji T, Kodama Y, Van Nguyen S, Umeda K, Oo HN, et al. Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients. Vaccine. 2012;30:4661&#x2013;4669. doi:10.1016/j.vaccine.2012.04.091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2012.04.091</ArticleId>
            <ArticleId IdType="pubmed">22575165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirose M, Ando T, Shofiqur R, Umeda K, Kodama Y, Nguyen S, Goto T, Shimada M, Nagaoka S. Anti-obesity activity of hen egg anti-lipase immunoglobulin yolk, a novel pancreatic lipase inhibitor. Nutr Metab (Lond). 2013;10:70. doi:10.1186/1743-7075-10-70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1743-7075-10-70</ArticleId>
            <ArticleId IdType="pmc">PMC4028892</ArticleId>
            <ArticleId IdType="pubmed">24321125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai YC, Wang YY, Zhang XF, Tan M, Xia M, Wu X-B, Jiang X, Nie J. Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles. J Virol Methods. 2012;186:126&#x2013;131. doi:10.1016/j.jviromet.2012.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jviromet.2012.07.002</ArticleId>
            <ArticleId IdType="pmc">PMC3496071</ArticleId>
            <ArticleId IdType="pubmed">22867844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KE, Han BK, Han JY, Hong JY, Kim MN, Heo WI, Sohn MH, Kim KW, Kim KE. Production of egg yolk antibodies specific to house dust mite proteins. Yonsei Med J. 2014;55:999&#x2013;1004. doi:10.3349/ymj.2014.55.4.999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3349/ymj.2014.55.4.999</ArticleId>
            <ArticleId IdType="pmc">PMC4075406</ArticleId>
            <ArticleId IdType="pubmed">24954330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee CH, Lee YC, Liang MH, Leu S-J, Lin L-T, Chiang J-R, Yang -Y-Y. Antibodies against venom of the snake deinagkistrodon acutus. Appl Environ Microbiol. 2015;82:71&#x2013;80. doi:10.1128/AEM.02608-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.02608-15</ArticleId>
            <ArticleId IdType="pmc">PMC4702639</ArticleId>
            <ArticleId IdType="pubmed">26475102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attallah AM, Abbas AT, Ismail H, Abdel-Raouf M, El-Dosoky I. Efficacy of passive immunization with IgY antibodies to a 58-kDa H. pylori antigen on severe gastritis in BALB/c mouse model. J Immunoassay Immunochem. 2009;30:359&#x2013;377. doi:10.1080/15321810903187922.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15321810903187922</ArticleId>
            <ArticleId IdType="pubmed">19739011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Najdi S, Nikbakht Brujeni G, Sheikhi N, Chakhkar S. Development of anti-Helicobacter pylori immunoglobulins Y (IgYs) in quail. Iranian J Veteri Res. 2016;17:106&#x2013;110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5090139</ArticleId>
            <ArticleId IdType="pubmed">27822235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thu HM, Myat TW, Win MM, Thant KZ, Rahman S, Umeda K, Nguyen SV, Icatlo FC, Higo-Moriguchi K, Taniguchi K, et al. Chicken egg yolk antibodies (IgY) for prophylaxis and treatment of rotavirus diarrhea in human and animal neonates: a concise review. Korean J Food Sci Animal Res. 2017;37:1&#x2013;9. doi:10.5851/kosfa.2017.37.1.1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5851/kosfa.2017.37.1.1</ArticleId>
            <ArticleId IdType="pmc">PMC5355572</ArticleId>
            <ArticleId IdType="pubmed">28316465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin LZ, Baidoo SK, Marquardt RR, Frohlich AA. In vitro inhibition of adhesion of enterotoxigenic Escherichia coli K88 to piglet intestinal mucus by egg-yolk antibodies. FEMS Immunol Med Microbiol. 1998;21:313&#x2013;321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9753004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee EN, Sunwoo HH, Menninen K, Sim JS. In vitro studies of chicken egg yolk antibody (IgY) against Salmonella enteritidis and Salmonella typhimurium. Poult Sci. 2002;81:632&#x2013;641. doi:10.1093/ps/81.5.632.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ps/81.5.632</ArticleId>
            <ArticleId IdType="pubmed">12033412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nie R, Wu D, Hu G, Zhang J, Yang H, Wen Z. Effect of specific egg yolk immunoglobulins on phagocytosis by neutrophils. Chin J Vet Med. 2004;12:23&#x2013;25.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhen YH, Jin LJ, Guo J, Li X-Y, Lu Y-N, Chen J, Xu Y-P. Characterization of specific egg yolk immunoglobulin (IgY) against mastitis-causing Escherichia coli. Vet Microbiol. 2008;130:126&#x2013;133. doi:10.1016/j.vetmic.2007.12.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2007.12.014</ArticleId>
            <ArticleId IdType="pubmed">18255238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomsen K, Christophersen L, Bjarnsholt T, Jensen PO, Moser C, Hoiby N. Anti-pseudomonas aeruginosa IgY antibodies induce specific bacterial aggregation and internalization in human polymorphonuclear neutrophils. Infect Immun. 2015;83:2686&#x2013;2693. doi:10.1128/IAI.02970-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.02970-14</ArticleId>
            <ArticleId IdType="pmc">PMC4468541</ArticleId>
            <ArticleId IdType="pubmed">25895968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang LH, Li XY, Jin LJ, You J-S, Zhou Y, Li S-Y, Xu Y-P. Characterization of chicken egg yolk immunoglobulins (IgYs) specific for the most prevalent capsular serotypes of mastitis-causing Staphylococcus aureus. Vet Microbiol. 2011;149:415&#x2013;421. doi:10.1016/j.vetmic.2010.11.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vetmic.2010.11.029</ArticleId>
            <ArticleId IdType="pubmed">21168286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Wang L, Zhen Y, Li S, Xu Y. Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review. J Anim Sci Biotechnol. 2015;6:40. doi:10.1186/s40104-015-0038-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40104-015-0038-8</ArticleId>
            <ArticleId IdType="pmc">PMC4549021</ArticleId>
            <ArticleId IdType="pubmed">26309735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikemori Y, Peralta RC, Kuroki M, Yokoyama H, Kodama Y. Research note: avidity of chicken yolk antibodies to enterotoxigenic Escherichia coli fimbriae. Poult Sci. 1993;72:2361&#x2013;2365. doi:10.3382/ps.0722361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3382/ps.0722361</ArticleId>
            <ArticleId IdType="pubmed">7906035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gassmann M, Thommes P, Weiser T, Hubscher U. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 1990;4:2528&#x2013;2532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1970792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jensenius JC, Andersen I, Hau J, Crone M, Koch C. Eggs: conveniently packaged antibodies. Methods for purification of yolk IgG. J Immunol Methods. 1981;46:63&#x2013;68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6169771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pauly D, Dorner M, Zhang X, Hlinak A, Dorner B, Schade R. Monitoring of laying capacity, immunoglobulin Y concentration, and antibody titer development in chickens immunized with ricin and botulinum toxins over a two-year period. Poult Sci. 2009;88:281&#x2013;290. doi:10.3382/ps.2008-00323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3382/ps.2008-00323</ArticleId>
            <ArticleId IdType="pmc">PMC7107060</ArticleId>
            <ArticleId IdType="pubmed">19151341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma JM. Introduction to poultry vaccines and immunity. Adv Vet Med. 1999;41:481&#x2013;494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9890037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leslie GA, Clem LW. Phylogen of immunoglobulin structure and function. 3. Immunoglobulins of the chicken. J Exp Med. 1969;130:1337&#x2013;1352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2138693</ArticleId>
            <ArticleId IdType="pubmed">5352783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimizu M, Nagashima H, Sano K, Hashimoto K, Ozeki M, Tsuda K, Hatta H. Molecular stability of chicken and rabbit immunoglobulin G. Biosci Biotechnol Biochem. 1992;56:270&#x2013;274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1368302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsson E, Stalberg J, Larsson A. IgY stability in eggs stored at room temperature or at +4 degrees C. Br Poult Sci. 2012;53:42&#x2013;46. doi:10.1080/00071668.2011.646951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00071668.2011.646951</ArticleId>
            <ArticleId IdType="pubmed">22404803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsson A, Balow RM, Lindahl TL, Forsberg PO. Chicken antibodies: taking advantage of evolution&#x2013;a review. Poult Sci. 1993;72:1807&#x2013;1812. doi:10.3382/ps.0721807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3382/ps.0721807</ArticleId>
            <ArticleId IdType="pubmed">8415358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staak C, Schwarzkopf C, Behn I, Hommel U, Hlinak A, Schade R, Erhard M. Isolation of IgY from Yolk In: Schade R, Behn I, Erhard M, Hlinak A, Staak C, editors Chicken egg yolk antibodies, production and application: IgY-technology. Berlin (Heidelberg): Springer Berlin Heidelberg; 2001. p. 65&#x2013;107.</Citation>
        </Reference>
        <Reference>
          <Citation>Shimizu M, Fitzsimmons RC, Nakai S. Anti-E. coli lmmunoglobulin Y isolated from egg yolk of immunized chickens as a potential food ingredient. J Food Sci. 1988;53:1360&#x2013;1368. doi:10.1111/jfds.1988.53.issue-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jfds.1988.53.issue-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu CY, Huang H, Wang XM, Liu Y-G, Wang Z-G, Cui S-J, Gao H-L, Li Z, Li J-P, Kong X-G. Preparation and evaluation of anti-SARS coronavirus IgY from yolks of immunized SPF chickens. J Virol Methods. 2006;133:112&#x2013;115. doi:10.1016/j.jviromet.2005.10.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jviromet.2005.10.027</ArticleId>
            <ArticleId IdType="pmc">PMC7112787</ArticleId>
            <ArticleId IdType="pubmed">16325277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoyama H, Peralta RC, Diaz R, Sendo S, Ikemori Y, Kodama Y. Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets. Infect Immun. 1992;60:998&#x2013;1007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC257586</ArticleId>
            <ArticleId IdType="pubmed">1347289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Losch U, Schranner I, Wanke R, Jurgens L. The chicken egg, an antibody source. Zentralblatt Fur Veterinarmedizin Reihe B J Vet Med Series B. 1986;33:609&#x2013;619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3799099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hatta H, Tsuda K, Akachi S, Kim M, Yamamoto T. Productivity and some properties of egg yolk antibody (IgY) against human rotavirus compared with rabbit IgG. Biosci Biotechnol Biochem. 1993;57:450&#x2013;454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7764050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimizu M, Nagashima H, Hashimoto K. Comparative studies in molecular stability of immunoglobulin G from different species. Comp Biochem Phys B. 1993;106:255&#x2013;261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8243054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KA, Chang SK, Lee YJ, Lee JH, Koo NS. Acid stability of anti-Helicobacter pyroli IgY in aqueous polyol solution. J Biochem Mol Biol. 2002;35:488&#x2013;493.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12359091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubickova B, Majerova B, Hadrabova J, Noskova L, Stiborova M, Hodek P. Effect of chicken antibodies on inflammation in human lung epithelial cell lines. Neuro Endocrinol Lett. 2014;35(Suppl 2):99&#x2013;104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25638373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsson E, Kollberg H, Johannesson M, Wejaker PE, Carlander D, Larsson A. More than 10 years&#x2019; continuous oral treatment with specific immunoglobulin Y for the prevention of Pseudomonas aeruginosa infections: a case report. J Med Food. 2007;10:375&#x2013;378. doi:10.1089/jmf.2006.214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/jmf.2006.214</ArticleId>
            <ArticleId IdType="pubmed">17651078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie MQ, Meng YX, Li ZH, Li Y-Q, Zhang K-X, Zhao X-M, Xiong G-J, Chen Y-M. [Effect of specific immunoglobulin Y in the treatment of acute and chronic pharyngitis]. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004;39:112&#x2013;115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15195596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M, Kitsutani P, Yu H, Guzman G, Coulibaly D, et al. Global role and burden of influenza in pediatric respiratory hospitalizations, 1982-2012: a systematic analysis. PLoS Med. 2016;13:e1001977. doi:10.1371/journal.pmed.1001977.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.1001977</ArticleId>
            <ArticleId IdType="pmc">PMC4807087</ArticleId>
            <ArticleId IdType="pubmed">27011229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, Charlson F, Davis A, Degenhardt L, Dicker D, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet (London, England). 2015;386:743&#x2013;800. doi:10.1016/S0140-6736(15)60692-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(15)60692-4</ArticleId>
            <ArticleId IdType="pmc">PMC4561509</ArticleId>
            <ArticleId IdType="pubmed">26063472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bassaganya-Riera J, Song R, Roberts PC, Hontecillas R. PPAR-gamma activation as an anti-inflammatory therapy for respiratory virus infections. Viral Immunol. 2010;23:343&#x2013;352. doi:10.1089/vim.2010.0016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/vim.2010.0016</ArticleId>
            <ArticleId IdType="pubmed">20712478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quigley E. Influenza therapies: vaccines and antiviral drugs. Drug Discov Today. 2006;11:478&#x2013;480. doi:10.1016/j.drudis.2006.04.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.drudis.2006.04.010</ArticleId>
            <ArticleId IdType="pubmed">16713898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berry CM. Antibody immunoprophylaxis and immunotherapy for influenza virus infection: utilization of monoclonal or polyclonal antibodies?. Hum Vaccin Immunother. 2017;14(3):1&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5861795</ArticleId>
            <ArticleId IdType="pubmed">28854120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang YE, Wen JL, Zhao SQ, Zhang K, Zhou YL. Prophylaxis and therapy of pandemic H1N1 virus infection using egg yolk antibody. J Virol Methods. 2014;206:19&#x2013;26. doi:10.1016/j.jviromet.2014.05.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jviromet.2014.05.016</ArticleId>
            <ArticleId IdType="pubmed">24880066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsukamoto M, Hiroi S, Adachi K, Kato H, Inai M, Konishi I, Tanaka M, Yamamoto R, Sawa M, Handharyani E, et al. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1. Mol Med Rep. 2011;4:209&#x2013;214. doi:10.3892/mmr.2011.410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mmr.2011.410</ArticleId>
            <ArticleId IdType="pubmed">21468553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maselli DJ, Keyt H, Restrepo MI. Inhaled antibiotic therapy in chronic respiratory diseases. Int J Mol Sci. 2017;18:1062. doi:10.3390/ijms18051062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms18051062</ArticleId>
            <ArticleId IdType="pmc">PMC5454974</ArticleId>
            <ArticleId IdType="pubmed">28509852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34:91&#x2013;100. doi:10.1002/ppul.10127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.10127</ArticleId>
            <ArticleId IdType="pubmed">12112774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr. 2001;138:699&#x2013;704. doi:10.1067/mpd.2001.112897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mpd.2001.112897</ArticleId>
            <ArticleId IdType="pubmed">11343046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breidenstein EB, De La Fuente-Nunez C, Hancock RE. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011;19:419&#x2013;426. doi:10.1016/j.tim.2011.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2011.04.005</ArticleId>
            <ArticleId IdType="pubmed">21664819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168:918&#x2013;951. doi:10.1164/rccm.200304-505SO.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.200304-505SO</ArticleId>
            <ArticleId IdType="pubmed">14555458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doring G, Flume P, Heijerman H, Elborn JS. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibr. 2012;11:461&#x2013;479. doi:10.1016/j.jcf.2012.10.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcf.2012.10.004</ArticleId>
            <ArticleId IdType="pubmed">23137712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsson E, Larsson A, Olesen HV, Wejaker PE, Kollberg H. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients. Pediatr Pulmonol. 2008;43:892&#x2013;899. doi:10.1002/ppul.20875.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.20875</ArticleId>
            <ArticleId IdType="pubmed">18680179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quie PG. Lung defense against infection. J Pediatr. 1986;108:813&#x2013;816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3701533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brett MM, Ghoneim AT, Littlewood JM. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child. 1990;65:259&#x2013;263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1792272</ArticleId>
            <ArticleId IdType="pubmed">2110441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomsen K, Christophersen L, Jensen PO, Bjarnsholt T, Moser C, Hoiby N. Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils. Hum Vaccin Immunother. 2016;12:1690&#x2013;1699.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4964812</ArticleId>
            <ArticleId IdType="pubmed">26901841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honko AN, Mizel SB. Effects of flagellin on innate and adaptive immunity. Immunol Res. 2005;33:83&#x2013;101. doi:10.1385/IR:33:1:083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1385/IR:33:1:083</ArticleId>
            <ArticleId IdType="pubmed">16120974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prince A. Flagellar activation of epithelial signaling. Am J Respir Cell Mol Biol. 2006;34:548&#x2013;551. doi:10.1165/rcmb.2006-0022SF.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2006-0022SF</ArticleId>
            <ArticleId IdType="pubmed">16439803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilsson E, Amini A, Wretlind B, Larsson A. Pseudomonas aeruginosa infections are prevented in cystic fibrosis patients by avian antibodies binding Pseudomonas aeruginosa flagellin. J Chromatograp B, Anal Technol Biomed Life Sci. 2007;856:75&#x2013;80. doi:10.1016/j.jchromb.2007.05.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jchromb.2007.05.029</ArticleId>
            <ArticleId IdType="pubmed">17581799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kollberg H, Carlander D, Olesen H, Wejaker PE, Johannesson M, Larsson A. Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study. Pediatr Pulmonol. 2003;35:433&#x2013;440. doi:10.1002/ppul.10290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.10290</ArticleId>
            <ArticleId IdType="pubmed">12746939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waters V, Smyth A. Cystic fibrosis microbiology: advances in antimicrobial therapy. J Cyst Fibr. 2015;14:551&#x2013;560. doi:10.1016/j.jcf.2015.02.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcf.2015.02.005</ArticleId>
            <ArticleId IdType="pubmed">25737165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009;7:439&#x2013;450. doi:10.1038/nrmicro2147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro2147</ArticleId>
            <ArticleId IdType="pmc">PMC2830095</ArticleId>
            <ArticleId IdType="pubmed">19430490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (New York, NY). 2003;300:1394&#x2013;1399. doi:10.1126/science.1085952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1085952</ArticleId>
            <ArticleId IdType="pubmed">12730500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drosten C, Gunther S, Preiser W, Van Der Werf S, Brodt H-R, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RAM, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967&#x2013;1976. doi:10.1056/NEJMoa030747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa030747</ArticleId>
            <ArticleId IdType="pubmed">12690091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lechartier B, Rybniker J, Zumla A, Cole ST. Tuberculosis drug discovery in the post-post-genomic era. EMBO Mol Med. 2014;6:158&#x2013;168. doi:10.1002/emmm.201201772.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/emmm.201201772</ArticleId>
            <ArticleId IdType="pmc">PMC3927952</ArticleId>
            <ArticleId IdType="pubmed">24401837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhatt K, Salgame P. Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol. 2007;27:347&#x2013;362. doi:10.1007/s10875-007-9084-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10875-007-9084-0</ArticleId>
            <ArticleId IdType="pubmed">17364232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization 
Global Tuberculosis Report, 2016. Geneva, Switzerland: WHO; 2017. 
Accessed
http://www.who.int/tb/publications/global_report/en/.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang XZ, Chen SS, Xu YJ, Zheng HJ, Xiao TY, Li YQ, Chen X, Huang MX, Zhang HF, Fang XJ, et al. Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis. Emerg Microbes Infect. 2017;6(6):6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5520311</ArticleId>
            <ArticleId IdType="pubmed">28588287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sudjarwo SA, Eraiko K, Sudjarwo GW. Koerniasari. The potency of chicken egg yolk immunoglobulin (IgY) specific as immunotherapy to Mycobacterium tuberculosis infection. J Adv Pharm Technol Res. 2017;8:91&#x2013;96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5527699</ArticleId>
            <ArticleId IdType="pubmed">28795022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stott EJ, Taylor G. Respiratory syncytial virus. Brief Rev Arch Virol. 1985;84:1&#x2013;52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3885919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O&#x2019;Brien KL, Roca A, Wright PF, Bruce N, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (London, England). 2010;375:1545&#x2013;1555. doi:10.1016/S0140-6736(10)60206-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(10)60206-1</ArticleId>
            <ArticleId IdType="pmc">PMC2864404</ArticleId>
            <ArticleId IdType="pubmed">20399493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor G. Animal models of respiratory syncytial virus infection. Vaccine. 2017;35:469&#x2013;480. doi:10.1016/j.vaccine.2016.11.054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2016.11.054</ArticleId>
            <ArticleId IdType="pmc">PMC5244256</ArticleId>
            <ArticleId IdType="pubmed">27908639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valarcher JF, Taylor G. Bovine respiratory syncytial virus infection. Vet Res. 2007;38:153&#x2013;180. doi:10.1051/vetres:2006053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1051/vetres:2006053</ArticleId>
            <ArticleId IdType="pubmed">17257568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferella A, Bellido D, Chacana P, Wigdorovitz A, Santos MJD, Mozgovoj MV. Chicken egg yolk antibodies against bovine respiratory syncytial virus neutralize the virus in vitro. Procedia Vaccinol. 2012;6:33&#x2013;38. doi:10.1016/j.provac.2012.04.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.provac.2012.04.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F. Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources. ILAR J. 2005;46:258&#x2013;268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15953833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee W, Syed Atif A, Tan SC, Leow CH. Insights into the chicken IgY with emphasis on the generation and applications of chicken recombinant monoclonal antibodies. J Immunol Methods. 2017;447:71&#x2013;85. doi:10.1016/j.jim.2017.05.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jim.2017.05.001</ArticleId>
            <ArticleId IdType="pubmed">28502720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spillner E, Braren I, Greunke K, Seismann H, Blank S, Du Plessis D. Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy. Biol J Int Assoc Biol Standard. 2012;40:313&#x2013;322. doi:10.1016/j.biologicals.2012.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biologicals.2012.05.003</ArticleId>
            <ArticleId IdType="pmc">PMC7106491</ArticleId>
            <ArticleId IdType="pubmed">22748514</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30230068</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>12</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2702</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>1-2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical nursing</Title>
          <ISOAbbreviation>J Clin Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Advancing the case for nurse practitioner-based models to accelerate scale-up of HIV pre-exposure prophylaxis.</ArticleTitle>
        <Pagination>
          <StartPage>351</StartPage>
          <EndPage>361</EndPage>
          <MedlinePgn>351-361</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jocn.14675</ELocationID>
        <Abstract>
          <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To explore the factors that position nurse practitioners (NPs) to lead the implementation of HIV pre-exposure prophylaxis.</AbstractText>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The HIV epidemic represents a global health crisis. Reducing new HIV infections is a public health priority, especially for Black and Latino men who have sex with men (MSM). When taken as directed, co-formulated emtricitabine and tenofovir have over 95% efficacy in preventing HIV; however, substantial gaps remain between those who would benefit from pre-exposure prophylaxis (PrEP) and current PrEP prescribing practices.</AbstractText>
          <AbstractText Label="DESIGN" NlmCategory="METHODS">This is a position paper that draws on concurrent assessments of research literature and advanced practice nursing frameworks.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">The arguments in this paper are grounded in the current literature on HIV PrEP implementation and evidence of the added value of nurse-based models in promoting health outcomes. The American Association of Colleges of Nursing's advanced nursing practice competencies were also included as a source of data for identifying and cross-referencing NP assets that align with HIV PrEP care continuum outcomes.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There are four main evidence-based arguments that can be used to advance policy-level and practice-level changes that harness the assets of nurse practitioners in accelerating the scale-up of HIV PrEP.</AbstractText>
          <AbstractText Label="RELEVANCE TO CLINICAL PRACTICE" NlmCategory="CONCLUSIONS">Global public health goals for HIV prevention cannot be achieved without the broader adoption of PrEP as a prevention practice among healthcare providers. NPs are the best hope for closing this gap in access for the populations that are most vulnerable to HIV infection.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nelson</LastName>
            <ForeName>LaRon E</ForeName>
            <Initials>LE</Initials>
            <Identifier Source="ORCID">0000-0002-2630-602X</Identifier>
            <AffiliationInfo>
              <Affiliation>University of Rochester, Rochester, New&#xA0;York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McMahon</LastName>
            <ForeName>James M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>University of Rochester, Rochester, New&#xA0;York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leblanc</LastName>
            <ForeName>Natalie M</ForeName>
            <Initials>NM</Initials>
            <AffiliationInfo>
              <Affiliation>University of Rochester, Rochester, New&#xA0;York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Braksmajer</LastName>
            <ForeName>Amy</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>University of Rochester, Rochester, New&#xA0;York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crean</LastName>
            <ForeName>Hugh F</ForeName>
            <Initials>HF</Initials>
            <AffiliationInfo>
              <Affiliation>University of Rochester, Rochester, New&#xA0;York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Kristin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>University of Rochester, Rochester, New&#xA0;York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xue</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>University of Rochester, Rochester, New&#xA0;York.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 AI078498</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Agency>University of Rochester School of Nursing Dean's Endowed Fellowship in Health Disparities</Agency>
            <Country/>
          </Grant>
          <Grant>
            <GrantID>AHRC 1066</GrantID>
            <Agency>Ontario HIV Treatment Network</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Clin Nurs</MedlineTA>
        <NlmUniqueID>9207302</NlmUniqueID>
        <ISSNLinking>0962-1067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006630" MajorTopicYN="N">Hispanic or Latino</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009722" MajorTopicYN="N">Nurse Practitioners</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057184" MajorTopicYN="N">Practice Patterns, Nurses'</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065129" MajorTopicYN="Y">Pre-Exposure Prophylaxis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000072339" MajorTopicYN="Y">Sexual and Gender Minorities</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HIV pre-exposure prophylaxis</Keyword>
        <Keyword MajorTopicYN="N">HIV prevention</Keyword>
        <Keyword MajorTopicYN="N">nurse practitioners</Keyword>
        <Keyword MajorTopicYN="N">prescribing practices</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30230068</ArticleId>
        <ArticleId IdType="doi">10.1111/jocn.14675</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30229521</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-2800</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>48</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Archives of sexual behavior</Title>
          <ISOAbbreviation>Arch Sex Behav</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Life History Approach to the Female Sexual Orientation Spectrum: Evolution, Development, Causal Mechanisms, and Health.</ArticleTitle>
        <Pagination>
          <StartPage>1273</StartPage>
          <EndPage>1308</EndPage>
          <MedlinePgn>1273-1308</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10508-018-1261-0</ELocationID>
        <Abstract>
          <AbstractText>Women's capacity for sexual fluidity is at least as interesting a phenomenon from the point of view of evolutionary biology and behavioral endocrinology as exclusively homosexual orientation. Evolutionary hypotheses for female nonheterosexuality have failed to fully account for the existence of these different categories of nonheterosexual women, while also overlooking broader data on the causal mechanisms, physiology, ontogeny, and phylogeny of female nonheterosexuality. We review the evolutionary-developmental origins of various phenotypes in the female sexual orientation spectrum using the synergistic approach of Tinbergen's four questions. We also present femme-specific and butch-specific hypotheses at proximate and ultimate levels of analysis. This review article indicates that various nonheterosexual female phenotypes emerge from and contribute to hormonally mediated fast life history strategies. Life history theory provides a biobehavioral explanatory framework for nonheterosexual women's masculinized body morphology, psychological dispositions, and their elevated likelihood of experiencing violence, substance use, obesity, teenage pregnancy, and lower general health. This pattern of life outcomes can create a feedback loop of environmental unpredictability and harshness which destabilizes intrauterine hormonal conditions in mothers, leading to a greater likelihood of fast life history strategies, global health problems, and nonheterosexual preferences in female offspring. We further explore the potential of female nonheterosexuality to function as an alloparental buffer that enables masculinizing alleles to execute their characteristic fast life history strategies as they appear in the female and the male phenotype. Synthesizing life history theory with the female sexual orientation spectrum enriches existing scientific knowledge on the evolutionary-developmental mechanisms of human sex differences.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Luoto</LastName>
            <ForeName>Severi</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-3904-3994</Identifier>
            <AffiliationInfo>
              <Affiliation>English, Drama and Writing Studies, University of Auckland, Arts 1, Building 206, Room 616, 14A Symonds St., Auckland, 1010, New Zealand. s.luoto@auckland.ac.nz.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Psychology, University of Auckland, Auckland, New Zealand. s.luoto@auckland.ac.nz.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krams</LastName>
            <ForeName>Indrikis</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Zoology and Animal Ecology, University of Latvia, Riga, Latvia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Ecology and Earth Sciences, University of Tartu, Tartu, Estonia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rantala</LastName>
            <ForeName>Markus J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology &amp; Turku Brain and Mind Center, University of Turku, Turku, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arch Sex Behav</MedlineTA>
        <NlmUniqueID>1273516</NlmUniqueID>
        <ISSNLinking>0004-0002</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Arch Sex Behav. 2019 Jul;48(5):1321-1324. doi: 10.1007/s10508-018-1312-6.</RefSource>
          <PMID Version="1">30291597</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Arch Sex Behav. 2019 Jul;48(5):1315-1320. doi: 10.1007/s10508-018-1313-5.</RefSource>
          <PMID Version="1">30311041</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Arch Sex Behav. 2019 Jul;48(5):1309-1313. doi: 10.1007/s10508-018-1343-z.</RefSource>
          <PMID Version="1">30456632</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Arch Sex Behav. 2019 Jul;48(5):1325-1328. doi: 10.1007/s10508-018-1338-9.</RefSource>
          <PMID Version="1">30465310</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Arch Sex Behav. 2019 Jul;48(5):1329-1333. doi: 10.1007/s10508-018-1350-0.</RefSource>
          <PMID Version="1">30511147</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Arch Sex Behav. 2019 Jul;48(5):1335-1347. doi: 10.1007/s10508-019-1439-0.</RefSource>
          <PMID Version="1">31119422</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071421" MajorTopicYN="Y">Life History Traits</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012725" MajorTopicYN="N">Sexual Behavior</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016387" MajorTopicYN="N">Women's Health</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Behavioral endocrinology</Keyword>
        <Keyword MajorTopicYN="N">Evolutionary-developmental psychology</Keyword>
        <Keyword MajorTopicYN="N">Female sexual orientation</Keyword>
        <Keyword MajorTopicYN="N">Homosexuality</Keyword>
        <Keyword MajorTopicYN="N">Life history evolution</Keyword>
        <Keyword MajorTopicYN="N">Neurodevelopment</Keyword>
        <Keyword MajorTopicYN="N">Women&#x2019;s health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30229521</ArticleId>
        <ArticleId IdType="doi">10.1007/s10508-018-1261-0</ArticleId>
        <ArticleId IdType="pii">10.1007/s10508-018-1261-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30229308</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1436-6215</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>58</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>European journal of nutrition</Title>
          <ISOAbbreviation>Eur J Nutr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Breast and complementary feeding in Ethiopia: new national evidence from systematic review and meta-analyses of studies in the past 10&#xA0;years.</ArticleTitle>
        <Pagination>
          <StartPage>2565</StartPage>
          <EndPage>2595</EndPage>
          <MedlinePgn>2565-2595</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00394-018-1817-8</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this systematic review and meta-analysis was to provide a national estimate of breast and complementary feeding practices and its predictors in Ethiopia.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, SCOPUS, EMBASE, CINHAL, Web of Science and WHO Global Health Library electronic databases were searched for all available literature published until April 2018. Observational studies including cross-sectional, case-control and cohort studies were included. Newcastle-Ottawa Scale was used to assess the quality of studies. Heterogeneity of studies was quantified using Cochran's Q &#x3C7;<sup>2</sup> statistic and Higgins's method (I<sup>2</sup>). A meta-analysis using a weighted inverse variance method was performed. Subgroup analysis was carried out based on region and study area.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 70 studies that involved&#x2009;&gt;&#x2009;55,000 women from nine regions and two chartered cities in Ethiopia were included. The pooled national prevalence for timely initiation of breastfeeding (TIBF), exclusive breastfeeding (EBF) and timely initiation of complementary feeding was 66.5%, 60.1% and 62.5%, respectively. Guidance and counselling on breastfeeding, vaginal delivery and health institution delivery significantly increased the odds of TIBF and EBF. In addition, TIBF significantly associated with high EBF practice. Maternal occupational status significantly associated with low EBF practice, but not TIBF.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on the WHO standard, the current breast and complementary feeding practice in Ethiopia is good and improving. Integrated intervention is still required for further improvement and minimizing the effect of occupational status.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Habtewold</LastName>
            <ForeName>Tesfa Dejenie</ForeName>
            <Initials>TD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nursing, College of Medicine and Health Science, Debre Berhan University, Debre Berhan, Ethiopia. tesfadej2003@gmail.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. tesfadej2003@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohammed</LastName>
            <ForeName>Shimels Hussien</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences-International Campus (TUMS-IC), Tehran, Islamic Republic of Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Endalamaw</LastName>
            <ForeName>Aklilu</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Child Health Nursing, School of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Akibu</LastName>
            <ForeName>Mohammed</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nursing, College of Medicine and Health Science, Debre Berhan University, Debre Berhan, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sharew</LastName>
            <ForeName>Nigussie Tadesse</ForeName>
            <Initials>NT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nursing, College of Medicine and Health Science, Debre Berhan University, Debre Berhan, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alemu</LastName>
            <ForeName>Yihun Mulugeta</ForeName>
            <Initials>YM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beyene</LastName>
            <ForeName>Misrak Getnet</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Ethiopian Public Health Institute, Addis Ababa, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sisay</LastName>
            <ForeName>Tesfamichael Awoke</ForeName>
            <Initials>TA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Public Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Birhanu</LastName>
            <ForeName>Mulugeta Molla</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Adult Health Nursing, School of Nursing, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Islam</LastName>
            <ForeName>Md Atiqul</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Statistics, Shahjalal University of Science and Technology, Sylhet, Bangladesh.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tegegne</LastName>
            <ForeName>Balewgizie Sileshi</ForeName>
            <Initials>BS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D017418">Meta-Analysis</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Nutr</MedlineTA>
        <NlmUniqueID>100888704</NlmUniqueID>
        <ISSNLinking>1436-6207</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Eur J Nutr. 2020 Mar;59(2):839. doi: 10.1007/s00394-019-02171-6.</RefSource>
          <PMID Version="1">32002606</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001942" MajorTopicYN="N">Breast Feeding</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005002" MajorTopicYN="N" Type="Geographic">Ethiopia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007227" MajorTopicYN="Y">Infant Nutritional Physiological Phenomena</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Breastfeeding</Keyword>
        <Keyword MajorTopicYN="N">Complementary feeding</Keyword>
        <Keyword MajorTopicYN="N">Ethiopia</Keyword>
        <Keyword MajorTopicYN="N">Infant nutritional physiological phenomena</Keyword>
        <Keyword MajorTopicYN="N">Meta-analysis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30229308</ArticleId>
        <ArticleId IdType="doi">10.1007/s00394-018-1817-8</ArticleId>
        <ArticleId IdType="pii">10.1007/s00394-018-1817-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lancet. 2016 Jan 30;387(10017):491-504</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26869576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ Open. 2017 Oct 24;7(10):e014145</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29070635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Food Nutr Bull. 2011 Jun;32(2):94-102</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22164971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matern Child Nutr. 2012 Jan;8 Suppl 1:5-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22168515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Public Health. 2011 Apr 08;11:217</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21473791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS One. 2017 Mar 27;12(3):e0174624</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28346497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rev Saude Publica. 2014 Aug;48(4):697-708</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25210829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Pediatr (Rio J). 2018 Mar - Apr;94(2):104-122</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28886401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Health Popul Nutr. 2015 May 01;34:9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26825334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ Open. 2013 Jun 20;3(6):</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23794590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2013 Aug 07;8(1):8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23919800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acta Paediatr. 2015 Dec;104(467):114-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26183031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 Jun 18;11:17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27330542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Public Health Nutr. 2016 Mar;19(4):753-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26096540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Jun 6;12:25</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28592986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matern Child Nutr. 2017 Oct;13 Suppl 2:</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29032623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sci Rep. 2017 Mar 21;7:44868</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28322265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 Aug 02;11:22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27489561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2012 Nov 27;7(1):17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23186223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Jan 6;12:1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28070207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Front Nutr. 2016 Oct 17;3:41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27800479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 Mar 22;11:5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27006686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Nov 2;12:45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29142586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Apr 21;12:20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28439290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ Open. 2017 Aug 3;7(8):e017437</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28775196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Nutr Metab. 2017;2017:9608315</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28808588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2015 Aug 19;10:24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26300951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med Insights Pediatr. 2017 Mar 10;11:1179556517698136</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28469519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Public Health. 2015 Dec 01;73:53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26629339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2017 Sep 21;358:j4008</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28935701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Jun 14;12:26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28630642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2015 Aug 13;10:23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26269708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Front Nutr. 2016 Aug 15;3:32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27574604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Jul 10;12:30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28702071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2015 Jul 07;10:22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26155301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):119-132</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28027215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Microbiol Infect. 2014 Feb;20(2):123-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24320992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Food Nutr Bull. 2016 Sep;37(3):409-424</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27402640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hum Lact. 2013 Nov;29(4):605-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23942391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 Mar 18;11:4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26997971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 Oct 6;11:28</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27757141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Res Notes. 2017 Jul 27;10(1):335</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28750674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 Sep 20;11:25</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27660644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 1997 Sep 13;315(7109):629-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9310563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Res Notes. 2017 Oct 10;10(1):501</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29017540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2015 Nov 19;10:30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26594231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2015 Jan 20;10(1):2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25621000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Feb 27;12:12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28261318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rev Saude Publica. 2015;49:</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26759970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matern Child Nutr. 2018 Jan;14(1):</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28621054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Public Health. 2015 Oct 21;15:1076</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26489955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Public Health Nutr. 2011 Nov;14(11):2029-36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21557873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan Afr Med J. 2014 Jun 17;18:143</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25419281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Aug 24;12:38</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28855954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 May 25;11:14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27231482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS Med. 2013;10(4):e1001419</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23585737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soz Praventivmed. 2005;50(1):52-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15771330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2014 Aug 25;9:13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25180042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ Open. 2016 Aug 08;6(8):e010551</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27503858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Med Insights Pediatr. 2017 Dec 17;11:1179556517748912</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29317851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Pregnancy Childbirth. 2016 Apr 26;16:90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27118118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Med Res Methodol. 2015 Apr 14;15:35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25880989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 Dec 9;11:32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27990174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 Oct 3;11:27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27729937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Pregnancy Childbirth. 2016 Oct 19;16(1):314</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27756253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matern Child Nutr. 2018 Apr;14(2):e12535</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29034551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2015 Jan 20;10(1):1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25635183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2014 Jul 21;9:11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25057283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Public Health. 2013 Nov 06;13:1050</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24195592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 Apr 08;11:7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27064535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Oct 3;12:44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29026432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2014 Dec 14;9(1):189</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25648571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Res Notes. 2017 Sep 7;10(1):466</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28882162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2016 May 17;11:13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27190547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2014 Jun 13;9:8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24971154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Epidemiol Community Health. 2013 Nov 1;67(11):974-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23963506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS One. 2017 Jun 28;12(6):e0179056</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28658257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paediatr Perinat Epidemiol. 2016 Sep;30(5):439-49</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27259184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paediatr Perinat Epidemiol. 2016 Jul;30(4):346-55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27009844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Jun 17;12:27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28638435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Res Synth Methods. 2017 Mar;8(1):5-18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28058794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS One. 2016 Oct 10;11(10):e0164128</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27723797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Public Health. 2016 Aug 25;16:884</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27562072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2013 Oct 23;8(1):14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24152996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Epidemiol. 2009 Oct;62(10):1006-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19631508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Pregnancy Childbirth. 2014 Aug 09;14:262</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25107331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Pediatr. 2016 Aug 19;16:131</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27542833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Public Health. 2012 May 18;12:363</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22607266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Pediatr. 2018 Jan 31;18(1):17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29386008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2017 Aug 1;12:36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28775760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Breastfeed J. 2018 Jan 23;13:4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29410699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Pediatr. 2015 Apr 08;15:35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25884185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2003 Sep 6;327(7414):557-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12958120</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">30228250</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>04</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>04</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-201X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>105</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Heart (British Cardiac Society)</Title>
          <ISOAbbreviation>Heart</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Resistant hypertension in times of changing definitions and treatment recommendations.</ArticleTitle>
        <Pagination>
          <StartPage>96</StartPage>
          <EndPage>97</EndPage>
          <MedlinePgn>96-97</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/heartjnl-2018-313786</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nazarzadeh</LastName>
            <ForeName>Milad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>George Institute for Global Health, University of Oxford, Oxford, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Collaboration Center of Meta-Analysis Research, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pinho-Gomes</LastName>
            <ForeName>Ana-Catarina</ForeName>
            <Initials>AC</Initials>
            <AffiliationInfo>
              <Affiliation>George Institute for Global Health, University of Oxford, Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rahimi</LastName>
            <ForeName>Kazem</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>George Institute for Global Health, University of Oxford, Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Heart</MedlineTA>
        <NlmUniqueID>9602087</NlmUniqueID>
        <ISSNLinking>1355-6037</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Heart. 2019 Jan;105(2):98-105. doi: 10.1136/heartjnl-2018-313599.</RefSource>
          <PMID Version="1">30087099</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">epidemiology</Keyword>
        <Keyword MajorTopicYN="N">global disease patterns</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">hypertension</Keyword>
        <Keyword MajorTopicYN="N">meta-analysis</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30228250</ArticleId>
        <ArticleId IdType="doi">10.1136/heartjnl-2018-313786</ArticleId>
        <ArticleId IdType="pii">heartjnl-2018-313786</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30223907</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2040-1752</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of developmental origins of health and disease</Title>
          <ISOAbbreviation>J Dev Orig Health Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The association between gestational age and otitis media during childhood: a population-based cohort analysis.</ArticleTitle>
        <Pagination>
          <StartPage>214</StartPage>
          <EndPage>220</EndPage>
          <MedlinePgn>214-220</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1017/S2040174418000685</ELocationID>
        <Abstract>
          <AbstractText>Otitis media (OM) carries a tremendous global health burden and potentially severe long-term consequences. The objective of this study was to determine the impact of birth at different gestational ages on the incidence of childhood OM.A population-based cohort analysis was conducted. All singleton deliveries occurring between 1991 and 2014 at a regional tertiary medical center were included. Gestational age on delivery was divided into six subgroups: early (&amp;lt;34 weeks gestation; 0 out of 7) and late (34 weeks gestation; 0 out of 7 to 36 weeks gestation; 6 out of 7) preterm, and early (37 weeks gestation; 0 out of 7 to 38 weeks gestation; 6 out of 7), full (39 weeks gestation; 0 out of 7 to 40 weeks gestation; 6 out of 7), late (41 weeks gestation; 0 out of 7 to 41 weeks gestation; 6 out of 7) and post (&#x2A7E;42 weeks 0 out of 7) term deliveries. Rates of OM-related hospitalizations up to 18 years of age were assessed. Weibull parametric hazards model was used to study the association between gestational age at birth and the risk for OM-related hospitalizations while controlling for potential confounders.During the study period, 238,622 deliveries met the inclusion criteria. OM-related hospitalizations of the offspring (n=4724) were significantly more common in the preterm (early 3.6%, late 2.4%) and early-term born children (2.2%) and decreased gradually across the full (1.9%), late (1.7%) and post (1.6%) term groups (&#x3C7;2-test for trends P&amp;lt;0.001). In the Weibull regression model, early preterm, as well as early-term deliveries exhibited an independent association with pediatric OM (adjusted hazard ratios: 1.67 and 1.09, respectively, P&amp;lt;0.02).Deliveries occurring at preterm and early term are associated with higher rates of pediatric OM-related hospitalizations, which decrease gradually as gestational age advances.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Imterat</LastName>
            <ForeName>Majdi</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0001-7174-8591</Identifier>
            <AffiliationInfo>
              <Affiliation>1Department of Obstetrics and Gynecology,Soroka University Medical Center,Ben-Gurion University of the Negev,Beer-Sheva,Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wainstock</LastName>
            <ForeName>Tamar</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>2Department of Public Health,Faculty of Health Sciences,Ben-Gurion University of the Negev,Beer-Sheva,Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moran-Gilad</LastName>
            <ForeName>Jacob</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>3Department of Health Systems Management,School of Public Health,Faculty of Health Sciences,Ben-Gurion University of the Negev,Beer-Sheva,Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sheiner</LastName>
            <ForeName>Eyal</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>1Department of Obstetrics and Gynecology,Soroka University Medical Center,Ben-Gurion University of the Negev,Beer-Sheva,Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Walfisch</LastName>
            <ForeName>Asnat</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>1Department of Obstetrics and Gynecology,Soroka University Medical Center,Ben-Gurion University of the Negev,Beer-Sheva,Israel.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Dev Orig Health Dis</MedlineTA>
        <NlmUniqueID>101517692</NlmUniqueID>
        <ISSNLinking>2040-1744</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005865" MajorTopicYN="Y">Gestational Age</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007233" MajorTopicYN="N">Infant, Postmature</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007234" MajorTopicYN="N">Infant, Premature</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010033" MajorTopicYN="N">Otitis Media</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">follow-up</Keyword>
        <Keyword MajorTopicYN="N">infection</Keyword>
        <Keyword MajorTopicYN="N">offspring</Keyword>
        <Keyword MajorTopicYN="N">pediatric morbidity</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30223907</ArticleId>
        <ArticleId IdType="doi">10.1017/S2040174418000685</ArticleId>
        <ArticleId IdType="pii">S2040174418000685</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30218371</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1573-6571</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>58</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of religion and health</Title>
          <ISOAbbreviation>J Relig Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dharmic Religions and Health: A Holistic Analysis of Global Health Literature Related to Hinduism, Buddhism, Sikhism and Jainism.</ArticleTitle>
        <Pagination>
          <StartPage>1161</StartPage>
          <EndPage>1171</EndPage>
          <MedlinePgn>1161-1171</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10943-018-0699-7</ELocationID>
        <Abstract>
          <AbstractText>Bibliometrics and scientometrics are popular and novel disciplines providing information in publication trends in a certain academic field. Although there has been an increasing popularity in bibliometric studies, a limited number of reports have been published in religion and health literature. In this study, to the best of our knowledge we aimed to perform a first bibliometric analysis in the health literature related to Dharmic religions, Hinduism, Buddhism, Sikhism and Jainism. We found a total of 655 health articles related to Dharmic religions as we searched Web of Science databases. The United States of America (USA) ranked first in Health and Hinduism literature with 62 documents followed by India, the UK and Bangladesh (n&#x2009;=&#x2009;40, 33 and 6, respectively). A detailed keyword analysis revealed that the most used keywords in the field of Hinduism and health were "Hinduism," "religion," "spirituality" and "Islam." The USA was also the leading county in the literature of Buddhism and Health with 159 articles (32.78%) and followed by Thailand, the UK and China (10.72, 6.8 and 6.39%, respectively). The Journal of Religion and Health was noted to be the most prolific source in this field. We found that the developing countries such as India, Thailand, Singapore and Taiwan were found to be included in the most productive countries list on the contrary to previous bibliometric studies in health and religion field.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>&#x15E;enel</LastName>
            <ForeName>Engin</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0001-8098-1686</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Faculty of Medicine, Hitit University, 19030, &#xC7;orum, Turkey. enginsenel@enginsenel.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Beekeeping and Bee Products Research and Application Center, Hitit University, &#xC7;orum, Turkey. enginsenel@enginsenel.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Traditional and Complementary Research and Application Center, Hitit University, &#xC7;orum, Turkey. enginsenel@enginsenel.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Relig Health</MedlineTA>
        <NlmUniqueID>2985199R</NlmUniqueID>
        <ISSNLinking>0022-4197</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015706" MajorTopicYN="N">Bibliometrics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002016" MajorTopicYN="Y">Buddhism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018596" MajorTopicYN="Y">Hinduism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012068" MajorTopicYN="Y">Religion and Medicine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bibliometrics</Keyword>
        <Keyword MajorTopicYN="N">Buddhism</Keyword>
        <Keyword MajorTopicYN="N">Dharmic religions</Keyword>
        <Keyword MajorTopicYN="N">Health</Keyword>
        <Keyword MajorTopicYN="N">Hinduism</Keyword>
        <Keyword MajorTopicYN="N">Jainism</Keyword>
        <Keyword MajorTopicYN="N">Sikhism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30218371</ArticleId>
        <ArticleId IdType="doi">10.1007/s10943-018-0699-7</ArticleId>
        <ArticleId IdType="pii">10.1007/s10943-018-0699-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Int J Psychiatry Med. 2014;48(3):199-215</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25492714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Eur Acad Dermatol Venereol. 2017 Mar;31(3):518-522</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27503253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Indian J Psychiatry. 2016 Oct-Dec;58(4):471-474</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28197009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Relig Health. 2018 Aug;57(4):1473-1482</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29299786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aesthetic Plast Surg. 2018 Jun;42(3):679-691</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29352346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Relig Health. 2018 Oct;57(5):1996-2012</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29992476</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30217961</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>Suppl 2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The WHO FCTC and global governance: effects and implications for future global public health instruments.</ArticleTitle>
        <Pagination>
          <StartPage>s89</StartPage>
          <EndPage>s93</EndPage>
          <MedlinePgn>s89-s93</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054358</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">This article analyses experience with the WHO Framework Convention on Tobacco Control (WHO FCTC) in the context of global governance. It examines ways in which the WHO FCTC has been addressed by international institutions, particularly within the UN system at the international and national levels. It seeks to understand the extent to which the WHO FCTC as an international legal obligation has contributed to its integration in the strategies, policies and programmes of UN system organisations.</AbstractText>
          <AbstractText Label="METHODS">The article examines documentation reflecting global governance responses to tobacco control since the Convention's entry into force in 2005. It also considers discussions with officials involved in the design and management of various UN initiatives. Finally, it draws on the findings of the Expert Group on the Impact Assessment of the WHO FCTC.</AbstractText>
          <AbstractText Label="CONCLUSIONS">The influence of the WHO FCTC in global governance can be at least partially attributed to its status as an international legal obligation. While tobacco control would have likely been a priority in international public health even in the absence of the WHO FCTC, the importance of tobacco control has been relatively greater as a result of the treaty. In assessing the potential utility of any future global public health instrument, it is important to consider the need to mobilise action by other global governance institutions and ensure that the chosen instrument will be capable of stimulating such action.</AbstractText>
          <CopyrightInformation>&#xA9; World Health Organization 2019. Licensee BMJ Publishing Group Limited.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McInerney</LastName>
            <ForeName>Thomas F</ForeName>
            <Initials>TF</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D062489" MajorTopicYN="Y">Health Impact Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074606" MajorTopicYN="Y">Smoking Prevention</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014944" MajorTopicYN="Y">World Health Organization</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">globalisation</Keyword>
        <Keyword MajorTopicYN="N">public policy</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>24</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30217961</ArticleId>
        <ArticleId IdType="pmc">PMC6589464</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054358</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054358</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Nikogosian H, Kickbusch I. The legal strength of international health instruments - what it brings to global health governance? Int J Health Policy Manag 2016;5:683&#x2013;5. 10.15171/ijhpm.2016.122</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15171/ijhpm.2016.122</ArticleId>
            <ArticleId IdType="pmc">PMC5144874</ArticleId>
            <ArticleId IdType="pubmed">28005547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Becoming a party to the protocol to eliminate illicit trade in tobacco products. http://www.who.int/fctc/protocol/about/becomingaparty.pdf?ua=1 (accessed on 29 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Bloomberg Philanthropies. Bloomberg Philanthropies &amp; the Bill &amp; Melinda Gates Foundation launch anti-tobacco trade litigation fund. https://www.bloomberg.org/press/releases/bloomberg-philanthropies-bill-melinda-gates-foundation-launch-anti-tobacco-trade-litigation-fund/ (accessed 29 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Press &amp; media. WHO report finds dramatic increase in life-saving tobacco control policies in last decade. https://www.bloomberg.org/press/releases/report-finds-dramatic-increase-life-saving-tobacco-control-policies-last-decade/ (accessed 29 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Michael R.
Bloomberg commits $360 million to reduce tobacco use &#x2013; raising total giving on tobacco control efforts to nearly $1 billion. https://www.bloomberg.org/press/releases/michael-r-bloomberg-commits-360-million-reduce-tobacco-use-raising-total-giving-tobacco-control-efforts-nearly-1-billion/ (accessed 29 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Global action plan for the prevention and control of noncommunicable diseases. http://www.who.int/nmh/events/ncd_action_plan/en/ (accessed 29 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
WHO. MPOWER in Action: Defeating the global tobacco epidemic. http://www.who.int/tobacco/mpower/publications/mpower_2013.pdf?ua=1 (accessed 29 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations. Transforming our world: The 2030 agenda for sustainable development un doc. A/Res/70/1.</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations. Millennium development declaration. UN Doc, A/Res/55/2.</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations. Political Declaration of the High Level Meeting of the General Assembly on the Prevention and Control of NCDs. 2011. UN Doc. A/66/L.1.</Citation>
        </Reference>
        <Reference>
          <Citation>Addis Ababa Action Agenda of the third international financing for development conference, (Addis Ababa, Ethiopia, 13&#x2013;16 July 2015) and endorsed by the General Assembly in its resolution 69/313. 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>
2016-2017. 
Work plan, inter-agency task force on NCDs
http://www.who.int/ncds/un-task-force/uniatf-work-plan-2016-2017.pdf?ua=1 (accessed 29 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Model policy for agencies of the United Nations system on preventing tobacco industry interference. http://www.who.int/ncds/un-task-force/events/model-policy-agencies-united-nations1.pdf (accessed 29 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Economic and Social Council. United Nations interagency task force on non-communicable disease. UN Doc. E/2017/L.21
http://www.un.org/ga/search/view_doc.asp?symbol=E/2017/L.21 (accessed 29 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations Committee on the Rights of the Child. General Comment 15. 2013. UN Doc. CRC/C/GC/15.</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations Committee on the Elimination of Discrimination Against Women. Concluding Observations. 2010. UN Doc. CEDAW/C/ARG/CO/6.</Citation>
        </Reference>
        <Reference>
          <Citation>UNITED STATES &#x2013; MEASURES AFFECTING THE PRODUCTION AND SALE OF CLOVE CIGARETTES. Report of the Panel, WT/DS406/R. 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Collin J. Tobacco control, global health policy and development: towards policy coherence in global governance. Tob Control 2012;21:274&#x2013;80. 10.1136/tobaccocontrol-2011-050418</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2011-050418</ArticleId>
            <ArticleId IdType="pmc">PMC4474152</ArticleId>
            <ArticleId IdType="pubmed">22345267</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30217960</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>e2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Flavour capsule heat-sticks for heated tobacco products.</ArticleTitle>
        <Pagination>
          <StartPage>e158</StartPage>
          <EndPage>e159</EndPage>
          <MedlinePgn>e158-e159</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054472</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cho</LastName>
            <ForeName>Yoo Jin</ForeName>
            <Initials>YJ</Initials>
            <Identifier Source="ORCID">0000-0001-9590-9206</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thrasher</LastName>
            <ForeName>James F</ForeName>
            <Initials>JF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005421">Flavoring Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005421" MajorTopicYN="N">Flavoring Agents</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006358" MajorTopicYN="N">Hot Temperature</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019460" MajorTopicYN="N">Tobacco Industry</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="N">Tobacco Products</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">non-cigarette tobacco products</Keyword>
        <Keyword MajorTopicYN="N">surveillance and monitoring</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>3</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30217960</ArticleId>
        <ArticleId IdType="pmc">PMC6996093</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054472</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054472</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Farsalinos KE, Yannovits N, Sarri T, et al. . Nicotine delivery to the aerosol of a heat-not-burn tobacco product: comparison with a tobacco cigarette and E-Cigarettes. Nicotine Tob Res 2018;20:ntx138 10.1093/ntr/ntx138</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntx138</ArticleId>
            <ArticleId IdType="pubmed">28637344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNeill A, Brose LS, Calder R, et al. . Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by Public Health England. London: Public Health England, 2018. (accessed 17 Apr 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Caputi TL. Industry watch: heat-not-burn tobacco products are about to reach their boiling point. Tob Control 2016;26:609&#x2013;10. 10.1136/tobaccocontrol-2016-053264</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2016-053264</ArticleId>
            <ArticleId IdType="pubmed">27558827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
IQOS. Phillip Morris: smoke-free products. https://www.pmi.com/smoke-free-products/iqos-our-tobacco-heating-system (accessed 17 Jul 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Caputi TL, Leas E, Dredze M, et al. . They&#x2019;re heating up: Internet search query trends reveal significant public interest in heat-not-burn tobacco products. PLoS One 2017;12:e0185735 10.1371/journal.pone.0185735</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0185735</ArticleId>
            <ArticleId IdType="pmc">PMC5636077</ArticleId>
            <ArticleId IdType="pubmed">29020019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tabuchi T, Gallus S, Shinozaki T, et al. . Heat-not-burn tobacco product use in Japan: its prevalence, predictors and perceived symptoms from exposure to secondhand heat-not-burn tobacco aerosol. Tob Control 2018;27:e25&#x2013;33. 10.1136/tobaccocontrol-2017-053947</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2017-053947</ArticleId>
            <ArticleId IdType="pmc">PMC6073918</ArticleId>
            <ArticleId IdType="pubmed">29248896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tabuchi T, Kiyohara K, Hoshino T, et al. . Awareness and use of electronic cigarettes and heat-not-burn tobacco products in Japan. Addiction 2016;111:706&#x2013;13. 10.1111/add.13231</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/add.13231</ArticleId>
            <ArticleId IdType="pubmed">26566956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Lugo A, Spizzichino L, et al. . Heat-not-burn tobacco products: concerns from the Italian experience. Tob Control 2019;28:113&#x2013;4. 10.1136/tobaccocontrol-2017-054054</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2017-054054</ArticleId>
            <ArticleId IdType="pubmed">29374094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brose LS, Simonavicius E, Cheeseman H. Awareness and Use of &#x2019;Heat-not-burn' tobacco products in Great Britain. Tob Regulat Sci 2018;4:44&#x2013;50. 10.18001/TRS.4.2.4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18001/TRS.4.2.4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Euromonitor International. Tobacco: euromonitor passport database. London: Euromonitor International, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Thrasher JF, Islam F, Barnoya J, et al. . Market share for flavour capsule cigarettes is quickly growing, especially in Latin America. Tob Control 2017;26:468&#x2013;70. 10.1136/tobaccocontrol-2016-053030</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2016-053030</ArticleId>
            <ArticleId IdType="pmc">PMC5177543</ArticleId>
            <ArticleId IdType="pubmed">27329114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Institute for Global Tobacco Control. Tobacco pack surveillance system:TPackSS. https://www.globaltobaccocontrol.org/tpackss/pack-search/ (accessed 26 Apr 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Kim H.
2017. 
Research on the impact of flavored tobacco products on smoking initiation. https://goo.gl/hGFdSe (accessed 26 Apr 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Euromonitor International. Global Tobacco: key findings part I - cigarettes. 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Kim M. Philip Morris International introduces new heat-not-burn product, IQOS, in South Korea. Tob Control 2018;27:e76&#x2013;8. 10.1136/tobaccocontrol-2017-053965</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2017-053965</ArticleId>
            <ArticleId IdType="pmc">PMC5966325</ArticleId>
            <ArticleId IdType="pubmed">29170165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yonhap News Agency. 2018. 
Sales of HNB e-cigarettes grow fast since debut last year:&#xA0;Yonhap News. http://english.yonhapnews.co.kr/search1/2603000000.html?cid=AEN20180516002600320
</Citation>
        </Reference>
        <Reference>
          <Citation>
Yonhap News Agency. 2018. 
Cigarette-caused fires dip amid popularity of HNB tobacco products:&#xA0;Yonhap News. http://english.yonhapnews.co.kr/search1/2603000000.html?cid=AEN20180629003700315
</Citation>
        </Reference>
        <Reference>
          <Citation>
KT&amp;G. The history of KT&amp;G. http://en.ktng.com/history?mode=GLOBAL (accessed 17 Apr 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Kim J.
2017. 
Measures to control the risks of flavored tobacco products:&#xA0;weekly issue. https://www.khealth.or.kr:8443/b/16/9561 (accessed 17 Apr 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Emond JA, Soneji S, Brunette MF, et al. . Flavour capsule cigarette use among US adult cigarette smokers. Tob Control 2018;27:650&#x2013;5. 10.1136/tobaccocontrol-2017-054198</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2017-054198</ArticleId>
            <ArticleId IdType="pubmed">29363609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abad-Vivero EN, Thrasher JF, Arillo-Santill&#xE1;n E, et al. . Recall, appeal and willingness to try cigarettes with flavour capsules: assessing the impact of a tobacco product innovation among early adolescents. Tob Control 2016;25:e113&#x2013;9. 10.1136/tobaccocontrol-2015-052805</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2015-052805</ArticleId>
            <ArticleId IdType="pmc">PMC5055844</ArticleId>
            <ArticleId IdType="pubmed">27060099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thrasher JF, Abad-Vivero EN, Moodie C, et al. . Cigarette brands with flavour capsules in the filter: trends in use and brand perceptions among smokers in the USA, Mexico and Australia, 2012-2014. Tob Control 2016;25:275&#x2013;83. 10.1136/tobaccocontrol-2014-052064</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-052064</ArticleId>
            <ArticleId IdType="pmc">PMC4798911</ArticleId>
            <ArticleId IdType="pubmed">25918129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HS, Pack EC, Koo YJ, et al. . Quantitative analysis of menthol and identification of other flavoring ingredients in capsule cigarettes marketed in Korea. Regul Toxicol Pharmacol 2018;92:420&#x2013;8. 10.1016/j.yrtph.2018.01.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yrtph.2018.01.002</ArticleId>
            <ArticleId IdType="pubmed">29309808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yerger VB, McCandless PM. Menthol sensory qualities and smoking topography: a review of tobacco industry documents. Tob Control 2011;20:ii37&#x2013;43. 10.1136/tc.2010.041988</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2010.041988</ArticleId>
            <ArticleId IdType="pmc">PMC3088462</ArticleId>
            <ArticleId IdType="pubmed">21504930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moodie C, Ford A, Dobbie F, et al. . The power of product innovation: smokers' perceptions of capsule cigarettes. Nicotine Tob Res 2018;20:ntx195 10.1093/ntr/ntx195</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntx195</ArticleId>
            <ArticleId IdType="pmc">PMC6093328</ArticleId>
            <ArticleId IdType="pubmed">29059391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moodie C, Ford A, Mackintosh A, et al. . Are all cigarettes just the same? Female&#x2019;s perceptions of slim, coloured, aromatized and capsule cigarettes. Health Educ Res 2015;30:1&#x2013;12. 10.1093/her/cyu063</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/her/cyu063</ArticleId>
            <ArticleId IdType="pubmed">25341674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>German Cancer Research Center. Menthol capsules in cigarette filters &#x2013; increasing the attractiveness of a harmful product Heidelberg, Germany. 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Huang LL, Baker HM, Meernik C, et al. . Impact of non-menthol flavours in tobacco products on perceptions and use among youth, young adults and adults: a systematic review. Tob Control 2017;26:709&#x2013;19. 10.1136/tobaccocontrol-2016-053196</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2016-053196</ArticleId>
            <ArticleId IdType="pmc">PMC5661267</ArticleId>
            <ArticleId IdType="pubmed">27872344</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30215887</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1547-5069</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>51</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing</Title>
          <ISOAbbreviation>J Nurs Scholarsh</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Firearm Violence: A Global Priority for Nursing Science.</ArticleTitle>
        <Pagination>
          <StartPage>229</StartPage>
          <EndPage>240</EndPage>
          <MedlinePgn>229-240</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jnu.12421</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE">This purpose of this article is to frame firearm violence as a health and public health problem, to illustrate the magnitude of the problem, to examine factors that increase the risk to be injured by a firearm, or conversely, that confer protection, and to identify relevant priority areas for nursing science.</AbstractText>
          <AbstractText Label="ORGANIZING CONSTRUCT">Firearm violence results in physical and psychological injuries and is a global health priority. Firearm violence is categorized as intentional (interpersonal and self-inflicted) and unintentional (interpersonal and self-inflicted) and accounts for an estimated 196,000 to 220,000 nonconflict deaths annually.</AbstractText>
          <AbstractText Label="METHODS">We reviewed the theoretical and scientific literature to analyze the magnitude and geographic distribution of firearm violence, the factors associated with firearm injury, the consequences of firearm violence, and areas where nursing science can make an impact on prevention, outcomes, and recovery.</AbstractText>
          <AbstractText Label="FINDINGS">Firearm violence is a significant public health problem that affects the health of individuals, families, and communities. The burdens and contributors to firearm violence vary worldwide, making it important to understand the local context of this global phenomenon. Relevant areas of inquiry span primary prevention focusing on individual and environmental risk factors; and focus on managing the physical and psychological consequences postinjury; and mitigating long-term consequences of firearm violence.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Reducing the global burden of firearm violence and improving the health and safety of individuals, families, and communities provide compelling reasons to integrate this area into nursing science.</AbstractText>
          <AbstractText Label="CLINICAL RELEVANCE">The goals of nursing are to keep people healthy and safe and to help return those injured to their optimal levels of health and well-being. Understanding the factors that come together to injure people with a firearm in various physical, social, economic, and cultural environments positions nurses to both extend the dialogue beyond pro-gun versus anti-gun and to design and carry out rigorous studies to reduce firearm violence.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Sigma Theta Tau International.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Richmond</LastName>
            <ForeName>Therese S</ForeName>
            <Initials>TS</Initials>
            <AffiliationInfo>
              <Affiliation>Andrea B. Laporte Professor of Nursing, Associate Dean for Research &amp; Innovation, Biobehavioral Health Sciences Department, School of Nursing, University of Pennsylvania, Penn Injury Science Center, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Foman</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Research Assistant, School of Nursing, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Student, History and Sociology of Science Department, School of Arts &amp; Sciences, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R49 CE002474</GrantID>
            <Acronym>CE</Acronym>
            <Agency>NCIPC CDC HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R49CE002474</GrantID>
            <Acronym>ACL</Acronym>
            <Agency>ACL HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Nurs Scholarsh</MedlineTA>
        <NlmUniqueID>100911591</NlmUniqueID>
        <ISSNLinking>1527-6546</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005389" MajorTopicYN="N">Firearms</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067073" MajorTopicYN="N">Psychological Trauma</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014754" MajorTopicYN="N">Violence</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014948" MajorTopicYN="N">Wounds, Gunshot</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Firearms</Keyword>
        <Keyword MajorTopicYN="N">homicide</Keyword>
        <Keyword MajorTopicYN="N">policy</Keyword>
        <Keyword MajorTopicYN="N">research</Keyword>
        <Keyword MajorTopicYN="N">suicide</Keyword>
        <Keyword MajorTopicYN="N">traumatic injury</Keyword>
      </KeywordList>
      <CoiStatement>Conflicts of Interest: Authors report no conflicts of interest</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30215887</ArticleId>
        <ArticleId IdType="mid">NIHMS994251</ArticleId>
        <ArticleId IdType="pmc">PMC6417970</ArticleId>
        <ArticleId IdType="doi">10.1111/jnu.12421</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ajdacic-Gross V, Killias M, Hepp U, Gadola E, Bopp M, Lauber C, &#x2026; &amp; R&#xF6;ssler W (2006). Changing times: a longitudinal analysis of international firearm suicide data. American Journal of Public Health, 96(10), 1752&#x2013;1755.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1586136</ArticleId>
            <ArticleId IdType="pubmed">16946021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcon LH, Germain A, Clontz AS, Roach E, Nicholas DH, Zenati MS, &#x2026; &amp; Sperry JL (2012). Predictors of acute posttraumatic stress disorder symptoms following civilian trauma: highest incidence and severity of symptoms after assault. Journal of Trauma and Acute Care Surgery, 72(3), 629&#x2013;637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22491546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ardila-G&#xF3;mez S, Lugo-Palacios DG, &amp; Vargas-Palacios E (2015). Marrying research evidence and policies in Latin America and the Caribbean: the case of violence. Global Health Promotion, 22(1), 6&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25762543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkin SL, Finch SA, Ip EH, Scheindlin B, Craig JA, Steffes J, &#x2026; &amp; Wasserman RC (2008). Is office-based counseling about media use, timeouts, and firearm storage effective? Results from a cluster-randomized, controlled trial. Pediatrics, 122(1), e15&#x2013;e25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4486046</ArticleId>
            <ArticleId IdType="pubmed">18595960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beaman V, Annest JL, Mercy JA, Kresnow MJ, &amp; Pollock DA (2000). Lethality of firearm-related injuries in the United States population. Annals of Emergency Medicine, 35(3), 258&#x2013;266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10692193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bell N, &amp; Schuurman N (2010). GIS and injury prevention and control: history, challenges, and opportunities. International Journal of Environmental Research and Public Health, 7(3), 1002&#x2013;1017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2872318</ArticleId>
            <ArticleId IdType="pubmed">20617015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blumstein A (1995). Youth violence, guns, and the illicit-drug industry. Journal of Criminal Law &amp; Criminology 86(1), 10&#x2013;36.</Citation>
        </Reference>
        <Reference>
          <Citation>Branas CC, Han S, &amp; Wiebe DJ (2016). Alcohol use and firearm violence. Epidemiologic Reviews, 38(1), 32&#x2013;45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4762248</ArticleId>
            <ArticleId IdType="pubmed">26811427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Branas CC, Nance ML, Elliott MR, Richmond TS, &amp; Schwab CW (2004). Urban&#x2013;rural shifts in intentional firearm death: Different causes, same results. American Journal of Public Health, 94(10), 1750&#x2013;1755.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1448529</ArticleId>
            <ArticleId IdType="pubmed">15451745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Branas CC, Richmond TS, Culhane DP, Ten Have TR, &amp; Wiebe DJ (2009). Investigating the link between gun possession and gun assault. American Journal of Public Health, 99(11), 2034&#x2013;2040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2759797</ArticleId>
            <ArticleId IdType="pubmed">19762675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Branas CC, Richmond TS, Ten Have TR, &amp; Wiebe DJ (2011). Acute alcohol consumption, alcohol outlets, and gun suicide. Substance Use and Misuse, 46(13), 1592&#x2013;1603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3989496</ArticleId>
            <ArticleId IdType="pubmed">21929327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Branas CC, Wiebe DJ, Schwab CW, &amp; Richmond TS (2005). Getting past the &#x201C;f&#x201D; word in federally funded public health research. Injury Prevention, 11(3), 191&#x2013;191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1730213</ArticleId>
            <ArticleId IdType="pubmed">15933414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brent DA, Perper JA, Allman CJ, Moritz GM, Wartella ME, &amp; Zelenak JP (1991). The presence and accessibility of firearms in the homes of adolescent suicides: a case-control study. JAMA, 266(21), 2989&#x2013;2995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1820470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brent DA, Perper JA, Moritz G, Baugher M, Schweers J, &amp; Roth C (1993). Firearms and adolescent suicide: a community case-control study. American Journal of Diseases of Children, 147(10), 1066&#x2013;1071.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8213677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bronfrenbrenner U (1979). The ecology of human development Cambridge: Harvard Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Bureau of Alcohol, Tobacco, Firearms and Explosives. (2017). Firearms Commerce in the United States: Annual Statistical Update
https://www.atf.gov/resource-center/data-statistics. (Accessed 11/1/17)</Citation>
        </Reference>
        <Reference>
          <Citation>Butts JA, Roman CG, Bostwick L, &amp; Porter JR (2015). Cure violence: a public health model to reduce gun violence. Annual Review of Public Health, 36, 39&#x2013;53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25581151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carr BG, Wiebe DJ, Richmond TS, Cheney R, &amp; Branas CC (2009) A randomized controlled feasibility trial of alcohol consumption and the ability to appropriately use a firearm. Injury Prevention, 15, 409&#x2013;412. Doi:10.1136/ip.2008.020768.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ip.2008.020768</ArticleId>
            <ArticleId IdType="pubmed">19959734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention (CDC). WISQARS database. (2015). Fatal &amp; Non-Fatal Injury Data
https://www.cdc.gov/injury/wisqars/fatal.html (Accessed 9/15/17).</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention (CDC). WISQARS database. (2016). Fatal Injury Data
https://www.cdc.gov/injury/wisqars/fatal.html (Accessed 1/28/18).</Citation>
        </Reference>
        <Reference>
          <Citation>Chapman S, Alpers P, &amp; Jones M (2016). Association between gun law reforms and intentional firearm deaths in Australia, 1979&#x2013;2013. JAMA, 316(3), 291&#x2013;299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27332876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark C, Ryan L, Kawachi I, Canner MJ, Berkman L, &amp; Wright RJ (2008). Witnessing community violence in residential neighborhoods: a mental health hazard for urban women. Journal of Urban Health, 85(1), 22&#x2013;38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2430129</ArticleId>
            <ArticleId IdType="pubmed">17965940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cukier W &amp; Eagen SA (2018). Gun violence. Current Opinion in Psychology, 19, 109&#x2013;112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29279206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Culyba AJ, Ginsburg KR, Fein JA, Branas CC, Richmond TS, &amp; Wiebe DJ (2016a). Protective Effects of Adolescent&#x2013;Adult Connection on Male Youth in Urban Environments. Journal of Adolescent Health, 58(2), 237&#x2013;240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4724385</ArticleId>
            <ArticleId IdType="pubmed">26802994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Culyba AJ, Jacoby SF, Richmond TS, Fein JA, Hohl BC, &amp; Branas CC (2016b). Modifiable neighborhood features associated with adolescent homicide. JAMA pediatrics, 170(5), 473&#x2013;480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4936414</ArticleId>
            <ArticleId IdType="pubmed">26954939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahlberg LL &amp; Krug EG (2002). Violence-a global public health problem. In Krug E, Dahlberg LL, Mercy JA, Zwi AB &amp; Lozano R (Eds). World report on violence and health Geneva: World Health Organization, 1&#x2013;56.</Citation>
        </Reference>
        <Reference>
          <Citation>DiScala C, &amp; Sege R (2004). Outcomes in children and young adults who are hospitalized for firearms-related injuries. Pediatrics, 113(5), 1306&#x2013;1312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15121946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doucet JM, &amp; Lee MR (2015). Civic communities and urban violence. Social Science Research, 52, 303&#x2013;316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26004464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dowd MD, Langley J, Koepsell T, Soderberg R, &amp; Rivara FP (1996). Hospitalizations for injury in New Zealand: prior injury as a risk factor for assaultive injury. American Journal of Public Health, 86(7), 929&#x2013;934.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1380432</ArticleId>
            <ArticleId IdType="pubmed">8669515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doyle C (2016). Explaining patterns of urban violence in Medellin, Colombia. Laws, 5(1), 3.</Citation>
        </Reference>
        <Reference>
          <Citation>Drapeau CW, McIntosh JL (2016). U.S.A. Suicide: 2015 Official Final Data
American Association of Suicideology; 
http://www.suicidology.org/resources/facts-statistics (Accessed 7/1/17)</Citation>
        </Reference>
        <Reference>
          <Citation>Duberstein PR, Conwell Y, Conner KR, Eberly S, &amp; Caine ED (2004). Suicide at 50 years of age and older: perceived physical illness, family discord and financial strain. Psychological Medicine, 34(1), 137&#x2013;146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14971634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duggan M (2001). More guns, more crime. Journal of Political Economy, 109(5), 1086&#x2013;1114.</Citation>
        </Reference>
        <Reference>
          <Citation>Elgar FJ, &amp; Aitken N (2010). Income inequality, trust and homicide in 33 countries. European Journal of Public Health, 21(2), 241&#x2013;246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20525751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feldmeyer B (2010). The effects of racial/ethnic segregation on Latino and Black homicide. The Sociological Quarterly, 51(4), 600&#x2013;623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20939127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fleegler EW, Lee LK, Monuteaux MC, Hemenway D, &amp; Mannix R (2013). Firearm legislation and firearm-related fatalities in the United States. JAMA Internal Medicine, 173(9), 732&#x2013;740.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23467753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glanz LH &amp; Annas GJ (2009). Handguns, health and the second amendment. The New England Journal of Medicine, 360, 2360&#x2013;2365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19474436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gross T, &amp; Amsler F (2011). Prevalence and incidence of longer term pain in survivors of polytrauma. Surgery, 150(5), 985&#x2013;995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21676423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grossman DC, Neckerman HJ, Koepsell TD, Liu PY, Asher KN, Beland K, &#x2026; &amp; Rivara FP (1997). Effectiveness of a violence prevention curriculum among children in elementary school: A randomized controlled trial. JAMA, 277(20), 1605&#x2013;1611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9168290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hahn RA, Bilukha O, Crosby A, Fullilove MT, Liberman A, Moscicki E, &#x2026; &amp; Briss PA (2005). Firearms laws and the reduction of violence. American Journal of Preventive Medicine, 28(2), 40&#x2013;71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15698747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardy MS (2002). Teaching firearm safety to children: failure of a program. Journal of Developmental and Behavioral Pediatrics, 23(2), 71&#x2013;76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11943968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hausman AJ, Baker CN, Komaroff E, Thomas N, Guerra T, Hohl BC, &amp; Leff SS (2013). Developing measures of community-relevant outcomes for violence prevention programs: A community-based participatory research approach to measurement. American Journal of Community Psychology, 52(3&#x2013;4), 249&#x2013;262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23846829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hemenway D, Miller M (2000). Firearm Availability and Homicide Rates across 26 High-Income Countries. Journal of Trauma and Acute Care Strategy, 49(6), 985&#x2013;988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11130511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hepburn L, Miller M, &amp; Azrael D (2007). The US gun stock: Results from the 2004 National Firearms Survey. Injury Prevention, 13(1), 15&#x2013;19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2610545</ArticleId>
            <ArticleId IdType="pubmed">17296683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Himle MB, Miltenberger RG, Gatheridge BJ, Flessner CA (2004). An evaluation of two procedures for training skills to prevent gun play in children. Pediatrics, 113(1), 70&#x2013;77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14702451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffmire CA, &amp; Bossarte RM (2014). A reconsideration of the correlation between veteran status and firearm suicide in the general population. Injury Prevention, 20(5), 317&#x2013;321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24670958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Institute of Medicine and National Research Council. (2013). Priorities for research to reduce the threat of firearm-related violence Washington, DC: The National Academies Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Jackman GA, Farah MM, Kellerman AL, &amp; Simon HK (2001) Seeing is believing: what do boys do when they find a real gun? Pediatrics, 107(6), 1247&#x2013;1250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11389238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacoby SF, Tach L, Guerra T, Wiebe DJ, &amp; Richmond TS (2017). The health status and well-being of low-resource, housing-unstable, single-parent families living in violent neighbourhoods in Philadelphia, Pennsylvania. Health &amp; Social Care in the Community, 25(2), 578&#x2013;589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5050059</ArticleId>
            <ArticleId IdType="pubmed">27043845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson SL, Solomon BS, Shields WC, McDonald EM, McKenzie LB, &amp; Gielen AC (2009). Neighborhood violence and its association with mothers&#x2019; health: Assessing the relative importance of perceived safety and exposure to violence. Journal of Urban Health, 86(4), 538&#x2013;550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2704268</ArticleId>
            <ArticleId IdType="pubmed">19343500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalesan B, Mobily ME, Keiser O, Fagan JA, &amp; Galea S (2016). Firearm legislation and firearm mortality in the USA: A cross-sectional, state-level study. The Lancet, 387(10030), 1847&#x2013;1855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26972843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karp A (2007). Completing the count: civilian firearms, 39&#x2013;70. In Berman EG, et al. (Eds.), Small Arms Survey 2007: Guns and the City Cambridge University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Kennedy BP, Kawachi I, Prothrow-Stith D, Lochner K, &amp; Gupta V. (1998). Social capital, income inequality, and firearm violent crime. Social Science and Medicine 47(1), 7&#x2013;17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9683374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krouse WJ (2012). Gun Control Legislation
Congressional Research Service, Library of Congress; 
https://fas.org/sgp/crs/misc/RL32842.pdf. (Accessed 9/15/17)</Citation>
        </Reference>
        <Reference>
          <Citation>Krug EG, Dahlberg LL, Mercy JA, Zwi AB, &amp; Lozano R (2002). World Report on Violence and Health Geneva: World Health Organization.</Citation>
        </Reference>
        <Reference>
          <Citation>LeardMann CA, Powell TM, Smith TC, Bell MR, Smith B, Boyko EJ, &#x2026; &amp; Hoge CW (2013). Risk factors associated with suicide in current and former US military personnel. JAMA, 310(5), 496&#x2013;506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23925620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leigh A, &amp; Neill C (2010). Do gun buybacks save lives? Evidence from panel data. American Law and Economics Review, 12(2), 509&#x2013;557.</Citation>
        </Reference>
        <Reference>
          <Citation>Liebschutz J, Schwartz S, Hoyte J, Conoscenti L, Christian AB Sr, Muhammad L, &#x2026; &amp; James T (2010). A chasm between injury and care: experiences of black male victims of violence. The Journal of Trauma, 69(6), 1372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3005415</ArticleId>
            <ArticleId IdType="pubmed">20838259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lotufo PA, &amp; Bensenor IM (2009). Income inequality and male homicide rates: S&#xE3;o Paulo, Brazil, 1996&#x2013;2007. The European Journal of Public Health, 19(6), 602&#x2013;604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19535608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Love J, &amp; Zatzick D (2014). Screening and intervention for comorbid substance disorders, PTSD, depression, and suicide: a trauma center survey. Psychiatric Services, 65(7), 918&#x2013;923.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4256134</ArticleId>
            <ArticleId IdType="pubmed">24733143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDonald CC, Deatrick JA, Kassam-Adams N, &amp; Richmond TS (2011). Community violence exposure and positive youth development in urban youth. Journal of Community Health, 36(6), 925.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3194062</ArticleId>
            <ArticleId IdType="pubmed">21461763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McEvoy C &amp; Hideg G (2017). Global Violent Deaths 2017: Executive Summary and Key Findings [http://www.smallarmssurvey.org/fileadmin/docs/M-files/Armed_violence/Global-Violent-Deaths-2017-ExSum.pdf].</Citation>
        </Reference>
        <Reference>
          <Citation>McGinty EE, Webster DW, &amp; Barry CL (2014). Gun policy and serious mental illness: Priorities for future research and policy. Psychiatric Services, 65(1), 50&#x2013;58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23852317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mertens B, &amp; Sorenson SB (2012). Current considerations about the elderly and firearms. American Journal of Public Health, 102(3), 396&#x2013;400.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3487668</ArticleId>
            <ArticleId IdType="pubmed">22390501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller M, Azrael D, &amp; Hemenway D (2001). Firearm availability and unintentional firearm deaths. Accident Analysis &amp; Prevention, 33(4), 477&#x2013;484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11426678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller M, Swanson SA, &amp; Azrael D (2016). Are we missing something pertinent? A bias analysis of unmeasured confounding in the firearm-suicide literature. Epidemiologic Reviews, 38(1), 62&#x2013;69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26769723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montgomerie JZ, Lawrence AE, Lamotte AD, &amp; Taft CT (2015). The link between posttraumatic stress disorder and firearm violence: A review. Aggression and Violent Behavior, 21, 39&#x2013;44.</Citation>
        </Reference>
        <Reference>
          <Citation>Monuteaux MC, Lee LK, Hemenway D, Mannix R, &amp; Fleegler EW (2015). Firearm ownership and violent crime in the US: an ecologic study. American Journal of Preventive Medicine, 49(2), 207&#x2013;214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26091930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naghavi M, Wang H, Lozano R, Davis A, Liang X, &amp; Zhou M (2015). GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990&#x2013;2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 385(9963), 117&#x2013;71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4340604</ArticleId>
            <ArticleId IdType="pubmed">25530442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nance ML, Carr BG, Kallan MJ, Branas CC, &amp; Wiebe DJ (2010). Variation in pediatric and adolescent firearm mortality rates in rural and urban US counties. Pediatrics, 125(6), 1112&#x2013;1118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20498168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Research Council. (2005). Firearms and Violence: A Critical Review Washington, DC: National Academies Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Resnick MD, Ireland M, &amp; Borowsky I (2004). Youth violence perpetration: what protects? What predicts? Findings from the National Longitudinal Study of Adolescent Health. Journal of Adolescent Health, 35(5), 424&#x2013;e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15488438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rich JA, &amp; Grey CM (2005). Pathways to recurrent trauma among young black men: traumatic stress, substance use, and the &#x201C;code of the street&#x201D;. American Journal of Public Health, 95(5), 816&#x2013;824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1449260</ArticleId>
            <ArticleId IdType="pubmed">15855457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardson EG, &amp; Hemenway D (2011). Homicide, suicide, and unintentional firearm fatality: comparing the United States with other high-income countries, 2003. Journal of Trauma and Acute Care Surgery, 70(1), 238&#x2013;243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20571454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richmond TS, &amp; Aitken LM (2011). A model to advance nursing science in trauma practice and injury outcomes research. Journal of Advanced Nursing, 67(12), 2741&#x2013;2753.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21707726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richmond TS, Amsterdam JD, Guo W, Ackerson T, Gracias V, Robinson KM, &amp; Hollander JE (2009). The effect of post-injury depression on return to pre-injury function: a prospective cohort study. Psychological Medicine, 39(10), 1709&#x2013;1720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2741535</ArticleId>
            <ArticleId IdType="pubmed">19250582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richmond TS, Cheney R, &amp; Schwab CW (2005). The global burden of non-conflict related firearm mortality. Injury Prevention, 11(6), 348&#x2013;352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1730298</ArticleId>
            <ArticleId IdType="pubmed">16326769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenbaum J (2012). Gun utopias? Firearm access and ownership in Israel and Switzerland. Journal of Public Health Policy, 31, 46&#x2013;58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3267868</ArticleId>
            <ArticleId IdType="pubmed">22089893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Runyan CW (2003). Introduction: Back to the future &#x2013; Revisiting Haddon&#x2019;s conceptualization of injury epidemiology and prevention. Epidemiologic Reviews, 25, 60&#x2013;64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12940231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwarz DF, Grisso JA, Miles CG, Holmes JH, Wishner AR, &amp; Sutton RL (1994). A longitudinal study of injury morbidity in an African-American population. JAMA, 271(10), 755&#x2013;760.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8114212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shih RA, Schell TL, Hambarsoomian K, Marshall GN, &amp; Belzberg H (2010). Prevalence of PTSD and major depression following trauma-center hospitalization. The Journal of Trauma, 69(6), 1560&#x2013;1566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3071627</ArticleId>
            <ArticleId IdType="pubmed">20693915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shihadeh ES, &amp; Flynn N (1996). Segregation and crime: The effect of black social isolation on the rates of black urban violence. Social Forces, 74(4), 1325&#x2013;1352.</Citation>
        </Reference>
        <Reference>
          <Citation>Sinauer N, Annest JL, &amp; Mercy JA (1996). Unintentional, nonfatal firearm-related injuries: a preventable public health burden. JAMA, 275(22), 1740&#x2013;1743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8637171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith RN, Seamon MJ, Kumar V, Robinson A, Shults J, Reilly PM, &amp; Richmond TS (2017). Lasting impression of violence: retained bullets and depressive symptoms. Injury In Press.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5771869</ArticleId>
            <ArticleId IdType="pubmed">28882377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sumner SA, Layde PM, &amp; Guse CE (2008). Firearm death rates and association with level of firearm purchase background check. American Journal of Preventive Medicine, 35(1), 1&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18482823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swanson JW, McGinty EE, Fazel S, &amp; Mays VM (2015). Mental illness and reduction of gun violence and suicide: bringing epidemiologic research to policy. Annals of Epidemiology, 25(5), 366&#x2013;376.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4211925</ArticleId>
            <ArticleId IdType="pubmed">24861430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teitelman A, McDonald CC, Wiebe DJ, Thomas N, Guerra T, Kassam&#x2010;Adams N, &amp; Richmond TS (2010). Youth&#x2019;s strategies for staying safe and coping. Journal of community psychology, 38(7), 874&#x2013;885.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3134540</ArticleId>
            <ArticleId IdType="pubmed">21765562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>UN Office for Disarmament Affairs and the Sustainable Development Goals.   https://s3.amazonaws.com/unoda-web/wp-content/uploads/2015/02/UNODA-SDG-Primer_v2.pdf (Accessed 9/15/17)</Citation>
        </Reference>
        <Reference>
          <Citation>UN Security Council (2015). 7442 Meeting. Human Cost of Illicit Flow of Small Arms, Light Weapons Stressed in Security Council Debate
https://www.un.org/press/en/2015/sc11889.doc.htm (Accessed 9/15/17)</Citation>
        </Reference>
        <Reference>
          <Citation>Vaughn NA, Jacoby SF, Williams T, Guerra T, Thomas NA, &amp; Richmond TS (2013). Digital animation as a method to disseminate research findings to the community using a community-based participatory approach. American Journal of Community Psychology, 51(1&#x2013;2), 30&#x2013;42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22395365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang F, &amp; Arnold MT (2008). Localized income inequality, concentrated disadvantage and homicide. Applied Geography, 28(4), 259&#x2013;270.</Citation>
        </Reference>
        <Reference>
          <Citation>Webster DW, Cerd&#xE1; M, Wintemute GJ, &amp; Cook PJ (2016). Epidemiologic evidence to guide the understanding and prevention of gun violence. Epidemiologic Reviews, 38(1), 1&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26905892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiebe DJ, Richmond TS, Guo W, Allison PD, Hollander JE, Nance ML, &amp; Branas CC (2016). Mapping activity patterns to quantify risk of violent assault in urban environments. Epidemiology (Cambridge, Mass.), 27(1), 32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4658670</ArticleId>
            <ArticleId IdType="pubmed">26414941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wintemute GJ, Parham CA, Beaumont JJ, Wright M, &amp; Drake C (1999). Mortality among recent purchasers of handguns. New England Journal of Medicine, 341(21), 1583&#x2013;1589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10564689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wintemute GJ (2015). Alcohol misuse, firearm violence perpetration, and public policy in the United States. Preventive Medicine, 79, 15&#x2013;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25937594</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30213737</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-7452</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>76</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Mar-Apr</Season>
            </PubDate>
          </JournalIssue>
          <Title>Journal of surgical education</Title>
          <ISOAbbreviation>J Surg Educ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Effect of a Global Surgery Resident Rotation on Physician Practices Following Residency: The Mount Sinai Experience.</ArticleTitle>
        <Pagination>
          <StartPage>480</StartPage>
          <EndPage>486</EndPage>
          <MedlinePgn>480-486</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsurg.2018.08.005</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1931-7204(18)30070-9</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The goal of the study was to evaluate the impact of Mount Sinai's international rotation on physician practices and attitudes following residency.</AbstractText>
          <AbstractText Label="DESIGN" NlmCategory="METHODS">An anonymous, retrospective study was conducted using an email survey. The initial survey was sent out in July 2015 with a second opportunity in September 2015.</AbstractText>
          <AbstractText Label="SETTING" NlmCategory="METHODS">Mount Sinai Hospital, New York City.</AbstractText>
          <AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">All 62 graduates of the Mount Sinai General and Plastic Surgery residencies who participated in the international rotation over the last 10 years.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The primary outcome was level of involvement in service medicine with a secondary outcome examining participants views on the value of international rotations during residency. The response rate for the survey was 71% (44/62). Since leaving residency, 53% have been involved in one or more types of service medicine, 59% have been involved in at least one experience practicing medicine in an underserved area and 45% state that their current practice incorporates global surgery or service. 61% report that the rotation encouraged an interest in practicing in an underserved area and 44% (8/18) of those with no prior interest in global health reported that the rotation encouraged an interest. Respondents generally believe global health work could be rewarding (89%), provide opportunity for professional development (77%), and that residency should include global health electives (93%).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results suggest that a mandatory global health rotation may encourage an interest in service medicine. Thus, program directors should continue to provide and encourage participation in international rotations during surgical residency.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Association of Program Directors in Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Flatow</LastName>
            <ForeName>Virginia</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Icahn School of Medicine at Mount Sinai, Department of Surgery, New York, New York. Electronic address: Virginia.flatow@icahn.mssm.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trinidad</LastName>
            <ForeName>Stephen M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Icahn School of Medicine at Mount Sinai, Department of Surgery, New York, New York. Electronic address: Stephen.trinidad@icahn.mssm.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Linda P</ForeName>
            <Initials>LP</Initials>
            <AffiliationInfo>
              <Affiliation>Icahn School of Medicine at Mount Sinai, Department of Surgery, New York, New York. Electronic address: Linda.Zhang@mountsinai.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marin</LastName>
            <ForeName>Michael L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Icahn School of Medicine at Mount Sinai, Department of Surgery, New York, New York. Electronic address: Michael.marin@mountsinai.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Divino</LastName>
            <ForeName>Celia M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Icahn School of Medicine at Mount Sinai, Department of Surgery, New York, New York. Electronic address: celia.divino@mountsinai.org.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Surg Educ</MedlineTA>
        <NlmUniqueID>101303204</NlmUniqueID>
        <ISSNLinking>1878-7452</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001291" MajorTopicYN="Y">Attitude of Health Personnel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013502" MajorTopicYN="N">General Surgery</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007393" MajorTopicYN="Y">International Educational Exchange</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007396" MajorTopicYN="N">Internship and Residency</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009519" MajorTopicYN="N" Type="Geographic">New York City</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010818" MajorTopicYN="Y">Practice Patterns, Physicians'</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013518" MajorTopicYN="N">Surgery, Plastic</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Global surgery</Keyword>
        <Keyword MajorTopicYN="N">International rotation</Keyword>
        <Keyword MajorTopicYN="N">International surgery</Keyword>
        <Keyword MajorTopicYN="N">Practice-Based Learning and Improvement</Keyword>
        <Keyword MajorTopicYN="N">Professionalism</Keyword>
        <Keyword MajorTopicYN="N">Systems-Based Practice</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30213737</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jsurg.2018.08.005</ArticleId>
        <ArticleId IdType="pii">S1931-7204(18)30070-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30212852</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1460-2245</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>34</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Health promotion international</Title>
          <ISOAbbreviation>Health Promot Int</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Updating the determinants of health model in the Information Age.</ArticleTitle>
        <Pagination>
          <StartPage>1241</StartPage>
          <EndPage>1249</EndPage>
          <MedlinePgn>1241-1249</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/heapro/day064</ELocationID>
        <Abstract>
          <AbstractText>In 1991, Dahlgren and Whitehead produced a highly influential model of the determinants of health that has since been used by numerous national and international public health organizations globally. The purpose of the model is to enable interventions that improve health to be addressed at four key policy levels. It is not a model of health or disease; instead the model is structured around health policy decision-making. However the model needs an update, since it was devised there has been a digital revolution that has transformed every aspect of: human life, our cities, society and the fundamental principles upon which the global economy operates. The article examines the impact of Information and Communication Technologies (ICT) on the determinants of health. ICT has given rise to a new Information Age that is implicated in many of the major global health issues today. Addressing contemporary health issues requires intervention at the level of ICT, particularly as health communication online is central to the delivery and dissemination of public health policies.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rice</LastName>
            <ForeName>Louis</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Architecture, University of the West of England, Coldharbour Lane, Bristol BS16 1QY, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sara</LastName>
            <ForeName>Rachel</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Architecture, University of the West of England, Coldharbour Lane, Bristol BS16 1QY, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Health Promot Int</MedlineTA>
        <NlmUniqueID>9008939</NlmUniqueID>
        <ISSNLinking>0957-4824</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020811" MajorTopicYN="N">Biomedical Technology</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003142" MajorTopicYN="Y">Communication</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058015" MajorTopicYN="N">Health Communication</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073256" MajorTopicYN="N">Information Technology</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007398" MajorTopicYN="N">Interpersonal Relations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011050" MajorTopicYN="N">Policy Making</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057185" MajorTopicYN="N">Sedentary Behavior</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064890" MajorTopicYN="N">Social Determinants of Health</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">determinants of health</Keyword>
        <Keyword MajorTopicYN="N">health</Keyword>
        <Keyword MajorTopicYN="N">health communication</Keyword>
        <Keyword MajorTopicYN="N">health promotion</Keyword>
        <Keyword MajorTopicYN="N">public health policy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30212852</ArticleId>
        <ArticleId IdType="doi">10.1093/heapro/day064</ArticleId>
        <ArticleId IdType="pii">5095999</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30209814</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2648</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>75</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of advanced nursing</Title>
          <ISOAbbreviation>J Adv Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Developing and validating learning domains, competencies, and evaluation items for global health clinical immersion practicums for graduate-level nursing programs.</ArticleTitle>
        <Pagination>
          <StartPage>234</StartPage>
          <EndPage>252</EndPage>
          <MedlinePgn>234-252</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jan.13851</ELocationID>
        <Abstract>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To develop and validate learning domains, competencies, and evaluation tool for graduate-level experiential nursing global health programs.</AbstractText>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Standard competencies have not been synthesized and delineated nor have evaluation tools been developed for global health programs at the graduate level.</AbstractText>
          <AbstractText Label="DESIGN" NlmCategory="METHODS">A combination of a documentary literature review and expert consensus panel to validate results was used as a design for this study.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The NLM and CINAHL databases were searched for articles published between 2007 - 2017 relevant to graduate-level global health nursing programs. Data&#xA0;were extracted and coded, from which themes regarding learning domains, competencies and evaluation items were derived. We then used a three-step expert panel to refine and form a statistical representation (&gt;0.78 agreement on importance, relevance and clarity) of the learning domains, competencies, and evaluation items.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Relevant articles (N = 26) were included for the documentary review, 18&#xA0;concerning learning domains of global health immersion programs and eight concerning interdisciplinary global health competencies specific to nursing. These learning relationships were then formatted into a table subdivided between learning categories for expert panel consensus. After expert panel review, a compendium of learning domains, competencies, and evaluation items resulted.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Global health clinical learning practicums are essential for graduate-level preparation of nurses. Learning domains, competencies, and evaluation tools need to be adopted and empirically tested by international and national&#xA0;nursing associations. The results of this study need further testing to aid these associations.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kelly</LastName>
            <ForeName>Tracy</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0002-8363-9330</Identifier>
            <AffiliationInfo>
              <Affiliation>Yale University School of Nursing, West Haven, Connecticut.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lazenby</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Yale University School of Nursing, West Haven, Connecticut.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Adv Nurs</MedlineTA>
        <NlmUniqueID>7609811</NlmUniqueID>
        <ISSNLinking>0309-2402</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057179" MajorTopicYN="N">Advanced Practice Nursing</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002983" MajorTopicYN="N">Clinical Competence</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003479" MajorTopicYN="Y">Curriculum</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004511" MajorTopicYN="N">Education, Nursing, Graduate</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011231" MajorTopicYN="N">Preceptorship</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016730" MajorTopicYN="N">Program Development</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">advanced practice nursing</Keyword>
        <Keyword MajorTopicYN="N">clinical immersion practicums</Keyword>
        <Keyword MajorTopicYN="N">competencies</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">host country partnership</Keyword>
        <Keyword MajorTopicYN="N">instrument development</Keyword>
        <Keyword MajorTopicYN="N">learning domains</Keyword>
        <Keyword MajorTopicYN="N">literature review</Keyword>
        <Keyword MajorTopicYN="N">nursing</Keyword>
        <Keyword MajorTopicYN="N">program evaluation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30209814</ArticleId>
        <ArticleId IdType="doi">10.1111/jan.13851</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30207826</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1557-8100</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Omics : a journal of integrative biology</Title>
          <ISOAbbreviation>OMICS</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rise of Clinical Microbial Proteogenomics: A Multiomics Approach to Nontuberculous Mycobacterium-The Case of Mycobacterium abscessus UC22.</ArticleTitle>
        <Pagination>
          <StartPage>1</StartPage>
          <EndPage>16</EndPage>
          <MedlinePgn>1-16</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/omi.2018.0116</ELocationID>
        <Abstract>
          <AbstractText>Nontuberculous mycobacterial (NTM) species present a major challenge for global health with serious clinical manifestations ranging from pulmonary to skin infections. Multiomics research and its applications toward clinical microbial proteogenomics offer veritable potentials in this context. For example, the Mycobacterium abscessus, a highly pathogenic NTM, causes bronchopulmonary infection and chronic pulmonary disease. The rough variant of the M. abscessus UC22 strain is extremely virulent and causes lung upper lobe fibrocavitary disease. Although several whole-genome next-generation sequencing studies have characterized the genes in the smooth variant of M. abscessus, a reference genome sequence for the rough variant was generated only recently and calls for further clinical applications. We carried out whole-genome sequencing and proteomic analysis for a clinical isolate of M. abscessus UC22 strain obtained from a pulmonary tuberculosis patient. We identified 5506 single-nucleotide variations (SNVs), 63 insertions, and 76 deletions compared with the reference genome. Using a high-resolution LC-MS/MS-based approach (liquid chromatography tandem mass spectrometry), we obtained protein coding evidence for 3601 proteins, representing 71% of the total predicted genes in this genome. Application of proteogenomic approach further revealed seven novel protein-coding genes and enabled refinement of six computationally derived gene models. We also identified 30 variant peptides corresponding to 16 SNVs known to be associated with drug resistance. These new observations offer promise for clinical applications of microbial proteogenomics and next-generation sequencing, and provide a resource for future global health applications for NTM species.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Advani</LastName>
            <ForeName>Jayshree</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>1 Institute of Bioinformatics , International Technology Park, Bangalore, India .</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2 Manipal Academy of Higher Education , Manipal, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Verma</LastName>
            <ForeName>Renu</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>1 Institute of Bioinformatics , International Technology Park, Bangalore, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chatterjee</LastName>
            <ForeName>Oishi</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>1 Institute of Bioinformatics , International Technology Park, Bangalore, India .</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3 Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University) , Mangalore, India .</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>4 School of Biotechnology , Amrita Vishwa Vidyapeetham, Kollam, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Devasahayam Arokia Balaya</LastName>
            <ForeName>Rex</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>3 Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University) , Mangalore, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Najar</LastName>
            <ForeName>Mohd Altaf</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>3 Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University) , Mangalore, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ravishankara</LastName>
            <ForeName>Namitha</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>5 Department of Biotechnology, M.S. Ramaiah Institute of Technology , Bangalore, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suresh</LastName>
            <ForeName>Sneha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>5 Department of Biotechnology, M.S. Ramaiah Institute of Technology , Bangalore, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pachori</LastName>
            <ForeName>Praveen Kumar</ForeName>
            <Initials>PK</Initials>
            <AffiliationInfo>
              <Affiliation>6 Department of Microbiology and Molecular Biology, ICMR-National JALMA Institute for Leprosy &amp; Other Mycobacterial Diseases , Agra, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Umesh D</ForeName>
            <Initials>UD</Initials>
            <AffiliationInfo>
              <Affiliation>6 Department of Microbiology and Molecular Biology, ICMR-National JALMA Institute for Leprosy &amp; Other Mycobacterial Diseases , Agra, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pinto</LastName>
            <ForeName>Sneha M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>3 Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University) , Mangalore, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chauhan</LastName>
            <ForeName>Devendra S</ForeName>
            <Initials>DS</Initials>
            <AffiliationInfo>
              <Affiliation>6 Department of Microbiology and Molecular Biology, ICMR-National JALMA Institute for Leprosy &amp; Other Mycobacterial Diseases , Agra, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tripathy</LastName>
            <ForeName>Srikanth Prasad</ForeName>
            <Initials>SP</Initials>
            <AffiliationInfo>
              <Affiliation>6 Department of Microbiology and Molecular Biology, ICMR-National JALMA Institute for Leprosy &amp; Other Mycobacterial Diseases , Agra, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gowda</LastName>
            <ForeName>Harsha</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>1 Institute of Bioinformatics , International Technology Park, Bangalore, India .</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Prasad</LastName>
            <ForeName>T S Keshava</ForeName>
            <Initials>TSK</Initials>
            <AffiliationInfo>
              <Affiliation>1 Institute of Bioinformatics , International Technology Park, Bangalore, India .</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3 Center for Systems Biology and Molecular Medicine, Yenepoya Research Centre, Yenepoya (Deemed to be University) , Mangalore, India .</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>OMICS</MedlineTA>
        <NlmUniqueID>101131135</NlmUniqueID>
        <ISSNLinking>1536-2310</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004352" MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073358" MajorTopicYN="N">Mycobacterium abscessus</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009170" MajorTopicYN="N">Nontuberculous Mycobacteria</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071696" MajorTopicYN="N">Proteogenomics</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014397" MajorTopicYN="N">Tuberculosis, Pulmonary</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">acquired resistance</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">multiomics</Keyword>
        <Keyword MajorTopicYN="N">next-generation sequencing</Keyword>
        <Keyword MajorTopicYN="N">nontuberculous mycobacterial species</Keyword>
        <Keyword MajorTopicYN="N">proteogenomics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30207826</ArticleId>
        <ArticleId IdType="doi">10.1089/omi.2018.0116</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30204711</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2202-4433</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>17</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>JBI database of systematic reviews and implementation reports</Title>
          <ISOAbbreviation>JBI Database System Rev Implement Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>49</StartPage>
          <EndPage>73</EndPage>
          <MedlinePgn>49-73</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.11124/JBISRIR-2017-003740</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The objective of the review was to evaluate the effectiveness of the use of phosphate binders on mortality and serum levels of phosphorus, calcium and parathyroid hormone in adult patients with end stage renal disease receiving hemodialysis compared to hemodialysis with no phosphate binder use.</AbstractText>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">End stage renal disease leading to hemodialysis is a common global health issue. Effective management of this population is focused on balancing alterations in bone mineral markers such as phosphorus, calcium and parathyroid hormone. Chronic imbalances are associated with all-cause mortality. Phosphate binders are a crucial element to regulating these levels.</AbstractText>
          <AbstractText Label="INCLUSION CRITERIA" NlmCategory="METHODS">The review considered studies including adult patients, age 18 and over, receiving hemodialysis. The intervention of interest was the use of any drug within the class of phosphate binders. Outcomes of interest were all-cause mortality and serum levels of phosphorus, calcium and parathyroid hormone. Experimental and quasi-experimental study designs were considered.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A search for relevant published and unpublished literature was conducted through November 5, 2017. Databases searched included PubMed, CINAHL, Embase and Cochrane Central Register of Controlled Trials (CENTRAL), in addition to gray literature sources. Articles that met the inclusion criteria were further assessed for methodological validity by two independent reviewers using the standard critical appraisal instruments from Joanna Briggs Institute. Data were extracted from papers included in the review using the standardized data extraction tool from the Joanna Briggs Institute. Quantitative data were pooled for statistical meta-analysis to evaluate the impact of phosphate binders on phosphorus and calcium.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven studies were included in this review. A meta-analysis of four studies showed that the use of phosphate binders resulted in a statistically significant decrease in phosphorus levels compared to placebo (mean difference -1.89&#x200A;mg/dL, 95% confidence interval -2.03&#x200A;mg/dL, -1.75&#x200A;mg/dL); three additional studies described narratively also showed a statistically significant decrease in phosphorus. A meta-analysis of three studies showed a statistically significant increase in calcium compared to placebo (mean difference 0.57&#x200A;mg/dL, 95% confidence interval 0.50&#x200A;mg/dL, 0.64&#x200A;mg/dL); two additional studies described narratively showed no difference in effect on calcium. Of the three studies that measured parathyroid hormone, one showed a statistically significant improvement with the use of phosphate binders (mean difference -83.0&#x200A;pg/mL, 95% confidence interval -154.63&#x200A;pg/mL, -11.37&#x200A;pg/mL) and two showed no difference in effect. No studies measured mortality.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Phosphate binders are effective in reducing serum phosphorus. The findings on parathyroid hormone and calcium did not provide adequate support for phosphate binder use. The impact on mortality was not directly measured in any of the included studies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gasu</LastName>
            <ForeName>Vivian</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>College of Health Professions, Pace University, New York, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Northeast Institute for Evidence Synthesis and Translation (NEST): a Joanna Briggs Institute Center of Excellence.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ashong</LastName>
            <ForeName>Mary</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>College of Health Professions, Pace University, New York, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Northeast Institute for Evidence Synthesis and Translation (NEST): a Joanna Briggs Institute Center of Excellence.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seferi</LastName>
            <ForeName>Arta</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>College of Health Professions, Pace University, New York, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Northeast Institute for Evidence Synthesis and Translation (NEST): a Joanna Briggs Institute Center of Excellence.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fitzpatrick</LastName>
            <ForeName>Aileen</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>College of Health Professions, Pace University, New York, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Northeast Institute for Evidence Synthesis and Translation (NEST): a Joanna Briggs Institute Center of Excellence.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>JBI Database System Rev Implement Rep</MedlineTA>
        <NlmUniqueID>101648258</NlmUniqueID>
        <ISSNLinking>2202-4433</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010710">Phosphates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>27YLU75U4W</RegistryNumber>
          <NameOfSubstance UI="D010758">Phosphorus</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>SY7Q814VUP</RegistryNumber>
          <NameOfSubstance UI="D002118">Calcium</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010281" MajorTopicYN="N">Parathyroid Hormone</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010710" MajorTopicYN="N">Phosphates</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010758" MajorTopicYN="N">Phosphorus</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30204711</ArticleId>
        <ArticleId IdType="doi">10.11124/JBISRIR-2017-003740</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30204240</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1097-0215</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>144</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of cancer</Title>
          <ISOAbbreviation>Int J Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.</ArticleTitle>
        <Pagination>
          <StartPage>110</StartPage>
          <EndPage>116</EndPage>
          <MedlinePgn>110-116</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.31863</ELocationID>
        <Abstract>
          <AbstractText>Kaposi sarcoma (KS) is among the most common childhood malignancies in central, eastern, and southern Africa. Although its unique clinical features have been established, biological mechanisms related to the causative agent, KS-associated herpes-virus (KSHV), have yet to be explored in children. We performed a prospective observational pilot study to explore associations between KSHV viral load (VL), human interleukin-6 (IL-6) and IL-10 levels, and clinical characteristics of 25 children with KS in Lilongwe, Malawi from June 2013-August 2015. The median age was 6.4 years. Lymphadenopathy was the most common site of KS involvement (64%), followed by skin and oral mucosa (44% each), woody edema (12%), and pulmonary (8%). Baseline samples for plasma KSHV VL, IL-6 and IL-10 analyses were available for 18/25 patients (72%) at time of KS diagnosis. KSHV VL was detectable at baseline in 12/18 (67%) patients, the median baseline IL-6 level was 8.53 pg/mL (range 4.31-28.33), and the median baseline IL-10 level was 19.53 pg/mL (range 6.91-419.69). Seven (39%) patients presented with an IL-6 level &gt; 10 pg/mL (exceeding twice the upper limit of normal). Detectable KSHV VL was significantly associated with lymphadenopathic KS (p = 0.004), while having undetectable KSHV VL was associated with a higher likelihood of presenting with hyperpigmented skin lesions (p = 0.01). Detectable KSHV VL and elevated IL-6 levels are present in a subset of children with KS. Lytic activation of KSHV and associated elevation in KSHV VL may contribute to the unique clinical manifestations of pediatric KS in KSHV-endemic regions of Africa.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 UICC.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>El-Mallawany</LastName>
            <ForeName>Nader Kim</ForeName>
            <Initials>NK</Initials>
            <Identifier Source="ORCID">0000-0001-6115-1046</Identifier>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine, Houston, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Texas Children's Cancer and Hematology Centers, Houston, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mehta</LastName>
            <ForeName>Parth S</ForeName>
            <Initials>PS</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine, Houston, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Texas Children's Cancer and Hematology Centers, Houston, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamiyango</LastName>
            <ForeName>William</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine Children's Foundation Malawi, Lilongwe, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Villiera</LastName>
            <ForeName>Jimmy</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine Children's Foundation Malawi, Lilongwe, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peckham-Gregory</LastName>
            <ForeName>Erin C</ForeName>
            <Initials>EC</Initials>
            <Identifier Source="ORCID">0000-0002-7593-8381</Identifier>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine, Houston, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Texas Children's Cancer and Hematology Centers, Houston, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kampani</LastName>
            <ForeName>Coxcilly</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>University of North Carolina (UNC) Project Malawi, Lilongwe, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krysiak</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>University of North Carolina (UNC) Project Malawi, Lilongwe, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sanders</LastName>
            <ForeName>Marcia K</ForeName>
            <Initials>MK</Initials>
            <AffiliationInfo>
              <Affiliation>Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Caro-Vegas</LastName>
            <ForeName>Carolina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eason</LastName>
            <ForeName>Anthony B</ForeName>
            <Initials>AB</Initials>
            <AffiliationInfo>
              <Affiliation>Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahmed</LastName>
            <ForeName>Saeed</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine, Houston, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine Children's Foundation Malawi, Lilongwe, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schutze</LastName>
            <ForeName>Gordon E</ForeName>
            <Initials>GE</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine, Houston, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Texas Children's Hospital, Houston, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martin</LastName>
            <ForeName>Stephen C</ForeName>
            <Initials>SC</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine, Houston, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Texas Children's Cancer and Hematology Centers, Houston, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine Children's Foundation Malawi, Lilongwe, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kazembe</LastName>
            <ForeName>Peter N</ForeName>
            <Initials>PN</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine Children's Foundation Malawi, Lilongwe, Malawi.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scheurer</LastName>
            <ForeName>Michael E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Baylor College of Medicine, Houston, TX.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Texas Children's Cancer and Hematology Centers, Houston, TX.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dittmer</LastName>
            <ForeName>Dirk P</ForeName>
            <Initials>DP</Initials>
            <AffiliationInfo>
              <Affiliation>Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, NC.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P01 CA019014</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>U54 CA190152</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA239583</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 AI036211</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA228172</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21 CA192744</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21 CA217137</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D064888">Observational Study</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Int J Cancer</MedlineTA>
        <NlmUniqueID>0042124</NlmUniqueID>
        <ISSNLinking>0020-7136</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019353" MajorTopicYN="N">Endemic Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006566" MajorTopicYN="N">Herpesviridae Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019288" MajorTopicYN="N">Herpesvirus 8, Human</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008295" MajorTopicYN="N" Type="Geographic">Malawi</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012514" MajorTopicYN="N">Sarcoma, Kaposi</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019562" MajorTopicYN="Y">Viral Load</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014775" MajorTopicYN="N">Virus Activation</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HHV8</Keyword>
        <Keyword MajorTopicYN="N">HIV</Keyword>
        <Keyword MajorTopicYN="N">IL-6</Keyword>
        <Keyword MajorTopicYN="N">KSHV</Keyword>
        <Keyword MajorTopicYN="N">Kaposi sarcoma</Keyword>
        <Keyword MajorTopicYN="N">Kaposi sarcoma-associated herpesvirus</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">human herpesvirus8</Keyword>
        <Keyword MajorTopicYN="N">interleukin-6</Keyword>
        <Keyword MajorTopicYN="N">pediatric oncology</Keyword>
      </KeywordList>
      <CoiStatement>The authors have nothing to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30204240</ArticleId>
        <ArticleId IdType="mid">NIHMS993079</ArticleId>
        <ArticleId IdType="pmc">PMC6261676</ArticleId>
        <ArticleId IdType="doi">10.1002/ijc.31863</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ziegler JL, Katongole-Mbidde E. Kaposi&#x2019;s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. International journal of cancer. Journal international du cancer 1996;65:200&#x2013;3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8567117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gantt S, Kakuru A, Wald A, Walusansa V, Corey L, Casper C, Orem J. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatric blood &amp; cancer 2010;54:670&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2839022</ArticleId>
            <ArticleId IdType="pubmed">20205254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cox CM, El-Mallawany NK, Kabue M, Kovarik C, Schutze GE, Kazembe PN, Mehta PS. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana. Pediatric blood &amp; cancer 2013;60:1274&#x2013;80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23487320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chagaluka G, Stanley C, Banda K, Depani S, Nijram&#x2019;madzi J, Katangwe T, Israels T, Bailey S, Mukaka M, Molyneux E. Kaposi&#x2019;s sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin. European journal of cancer 2014;50:1472&#x2013;81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24636877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Mallawany NK, Kamiyango W, Slone JS, Villiera J, Kovarik CL, Cox CM, Dittmer DP, Ahmed S, Schutze GE, Scheurer ME, Kazembe PN, Mehta PS. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PloS one 2016;11:e0153335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4833299</ArticleId>
            <ArticleId IdType="pubmed">27082863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Mallawany NK, Kamiyango W, Villiera J, Slone JS, Kovarik CL, Campbell LR, Agrawal AK, Dittmer DP, Eason AB, Ahmed S, Schutze GE, Scheurer ME, et al. Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol 2017:JGO1700054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6180767</ArticleId>
            <ArticleId IdType="pubmed">29272148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macken M, Dale H, Moyo D, Chakmata E, Depani S, Israels T, Niyrenda D, Bailey S, Chagaluka G, Molyneux EM. Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children. Pediatric blood &amp; cancer 2018;65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28988435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stefan DC. Patterns of distribution of childhood cancer in Africa. Journal of tropical pediatrics 2015;61:165&#x2013;73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25724211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polizzotto MN, Uldrick TS, Hu D, Yarchoan R. Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome. Frontiers in microbiology 2012;3:73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3291870</ArticleId>
            <ArticleId IdType="pubmed">22403576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Marshall V, Wang V, Whitby D, Pittaluga S, Jaffe ES, Millo C, Tosato G, Little RF, et al. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016;62:730&#x2013;38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4772848</ArticleId>
            <ArticleId IdType="pubmed">26658701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goncalves PH, Uldrick TS, Yarchoan R. HIV-associated Kaposi sarcoma and related diseases. Aids 2017;31:1903&#x2013;16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6310482</ArticleId>
            <ArticleId IdType="pubmed">28609402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakakibara S, Tosato G. Viral interleukin-6: role in Kaposi&#x2019;s sarcoma-associated herpesvirus: associated malignancies. Journal of interferon &amp; cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2011;31:791&#x2013;801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3216071</ArticleId>
            <ArticleId IdType="pubmed">21767154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 2002;298:1432&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12434062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hosseinipour MC, Sweet KM, Xiong J, Namarika D, Mwafongo A, Nyirenda M, Chiwoko L, Kamwendo D, Hoffman I, Lee J, Phiri S, Vahrson W, et al. Viral profiling identifies multiple subtypes of Kaposi&#x2019;s sarcoma. mBio 2014;5:e01633&#x2013;14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4173763</ArticleId>
            <ArticleId IdType="pubmed">25249280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcelin AG, Motol J, Guihot A, Caumes E, Viard JP, Dussaix E, Cadranel J, Frances C, Carcelain G, Calvez V, Dupin N. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease. The Journal of infectious diseases 2007;196:1163&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17955434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C, Brett-Smith H, Haase AT. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi&#x2019;s sarcoma, primary effusion lymphoma, and multicentric Castleman&#x2019;s disease. Journal of virology 1999;73:4181&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC104197</ArticleId>
            <ArticleId IdType="pubmed">10196314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulz TF. The pleiotropic effects of Kaposi&#x2019;s sarcoma herpesvirus. The Journal of pathology 2006;208:187&#x2013;98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16362980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campbell TB, Borok M, White IE, Gudza I, Ndemera B, Taziwa A, Weinberg A, Gwanzura L. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36:1144&#x2013;51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12715309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duprez R, Kassa-Kelembho E, Plancoulaine S, Briere J, Fossi M, Kobangue L, Minsart P, Huerre M, Gessain A. Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi&#x2019;s sarcoma in Central African Republic. J Clin Microbiol 2005;43:4840&#x2013;3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1234088</ArticleId>
            <ArticleId IdType="pubmed">16145154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haq IU, Dalla Pria A, Papanastasopoulos P, Stegmann K, Bradshaw D, Nelson M, Bower M. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients. HIV Med 2016;17:56&#x2013;61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26111246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krown SE, Testa MA, Huang J. AIDS-related Kaposi&#x2019;s sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15:3085&#x2013;92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9294471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Mallawany NK, McAtee CL, Campbell LR, Kazembe PN. Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives. Pediatric Health Med Ther 2018;9:35&#x2013;46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5919159</ArticleId>
            <ArticleId IdType="pubmed">29722363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobson MA, Ditmer DP, Sinclair E, Martin JN, Deeks SG, Hunt P, Mocarski ES, Shiboski C. Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. PloS one 2009;4:e5277.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2667217</ArticleId>
            <ArticleId IdType="pubmed">19381272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westmoreland KD, Montgomery ND, Stanley CC, El-Mallawany NK, Wasswa P, van der Gronde T, Mtete I, Butia M, Itimu S, Chasela M, Mtunda M, Kampani C, et al. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi. International journal of cancer. Journal international du cancer 2017;140:2509&#x2013;16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5386821</ArticleId>
            <ArticleId IdType="pubmed">28268254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel JP, Agbalika F. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 2000;96:2069&#x2013;73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10979949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, Orlowski RZ, Neelapu S, Boddu PC, Akosile MA, Uldrick TS, Yarchoan R, et al. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood 2017;129:1658&#x2013;68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5364343</ArticleId>
            <ArticleId IdType="pubmed">28100459</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30203042</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1537-6613</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>219</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>09</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of infectious diseases</Title>
          <ISOAbbreviation>J Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Structural Characterization of Pan-Ebolavirus Antibody 6D6 Targeting the Fusion Peptide of the Surface Glycoprotein.</ArticleTitle>
        <Pagination>
          <StartPage>415</StartPage>
          <EndPage>419</EndPage>
          <MedlinePgn>415-419</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiy532</ELocationID>
        <Abstract>
          <AbstractText>Ebola virus infection causes severe disease in humans and represents a global health threat. Candidates for immunotherapeutics and vaccines have shown promise in clinical trials, although they are ineffective against other members of the Ebolavirus genus that also cause periodic, lethal outbreaks. In this study, we present a crystal structure of a pan-ebolavirus antibody, 6D6, as well as single-particle electron microscopy reconstructions of 6D6 in complex with Ebola and Bundibugyo virus glycoproteins. 6D6 binds to the conserved glycoprotein fusion peptide, implicating it as a site of immune vulnerability that could be exploited to reliably elicit a pan-ebolavirus neutralizing antibody response.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Milligan</LastName>
            <ForeName>Jacob C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immunology and Microbiology, La Jolla, California.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parekh</LastName>
            <ForeName>Diptiben V</ForeName>
            <Initials>DV</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immunology and Microbiology, La Jolla, California.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fuller</LastName>
            <ForeName>Katherine M</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immunology and Microbiology, La Jolla, California.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Igarashi</LastName>
            <ForeName>Manabu</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takada</LastName>
            <ForeName>Ayato</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saphire</LastName>
            <ForeName>Erica Ollmann</ForeName>
            <Initials>EO</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immunology and Microbiology, La Jolla, California.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>T32 AI007354</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>U19 AI109762</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AI132204</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Infect Dis</MedlineTA>
        <NlmUniqueID>0413675</NlmUniqueID>
        <ISSNLinking>0022-1899</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010455">Peptides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014760">Viral Fusion Proteins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D029043" MajorTopicYN="N">Ebolavirus</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019142" MajorTopicYN="N">Hemorrhagic Fever, Ebola</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016233" MajorTopicYN="N">Immunotherapy, Active</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014760" MajorTopicYN="N">Viral Fusion Proteins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>9</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30203042</ArticleId>
        <ArticleId IdType="pmc">PMC6325343</ArticleId>
        <ArticleId IdType="doi">10.1093/infdis/jiy532</ArticleId>
        <ArticleId IdType="pii">5093891</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
World Health Organization. Situation Report - Ebola Virus Disease. 2016.  Available at: http://apps.who.int/iris/bitstream/handle/10665/208883/ebolasitrep_10Jun2016_eng.pdf. Accessed 18 July 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Burk R, Bollinger L, Johnson JC, et al. . Neglected filoviruses. FEMS Microbiol Rev 2016; 40:494&#x2013;519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4931228</ArticleId>
            <ArticleId IdType="pubmed">27268907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu X, Wong G, Audet J, et al. . Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014; 514:47&#x2013;53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4214273</ArticleId>
            <ArticleId IdType="pubmed">25171469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Li J, Hu Y, Liang Q, Wei M, Zhu F. Ebola vaccines in clinical trial: the promising candidates. Hum Vaccin Immunother 2017; 13:153&#x2013;68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5287303</ArticleId>
            <ArticleId IdType="pubmed">27764560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pascal KE, Dudgeon D, Trefry JC, et al. . Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in non-human primates. J Infect Dis 2018; doi: 10.1093/infdis/jiy285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiy285</ArticleId>
            <ArticleId IdType="pmc">PMC6249601</ArticleId>
            <ArticleId IdType="pubmed">29860496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wec AZ, Herbert AS, Murin CD, et al. . Antibodies from a human survivor define sites of vulnerability for broad protection against Ebolaviruses. Cell 2017; 169:878&#x2013;90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5808922</ArticleId>
            <ArticleId IdType="pubmed">28525755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao X, Howell KA, He S, et al. . Immunization-elicited broadly protective antibody reveals Ebolavirus fusion loop as a site of vulnerability. Cell 2017; 169:891&#x2013;904.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5803079</ArticleId>
            <ArticleId IdType="pubmed">28525756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howell KA, Qiu X, Brannan JM, et al. . Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site. Cell Rep 2016; 15:1514&#x2013;26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4871745</ArticleId>
            <ArticleId IdType="pubmed">27160900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furuyama W, Marzi A, Nanbo A, et al. . Discovery of an antibody for pan-ebolavirus therapy. Sci Rep 2016; 6:20514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4748290</ArticleId>
            <ArticleId IdType="pubmed">26861827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adams PD, Afonine PV, Bunk&#xF3;czi G, et al. . PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 2010; 66:213&#x2013;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2815670</ArticleId>
            <ArticleId IdType="pubmed">20124702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grigorieff N, Grant T, Rohou A. cisTEM: user-friendly software for single-particle image processing. Elife 2018; 7: pii:e3583.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5854467</ArticleId>
            <ArticleId IdType="pubmed">29513216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008; 454:177&#x2013;82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2700032</ArticleId>
            <ArticleId IdType="pubmed">18615077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pallesen J, Murin CD, de Val N, et al. . Structures of Ebola virus GP and sGP in complex with therapeutic antibodies. Nat Microbiol 2016; 1:16128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5003320</ArticleId>
            <ArticleId IdType="pubmed">27562261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Misasi J, Gilman MS, Kanekiyo M, et al. . Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science 2016; 351:1343&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5241105</ArticleId>
            <ArticleId IdType="pubmed">26917592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshida R, Muramatsu S, Akita H, et al. . Development of an immunochromatography assay (QuickNavi-Ebola) to detect multiple species of Ebolaviruses. J Infect Dis 2016; 214:185&#x2013;91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5050476</ArticleId>
            <ArticleId IdType="pubmed">27462094</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30196569</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1550-9613</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>38</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine</Title>
          <ISOAbbreviation>J Ultrasound Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Shake No Bake: A Homemade Ultrasound Gel Recipe for Low-Resource Settings.</ArticleTitle>
        <Pagination>
          <StartPage>1069</StartPage>
          <EndPage>1073</EndPage>
          <MedlinePgn>1069-1073</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jum.14788</ELocationID>
        <Abstract>
          <AbstractText>Commercially produced ultrasound coupling gel is often a scarce resource in rural regions of low-income countries that use sonography as their main imaging modality and, when available, may be cost prohibitive. Various homemade gels were created and tested to assure image quality was not compromised. Glucomannan-based gel and guar gum-based gel had superior physical properties in initial testing and showed no substantial difference compared with commercially available ultrasound gel on subject and phantom imaging and analysis (P&#x2009;&gt;&#x2009;.05 using a 1-tailed sign test). Neither gel required heating, attracted insects, damaged ultrasound transducers, stained samples of clothing, or had harmful effects to subjects.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 by the American Institute of Ultrasound in Medicine.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cherukuri</LastName>
            <ForeName>Anjuli R</ForeName>
            <Initials>AR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, University of Colorado-Denver, Aurora, Colorado, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lane</LastName>
            <ForeName>Lucy</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Vermont Medical Center, The University of Vermont Larner College of Medicine, Burlington, Vermont, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guy</LastName>
            <ForeName>Dave</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Vermont Medical Center, The University of Vermont Larner College of Medicine, Burlington, Vermont, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perusse</LastName>
            <ForeName>Karina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Vermont Medical Center, The University of Vermont Larner College of Medicine, Burlington, Vermont, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Keating</LastName>
            <ForeName>David P</ForeName>
            <Initials>DP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Vermont Medical Center, The University of Vermont Larner College of Medicine, Burlington, Vermont, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeStigter</LastName>
            <ForeName>Kristen K</ForeName>
            <Initials>KK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Vermont Medical Center, The University of Vermont Larner College of Medicine, Burlington, Vermont, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Ultrasound Med</MedlineTA>
        <NlmUniqueID>8211547</NlmUniqueID>
        <ISSNLinking>0278-4297</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005685">Galactans</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005782">Gels</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008351">Mannans</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053149">Plant Gums</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>36W3E5TAMG</RegistryNumber>
          <NameOfSubstance UI="C022901">(1-6)-alpha-glucomannan</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>E89I1637KE</RegistryNumber>
          <NameOfSubstance UI="C007894">guar gum</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003365" MajorTopicYN="N">Costs and Cost Analysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005685" MajorTopicYN="N">Galactans</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005782" MajorTopicYN="N">Gels</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName>
          <QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008351" MajorTopicYN="N">Mannans</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019047" MajorTopicYN="N">Phantoms, Imaging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053149" MajorTopicYN="N">Plant Gums</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011203" MajorTopicYN="N">Poverty</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014783" MajorTopicYN="N">Viscosity</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">coupling gel</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">imaging</Keyword>
        <Keyword MajorTopicYN="N">low-resource</Keyword>
        <Keyword MajorTopicYN="N">sonography</Keyword>
        <Keyword MajorTopicYN="N">ultrasound gel</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30196569</ArticleId>
        <ArticleId IdType="doi">10.1002/jum.14788</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30195255</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1600-0668</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Indoor air</Title>
          <ISOAbbreviation>Indoor Air</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Exposure to household air pollution from biomass cookstoves and blood pressure among women in rural Honduras: A cross-sectional study.</ArticleTitle>
        <Pagination>
          <StartPage>130</StartPage>
          <EndPage>142</EndPage>
          <MedlinePgn>130-142</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ina.12507</ELocationID>
        <Abstract>
          <AbstractText>Growing evidence links household air pollution exposure from biomass cookstoves with elevated blood pressure. We assessed cross-sectional associations of 24-hour mean concentrations of personal and kitchen fine particulate matter (PM<sub>2.5</sub> ), black carbon (BC), and stove type with blood pressure, adjusting for confounders, among 147 women using traditional or cleaner-burning Justa stoves in Honduras. We investigated effect modification by age and body mass index. Traditional stove users had mean (standard deviation) personal and kitchen 24-hour PM<sub>2.5</sub> concentrations of 126&#xA0;&#x3BC;g/m<sup>3</sup> (77) and 360&#xA0;&#x3BC;g/m<sup>3</sup> (374), while Justa stove users' exposures were 66&#xA0;&#x3BC;g/m<sup>3</sup> (38) and 137&#xA0;&#x3BC;g/m<sup>3</sup> (194), respectively. BC concentrations were similarly lower among Justa stove users. Adjusted mean systolic blood pressure was 2.5&#xA0;mm Hg higher (95% CI, 0.7-4.3) per unit increase in natural log-transformed kitchen PM<sub>2.5</sub> concentration; results were stronger among women of 40&#xA0;years or older (5.2&#xA0;mm Hg increase, 95% CI, 2.3-8.1). Adjusted odds of borderline high and high blood pressure (categorized) were also elevated (odds ratio&#xA0;=&#xA0;1.5, 95% CI, 1.0-2.3). Some results included null values and are suggestive. Results suggest that reduced household air pollution, even when concentrations exceed air quality guidelines, may help lower cardiovascular disease risk, particularly among older subgroups.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Young</LastName>
            <ForeName>Bonnie N</ForeName>
            <Initials>BN</Initials>
            <Identifier Source="ORCID">0000-0002-6524-2348</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Clark</LastName>
            <ForeName>Maggie L</ForeName>
            <Initials>ML</Initials>
            <Identifier Source="ORCID">0000-0002-8613-5736</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rajkumar</LastName>
            <ForeName>Sarah</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-7567-9869</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Benka-Coker</LastName>
            <ForeName>Megan L</ForeName>
            <Initials>ML</Initials>
            <Identifier Source="ORCID">0000-0003-2646-3604</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Health Sciences, Gettysburg College, Gettysburg, Pennsylvania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bachand</LastName>
            <ForeName>Annette</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-5265-1572</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brook</LastName>
            <ForeName>Robert D</ForeName>
            <Initials>RD</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, Michigan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nelson</LastName>
            <ForeName>Tracy L</ForeName>
            <Initials>TL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Volckens</LastName>
            <ForeName>John</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-7563-9525</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical Engineering, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reynolds</LastName>
            <ForeName>Stephen J</ForeName>
            <Initials>SJ</Initials>
            <Identifier Source="ORCID">0000-0003-0249-4457</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Mountain and Plains ERC, Colorado School of Public Health, Aurora, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>L'Orange</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0003-1905-8694</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical Engineering, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Good</LastName>
            <ForeName>Nicholas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koehler</LastName>
            <ForeName>Kirsten</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-0516-6945</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Africano</LastName>
            <ForeName>Sebastian</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-7175-1571</Identifier>
            <AffiliationInfo>
              <Affiliation>Trees, Water &amp; People, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Osorto Pinel</LastName>
            <ForeName>Anibal B</ForeName>
            <Initials>AB</Initials>
            <AffiliationInfo>
              <Affiliation>Trees, Water &amp; People, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Asociaci&#xF3;n Hondure&#xF1;a para el Desarrollo, Tegucigalpa, Honduras.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peel</LastName>
            <ForeName>Jennifer L</ForeName>
            <Initials>JL</Initials>
            <Identifier Source="ORCID">0000-0001-5155-1580</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 DK092926</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21 ES022810</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T42 OH009229</GrantID>
            <Acronym>OH</Acronym>
            <Agency>NIOSH CDC HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>ES022810</GrantID>
            <Agency>National Institutes of Health, National Institute of Environmental Health Sciences</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Indoor Air</MedlineTA>
        <NlmUniqueID>9423515</NlmUniqueID>
        <ISSNLinking>0905-6947</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D052638">Particulate Matter</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016902" MajorTopicYN="N">Air Pollution, Indoor</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018533" MajorTopicYN="N">Biomass</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003296" MajorTopicYN="N">Cooking</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004736" MajorTopicYN="N">Energy-Generating Resources</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006721" MajorTopicYN="N" Type="Geographic">Honduras</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D052638" MajorTopicYN="N">Particulate Matter</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Latin America</Keyword>
        <Keyword MajorTopicYN="N">biomass</Keyword>
        <Keyword MajorTopicYN="N">blood pressure</Keyword>
        <Keyword MajorTopicYN="N">cookstoves</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">household air pollution</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30195255</ArticleId>
        <ArticleId IdType="mid">NIHMS988659</ArticleId>
        <ArticleId IdType="pmc">PMC6301093</ArticleId>
        <ArticleId IdType="doi">10.1111/ina.12507</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390:1345&#x2013;1422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5614451</ArticleId>
            <ArticleId IdType="pubmed">28919119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>GBD Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990&#x2013;2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659&#x2013;1724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5388856</ArticleId>
            <ArticleId IdType="pubmed">27733284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCracken JP, Smith KR, Diaz A, Mittleman MA, Schwartz J. Chimney stove intervention to reduce long-term wood smoke exposure lowers blood pressure among Guatemalan women. Environ Health Perspect 2007;115(7):996&#x2013;1001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1913602</ArticleId>
            <ArticleId IdType="pubmed">17637912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith KR, Peel JL. Mind the gap. Environ Health Perspect 2010;118(12):1643&#x2013;1645.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3002182</ArticleId>
            <ArticleId IdType="pubmed">20729177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCracken J, Smith KR, Stone P, Diaz A, Arana B, Schwartz J. Intervention to Lower Household Woodsmoke Exposure in Guatemala Reduces ST-segment Depression on Electrocardiograms. Environ Health Perspect 2011;119:1562&#x2013;1568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3226487</ArticleId>
            <ArticleId IdType="pubmed">21669557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark ML, Bazemore H, Reynolds SJ, et al. A baseline evaluation of traditional cook stove smoke exposures and indicators of cardiovascular and respiratory health among Nicaraguan women. Int J Occup Environ Health. 2011;17(2):113&#x2013;121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21618943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baumgartner J, Schauer JJ, Ezzati M, et al. Indoor air pollution and blood pressure in adult women living in rural china. Environmental Health Perspectives. 2011;119(10):1390&#x2013;1395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3230444</ArticleId>
            <ArticleId IdType="pubmed">21724522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baumgartner J, Zhang YX, Schauer JJ, Huang W, Wang YQ, Ezzati M. Highway proximity and black carbon from cookstoves as a risk factor for higher blood pressure in rural China. Proc Natl Acad Sci U S A. 2014;111(36):13229&#x2013;13234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4246974</ArticleId>
            <ArticleId IdType="pubmed">25157159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alexander D, Larson T, Bolton S, Vedal S. Systolic blood pressure changes in indigenous Bolivian women associated with an improved cookstove intervention. Air Qual Atmos Hlth 2015;8(1):47&#x2013;53.</Citation>
        </Reference>
        <Reference>
          <Citation>The World Bank. The World Bank Country Data: Honduras. 2016; http://data.worldbank.org/country/honduras.
Accessed January 3, 2017, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990&#x2013;2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (London, England). 2016;388(10053):1659&#x2013;1724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5388856</ArticleId>
            <ArticleId IdType="pubmed">27733284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>IEA (International Energy Agency). World Energy Outlook 2011. Paris: International Energy Agency and OECD Available: http://wwwworldenergyoutlookorg/publications/weo-2011/ [Accessed
October 2015]. 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Global Alliance for Clean Cookstoves. Global Alliance for Clean Cookstoves Country Profile: Honduras. 2016; http://cleancookstoves.org/country-profiles/103-honduras.html.
Accessed January 3, 2017, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Still D, MacCarty N, Ogle D, Bond T, Bryden M. Test results of cook stove performance. 2011; http://www.pciaonline.org/files/Test-Results-Cookstove-Performance.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Clark ML, Peel JL, Burch JB, et al. Impact of improved cookstoves on indoor air pollution and adverse health effects among Honduran women. Int J Environ Health Res 2009;19(5):357&#x2013;368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19626518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith KR, Dutta K, Chengappa C, et al. Monitoring and evaluation of improved biomass cookstove programs for indoor air quality and stove performances: conclusions from the Household Energy and Health Project. Energy for Sustainable Development. 2007;11(2):5&#x2013;18.</Citation>
        </Reference>
        <Reference>
          <Citation>Sambandam S, Balakrishnan K, Ghosh S, et al. Can currently available advanced combustion biomass cook-stoves provide health relevant exposure reductions? Results from initial assessment of select commercial models in India. EcoHealth. 2015;12(1):25&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25293811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pope D, Bruce N, Dherani M, Jagoe K, Rehfuess E. Real-life effectiveness of &#x2018;improved&#x2019; stoves and clean fuels in reducing PM2.5 and CO: Systematic review and meta-analysis. Environ Int 2017;101:7&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28285622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO. WHO Air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide: Global update 2005; Summary of risk assessment. 2006; http://apps.who.int/iris/bitstream/handle/10665/69477/WHO_SDE_PHE_OEH_06.02_eng.pdf;jsessionid=A486614BB701DC857FA749675A654900?sequence=1.</Citation>
        </Reference>
        <Reference>
          <Citation>Clark ML, Bachand AM, Heiderscheidt JM, et al. Impact of a cleaner-burning cookstove intervention on blood pressure in Nicaraguan women. Indoor Air 2013;23(2):105&#x2013;114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3528797</ArticleId>
            <ArticleId IdType="pubmed">22913364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacDougall D, Crummett WB, et al. Guidelines for data acquisition and data quality evaluation in environmental chemistry. Analytical Chemistry. 1980;52(14):2242&#x2013;2249.</Citation>
        </Reference>
        <Reference>
          <Citation>Hansen ADA, Rosen H, Novakov T. The aethalometer &#x2014; An instrument for the real-time measurement of optical absorption by aerosol particles. Sci Total Environ 1984;36:191&#x2013;196.</Citation>
        </Reference>
        <Reference>
          <Citation>Chylek P, Ramaswamy V, Cheng R, Pinnick RG. Optical properties and mass concentration of carbonaceous smokes. Applied optics 1981;20(17):2980&#x2013;2985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20333084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirchstetter TW, Novakov T. Controlled generation of black carbon particles from a diffusion flame and applications in evaluating black carbon measurement methods. Atmospheric Environment. 2007;41(9):1874&#x2013;1888.</Citation>
        </Reference>
        <Reference>
          <Citation>Kshirsagar MP, Kalamkar VR. A comprehensive review on biomass cookstoves and a systematic approach for modern cookstove design. Renewable and Sustainable Energy Reviews. 2014;30:580&#x2013;603.</Citation>
        </Reference>
        <Reference>
          <Citation>AHA. American Heart Association Procedures: Monitoring your blood pressure at home. 2018; http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/KnowYourNumbers/Monitoring-Your-Blood-Pressure-at-Home_UCM_301874_Article.jsp#.W05WHntKguV.</Citation>
        </Reference>
        <Reference>
          <Citation>Hartung C, Anokwa Y, Brunette W, Lerer A, Tseng C, Borriello G. Open Data Kit: Tools to Build Information Services for Developing Regions 4th ACM/IEEE International Conference on Information and Communication Technologies and Development; 2010; London, UK.</Citation>
        </Reference>
        <Reference>
          <Citation>Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of Physical Activities: A Second Update of Codes and MET Values. Med Sci Sport Exer 2011;43(8):1575&#x2013;1581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21681120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>USDHHS. Physical activity guidelines for Americans. 2008; https://health.gov/paguidelines/guidelines/, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Wu S, Fisher-Hoch SP, Reininger B, McCormick JB. Recommended Levels of Physical Activity Are Associated with Reduced Risk of the Metabolic Syndrome in Mexican-Americans. PLoS One. 2016;11(4):e0152896.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4824434</ArticleId>
            <ArticleId IdType="pubmed">27054324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bassett DR, Schneider PL, Huntington GE. Physical activity in an Old Order Amish community. Medicine and science in sports and exercise. 2004;36(1):79&#x2013;85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14707772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz-Mercado I, Masera O. Patterns of stove use in the context of fuel-device stacking: rationale and implications. Ecohealth. 2015;12(1):42&#x2013;56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25724593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz-Mercado I, Masera O, Zamora H, Smith KR. Adoption and sustained use of improved cookstoves. Energy Policy. 2011;39:7557&#x2013;7566.</Citation>
        </Reference>
        <Reference>
          <Citation>Mobarak AM, Dwivedi P, Bailis R, Hildemann L, Miller G. Low demand for nontraditional cookstove technologies. Proc Natl Acad Sci U S A. 2012;109(27):10815&#x2013;10820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3390883</ArticleId>
            <ArticleId IdType="pubmed">22689941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark ML, Peel JL, Balakrishnan K, et al. Health and household air pollution from solid fuel use: the need for improved exposure assessment. Environ Health Perspect 2013;121(10):1120&#x2013;1128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3801460</ArticleId>
            <ArticleId IdType="pubmed">23872398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dutta A, Ray MR. Prevalence of hypertension and pre-hypertension in rural women: A report from the villages of West Bengal, a state in the eastern part of India. Australian Journal of Rural Health. 2012;20(4):219&#x2013;225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22827431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pena MB, Romero KM, Velazquez EJ, et al. Relationship Between Daily Exposure to Biomass Fuel Smoke and Blood Pressure in High-Altitude Peru. Hypertension. 2015;65(5):1134&#x2013;1140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4466100</ArticleId>
            <ArticleId IdType="pubmed">25753976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697&#x2013;716.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15699287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brook RD, Rajagopalan S, Pope CA, 3rd, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331&#x2013;2378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20458016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903&#x2013;1913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12493255</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30191535</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1970-9366</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Internal and emergency medicine</Title>
          <ISOAbbreviation>Intern Emerg Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation.</ArticleTitle>
        <Pagination>
          <StartPage>59</StartPage>
          <EndPage>69</EndPage>
          <MedlinePgn>59-69</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11739-018-1938-3</ELocationID>
        <Abstract>
          <AbstractText>Frailty is an important prognostic factor in older adults with cardiovascular diseases. We aim to describe the characteristics of elderly hospitalised frail patients with non-valvular atrial fibrillation (NVAF) and to assess the influence of frailty, along with other functional and health status variables on anticoagulation prescription, 1-year all-cause mortality, and the incidence of ischemic and bleeding complications. An observational, prospective multicentre study was carried out on patients with NVAF over the age of 75, who were admitted to the Internal Medicine departments in Spain. A total of 615 patients were evaluated (mean age 85.23&#x2009;&#xB1;&#x2009;5.16&#xA0;years, 54.3% females, 48.3% frail). Frail patients had higher CHA2DS2-VASc and HAS-BLED scores, more comorbidities and worse functional status and cognitive impairment compared to non-frail. During hospitalisation, 58 (9.4%) patients died (12.5% frail, 6.6% non-frail, p&#x2009;=&#x2009;0.01). Among the participants discharged, 69.8% received anticoagulants, 13% anti-platelets only and 16.9% no anti-thrombotics, with no difference by frailty status. Frailty is not a predictor of anticoagulant prescription at discharge (OR 0.93, 95% CI 0.55-1.57), while functional dependency remains significantly associated (OR for severe dependency 0.44, 95% CI 0.23-0.82). After the 1-year follow-up, frail patients have a higher risk of death (HR 1.99, 95% CI 1.43-2.76). Among patients taking anticoagulants, the incidence of stroke and major bleeding is similar between frailty groups. In our study, frailty is related to worse global health status. It has no impact on antithrombotic prescription, nor is a predictor of AF complications, even though frail subjects have a higher mortality during hospitalisation and after 1-year follow-up.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gull&#xF3;n</LastName>
            <ForeName>Alejandra</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-5728-9309</Identifier>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, University Hospital of La Princesa, Institute for Biomedical Research IIS-IPrincesa, C/Diego de Le&#xF3;n 62, 28006, Madrid, Spain. a.gullon.ojesto@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Formiga</LastName>
            <ForeName>Francesc</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, Geriatric Unit, University Hospital of Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>D&#xED;ez-Manglano</LastName>
            <ForeName>Jes&#xFA;s</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, University Hospital Miguel Servet, Zaragoza, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mostaza</LastName>
            <ForeName>Jos&#xE9; Mar&#xED;a</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, University Hospital of La Paz-Carlos III, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cepeda</LastName>
            <ForeName>Jos&#xE9; Mar&#xED;a</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, Hospital Vega Baja, Orihuela, Alicante, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pose</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Castiella</LastName>
            <ForeName>Jes&#xFA;s</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, Fundaci&#xF3;n Hospital Calahorra, Calahorra, La Rioja, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Su&#xE1;rez-Fern&#xE1;ndez</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, University Hospital of La Princesa, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>NONAVASC study group Vascular Risk Group of the Spanish Society of Internal Medicine</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016448">Multicenter Study</PublicationType>
          <PublicationType UI="D064888">Observational Study</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>Intern Emerg Med</MedlineTA>
        <NlmUniqueID>101263418</NlmUniqueID>
        <ISSNLinking>1828-0447</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Intern Emerg Med. 2019 Jan;14(1):5-6. doi: 10.1007/s11739-018-1986-8.</RefSource>
          <PMID Version="1">30478750</PMID>
        </CommentsCorrections>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>Intern Emerg Med. 2019 Mar;14(2):335. doi: 10.1007/s11739-019-02032-4.</RefSource>
          <PMID Version="1">30684096</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016330" MajorTopicYN="Y">Frail Elderly</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015577" MajorTopicYN="N">Geriatric Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Aged</Keyword>
        <Keyword MajorTopicYN="N">Anticoagulants</Keyword>
        <Keyword MajorTopicYN="N">Antithrombotic therapy</Keyword>
        <Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
        <Keyword MajorTopicYN="N">Elderly</Keyword>
        <Keyword MajorTopicYN="N">Frailty</Keyword>
      </KeywordList>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Camafort</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rovira</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Jarauta</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Garc&#xED;a</LastName>
          <ForeName>I</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ar&#xE9;valo</LastName>
          <ForeName>J C</ForeName>
          <Initials>JC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Portillo</LastName>
          <ForeName>J</ForeName>
          <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mart&#xED;nez</LastName>
          <ForeName>I</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>de la Guerra</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Arg&#xFC;ello</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Aranda</LastName>
          <ForeName>S I</ForeName>
          <Initials>SI</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Novo</LastName>
          <ForeName>I</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Pena</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Salgado</LastName>
          <ForeName>F</ForeName>
          <Initials>F</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Vargas</LastName>
          <ForeName>J A</ForeName>
          <Initials>JA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gonz&#xE1;lez</LastName>
          <ForeName>J</ForeName>
          <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Tobares</LastName>
          <ForeName>N R</ForeName>
          <Initials>NR</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Freixas</LastName>
          <ForeName>P</ForeName>
          <Initials>P</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Campodarve</LastName>
          <ForeName>I</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Fern&#xE1;ndez</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Palomar</LastName>
          <ForeName>L M</ForeName>
          <Initials>LM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>G&#xF3;mez</LastName>
          <ForeName>A B</ForeName>
          <Initials>AB</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Chivite</LastName>
          <ForeName>D</ForeName>
          <Initials>D</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rico</LastName>
          <ForeName>M A</ForeName>
          <Initials>MA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hern&#xE1;ndez</LastName>
          <ForeName>J L</ForeName>
          <Initials>JL</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Coloma</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Sobrino</LastName>
          <ForeName>X</ForeName>
          <Initials>X</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Grandes</LastName>
          <ForeName>J</ForeName>
          <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mart&#xED;n</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Cuenca</LastName>
          <ForeName>R</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>P&#xE9;rez</LastName>
          <ForeName>J B</ForeName>
          <Initials>JB</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>de la Pe&#xF1;a</LastName>
          <ForeName>A</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>L&#xF3;pez</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Montero</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Calder&#xF3;n</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lahoz</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>de los Santos</LastName>
          <ForeName>A</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mart&#xED;nez</LastName>
          <ForeName>J A</ForeName>
          <Initials>JA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Alfonso</LastName>
          <ForeName>J</ForeName>
          <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Cuende</LastName>
          <ForeName>J I</ForeName>
          <Initials>JI</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Cotos</LastName>
          <ForeName>R</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Tamarit</LastName>
          <ForeName>J J</ForeName>
          <Initials>JJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Bonilla</LastName>
          <ForeName>F</ForeName>
          <Initials>F</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Epalza</LastName>
          <ForeName>A</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Morales</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Manzano</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Freire</LastName>
          <ForeName>S</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rodr&#xED;guez</LastName>
          <ForeName>A</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mendui&#xF1;a</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>L&#xF3;pez</LastName>
          <ForeName>A</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>S&#xE1;nchez</LastName>
          <ForeName>J F</ForeName>
          <Initials>JF</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mart&#xED;n</LastName>
          <ForeName>M D</ForeName>
          <Initials>MD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ortiz</LastName>
          <ForeName>J A</ForeName>
          <Initials>JA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mart&#xED;nez-Acitores</LastName>
          <ForeName>J C</ForeName>
          <Initials>JC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Alonso</LastName>
          <ForeName>M B</ForeName>
          <Initials>MB</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Filella</LastName>
          <ForeName>D</ForeName>
          <Initials>D</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>&#xC1;greda</LastName>
          <ForeName>H</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Romero</LastName>
          <ForeName>M</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Fern&#xE1;ndez</LastName>
          <ForeName>M E</ForeName>
          <Initials>ME</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>D&#xED;az</LastName>
          <ForeName>J L</ForeName>
          <Initials>JL</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>P&#xE9;rez</LastName>
          <ForeName>C</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mart&#xED;nez</LastName>
          <ForeName>R</ForeName>
          <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Nieto</LastName>
          <ForeName>J A</ForeName>
          <Initials>JA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Masferrer</LastName>
          <ForeName>J</ForeName>
          <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>M&#xE9;rida</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Varela</LastName>
          <ForeName>J M</ForeName>
          <Initials>JM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mujal</LastName>
          <ForeName>A</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Castilla</LastName>
          <ForeName>L</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Castellanos</LastName>
          <ForeName>P</ForeName>
          <Initials>P</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Tiberio</LastName>
          <ForeName>G</ForeName>
          <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Guevara</LastName>
          <ForeName>E</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Fern&#xE1;ndez</LastName>
          <ForeName>J</ForeName>
          <Initials>J</Initials>
        </Investigator>
      </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30191535</ArticleId>
        <ArticleId IdType="doi">10.1007/s11739-018-1938-3</ArticleId>
        <ArticleId IdType="pii">10.1007/s11739-018-1938-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Am Geriatr Soc. 1975 Oct;23(10):433-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1159263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Invest. 2005 Dec;35(12):723-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16313247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Cardiovasc Disord. 2015 Nov 04;15:143</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26530138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Gerontol Geriatr. 2016 Jul-Aug;65:248-54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27131228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Chronic Dis. 1987;40(5):373-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3558716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Med. 2015 Jun;128(6):654.e1-654.e10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25554371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Med Dir Assoc. 2015 May 1;16(5):358-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25680239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Geriatr Soc. 2012 Aug;60(8):1478-86</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22861118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Med Dir Assoc. 2013 Jun;14(6):392-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23764209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Prev Cardiol. 2014 Oct;21(10):1216-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23644488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Can J Cardiol. 2016 Feb;32(2):169-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26277091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Cardiol. 2013 Oct 3;168(3):1745-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23931976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thromb Haemost. 2005 Apr;3(4):692-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15842354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Md State Med J. 1965 Feb;14:61-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14258950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Clin (Barc). 2017 Mar 3;148(5):204-210</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27993408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Gerontol Geriatr. 2015 May-Jun;60(3):464-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25697060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Gerontol Geriatr. 2017 May - Jun;70:1-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28006693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 2009 Sep 1;151(5):297-305</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19721017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chest. 2010 Nov;138(5):1093-100</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20299623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 2016 Oct 7;37(38):2893-2962</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27567408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geriatr Gerontol Int. 2017 Mar;17(3):416-423</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26818463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS One. 2012;7(3):e33559</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22479411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Intern Med J. 2016 Jan;46(1):86-95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26388116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Age Ageing. 2009 Mar;38(2):156-62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19151165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Clin (Barc). 2012 Mar 17;138(6):231-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21940001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Intern Emerg Med. 2017 Feb;12(1):53-61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27514718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11253156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Med Dir Assoc. 2013 Aug;14(8):531-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23810110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heart. 2013 Jan;99(2):127-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23086966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroke. 1991 Aug;22(8):983-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1866765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chest. 2010 Feb;137(2):263-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19762550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Nutr Health Aging. 2012 Jul;16(7):601-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22836700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Geriatr Soc. 2013 Dec;61(12):2236-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24329827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Geriatr Soc. 2012 Jan;60(1):171-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22239307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroke. 2006 Apr;37(4):1075-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16527999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rev Esp Geriatr Gerontol. 2016 Sep-Oct;51(5):254-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26980117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Gerontol Geriatr. 2013 Nov-Dec;57(3):325-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23706973</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30188802</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2045-7723</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>42</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>The journal of spinal cord medicine</Title>
          <ISOAbbreviation>J Spinal Cord Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Contextualizing the lived experience of quality of life for persons with spinal cord injury: A mixed-methods application of the response shift model.</ArticleTitle>
        <Pagination>
          <StartPage>469</StartPage>
          <EndPage>477</EndPage>
          <MedlinePgn>469-477</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10790268.2018.1517471</ELocationID>
        <Abstract>
          <AbstractText><b>Objective</b>: The objective of this study was to gain greater insight into individuals' quality of life (QOL) definitions, appraisals, and adaptations following spinal cord injury (SCI). <b>Design</b>: A mixed-methods design, applying the Schwartz and Sprangers response shift (RS) model. RS is a cognitive process wherein, in response to a change in health status, individuals change internal standards, values, or conceptualization of QOL <b>Setting</b>: Community-dwelling participants who receive medical treatment at a major Midwestern medical system and nearby Veterans' Affairs hospital. <b>Participants</b>: A purposive sample of participants with SCI (N&#x2009;=&#x2009;40) completed semi-structured interviews and accompanying quantitative measures. <b>Interventions</b>: Not applicable. <b>Outcome Measures</b>: Qualitative data were analyzed using content analysis to identify themes. Analysis of variance were performed to detect differences based on themes and QOL, well-being, and demographic and injury characteristics. <b>Results:</b> Four RS themes were identified, capturing the range of participant perceptions of QOL. The themes ranged from complete RS, indicating active engagement in maintaining QOL, to awareness and comparisons redefining QOL, to a relative lack of RS. Average QOL ratings differed as a function of response shift themes. PROMIS Global Health, Anxiety, and Depression also differed as a function of RS themes. <b>Conclusion:</b> The RS model contextualizes differences in QOL definitions, appraisals, and adaptations in a way standardized QOL measures alone do not.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rohn</LastName>
            <ForeName>Edward J</ForeName>
            <Initials>EJ</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Physical Medicine and Rehabilitation , University of Michigan , Ann Arbor , Michigan , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tate</LastName>
            <ForeName>Denise G</ForeName>
            <Initials>DG</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Physical Medicine and Rehabilitation , University of Michigan , Ann Arbor , Michigan , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Forchheimer</LastName>
            <ForeName>Martin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Physical Medicine and Rehabilitation , University of Michigan , Ann Arbor , Michigan , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DiPonio</LastName>
            <ForeName>Lisa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Physical Medicine and Rehabilitation , University of Michigan , Ann Arbor , Michigan , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Veterans Administration Ann Arbor Healthcare System , Ann Arbor , Michigan , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Spinal Cord Med</MedlineTA>
        <NlmUniqueID>9504452</NlmUniqueID>
        <ISSNLinking>1079-0268</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008960" MajorTopicYN="Y">Models, Psychological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009042" MajorTopicYN="N">Motivation</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013119" MajorTopicYN="N">Spinal Cord Injuries</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Mixed methods research</Keyword>
        <Keyword MajorTopicYN="N">Neurogenic bladder and bowel</Keyword>
        <Keyword MajorTopicYN="N">Patient experiences</Keyword>
        <Keyword MajorTopicYN="N">Qualitative research</Keyword>
        <Keyword MajorTopicYN="N">Quality of life</Keyword>
        <Keyword MajorTopicYN="N">Response shift</Keyword>
        <Keyword MajorTopicYN="N">Spinal cord injury</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30188802</ArticleId>
        <ArticleId IdType="pmc">PMC6718176</ArticleId>
        <ArticleId IdType="doi">10.1080/10790268.2018.1517471</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Boschen KA, Tonack M, Gargaro J.. Long-term adjustment and community reintegration following spinal cord injury. Int J Rehabil Res 2003;26(3):157&#x2013;64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14501566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reitz A, Tobe V, Knapp P, Schurch B.. Impact of spinal cord injury on sexual health and quality of life. Int J Impot Res 2004;16(2):167&#x2013;74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14973522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tate DG, Kalpakjian CZ, Forchheimer MB.. Quality of life issues in individuals with spinal cord injury. Arch Phys Med Rehabil 2002;83:S18&#x2013;25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12474168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fritz HA, Lysack C, Luborsky MR, Messinger SD.. Long-term community reintegration: concepts, outcomes and dilemmas in the case of a military service member with a spinal cord injury. Disabil Rehabil 2015;37(16):1501&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25270306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lusilla-Palacios P, Castellano-Tejedor C, Navarro-Sanch&#xED;s JA, et al. . Training professionals&#x2019; communication and motivation skills to improve spinal cord injury patients&#x2019; satisfaction and clinical outcomes: study protocol of the ESPELMA trial. J Health Psychol 2015;20(10):1357&#x2013;68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24311743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tulsky DS, Kisala PA, Victorson D, Tate D, Heinemann AW, Amtmann D, et al. . Developing a contemporary patient-reported outcomes measure for spinal cord injury. Arch Phys Med Rehabil 2011;92(10):S44&#x2013;51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6309317</ArticleId>
            <ArticleId IdType="pubmed">21958922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barker RN, Kendall M, Amsters D, Pershouse KJ, Haines TP, Kuipers P.. The relationship between quality of life and disability across the lifespan for people with spinal cord injury. Spinal Cord 2009;47(2):149&#x2013;55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18594553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dijkers MP. Quality of life of individuals with spinal cord injury: a review of conceptualization, measurement, and research findings. J Rehabil Res Dev 2005;42(3):87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16195966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lidal IB, Veenstra M, Hjeltnes N, Biering-S&#xF8;rensen F.. Health-related quality of life in persons with long-standing spinal cord injury. Spinal Cord 2008;46(11):710&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18332888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simpson LA, Eng JJ, Hsieh JT, Wolfe, the spinal cord injury rehabilitation evidence research team DL. The health and life priorities of individuals with spinal cord injury: a systematic review. J Neurotrauma 2012;29(8):1548&#x2013;55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3501530</ArticleId>
            <ArticleId IdType="pubmed">22320160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwartz CE, Finkelstein JA.. Understanding inconsistencies in patient-reported outcomes after spine treatment: response shift phenomena. Spine J 2009;9(12):1039&#x2013;45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19574107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krause JS, Saladin LK, Adkins RH.. Disparities in subjective well-being, participation, and health after spinal cord injury: a 6-year longitudinal study. Neurorehabilitation 2009;24(1):47&#x2013;56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19208957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tate DG, Forchheimer MB, Karana-Zebari D, Chiodo AE, Kendall Thomas JY.. Depression and pain among inpatients with spinal cord injury and spinal cord disease: differences in symptoms and neurological function. Disabil Rehabil 2013;35(14):1204&#x2013;12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23072715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cameron AP, Wallner LP, Forchheimer MB, Clemens JQ, Dunn RL, Rodriguez G, et al. . Medical and psychosocial complications associated with method of bladder management after traumatic spinal cord injury. Arch Phys Med Rehabil 2011;92(3):449&#x2013;56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21276958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ullrich PM, Lincoln RK, Tackett MJ, Miskevics S, Smith BM, Weaver FM.. Pain, depression, and health care utilization over time after spinal cord injury. Rehabil Psychol 2013;58(2):158&#x2013;65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23713727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coggrave M, Norton C, Wilson-Barnett J.. Management of neurogenic bowel dysfunction in the community after spinal cord injury: a postal survey in the United Kingdom. Spinal Cord 2009;47(4):323&#x2013;33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19015665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prysak GM, Andresen EM, Meyers AR.. Prevalence of secondary conditions in veterans with spinal cord injury and their interference with life activities. Top Spinal Cord Inj Rehabil 2000;6(1):34&#x2013;42.</Citation>
        </Reference>
        <Reference>
          <Citation>Tate DG, Forchheimer M, Rodriguez G, et al. . Risk factors associated with neurogenic bowel complications and dysfunction in spinal cord injury. Arch Phys Med Rehabil 2016;97(10):1679&#x2013;86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27109330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faaborg PM, Christensen P, Finnerup N, Laurberg S, Krogh K.. The pattern of colorectal dysfunction changes with time since spinal cord injury. Spinal Cord 2008;46(3):234&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17893697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burns AS, St-Germain D, Connolly M, Delparte JJ, Guindon A, Hitzig SL, et al. . Neurogenic bowel after spinal cord injury from the perspective of support providers: a phenomenological study. PM R 2015;7:407&#x2013;16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25305370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engkasan J, Ng C, Low W.. Factors influencing bladder management in male patients with spinal cord injury: a qualitative study. Spinal Cord 2014;52(2):157&#x2013;62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24276416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munce SE, Webster F, Fehlings MG, Straus SE, Jang E, Jaglal SB.. Perceived facilitators and barriers to self-management in individuals with traumatic spinal cord injury: a qualitative descriptive study. BMC Neurol 2014;14:48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4007626</ArticleId>
            <ArticleId IdType="pubmed">24624961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hicken BL, Putzke JD, Richards JS.. Bladder management and quality of life after spinal cord injury. Am J Phys Med Rehabil 2001;80(12):916&#x2013;22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11821674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Charlifue S, Post M, Biering-S&#xF8;rensen F, Catz A, Dijkers M, Geyh S, et al. . International spinal cord injury quality of life basic data set. Spinal Cord 2012;50(9):672&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22450884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jackson J, Carlson M, Rubayi S, Scott MD, Atkins MS, Blanche EI, et al. . Qualitative study of principles pertaining to lifestyle and pressure ulcer risk in adults with spinal cord injury. Disabil Rehabil 2010;32(7):567&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20136475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munce SE, Webster F, Fehlings MG, Straus SE, Jang E, Jaglal SB.. Perceived facilitators and barriers to self-management in individuals with traumatic spinal cord injury: a qualitative descriptive study. BMC Neurol 2014;14(1):1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4007626</ArticleId>
            <ArticleId IdType="pubmed">24624961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammell KW. Quality of life after spinal cord injury: a meta-synthesis of qualitative findings. Spinal Cord 2007;45(2):124&#x2013;39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17091119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rapkin BD, Schwartz CE.. Toward a theoretical model of quality-of-life appraisal: implications of findings from studies of response shift. Health Qual Life Outcomes 2004;2(1):1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC408464</ArticleId>
            <ArticleId IdType="pubmed">15023229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lazarus RS, Folkman S.. Stress, appraisal, and coping. New York: Springer Publishing; 1986.</Citation>
        </Reference>
        <Reference>
          <Citation>Schwartz CE, Sprangers MA.. Adaptation to changing health: response shift in quality-of-life research American Psychological Association; 2000.</Citation>
        </Reference>
        <Reference>
          <Citation>Sprangers MA, Schwartz CE.. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 1999;48(11):1507&#x2013;15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10400253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwartz CE. Applications of response shift theory and methods to participation measurement: a brief history of a young field. Arch Phys Med Rehabil 2010;91(9):S38&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20801278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>NVivo 11 [computer program] [computer program]. Version 11. Doncaster, Victoria, Australia: QSR International; 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Tate DG, Forchheimer M, Hartwig R, Kalpakjian C.. The bowel and bladder treatment index (BBTI): a new tool to assess bowel and bladder management in SCI. Arch Phys Med Rehabil 2015;96(10):e24&#x2013;5.</Citation>
        </Reference>
        <Reference>
          <Citation>Forchheimer M, Meade MA, Tate D, Cameron AP, Rodriguez G, DiPonio L.. Self-Report of behaviors to manage neurogenic bowel and bladder by individuals with chronic spinal cord injury: frequency and associated outcomes. Top Spinal Cord Inj Rehabil 2016;22(2):85&#x2013;98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4896324</ArticleId>
            <ArticleId IdType="pubmed">29339851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. . The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care 2007;45(5 Suppl 1):S3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2829758</ArticleId>
            <ArticleId IdType="pubmed">17443116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG.. Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42(2):377&#x2013;81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2700030</ArticleId>
            <ArticleId IdType="pubmed">18929686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>SPSS Statistics for Windows [computer program] [computer program]. Version 22.0. Armonk, NY: IBM Corporation; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Bernard HR. Research methods in anthropology: qualitative and quantitative approaches. Lanham: Rowman &amp; Littlefield; 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Emerson RM, Fretz RI, Shaw LL.. Writing ethnographic fieldnotes. Chicago: University of Chicago Press; 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Lequerica AH, Forchheimer M, Albright KJ, Tate DG, Duggan CH, Rahman RO.. Stress appraisal in women with spinal cord injury: supplementary findings through mixed methods. Int J Stress Manag 2010;17(3):259&#x2013;75.</Citation>
        </Reference>
        <Reference>
          <Citation>Luborsky MR.  The identification and analysis of themes and patterns. 1994. Retrieved from  https://www.researchgate.net/publication/232539481_The_Identification_and_Analysis_of_Themes_and_Patterns.</Citation>
        </Reference>
        <Reference>
          <Citation>Ryan GW, Bernard HR.. Techniques to identify themes. Field Methods 2003;15(1):85&#x2013;109.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30187941</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1600-0528</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Community dentistry and oral epidemiology</Title>
          <ISOAbbreviation>Community Dent Oral Epidemiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Responsiveness to change of the Malay-ECOHIS following treatment of early childhood caries under general anaesthesia.</ArticleTitle>
        <Pagination>
          <StartPage>24</StartPage>
          <EndPage>31</EndPage>
          <MedlinePgn>24-31</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cdoe.12417</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES">To evaluate the sensitivity and responsiveness of the Malay version of Early Childhood Oral Health Impact Scale (Malay-ECOHIS) to dental treatment of early childhood caries (ECC) under general anaesthesia (GA) and determine the minimally important difference (MID) for the Malay-ECOHIS.</AbstractText>
          <AbstractText Label="METHODS">A sample of 158 preschool children with ECC awaiting dental treatment under GA was recruited over an 8-month period. Parents self-completed the Malay-ECOHIS before and 4&#xA0;weeks after their child's dental treatment. At 4&#xA0;weeks follow-up, parents also responded to a global health transition judgement item. Data were analysed using independent and paired samples t tests, ANOVA and Pearson correlation coefficients.</AbstractText>
          <AbstractText Label="RESULTS">The response rate was 87.3%. The final sample comprised 76 male (55.1%) and 62 female (44.9%) preschool children with mean age of 4.5 (SD&#xA0;=&#xA0;1.0) years. Following treatment, there were significant reductions in mean scores for total Malay-ECOHIS, child impact section (CIS), family impact section (FIS) and all domains, respectively (P&#xA0;&lt;&#xA0;0.001). The effect size (ES) for the Malay-ECOHIS was +1.0; across the domains, it ranged from +0.4 to +1.9. There was a weak, positive correlation for Malay-ECOHIS change scores (r&#xA0;=&#xA0;0.165) and CIS change scores (r&#xA0;=&#xA0;0.175) with the number of decayed teeth (dt), respectively. Similar correlation was also observed between Malay-ECOHIS change scores and the number of extracted teeth (r&#xA0;=&#xA0;0.129). Based on the global health transition judgement, 62.3% of parents reported their child's oral condition to be "a little improved" while 37.7% reported it to be "much improved" following treatment, with Malay-ECOHIS mean change scores of 6.7 (ES&#xA0;=&#xA0;+1.1) and 9.6 (ES&#xA0;=&#xA0;+1.2), respectively. There was an observed gradient in the Malay-ECOHIS change scores and ES in relation to parents' perception of their child's oral health improvement after treatment, supporting the responsiveness of the measure. The Malay-ECOHIS MID was found to be 7 scale points.</AbstractText>
          <AbstractText Label="CONCLUSION">The Malay-ECOHIS is empirically shown to be sensitive and responsiveness to dental treatment of ECC under GA.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hashim</LastName>
            <ForeName>Nor Azlina</ForeName>
            <Initials>NA</Initials>
            <Identifier Source="ORCID">0000-0003-4952-2849</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Community Oral Health and Clinical Prevention, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yusof</LastName>
            <ForeName>Zamros Yuzadi Mohd</ForeName>
            <Initials>ZYM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Community Oral Health and Clinical Prevention, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Community Oral Health Research Group, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saub</LastName>
            <ForeName>Roslan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Community Oral Health and Clinical Prevention, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Community Oral Health Research Group, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>GENBANK</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>CO1601</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Denmark</Country>
        <MedlineTA>Community Dent Oral Epidemiol</MedlineTA>
        <NlmUniqueID>0410263</NlmUniqueID>
        <ISSNLinking>0301-5661</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019140" MajorTopicYN="N">Dental Care for Children</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003731" MajorTopicYN="Y">Dental Caries</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008296" MajorTopicYN="N" Type="Geographic">Malaysia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009909" MajorTopicYN="Y">Oral Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Malay-ECOHIS</Keyword>
        <Keyword MajorTopicYN="N">Malaysia</Keyword>
        <Keyword MajorTopicYN="N">preschool children</Keyword>
        <Keyword MajorTopicYN="N">responsiveness</Keyword>
        <Keyword MajorTopicYN="N">sensitivity</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30187941</ArticleId>
        <ArticleId IdType="doi">10.1111/cdoe.12417</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30185389</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-8171</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>The American journal of emergency medicine</Title>
          <ISOAbbreviation>Am J Emerg Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Global Health Service Partnership's point-of-care ultrasound initiatives in Malawi, Tanzania and Uganda.</ArticleTitle>
        <Pagination>
          <StartPage>777</StartPage>
          <EndPage>779</EndPage>
          <MedlinePgn>777-779</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajem.2018.08.065</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0735-6757(18)30716-2</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Boniface</LastName>
            <ForeName>Keith S</ForeName>
            <Initials>KS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, The George Washington University Medical Center, Washington DC, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raymond</LastName>
            <ForeName>Aislynn</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, The George Washington University Medical Center, Washington DC, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fleming</LastName>
            <ForeName>Katelyn</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Seed Global Health, Boston MA, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scott</LastName>
            <ForeName>James</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, The George Washington University Medical Center, Washington DC, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kerry</LastName>
            <ForeName>Vanessa B</ForeName>
            <Initials>VB</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Global Health, Massachusetts General Hospital, Boston MA; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA; Seed Global Health, Boston MA, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haile-Mariam</LastName>
            <ForeName>Tenagne</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, The George Washington University Medical Center, Washington DC, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sayeed</LastName>
            <ForeName>Sadath</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Global Health and Social Meicine, Harvard Medical School, Boston MA; Department of Medicine, Boston Children's Hospital, Boston MA; Seed Global Health, Boston MA, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shokoohi</LastName>
            <ForeName>Hamid</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston MA; and The George Washington University Medical Center, Washington DC, United States of America. Electronic address: hshokoohi@mgh.harvard.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Emerg Med</MedlineTA>
        <NlmUniqueID>8309942</NlmUniqueID>
        <ISSNLinking>0735-6757</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008295" MajorTopicYN="N" Type="Geographic">Malawi</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019095" MajorTopicYN="Y">Point-of-Care Systems</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013636" MajorTopicYN="N" Type="Geographic">Tanzania</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014454" MajorTopicYN="N" Type="Geographic">Uganda</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014463" MajorTopicYN="Y">Ultrasonography</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Africa</Keyword>
        <Keyword MajorTopicYN="N">Global Health Service Partnership</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Handheld ultrasound</Keyword>
        <Keyword MajorTopicYN="N">Ultrasonography</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30185389</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ajem.2018.08.065</ArticleId>
        <ArticleId IdType="pii">S0735-6757(18)30716-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30184193</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1876-3405</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>International health</Title>
          <ISOAbbreviation>Int Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Non-communicable diseases: ditch the label and recapture public awareness.</ArticleTitle>
        <Pagination>
          <StartPage>5</StartPage>
          <EndPage>6</EndPage>
          <MedlinePgn>5-6</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/inthealth/ihy063</ELocationID>
        <Abstract>
          <AbstractText>Non-communicable diseases (NCDs) are branded as the leading cause of global mortality. Global health thinking has dichotomised NCDs from communicable diseases to attract funding and end a dangerous neglect. However, NCDs can also have infectious disease risk factors, and mortality from NCDs is greatest in low- and middle-income countries, which face a syndemic burden of disease. As a non-term, attention is not immediately focused around key 'human-made' risk factors for chronic disease. By continuing to use this flawed and ambiguous label, policymakers risk enforcing an ideological approach, which fails to encourage global health researchers to work collaboratively and to capture the political and public awareness required to motivate sustainable change.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Blundell</LastName>
            <ForeName>Harriet J</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences, Centre for Evidence Synthesis in Global Health, Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hine</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Sciences, Centre for Evidence Synthesis in Global Health, Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int Health</MedlineTA>
        <NlmUniqueID>101517095</NlmUniqueID>
        <ISSNLinking>1876-3405</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073296" MajorTopicYN="Y">Noncommunicable Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009626" MajorTopicYN="Y">Terminology as Topic</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30184193</ArticleId>
        <ArticleId IdType="doi">10.1093/inthealth/ihy063</ArticleId>
        <ArticleId IdType="pii">5088763</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30181384</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>10</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>Suppl 2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact assessment of the WHO Framework Convention on Tobacco Control: introduction, general findings and discussion.</ArticleTitle>
        <Pagination>
          <StartPage>s81</StartPage>
          <EndPage>s83</EndPage>
          <MedlinePgn>s81-s83</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054429</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Puska</LastName>
            <ForeName>Pekka</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Health and Welfare, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Daube</LastName>
            <ForeName>Mike</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Curtin University, Perth, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>WHO FCTC Impact Assessment Expert Group</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D062489" MajorTopicYN="Y">Health Impact Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074606" MajorTopicYN="Y">Smoking Prevention</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014944" MajorTopicYN="Y">World Health Organization</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">prevention</Keyword>
        <Keyword MajorTopicYN="N">public policy</Keyword>
        <Keyword MajorTopicYN="N">surveillance and monitoring</Keyword>
        <Keyword MajorTopicYN="N">tobacco industry</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Fong</LastName>
          <ForeName>Geoffrey T</ForeName>
          <Initials>GT</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gupta</LastName>
          <ForeName>Sudhir</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mcinerney</LastName>
          <ForeName>Thomas F</ForeName>
          <Initials>TF</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Zaatari</LastName>
          <ForeName>Ghazi</ForeName>
          <Initials>G</Initials>
        </Investigator>
      </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>24</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30181384</ArticleId>
        <ArticleId IdType="pmc">PMC6589462</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054429</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054429</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
World Health Organization. Global strategy for the prevention and control of noncommunicable diseases. Report by the Director General. EB105/42. 2000. 
http://apps.who.int/iris/handle/10665/78986
</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization &amp; Public Health Agency of Canada. Preventing chronic diseases&#x2014;a vital investment. 2005. 
http://apps.who.int/iris/bitstream/handle/10665/43314/9241563001_eng.pdf?sequence=1
</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization. WHA23.32 Health consequences of smoking. 1970. 
http://www.who.int/tobacco/framework/wha_eb/wha23_32/en/
</Citation>
        </Reference>
        <Reference>
          <Citation>WHO Expert Committee on Smoking Control &amp; World Health Organization. Controlling the smoking epidemic. Report of the WHO expert Committee on Smoking Control. World Health Organ Tech Rep Ser 1979:7&#x2013;87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">112784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
World Health Organization. WHO Framework Convention on Tobacco Control. 2003. 
http://apps.who.int/iris/bitstream/10665/42811/1/9241591013.pdf?ua=1
</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization. Global plan for prevention and control of NCDs 2013&#x2013;2020. 2013. 
http://www.who.int/nmh/events/ncd_action_plan/en/
</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization. Global strategy to reduce the harmful use of alcohol. 2010. 
http://www.who.int/substance_abuse/activities/gsrhua/en/
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7047030</ArticleId>
            <ArticleId IdType="pubmed">32132758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
WHO Convention Secretariat. Impact Assessment of the WHO FCTC. 2016. 
http://www.who.int/fctc/implementation/impact/en/
</Citation>
        </Reference>
        <Reference>
          <Citation>Fong GT, Chung-Hall J, Craig L. WHO FCTC Impact Assessment Expert Group. Impact assessment of the WHO FCTC over its first decade: methodology of the expert group. Tob Control 2019;28(suppl 2):s84&#x2013;s88. 10.1136/tobaccocontrol-2018-054374</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054374</ArticleId>
            <ArticleId IdType="pmc">PMC6589466</ArticleId>
            <ArticleId IdType="pubmed">29954859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung-Hall J, Craig L, Gravely S, et al. . Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group. Tob Control 2019;28(suppl 2):s119&#x2013;s128. 10.1136/tobaccocontrol-2018-054389</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054389</ArticleId>
            <ArticleId IdType="pmc">PMC6589489</ArticleId>
            <ArticleId IdType="pubmed">29880598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chung-Hall J, Craig L, Gravely S, et al. . 
Impact of the WHO Framework Convention on Tobacco Control on the implementation and effectiveness of tobacco control measures: a global evidence review. 2016. 
http://www.who.int/fctc/cop/cop7/Documentation-Supplementary-information/en/
</Citation>
        </Reference>
        <Reference>
          <Citation>Gravely S, Giovino GA, Craig L, et al. . Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. Lancet Public Health 2017;2:e166&#x2013;e174. 10.1016/S2468-2667(17)30045-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2468-2667(17)30045-2</ArticleId>
            <ArticleId IdType="pubmed">29253448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou SY, Liberman JD, Ricafort E. The impact of the WHO Framework Convention on Tobacco Control in defending legal challenges to tobacco control measures. Tob Control 2019;28(suppl 2):s113&#x2013;s118. 10.1136/tobaccocontrol-2018-054329</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054329</ArticleId>
            <ArticleId IdType="pmc">PMC6589463</ArticleId>
            <ArticleId IdType="pubmed">29860233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bialous S.
Impact of implementation of the WHO FCTC on the tobacco industry&#x2019;s behaviour. 2015. 
http://www.who.int/fctc/cop/cop7/Documentation-Supplementary-information/en/
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6589456</ArticleId>
            <ArticleId IdType="pubmed">30659104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beaglehole R, Bonita R, Horton R, et al. . Priority actions for the non-communicable disease crisis. Lancet 2011;377:1438&#x2013;47. 10.1016/S0140-6736(11)60393-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(11)60393-0</ArticleId>
            <ArticleId IdType="pubmed">21474174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
United Nations. Transforming our world: the 2030 agend for sustainable development. A/RES/70/1. 2015. 
https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Puska P, St&#xE5;hl T. Health in all policies&#x2014;the Finnish initiative: background, principles, and current issues. Annu Rev Public Health 2010;31:315&#x2013;28. 10.1146/annurev.publhealth.012809.103658</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.publhealth.012809.103658</ArticleId>
            <ArticleId IdType="pubmed">20070201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
World Commission on the Social Dimension of Globalization. A fair globalization: creating opportunities for all. 2004. 
http://www.ilo.org/public/english/wcsdg/docs/report.pdf
</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30179286</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>11</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1460-9568</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>50</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>The European journal of neuroscience</Title>
          <ISOAbbreviation>Eur J Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neuroimmune mechanisms of psychostimulant and opioid use disorders.</ArticleTitle>
        <Pagination>
          <StartPage>2562</StartPage>
          <EndPage>2573</EndPage>
          <MedlinePgn>2562-2573</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ejn.14143</ELocationID>
        <Abstract>
          <AbstractText>Substance use disorders are global health problems with few effective treatment options. Unfortunately, most potential pharmacological treatments are hindered by abuse potential of their own, limited efficacy, or adverse side effects. As a consequence, there is a pressing need for the development of addiction treatments with limited abuse potential and fewer off target effects. Given the difficulties in developing new pharmacotherapies for substance use disorders, there has been growing interest in medications that act on non-traditional targets. Recent evidence suggests a role for dysregulated immune signaling in the pathophysiology of multiple psychiatric diseases. While there is evidence that immune responses in the periphery and the central nervous system are altered by exposure to drugs of abuse, the contributions of neuroimmune interactions to addictive behaviors are just beginning to be appreciated. In this review, we discuss the data on immunological changes seen in clinical populations with substance use disorders, as well as in translational animal models of addiction. Importantly, we highlight those mechanistic findings showing causal roles for central or peripheral immune mediators in substance use disorder and appropriate animal models. Based on the literature reviewed here, it is clear that brain-immune system interactions in substance use disorders are much more complex and important than previously understood. While much work remains to be done, there are tremendous potential therapeutic implications for immunomodulatory treatments in substance use disorders.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Federation of European Neuroscience Societies and John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hofford</LastName>
            <ForeName>Rebecca S</ForeName>
            <Initials>RS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Russo</LastName>
            <ForeName>Scott J</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kiraly</LastName>
            <ForeName>Drew D</ForeName>
            <Initials>DD</Initials>
            <Identifier Source="ORCID">0000-0002-4818-5169</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>DA044308</GrantID>
            <Acronym>GF</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 MH104559</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Agency>Seaver Family Foundation</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>K08 DA044308</GrantID>
            <Acronym>DA</Acronym>
            <Agency>NIDA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <Agency>Leon Levy Foundation</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <Agency>Brain and Behavior Research Foundation</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>MH104559</GrantID>
            <Acronym>GF</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>France</Country>
        <MedlineTA>Eur J Neurosci</MedlineTA>
        <NlmUniqueID>8918110</NlmUniqueID>
        <ISSNLinking>0953-816X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000697">Central Nervous System Stimulants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000697" MajorTopicYN="N">Central Nervous System Stimulants</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015213" MajorTopicYN="N">Neuroimmunomodulation</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009293" MajorTopicYN="N">Opioid-Related Disorders</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">addiction</Keyword>
        <Keyword MajorTopicYN="N">immune effects of drugs of abuse</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">microbiome</Keyword>
      </KeywordList>
      <CoiStatement>Conflict of interests. The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30179286</ArticleId>
        <ArticleId IdType="mid">NIHMS1029045</ArticleId>
        <ArticleId IdType="pmc">PMC6531363</ArticleId>
        <ArticleId IdType="doi">10.1111/ejn.14143</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Acharya C, Betrapally NS, Gillevet PM, Sterling RK, Akbarali H, White MB, Ganapathy D, Fagan A et al. (2017) Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis. Aliment. Pharmacol. Ther, 45, 319&#x2013;331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27868217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alcabes P &amp; Friedland G (1995) Injection drug use and human immunodeficiency virus infection. Clin. Infect. Dis, 20, 1467&#x2013;1479.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7548494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Araos P, Pedraz M, Serrano A, Lucena M, Barrios V, Garc&#x131;a-Marchena N, Campos-Cloute R, Ruiz JJ et al. (2015) Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity. Addict. Biol, 20, 756&#x2013;772.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24854157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arreola R, Alvarez-Herrera S, Perez-Sanchez G, Becerril-Villanueva E, Cruz-Fuentes C, Flores-Gutierrez EO, Garces-Alvarez ME, de la Cruz-Aguilera DL et al. (2016) Immunomodulatory effects mediated by dopamine. J. Immunol. Res, 2016, 3160486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5067323</ArticleId>
            <ArticleId IdType="pubmed">27795960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attarzadeh-Yazdi G, Arezoomandan R &amp; Haghparast A (2014) Minocy-cline, an antibiotic with inhibitory effect on microglial activation, attenu-ates the maintenance and reinstatement of methamphetamine-seeking behavior in rat. Prog. Neuro-Psychopha, 53, 142&#x2013;148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24768984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azarang A, Mahmoodi M, Rajabalian S, Shekari MA, Nosratabadi J &amp; Rezaei N (2007) T-helper 1 and 2 serum cytokine assay in chronic opioid addicts. Eur. Cytokine Netw, 18, 210&#x2013;214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17993452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bachtell RK, Jones JD, Heinzerling KG, Beardsley PM &amp; Comer SD (2017) Glial and neuroinflammatory targets for treating substance use disorders. Drug Alcohol Depen, 180, 156&#x2013;170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5790191</ArticleId>
            <ArticleId IdType="pubmed">28892721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banati RB (2002) Visualising microglial activation in vivo. Glia, 40, 206&#x2013;217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12379908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banerjee S, Sindberg G, Wang F, Meng J, Sharma U, Zhang L, Dauer P, Chen C et al. (2016) Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol, 9, 1418&#x2013;1428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4996771</ArticleId>
            <ArticleId IdType="pubmed">26906406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P et al. (2011) The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology, 141, 599&#x2013;609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21683077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bland ST, Hutchinson MR, Maier SF, Watkins LR &amp; Johnson KW (2009) The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release. Brain Behav. Immun, 23, 492&#x2013;497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2783267</ArticleId>
            <ArticleId IdType="pubmed">19486648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown KT, Levis SC, O&#x2019;Neill CE, Northcutt AL, Fabisiak TJ, Watkins LR &amp; Bachtell RK (2018) Innate immune signaling in the ventral tegmental area contributes to drug-primed reinstatement of cocaine seeking. Brain Behav. Immun, 67, 130&#x2013;138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6252252</ArticleId>
            <ArticleId IdType="pubmed">28813640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brydon L, Harrison NA, Walker C, Steptoe A, &amp; Critchley HD (2008). Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol. Psychiatry, 63, 1022&#x2013;1029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2885493</ArticleId>
            <ArticleId IdType="pubmed">18242584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Budd K (2006) Pain management: is opioid immunosuppression a clinical problem? Biomed. Pharmacother, 60, 310&#x2013;317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16860971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bylicky MA, Mueller GP &amp; Day RM (2018) Mechanisms of endogenous neuroprotective effects of astrocytes in brain injury. Oxid. Med. Cell. Longev, 2018, 6501031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5901819</ArticleId>
            <ArticleId IdType="pubmed">29805731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calipari ES, Godino A, Peck EG, Salery M, Mervosh NL, Landry JA, Russo SJ, Hurd YL et al. (2018) Granulocyte-colony stimulating factor controls neural and behavioral plasticity in response to cocaine. Nat. Commun, 9, 9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5770429</ArticleId>
            <ArticleId IdType="pubmed">29339724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campbell LA, Avdoshina V, Rozzi S &amp; Mocchetti I (2013) CCL5 and cytokine expression in the rat brain: Differential modulation by chronic morphine and morphine withdrawal. Brain Behav. Immun, 34, 130&#x2013;140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3795805</ArticleId>
            <ArticleId IdType="pubmed">23968971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Capuron L, Pagnoni G, Drake DF, Woolwine BJ, Spivey JR, Crowe RJ, Votaw JR, Goodman MM, &amp; Miller AH (2012). Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch. Gen. Psychiatry, 69, 1044&#x2013;1053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3640298</ArticleId>
            <ArticleId IdType="pubmed">23026954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carrigan KA, Saurer TB, Ijames SG &amp; Lysle DT (2004) Buprenorphine produces naltrexone reversible alterations of immune status. Int. Immunopharmacol, 4, 419&#x2013;428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15037219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castells X, Cunill R, PerezMa&#xF1;a C, Vidal X &amp; Capella D (2016) Psychostimulant drugs for cocaine dependence. Cochrane Database Syst. Rev, 9, CD007380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6457633</ArticleId>
            <ArticleId IdType="pubmed">27670244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chao J, &amp; Nestler EJ (2004). Molecular neurobiology of drug addiction. Annu. Rev. Med, 55, 113&#x2013;132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14746512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen H, Uz T &amp; Manev H (2009) Minocycline affects cocaine sensitization in mice. Neurosci. Lett, 452, 258&#x2013;261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2680252</ArticleId>
            <ArticleId IdType="pubmed">19348734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA, Manubay J, Martinez D et al. (2016) The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addict. Biol, 21, 895&#x2013;903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4644513</ArticleId>
            <ArticleId IdType="pubmed">25975386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cosenza-Nashat M, Zhao M-L, Suh H-S, Morgan J, Natividad R, Morgello S &amp; Lee SC (2009) Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohisto-chemical localization in abnormal human brain. Neuropathol. Appl. Neurobiol, 35, 306&#x2013;328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2693902</ArticleId>
            <ArticleId IdType="pubmed">19077109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crews FT, Lawrimore CJ, Walter TJ &amp; Coleman LG (2017) The role of neuroimmune signaling in alcoholism. Neuropharmacology, 122, 56&#x2013;73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5493978</ArticleId>
            <ArticleId IdType="pubmed">28159648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desbonnet L, Clarke G, Traplin A, O&#x2019;Sullivan O, Crispie F, Moloney RD, Cotter PD, Dinan TG et al. (2015) Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. Brain Behav. Immun, 48, 165&#x2013;173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25866195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinarello CA (2011) A clinical perspective of IL-1b as the gatekeeper of inflammation. Eur. J. Immunol, 41, 1203&#x2013;1217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21523780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donahoe RM &amp; Vlahov D (1998) Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J. Neuroimmunol, 83, 77&#x2013;87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9610676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong Y, Taylor JR, Wolf ME, &amp; Shaham Y (2017). Circuit and synaptic plasticity mechanisms of drug relapse. J. Neurosci, 37, 10867&#x2013;10876.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5678019</ArticleId>
            <ArticleId IdType="pubmed">29118216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eidson LN &amp; Murphy AZ (2013) Blockade of toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine. J. Neurosci, 33, 15952&#x2013;15963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3787504</ArticleId>
            <ArticleId IdType="pubmed">24089500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eidson LN, Inoue K, Young LJ, Tansey MG &amp; Murphy AZ (2016) Toll-like receptor 4 mediates morphine-induced neuroinflammation and tolerance via soluble tumor necrosis factor signaling. Neuropsychopharmacology, 42, 661.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5240168</ArticleId>
            <ArticleId IdType="pubmed">27461080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A &amp; Hauser KF (2005) Synergistic increases in intracellular Ca(2+), and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia, 50, 91&#x2013;106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4301446</ArticleId>
            <ArticleId IdType="pubmed">15630704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ersche KD, Hagan CC, Smith DG, Abbott S, Jones PS, ApergisSchoute AM &amp; D&#xF6;ffinger R (2014) Aberrant disgust responses and immune reactivity in cocainedependent men. Biol. Psychiatry, 75, 140&#x2013;147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3898808</ArticleId>
            <ArticleId IdType="pubmed">24090796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fecho K, Nelson CJ &amp; Lysle DT (2000) Phenotypic and functional assessments of immune status in the rat spleen following acute heroin treatment. Immunopharmacology, 46, 193&#x2013;207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10741900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, &amp; Miller AH (2016). Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Molecular Psychiatry, 21, 1358&#x2013;1365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4862934</ArticleId>
            <ArticleId IdType="pubmed">26552591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felger JC, &amp; Miller AH (2012). Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol, 33, 315&#x2013;327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3484236</ArticleId>
            <ArticleId IdType="pubmed">23000204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felger JC, &amp; Treadway MT (2017). Inflammation effects on motivation and motor activity: role of dopamine. Neuropsychopharmacology, 42, 216&#x2013;241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5143486</ArticleId>
            <ArticleId IdType="pubmed">27480574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrante CJ &amp; Leibovich SJ (2012) Regulation of macrophage polarization and wound healing. Adv. Wound Care, 1, 10&#x2013;16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3623587</ArticleId>
            <ArticleId IdType="pubmed">24527272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster JA, Rinaman L &amp; Cryan JF (2017) Stress &amp; the gut-brain axis: regulation by the microbiome. Neurobiol. Stress, 7, 124&#x2013;136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5736941</ArticleId>
            <ArticleId IdType="pubmed">29276734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fox HC, D&#x2019;Sa C, Kimmerling A, Siedlarz KM, Tuit KL, Stowe R &amp; Sinha R (2012) Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum. Psychopharmacol. Clin. Exp, 27, 156&#x2013;166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3674778</ArticleId>
            <ArticleId IdType="pubmed">22389080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frank MG, Weber MD, Watkins LR &amp; Maier SF (2015) Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav. Immun, 48, 1&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4508196</ArticleId>
            <ArticleId IdType="pubmed">25816800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukagawa H, Koyama T, Kakuyama M &amp; Fukuda K (2013) Microglial activation involved in morphine tolerance is not mediated by toll-like receptor 4. J. Anesth, 27, 93&#x2013;97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22926420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fung TC, Olson CA &amp; Hsiao EY (2017) Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci, 20, 145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6960010</ArticleId>
            <ArticleId IdType="pubmed">28092661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galli SJ, Borregaard N &amp; Wynn TA (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol, 12, 1035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3412172</ArticleId>
            <ArticleId IdType="pubmed">22012443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>G&#xF3;mez-Coronado N, Walker AJ, Berk M &amp; Dodd S (2018) Current and emerging pharmacotherapies for cessation of tobacco smoking. Pharmacother. J. Hum. Pharmacol. Drug Ther, 38, 235&#x2013;258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29250815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grimm MC, Ben-Baruch A, Taub DD, Howard OMZ, Wang JM &amp; Oppenheim JJ (1998) Opiate inhibition of chemokine-induced chemotaxis. Ann. N.Y. Acad. Sci, 840, 9&#x2013;20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9629232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta K, Sharma R, Singh V, Masoomi R, Dileepan KN, He J, Smith DD, Dawn B et al. (2018) Intravenous cocaine results in an acute decrease in levels of biomarkers of vascular inflammation in humans. Cardiovasc. Toxicol, 18, 295&#x2013;303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29372505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guyon A, Skrzydelski D, De Giry I, Rovere C, Conductier G, Tro-cello JM, Dauge V, Kitabgi P et al. (2009) Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience, 162, 1072&#x2013;1080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19477239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>den Haan JMM, Arens R &amp; van Zelm MC (2014) The activation of the adaptive immune system: cross-talk between antigen-presenting cells, T cells and B cells. Immunol. Lett, 162, 103&#x2013;112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25455596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halpern JH, Sholar MB, Glowacki J, Mello NK, Mendelson JH &amp; Siegel AJ (2003) Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration. J. Clin. Endocrinol. Metab, 88, 1188&#x2013;1193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12629105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Happel C, Steele AD, Finley MJ, Kutzler MA &amp; Rogers TJ (2008) DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF-b1. J. Leukoc. Biol, 83, 956&#x2013;963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18252865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heijtz RD, Wang S, Anuar F, Qian Y, Bj&#xF6;rkholm B, Samuelsson A, Hibberd ML, Forssberg H et al. (2011) Normal gut microbiota modulates brain development and behavior. Proc. Natl Acad. Sci. USA, 108, 3047&#x2013;3052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3041077</ArticleId>
            <ArticleId IdType="pubmed">21282636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hodes GE, Kana V, Menard C, Merad M &amp; Russo SJ (2015) Neuroimmune mechanisms of depression. Nat. Neurosci, 18, 1386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4843114</ArticleId>
            <ArticleId IdType="pubmed">26404713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutchinson MR, Coats BD, Lewis SS, Zhang Y, Sprunger DB, Rezvani N, Baker EM, Jekich BM et al. (2008a) Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav. Immun, 22, 1178&#x2013;1189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2783238</ArticleId>
            <ArticleId IdType="pubmed">18599265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutchinson MR, Northcutt AL, Chao LW, Kearney JJ, Zhang Y, Berkelhammer DL, Loram LC, Rozeske RR et al. (2008b) Minocycline suppresses morphine-induced respiratory depression, suppresses mor-phine-induced reward, and enhances systemic morphine-induced analgesia. Brain Behav. Immun, 22, 1248&#x2013;1256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2783326</ArticleId>
            <ArticleId IdType="pubmed">18706994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutchinson MR, Lewis SS, Coats BD, Skyba DA, Crysdale NY, Berkelhammer DL, Brzeski A, Northcutt A et al. (2009) Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav. Immun, 23, 240&#x2013;250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2662518</ArticleId>
            <ArticleId IdType="pubmed">18938237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, Slivka PF, Coats BD et al. (2010) Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav. Immun, 24, 83&#x2013;95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2788078</ArticleId>
            <ArticleId IdType="pubmed">19679181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutchinson MR, Northcutt AL, Hiranita T, Wang X, Lewis SS, Thomas J, van Steeg K, Kopajtic TA et al. (2012) Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J. Neurosci, 32, 11187&#x2013;11200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3454463</ArticleId>
            <ArticleId IdType="pubmed">22895704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irwin MR, Olmos L, Wang M, Valladares EM, Motivala SJ, Fong T, Newton T, Butch A et al. (2007) Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms. J. Pharmacol. Exp. Ther, 320, 507&#x2013;515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17068203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang R, Lee I, Lee TA &amp; Pickard AS (2017) The societal cost of heroin use disorder in the United States. PLoS ONE, 12, e0177323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5448739</ArticleId>
            <ArticleId IdType="pubmed">28557994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson SW &amp; North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci, 12, 483&#x2013;488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6575608</ArticleId>
            <ArticleId IdType="pubmed">1346804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D et al. (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci, 24, 7353&#x2013;7365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6729781</ArticleId>
            <ArticleId IdType="pubmed">15317861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalivas PW, Volkow N &amp; Seamans J (2005) Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron, 45, 647&#x2013;650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15748840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang M, Mischel RA, Bhave S, Komla E, Cho A, Huang C, Dewey WL &amp; Akbarali HI (2017) The effect of gut microbiome on tolerance to morphine mediated antinociception in mice. Sci. Rep, 7, 42658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5314392</ArticleId>
            <ArticleId IdType="pubmed">28211545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashima DT &amp; Grueter BA (2017) Toll-like receptor 4 deficiency alters nucleus accumbens synaptic physiology and drug reward behavior. Proc. Natl Acad. Sci. USA, 114, 8865&#x2013;8870.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5565449</ArticleId>
            <ArticleId IdType="pubmed">28760987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, Bhasker V, Gordillo GM et al. (2010) Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE, 5, e9539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2832020</ArticleId>
            <ArticleId IdType="pubmed">20209061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiraly DD, Walker DM, Calipari ES, Labonte B, Issler O, Pena CJ, Ribeiro EA, Russo SJ et al. (2016) Alterations of the host microbiome affect behavioral responses to cocaine. Sci. Rep, 6, 35455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5067576</ArticleId>
            <ArticleId IdType="pubmed">27752130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lacagnina MJ, Kopec AM, Cox SS, Hanamsagar R, Wells C, Slade S, Grace PM, Watkins LR et al. (2017a) opioid self-administration is attenuated by early-life experience and Gene therapy for anti-inflammatory IL-10 in the nucleus accumbens of male rats. Neuropsychopharmacology, 42, 2128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5603817</ArticleId>
            <ArticleId IdType="pubmed">28436446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lacagnina MJ, Rivera PD &amp; Bilbo SD (2017b) Glial and neuroimmune mechanisms as critical modulators of drug use and abuse. Neuropsy-chopharmacology, 42, 156&#x2013;177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5143481</ArticleId>
            <ArticleId IdType="pubmed">27402494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lang J-Y, Wang J-S, Zhai H-F, Fang Q, Wu P &amp; Lu L (2009) Interferon-alpha reinstates morphine-conditioned place preference through opioid receptors in rats. Behav. Pharmacol, 20, 166&#x2013;173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19322075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levandowski ML, Hess ARB, Grassi-Oliveira R &amp; de Almeida RMM (2016) Plasma interleukin-6 and executive function in crack cocaine-dependent women. Neurosci. Lett, 628, 85&#x2013;90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27297769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewitus GM, Pribiag H, Duseja R, St-Hilaire M &amp; Stellwagen D (2014) An adaptive role of TNF in the regulation of striatal synapses. J. Neurosci, 34, 6146&#x2013;6155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6608116</ArticleId>
            <ArticleId IdType="pubmed">24790185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewitus GM, Konefal SC, Greenhalgh AD, Pribiag H, Augereau K &amp; Stellwagen D (2016) Microglial TNFa suppresses cocaine-induced plasticity and behavioral sensitization. Neuron, 90, 483&#x2013;491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4860141</ArticleId>
            <ArticleId IdType="pubmed">27112496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Little KY, Ramssen E, Welchko R, Volberg V, Roland CJ &amp; Cassin B (2009) Decreased brain dopamine cell numbers in human cocaine users. Psychiatry Res, 168, 173&#x2013;180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19233481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu L, Coller JK, Watkins LR, Somogyi AA &amp; Hutchinson MR (2011) Naloxone-precipitated morphine withdrawal behavior and brain IL-1b expression: comparison of different mouse strains. Brain Behav. Immun, 25, 1223&#x2013;1232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3142610</ArticleId>
            <ArticleId IdType="pubmed">21447380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lysle DT, Coussons ME, Watts VJ, Bennett EH &amp; Dykstra LA (1993) Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther, 265, 1071&#x2013;1078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7685383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Makman MH, Bilfinger TV &amp; Stefano GB (1995) Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cyto-kine-induced activation and chemotaxis. J. Immunol, 154, 1323&#x2013;1330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7822801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manetti L, Cavagnini F, Martino E &amp; Ambrogio A (2014) Effects of cocaine on the hypothalamic&#x2013;pituitary&#x2013;adrenal axis. J. Endocrinol. Invest, 37, 701&#x2013;708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24852417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A et al. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the l-opioid-receptor gene. Nature, 383, 819.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8893006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mattick RP, Breen C, Kimber J &amp; Davoli M (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev, 6, CD002207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15266465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mattioli TA, Leduc-Pessah H, Skelhorne-Gross G, Nicol CJB, Milne B, Trang T &amp; Cahill CM (2014) Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence. PLoS ONE, 9, e97361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4019634</ArticleId>
            <ArticleId IdType="pubmed">24824631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayfield J, Ferguson L &amp; Harris RA (2013) Neuroimmune signaling: a key component of alcohol abuse. Curr. Opin. Neurobiol, 23, 513&#x2013;520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3694992</ArticleId>
            <ArticleId IdType="pubmed">23434064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maza-Quiroga R, Garc&#x131;a-Marchena N, Romero-Sanchiz P, Barrios V, Pedraz M, Serrano A, Nogueira-Arjona R, Ruiz JJ et al. (2017) Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFa) as a potential biomarker of consumption and dual diagnosis. PeerJ, 5, e3926.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5641428</ArticleId>
            <ArticleId IdType="pubmed">29038767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meijerink H, Indrati A, Utami F, Soedarmo S, Alisjahbana B, Netea MG, van Crevel R, Wisaksana R et al. (2015) Heroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individuals. PLoS ONE, 10, e0122822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4382331</ArticleId>
            <ArticleId IdType="pubmed">25830312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME et al. (2017) Social stress induces neurovascular pathology promoting depression. Nat. Neurosci, 20, 1752&#x2013;1760.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5726568</ArticleId>
            <ArticleId IdType="pubmed">29184215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng J, Banerjee S, Li D, Sindberg GM, Wang F, Ma J &amp; Roy S (2015) Opioid exacerbation of gram-positive sepsis, induced by gut microbial modulation, is rescued by IL-17A neutralization. Sci. Rep, 5, 10918.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4454150</ArticleId>
            <ArticleId IdType="pubmed">26039416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mesgarpour B, Griebler U, Glechner A, Kien C, Strobelberger M, Van Noord MG &amp; Michalek-Sauberer A (2014) Extended-release opioids in the management of cancer pain: a systematic review of efficacy and safety. Eur. J. Pain (United Kingdom), 18, 605&#x2013;616.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24115561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Messmer D, Hatsukari I, Hitosugi N, Schmidt-Wolf IGH &amp; Singhal PC (2006) Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Mol. Med, 12, 284&#x2013;290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1829197</ArticleId>
            <ArticleId IdType="pubmed">17380193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metz VE, Jones JD, Manubay J, Sullivan MA, Mogali S, Segoshi A, Madera G, Johnson KW et al. (2017) Effects of ibudilast on the subjective, reinforcing, and analgesic effects of oxycodone in recently detoxified adults with opioid dependence. Neuropsychopharmacology, 42, 1825.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5520790</ArticleId>
            <ArticleId IdType="pubmed">28393896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miguel-Hidalgo JJ (2009) The role of glial cells in drug abuse. Curr. Drug Abuse Rev, 2, 72&#x2013;82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19630738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller BJ, &amp; Goldsmith DR (2017). Towards an immunophenotype of schizophrenia: progress, potential mechanisms, and future directions. Neu-ropsychopharmacology, 42, 299&#x2013;317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5143505</ArticleId>
            <ArticleId IdType="pubmed">27654215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montaldo E, Vacca P, Moretta L &amp; Mingari MC (2014) Development of human natural killer cells and other innate lymphoid cells. Semin. Immunol, 26, 107&#x2013;113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24559836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montesinos J, Alfonso-Loeches S &amp; Guerri C (2016) Impact of the innate immune response in the actions of ethanol on the central nervous system. Alcohol. Clin. Exp. Res, 40, 2260&#x2013;2270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27650785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreira FP, Medeiros JRC, Lhullier AC, Souza L.D.de.M., Jansen K, Portela LV, Lara DR, Silva R.A.da. et al. (2016) Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10. Drug Alcohol Depen, 158, 181&#x2013;185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26679059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moussawi K, Pacchioni A, Moran M, Olive MF, Gass JT, Lavin A, &amp; Kalivas PW (2009). N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat. Neurosci, 12, 182&#x2013;189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2661026</ArticleId>
            <ArticleId IdType="pubmed">19136971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Narendran R, Lopresti BJ, Mason NS, Deuitch L, Paris J, Himes ML, Kodavali CV &amp; Nimgaonkar VL (2014) Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [(11)C]PBR28. J. Neurosci, 34, 9945&#x2013;9950.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4107410</ArticleId>
            <ArticleId IdType="pubmed">25057196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ning T, Gong X, Xie L &amp; Ma B (2017) Gut microbiota analysis in rats with methamphetamine-induced conditioned place preference. Front. Microbiol, 8, 1620.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5575146</ArticleId>
            <ArticleId IdType="pubmed">28890714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niwa M, Nitta A, Yamada Y, Nakajima A, Saito K, Seishima M, Noda Y &amp; Nabeshima T (2007) Tumor necrosis factora and its inducer inhibit morphine-induced rewarding effects and sensitization. Biol. Psychiatry, 62, 658&#x2013;668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17217924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Northcutt AL, Hutchinson MR, Wang X, Baratta MV, Hiranita T, Cochran TA, Pomrenze MB, Galer EL et al. (2015) DAT isn&#x2019;t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling. Mol. Psychiatry, 20, 1525.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4523496</ArticleId>
            <ArticleId IdType="pubmed">25644383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pacifici R, di Carlo S, Bacosi A, Pichini S &amp; Zuccaro P (2000) Phar-macokinetics and cytokine production in heroin and morphine-treated mice. Int. J. Immunopharmacol, 22, 603&#x2013;614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10988355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, Ferrari AJ, Hyman S et al. (2016) Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet, 387, 1672&#x2013;1685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26454360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedraz M, Araos P, Garc&#x131;a-Marchena N, Serrano A, Romero-Sanchiz P, Suarez J, Castilla-Ortega E, Mayoral-Cleries F et al. (2015) Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings. Front. Psychiatry, 6, 17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4329735</ArticleId>
            <ArticleId IdType="pubmed">25762940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peineau S, Rabiant K, Pierrefiche O &amp; Potier B (2018) Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer&#x2019;s disease. Pharmacol. Res, 130, 385&#x2013;401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29425728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perez-Castrillon JL, Perez-Arellano JL, Garc&#x131;a-Palomo JD, Jimenez-Lopez A &amp; Castro S.De. (1992) Opioids depress in vitro human monocyte chemotaxis. Immunopharmacology, 23, 57&#x2013;61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1314788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peterson PK, Sharp B, Gekker G, Brummitt C &amp; Keane WF (1987) Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J. Clin. Invest, 80, 824&#x2013;831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC442309</ArticleId>
            <ArticleId IdType="pubmed">3040807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piepenbrink MS, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, Kiebala M, Khan AA et al. (2016) Humoral dysregulation associated with increased systemic inflammation among injection heroin users. PLoS ONE, 11, e0158641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4933366</ArticleId>
            <ArticleId IdType="pubmed">27379802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Portou MJ, Baker D, Abraham D &amp; Tsui J (2015) The innate immune system, toll-like receptors and dermal wound healing: a review. Vascular Pharmacol, 71, 31&#x2013;36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25869514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prata J, Santos SG, Almeida MI, Coelho R &amp; Barbosa MA (2017) Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers &#x2013; pre-clinical and clinical investigations. J. Neuroinflammation, 14, 179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5584030</ArticleId>
            <ArticleId IdType="pubmed">28870209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raghavendra V, Rutkowski MD &amp; DeLeo JA (2002) The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J. Neurosci, 22, 9980&#x2013;9989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6757841</ArticleId>
            <ArticleId IdType="pubmed">12427855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raghavendra V, Tanga FY &amp; DeLeo JA (2003) Attenuation of mor-phine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology, 29, 327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14532913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ripke S, Neale BM, Corvin A, Walters JTR, Farh KH, Holmans PA, Lee P, Bulik-Sullivan B et al. (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511, 421&#x2013;427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4112379</ArticleId>
            <ArticleId IdType="pubmed">25056061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Risdahl JM, Khanna KV, Peterson PK &amp; Molitor TW (1998) Opiates and infection. J. Neuroimmunol, 83, 4&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9610668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts M, Brodribb W &amp; Mitchell G (2012) Reducing the pain: a systematic review of postdischarge analgesia following elective orthopedic surgery. Pain Med, 13, 711&#x2013;727.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22494470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rock RB, Hu S, Sheng WS &amp; Peterson PK (2006) Morphine stimulates CCL2 production by human neurons. J. Neuroinflammation, 3, 32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1712222</ArticleId>
            <ArticleId IdType="pubmed">17156455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudd RA, Aleshire N, Zibbell JE &amp; Matthew Gladden R. (2016) Increases in drug and opioid overdose deaths&#x2014;United States, 2000&#x2013;2014. Am. J. Transplant, 16, 1323&#x2013;1327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26720857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacerdote P (2008) Opioid-induced immunosuppression. Curr. Opin. Support Pa, 2, 14&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18685388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salter MW &amp; Stevens B (2017) Microglia emerge as central players in brain disease. Nat. Med, 23, 1018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28886007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE et al. (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson&#x2019;s disease. Cell, 167, 1469&#x2013;1480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5718049</ArticleId>
            <ArticleId IdType="pubmed">27912057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Savignac HM, Corona G, Mills H, Chen L, Spencer JPE, Tzortzis G &amp; Burnet PWJ (2013) Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine. Neurochem. Int, 63, 756&#x2013;764.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3858812</ArticleId>
            <ArticleId IdType="pubmed">24140431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sayana P, Colpo GD, Sim&#xF5;es LR, Giridharan VV, Teixeira AL, Quevedo J, &amp; Barichello T (2017). A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J. Psychiatr. Res, 92, 160&#x2013;182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28458141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schuckit MA (2016) Treatment of opioiduse disorders. N. Engl. J. Med, 375, 357&#x2013;368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27464203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwarz JM, Hutchinson MR &amp; Bilbo SD (2011) Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-Inflammatory IL-10 expression. J. Neurosci, 31, 17835&#x2013;17847.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3259856</ArticleId>
            <ArticleId IdType="pubmed">22159099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scofield MD, &amp; Kalivas PW (2014). Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis. Neuroscientist, 20, 610&#x2013;622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4913887</ArticleId>
            <ArticleId IdType="pubmed">24496610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekine Y, Ouchi Y, Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ et al. (2008) Methamphetamine causes microglial activation in the brains of human abusers. J. Neurosci, 28, 5756&#x2013;5761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2491906</ArticleId>
            <ArticleId IdType="pubmed">18509037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shavit Y, Wolf G, Goshen I, Livshits D &amp; Yirmiya R (2005) Inter-leukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain, 115, 50&#x2013;59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15836969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi C &amp; Pamer EG (2011) Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol, 11, 762&#x2013;774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3947780</ArticleId>
            <ArticleId IdType="pubmed">21984070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smyth B, Fan J &amp; Hser Y (2006) Life expectancy and productivity loss among narcotics addicts thirty-three years after index treatment. J. Addict. Dis, 25, 37&#x2013;47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17088224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Snider SE, Hendrick ES &amp; Beardsley PM (2013) Glial cell modulators attenuate methamphetamine self-administration in therat. Eur. J. Pharmacol, 701, 124&#x2013;130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3593742</ArticleId>
            <ArticleId IdType="pubmed">23375937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sofroniew MV (2013) Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators. Neuroscience, 20, 160&#x2013;172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24106265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F et al. (2017) Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review. Ther. Clin. Risk Manag, 13, 757&#x2013;777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5499790</ArticleId>
            <ArticleId IdType="pubmed">28721057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song P &amp; Zhao Z-Q (2001) The involvement of glial cells in the development of morphine tolerance. Neurosci. Res, 39, 281&#x2013;286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11248367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soyka M &amp; M&#xFC;ller CA (2017) Pharmacotherapy of alcoholism &#x2013; an update on approved and off-label medications. Expert Opin. Pharma-cother, 18, 1187&#x2013;1199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28658981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Substance Abuse and Mental Health Services Administration (2008) The NSDUH Report, Treatment for Depression Among Adults. Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Dept. of Health &amp; Human Services, Rockville, MD.</Citation>
        </Reference>
        <Reference>
          <Citation>Suzumura A, Ito A, Yoshikawa M &amp; Sawada M (1999) Ibudilast suppresses TNFa production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS. Brain Res, 837, 203&#x2013;212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10434004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szabo I, Rojavin M, Bussiere JL, Eisenstein TK, Adler MW &amp; Rogers TJ (1993) Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J. Pharmacol. Exp. Ther, 267, 703&#x2013;706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8246144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanda G, Mereu M, Hiranita T, Quarterman JC, Coggiano M &amp; Katz JL (2016) Lack of specific involvement of (+)-Naloxone and (+)-Naltrex-one on the reinforcing and neurochemical effects of cocaine and opioids. Neuropsychopharmacology, 41, 2772.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5026747</ArticleId>
            <ArticleId IdType="pubmed">27296151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thanos PK, Kim R, Delis F, Ananth M, Chachati G, Rocco MJ, Masad I, Muniz JA et al. (2016) Chronic methamphetamine effects on brain structure and function in rats. PLoS ONE, 11, e0155457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4898739</ArticleId>
            <ArticleId IdType="pubmed">27275601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Theberge FR, Li X, Kambhampati S, Pickens CL, Laurent R, Bossert JM, Baumann MH, Hutchinson MR et al. (2013) Effect of chronic delivery of the toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving. Biol. Psychiatry, 73, 729&#x2013;737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3615146</ArticleId>
            <ArticleId IdType="pubmed">23384483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tilleux S, &amp; Hermans E (2007). Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J. Neurosci. Res, 85, 2059&#x2013;2070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17497670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tollefson G (1991) Antidepressant treatment and side effect considerations. J. Clin. Psychiatry, 52, 4&#x2013;13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2030103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trecki J &amp; Unterwald EM (2009) Modulation of cocaine-induced activity by intracerebral administration of CXCL12. Neuroscience, 161, 13&#x2013;22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2680459</ArticleId>
            <ArticleId IdType="pubmed">19303923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trocello JM, Rostene W, Melik-Parsadaniantz S, Godefroy D, Roze E, Kitabgi P, Kuziel WA, Chalon S et al. (2011) Implication of CCR2 chemokine receptor in cocaine-induced sensitization. J. Mol. Neu-rosci, 44, 147&#x2013;151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21424761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyagi M, Weber J, Bukrinsky M &amp; Simon GL (2016) The effects of cocaine on HIV transcription. J. Neurovirol, 22, 261&#x2013;274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4868789</ArticleId>
            <ArticleId IdType="pubmed">26572787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, &amp; Pardo CA (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol, 57, 67&#x2013;81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15546155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Volpe GE, Ward H, Mwamburi M, Dinh D, Bhalchandra S, Wanke C &amp; Kane AV (2014) Associations of cocaine use and HIV infection with the intestinal microbiota, microbial translocation, and inflammation. J. Stud. Alcohol Drugs, 75, 347&#x2013;357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3965688</ArticleId>
            <ArticleId IdType="pubmed">24650829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vuong HE &amp; Hsiao EY (2017) Emerging roles for the gut microbiome in autism spectrum disorder. Biol. Psychiatry, 81, 411&#x2013;423.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5285286</ArticleId>
            <ArticleId IdType="pubmed">27773355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Barke RA, Charboneau R &amp; Roy S (2005) Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J. Immunol, 174, 426&#x2013;434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15611267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Barke RA &amp; Roy S (2007) Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine. J. Biol. Chem, 282, 7164&#x2013;7171.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17227776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Loram LC, Ramos K, de Jesus AJ, Thomas J, Cheng K, Reddy A, Somogyi AA et al. (2012) Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc. Natl Acad. Sci. USA, 109, 6325&#x2013;6330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3341002</ArticleId>
            <ArticleId IdType="pubmed">22474354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Zhang Y, Peng Y, Hutchinson MR, Rice KC, Yin H &amp; Watkins LR (2016) Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4. Br. J. Pharmacol, 173, 856&#x2013;869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4761092</ArticleId>
            <ArticleId IdType="pubmed">26603732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang F, Meng J, Zhang L, Johnson T, Chen C &amp; Roy S (2018) Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model. Sci. Rep, 8, 3596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5827657</ArticleId>
            <ArticleId IdType="pubmed">29483538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webber MP, Schoenbaum EE, Gourevitch MN, Buono D &amp; Klein RS (1999) A prospective study of HIV disease progression in female and male drug users. Aids, 13, 257&#x2013;262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10202832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wohleb ES, Franklin T, Iwata M &amp; Duman RS (2016) Integrating neuroimmune systems in the neurobiology of depression. Nat. Rev. Neurosci, 17, 497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27277867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, Adams MJ, Agerbo E et al. (2018). Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet, 50, 668&#x2013;681.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5934326</ArticleId>
            <ArticleId IdType="pubmed">29700475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yaksh TL (1981) Spinal opiate analgesia: characterstics and principles of action. Pain, 11, 293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6276842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, Weiss J &amp; Guyre PM (1995) Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology, 83, 500&#x2013;508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7661350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L &amp; Wang C-C (2014) Inflammatory response of macrophages in infection. Hepatob. Pancreat. Dis. Int, 13, 138&#x2013;152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24686541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Li H, Li Y, Sun X, Zhu M, Hanley G, LeSage G &amp; Yin D (2011) Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice. Neurosci. Lett, 489, 43&#x2013;47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3018547</ArticleId>
            <ArticleId IdType="pubmed">21130144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X-Q, Cui Y, Cui Y, Chen Y, Na X-D, Chen F-Y, Wei X-H, Li Y-Y et al. (2012) Activation of p38 signaling in the microglia in the nucleus accumbens contributes to the acquisition and maintenance of morphine-induced conditioned place preference. Brain Behav. Immun, 26, 318&#x2013;325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22004988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O&#x2019;Keeffe S, Phatnani HP, Guarnieri P et al. (2014) An RNA-sequencing tran-scriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci, 34, 11929&#x2013;11947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4152602</ArticleId>
            <ArticleId IdType="pubmed">25186741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu J-W, Liu F-L, Mu D, Deng D-Y &amp; Zheng Y-T (2017) Heroin use is associated with lower levels of restriction factors and type I inter-feron expression and facilitates HIV-1 replication. Microbes Infect, 19, 288&#x2013;294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28104465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zuckerman RL, &amp; Harris AP, (1994) Anesthesia in obstetrics. Curr. Opin. Obstet. Gynecol, 6, 408&#x2013;413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7827269</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30176445</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1026</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>649</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Science of the total environment</Title>
          <ISOAbbreviation>Sci Total Environ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparative network analysis revealing the mechanisms of antibiotic resistance genes removal by leachate recirculation under different hydraulic loadings.</ArticleTitle>
        <Pagination>
          <StartPage>318</StartPage>
          <EndPage>326</EndPage>
          <MedlinePgn>318-326</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scitotenv.2018.08.361</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0048-9697(18)33332-1</ELocationID>
        <Abstract>
          <AbstractText>The wide dissemination of antibiotic resistance is a pervasive global health threat, and landfill leachate has been an important hotspot of antibiotic resistance genes (ARGs). This study aimed to investigate the removal performance and mechanism of ARGs from leachate under different hydraulic loadings. ARGs removal efficiencies were dependent on hydraulic loadings and ARGs types other than operating time, and reactors operated with hydraulic loadings of 25 and 50&#x202F;L&#xB7;m<sup>-3</sup>&#xB7;d<sup>-1</sup> exhibited greater removal potential than 100&#x202F;L&#xB7;m<sup>-3</sup>&#xB7;d<sup>-1</sup>. ARGs removal patterns varied from different subtypes, for genes sul2, tetQ, aadA1 and bla<sub>CTX-M</sub> were eliminated from both leachate and refuse, and tetM, ermB, mefA, and strB were removed from leachate but enriched in refuse. Under different hydraulic loadings, bacterial communities shift shaped ARGs fates in leachate, but refuse had more stable antibiotic resistome and community structure. The topology comparison analysis of co-occurrence network suggested a closer hosting relationship between ARGs and genera in refuse than leachate. Furthermore, taxonomic category of host bacteria other than diversity of host genera determined the ARGs removal, and the ARGs harbored in phyla Cyanobacteria, Tenericutes and Acidobacteria were more likely to be removed. These findings can potentially foster the understanding of ARGs removal mechanism in biological treatment processes under different operating conditions.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Su</LastName>
            <ForeName>Yinglong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Urban and Ecological Restoration of Shanghai, School of Ecology and Environmental Sciences, East China Normal University, Shanghai 200241, China; Shanghai Institute of Pollution Control and Ecological Security, Shanghai 200092, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jiaxin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Urban and Ecological Restoration of Shanghai, School of Ecology and Environmental Sciences, East China Normal University, Shanghai 200241, China; Shanghai Institute of Pollution Control and Ecological Security, Shanghai 200092, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xia</LastName>
            <ForeName>Huipeng</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Urban and Ecological Restoration of Shanghai, School of Ecology and Environmental Sciences, East China Normal University, Shanghai 200241, China; Shanghai Institute of Pollution Control and Ecological Security, Shanghai 200092, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Bing</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory for Urban and Ecological Restoration of Shanghai, School of Ecology and Environmental Sciences, East China Normal University, Shanghai 200241, China; Shanghai Institute of Pollution Control and Ecological Security, Shanghai 200092, China. Electronic address: bxie@des.ecnu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Sci Total Environ</MedlineTA>
        <NlmUniqueID>0330500</NlmUniqueID>
        <ISSNLinking>0048-9697</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014874">Water Pollutants, Chemical</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018407" MajorTopicYN="N">Bacterial Physiological Phenomena</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019149" MajorTopicYN="Y">Bioreactors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004352" MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005798" MajorTopicYN="Y">Genes, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014874" MajorTopicYN="N">Water Pollutants, Chemical</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antibiotic resistance genes</Keyword>
        <Keyword MajorTopicYN="N">Host bacterial taxonomy</Keyword>
        <Keyword MajorTopicYN="N">Hydraulic loadings</Keyword>
        <Keyword MajorTopicYN="N">Leachate recirculation</Keyword>
        <Keyword MajorTopicYN="N">Removal mechanism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30176445</ArticleId>
        <ArticleId IdType="doi">10.1016/j.scitotenv.2018.08.361</ArticleId>
        <ArticleId IdType="pii">S0048-9697(18)33332-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30169662</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1930-613X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>184</Volume>
            <Issue>3-4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Military medicine</Title>
          <ISOAbbreviation>Mil Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Naval Medicine's Involvement in Global Health: The Participation of Women's Healthcare Providers in Continuing Promise 2017.</ArticleTitle>
        <Pagination>
          <StartPage>e135</StartPage>
          <EndPage>e138</EndPage>
          <MedlinePgn>e135-e138</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/milmed/usy208</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">This is a retrospective review of information collected during operation Continuing Promise 2017 from the Wayuu population in Colombia, South America.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS">Team objective was to present an overview of women's health care needs in an isolated underserved population of Colombia by a humanitarian mission of health care providers from the U.S. Navy. We analyzed demographics, contraceptive selection, presenting complaint, diagnosis, and disposition of those female patients presenting for care.</AbstractText>
          <AbstractText Label="RESULTS">The acute care clinics of this mission saw patients for 10 full clinic days in each of the countries of Guatemala, Honduras, and Colombia. In the Wayuu clinic of Colombia, 356 patients were seen in the acute care women's clinic. These women averaged 36 years of age with an age range of 9-77 years of age and a gravidity of 3 &#xB1; 3.3 and a range of 0-18. Of the women less than the age of 50, not permanently sterilized, 186/220 (84.5%) were not using any form of contraception. The most common chief complaints were vaginal discharge and pelvic pain and the most common final diagnosis was bacterial vaginosis. The two most common secondary diagnoses of the pregnant women were urinary tract infection and anemia. Other significant diagnoses included uterine cancer, preterm labor, and fetal posterior urethral valve syndrome.</AbstractText>
          <AbstractText Label="CONCLUSIONS">A majority of Wayuu women presenting to an acute clinic setting in Colombia, South America were in their mid-thirties having had three pregnancies and the majority were not using any form of contraception. The most common diagnoses were straightforward diagnoses such as vaginal infections, urinary tract infections, and abnormal uterine bleeding. Our findings suggest a need for access to routine gynecologic care, general hygiene education, and increased availability of birth control among the Wayuu population.</AbstractText>
          <CopyrightInformation>Published by Oxford University Press on behalf of Association of Military Surgeons of the United States 2018.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wood</LastName>
            <ForeName>Kristi M</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Health Clinic, Ft Belvoir Community Hospital, 9300 De Witt Loop, Ft Belvoir, VA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ellison</LastName>
            <ForeName>Carolyn</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Women's Health Clinic, Naval Health Clinic Hawaii, 480 Central Ave., Pearl Harbor, HI.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Magann</LastName>
            <ForeName>Everett F</ForeName>
            <Initials>EF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, 4301 W. Markham #518, Little Rock, AR.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Mil Med</MedlineTA>
        <NlmUniqueID>2984771R</NlmUniqueID>
        <ISSNLinking>0026-4075</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003105" MajorTopicYN="N" Type="Geographic">Colombia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003268" MajorTopicYN="N">Contraception Behavior</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006166" MajorTopicYN="N" Type="Geographic">Guatemala</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006721" MajorTopicYN="N" Type="Geographic">Honduras</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008887" MajorTopicYN="N">Military Medicine</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014932" MajorTopicYN="N">Women's Health Services</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
          <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Humanitarian mission</Keyword>
        <Keyword MajorTopicYN="N">contraception</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
        <Keyword MajorTopicYN="N">women&#x2019;s health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30169662</ArticleId>
        <ArticleId IdType="doi">10.1093/milmed/usy208</ArticleId>
        <ArticleId IdType="pii">5085553</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30168618</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-9101</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>51</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Lasers in surgery and medicine</Title>
          <ISOAbbreviation>Lasers Surg Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Development and evaluation of a low-cost, portable, LED-based device for PDT treatment of early-stage oral cancer in resource-limited settings.</ArticleTitle>
        <Pagination>
          <StartPage>345</StartPage>
          <EndPage>351</EndPage>
          <MedlinePgn>345-351</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/lsm.23019</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Photodynamic therapy (PDT) using &#x3B4;-aminolevulinic acid (ALA) photosensitization has shown promise in clinical studies for the treatment of early-stage oral malignancies with fewer potential side effects than traditional therapies. Light delivery to oral lesions can also carried out with limited medical infrastructure suggesting the potential for implementation of PDT in global health settings.</AbstractText>
          <AbstractText Label="OBJECTIVES">We sought to develop a cost-effective, battery-powered, fiber-coupled PDT system suitable for intraoral light delivery enabled by smartphone interface and embedded electronics for ease of operation.</AbstractText>
          <AbstractText Label="METHODS">Device performance was assessed in measurements of optical power output, spectral stability, and preclinical assessment of PDT response in ALA-photosensitized squamous carcinoma cell cultures and murine subcutaneous tumor xenografts.</AbstractText>
          <AbstractText Label="RESULTS">The system achieves target optoelectronic performance with a stable battery-powered output of approximately 180&#x2009;mW from the fiber tip within the desired spectral window for PpIX activation. The device has a compact configuration, user friendly operation and flexible light delivery for the oral cavity. In cell culture, we show that the overall dose-response is consistent with established light sources and complete cell death of ALA photosensitized cells can be achieved in the irradiated zone. In vivo PDT response (reduction in tumor volume) is comparable with a commercial 635&#x2009;nm laser.</AbstractText>
          <AbstractText Label="CONCLUSIONS">We developed a low-cost, LED-based, fiber-coupled PDT light delivery source that has stable output on battery power and suitable form factor for deployment in rural and/or resource-limited settings. Lasers Surg. Med. 9999:1-7, 2018. &#xA9; 2018 Wiley Periodicals, Inc.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Hui</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physics, University of Massachusetts, Boston, Massachusetts, 02125.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Daly</LastName>
            <ForeName>Liam</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Engineering, University of Massachusetts, Boston, Massachusetts, 02125.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rudd</LastName>
            <ForeName>Grant</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Engineering, University of Massachusetts, Boston, Massachusetts, 02125.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khan</LastName>
            <ForeName>Amjad P</ForeName>
            <Initials>AP</Initials>
            <AffiliationInfo>
              <Affiliation>Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, 02114.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mallidi</LastName>
            <ForeName>Srivalleesha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, 02114.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yiran</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physics, University of Massachusetts, Boston, Massachusetts, 02125.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cuckov</LastName>
            <ForeName>Filip</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Engineering, University of Massachusetts, Boston, Massachusetts, 02125.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hasan</LastName>
            <ForeName>Tayyaba</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, 02114.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Celli</LastName>
            <ForeName>Jonathan P</ForeName>
            <Initials>JP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physics, University of Massachusetts, Boston, Massachusetts, 02125.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>S10 OD012326</GrantID>
            <Acronym>OD</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UH3 CA189901</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UH2 CA189901</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D023362">Evaluation Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Lasers Surg Med</MedlineTA>
        <NlmUniqueID>8007168</NlmUniqueID>
        <ISSNLinking>0196-8092</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D017319">Photosensitizing Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>88755TAZ87</RegistryNumber>
          <NameOfSubstance UI="D000622">Aminolevulinic Acid</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000622" MajorTopicYN="N">Aminolevulinic Acid</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008027" MajorTopicYN="Y">Light</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009062" MajorTopicYN="N">Mouth Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055100" MajorTopicYN="N">Optical Fibers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010778" MajorTopicYN="N">Photochemotherapy</DescriptorName>
          <QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017319" MajorTopicYN="N">Photosensitizing Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000068997" MajorTopicYN="N">Smartphone</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Oral Cancer</Keyword>
        <Keyword MajorTopicYN="N">aminolevulinic acid (ALA)</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">light emitting diode (LED)</Keyword>
        <Keyword MajorTopicYN="N">photodynamic therapy (PDT)</Keyword>
        <Keyword MajorTopicYN="N">protoporphhyrin IX (PpIX)</Keyword>
      </KeywordList>
      <CoiStatement>Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30168618</ArticleId>
        <ArticleId IdType="mid">NIHMS1063535</ArticleId>
        <ArticleId IdType="pmc">PMC6934354</ArticleId>
        <ArticleId IdType="doi">10.1002/lsm.23019</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Casiglia J, Woo SB. A comprehensive review of oral cancer. Gen Dent 2001;49(1):72&#x2013;82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12004680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodu B, Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med 2004;15(5):252&#x2013;263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15470264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coelho KR. Challenges of the oral cancer burden in India. J Cancer Epidemiol 2012; 2012: 701932.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3471448</ArticleId>
            <ArticleId IdType="pubmed">23093961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Celli JP, Spring BQ, Rizvi I, et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010;110(5):2795&#x2013;2838.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2896821</ArticleId>
            <ArticleId IdType="pubmed">20353192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felsher DW. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3(5):375&#x2013;380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12724735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen HM, Yu CH, Lin HP, Cheng SJ, Chiang CP. 5- Aminolevulinic acid-mediated photodynamic therapy for oral cancers and precancers. J Dent Sci 2012;7(4):307&#x2013;315.</Citation>
        </Reference>
        <Reference>
          <Citation>Fan KF, Hopper C, Speight PM, Buonaccorsi G, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer 1996;78(7):1374&#x2013;1383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8839541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gallagher-Colombo SM, Quon H, Malloy KM, et al. Measuring the physiologic properties of oral lesions receiving fractionated photodynamic therapy. Photochem Photobiol 2015;91(5): 1210&#x2013;1218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4560604</ArticleId>
            <ArticleId IdType="pubmed">26037487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grant WE, Hopper C, MacRobert AJ, Speight PM, Bown SG. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet 1993;342(8864): 147&#x2013;148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7687318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubler A, Haase T, Rheinwald M, Barth T, Muhling J. Treatment of oral leukoplakia by topical application of 5- aminolevulinic acid. Int J Oral Maxillofac Surg 1998;27(6): 466&#x2013;469.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9869290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai JC, Chiang CP, Chen HM, et al. Photodynamic Therapy of oral dysplasia with topical 5-aminolevulinic acid and light- emitting diode array. Lasers Surg Med 2004;34(1):18&#x2013;24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14755421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pei-Jen L, Linda J, Colin H. Clinical outcomes of photodynamic therapy for head-and-neck cancer. Technol Cancer Res Treat 2003;2(4):311&#x2013;317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12892513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen H-M, Yu C-H, Tu P-C, Yeh C-Y, Tsai T, Chiang C-P. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Lasers Surg Med 2005;37(2):114&#x2013;122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16037967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H, Rudd G, Daly L, et al. Development of low-cost devices for image-guided photodynamic therapy treatment of oral cancer in global health settings. In: SPIE BiOS: 2016: SPIE; 2016: 6.</Citation>
        </Reference>
        <Reference>
          <Citation>Yu CH, Lin HP, Chen HM, Yang H, Wang YP, Chiang CP. Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light- emitting diode or laser light. Lasers Surg Med 2009;41(9): 628&#x2013;633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19816916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hempstead J, Jones DP, Ziouche A, et al. Low-cost photodynamic therapy devices for global health settings: characterization of battery-powered LED performance and smartphone imaging in 3D tumor models. Sci Rep 2015; 5: 10093.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4428052</ArticleId>
            <ArticleId IdType="pubmed">25965295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mallidi S, Mai Z, Rizvi I, et al. In vivo evaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpoints. J Biomed Opt 2015;20 (4): 048003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4408448</ArticleId>
            <ArticleId IdType="pubmed">25909707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Celli JP, Rizvi I, Blanden AR, et al. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Sci Rep 2014; 4:3751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3894557</ArticleId>
            <ArticleId IdType="pubmed">24435043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>M&#xFC;ller S, Walt H, Dobler-Girdziunaite D, Fiedler D, Haller U. Enhanced photodynamic effects using fractionated laser light. J Photochem Photobiol B 1998;42(1):67&#x2013;70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9491597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pogue BW, Hasan T. A theoretical study of light fractionation and dose-rate effects in photodynamic therapy. Radiat Res 1997;147(5):551&#x2013;559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9146700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahle J, Bagdonas S, Kaalhus O, Olsen G, Steen HB, Moan J. The bystander effect in photodynamic inactivation of cells. Biochim Biophys Acta 2000;1475(3):273&#x2013;280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10913826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poyer F, Thomas CD, Garcia G, et al. PDT induced bystander effect on human xenografted colorectal tumors as evidenced by sodium MRI. Photodiagnosis Photodyn Ther 9(4):303&#x2013;309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23200010</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30165415</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1537-6613</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>219</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of infectious diseases</Title>
          <ISOAbbreviation>J Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Extended Impact of Human Immunodeficiency Virus/AIDS Research.</ArticleTitle>
        <Pagination>
          <StartPage>6</StartPage>
          <EndPage>9</EndPage>
          <MedlinePgn>6-9</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiy441</ELocationID>
        <Abstract>
          <AbstractText>Human immunodeficiency virus (HIV) is one of the most extensively studied viruses in history, and numerous extraordinary scientific advances, including an in-depth understanding of viral biology, pathogenesis, and life-saving antiretroviral therapies, have resulted from investments in HIV/AIDS research. While the substantial investments in HIV/AIDS research are validated solely on these advances, the collateral broader scientific progress resulting from the support of HIV/AIDS research over the past 30 years is extraordinary as well. The positive impact has ranged from innovations in basic immunology and structural biology to treatments for immune-mediated diseases and cancer and has had an enormous effect on the research and public and global health communities well beyond the field of HIV/AIDS. This article highlights a few select examples of the unanticipated and substantial positive spin-offs of HIV/AIDS research on other scientific areas.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Schwetz</LastName>
            <ForeName>Tara A</ForeName>
            <Initials>TA</Initials>
            <AffiliationInfo>
              <Affiliation>Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fauci</LastName>
            <ForeName>Anthony S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Infect Dis</MedlineTA>
        <NlmUniqueID>0413675</NlmUniqueID>
        <ISSNLinking>0022-1899</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016915">AIDS Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D016915" MajorTopicYN="N">AIDS Vaccines</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006678" MajorTopicYN="N">HIV</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007674" MajorTopicYN="N">Kidney Diseases</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008107" MajorTopicYN="N">Liver Diseases</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30165415</ArticleId>
        <ArticleId IdType="pmc">PMC6455931</ArticleId>
        <ArticleId IdType="doi">10.1093/infdis/jiy441</ArticleId>
        <ArticleId IdType="pii">5063659</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Joint United Nations Progamme on HIV/AIDS. Fact sheet: latest statistics on the status of the AIDS epidemic. http://www.unaids.org/en/resources/fact-sheet. Accessed 23 July 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Fischl MA, Richman DD, Grieco MH, et al. &#xA0;The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med&#xA0;1987; 317:185&#x2013;91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3299089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samji H, Cescon A, Hogg RS, et al. &#xA0;North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One&#xA0;2013; 8:e81355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3867319</ArticleId>
            <ArticleId IdType="pubmed">24367482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundgren JD, Babiker AG, Gordin F, et al. &#xA0;INSIGHT START Study Group Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med&#xA0;2015; 373:795&#x2013;807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4569751</ArticleId>
            <ArticleId IdType="pubmed">26192873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trovato M, D&#x2019;Apice L, Prisco A, De Berardinis P. HIV vaccination: a roadmap among advancements and concerns. Int J Mol Sci&#xA0;2018; 19. doi:10.3390/ijms19041241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19041241</ArticleId>
            <ArticleId IdType="pmc">PMC5979448</ArticleId>
            <ArticleId IdType="pubmed">29671786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature&#xA0;1984; 312:763&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6096719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulz TF, Boshoff CH, Weiss RA. HIV infection and neoplasia. Lancet&#xA0;1996; 348:587&#x2013;91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8774574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wyles DL. Antiviral resistance and the future landscape of hepatitis C virus infection therapy. J Infect Dis&#xA0;2013; 207(Suppl 1):S33&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23390303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyd SD, Crowe JE Jr. Deep sequencing and human antibody repertoire analysis. Curr Opin Immunol&#xA0;2016; 40:103&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5203765</ArticleId>
            <ArticleId IdType="pubmed">27065089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flyak AI, Kuzmina N, Murin CD, et al. &#xA0;Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region. Nat Microbiol&#xA0;2018; 3:670&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6030461</ArticleId>
            <ArticleId IdType="pubmed">29736037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sapparapu G, Fernandez E, Kose N, et al. &#xA0;Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature&#xA0;2016; 540:443&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5583716</ArticleId>
            <ArticleId IdType="pubmed">27819683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raymond DD, Bajic G, Ferdman J, et al. &#xA0;Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody. Proc Natl Acad Sci U S A&#xA0;2018; 115:168&#x2013;73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5776812</ArticleId>
            <ArticleId IdType="pubmed">29255041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>R&#xF6;hn TA, Bachmann MF. Vaccines against non-communicable diseases. Curr Opin Immunol&#xA0;2010; 22:391&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20338740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian D, Battles MB, Moin SM, et al. &#xA0;Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein. Nat Commun&#xA0;2017; 8:1877.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5707411</ArticleId>
            <ArticleId IdType="pubmed">29187732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>US Food and Drug Administration FDA approval brings first gene therapy to the United States. Silver Spring, MD: FDA, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Gottlieb MS, Schroff R, Schanker HM, et al. &#xA0;Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med&#xA0;1981; 305:1425&#x2013;31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6272109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chattopadhyay PK, Roederer M. Cytometry: today&#x2019;s technology and tomorrow&#x2019;s horizons. Methods&#xA0;2012; 57:251&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3374038</ArticleId>
            <ArticleId IdType="pubmed">22391486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kestens L, Mandy F. Thirty-five years of CD4 T-cell counting in HIV infection: from flow cytometry in the lab to point-of-care testing in the field. Cytometry B Clin Cytom&#xA0;2017; 92:437&#x2013;44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27406947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moir S, Fauci AS. B-cell exhaustion in HIV infection: the role of immune activation. Curr Opin HIV AIDS&#xA0;2014; 9:472&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25023621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paiardini M, M&#xFC;ller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev&#xA0;2013; 254:78&#x2013;101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3729961</ArticleId>
            <ArticleId IdType="pubmed">23772616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lucas S, Nelson AM. HIV and the spectrum of human disease. J Pathol&#xA0;2015; 235:229&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25251832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boccara F, Lang S, Meuleman C, et al. &#xA0;HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol&#xA0;2013; 61:511&#x2013;23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23369416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torres RA, Lewis W. Aging and HIV/AIDS: pathogenetic role of therapeutic side effects. Lab Invest&#xA0;2014; 94:120&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4144856</ArticleId>
            <ArticleId IdType="pubmed">24336070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thrift AP, Chiao EY. Are non-HIV malignancies increased in the HIV-infected population?Curr Infect Dis Rep&#xA0;2018; 20:22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC9392463</ArticleId>
            <ArticleId IdType="pubmed">29804238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis&#xA0;2010; 50(Suppl 3):S201&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20397949</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30155650</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-0878</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>375</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cell and tissue research</Title>
          <ISOAbbreviation>Cell Tissue Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cotton rat (Sigmodon hispidus) develops metabolic disorders associated with visceral adipose inflammation and fatty pancreas without obesity.</ArticleTitle>
        <Pagination>
          <StartPage>483</StartPage>
          <EndPage>492</EndPage>
          <MedlinePgn>483-492</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00441-018-2908-9</ELocationID>
        <Abstract>
          <AbstractText>Obesity induces metabolic disorders such as type 2 diabetes, hypertension, and cardiovascular diseases and has become a global health concern. Recent studies imply that fat accumulation in nonadipose tissue correlates with metabolic disorders. However, there are no suitable animal models to evaluate this phenomenon. This study investigated the characteristics of metabolic disorders found in cotton rat (Sigmodon hispidus). Blood biochemical examinations revealed that cotton rats, predominantly males, developed hyperinsulinemia, hyperglycemia, and dyslipidemia when fed a normal diet. The islets increased in size through &#x3B2;-cell hyperplasia, which was associated with serum insulin level in both sexes, strongly indicating insulin resistance. In male cotton rats, oxidative stress was observed in &#x3B2; cells, and macrophage infiltration into the visceral white adipose tissue was reported, both of which were associated with serum insulin level without visceral obesity. In contrast, female cotton rats developed hyperinsulinemia without histopathological changes that were reported in males. Adipocytes were found to be accumulated in the pancreas but not in the liver of both sexes during aging. Pancreatic fat accumulation was associated with the serum insulin level only in females. Taken together, cotton rats developed metabolic disorders associated with visceral fat inflammation in the absence of obesity. In addition, pancreatic ectopic fat may also be related to the early stages of these conditions. Thus, the cotton rat may serve as a novel and useful model for metabolic disorders characterized by visceral adipose inflammation and ectopic fat accumulation in the pancreas without obesity.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nakamura</LastName>
            <ForeName>Teppei</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0003-3204-0245</Identifier>
            <AffiliationInfo>
              <Affiliation>Section of Biological Science, Chitose Laboratory, Japan Food Research Laboratories, Chitose, Hokkaido, 066-0052, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Laboratory of Anatomy, Division of Veterinary Medicine, Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0818, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ichii</LastName>
            <ForeName>Osamu</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Anatomy, Division of Veterinary Medicine, Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0818, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Irie</LastName>
            <ForeName>Takao</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Zoology Group, Department of Infectious Diseases, Hokkaido Institute of Public Health, Sapporo, Hokkaido, 060-0819, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kouguchi</LastName>
            <ForeName>Hirokazu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Zoology Group, Department of Infectious Diseases, Hokkaido Institute of Public Health, Sapporo, Hokkaido, 060-0819, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sotozaki</LastName>
            <ForeName>Kozue</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Sankyo Labo Service Corporation, Inc., Sapporo, Hokkaido, 004-0802, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chihara</LastName>
            <ForeName>Masataka</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Anatomy, Division of Veterinary Medicine, Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0818, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sunden</LastName>
            <ForeName>Yuji</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Veterinary Pathology, Faculty of Agriculture, Tottori University, Tottori, 680-0945, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nagasaki</LastName>
            <ForeName>Ken-Ichi</ForeName>
            <Initials>KI</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Biological Safety Research, Tama Laboratory, Japan Food Research Laboratories, Tama, Tokyo, 206-0025, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tatsumi</LastName>
            <ForeName>Osamu</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Biological Science, Chitose Laboratory, Japan Food Research Laboratories, Chitose, Hokkaido, 066-0052, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Elewa</LastName>
            <ForeName>Yaser Hosny Ali</ForeName>
            <Initials>YHA</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Anatomy, Division of Veterinary Medicine, Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0818, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Histology and Cytology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, 44519, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kon</LastName>
            <ForeName>Yasuhiro</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Anatomy, Division of Veterinary Medicine, Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, 060-0818, Japan. y-kon@vetmed.hokudai.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>JP18K0703708</GrantID>
            <Agency>JSPS KAKENHI</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Cell Tissue Res</MedlineTA>
        <NlmUniqueID>0417625</NlmUniqueID>
        <ISSNLinking>0302-766X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050152" MajorTopicYN="N">Intra-Abdominal Fat</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008659" MajorTopicYN="N">Metabolic Diseases</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016205" MajorTopicYN="N">Sigmodontinae</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cotton rat</Keyword>
        <Keyword MajorTopicYN="N">Ectopic fat</Keyword>
        <Keyword MajorTopicYN="N">Metabolic disorder</Keyword>
        <Keyword MajorTopicYN="N">Obesity</Keyword>
        <Keyword MajorTopicYN="N">Visceral fat inflammation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30155650</ArticleId>
        <ArticleId IdType="doi">10.1007/s00441-018-2908-9</ArticleId>
        <ArticleId IdType="pii">10.1007/s00441-018-2908-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30137469</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>31</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1708-8305</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of travel medicine</Title>
          <ISOAbbreviation>J Travel Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>S. typhi Vi capsular polysaccharide vaccine-induced humoral immunity in travellers with immunosuppressive therapy for rheumatoid disease.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jtm/tay073</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Typhoid fever is a global health problem, causing significant morbidity and mortality. Currently, the most widely used vaccine is the typhoid Vi capsular polysaccharide (Vi-PS) vaccine. While epidemiological studies on its efficacy have been performed in children in endemic countries, there are no efficacy studies evaluating its use in travel medicine. Response to vaccination may differ in travellers receiving immunosuppressive therapy. This study investigates the humoral response to Vi-PS vaccination in travellers receiving immunosuppressive therapy for rheumatoid disease.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We recruited patients from the LUMC rheumatology outpatient clinic and travellers from the travel clinic who had previously received Vi-PS vaccination and also immunosuppressive therapy for rheumatoid disease. We analysed blood samples acquired from 42 patients over a period of 3 years. We estimated the length of persistence of protective titres using the survival analysis using multiple cut-off values for protection and measured titre half-life and the influence of immunosuppressive medication on titre half-life using mixed models.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Anti-Vi-PS antibody levels stayed above 10 EU/ml for a mean of 13.3 years, above 15 EU/ml for a mean of 10.1 years and above 20 EU/ml for a mean of 8.6 years after Vi-PS vaccination. Titre half-life was 7.5 years (95% CI 5.0-14.7 years, P &lt; 0.001). No significant influence of medication on titre half-life was found.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Both persistence of protective antibody titres and titre half-life are longer than expected based on other studies. This warrants further study in adult volunteers, both in healthy individuals and patients suffering from rheumatoid disease.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>von Asmuth</LastName>
            <ForeName>E G J</ForeName>
            <Initials>EGJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, LUMC, Leiden, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brockhoff</LastName>
            <ForeName>H J</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>GGD Haaglanden, Den Haag, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wallinga</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Statistics and Bio-informatics, LUMC, Leiden, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Visser</LastName>
            <ForeName>L G</ForeName>
            <Initials>LG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, LUMC, Leiden, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Travel Med</MedlineTA>
        <NlmUniqueID>9434456</NlmUniqueID>
        <ISSNLinking>1195-1982</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011135">Polysaccharides, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014436">Typhoid-Paratyphoid Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018074">Vaccines, Conjugate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay090.</RefSource>
          <PMID Version="1">30325433</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056724" MajorTopicYN="Y">Immunity, Humoral</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011135" MajorTopicYN="N">Polysaccharides, Bacterial</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012485" MajorTopicYN="N">Salmonella typhi</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014195" MajorTopicYN="N">Travel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014435" MajorTopicYN="N">Typhoid Fever</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014436" MajorTopicYN="N">Typhoid-Paratyphoid Vaccines</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018074" MajorTopicYN="N">Vaccines, Conjugate</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30137469</ArticleId>
        <ArticleId IdType="doi">10.1093/jtm/tay073</ArticleId>
        <ArticleId IdType="pii">5077767</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30137468</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>08</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1708-8305</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of travel medicine</Title>
          <ISOAbbreviation>J Travel Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>ISTM's migration and refugee health interest group: what is our mandate?</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">tay072</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jtm/tay072</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Adachi</LastName>
            <ForeName>Masatoki</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Dr Masatoki Adachi Clinic Kobe, Kobe, Hyogo, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>US Consulate General Osaka-Kobe, Osaka, Osaka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Travel Med</MedlineTA>
        <NlmUniqueID>9434456</NlmUniqueID>
        <ISSNLinking>1195-1982</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003226" MajorTopicYN="N">Congresses as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011639" MajorTopicYN="Y">Public Opinion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012036" MajorTopicYN="Y">Refugees</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057236" MajorTopicYN="Y">Travel Medicine</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Migration</Keyword>
        <Keyword MajorTopicYN="N">global health policy</Keyword>
        <Keyword MajorTopicYN="N">refugee</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30137468</ArticleId>
        <ArticleId IdType="doi">10.1093/jtm/tay072</ArticleId>
        <ArticleId IdType="pii">5076820</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30133332</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1557-9034</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of laparoendoscopic &amp; advanced surgical techniques. Part A</Title>
          <ISOAbbreviation>J Laparoendosc Adv Surg Tech A</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Minimally Invasive Pediatric Surgery During Remote Humanitarian Missions Is Feasible, Safe, and Effective.</ArticleTitle>
        <Pagination>
          <StartPage>94</StartPage>
          <EndPage>97</EndPage>
          <MedlinePgn>94-97</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/lap.2018.0187</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">There remains a critical need for the provision for pediatric humanitarian aid worldwide. Historically, the emphasis of global pediatric health needs has been focused on infectious diseases. Today, we are witnessing a shift in this paradigm, with growing attention being paid toward the surgical needs of children. The use and deployment of minimally invasive surgery (MIS) in these austere environments with its concomitant reduction in length of hospitalization, pain, and morbidity is logical. The goal of this study was to report our deployment strategy and review our experience with pediatric MIS during humanitarian missions to determine if it is safe, feasible, and efficacious.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">As part of the World Pediatric Project (WPP), data were collected retrospectively from the general pediatric surgery (GPS) team missions from January 2007 to January 2017. All cases were performed at a single medical center in the Eastern Caribbean Island Nation of St. Vincent and the Grenadines (SVG). Data included patient demographics, diagnosis, procedure, conversion to open procedure, complications, and postoperative course. The teams utilized a dedicated WPP operating theater, prepositioned and deployed GPS supplies, and MIS resources. All anesthesia, surgical, and nursing personal were board certified and trained professionals functioning as part of the WPP team.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred thirty-four children underwent general and thoracic pediatric surgical procedures during the study period. Mean age 9.2 years (2-19 years). Thirty-seven children underwent MIS procedures (27%). There were no conversions to open procedures. There were only two postoperative complications, cellulitis following laparoscopic appendicostomies, which required intravenous antibiotics and were discharged on a course of oral antibiotics. The postoperative course for all children was uneventful and no child required readmission. There were no technical failures in the MIS systems or instrumentation.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our retrospective review supports the use of MIS techniques as part of GPS humanitarian missions. We have found it to be a safe, feasible, and effective modality that may reduce length of stay, pain, and morbidity compared with open procedures in these remote environments. Although our MIS systems and instrumentations functioned effectively, concerns regarding the storage and sustainability for future missions are significant. Onsite health care partners, redundant systems, and remote technical support access could potentially alleviate these concerns.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lukish</LastName>
            <ForeName>Jeffrey</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>1 Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ellis Davy</LastName>
            <ForeName>Jasmine</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>2 Department of Pediatrics, Milton Cato Memorial Hospital, St. Vincent's and the Grenadines, West Indies.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lanning</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>3 Division of Pediatric Surgery, Department of Surgery, Virginia Commonwealth University Health System, Richmond, Virginia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Datta</LastName>
            <ForeName>Bharati</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>2 Department of Pediatrics, Milton Cato Memorial Hospital, St. Vincent's and the Grenadines, West Indies.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeAntonio</LastName>
            <ForeName>Jonathan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>3 Division of Pediatric Surgery, Department of Surgery, Virginia Commonwealth University Health System, Richmond, Virginia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Laparoendosc Adv Surg Tech A</MedlineTA>
        <NlmUniqueID>9706293</NlmUniqueID>
        <ISSNLinking>1092-6429</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008493" MajorTopicYN="Y">Medical Missions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009873" MajorTopicYN="N">Operating Rooms</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019436" MajorTopicYN="N" Type="Geographic">Saint Vincent and the Grenadines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013906" MajorTopicYN="N">Thoracoscopy</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">humanitarian outreach</Keyword>
        <Keyword MajorTopicYN="N">minimally invasive pediatric surgery</Keyword>
        <Keyword MajorTopicYN="N">pediatric</Keyword>
        <Keyword MajorTopicYN="N">surgical improvisation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30133332</ArticleId>
        <ArticleId IdType="doi">10.1089/lap.2018.0187</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30129085</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1098-2825</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>33</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical laboratory analysis</Title>
          <ISOAbbreviation>J Clin Lab Anal</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Naked eye detection of the Mycobacterium tuberculosis complex by recombinase polymerase amplification-SYBR green I assays.</ArticleTitle>
        <Pagination>
          <StartPage>e22655</StartPage>
          <MedlinePgn>e22655</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e22655</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jcla.22655</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Rapid diagnosis of Mycobacterium tuberculosis (Mtb) is key to controlling the spread of tuberculosis, which is a global health concern. In this study, isothermal recombinase polymerase amplification (RPA) was developed to detect specific targets of Mtb, IS6110 and IS1081. Additionally, SYBR Green I was used for endpoint detection of the RPA products by the naked eye.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">A total of 146 genomic Mtb DNA samples and 24 genomic nontuberculous mycobacteria (NTM) DNA samples were amplified at IS6110 and IS1081 by RPA. After a complete amplification, the RPA amplicons were examined by agarose gel electrophoresis (RPA-AGE) and SYBR Green I (RPA-S) assays. The performance of the RPA assays was evaluated by comparing them to a conventional PCR.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The RPA assay demonstrated to have a good capability to differentiate Mtb from NTM with a very short turnaround time at a constant temperature. Compared to conventional PCR, the sensitivities and specificities of RPA-AGE for IS6110 and IS1081 were 100%. The specificity of RPA-S was 100% for both targets; however, its sensitivities for IS6110 and IS1081 were 97.95% and 99.32%, respectively. The limits of detection of IS6110 RPA-AGE and RPA-S were 0.05 and 0.5&#xA0;ng, respectively, while the LODs of IS1081 RPA-AGE and RPA-S were 0.00005 and 0.05&#xA0;ng, respectively. Both RPA assays showed a satisfying diagnostic specificity, with no cross-reaction with other bacteria.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A rapid, sensitive, naked eye RPA assay can be integrated into point-of-care diagnosis for Mtb detection, especially in remote areas where laboratory instrument resources are limited.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Singpanomchai</LastName>
            <ForeName>Nuntita</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Program of Molecular sciences in Medical Microbiology and Immunology, Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Akeda</LastName>
            <ForeName>Yukihiro</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infection Control and Prevention, Osaka University Hospital, Osaka University, Osaka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tomono</LastName>
            <ForeName>Kazunori</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infection Control and Prevention, Osaka University Hospital, Osaka University, Osaka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tamaru</LastName>
            <ForeName>Aki</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Bacteriology, Osaka Prefectural Institute of Public Health, Osaka, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santanirand</LastName>
            <ForeName>Pitak</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Microbiology Unit, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ratthawongjirakul</LastName>
            <ForeName>Panan</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-3084-0863</Identifier>
            <AffiliationInfo>
              <Affiliation>Research Group of Innovative Diagnosis of Antimicrobial Resistance, Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>90th Anniversary Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)</Agency>
            <Country/>
          </Grant>
          <Grant>
            <Agency>Chulalongkorn University Office of International Affairs</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Clin Lab Anal</MedlineTA>
        <NlmUniqueID>8801384</NlmUniqueID>
        <ISSNLinking>0887-8013</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D052160">Benzothiazoles</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004269">DNA, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003959">Diamines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009930">Organic Chemicals</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011804">Quinolines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D045522">Recombinases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>163795-75-3</RegistryNumber>
          <NameOfSubstance UI="C098022">SYBR Green I</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D052160" MajorTopicYN="N">Benzothiazoles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004269" MajorTopicYN="N">DNA, Bacterial</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003959" MajorTopicYN="N">Diamines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005798" MajorTopicYN="N">Genes, Bacterial</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057230" MajorTopicYN="N">Limit of Detection</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D021141" MajorTopicYN="N">Nucleic Acid Amplification Techniques</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009930" MajorTopicYN="N">Organic Chemicals</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011804" MajorTopicYN="N">Quinolines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045522" MajorTopicYN="N">Recombinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">IS1081</Keyword>
        <Keyword MajorTopicYN="N">IS6110</Keyword>
        <Keyword MajorTopicYN="N">Mycobacterium tuberculosis (Mtb)</Keyword>
        <Keyword MajorTopicYN="N">SYBR Green I</Keyword>
        <Keyword MajorTopicYN="N">recombinase polymerase amplification (RPA)</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>20</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30129085</ArticleId>
        <ArticleId IdType="pmc">PMC6818612</ArticleId>
        <ArticleId IdType="doi">10.1002/jcla.22655</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
WHO
. Global Tuberculosis Report 2017. Geneva: World Health Organization; 2017. 
http://www.who.int/tb/publications/global_report/en/. Accessed December 22, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>
WHO
. Global Tuberculosis Report 2016. Geneva: World Health Organization; 2016. 
http://www.who.int/tb/publications/global_report/en/. Accessed December 22, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Uys PW, Warren R, van Helden PD, Murray M, Victor TC. Potential of rapid diagnosis for controlling drug&#x2010;susceptible and drug&#x2010;resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent. J Clin Microbiol. 2009;47(5):1484&#x2010;1490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2681859</ArticleId>
            <ArticleId IdType="pubmed">19297604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CDC . Core Curriculum on Tuberculosis: What the Clinician Should Know, 6th ed Atlanta, GA: Centers for Disease Control and Prevention; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>
WHO
. Internaltional standards for tuberculosis care. http://www.who.int/tb/publications/ISTC_3rdEd.pdf. Accessed May 15, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Reechaipichitkul W, Suleesathira T, Chaimanee P. Comparison of GeneXpert MTB/RIF assay with conventional AFB smear for duagnosis of pulmonary tuberculosis in northeastern Thailand. Southeast Asian J Trop Med Public Health. 2017;48:313&#x2010;321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29641882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinyopornpanish K, Chaiwarith R, Pantip C, et&#xA0;al. Comparison of Xpert MTB/RIF assay and the conventional sputum microscopy in detecting Mycobacterium tuberculosis in northern Thailand. Tuberc Res Treat. 2015; 10.1155/2015/571782</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2015/571782</ArticleId>
            <ArticleId IdType="pmc">PMC4430669</ArticleId>
            <ArticleId IdType="pubmed">26064681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dhingra VK, Aggarwal N, Rajpal S, Aggarwal JK, Gaur SN. Validity and reliability of sputum smear examination as diagnostic and screening test for tuberculosis. Indian J Allergy Asthma Immunol. 2003;17(2):67&#x2010;69.</Citation>
        </Reference>
        <Reference>
          <Citation>Ganoza CA, Ricaldi JN, Chauca J, et&#xA0;al. Novel hypertonic saline&#x2010;sodium hydroxide (HS&#x2010;SH) method for decontamination and concentration of sputum samples for Mycobacterium tuberculosis microscopy and culture. J Med Microbiol. 2008;57(Pt 9):1094&#x2010;1098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18719178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simner PJ, Doerr KA, Steinmetz LK, Wengenack NL. Mycobacterium and aerobic Actinomycete culture: are two medium types and extended incubation times necessary? J Clin Microbiol. 2016;54(4):1089&#x2010;1093.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4809932</ArticleId>
            <ArticleId IdType="pubmed">26865689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park S&#x2010;H, Kim C&#x2010;K, Jeong H&#x2010;R, Son H, Kim S&#x2010;H, Park M&#x2010;S. Evaluation and comparison of molecular and conventional diagnostic tests for detecting tuberculosis in Korea, 2013. Osong Public Health Res Perspect. 2014;5(Suppl):S3&#x2010;S7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4301634</ArticleId>
            <ArticleId IdType="pubmed">25861577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Causse M, Ruiz P, Gutierrez&#x2010;Aroca JB, Casal M. Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis. J Clin Microbiol. 2011;49(8):3065&#x2010;3067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3147762</ArticleId>
            <ArticleId IdType="pubmed">21653775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
WHO
. Rapid Implementation of the Xpert MTB/RIF Diagnostic Test. World Health Organization; 2011. 
http://apps.who.int/iris/bitstream/10665/44593/1/9789241501569_eng.pdf. Accessed March 8, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Teo J, Jureen R, Chiang D, Chan D, Lin R. Comparison of two nucleic acid amplification assays, the Xpert MTB/RIF assay and the amplified Mycobacterium tuberculosis Direct assay, for detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol. 2011;49(10):3659&#x2010;3662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3187313</ArticleId>
            <ArticleId IdType="pubmed">21865419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNerney R, Daley P. Towards a point&#x2010;of&#x2010;care test for active tuberculosis: obstacles and opportunities. Nat Rev Microbiol. 2011;9(3):204&#x2010;213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21326275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller N, Hernandez SG, Cleary TJ. Evaluation of Gen&#x2010;probe amplified Mycobacterium tuberculosis direct test and PCR for direct detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol. 1994;32(2):393&#x2010;397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC263042</ArticleId>
            <ArticleId IdType="pubmed">8150948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwamoto T, Sonobe T, Hayashi K. Loop&#x2010;mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples. J Clin Microbiol. 2003;41(6):2616&#x2010;2622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC156570</ArticleId>
            <ArticleId IdType="pubmed">12791888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO . The Use of a Commercial Loop&#x2010;Mediated Isothermal Amplification Assay (TB&#x2010;LAMP) for the Detection of Tuberculosis: Expert Group Meeting Report Geneva. World Health Oraganization; 2013. apps.who.int/iris/bitstream/10665/&#x2026;/WHO_HTM_TB_2013.05_eng.pdf. Accessed January 15, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>
WHO
. The Use of Loop&#x2010;Mediated Isothermal Amplification (TB&#x2010;LAMP) for the Diagnosis of Pulmonary Tuberculosis: Policy Guidance. World Health Organization; 2016. 
http://www.who.int/tb/publications/lamp-diagnosis-molecular/en/. Accessed January 15, 2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27606385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daher RK, Stewart G, Boissinot M, Bergeron MG. Recombinase polymerase amplification for diagnostic applications. Clin Chem. 2016;62(7):947&#x2010;958.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7108464</ArticleId>
            <ArticleId IdType="pubmed">27160000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piepenburg O, Williams CH, Stemple DL, Armes NA. DNA detection using recombination proteins. PLoS Biol. 2006;4(7):e204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1475771</ArticleId>
            <ArticleId IdType="pubmed">16756388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crannell ZA, Rohrman B, Richards&#x2010;Kortum R. Equipment&#x2010;free incubation of recombinase polymerase amplification reactions using body heat. PLoS One. 2014;9(11):e112146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4221156</ArticleId>
            <ArticleId IdType="pubmed">25372030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang R, Zhang F, Wang L, et&#xA0;al. Instant, visual, and instrument&#x2010;free method for on&#x2010;site screening of GTS 40&#x2010;3&#x2010;2 soybean based on body&#x2010;heat triggered recombinase polymerase amplification. Anal Chem. 2017;89(8):4413&#x2010;4418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28345860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyle DS, McNerney R, Teng Low H, et&#xA0;al. Rapid detection of Mycobacterium tuberculosis by recombinase polymerase amplification. PLoS One. 2014;9(8):e103091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4138011</ArticleId>
            <ArticleId IdType="pubmed">25118698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng BYC, Wee EJH, West NP, Trau M. Rapid DNA detection of Mycobacterium tuberculosis&#x2010;towards single cell sensitivity in point&#x2010;of&#x2010;care diagnosis. Sci Rep. 2015;5:15027.</Citation>
        </Reference>
        <Reference>
          <Citation>Keeler E, Perkins MD, Small P, et&#xA0;al. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature. 2006;444(Suppl 1):49&#x2010;57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17159894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moon SH, Kim EJ, Tomono J, et&#xA0;al. Detection of Mycobacterium tuberculosis complex in sputum specimens using a loop&#x2010;mediated isothermal amplification assay in Korea. J Med Microbiol. 2015;64(11):1335&#x2010;1340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26338293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mori Y, Notomi T. Loop&#x2010;mediated isothermal amplification (LAMP): a rapid, accurate, and cost&#x2010;effective diagnostic method for infectious diseases. J Infect Chemother. 2009;15(2):62&#x2010;69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7087713</ArticleId>
            <ArticleId IdType="pubmed">19396514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Y, Chen F, Li Q, Wang L, Fan C. Isothermal amplification of nucleic acids. Chem Rev. 2015;115(22):12491&#x2010;12545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26551336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Escadafal C, Paweska JT, Grobbelaar A, et&#xA0;al. International external quality assessment of molecular detection of Rift Valley fever virus. PLoS Negl Trop Dis. 2013;7(5):e2244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3662703</ArticleId>
            <ArticleId IdType="pubmed">23717706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed SA, van de Sande WW, Desnos&#x2010;Ollivier M, Fahal AH, Mhmoud NA, de Hoog GS. Application of isothermal amplification techniques for identification of Madurella mycetomatis, the prevalent agent of human mycetoma. J Clin Microbiol. 2015;53(10):3280&#x2010;3285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4572522</ArticleId>
            <ArticleId IdType="pubmed">26246484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
TwistDx
. Appendix to the TwistAmp&#x2122; reaction kit manuals. https://www.twistdx.co.uk/docs/default-source/twistamp-manuals/newappendix_2_.pdf?sfvrsn=8. Accessed December 25, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Debode F, Marien A, Janssen &#xC9;, Bragard C, Berben G. The influence of amplicon length on real&#x2010;time PCR results. Biotechnol Agron Soc Environ. 2017;21(1):3&#x2010;11.</Citation>
        </Reference>
        <Reference>
          <Citation>Birmpa A, Kalogeropoulos K, Kokkinos P, Vantarakis A. Evaluation of two loop&#x2010;mediated isothermal amplification methods for the detection of Salmonella Enteritidis and Listeria Monocytogenes in artificially contaminated ready&#x2010;to&#x2010;eat fresh produce. Ital J Food Saf. 2015;4(3):5383 10.4081/ijfs.2015.5383</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/ijfs.2015.5383</ArticleId>
            <ArticleId IdType="pmc">PMC5076642</ArticleId>
            <ArticleId IdType="pubmed">27800413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Yang K, Bai C, et&#xA0;al. Development of a SYBR Green I real&#x2010;time PCR for the detection of the orf virus. AMB Express. 2017;7:21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5218949</ArticleId>
            <ArticleId IdType="pubmed">28063148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Lei T, Liu Z, Kuang Y, Lyu J, Wang Q. A Novel technique to detect EGFR mutations in lung cancer. Int J Mol Sci. 2016;17(5):792.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4881608</ArticleId>
            <ArticleId IdType="pubmed">27223277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gudnason H, Dufva M, Bang D, Wolff A. Comparison of multiple DNA dyes for real&#x2010;time PCR: effects of dye concentration and sequence composition on DNA amplification and melting temperature. Nucleic Acids Res. 2007;35(19):e127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2095797</ArticleId>
            <ArticleId IdType="pubmed">17897966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Negura L, Negura A. Limits and pitfalls of SYBR Green detection in quantitative PCR. Analele &#x15E;tiin&#x163;ifice Ale Universit&#x103;&#x163;ii Alexandru Ioan Cuza din Ia&#x219;i,Sectiunea II A: Genetica si Biologie Moleculara; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Flores LL, Pai M, Colford JM, Riley LW. In&#x2010;house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta&#x2010;analysis and meta&#x2010;regression. BMC Microbiol. 2005;5:55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1260021</ArticleId>
            <ArticleId IdType="pubmed">16202138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huyen MN, Tiemersma EW, Kremer K, et&#xA0;al. Characterisation of Mycobacterium tuberculosis isolates lacking IS6110 in Viet Nam. Int J Tuberc Lung Dis. 2013;17(11):1479&#x2010;1485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24125454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collins DM, Stephens DM. Identification of an insertion sequence, IS1081, in Mycobacterium bovis . FEMS Microbiol Lett. 1991;67(1):11&#x2010;15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1663885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gallex
. UltraPower DNA/RNA safe dye. http://www.gellex.jp/item/ultrapower_safedye. Accessed February 24, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>
TaKaRa
. SYBR green I nucleic acid gel stain. http://catalog.takara-bio.co.jp/PDFS/5760A_5761A_5770A_5771A_j.pdf. Accessed February 26, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Nghiem MN, Nguyen BV, Nguyen ST, Vo TT, Nong HV. A Simple, single triplex PCR of IS6110, IS1081, and 23S ribosomal DNA targets, developed for rapid detection and discrimination of Mycobacterium from clinical samples. J Microbiol Biotechnol. 2015;25(5):745&#x2010;752.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25433552</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30126292</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2025</Year>
        <Month>01</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-3799</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical nursing research</Title>
          <ISOAbbreviation>Clin Nurs Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>mHealth Applications for Children and Young People With Persistent Pain: A Scoping Review.</ArticleTitle>
        <Pagination>
          <StartPage>779</StartPage>
          <EndPage>794</EndPage>
          <MedlinePgn>779-794</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1054773818795078</ELocationID>
        <Abstract>
          <AbstractText>Persistent pain is a global health care issue affecting more than 30% of children and young people. mHealth applications delivered using smartphones, are an innovative method to engage children in pain self-management. This article outlines the evidence concerning the development, implementation, and evaluation of mHealth apps for these children in terms of feasibility, acceptability, and impact on important pain outcomes such as quality of life and health care utilization.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Schults</LastName>
            <ForeName>Jessica</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-5406-9519</Identifier>
            <AffiliationInfo>
              <Affiliation>1 Department of Anaesthesia and Pain Management, Lady Cilento Children's Hospital, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2 Menzies Health Queensland, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cooke</LastName>
            <ForeName>Marie</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>2 Menzies Health Queensland, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Richards</LastName>
            <ForeName>Julianne</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Anaesthesia and Pain Management, Lady Cilento Children's Hospital, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Theodoros</LastName>
            <ForeName>Joanne</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Anaesthesia and Pain Management, Lady Cilento Children's Hospital, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andresen</LastName>
            <ForeName>Elizabeth</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Anaesthesia and Pain Management, Lady Cilento Children's Hospital, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paterson</LastName>
            <ForeName>Rebecca</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>2 Menzies Health Queensland, Griffith University, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alcock</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>1 Department of Anaesthesia and Pain Management, Lady Cilento Children's Hospital, Queensland, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000098583">Scoping Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Nurs Res</MedlineTA>
        <NlmUniqueID>9208508</NlmUniqueID>
        <ISSNLinking>1054-7738</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004059" MajorTopicYN="N">Diffusion of Innovation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059408" MajorTopicYN="Y">Pain Management</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010342" MajorTopicYN="Y">Patient Acceptance of Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000068997" MajorTopicYN="N">Smartphone</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adolescents</Keyword>
        <Keyword MajorTopicYN="N">chronic pain</Keyword>
        <Keyword MajorTopicYN="N">mHealth</Keyword>
        <Keyword MajorTopicYN="N">pediatrics</Keyword>
        <Keyword MajorTopicYN="N">persistent pain</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30126292</ArticleId>
        <ArticleId IdType="doi">10.1177/1054773818795078</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30125569</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1527-3792</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>201</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of urology</Title>
          <ISOAbbreviation>J Urol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact of Post-Hospital Syndrome on Penile Prosthesis Outcomes: A Period of Global Health Risk.</ArticleTitle>
        <Pagination>
          <StartPage>154</StartPage>
          <EndPage>159</EndPage>
          <MedlinePgn>154-159</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.juro.2018.08.039</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE">Post-hospital syndrome is an acquired transient period of health vulnerability following inpatient admission. We assessed the impact of a preoperative hospitalization on outcomes following penile prosthesis surgery and sought to optimize surgical timing after inpatient admission.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS">We used the Healthcare Cost and Utilization Project State Inpatient Databases and State Ambulatory Surgery Database for California from 2007 to 2011 and for Florida from 2009 to 2014. Patients were identified as having undergone prosthesis placement by ICD-9 and CPT codes. The primary exposure was post-hospital syndrome, defined as any inpatient admission 90 days or less before prosthesis placement. Patients were further categorized by how recently the inpatient hospitalization occurred. The primary study outcome was 30-day hospital readmission. Secondary outcomes were length of stay, and device and postoperative complications.</AbstractText>
          <AbstractText Label="RESULTS">We identified 16,923 patients who received a penile prosthesis, of whom 477 (3%) had post-hospital syndrome exposure 90 days or less before prosthesis placement. After risk adjustment patients with post-hospital syndrome had higher odds of 30-day readmission (OR 3.0, 95% CI 2.2-4.1), length of stay 2 days or longer (OR 1.7, 95% CI 1.3-2.3) and device complications (OR 1.7, 95% CI 1.2-2.5). When categorizing patients by 30-day intervals, we found a linear decrease in the risk of 30-day readmission as the interval increased between post-hospital syndrome exposure and prosthesis surgery.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Post-hospital syndrome exposure is a risk adjusted predictor of 30-day readmissions, prolonged length of stay and device complications. Medical optimization and delayed surgery can help combat the adverse effects associated with post-hospital syndrome exposure and may improve surgical outcomes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kirshenbaum</LastName>
            <ForeName>Eric J</ForeName>
            <Initials>EJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>One:MAP Division of Clinical Informatics and Analytics, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nelson</LastName>
            <ForeName>Marc</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hehemann</LastName>
            <ForeName>Marah C</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kothari</LastName>
            <ForeName>Anai N</ForeName>
            <Initials>AN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of 3 Surgery, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>One:MAP Division of Clinical Informatics and Analytics, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eguia</LastName>
            <ForeName>Emanuel</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of 3 Surgery, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>One:MAP Division of Clinical Informatics and Analytics, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Farooq</LastName>
            <ForeName>Ahmer</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bresler</LastName>
            <ForeName>Larissa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Gopal</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>One:MAP Division of Clinical Informatics and Analytics, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santos</LastName>
            <ForeName>Grace Delos</ForeName>
            <Initials>GD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Urology, Loyola University Medical Center, Maywood, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Urol</MedlineTA>
        <NlmUniqueID>0376374</NlmUniqueID>
        <ISSNLinking>0022-5347</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002140" MajorTopicYN="N" Type="Geographic">California</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005431" MajorTopicYN="N" Type="Geographic">Florida</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019935" MajorTopicYN="Y">Penile Implantation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015917" MajorTopicYN="Y">Penile Prosthesis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30125569</ArticleId>
        <ArticleId IdType="doi">10.1016/j.juro.2018.08.039</ArticleId>
        <ArticleId IdType="pii">S0022-5347(18)43721-4</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30124910</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1938-2928</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>56</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>08</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of medical entomology</Title>
          <ISOAbbreviation>J Med Entomol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identification, Molecular Characterization, and In Silico Structural Analysis of Carboxypeptidase B2 of Anopheles stephensi.</ArticleTitle>
        <Pagination>
          <StartPage>72</StartPage>
          <EndPage>85</EndPage>
          <MedlinePgn>72-85</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jme/tjy127</ELocationID>
        <Abstract>
          <AbstractText>Malaria is a vector-borne infectious disease that is considered a priority of the World Health Organization due to its enormous impacts on global health. Plasmodium spp. (Haemosporida: Plasmodiidae), Anopheles spp. (Diptera: Culicidae), and a suitable host are the key elements for malaria transmission. To disrupt the parasitic life cycle of malaria or prevent its transmission, these three key elements should be targeted by effective control strategies. Development of vaccines that interrupt malaria transmission is one of the solutions that has been recommended to the countries that aim to eliminate malaria. With respect to the important role of Anopheles stephensi in malaria transmission and involvement of Anopheles carboxypeptidase B1 in sexual parasite development, we characterized the second member of cpb gene family (cpbAs2) of An. Stephensi to provide some basic information and evaluate significance of cpbAs2's role in complementing sexual plasmodium development role of cpbAs1. The cpbAs2 mRNA sequence was characterized by 3' and 5' RACE and the structural features of its coded protein were studied by in silico modeling. The coding sequence and gene structure of cpbAs2 were determined empirically and compared with the in silico predictions from the An. stephensi genome sequencing project. Furthermore, homology modeling revealed that its structure is very similar to the structurally important domains of procarboxypeptidase B2 in humans. This study provides basic molecular and structural information about another member of the cpb gene family of An. stephensi. The reported results are informative and necessary for evaluation of the role of this gene in sexual parasite development by future studies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Khamsehnejad</LastName>
            <ForeName>Mahdokht Ilbeigi</ForeName>
            <Initials>MI</Initials>
            <AffiliationInfo>
              <Affiliation>Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran (PII), Pasteur Avenue, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Djadid</LastName>
            <ForeName>Navid Dinparast</ForeName>
            <Initials>ND</Initials>
            <AffiliationInfo>
              <Affiliation>Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran (PII), Pasteur Avenue, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raz</LastName>
            <ForeName>Abbasali</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Malaria and Vector Research Group (MVRG), Biotechnology Research Center (BRC), Pasteur Institute of Iran (PII), Pasteur Avenue, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Med Entomol</MedlineTA>
        <NlmUniqueID>0375400</NlmUniqueID>
        <ISSNLinking>0022-2585</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 3.4.17.20</RegistryNumber>
          <NameOfSubstance UI="D025901">Carboxypeptidase B2</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000852" MajorTopicYN="N">Anopheles</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
          <QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D025901" MajorTopicYN="N">Carboxypeptidase B2</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010961" MajorTopicYN="N">Plasmodium</DescriptorName>
          <QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040681" MajorTopicYN="N">Structural Homology, Protein</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>6</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30124910</ArticleId>
        <ArticleId IdType="doi">10.1093/jme/tjy127</ArticleId>
        <ArticleId IdType="pii">5073206</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30112952</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>10</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1478-7083</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>101</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of the Royal College of Surgeons of England</Title>
          <ISOAbbreviation>Ann R Coll Surg Engl</ISOAbbreviation>
        </Journal>
        <ArticleTitle>ENT in the context of global health.</ArticleTitle>
        <Pagination>
          <StartPage>93</StartPage>
          <EndPage>96</EndPage>
          <MedlinePgn>93-96</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1308/rcsann.2018.0138</ELocationID>
        <Abstract>
          <AbstractText>Global health is a fashionable term frequently used in the twenty-first century's news that is rarely understood by ear, nose and throat (ENT) professionals. Communicable diseases such as HIV, tuberculosis and malaria have been in the headlines of global health for decades. Despite the recent public health concerns about noncommunicable diseases, including ENT disorders, these disorders still receive little attention on the global health stage. Despite the 'benign' nature and a large number of patients affected at a given time, noncommunicable diseases were found to account for 60% of international mortality in 2008. More specifically to ENT, disabling hearing impairment has been found to be the most common disability globally. Therefore, it is now critical for otolaryngologists worldwide to get involved in the overlooked ENT global issues. This article discusses the main challenges faced by the ENT community in the developing world and proposes what can be done to help.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ta</LastName>
            <ForeName>N H</ForeName>
            <Initials>NH</Initials>
            <AffiliationInfo>
              <Affiliation>Norwich Medical School, University of East Anglia , Norwich , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ann R Coll Surg Engl</MedlineTA>
        <NlmUniqueID>7506860</NlmUniqueID>
        <ISSNLinking>0035-8843</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006297" MajorTopicYN="Y">Health Services Accessibility</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D034381" MajorTopicYN="Y">Hearing Loss</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008507" MajorTopicYN="Y">Medically Underserved Area</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010036" MajorTopicYN="Y">Otolaryngology</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010819" MajorTopicYN="Y">Physician's Role</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ENT</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Hearing loss</Keyword>
        <Keyword MajorTopicYN="N">Otolaryngology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30112952</ArticleId>
        <ArticleId IdType="pmc">PMC6351874</ArticleId>
        <ArticleId IdType="doi">10.1308/rcsann.2018.0138</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Koplan J, Bond T, Merson M et al. . Towards a common definition of global health. Lancet 2009; (9679): 1,993&#x2013;1,995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC9905260</ArticleId>
            <ArticleId IdType="pubmed">19493564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization The Global Burden of Disease: 2004 Update. Geneva: WHO; 2008.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013&#x2013;2020. Geneva: WHO; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Mackenzie I, Smith A. Deafness: the neglected and hidden disability. Ann Trop Med Parasitol 2009; (7): 565&#x2013;571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19825278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fagan J, Jacobs M. Survey of ENT services in Africa: need for a comprehensive intervention. Glob Health Action 2009; (1): doi: 10.3402/gha.v2i0.1932.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2779942</ArticleId>
            <ArticleId IdType="pubmed">20027268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandra A. The metrics of the physician brain drain. N Engl J Med 2006; (5): 528&#x2013;530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16456943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olusanya B, Neumann K, Saunders J. The global burden of disabling hearing impairment: a call to action. Bull World Health Organ 2014; (5): 367&#x2013;373.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4007124</ArticleId>
            <ArticleId IdType="pubmed">24839326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pascolini D, Smith A. Hearing Impairment in 2008: A compilation of available epidemiological studies. Int J Audiol 2009; (7): 473&#x2013;485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19444763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization Millions of People in the World have Hearing Loss that can be Treated or Prevented. Geneva: WHO; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Jacobs L. A Deaf Adult Speaks Out. Washington DC: Gallaudet University Press; 1994.</Citation>
        </Reference>
        <Reference>
          <Citation>Mawson S, Ludman H. Diseases of the Ear. London: Arnold; 1979.</Citation>
        </Reference>
        <Reference>
          <Citation>Shenoi P. Management of chronic suppurative otitis media : Scott-Brown WG. Scott-Brown's Otolaryngology, 6th ed. Oxford: Butterworth-Heinemann; 1987. 215&#x2013;237.</Citation>
        </Reference>
        <Reference>
          <Citation>Foundation, history and aims of BRINOS 
http://www.brinos.org.uk/History.htm (cited
June
2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Geers AE, Moog JS. The effectiveness of cochlear implants and tactile aids for deaf education: a report of the CID Sensory Aids Study. Volta Review Monograph 1994; (5).</Citation>
        </Reference>
        <Reference>
          <Citation>Osberger MJ, Maso M, Sam LK. Speech intelligibility of children with cochlear implants, tactile aids, or hearing aids. J Speech Hear Res 1993; (1): 186&#x2013;203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8450658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weir N. Ear surgery camps in Nepal and the work of the Britain Nepal Otology Service (BRINOS). J Laryngol Otol 1991; (12): 1,113&#x2013;1,115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1787375</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30111174</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>31</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1360-0451</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>31</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>AIDS care</Title>
          <ISOAbbreviation>AIDS Care</ISOAbbreviation>
        </Journal>
        <ArticleTitle>HIV serostatus disclosure in the Democratic Republic of the Congo: a systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>489</StartPage>
          <EndPage>493</EndPage>
          <MedlinePgn>489-493</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09540121.2018.1510103</ELocationID>
        <Abstract>
          <AbstractText>HIV status disclosure among people living with HIV/AIDS has been shown to have a number of both personal and public health benefits, but rates of HIV status disclosure remain low in many African countries, including the Democratic Republic of the Congo (DRC). This systematic review uses the Disclosure Process Model to examine the factors involved in serostatus disclosure and nondisclosure to various persons in the lives of people living with HIV/AIDS (PLWHA) in the DRC, as well as the specific outcomes of their disclosure or nondisclosure. MEDLINE/PubMed, Embase, Web of Science, Global Health, and PsycINFO were searched and research studies were included if: (i) the study discussed disclosure of HIV status; (ii) the study population included HIV-infected people in DRC; and (iii) the study was published in English. Fourteen articles met the inclusion criteria and were included in the study. Factors contributing to nondisclosure were generally associated with high stigma of HIV in adults and concern for emotional wellbeing when disclosing to HIV positive minors. Factors contributing to disclosure among adults were increased social support and religion. In disclosing to HIV positive minors, increasing age and health benefits were identified as approach goals that supported disclosure. The findings highlight the importance of understanding the avoidance and approach goals involved in HIV status disclosure among populations living in the DRC. Interventions and future research directed at increasing HIV disclosure among Congolese PLWHA should move beyond individual-level to consider multilevel factors including circumstantial social behaviors.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Whembolua</LastName>
            <ForeName>Guy-Lucien</ForeName>
            <Initials>GL</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Africana Studies , University of Cincinnati , Cincinnati , OH , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Conserve</LastName>
            <ForeName>Donaldson F</ForeName>
            <Initials>DF</Initials>
            <AffiliationInfo>
              <Affiliation>b Arnold School of Public Health , University of South Carolina , Charleston , SC , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thomas</LastName>
            <ForeName>Kirstyn</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Africana Studies , University of Cincinnati , Cincinnati , OH , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tshiswaka</LastName>
            <ForeName>Daudet Ilunga</ForeName>
            <Initials>DI</Initials>
            <AffiliationInfo>
              <Affiliation>c Department of Public Health , University of West Florida , 11000 University Parkway, Pensacola , FL , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Handler</LastName>
            <ForeName>Lara</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>d Health Sciences Library , UNC Chapel Hill , CB 7585, Chapel Hill , NC , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>AIDS Care</MedlineTA>
        <NlmUniqueID>8915313</NlmUniqueID>
        <ISSNLinking>0954-0121</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015023" MajorTopicYN="N" Type="Geographic">Democratic Republic of the Congo</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D030881" MajorTopicYN="Y">Disclosure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007398" MajorTopicYN="N">Interpersonal Relations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012067" MajorTopicYN="N">Religion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057545" MajorTopicYN="Y">Social Stigma</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012944" MajorTopicYN="Y">Social Support</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Africa</Keyword>
        <Keyword MajorTopicYN="N">Congo</Keyword>
        <Keyword MajorTopicYN="N">Disclosure</Keyword>
        <Keyword MajorTopicYN="N">HIV</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30111174</ArticleId>
        <ArticleId IdType="doi">10.1080/09540121.2018.1510103</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30109534</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>10</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1557-1920</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of immigrant and minority health</Title>
          <ISOAbbreviation>J Immigr Minor Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mental Health Status and Service Assessment for Adult Syrian Refugees Resettled in Metropolitan Atlanta: A Cross-Sectional Survey.</ArticleTitle>
        <Pagination>
          <StartPage>1019</StartPage>
          <EndPage>1025</EndPage>
          <MedlinePgn>1019-1025</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10903-018-0806-6</ELocationID>
        <Abstract>
          <AbstractText>Because little is known about the mental health status of Syrian refugees in the United States, we conducted a survey among a convenience sample of those resettled in Atlanta between March 2011 and 2017. Though home visits, we delivered a questionnaire including standardized instruments (HSCL25 and PTSD-8) to assess symptoms of anxiety, depression and Posttraumatic Stress Disorder. We found high rates of anxiety (60%), depression (44%) and Posttraumatic Stress Disorder (84%) symptoms; however, only 20% of participants had seen a mental health professional. Reported reasons for not seeking professional help were lack of transportation and access to information. Findings of this survey indicate the high burden of mental health symptoms and the need for services to the study population. A longitudinal study with a larger sample size would improve the understanding of mental health needs and resilience factors of Syrian refugees resettled in the US.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>M'zah</LastName>
            <ForeName>Skander</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-3692-1867</Identifier>
            <AffiliationInfo>
              <Affiliation>Center for Humanitarian Emergencies, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Skander.mzah@gmail.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>, Tunis, Tunisia. Skander.mzah@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lopes Cardozo</LastName>
            <ForeName>Barbara</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Emergency Response and Recovery Branch, Division of Global Health Protection, Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Evans</LastName>
            <ForeName>Dabney P</ForeName>
            <Initials>DP</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Humanitarian Emergencies, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>CC999999</GrantID>
            <Agency>Intramural CDC HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Immigr Minor Health</MedlineTA>
        <NlmUniqueID>101256527</NlmUniqueID>
        <ISSNLinking>1557-1912</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005845" MajorTopicYN="N" Type="Geographic">Georgia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName>
          <QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012036" MajorTopicYN="N">Refugees</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013313" MajorTopicYN="N">Stress Disorders, Post-Traumatic</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013593" MajorTopicYN="N" Type="Geographic">Syria</DescriptorName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014505" MajorTopicYN="N">Urban Population</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anxiety</Keyword>
        <Keyword MajorTopicYN="N">Depression</Keyword>
        <Keyword MajorTopicYN="N">Global health security</Keyword>
        <Keyword MajorTopicYN="N">Mental health</Keyword>
        <Keyword MajorTopicYN="N">PTSD</Keyword>
        <Keyword MajorTopicYN="N">Psychological distress</Keyword>
        <Keyword MajorTopicYN="N">Refugees</Keyword>
        <Keyword MajorTopicYN="N">Syria</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30109534</ArticleId>
        <ArticleId IdType="mid">NIHMS994039</ArticleId>
        <ArticleId IdType="pmc">PMC6375803</ArticleId>
        <ArticleId IdType="doi">10.1007/s10903-018-0806-6</ArticleId>
        <ArticleId IdType="pii">10.1007/s10903-018-0806-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>UNHCR. Global Trends: forced displacement in 2015 [Internet]. 2015. 
http://www.unhcr.org/en-us/statistics/unhcrstats/576408cd7/unhcr-global-trends-2016.html.</Citation>
        </Reference>
        <Reference>
          <Citation>UNHCR. Resettlement [Internet]. http://www.unhcr.org/en-us/resettlement.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Refugee Processing Center, the U.S department of State, bureau of population, refugees and migration. Syrian Refugees resettled in the United States, FY 2012&#x2013;17: admissions and arrivals database. Refugee Processing Center; 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Hassan G, Ventevogel P, Jefee-Bahloul H, Barkil-Oteo A, Kir-mayer LJ. Mental health and psychosocial wellbeing of Syrians affected by armed conflict. Epidemiol Psychiatr Sci. 2016;25:129&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6998596</ArticleId>
            <ArticleId IdType="pubmed">26829998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>UNHCR. Culture, context and the mental health and psychosocial wellbeing of Syrians a review for mental health and psychosocial support staff working with syrians affected by armed conflict 2015 [Internet]. 2015. 
http://www.unhcr.org/55f6b90f9.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Bastin P, Bastard M, Rossel L, Melgar P, Jones A, Antierens A. Description and Predictive Factors of Individual Outcomes in a Refugee Camp Based Mental Health Intervention (Beirut, Lebanon). PLoS ONE. 2013;8:e54107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3547969</ArticleId>
            <ArticleId IdType="pubmed">23349795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alpak G, Unal A, Bulbul F, Sagaltici E, Bez Y, Altindag A, et al. Post-traumatic stress disorder among Syrian refugees in Turkey: a cross-sectional study. Int J Psychiatry Clin Pract. 2015;19:45&#x2013;50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25195765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>IMC. SYRIA CRISIS addressing regional mental health needs and gaps in the context of the Syria crisis [Internet]. 2014. 
http://internationalmedicalcorps.org/document.doc?id=526.</Citation>
        </Reference>
        <Reference>
          <Citation>Inter-Agency Standing Committee (IASC). IASC guidelines on mental health and psychosocial support in emergency settings. Geneva: IASC; 2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">36502397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weissbecker I, Leichner A: Addressing mental health needs among Syrian refugees. Washington, DC: Middle East Inst.; 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Ao T, Shetty S, Sivilli T, Blanton C, Ellis H, Geltman PL, et al. Suicidal ideation and mental health of Bhutanese refugees in the United States. J Immigr Minor Health. 2016;18:828&#x2013;35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4905789</ArticleId>
            <ArticleId IdType="pubmed">26711245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagaman AK, Sivilli TI, Ao T, Blanton C, Ellis H, Lopes Cardozo B, et al. An investigation into suicides among Bhutanese refugees resettled in the United States between 2008 and 2011. J Immigr Minor Health. 2016;18:819&#x2013;27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4905799</ArticleId>
            <ArticleId IdType="pubmed">26758579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Porter M, Haslam N. Predisplacement and postdisplacement factors associated with mental health of refugees and internally displaced persons: a meta-analysis. JAMA 2005;294:602&#x2013;12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16077055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bogic M, Njoku A, Priebe S: Long-term mental health of war-refugees: a systematic literature review. BMC Int Health Hum Rights [Internet]. 2015. 
http://bmcinthealthhumrights.biomedcentral.com/articles/10.1186/s12914-015-0064-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12914-015-0064-9</ArticleId>
            <ArticleId IdType="pmc">PMC4624599</ArticleId>
            <ArticleId IdType="pubmed">26510473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steel Z, Chey T, Silove D, Marnane C, Bryant RA, van Ommeren M. Association of torture and other potentially traumatic events with mental health outcomes among populations exposed to mass conflict and displacement: a systematic review and meta-analysis. JAMA 2009;302:537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19654388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parloff MB, Kelman HC, Frank JD. Comfort, effectiveness, and self-awareness as criteria of improvement in psychotherapy. Am J Psychiatry. 1954;111:343&#x2013;52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13197596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mollica R: The Harvard Trauma Questionnaire. Validating a cross-cultural instrument for measuring torture, trauma, and post-traumatic stress disorder in Indochinese refugees. J Nerv Ment Dis. 1992;180(2):111&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1737972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansen M, Andersen TE, Armour C, Elklit A, Palic S, Mackril T. PTSD-8: a short PTSD inventory. Clin Pract Epidemiol Ment Health. 2010;1:101&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3023946</ArticleId>
            <ArticleId IdType="pubmed">21253461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellis BH, Lankau EW, Ao T, Benson MA, Miller AB, Shetty S, et al. Understanding Bhutanese refugee suicide through the interpersonal-psychological theory of suicidal behavior. Am J Orthopsychiatry. 2015;85:43&#x2013;55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4732867</ArticleId>
            <ArticleId IdType="pubmed">25642653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnetz BB, Broadbridge CL, Jamil H, Lumley MA, Pole N, Barkho E, et al. Specific trauma subtypes improve the predictive validity of the Harvard trauma questionnaire in Iraqi refugees. J Immigr Minor Health. 2014;16:1055&#x2013;61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4138298</ArticleId>
            <ArticleId IdType="pubmed">24549491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vonnahme LA, Lankau EW, Ao T, Shetty S, Cardozo BL. Factors associated with symptoms of depression among Bhutanese refugees in the United States. J Immigr Minor Health. 2015;17:1705&#x2013;14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4631124</ArticleId>
            <ArticleId IdType="pubmed">25348425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleijn WC, Hovens JE, Rodenburg JJ. Posttraumatic stress symptoms in refugees: assessments with the Harvard trauma questionnaire and the hopkins symptoms checklist- 25 in different languages. Psychol Rep. 2001;88:527&#x2013;32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11351903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindert J, von Ehrenstein OS, Priebe S, Mielck A, Br&#xE4;hler E. Depression and anxiety in labor migrants and refugees&#x2014;a systematic review and meta-analysis. Soc Sci Med. 2009;69:246&#x2013;57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19539414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naja WJ, Aoun MP, El Khoury EL, Abdallah FJB, Haddad RS. Prevalence of depression in Syrian refugees and the influence of religiosity. Compr Psychiatry. 2016;68:78&#x2013;85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27234187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43:897&#x2013;910.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22781489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hollifield M, Verbillis-Kolp S, Farmer B, Toolson EC, Woldehaimanot T, Yamazaki J, et al. The Refugee Health Screener-15 (RHS-15): development and validation of an instrument for anxiety, depression, and PTSD in refugees. Gen Hosp Psychiatry. 2013;35:202&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23347455</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30102776</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1527-3350</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>69</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Hepatology (Baltimore, Md.)</Title>
          <ISOAbbreviation>Hepatology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long-Term Relationship.</ArticleTitle>
        <Pagination>
          <StartPage>889</StartPage>
          <EndPage>900</EndPage>
          <MedlinePgn>889-900</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.30214</ELocationID>
        <Abstract>
          <AbstractText>Chronic hepatitis C virus (HCV) infection-associated liver disease is a global health problem. HCV often causes silent disease, and eventually progresses to end-stage liver disease. HCV infects hepatocytes; however, initial manifestation of liver disease is mostly displayed in hepatic stellate cells (HSCs), causing fibrosis/cirrhosis, and is believed to occur from inflammation in the liver. It remains unclear why HCV is not spontaneously cleared from infected liver in the majority of individuals and develops chronic infection with progressive liver disease. Direct-acting antivirals (DAAs) show excellent results in controlling viremia, although beneficial consequence in advanced liver disease remains to be understood. In this review, we highlight the current knowledge that has contributed to our understanding of the role of HCV in inflammation, immune evasion, metabolic disorders, liver pathogeneses, and efforts in vaccine development.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 by the American Association for the Study of Liver Diseases.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ray</LastName>
            <ForeName>Ratna B</ForeName>
            <Initials>RB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Saint Louis University, Saint Louis, MO.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Saint Louis University, Saint Louis, MO.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ray</LastName>
            <ForeName>Ranjit</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Saint Louis University, Saint Louis, MO.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R21 CA188472</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK113645</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK081817</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Hepatology</MedlineTA>
        <NlmUniqueID>8302946</NlmUniqueID>
        <ISSNLinking>0270-9139</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014761">Viral Hepatitis Vaccines</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D056704" MajorTopicYN="N">Adaptive Immunity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016174" MajorTopicYN="N">Hepacivirus</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006526" MajorTopicYN="N">Hepatitis C</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008659" MajorTopicYN="N">Metabolic Diseases</DescriptorName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014761" MajorTopicYN="N">Viral Hepatitis Vaccines</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>Potential conflict of interest:</b> Nothing to report.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30102776</ArticleId>
        <ArticleId IdType="mid">NIHMS985320</ArticleId>
        <ArticleId IdType="pmc">PMC6351149</ArticleId>
        <ArticleId IdType="doi">10.1002/hep.30214</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Houghton M The long and winding road leading to the identification of the hepatitis C virus. J Hepatol 2009;51:939&#x2013;948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19781804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 2014;59:318&#x2013;327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4063340</ArticleId>
            <ArticleId IdType="pubmed">24115039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paul D, Madan V, Bartenschlager R. Hepatitis C virus RNA replication and assembly: living on the fat of the land. Cell Host Microbe 2014;16:569&#x2013;579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7172941</ArticleId>
            <ArticleId IdType="pubmed">25525790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindenbach BD, Rice CM. The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 2013;11:688&#x2013;700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3897199</ArticleId>
            <ArticleId IdType="pubmed">24018384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwon YC, Ray RB, Ray R. Hepatitis C virus infection: establishment of chronicity and liver disease progression. EXCLI J 2014;13:977&#x2013;996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4464452</ArticleId>
            <ArticleId IdType="pubmed">26417315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Yamane D, Masaki T, Lemon SM. The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA. Nat Rev Microbiol 2015;13:544&#x2013;558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4756644</ArticleId>
            <ArticleId IdType="pubmed">26256788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ait-Goughoulte M, Kanda T, Meyer K, Ryerse JS, Ray RB, Ray R. Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol 2008;82:2241&#x2013;2249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2258951</ArticleId>
            <ArticleId IdType="pubmed">18077704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dreux M, Gastaminza P, Wieland SF, Chisari FV. The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci U S A 2009;106:14046&#x2013;14051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2729017</ArticleId>
            <ArticleId IdType="pubmed">19666601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan ST, Ou JJ. Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response. Viruses 2017;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5580481</ArticleId>
            <ArticleId IdType="pubmed">28805674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramakrishnaiah V, Thumann C, Fofana I, Habersetzer F, Pan Q, de Ruiter PE, Willemsen R, et al. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci U S A 2013;110:13109&#x2013;13113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3740869</ArticleId>
            <ArticleId IdType="pubmed">23878230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bukong TN, Momen-Heravi F, Kodys K, Bala S, Szabo G. Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Pathog 2014;10:e1004424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4183590</ArticleId>
            <ArticleId IdType="pubmed">25275643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrivastava S, Devhare P, Sujijantarat N, Steele R, Kwon YC, Ray R, Ray RB. Knockdown of Autophagy Inhibits Infectious Hepatitis C Virus Release by the Exosomal Pathway. J Virol 2016;90:1387&#x2013;1396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4719613</ArticleId>
            <ArticleId IdType="pubmed">26581990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791&#x2013;796.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2918402</ArticleId>
            <ArticleId IdType="pubmed">15951748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanda T, Basu A, Steele R, Wakita T, Ryerse JS, Ray R, Ray RB. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J Virol 2006;80:4633&#x2013;4639.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1472020</ArticleId>
            <ArticleId IdType="pubmed">16611923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A 2006;103:2310&#x2013;2315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1413728</ArticleId>
            <ArticleId IdType="pubmed">16461899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pawlotsky JM. Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens. Gastroenterology 2016;151:70&#x2013;86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27080301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spengler U Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection. Pharmacol Ther 2018;183:118&#x2013;126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29024739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horner SM, Gale M Jr. Regulation of hepatic innate immunity by hepatitis C virus. Nat Med 2013;19:879&#x2013;888.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4251871</ArticleId>
            <ArticleId IdType="pubmed">23836238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raychoudhuri A, Shrivastava S, Steele R, Dash S, Kanda T, Ray R, Ray RB. Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes. J Virol 2010;84:10991&#x2013;10998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2953153</ArticleId>
            <ArticleId IdType="pubmed">20810735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SJ, Syed GH, Khan M, Chiu WW, Sohail MA, Gish RG, Siddiqui A. Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proc Natl Acad Sci U S A 2014;111:6413&#x2013;6418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4035934</ArticleId>
            <ArticleId IdType="pubmed">24733894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heim MH, Thimme R. Innate and adaptive immune responses in HCV infections. J Hepatol 2014;61:S14&#x2013;25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25443342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, Ray RB. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J Virol 2012;86:10221&#x2013;10225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3446586</ArticleId>
            <ArticleId IdType="pubmed">22787204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mukherjee A, Di Bisceglie AM, Ray RB. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway. J Virol 2015;89:3356&#x2013;3365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4337546</ArticleId>
            <ArticleId IdType="pubmed">25589644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schnell G, Loo YM, Marcotrigiano J, Gale M Jr. Uridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I. PLoS Pathog 2012;8:e1002839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3410852</ArticleId>
            <ArticleId IdType="pubmed">22912574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosen HR. Emerging concepts in immunity to hepatitis C virus infection. J Clin Invest 2013;123:4121&#x2013;4130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3784533</ArticleId>
            <ArticleId IdType="pubmed">24084744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrivastava S, Raychoudhuri A, Steele R, Ray R, Ray RB. Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes. Hepatology 2011;53:406&#x2013;414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3335751</ArticleId>
            <ArticleId IdType="pubmed">21274862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Li Y, Fang S, Su J, Jiang J, Liang B, Huang J, et al. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-lambda1 contributes to its anti-HCV activity in human hepatoma cells. Antiviral Res 2017;140:83&#x2013;94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28131804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol 2015;12:387&#x2013;400.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26055245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrivastava S, Mukherjee A, Ray R, Ray RB. Hepatitis C virus induces interleukin-1beta (IL-1beta)/IL-18 in circulatory and resident liver macrophages. J Virol 2013;87:12284&#x2013;12290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3807883</ArticleId>
            <ArticleId IdType="pubmed">24006444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B, Papic N, Delker DA, et al. IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog 2013;9:e1003330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3635973</ArticleId>
            <ArticleId IdType="pubmed">23633957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chattergoon MA, Latanich R, Quinn J, Winter ME, Buckheit RW 3rd, Blankson JN, Pardoll D, et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog 2014;10:e1004082.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4006909</ArticleId>
            <ArticleId IdType="pubmed">24788318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasaki R, Devhare PB, Steele R, Ray R, Ray RB. Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells. Hepatology 2017;66:746&#x2013;757.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5570659</ArticleId>
            <ArticleId IdType="pubmed">28318046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim H, Bose SK, Meyer K, Ray R. Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis. J Virol 2014;88:2564&#x2013;2571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3958077</ArticleId>
            <ArticleId IdType="pubmed">24352446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cummings KL, Rosen HR, Hahn YS. Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection. Clin Immunol 2009;132:401&#x2013;411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2720442</ArticleId>
            <ArticleId IdType="pubmed">19473882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qing X, Koo GC, Salmon JE. Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-beta1 in Gr-1+ myeloid cells. Eur J Immunol 2012;42:1723&#x2013;1734.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3653187</ArticleId>
            <ArticleId IdType="pubmed">22535677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carroll MC. Complement and humoral immunity. Vaccine 2008;26 Suppl 8:I28&#x2013;33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4018718</ArticleId>
            <ArticleId IdType="pubmed">19388161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwon YC, Meyer K, Peng G, Chatterjee S, Hoft DF, Ray R. Hepatitis C virus E2 envelope glycoprotein induces an immunoregulatory phenotype in macrophages. Hepatology 2018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6092255</ArticleId>
            <ArticleId IdType="pubmed">29443378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saito K, Ait-Goughoulte M, Truscott SM, Meyer K, Blazevic A, Abate G, Ray RB, et al. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J Virol 2008;82:3320&#x2013;3328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2268470</ArticleId>
            <ArticleId IdType="pubmed">18216090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwon YC, Kim H, Meyer K, Di Bisceglie AM, Ray R. Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus. Journal of Immunology 2016;197:1127&#x2013;1136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4976035</ArticleId>
            <ArticleId IdType="pubmed">27357152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smyk-Pearson S, Tester IA, Klarquist J, Palmer BE, Pawlotsky JM, Golden-Mason L, Rosen HR. Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help. J Virol 2008;82:1827&#x2013;1837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2258714</ArticleId>
            <ArticleId IdType="pubmed">18045940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kared H, Fabre T, Bedard N, Bruneau J, Shoukry NH. Galectin-9 and IL-21 Mediate Cross-regulation between Th17 and Treg Cells during Acute Hepatitis C. Plos Pathogens 2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3688567</ArticleId>
            <ArticleId IdType="pubmed">23818845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keoshkerian E, Hunter M, Cameron B, Nguyen N, Sugden P, Bull R, Zekry A, et al. Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection. J Viral Hepat 2016;23:985&#x2013;993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27558465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauer GM. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies. J Infect Dis 2013;207 Suppl 1:S7&#x2013;S12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23390305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin B, Hennecke N, Lohmann V, Kayser A, Neumann-Haefelin C, Kukolj G, Bocher WO, et al. Restoration of HCV-specific CD8+ T cell function by interferon-free therapy. J Hepatol 2014;61:538&#x2013;543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24905492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burchill MA, Golden-Mason L, Wind-Rotolo M, Rosen HR. Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals. J Viral Hepat 2015;22:983&#x2013;991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26482547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alao H, Cam M, Keembiyehetty C, Zhang F, Serti E, Suarez D, Park H, et al. Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During DAA Therapy. Hepatology 2018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6204120</ArticleId>
            <ArticleId IdType="pubmed">29704252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mendez-Lagares G, Lu D, Chen C, Terrault N, Segal MR, Khalili M, Monto A, et al. Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success. Journal of Immunology 2018;200:1124&#x2013;1132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5780234</ArticleId>
            <ArticleId IdType="pubmed">29263212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrovic D, Dempsey E, Doherty DG, Kelleher D, Long A. Hepatitis C virus--T-cell responses and viral escape mutations. Eur J Immunol 2012;42:17&#x2013;26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22125159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raziorrouh B, Ulsenheimer A, Schraut W, Heeg M, Kurktschiev P, Zachoval R, Jung MC, et al. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection. Gastroenterology 2011;141:1422&#x2013;1431, 1431 e1421&#x2013;1426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21763239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mele D, Mantovani S, Oliviero B, Grossi G, Ludovisi S, Mondelli MU, Varchetta S. Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7. Antiviral Res 2017;137:108&#x2013;111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27876497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin EC, Sung PS, Park SH. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat Rev Immunol 2016;16:509&#x2013;523.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27374637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 2008;118:1017&#x2013;1026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2214845</ArticleId>
            <ArticleId IdType="pubmed">18246204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sung PS, Racanelli V, Shin EC. CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection. Front Immunol 2014;5:266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4047488</ArticleId>
            <ArticleId IdType="pubmed">24936203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Negro F, Forton D, Craxi A, Sulkowski MS, Feld JJ, Manns MP. Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology 2015;149:1345&#x2013;1360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26319013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banerjee A, Meyer K, Mazumdar B, Ray RB, Ray R. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J Virol 2010;84:5936&#x2013;5946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2876629</ArticleId>
            <ArticleId IdType="pubmed">20357092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abenavoli L, Masarone M, Peta V, Milic N, Kobyliak N, Rouabhia S, Persico M. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. World J Gastroenterol 2014;20:15233&#x2013;15240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4223256</ArticleId>
            <ArticleId IdType="pubmed">25386071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deng L, Shoji I, Ogawa W, Kaneda S, Soga T, Jiang DP, Ide YH, et al. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 2011;85:8556&#x2013;8568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3165828</ArticleId>
            <ArticleId IdType="pubmed">21697492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bose SK, Kim H, Meyer K, Wolins N, Davidson NO, Ray R. Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus. J Virol 2014;88:4195&#x2013;4203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3993747</ArticleId>
            <ArticleId IdType="pubmed">24478438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin MV, King LY, Chung RT. Hepatitis C virus-associated cancer. Annu Rev Pathol 2015;10:345&#x2013;370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25387053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366&#x2013;375.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11832451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Preisser L, Miot C, Le Guillou-Guillemette H, Beaumont E, Foucher ED, Garo E, Blanchard S, et al. IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells. Hepatology 2014;60:1879&#x2013;1890.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25066464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology 2014;147:577&#x2013;594 e571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25066692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwon YC, Bose SK, Steele R, Meyer K, Di Bisceglie AM, Ray RB, Ray R. Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes. J Virol 2015;89:11549&#x2013;11556.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4645669</ArticleId>
            <ArticleId IdType="pubmed">26355082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasaki R, Devhare P, Ray RB, Ray R. Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model. Hepatology 2017;66:1766&#x2013;1778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5696059</ArticleId>
            <ArticleId IdType="pubmed">28664988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato K, Meng F, Glaser S, Alpini G. Exosomes in liver pathology. J Hepatol 2016;65:213&#x2013;221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4912847</ArticleId>
            <ArticleId IdType="pubmed">26988731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells. J Virol 2017;91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5331806</ArticleId>
            <ArticleId IdType="pubmed">28077652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, Charrier A, Zhou Y, Chen R, Yu B, Agarwal K, Tsukamoto H, et al. Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 2014;59:1118&#x2013;1129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3943742</ArticleId>
            <ArticleId IdType="pubmed">24122827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bose SK, Ray R. Hepatitis C virus infection and insulin resistance. World J Diabetes 2014;5:52&#x2013;58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3932427</ArticleId>
            <ArticleId IdType="pubmed">24567801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ray R Progress Toward Development of a Hepatitis C Vaccine with Broad Shoulders. Science Translational Medicine 2011;3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21813753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nevens F, Roskams T, Van Vlierberghe H, Horsmans Y, Sprengers D, Elewaut A, Desmet V, et al. A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C. Hepatology 2003;38:1289&#x2013;1296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14578869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giang E, Dorner M, Prentoe JC, Dreux M, Evans MJ, Bukh J, Rice CM, et al. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci U S A 2012;109:6205&#x2013;6210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3341081</ArticleId>
            <ArticleId IdType="pubmed">22492964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, et al. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci Transl Med 2014;6:254ra129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4312107</ArticleId>
            <ArticleId IdType="pubmed">25232181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crotta S, Ronconi V, Ulivieri C, Baldari CT, Valiante NM, Abrignani S, Wack A. Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells. Eur J Immunol 2006;36:919&#x2013;929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16552713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang TJ. Current progress in development of hepatitis C virus vaccines. Nat Med 2013;19:869&#x2013;878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6263146</ArticleId>
            <ArticleId IdType="pubmed">23836237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosen HR. &#x201C;Hep C, where art thou&#x201D;: What are the remaining (fundable) questions in hepatitis C virus research? Hepatology 2017;65:341&#x2013;349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27640881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Delft A, Humphreys IS, Brown A, Pfafferott K, Lucas M, Klenerman P, Lauer GM, et al. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. Gut 2016;65:112&#x2013;123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4717358</ArticleId>
            <ArticleId IdType="pubmed">26092843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wijesundara DK, Gummow J, Li Y, Yu W, Quah BJ, Ranasinghe C, Torresi J, et al. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice. J Virol 2018;92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5874410</ArticleId>
            <ArticleId IdType="pubmed">29437963</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30101660</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-1706</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global public health</Title>
          <ISOAbbreviation>Glob Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rituals of global health: Negotiating the World Health Assembly.</ArticleTitle>
        <Pagination>
          <StartPage>161</StartPage>
          <EndPage>174</EndPage>
          <MedlinePgn>161-174</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2018.1504104</ELocationID>
        <Abstract>
          <AbstractText>The World Health Assembly is the WHO's supreme decision-making body and consists of representatives from the 194 WHO Member States who take formal decisions on the WHO's policies, workplan and budget. The event is also attended by representatives of non-governmental organisations, the private sector, the press and even members of the public. Based on participant observation at six World Health Assemblies, in-depth interviews with 53 delegates to the WHA, and an analysis of WHA Official Records, this article examines the ritualistic aspects of WHA negotiations. We argue that analysing the WHA as a ritual provides an insight into power and legitimacy within global health. Not only are certain understandings of health issues and courses of actions decided by the Assembly, but also the very boundaries of global health community are set. The rules of the ritual place limits on different categories of actors, while both formal and informal rules of behaviour further serve to include or exclude actors from the rituals. Success in negotiation is measured by through the inclusion of certain ideas, norms and values in the wording of resolutions and is achieved through the repetition of language in speeches and by adhering to the rules of behaviour.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Irwin</LastName>
            <ForeName>Rachel</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Arts and Cultural Sciences , Lund University , Lund , Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Richard</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Global Health and Development , London School of Hygiene and Tropical Medicine , London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Public Health</MedlineTA>
        <NlmUniqueID>101256323</NlmUniqueID>
        <ISSNLinking>1744-1692</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003659" MajorTopicYN="Y">Decision Making, Organizational</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017008" MajorTopicYN="Y">Negotiating</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019370" MajorTopicYN="N">Observation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014944" MajorTopicYN="Y">World Health Organization</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ethnography</Keyword>
        <Keyword MajorTopicYN="N">World Health Organization</Keyword>
        <Keyword MajorTopicYN="N">diplomacy</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">ritual</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30101660</ArticleId>
        <ArticleId IdType="doi">10.1080/17441692.2018.1504104</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30100204</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1399-0020</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>48</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of oral and maxillofacial surgery</Title>
          <ISOAbbreviation>Int J Oral Maxillofac Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Health-related quality of life of parotid carcinoma patients-a comparative study with parotid adenoma patients and assessment of the influence of demographic, treatment, and pathological factors.</ArticleTitle>
        <Pagination>
          <StartPage>163</StartPage>
          <EndPage>172</EndPage>
          <MedlinePgn>163-172</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijom.2018.07.017</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0901-5027(18)30310-2</ELocationID>
        <Abstract>
          <AbstractText>The aim of this study was to compare the health-related quality of life (HRQoL) of patients treated for parotid carcinoma (PC) and parotid adenoma (PA). The impact of demographic, treatment, and pathological factors was analyzed within the PC group. The EORTC QLQ-C30 and QLQ-H&amp;N35 questionnaires were completed by 45 PC patients and 46 PA patients. A number of HRQoL domains were significantly worse in the PC group than in the PA group: global health status, pain, insomnia, loss of appetite, mouth opening, swallowing problems, dry mouth, sticky saliva, problems with senses and speech, social eating, and cognitive functioning (P&lt;0.05). In the PC group, significantly worse scores were found for age &gt;55years, radical parotidectomy, neck dissection, radiotherapy, recurrence of the disease, pT3/T4 stage, pN+ status, and high-grade tumour (P&lt;0.05). Worse results were related to global health status, social contact, mouth opening, weight and appetite loss, physical, role, emotional, and social functioning, fatigue, speech problems, social eating, and financial difficulties. The study results demonstrate worse HRQoL in PC patients in comparison to PA patients. Older age, radical parotidectomy, neck dissection, radiotherapy, T3/T4 stage, pN+, high-grade tumours, and recurrence had a significant influence on HRQoL in PC patients.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stodulski</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Medical University of Gda&#x144;sk, Gda&#x144;sk, Poland. Electronic address: dstodulski@gumed.edu.pl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>&#x15A;wi&#x105;tkowska-Stodulska</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Internal Medicine, Medical University of Gda&#x144;sk, Gda&#x144;sk, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mikaszewski</LastName>
            <ForeName>B</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Medical University of Gda&#x144;sk, Gda&#x144;sk, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuczkowski</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, Medical University of Gda&#x144;sk, Gda&#x144;sk, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Denmark</Country>
        <MedlineTA>Int J Oral Maxillofac Surg</MedlineTA>
        <NlmUniqueID>8605826</NlmUniqueID>
        <ISSNLinking>0901-5027</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000236" MajorTopicYN="N">Adenoma</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006305" MajorTopicYN="N">Health Status Indicators</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D037981" MajorTopicYN="N">Neck Dissection</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010307" MajorTopicYN="N">Parotid Neoplasms</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">EORTC QLQ-C30</Keyword>
        <Keyword MajorTopicYN="N">EORTC QLQ-H&amp;N35</Keyword>
        <Keyword MajorTopicYN="N">carcinoma</Keyword>
        <Keyword MajorTopicYN="N">parotid gland</Keyword>
        <Keyword MajorTopicYN="N">predictive factors</Keyword>
        <Keyword MajorTopicYN="N">quality of life</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30100204</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ijom.2018.07.017</ArticleId>
        <ArticleId IdType="pii">S0901-5027(18)30310-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30099831</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>12</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-0528</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>126</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>BJOG : an international journal of obstetrics and gynaecology</Title>
          <ISOAbbreviation>BJOG</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Parents' and healthcare professionals' experiences of care after stillbirth in low- and middle-income countries: a systematic review and meta-summary.</ArticleTitle>
        <Pagination>
          <StartPage>12</StartPage>
          <EndPage>21</EndPage>
          <MedlinePgn>12-21</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/1471-0528.15430</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Stillbirth has a profound impact on women, families, and healthcare workers. The burden is highest in low- and middle-income countries (LMICs). There is need for respectful and supportive care for women, partners, and families after bereavement.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To perform a qualitative meta-summary of parents' and healthcare professionals' experiences of care after stillbirth in LMICs.</AbstractText>
          <AbstractText Label="SEARCH STRATEGY" NlmCategory="METHODS">Search terms were formulated by identifying all synonyms, thesaurus terms, and variations for stillbirth. Databases searched were AMED, EMBASE, MEDLINE, PsychINFO, BNI, CINAHL.</AbstractText>
          <AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Qualitative, quantitative, and mixed method studies that addressed parents' or healthcare professionals' experience of care after stillbirth in LMICs.</AbstractText>
          <AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Studies were screened, and data extracted in duplicate. Data were analysed using the Sandelowski meta-summary technique that calculates frequency and intensity effect sizes (FES/IES).</AbstractText>
          <AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">In all, 118 full texts were screened, and 34 studies from 17 countries were included. FES range was 15-68%. Most studies had IES 1.5-4.5. Women experience a broad range of manifestations of grief following stillbirth, which may not be recognised by healthcare workers or in their communities. Lack of recognition exacerbates negative experiences of stigmatisation, blame, devaluation, and loss of social status. Adequately developed health systems, with trained and supported staff, are best equipped to provide the support and information that women want after stillbirth.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Basic interventions could have an immediate impact on the experiences of women and their families after stillbirth. Examples include public education to reduce stigma, promoting the respectful maternity care agenda, and investigating stillbirth appropriately.</AbstractText>
          <AbstractText Label="TWEETABLE ABSTRACT" NlmCategory="CONCLUSIONS">Reducing stigma, promoting respectful care and investigating stillbirth have a positive impact after stillbirth for women and families in LMICs.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Royal College of Obstetricians and Gynaecologists.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shakespeare</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Women and Children's Health, The Chilterns, Southmead Hospital, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Merriel</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>School of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Women and Children's Health, The Chilterns, Southmead Hospital, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bakhbakhi</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>School of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Women and Children's Health, The Chilterns, Southmead Hospital, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baneszova</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>2nd Department of Obstetrics and Gynaecology, Faculty of Medicine, University Hospital Bratislava, Comenius University, Bratislava, Slovakia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barnard</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Library and Knowledge Service, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lynch</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Women and Children's Health, The Chilterns, Southmead Hospital, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Storey</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>International Stillbirth Alliance, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Blencowe</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>London School of Hygiene and Tropical Medicine, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boyle</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Centre of Research Excellence in Stillbirth, Mater Research Institute, University of Queensland, South Brisbane, Qld, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flenady</LastName>
            <ForeName>V</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Centre of Research Excellence in Stillbirth, Mater Research Institute, University of Queensland, South Brisbane, Qld, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gold</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Horey</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>La Trobe University, Bundoora, Vic., Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mills</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siassakos</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>School of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Women and Children's Health, The Chilterns, Southmead Hospital, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>BJOG</MedlineTA>
        <NlmUniqueID>100935741</NlmUniqueID>
        <ISSNLinking>1470-0328</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>BJOG. 2019 Jan;126(1):22. doi: 10.1111/1471-0528.15461.</RefSource>
          <PMID Version="1">30207626</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001291" MajorTopicYN="Y">Attitude of Health Personnel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076605" MajorTopicYN="N">Disenfranchised Grief</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011181" MajorTopicYN="N">Postnatal Care</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013240" MajorTopicYN="N">Stereotyping</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050497" MajorTopicYN="N">Stillbirth</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bereavement care</Keyword>
        <Keyword MajorTopicYN="N">Low- and middle-income countries</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">qualitative meta-summary</Keyword>
        <Keyword MajorTopicYN="N">stillbirth</Keyword>
        <Keyword MajorTopicYN="N">systematic review</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30099831</ArticleId>
        <ArticleId IdType="doi">10.1111/1471-0528.15430</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30099092</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-2939</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>101</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of hospital infection</Title>
          <ISOAbbreviation>J Hosp Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Balancing the risks to individual and society: a systematic review and synthesis of qualitative research on antibiotic prescribing behaviour in hospitals.</ArticleTitle>
        <Pagination>
          <StartPage>428</StartPage>
          <EndPage>439</EndPage>
          <MedlinePgn>428-439</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhin.2018.08.007</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0195-6701(18)30418-3</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antimicrobial resistance is a global health threat, partly driven by inappropriate antibiotic prescriptions for acute medical patients in hospitals.</AbstractText>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To provide a systematic review of qualitative research on antibiotic prescribing decisions in hospitals worldwide, including broad-spectrum antibiotic use.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search of qualitative research on antibiotic prescribing for adult hospital patients published between 2007 and 2017 was conducted. Drawing on the Health Belief Model, a framework synthesis was conducted to assess threat perceptions associated with antimicrobial resistance, and perceived benefits and barriers associated with antibiotic stewardship.</AbstractText>
          <AbstractText Label="FINDINGS" NlmCategory="RESULTS">The risk of antimicrobial resistance was generally perceived to be serious, but the abstract and long-term nature of its consequences led physicians to doubt personal susceptibility. While prescribers believed in the benefits of optimizing prescribing, the direct link between over-prescribing and antimicrobial resistance was questioned, and prescribers' behaviour change was frequently considered futile when fighting the complex problem of antimicrobial resistance. The salience of individual patient risks was a key barrier to more conservative prescribing. Physicians perceived broad-spectrum antibiotics to be effective and low risk; prescribing broad-spectrum antibiotics involved low cognitive demand and enabled physicians to manage patient expectations. Antibiotic prescribing decisions in low-income countries were shaped by a context of heightened uncertainty and risk due to poor microbiology and infection control services.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">When tackling antimicrobial resistance, the tensions between immediate individual risks and long-term collective risks need to be taken into account. Efforts to reduce diagnostic uncertainty and to change risk perceptions will be critical in shifting practice.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Krockow</LastName>
            <ForeName>E M</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, University of Leicester, Leicester, UK. Electronic address: emk12@le.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Colman</LastName>
            <ForeName>A M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chattoe-Brown</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>School of Media, Communication and Sociology, University of Leicester, Leicester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jenkins</LastName>
            <ForeName>D R</ForeName>
            <Initials>DR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perera</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mehtar</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Tygerberg Academic Hospital and Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tarrant</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Sciences, University of Leicester, Leicester, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Hosp Infect</MedlineTA>
        <NlmUniqueID>8007166</NlmUniqueID>
        <ISSNLinking>0195-6701</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001291" MajorTopicYN="Y">Attitude of Health Personnel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010818" MajorTopicYN="Y">Practice Patterns, Physicians'</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Acute medical patients</Keyword>
        <Keyword MajorTopicYN="N">Antibiotic prescribing</Keyword>
        <Keyword MajorTopicYN="N">Antimicrobial resistance</Keyword>
        <Keyword MajorTopicYN="N">Broad-spectrum antibiotics</Keyword>
        <Keyword MajorTopicYN="N">Hospital</Keyword>
        <Keyword MajorTopicYN="N">Qualitative methods</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30099092</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jhin.2018.08.007</ArticleId>
        <ArticleId IdType="pii">S0195-6701(18)30418-3</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30098382</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-2939</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>101</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of hospital infection</Title>
          <ISOAbbreviation>J Hosp Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Barriers and enablers to meticillin-resistant Staphylococcus aureus admission screening in hospitals: a mixed-methods study.</ArticleTitle>
        <Pagination>
          <StartPage>100</StartPage>
          <EndPage>108</EndPage>
          <MedlinePgn>100-108</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhin.2018.08.006</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0195-6701(18)30417-1</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To reduce the risk of transmission of meticillin-resistant Staphylococcus aureus (MRSA), international guidelines recommend admission screening to identify hospital patients at risk of colonization. However, routine monitoring indicates that optimum screening compliance levels are not always achieved. In order to enhance compliance, we must better understand those factors which influence staff screening behaviours.</AbstractText>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To identify factors which influence staff compliance with hospital MRSA screening policies.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A sequential two-stage mixed-methods design applied constructs from normalization process theory and the theoretical domains framework to guide data collection and analysis. Initial qualitative findings informed subsequent development of a national cross-sectional survey of nursing staff (N&#xA0;=&#xA0;450). Multiple regression modelling identified which barriers and enablers best predict staff compliance.</AbstractText>
          <AbstractText Label="FINDINGS" NlmCategory="RESULTS">Three factors were significant in predicting optimum (&gt;90%) compliance with MRSA screening: having MRSA screening routinized within the admission process; category of clinical area; feedback of MRSA screening compliance within the clinical area. Integration of data-sets indicated that organizational systems which 'make doing the right thing easy' influence compliance, as does local ward culture. Embedded values and beliefs regarding the relative (de)prioritization of MRSA screening are important.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">To our knowledge, this is the first study to provide original evidence of barriers and enablers to MRSA screening, applying both sociological and psychological theory. As antimicrobial resistance is a global health concern, these findings have international relevance for screening programmes. Future policy recommendations or behaviour change interventions, based on the insights presented here, could have significant impact upon improving screening compliance.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Currie</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Safeguarding Health through Infection Prevention (SHIP) Research Group, Glasgow Caledonian University, Glasgow, UK. Electronic address: k.currie@gcu.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>King</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Safeguarding Health through Infection Prevention (SHIP) Research Group, Glasgow Caledonian University, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McAloney-Kocaman</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Safeguarding Health through Infection Prevention (SHIP) Research Group, Glasgow Caledonian University, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roberts</LastName>
            <ForeName>N J</ForeName>
            <Initials>NJ</Initials>
            <AffiliationInfo>
              <Affiliation>Safeguarding Health through Infection Prevention (SHIP) Research Group, Glasgow Caledonian University, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>MacDonald</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Safeguarding Health through Infection Prevention (SHIP) Research Group, Glasgow Caledonian University, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dickson</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Safeguarding Health through Infection Prevention (SHIP) Research Group, Glasgow Caledonian University, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cairns</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>NHS Health Protection Scotland, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khanna</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>NHS Greater Glasgow &amp; Clyde, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Flowers</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Safeguarding Health through Infection Prevention (SHIP) Research Group, Glasgow Caledonian University, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reilly</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Safeguarding Health through Infection Prevention (SHIP) Research Group, Glasgow Caledonian University, Glasgow, UK; NHS Health Protection Scotland, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Price</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Safeguarding Health through Infection Prevention (SHIP) Research Group, Glasgow Caledonian University, Glasgow, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>SPHSU12</GrantID>
            <Acronym>CSO_</Acronym>
            <Agency>Chief Scientist Office</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Hosp Infect</MedlineTA>
        <NlmUniqueID>8007166</NlmUniqueID>
        <ISSNLinking>0195-6701</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003955" MajorTopicYN="N">Diagnostic Tests, Routine</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018562" MajorTopicYN="N">Disease Transmission, Infectious</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019983" MajorTopicYN="Y">Guideline Adherence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055624" MajorTopicYN="N">Methicillin-Resistant Staphylococcus aureus</DescriptorName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antimicrobial resistance</Keyword>
        <Keyword MajorTopicYN="N">Compliance</Keyword>
        <Keyword MajorTopicYN="N">Meticillin-resistant Staphylococcus aureus</Keyword>
        <Keyword MajorTopicYN="N">Normalization process theory</Keyword>
        <Keyword MajorTopicYN="N">Screening</Keyword>
        <Keyword MajorTopicYN="N">Theoretical domains framework</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30098382</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jhin.2018.08.006</ArticleId>
        <ArticleId IdType="pii">S0195-6701(18)30417-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30093332</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-7452</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>76</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Jan-Feb</Season>
            </PubDate>
          </JournalIssue>
          <Title>Journal of surgical education</Title>
          <ISOAbbreviation>J Surg Educ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Global Health in the 21st Century: Equity in Surgical Training Partnerships.</ArticleTitle>
        <Pagination>
          <StartPage>9</StartPage>
          <EndPage>13</EndPage>
          <MedlinePgn>9-13</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsurg.2018.07.010</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1931-7204(18)30160-0</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Safe and affordable surgical care has been recognized as an important component of global health. One of the challenges in providing safe and affordable surgical care is the shortage of trained surgical workforce. Partnerships have developed between institutions in high-income countries (HICs) and low- and middle-income countries (LMICs) to strengthen and expand surgical education in LMICs. As these relationships evolve, emphasis needs to focus on development of equitable, bilateral partnerships.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We reviewed different global surgery education partnerships to describe key components and features of successful partnerships. We then provide a framework for equitable global surgical training partnerships.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Key features of equitable global surgical education partnerships included an alignment with local priorities, long term collaborations, and locally integrated, competency-based training. To develop a partnership, both parties must meet and perform a needs assessment of the LMIC institution and jointly agree how the partnership can best address these needs. Both the HIC and LMIC institutions must clearly define their goals and expectations. Ideally, a set of output measures will be defined to assess the success of the partnership.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Improving surgical education in LMIC countries is an integral part of health equity in global surgery. Key components of equitable education partnerships focus on local ownership and long-term relationships. Each party needs to clearly define goals and expectations for the partnership. Equity is essential and unequal relationships must be avoided.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Association of Program Directors in Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rickard</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Minnesota, Minneapolis, Minnesota. Electronic address: gehr0059@umn.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ntirenganya</LastName>
            <ForeName>Faustin</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Rwanda, Kigali, Rwanda.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ntakiyiruta</LastName>
            <ForeName>Georges</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Ejo Heza Surgical Centre, Kigali, Rwanda.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chu</LastName>
            <ForeName>Kathryn</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Cape Town, Groote Schuur Hospital, Cape Town.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Surg Educ</MedlineTA>
        <NlmUniqueID>101303204</NlmUniqueID>
        <ISSNLinking>1878-7452</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004503" MajorTopicYN="N">Education, Medical, Graduate</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013043" MajorTopicYN="N">Specialties, Surgical</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Interpersonal and Communication Skills</Keyword>
        <Keyword MajorTopicYN="N">Medical Knowledge</Keyword>
        <Keyword MajorTopicYN="N">Practice-Based Learning and Improvement</Keyword>
        <Keyword MajorTopicYN="N">Systems-Based Practice.</Keyword>
        <Keyword MajorTopicYN="N">curriculum</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">health equity</Keyword>
        <Keyword MajorTopicYN="N">medical education</Keyword>
        <Keyword MajorTopicYN="N">postgraduate</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30093332</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jsurg.2018.07.010</ArticleId>
        <ArticleId IdType="pii">S1931-7204(18)30160-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30077352</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-0739</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>70</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nutrition research (New York, N.Y.)</Title>
          <ISOAbbreviation>Nutr Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The importance of healthy dietary patterns in chronic disease prevention.</ArticleTitle>
        <Pagination>
          <StartPage>3</StartPage>
          <EndPage>6</EndPage>
          <MedlinePgn>3-6</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nutres.2018.06.002</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0271-5317(18)30222-7</ELocationID>
        <Abstract>
          <AbstractText>The prevalence of chronic diseases in the United States and around the world is very high and not sustainable by most health care systems. While the etiology is complex, many chronic diseases are preventable through life long practices of adhering to healthy dietary patterns, engaging in physical activity and maintaining acceptable weight. Healthy dietary patterns were defined in the 2015 Dietary Guidelines Advisory Committee Scientific Report as diets that are high in fruits, vegetables, whole grains, low and non-fat dairy and lean protein. Other characteristics of healthy dietary patterns are that they are low in saturated fat, trans fat, sodium and added sugars. The preponderance of evidence to date suggests that healthy dietary patterns reduce the risk of the major diet-related chronic diseases, such as diabetes, cardiovascular disease and some cancers. While several methods exist for assessing dietary patterns in population studies, those that characterize dietary patterns using a priori scoring systems of indices, such as the Healthy Eating Index, may be of the most value because they offer a consistent metric that can be applied across multiple studies. It follows that consistency in methods then allows comparisons of results across populations. The nutrition science community can play a major leadership role in national and global health by promoting access to the ability of all population groups to consume a healthy dietary pattern.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Neuhouser</LastName>
            <ForeName>Marian L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, M4-B402, Seattle, WA 98109-1024. Electronic address: mneuhous@fredhutch.org.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 CA119171</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Nutr Res</MedlineTA>
        <NlmUniqueID>8303331</NlmUniqueID>
        <ISSNLinking>0271-5317</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004032" MajorTopicYN="Y">Diet</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000072001" MajorTopicYN="Y">Diet, Healthy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005247" MajorTopicYN="Y">Feeding Behavior</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015438" MajorTopicYN="Y">Health Behavior</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018673" MajorTopicYN="Y">Nutrition Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chronic diseases</Keyword>
        <Keyword MajorTopicYN="N">Dietary patterns</Keyword>
        <Keyword MajorTopicYN="N">Healthy Eating Index</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30077352</ArticleId>
        <ArticleId IdType="mid">NIHMS1504316</ArticleId>
        <ArticleId IdType="pmc">PMC6328339</ArticleId>
        <ArticleId IdType="doi">10.1016/j.nutres.2018.06.002</ArticleId>
        <ArticleId IdType="pii">S0271-5317(18)30222-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, Kutz MJ, Huynh C et al. US county-level trends in mortality rates for major causes of death, 1980&#x2013;2014. JAMA 2016; 316:2385&#x2013;2401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5576343</ArticleId>
            <ArticleId IdType="pubmed">27959996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Odgen CL. Trends in obesity among adults in the United States 2005&#x2013;2014. JAAM 2016; 315:2284&#x2013;2291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC11197437</ArticleId>
            <ArticleId IdType="pubmed">27272580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G et al. Global, regional and national burden of cardiovascular diseases for 10 causes, 1990 t0 2015. J Am Coll Cardiol 2017; 70:1015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5491406</ArticleId>
            <ArticleId IdType="pubmed">28527533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>GBD 2015 Obesity Collaborators, Afshin A, Forozanfar MH, Reitsna MB, Sur P, Estep K et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017; 377: 13&#x2013;27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5477817</ArticleId>
            <ArticleId IdType="pubmed">28604169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez-Olmedo N, Popkin BM, Tallie LS. The socioeconomic disparities in intakes and purchases of less-healthy foods and beverages have changed over time in urban Mexico. J Nutr 2018; 148:109&#x2013;116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6251618</ArticleId>
            <ArticleId IdType="pubmed">29378043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murkamal KJ, Siscovick DS, de Boer IH, Ix JH, Kizer JR, Djousse L et al. Metabolic clusters and outcomes in older adults: the cardiovascular health study. Journal of the American Geriatrics Society 12 February 2018. [Epub before print]. DOIU 10.1111/jgs.15205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5813705</ArticleId>
            <ArticleId IdType="pubmed">29431855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>40th Annual report on the health of the nation features long-term trends in health and health care delivery in the United States. Centers for Disease Control and Prevention, US Department of Health and Human Services, National Center for Health Statistics, DHHS Publication No. 2017&#x2013;1232, May 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, Stubbs RW, Bertozzi-Villa A, Morozoff C et al. Trends and patterns of disparities in cancer mortality among US counties, 1980&#x2013;2014. JAMA 2017; 317:388&#x2013;406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5617139</ArticleId>
            <ArticleId IdType="pubmed">28118455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roth GA, Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C. Naghavi M et al. Trends and patterns of geographic variation in cardiovascular mortality among US counties 1980&#x2013;2014. JAMA 2017; 317:1976&#x2013;1992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5598768</ArticleId>
            <ArticleId IdType="pubmed">28510678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999&#x2013;2010. JAAM 2012; 307:491&#x2013;497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22253363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liese AD, Krebs-Smith SM, Subar AF, George SM, Harmon BE, Neuhouser ML et al. The Dietary Patterns Methods Project: Synthesis of Findings across Cohorts and Relevance to Dietary Guidance. J Nutr 2015; 145(3):393&#x2013;402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4336525</ArticleId>
            <ArticleId IdType="pubmed">25733454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Millen BE, Abrams S, Adams-Campbell L, Anderson CA, Brenna JT, Campbell WW et al. The 2015 Dietary Guidelines Advisory Committee Scientific Report: Development and Major Conclusions. Adv Nutr May 2016; 7(3):438&#x2013;44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4863277</ArticleId>
            <ArticleId IdType="pubmed">27184271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>George SM, Ballard-Barbash R, Manson JE, Reedy J, Shikany JM, Subar AF et al. Comparing Indices of Diet Quality With Chronic Disease Mortality Risk in Postmenopausal Women in the Women&#x2019;s Health Initiative Observational Study: Evidence to Inform National Dietary Guidance. Am J Epidemiol 2014; 180(6):616&#x2013;25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4157698</ArticleId>
            <ArticleId IdType="pubmed">25035143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cespedes EM, Hu FB, Tinker L, Rosner B, Redline S, Garcia L et al. Multiple Healthful Dietary Patterns and Type 2 Diabetes in the Women&#x2019;s Health Initiative. Am J Epidemiol 2016. April 1; 183(7):622&#x2013;33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4801136</ArticleId>
            <ArticleId IdType="pubmed">26940115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117&#x2013;24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9099655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-sodium Collaborative Research Group. N Engl J Med 2001; 344:3&#x2013;10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11136953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuhouser ML, Tinker L, Shaw PA, Schoeller D, Bingham SA, van Horn LV, et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women&#x2019;s Health Initiative. Am J Epidemiol 2008; 167(10): 1247&#x2013;59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18344516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prentice RL, Tinker LF, Huang Y, Neuhouser ML. Calibration of self-reported dietary measures using biomarkers: an approach to enhancing nutritional epidemiology reliability. Curr Atheroscler Rep 2013; 15(9):353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3832356</ArticleId>
            <ArticleId IdType="pubmed">23881548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Playdon MC, Ziegler RG, Sampson JN, Stolzenberg-Solomon R, Thompson HJ, Irwin ML et al. Nutritional Metabolomics and breast cancer risk in a prospective study. Am J Clin Nutr 2017; 106:637&#x2013;49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5525118</ArticleId>
            <ArticleId IdType="pubmed">28659298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>US Department of Health and Human Services and US Department of Agriculture. 2015&#x2013;2010 Dietary Guidelines for Americans 8th Edition. December 2015</Citation>
        </Reference>
        <Reference>
          <Citation>Perez-Escamilla R The Mexican dietary and physical activity guidelines: moving public nutrition forward in a globalized world. J Nutr 2016; 146: 1924S&#x2013;7S</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27511930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Popkin BM, Hawkes C. Sweetening of the global diet, particularly beverages: patterns, trends and policy responses. Lancet Diabetes Endocrinol 2016; 4:174&#x2013;86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4733620</ArticleId>
            <ArticleId IdType="pubmed">26654575</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30076040</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-1932</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>54</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Best practice &amp; research. Clinical obstetrics &amp; gynaecology</Title>
          <ISOAbbreviation>Best Pract Res Clin Obstet Gynaecol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Breaking news in the prediction of pelvic floor disorders.</ArticleTitle>
        <Pagination>
          <StartPage>41</StartPage>
          <EndPage>48</EndPage>
          <MedlinePgn>41-48</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpobgyn.2018.05.004</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1521-6934(18)30125-1</ELocationID>
        <Abstract>
          <AbstractText>Urinary incontinence (UI) and fecal incontinence (FI) together with pelvic organ prolapse (POP) constitute a huge global health problem affecting millions of women throughout the world. These pelvic floor disorders (PFDs) can have a negative influence on a woman's well-being, quality of life, and sexual function and prevent many women from participating in recreational and sporting activities. The global costs of PFDs to health care systems and society are enormous and approximately one in five women will undergo surgery for genital prolapse or UI by the age of 85 years.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018. Published by Elsevier Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Milsom</LastName>
            <ForeName>Ian</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics &amp; Gynaecology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden. Electronic address: ian.milsom@gu.se.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gyhagen</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics &amp; Gynaecology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Best Pract Res Clin Obstet Gynaecol</MedlineTA>
        <NlmUniqueID>101121582</NlmUniqueID>
        <ISSNLinking>1521-6934</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001827" MajorTopicYN="Y">Body Height</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005242" MajorTopicYN="N">Fecal Incontinence</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020567" MajorTopicYN="Y">Fetal Weight</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008423" MajorTopicYN="N">Maternal Age</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008487" MajorTopicYN="N">Medical History Taking</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010298" MajorTopicYN="N">Parity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059952" MajorTopicYN="N">Pelvic Floor Disorders</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056887" MajorTopicYN="N">Pelvic Organ Prolapse</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014549" MajorTopicYN="N">Urinary Incontinence</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Fecal incontinence</Keyword>
        <Keyword MajorTopicYN="N">Pelvic floor disorders</Keyword>
        <Keyword MajorTopicYN="N">Pelvic organ prolapse</Keyword>
        <Keyword MajorTopicYN="N">Predictive modeling</Keyword>
        <Keyword MajorTopicYN="N">Urinary incontinence</Keyword>
        <Keyword MajorTopicYN="N">Vaginal delivery</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30076040</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bpobgyn.2018.05.004</ArticleId>
        <ArticleId IdType="pii">S1521-6934(18)30125-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30073625</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>10</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1573-3645</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>40</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of medical humanities</Title>
          <ISOAbbreviation>J Med Humanit</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Queer Theory and Biomedical Practice: The Biomedicalization of Sexuality/The Cultural Politics of Biomedicine.</ArticleTitle>
        <Pagination>
          <StartPage>7</StartPage>
          <EndPage>20</EndPage>
          <MedlinePgn>7-20</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10912-018-9526-0</ELocationID>
        <Abstract>
          <AbstractText>This article works across multiple disciplinary boundaries, especially queer theory, to examine critically the controversial, and often socially controlling, role of biomedical knowledge and interventions in the realm of human sexuality. It will attempt to situate scientific/medical discourses on sexuality historically, socially, and culturally in order to expose the ways in which "proper" sexual health in medical research and clinical practice has been conflated with prevailing social norms at particular historical junctures in the 20th and 21st centuries. How might the relationship between clinical and cultural spheres be better engaged in biomedical knowledge and clinical practice in understanding sexual health, given the impact of homophobic and transphobic assumptions in the diagnostic histories of homosexuality and Gender Identity Disorder in Childhood, a new diagnostic category introduced into the DSM following the removal of homosexuality from the DSM-III? The article will argue further that biomedical knowledge is always already mediated through culture by analyzing normative racial, gender, class, and sexual ideologies that regulated early understandings of the epidemiology of the HIV/AIDS pandemic in the West and in the postcolonial world while informing global health policy on HIV/AIDS. The article concludes by examining the implications of medical education for both LGBTQI patients and medical professionals, for understanding gender and sexual rights as human rights, and for thinking about new kinds of interventions, contestations, and struggles to resist continued homophobic and transphobic assumptions in biomedical practice today and their ongoing effects in the everyday world.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Spurlin</LastName>
            <ForeName>William J</ForeName>
            <Initials>WJ</Initials>
            <Identifier Source="ORCID">0000-0003-2444-2308</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Arts and Humanities, Brunel University London, Uxbridge, England, UB8 3PH, UK. William.Spurlin@brunel.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Med Humanit</MedlineTA>
        <NlmUniqueID>8917478</NlmUniqueID>
        <ISSNLinking>1041-3545</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003469" MajorTopicYN="Y">Culture</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006716" MajorTopicYN="Y">Homosexuality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062528" MajorTopicYN="Y">Medicalization</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011057" MajorTopicYN="Y">Politics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012725" MajorTopicYN="Y">Sexual Behavior</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Biomedical knowledge</Keyword>
        <Keyword MajorTopicYN="N">Gender dysphoria</Keyword>
        <Keyword MajorTopicYN="N">Gender identity disorder</Keyword>
        <Keyword MajorTopicYN="N">HIV/AIDS</Keyword>
        <Keyword MajorTopicYN="N">Homosexuality</Keyword>
        <Keyword MajorTopicYN="N">Queer theory</Keyword>
        <Keyword MajorTopicYN="N">Sexual health</Keyword>
      </KeywordList>
      <CoiStatement><sup>1</sup> See Foucault 1980, 42-43 <i>History of Sexuality</i>. <sup>2</sup> For psychoanalytic work on homosexuality from this early period, from the late 1940s through 1970, see Sandor Rado, 1949; Edmund Bergler, 1956; Bieber, et al., 1962, <i>Homosexuality: A Psychoanalytic Study of Male Homosexuals</i>, New York: Basic Books, reprinted as Irving Bieber, et al., 1988, <i>Homosexuality: A Psychoanalytic Study</i>, Northvale, NJ: Aronson; and Charles Socarides, 1968. <sup>3</sup> In his <i>Three Essays on the Theory of Sexuality</i>, Freud remarks that &#x201C;the exclusive sexual&#xA0;interest felt by men for women is also a problem that needs elucidating and is not a self-evident fact based upon an attraction that is ultimately of a chemical nature. A person&#x2019;s final sexual attitude is not decided until after puberty and is the result of a number of factors, not all of which are yet known; some are of a constitutional nature but others are accidental&#x201D; (Freud 1962, n1, 12). <sup>4</sup> While the connection to the medicalization of gender has already been discussed in Bieber&#x2019;s work on the etiology of homosexuality in the post-war years, the descriptions of GIDC in the <i>DSM-III</i> and <i>DSM-IV</i> list such diagnostic criteria as a preference for cross-dressing or simulating female attire in boys, an insistence on wearing only stereotypically masculine clothing in girls; strong and persistent preferences for cross-sex roles in make-believe play or persistent fantasies of being the other sex; intense desires to participate in the stereotypical games and pastimes of the other sex, and a strong preference for playmates of the other sex (APA 1994, 537). The <i>DSM-V</i> does stipulate that the clinical problem is on dysphoria and not on gender identity per se (APA 2013). <sup>5</sup> For the German language text to which Proctor is referring, see J. Lange, 1938. <sup>6</sup> For the German source to which Proctor refers, see &#x201C;Staatsfeinde sind auszumerzen!&#x201D; <i>Informationsdienst</i>, June 20, 1938. <sup>7</sup> As I have argued elsewhere, the social use of biomedical discourses relegated homosexuals under National Socialism as threats to the economic and political well-being of the German nation-state, and played a role in justifying persecutions against them, including the revision of Paragraph 175 of the Reich Penal Code. See Spurlin, 2009, <i>Lost Intimacies: Rethinking Homosexuality under National Socialism</i>, especially Chapters 2 and 3. <sup>8</sup> For example, an article on HIV/AIDS in southern Africa in <i>The Economist</i> in 2002 begins with a voyeuristic narrative of sexual practices in Botswana, describing some indigenous men&#x2019;s preferences for &#x201C;dry sex&#x201D; whereby women, in order to provide more pleasure for their male partners, insert toothpaste or herbs into their vaginas in order to prevent lubrication, which can lead to tears in vaginal tissues and bleeding during penetration and thereby allow the human immunodeficiency virus to penetrate the tissue. While the practice, provided the male partner is HIV-infected, can place the woman at risk for infection, beginning an article about HIV/AIDS in southern Africa with &#x201C;dry sex&#x201D; reproduces textually an orientalist erotics that imagines non-western exotic otherness as a site of sexual deviance or excess, supposedly far removed from the sexual epistemologies and practices of the West. See &#x201C;Fighting Back. Special Report: AIDS in Southern Africa&#x201D; 2002. <sup>9</sup> McRuer also links able-bodied identity and heterosexual identity as performative given that each identity &#x201C;is simultaneously the ground on which all identities supposedly rest (as natural, as given) and an impressive achievement that is always deferred and thus never really guaranteed&#x201D; (2010, 386; parentheses mine). This calls to mind Butler&#x2019;s theory of gender performativity through the citation and embodiment of gender norms, which creates the illusion of gender as a substance of being instead of as &#x201C;a complexity whose totality is permanently deferred, never fully what it is at any given juncture in time&#x2019; (Butler 1999, 22). <sup>10</sup> As examples, the study indicated that cervical cancer and genital human papillomavirus often go untreated in lesbians, high rates of hepatitis remain high among gay men, and transgendered individuals who take unprescribed hormones in the later stages of gender transitioning risk infection and other side effects. See Juno Obedin-Maliver, Elizabeth S. Goldsmith, Leslie Stewart, et al., 2011.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>3</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30073625</ArticleId>
        <ArticleId IdType="pmc">PMC6373286</ArticleId>
        <ArticleId IdType="doi">10.1007/s10912-018-9526-0</ArticleId>
        <ArticleId IdType="pii">10.1007/s10912-018-9526-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>American Psychiatric Association (APA). 1994. The Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association.</Citation>
        </Reference>
        <Reference>
          <Citation>----. 2013. The Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington DC: American Psychiatric Association. 10.1176/appi.books.9780890425596.dms14.</Citation>
        </Reference>
        <Reference>
          <Citation>Anderseen, Erin. 2016. &#x201C;Gender Identity Debate Swirls over CAMH Psychologist, Transgender Program.&#x201D; The Globe and Mail. February 14. http://www.theglobeandmail.com/news/toronto/gender-identity-debate-swirls-over-camh-psychologist-transgender-program/article28758828/.</Citation>
        </Reference>
        <Reference>
          <Citation>Bergler, Edmund. 1956, Homosexuality: Disease or Way of Life?, New York: Hill and Wang;</Citation>
        </Reference>
        <Reference>
          <Citation>Bieber, Irving, et al. (1962) 1988. Homosexuality: A Psychoanalytic Study. Northvale, NJ: Aronson.</Citation>
        </Reference>
        <Reference>
          <Citation>Butler, Judith. (1990) 1999. Gender Trouble: Feminism and the Subversion of Identity. New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>----. 1993. Bodies that Matter: On the Discursive Limits of &#x2018;Sex&#x2019;. New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Coates S, Person ES. Extreme boyhood femininity: Isolated behavior or pervasive disorder? Journal of the American Academy of Child and Adolescent Psychiatry. 1985;24(6):702&#x2013;709. doi: 10.1016/S0002-7138(10)60113-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-7138(10)60113-6</ArticleId>
            <ArticleId IdType="pubmed">4067139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corber, Robert J. 1997. Homosexuality in Cold War America: Resistance and the Crisis of Masculinity. Durham: Duke University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Corbett, Ken. 1999. &#x201C;Homosexual Boyhood: Notes on Girlyboys.&#x201D; In Sissies and Tomboys: Gender Nonconformity and Homosexual Childhood, edited by Matthew Rottek, 107-139. New York: New York University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Eckstrand, Kristen L. and Andr&#xE9;s F. Sciolla. 2014. &#x201C;History of Health Disparities Among Individuals Who Are or May Be LGBT, Gender Nonconforming, and/or Born with DSD.&#x201D; In Implementing Curricular and Institutional Climate Changes to Improve Health Care for Individuals Who Are LGBT, Gender Nonconforming, or Born with DSD, 10-21. Washington, DC: Association of American Medical Colleges.</Citation>
        </Reference>
        <Reference>
          <Citation>Fallin-Bennett, Keisa. 2015. &#x201C;Implicit Bias against Sexual Minorities in Medicine: Cycle of Professional Influence and the Role of the Hidden Curriculum.&#x201D; Academic Medicine 90 (5): 549-552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25674911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fanon, Frantz. 1963. The Wretched of the Earth. Translated by Constance Farrington. New York: Grove Press.</Citation>
        </Reference>
        <Reference>
          <Citation>&#x201C;Fighting Back. 2002. Special Report: AIDS in Southern Africa.&#x201D; The Economist. May 11: 27-29.</Citation>
        </Reference>
        <Reference>
          <Citation>Foucault, Michel. (1963) 1973. The Birth of the Clinic: An Archaeology of Medical Perception. Translated by A.M. Sheridan Smith. New York: Vintage.</Citation>
        </Reference>
        <Reference>
          <Citation>----. (1976) 1980. The History of Sexuality, Volume I: An Introduction. Translated by Robert Hurley. New York: Vintage.</Citation>
        </Reference>
        <Reference>
          <Citation>Freud, Sigmund. 1962. Three Essays on the Theory of Sexuality. Translated by James Strachey. New York: Basic Books.</Citation>
        </Reference>
        <Reference>
          <Citation>Friedman, Richard C. 1988. Male Homosexuality: A Contemporary Psychoanalytic Perspective. New Haven: Yale University Press.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2064545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herzog, Dagmar. 2011. Sexuality in Europe: A Twentieth-Century History. Cambridge: Cambridge University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Keller, Richard C. 2007. Colonial Madness: Psychiatry in French North Africa. Chicago: University of Chicago Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Kinsey, Alfred C., et al. 1948. Sexual Behavior in the Human Male. Philadelphia: W.B. Saunders.</Citation>
        </Reference>
        <Reference>
          <Citation>Lange, J. 1938. &#x201C;Die Feststellung und Wertung geistiger St&#xF6;rungen im Ehegesundheitsgesetz,&#x201D; &#xD6;ffentlicher Gesundheitsdienst 4: 533.</Citation>
        </Reference>
        <Reference>
          <Citation>Mansh, M. and W. White. 2011. &#x201C;Lesbian, Gay, Bisexual, and Transgender Medical Student Experiences: &#x2018;Out&#x2019; in Medical School and Perspectives on Curricular Content.&#x201D; Poster Presentation. Annual Meeting of the Association of American Medical Colleges. Denver.</Citation>
        </Reference>
        <Reference>
          <Citation>McRuer, Robert. 2010. &#x201C;Compulsory Able-Bodiedness and Queer/Disabled Existence.&#x201D; In The Disability Studies Reader, edited by Lennard J. Davis, 3rd edition, 383-392. New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Metzl, Jonathan M. and Helena Hansen. 2014. &#x201C;Structural Competency: Theorizing a New Medical Engagement with Stigma and Inequality.&#x201D; Social Science &amp; Medicine 103: 126-133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4269606</ArticleId>
            <ArticleId IdType="pubmed">24507917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metzl, Jonathan M. and Dorothy E. Roberts. 2014. &#x201C;Structural Competency Meets Structural Racism: Race, Politics, and the Structure of Medical Knowledge.&#x201D; Virtual Mentor: American Medical Association Journal of Ethics 16 (9): 674-690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25216304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mosse George. 1999. The Fascist Revolution: Toward a General Theory of Fascism. New York: Howard Fertig.</Citation>
        </Reference>
        <Reference>
          <Citation>Obedin-Maliver, June, Elizabeth S. Goldsmith, Leslie Stewart, et al. 2011. &#x201C;Lesbian, Gay, Bisexual, and Transgender-Related Content in Undergraduate Medical Education.&#x201D; JAMA 306 (9): 971-977.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21900137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parker, Andrew, Mary Russo, et al, eds. 1992. Nationalisms and Sexualities. New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>Patton, Cindy. 1990. Inventing AIDS. New York: Routledge.</Citation>
        </Reference>
        <Reference>
          <Citation>----. 2002. Globalizing AIDS. Minneapolis: University of Minnesota Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Proctor, Robert N. 1988. Racial Hygiene: Medicine under the Nazis. Cambridge, MA: Harvard University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Rado, Sandor. 1949, &#x201C;An Adaptational View of Sexual Behavior.&#x201D; Psychosexual Development in Health and Disease, Eds. P. Hoch and J. Zubin, 159-189. New York: Grune and Stratton.</Citation>
        </Reference>
        <Reference>
          <Citation>Socarides, Charles. 1968, The Overt Homosexual, New York: Grune and Stratton.</Citation>
        </Reference>
        <Reference>
          <Citation>Sontag, Susan. 1989. AIDS and Its Metaphors. New York: Farrar, Straus and Giroux.</Citation>
        </Reference>
        <Reference>
          <Citation>Spurlin, William J. 1998. &#x201C;Sissies and Sisters: Gender, Sexuality and the Possibilities of Coalition.&#x201D; In Coming Out of Feminism?, edited by Mandy Merck, Naomi Segal, and Elizabeth Wright, 74-101. Oxford: Blackwell.</Citation>
        </Reference>
        <Reference>
          <Citation>----. 2009. Lost Intimacies: Rethinking Homosexuality under National Socialism. New York: Lang Publishing.</Citation>
        </Reference>
        <Reference>
          <Citation>Statistics South Africa Report, 2015. South African Government. https://www.statssa.gov.za/publications/P0302/P03022015.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Stoller, Robert J. 1964. &#x201C;A Contribution to the Study of Gender Identity.&#x201D; International Journal of Psychoanalysis 45: 220-226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14167035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>UNAIDS Global Coalition on Women and AIDS and WHO. 2005. &#x201C;Violence against Women and HIV/AIDS: Critical Intersections. Intimate Partner Violence and HIV/AIDS.&#x201D; World Health Organization. http://www.who.int/hac/techguidance/pht/InfoBulletinIntimatePartnerViolenceFinal.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations High Commissioner for Human Rights. 2015. &#x201C;Discrimination and Violence against Individuals Based on their Sexual Orientation and Gender Identity.&#x201D; New York: General Assembly and Human Rights Council of the United Nations. 4 May.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30070932</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1530-6860</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>33</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>
          <ISOAbbreviation>FASEB J</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.</ArticleTitle>
        <Pagination>
          <StartPage>1008</StartPage>
          <EndPage>1019</EndPage>
          <MedlinePgn>1008-1019</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1096/fj.201800620R</ELocationID>
        <Abstract>
          <AbstractText>Hepatitis E virus (HEV) infection has emerged as a global health problem. However, no approved medication is available, and the infection biology remains largely elusive. Electron transport chain (ETC), a key component of the mitochondria, is the main site that produces ATP and reactive oxygen species (ROS). By profiling the role of the different complexes of the mitochondrial ETC, we found that pharmacological inhibition of complex III, a well-defined drug target for the treatment of malaria and Pneumocystis pneumonia, potently restricts HEV replication. This effect demonstrated in our HEV models is equivalent to the anti-HEV potency of ribavirin, a widely used off-label treatment for patients with chronic HEV. Mechanistically, we found that this effect is independent of ATP production, ROS level, and pyridine depletion. By using pharmacological inhibitors and genetic approaches, we found that mitochondrial permeability transition pore (MPTP), a newly identified component of ETC, provides basal defense against HEV infection. HEV interferes with the opening of the MPTP. Furthermore, inhibition of the MPTP attenuated the anti-HEV effect of complex III inhibitors, suggesting that the MPTP mediates the antiviral effects of these inhibitors. These findings reveal new insights on HEV-host interactions and provide viable anti-HEV targets for therapeutic development.-Qu, C., Zhang, S., Wang, W., Li, M., Wang, Y., van der Heijde-Mulder, M., Shokrollahi, E., Hakim, M. S., Raat, N. J. H., Peppelenbosch, M. P., Pan, Q. Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Qu</LastName>
            <ForeName>Changbo</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Shaoshi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Wenshi</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Meng</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Yijin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Hepatology, Beijing 302 Hospital, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van der Heijde-Mulder</LastName>
            <ForeName>Marieke</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shokrollahi</LastName>
            <ForeName>Ehsan</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Laboratory of Experimental Anesthesiology, The Erasmus University Medical Center (Erasmus MC), Rotterdam, The Netherlands; and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hakim</LastName>
            <ForeName>Mohamad S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raat</LastName>
            <ForeName>Nicolaas J H</ForeName>
            <Initials>NJH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Laboratory of Experimental Anesthesiology, The Erasmus University Medical Center (Erasmus MC), Rotterdam, The Netherlands; and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peppelenbosch</LastName>
            <ForeName>Maikel P</ForeName>
            <Initials>MP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Qiuwei</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>FASEB J</MedlineTA>
        <NlmUniqueID>8804484</NlmUniqueID>
        <ISSNLinking>0892-6638</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 7.1.1.8</RegistryNumber>
          <NameOfSubstance UI="D014450">Electron Transport Complex III</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014450" MajorTopicYN="N">Electron Transport Complex III</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016752" MajorTopicYN="N">Hepatitis E virus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ETC</Keyword>
        <Keyword MajorTopicYN="N">HEV</Keyword>
        <Keyword MajorTopicYN="N">MPTP</Keyword>
        <Keyword MajorTopicYN="N">virus-host interaction</Keyword>
      </KeywordList>
      <CoiStatement>The authors thank Dr. Suzanne U. Emerson (U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases) for kindly providing the plasmids to generate subgenomic and full-length HEV genotype 3 cell culture systems. This work was supported by Dutch Digestive Foundation (MLDS) for Career Development Grant CDG 1304 (to Q.P.); Dutch Cancer Society (KWF) Young Investigator Grant 10140 (to Q.P.); National Natural Science Foundation of China Grant 31770186 (to Y.W.); and the China Scholarship Council for funding Ph.D. Fellowship Grants 201509110121 (to C.Q.), 201303250056 (to W.W.), and 201506100033 (to M.L.). The authors declare no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30070932</ArticleId>
        <ArticleId IdType="pmc">PMC6355081</ArticleId>
        <ArticleId IdType="doi">10.1096/fj.201800620R</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Debing Y., Emerson S. U., Wang Y., Pan Q., Balzarini J., Dallmeier K., Neyts J. (2014) Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob. Agents Chemother. 58, 267&#x2013;273 10.1128/AAC.01795-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01795-13</ArticleId>
            <ArticleId IdType="pmc">PMC3910773</ArticleId>
            <ArticleId IdType="pubmed">24145541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou X., Huang F., Xu L., Lin Z., de Vrij F. M. S., Ayo-Martin A. C., van der Kroeg M., Zhao M., Yin Y., Wang W., Cao W., Wang Y., Kushner S. A., Marie Peron J., Alric L., de Man R. A., Jacobs B. C., van Eijk J. J., Aronica E. M. A., Sprengers D., Metselaar H. J., de Zeeuw C. I., Dalton H. R., Kamar N., Peppelenbosch M. P., Pan Q. (2017) Hepatitis E virus infects neurons and brains. J. Infect. Dis. 215, 1197&#x2013;1206 10.1093/infdis/jix079</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jix079</ArticleId>
            <ArticleId IdType="pubmed">28199701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Debing Y., Gisa A., Dallmeier K., Pischke S., Bremer B., Manns M., Wedemeyer H., Suneetha P. V., Neyts J. (2014) A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology 147, 1008&#x2013;1011</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25181691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Todt D., Gisa A., Radonic A., Nitsche A., Behrendt P., Suneetha P. V., Pischke S., Bremer B., Brown R. J., Manns M. P., Cornberg M., Bock C. T., Steinmann E., Wedemeyer H. (2016) In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut 65, 1733&#x2013;1743 10.1136/gutjnl-2015-311000</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2015-311000</ArticleId>
            <ArticleId IdType="pmc">PMC5036239</ArticleId>
            <ArticleId IdType="pubmed">27222534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Debing Y., Neyts J. (2014) Antiviral strategies for hepatitis E virus. Antiviral Res. 102, 106&#x2013;118 10.1016/j.antiviral.2013.12.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.antiviral.2013.12.005</ArticleId>
            <ArticleId IdType="pmc">PMC7113752</ArticleId>
            <ArticleId IdType="pubmed">24374149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Degli Esposti D., Hamelin J., Bosselut N., Saffroy R., Sebagh M., Pommier A., Martel C., Lemoine A. (2012) Mitochondrial roles and cytoprotection in chronic liver injury. Biochem. Res. Int. 2012, 387626 10.1155/2012/387626</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/387626</ArticleId>
            <ArticleId IdType="pmc">PMC3382253</ArticleId>
            <ArticleId IdType="pubmed">22745910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Wang W., Xu L., Zhou X., Shokrollahi E., Felczak K., van der Laan L. J., Pankiewicz K. W., Sprengers D., Raat N. J., Metselaar H. J., Peppelenbosch M. P., Pan Q. (2016) Cross talk between nucleotide synthesis pathways with cellular immunity in constraining hepatitis E virus replication. Antimicrob. Agents Chemother. 60, 2834&#x2013;2848 10.1128/AAC.02700-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.02700-15</ArticleId>
            <ArticleId IdType="pmc">PMC4862450</ArticleId>
            <ArticleId IdType="pubmed">26926637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ac&#xED;n-P&#xE9;rez R., Bayona-Bafaluy M. P., Fern&#xE1;ndez-Silva P., Moreno-Loshuertos R., P&#xE9;rez-Martos A., Bruno C., Moraes C. T., Enr&#xED;quez J. A. (2004) Respiratory complex III is required to maintain complex I in mammalian mitochondria. Mol. Cell 13, 805&#x2013;815 10.1016/S1097-2765(04)00124-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(04)00124-8</ArticleId>
            <ArticleId IdType="pmc">PMC3164363</ArticleId>
            <ArticleId IdType="pubmed">15053874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birsoy K., Wang T., Chen W. W., Freinkman E., Abu-Remaileh M., Sabatini D. M. (2015) An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540&#x2013;551 10.1016/j.cell.2015.07.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2015.07.016</ArticleId>
            <ArticleId IdType="pmc">PMC4522279</ArticleId>
            <ArticleId IdType="pubmed">26232224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S. J., Ahn D. G., Syed G. H., Siddiqui A. (2018) The essential role of mitochondrial dynamics in antiviral immunity. Mitochondrion 41, 21&#x2013;27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5988924</ArticleId>
            <ArticleId IdType="pubmed">29246869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alavian K. N., Beutner G., Lazrove E., Sacchetti S., Park H. A., Licznerski P., Li H., Nabili P., Hockensmith K., Graham M., Porter G. A., Jr., Jonas E. A. (2014) An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc. Natl. Acad. Sci. USA 111, 10580&#x2013;10585 10.1073/pnas.1401591111</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1401591111</ArticleId>
            <ArticleId IdType="pmc">PMC4115574</ArticleId>
            <ArticleId IdType="pubmed">24979777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giorgio V., von Stockum S., Antoniel M., Fabbro A., Fogolari F., Forte M., Glick G. D., Petronilli V., Zoratti M., Szab&#xF3; I., Lippe G., Bernardi P. (2013) Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl. Acad. Sci. USA 110, 5887&#x2013;5892 10.1073/pnas.1217823110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1217823110</ArticleId>
            <ArticleId IdType="pmc">PMC3625323</ArticleId>
            <ArticleId IdType="pubmed">23530243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Machida K., Cheng K. T., Lai C. K., Jeng K. S., Sung V. M., Lai M. M. (2006) Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J. Virol. 80, 7199&#x2013;7207 10.1128/JVI.00321-06</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.00321-06</ArticleId>
            <ArticleId IdType="pmc">PMC1489016</ArticleId>
            <ArticleId IdType="pubmed">16809325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moin S. M., Panteva M., Jameel S. (2007) The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J. Biol. Chem. 282, 21124&#x2013;21133 10.1074/jbc.M701696200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M701696200</ArticleId>
            <ArticleId IdType="pmc">PMC2440810</ArticleId>
            <ArticleId IdType="pubmed">17488721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma X., Jin M., Cai Y., Xia H., Long K., Liu J., Yu Q., Yuan J. (2011) Mitochondrial electron transport chain complex III is required for antimycin A to inhibit autophagy. Chem. Biol. 18, 1474&#x2013;1481 10.1016/j.chembiol.2011.08.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chembiol.2011.08.009</ArticleId>
            <ArticleId IdType="pmc">PMC3225892</ArticleId>
            <ArticleId IdType="pubmed">22118681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ichinohe T., Yamazaki T., Koshiba T., Yanagi Y. (2013) Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc. Natl. Acad. Sci. USA 110, 17963&#x2013;17968 10.1073/pnas.1312571110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1312571110</ArticleId>
            <ArticleId IdType="pmc">PMC3816452</ArticleId>
            <ArticleId IdType="pubmed">24127597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou X., Wang Y., Metselaar H. J., Janssen H. L., Peppelenbosch M. P., Pan Q. (2014) Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway. J. Hepatol. 61, 746&#x2013;754 10.1016/j.jhep.2014.05.026</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2014.05.026</ArticleId>
            <ArticleId IdType="pubmed">24859454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Zhou X., Debing Y., Chen K., Van Der Laan L. J., Neyts J., Janssen H. L., Metselaar H. J., Peppelenbosch M. P., Pan Q. (2014) Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology 146, 1775&#x2013;1783 10.1053/j.gastro.2014.02.036</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2014.02.036</ArticleId>
            <ArticleId IdType="pubmed">24582714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shukla P., Nguyen H. T., Faulk K., Mather K., Torian U., Engle R. E., Emerson S. U. (2012) Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J. Virol. 86, 5697&#x2013;5707 10.1128/JVI.00146-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.00146-12</ArticleId>
            <ArticleId IdType="pmc">PMC3347312</ArticleId>
            <ArticleId IdType="pubmed">22398290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khutornenko A. A., Roudko V. V., Chernyak B. V., Vartapetian A. B., Chumakov P. M., Evstafieva A. G. (2010) Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway. Proc. Natl. Acad. Sci. USA 107, 12828&#x2013;12833 10.1073/pnas.0910885107</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0910885107</ArticleId>
            <ArticleId IdType="pmc">PMC2919937</ArticleId>
            <ArticleId IdType="pubmed">20566882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khare S., Roach S. L., Barnes S. W., Hoepfner D., Walker J. R., Chatterjee A. K., Neitz R. J., Arkin M. R., McNamara C. W., Ballard J., Lai Y., Fu Y., Molteni V., Yeh V., McKerrow J. H., Glynne R. J., Supek F. (2015) Utilizing chemical genomics to identify cytochrome b as a novel drug target for Chagas disease. PLoS Pathog. 11, e1005058 10.1371/journal.ppat.1005058</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1005058</ArticleId>
            <ArticleId IdType="pmc">PMC4506092</ArticleId>
            <ArticleId IdType="pubmed">26186534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carelli V., Chan D. C. (2014) Mitochondrial DNA: impacting central and peripheral nervous systems. Neuron 84, 1126&#x2013;1142 10.1016/j.neuron.2014.11.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2014.11.022</ArticleId>
            <ArticleId IdType="pmc">PMC4271190</ArticleId>
            <ArticleId IdType="pubmed">25521375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pham N. A., Robinson B. H., Hedley D. W. (2000) Simultaneous detection of mitochondrial respiratory chain activity and reactive oxygen in digitonin-permeabilized cells using flow cytometry. Cytometry 41, 245&#x2013;251 10.1002/1097-0320(20001201)41:4&lt;245::AID-CYTO2&gt;3.0.CO;2-</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1097-0320(20001201)41:4&lt;245::AID-CYTO2&gt;3.0.CO;2-</ArticleId>
            <ArticleId IdType="pubmed">11084609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maguire J. J., Kagan V. E., Packer L. (1992) Electron transport between cytochrome c and alpha tocopherol. Biochem. Biophys. Res. Commun. 188, 190&#x2013;197 10.1016/0006-291X(92)92368-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-291X(92)92368-8</ArticleId>
            <ArticleId IdType="pubmed">1329744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahmoudabadi G., Milo R., Phillips R. (2017) Energetic cost of building a virus. Proc. Natl. Acad. Sci. USA 114, E4324&#x2013;E4333 10.1073/pnas.1701670114</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1701670114</ArticleId>
            <ArticleId IdType="pmc">PMC5465929</ArticleId>
            <ArticleId IdType="pubmed">28512219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buskiewicz I. A., Montgomery T., Yasewicz E. C., Huber S. A., Murphy M. P., Hartley R. C., Kelly R., Crow M. K., Perl A., Budd R. C., Koenig A. (2016) Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus [published correction in Sci. Signal 2017, 10, eean5765. Sci. Signal. 9, ra115 10.1126/scisignal.aaf1933</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scisignal.aaf1933</ArticleId>
            <ArticleId IdType="pmc">PMC5321043</ArticleId>
            <ArticleId IdType="pubmed">27899525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gattermann N., Dadak M., Hofhaus G., Wulfert M., Berneburg M., Loeffler M. L., Simmonds H. A. (2004) Severe impairment of nucleotide synthesis through inhibition of mitochondrial respiration. Nucleosides Nucleotides Nucleic Acids 23, 1275&#x2013;1279 10.1081/NCN-200027545</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1081/NCN-200027545</ArticleId>
            <ArticleId IdType="pubmed">15571245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qu C., Xu L., Yin Y., Peppelenbosch M. P., Pan Q., Wang W. (2017) Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin. Arch. Virol. 162, 2989&#x2013;2996</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5602043</ArticleId>
            <ArticleId IdType="pubmed">28623406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quarato G., D&#x2019;Aprile A., Gavillet B., Vuagniaux G., Moradpour D., Capitanio N., Piccoli C. (2012) The cyclophilin inhibitor alisporivir prevents hepatitis C virus-mediated mitochondrial dysfunction. Hepatology 55, 1333&#x2013;1343 10.1002/hep.25514</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.25514</ArticleId>
            <ArticleId IdType="pubmed">22135208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaseva A. V., Marchenko N. D., Ji K., Tsirka S. E., Holzmann S., Moll U. M. (2012) p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149, 1536&#x2013;1548 10.1016/j.cell.2012.05.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2012.05.014</ArticleId>
            <ArticleId IdType="pmc">PMC3383624</ArticleId>
            <ArticleId IdType="pubmed">22726440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Marchi E., Bonora M., Giorgi C., Pinton P. (2014) The mitochondrial permeability transition pore is a dispensable element for mitochondrial calcium efflux. Cell Calcium 56, 1&#x2013;13 10.1016/j.ceca.2014.03.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceca.2014.03.004</ArticleId>
            <ArticleId IdType="pmc">PMC4074345</ArticleId>
            <ArticleId IdType="pubmed">24755650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., Inohara H., Kubo T., Tsujimoto Y. (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652&#x2013;658 10.1038/nature03317</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature03317</ArticleId>
            <ArticleId IdType="pubmed">15800626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta M. M., Weinberg S. E., Chandel N. S. (2017) Mitochondrial control of immunity: beyond ATP. Nat. Rev. Immunol. 17, 608&#x2013;620 10.1038/nri.2017.66</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri.2017.66</ArticleId>
            <ArticleId IdType="pubmed">28669986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang T., Weinman S. A. (2013) Interactions between hepatitis C virus and mitochondria: impact on pathogenesis and innate immunity. Curr. Pathobiol. Rep. 1, 179&#x2013;187 10.1007/s40139-013-0024-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40139-013-0024-9</ArticleId>
            <ArticleId IdType="pmc">PMC3743448</ArticleId>
            <ArticleId IdType="pubmed">23956955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mills E. L., Kelly B., O&#x2019;Neill L. A. J. (2017) Mitochondria are the powerhouses of immunity. Nat. Immunol. 18, 488&#x2013;498 10.1038/ni.3704</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.3704</ArticleId>
            <ArticleId IdType="pubmed">28418387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan M., Syed G. H., Kim S. J., Siddiqui A. (2015) Mitochondrial dynamics and viral infections: a close nexus. Biochim. Biophys. Acta 1853(10 Pt B), 2822&#x2013;2833 10.1016/j.bbamcr.2014.12.040</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2014.12.040</ArticleId>
            <ArticleId IdType="pmc">PMC4500740</ArticleId>
            <ArticleId IdType="pubmed">25595529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Y. X., Huang C. J., Yang Z. G. (2016) Impact of hepatitis B virus infection on hepatic metabolic signaling pathway. World J. Gastroenterol. 22, 8161&#x2013;8167 10.3748/wjg.v22.i36.8161</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v22.i36.8161</ArticleId>
            <ArticleId IdType="pmc">PMC5037084</ArticleId>
            <ArticleId IdType="pubmed">27688657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez E. L., Lagunoff M. (2015) Viral activation of cellular metabolism. Virology 479-480, 609&#x2013;618 10.1016/j.virol.2015.02.038</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.virol.2015.02.038</ArticleId>
            <ArticleId IdType="pmc">PMC4424078</ArticleId>
            <ArticleId IdType="pubmed">25812764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ando T., Imamura H., Suzuki R., Aizaki H., Watanabe T., Wakita T., Suzuki T. (2012) Visualization and measurement of ATP levels in living cells replicating hepatitis C virus genome RNA. PLoS Pathog. 8, e1002561 10.1371/journal.ppat.1002561</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1002561</ArticleId>
            <ArticleId IdType="pmc">PMC3291659</ArticleId>
            <ArticleId IdType="pubmed">22396648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nobre L., Wise D., Ron D., Volmer R. (2015) Modulation of innate immune signalling by lipid-mediated MAVS transmembrane domain oligomerization. PLoS One 10, e0136883 10.1371/journal.pone.0136883</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0136883</ArticleId>
            <ArticleId IdType="pmc">PMC4552940</ArticleId>
            <ArticleId IdType="pubmed">26317833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin X., Li X., Ambardekar C., Hu Z., Lhomme S., Feng Z. (2017) Hepatitis E virus persists in the presence of a type III interferon response. PLoS Pathog. 13, e1006417 10.1371/journal.ppat.1006417</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1006417</ArticleId>
            <ArticleId IdType="pmc">PMC5466342</ArticleId>
            <ArticleId IdType="pubmed">28558073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Bacha T., Da Poian A. T. (2013) Virus-induced changes in mitochondrial bioenergetics as potential targets for therapy. Int. J. Biochem. Cell Biol. 45, 41&#x2013;46 10.1016/j.biocel.2012.09.021</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2012.09.021</ArticleId>
            <ArticleId IdType="pubmed">23036789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brault C., Levy P. L., Bartosch B. (2013) Hepatitis C virus-induced mitochondrial dysfunctions. Viruses 5, 954&#x2013;980 10.3390/v5030954</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v5030954</ArticleId>
            <ArticleId IdType="pmc">PMC3705306</ArticleId>
            <ArticleId IdType="pubmed">23518579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Claus C., Sch&#xF6;nefeld K., H&#xFC;bner D., Chey S., Reibetanz U., Liebert U. G. (2013) Activity increase in respiratory chain complexes by rubella virus with marginal induction of oxidative stress. J. Virol. 87, 8481&#x2013;8492 10.1128/JVI.00533-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.00533-13</ArticleId>
            <ArticleId IdType="pmc">PMC3719815</ArticleId>
            <ArticleId IdType="pubmed">23720730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Painter H. J., Morrisey J. M., Mather M. W., Vaidya A. B. (2007) Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum. Nature 446, 88&#x2013;91 10.1038/nature05572</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature05572</ArticleId>
            <ArticleId IdType="pubmed">17330044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quinlan C. L., Gerencser A. A., Treberg J. R., Brand M. D. (2011) The mechanism of superoxide production by the antimycin-inhibited mitochondrial Q-cycle. J. Biol. Chem. 286, 31361&#x2013;31372 10.1074/jbc.M111.267898</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.267898</ArticleId>
            <ArticleId IdType="pmc">PMC3173136</ArticleId>
            <ArticleId IdType="pubmed">21708945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taddeo E. P., Laker R. C., Breen D. S., Akhtar Y. N., Kenwood B. M., Liao J. A., Zhang M., Fazakerley D. J., Tomsig J. L., Harris T. E., Keller S. R., Chow J. D., Lynch K. R., Chokki M., Molkentin J. D., Turner N., James D. E., Yan Z., Hoehn K. L. (2013) Opening of the mitochondrial permeability transition pore links mitochondrial dysfunction to insulin resistance in skeletal muscle. Mol. Metab. 3, 124&#x2013;134 10.1016/j.molmet.2013.11.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molmet.2013.11.003</ArticleId>
            <ArticleId IdType="pmc">PMC3953683</ArticleId>
            <ArticleId IdType="pubmed">24634818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding Q., Heller B., Capuccino J. M., Song B., Nimgaonkar I., Hrebikova G., Contreras J. E., Ploss A. (2017) Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles [published correction in Proc. Natl. Acad. Sci. USA 2017, 114, E4897]. Proc. Natl. Acad. Sci. USA 114, 1147&#x2013;1152 10.1073/pnas.1614955114</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1614955114</ArticleId>
            <ArticleId IdType="pmc">PMC5293053</ArticleId>
            <ArticleId IdType="pubmed">28096411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Norenberg M. D., Rao K. V. (2007) The mitochondrial permeability transition in neurologic disease. Neurochem. Int. 50, 983&#x2013;997 10.1016/j.neuint.2007.02.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuint.2007.02.008</ArticleId>
            <ArticleId IdType="pmc">PMC4714712</ArticleId>
            <ArticleId IdType="pubmed">17397969</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30069696</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1433-7339</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</Title>
          <ISOAbbreviation>Support Care Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The feasibility of dexamethasone omission in weekly paclitaxel treatment for breast cancer patients.</ArticleTitle>
        <Pagination>
          <StartPage>927</StartPage>
          <EndPage>931</EndPage>
          <MedlinePgn>927-931</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00520-018-4381-0</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Patients with breast cancer who receive weekly paclitaxel therapy may experience deleterious effects associated with prophylactic dexamethasone use for 12 consecutive weeks. Approximately 90% of paclitaxel hypersensitivity reactions (HSRs) occur within the first 10 to 15&#xA0;min of the first two infusions. We investigated the feasibility of dexamethasone withdrawal between weeks 3 and 12 (W3 and W12) in early stage breast cancer patients treated with weekly paclitaxel at the standard dose (80&#xA0;mg/m<sup>2</sup>).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">All patients received intravenous prophylaxis of dexamethasone 20&#xA0;mg, ranitidine 50&#xA0;mg, and diphenhydramine 50&#xA0;mg in the first 2&#xA0;weeks (W1 and W2) of treatment. Provided that no serious (G3/G4) HSRs events occurred, dexamethasone was omitted between W3 and W12, while ranitidine and diphenhydramine were continued. The primary end point was the incidence of any grade HSRs during the treatment period, and the secondary end points were quality of life and weight changes.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-five patients were included in the study, and 300 infusion cycles of paclitaxel were evaluated for HSRs. The overall incidence of HSRs was 0.6% (2 events), and both of these events occurred in the first week. There were no incidents of serious HSRs or anaphylaxis and no G3 or G4 toxicities. Scores from the EORTC QLQ-C30 questionnaire did not change significantly for the global health status/quality of life scale or for the symptoms scales, although changes in scores differed significantly for the functional scales. There were no clinically relevant weight changes during the treatment period.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dexamethasone withdrawal from W3 to W12 in early stage breast cancer patients treated with weekly paclitaxel is feasible. The incidence of all grades of HSRs was comparable to that reported in trials with dexamethasone for 12 consecutive weeks, and no serious events (G3/G4) occurred. Studies with larger sample sizes are needed to confirm our results which are important, especially for patients for whom corticosteroids are contraindicated.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>de Castro Baccarin</LastName>
            <ForeName>Ana Lu&#xED;sa</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Brasileiro de Controle do C&#xE2;ncer, S&#xE3;o Paulo, Brazil. larciprete@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Irene</LastName>
            <ForeName>Macilon Nonato</ForeName>
            <Initials>MN</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Brasileiro de Controle do C&#xE2;ncer, S&#xE3;o Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Iracema Gomes Cubero</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Faculdade de Medicina do ABC, Santo Andr&#xE9;, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luz</LastName>
            <ForeName>Ariana Sales</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Brasileiro de Controle do C&#xE2;ncer, S&#xE3;o Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Castro</LastName>
            <ForeName>Suelen Nastri</ForeName>
            <Initials>SN</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Brasileiro de Controle do C&#xE2;ncer, S&#xE3;o Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sordi</LastName>
            <ForeName>Renan</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Brasileiro de Controle do C&#xE2;ncer, S&#xE3;o Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>M&#xF3;z</LastName>
            <ForeName>Luis Eduardo Silva</ForeName>
            <Initials>LES</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto Brasileiro de Controle do C&#xE2;ncer, S&#xE3;o Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Del Giglio</LastName>
            <ForeName>Auro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculdade de Medicina do ABC (Chief), S&#xE3;o Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016430">Clinical Trial</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Support Care Cancer</MedlineTA>
        <NlmUniqueID>9302957</NlmUniqueID>
        <ISSNLinking>0941-4355</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000972">Antineoplastic Agents, Phytogenic</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7S5I7G3JQL</RegistryNumber>
          <NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>8GTS82S83M</RegistryNumber>
          <NameOfSubstance UI="D004155">Diphenhydramine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>P88XT4IS4D</RegistryNumber>
          <NameOfSubstance UI="D017239">Paclitaxel</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000972" MajorTopicYN="N">Antineoplastic Agents, Phytogenic</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004155" MajorTopicYN="N">Diphenhydramine</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004342" MajorTopicYN="N">Drug Hypersensitivity</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057915" MajorTopicYN="N">Drug Substitution</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017239" MajorTopicYN="N">Paclitaxel</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011292" MajorTopicYN="N">Premedication</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Dexamethasone</Keyword>
        <Keyword MajorTopicYN="N">Hypersensitivity reactions</Keyword>
        <Keyword MajorTopicYN="N">Paclitaxel</Keyword>
        <Keyword MajorTopicYN="N">Prophylaxis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30069696</ArticleId>
        <ArticleId IdType="doi">10.1007/s00520-018-4381-0</ArticleId>
        <ArticleId IdType="pii">10.1007/s00520-018-4381-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Cancer J Sci Am. 1999 May-Jun;5(3):179-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10367176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onkologie. 2001 Jun;24(3):283-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11455223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gynecol Oncol. 2001 Sep;82(3):550-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11520154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Invest. 2002;20(5-6):666-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12197222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semin Oncol. 1992 Oct;19(5):458-77</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1384149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chemotherapy. 2005 May;51(2-3):116-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15886470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oncologist. 2007 May;12(5):601-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17522249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2008 Apr 17;358(16):1663-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18420499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rev Allergy Immunol. 2015 Oct;49(2):177-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24740483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):428-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25017531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rev Bras Ginecol Obstet. 2014 Nov;36(11):503-508</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25493402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Support Care Cancer. 2015 Jul;23(7):2019-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25519756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8433390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qual Life Res. 1997 Jan;6(1):27-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9062439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Cancer. 1998 Oct;34(11):1670-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9893650</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30068563</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>02</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Plain packaging: legislative differences in Australia, France, the UK, New Zealand and Norway, and options for strengthening regulations.</ArticleTitle>
        <Pagination>
          <StartPage>485</StartPage>
          <EndPage>492</EndPage>
          <MedlinePgn>485-492</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054483</ELocationID>
        <Abstract>
          <AbstractText>By July 2018, five countries (Australia, France, the UK, New Zealand and Norway) had fully implemented plain (standardised) packaging. Using government documents, we reviewed the key legislative differences between these five countries to identify best practice measures and potential lacuna. We then discuss how governments planning to introduce plain packaging could strengthen their legislation. Differences between countries include the terminology used (either 'plain', 'standardised' or 'plain and standardised'), products covered and transition times (ranging from 2 to 12 months). Myriad differences exist with respect to the packaging, including the dimensions (explicitly stated for height, width and depth vs minimum dimensions for the health warnings only), structure (straight-edged flip-top packs vs straight, rounded and bevelled-edged flip-top packs and shoulder boxes) and size (minimum number of cigarettes and weight of tobacco vs fixed amounts) and warning content (eg, inclusion of a stop-smoking web address and/or quitline displayed on warnings on one or both principal display areas). Future options that merit further analysis include banning colour descriptors in brand and variant names, allowing pack inserts promoting cessation and permitting cigarettes that are designed to be dissuasive. Plain packaging legislation and regulations are divergent. Countries moving towards plain packaging should consider incorporating the strengths of existing policies and review opportunities for extending these. While plain packaging represents a milestone in tobacco-control policy, future legislation need not simply reflect the past but could set new benchmarks to maximise the potential benefits of this policy.</AbstractText>
          <CopyrightInformation>&#xA9; Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Moodie</LastName>
            <ForeName>Crawford</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences and Sport, Centre for Tobacco Control Research, Institute for Social Marketing, University of Stirling, Stirling, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoek</LastName>
            <ForeName>Janet</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0003-4362-1539</Identifier>
            <AffiliationInfo>
              <Affiliation>Departments of Public Health and Marketing, University of Otago, Dunedin, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scheffels</LastName>
            <ForeName>Janne</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gallopel-Morvan</LastName>
            <ForeName>Karine</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>EHESP School of Public Health, Rennes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lindorff</LastName>
            <ForeName>Kylie</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Council Victoria, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>15192</GrantID>
            <Acronym>CRUK_</Acronym>
            <Agency>Cancer Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>20456</GrantID>
            <Acronym>CRUK_</Acronym>
            <Agency>Cancer Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011356" MajorTopicYN="N">Product Labeling</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019064" MajorTopicYN="N">Product Packaging</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011640" MajorTopicYN="N">Public Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009626" MajorTopicYN="N">Terminology as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="N">Tobacco Products</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">packaging</Keyword>
        <Keyword MajorTopicYN="N">public policy</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30068563</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054483</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054483</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30066123</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1618-727X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of digital imaging</Title>
          <ISOAbbreviation>J Digit Imaging</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Tumor Identification in Colorectal Histology Images Using a Convolutional Neural Network.</ArticleTitle>
        <Pagination>
          <StartPage>131</StartPage>
          <EndPage>140</EndPage>
          <MedlinePgn>131-140</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10278-018-0112-9</ELocationID>
        <Abstract>
          <AbstractText>Colorectal cancer (CRC) is a major global health concern. Its early diagnosis is extremely important, as it determines treatment options and strongly influences the length of survival. Histologic diagnosis can be made by pathologists based on images of tissues obtained from a colonoscopic biopsy. Convolutional neural networks (CNNs)-i.e., deep neural networks (DNNs) specifically adapted to image data-have been employed to effectively classify or locate tumors in many types of cancer. Colorectal histology images of 28 normal and 29 tumor samples were obtained from the National Cancer Center, South Korea, and cropped into 6806 normal and 3474 tumor images. We developed five modifications of the system from the Visual Geometry Group (VGG), the winning entry in the classification task in the 2014 ImageNet Large Scale Visual Recognition Competition (ILSVRC) and examined them in two experiments. In the first experiment, we determined the best modified VGG configuration for our partial dataset, resulting in accuracies of 82.50%, 87.50%, 87.50%, 91.40%, and 94.30%, respectively. In the second experiment, the best modified VGG configuration was applied to evaluate the performance of the CNN model. Subsequently, using the entire dataset on the modified VGG-E configuration, the highest results for accuracy, loss, sensitivity, and specificity, respectively, were 93.48%, 0.4385, 95.10%, and 92.76%, which equates to correctly classifying 294 normal images out of 309 and 667 tumor images out of 719.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yoon</LastName>
            <ForeName>Hongjun</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Innovative Medical Engineering and Technology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Engineering and Computer Science, Syracuse University, Syracuse, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Joohyung</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Innovative Medical Engineering and Technology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oh</LastName>
            <ForeName>Ji Eun</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Innovative Medical Engineering and Technology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Hong Rae</ForeName>
            <Initials>HR</Initials>
            <AffiliationInfo>
              <Affiliation>Innovative Medical Engineering and Technology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Seonhye</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Innovative Medical Engineering and Technology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Hee Jin</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sohn</LastName>
            <ForeName>Dae Kyung</ForeName>
            <Initials>DK</Initials>
            <Identifier Source="ORCID">0000-0003-3296-6646</Identifier>
            <AffiliationInfo>
              <Affiliation>Innovative Medical Engineering and Technology Branch, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea. gsgsbal@ncc.re.kr.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, Republic of Korea. gsgsbal@ncc.re.kr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Digit Imaging</MedlineTA>
        <NlmUniqueID>9100529</NlmUniqueID>
        <ISSNLinking>0897-1889</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003952" MajorTopicYN="N">Diagnostic Imaging</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016571" MajorTopicYN="Y">Neural Networks, Computer</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Colonoscopic biopsy</Keyword>
        <Keyword MajorTopicYN="N">Convolutional neural network</Keyword>
        <Keyword MajorTopicYN="N">Histology image</Keyword>
        <Keyword MajorTopicYN="N">Visual geometry group</Keyword>
      </KeywordList>
      <CoiStatement>The study was conducted according to the principles of the Declaration of Helsinki and was approved by the institutional review board of our institution (NCC2016-0048). All patients provided written informed consent to participate. CONFLICT OF INTEREST: The authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30066123</ArticleId>
        <ArticleId IdType="pmc">PMC6382645</ArticleId>
        <ArticleId IdType="doi">10.1007/s10278-018-0112-9</ArticleId>
        <ArticleId IdType="pii">10.1007/s10278-018-0112-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359&#x2013;E386. doi: 10.1002/ijc.29210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.29210</ArticleId>
            <ArticleId IdType="pubmed">25220842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung KW, Wong YJ, Kong HJ, Lee ES. Community of Population-Based Regional Cancer Registries: Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018;50:303&#x2013;316. doi: 10.4143/crt.2018.143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4143/crt.2018.143</ArticleId>
            <ArticleId IdType="pmc">PMC5912151</ArticleId>
            <ArticleId IdType="pubmed">29566481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Cancer Institute: Surveillance, Epidemiology, and End Results Program, Cancer Stat Facts: Colon and Rectum Cancer. Maryland, USA https://seer.cancer.gov/statfacts/html/colorect.html</Citation>
        </Reference>
        <Reference>
          <Citation>Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87&#x2013;108. doi: 10.3322/caac.21262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3322/caac.21262</ArticleId>
            <ArticleId IdType="pubmed">25651787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teramoto A, Tsukamoto T, Kiriyama Y, Fujita H: Automated classification of lung cancer types from cytological images using deep convolutional neural networks. BioMed Res Int 2017. Accessed June 3, 2018. doi:10.1155/2017/4067832</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5572620</ArticleId>
            <ArticleId IdType="pubmed">28884120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bengio Y. Learning deep architectures for AI. Boston: Now Publishers, Inc.; 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>Nicholson CV, Gibson A. A Beginner&#x2019;s guide to deep convolutional neural networks (CNNs). What&#x2019;s the difference between artificial intelligence (AI), machine learning and deep learning?. Deeplearning4j: Open-source, Distributed Deep Learning for the JVM. Accessed June 04, 2018. https://deeplearning4j.org/convolutionalnetwork</Citation>
        </Reference>
        <Reference>
          <Citation>Sirinukunwattana K, Ahmed Raza SE, Tsang Y-W, Snead DRJ, Cree IA, Rajpoot NM. Locality sensitive deep learning for detection and classification of nuclei in routine colon cancer histology images. IEEE Trans Med Imaging. 2016;35(5):1196&#x2013;1206. doi: 10.1109/TMI.2016.2525803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1109/TMI.2016.2525803</ArticleId>
            <ArticleId IdType="pubmed">26863654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deng J, Dong W, Socher R, Li LJ, Li K, Fei-Fei L: ImageNet: A large-scale hierarchical image database. IEEE Conf Computer Vision Pattern Recogn (CVPR2009) 248&#x2013;255, 2009</Citation>
        </Reference>
        <Reference>
          <Citation>Simonyan K, Zisserman A: Very deep convolutional networks for large-scale image recognition, ICLR 2015. Available at https://arxiv.org/abs/1409.1556. Accessed June 10, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Anthimopoulos M, Christodoulidis S, Ebner L, Christe A, Mougiakakou S. Lung pattern classification for interstitial lung diseases using a deep convolutional neural network. IEEE Trans Med Imaging. 2016;35(5):1207&#x2013;1216. doi: 10.1109/TMI.2016.2535865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1109/TMI.2016.2535865</ArticleId>
            <ArticleId IdType="pubmed">26955021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CS231n, Convolutional neural networks (CNNs / ConvNets). CS231n Convolutional Neural Networks for Visual Recognition. Available at http://cs231n.github.io/convolutional-networks/#case. Accessed October 10, 2017</Citation>
        </Reference>
        <Reference>
          <Citation>Joshi P: What is local response normalization in convolutional neural networks. Perpetual Enigma. Available at https://prateekvjoshi.com/2016/04/05/what-is-local-response-normalization-in-convolutional-neural-networks/. Accessed October 02, 2017</Citation>
        </Reference>
        <Reference>
          <Citation>G&#xE9;ron ACA. Hands-on machine learning with Scikit-Learn and TensorFlow: Concepts, tools, and techniques to build intelligent systems. California: O&#x2019;Reilly Media; 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Numpy and Scipy Documentation. Available at https://www.numpy.org/. Accessed June 03, 2017</Citation>
        </Reference>
        <Reference>
          <Citation>MathWorks. Machine Learning with MATLAB - Quantcast. Available at https://www.mathworks.com/campaigns/products/display/machine-learning-with-matlab.html?s_eid=PSB_16169. Accessed October 03, 2017</Citation>
        </Reference>
        <Reference>
          <Citation>Large Scale Visual Recognition Challenge 2014. ImageNet Large Scale Visual Recognition Competition 2014 (ILSVRC2014). Available at http://www.imagenet.org/challenges /LSVRC/2014/results. Accessed October 01, 2017</Citation>
        </Reference>
        <Reference>
          <Citation>Havaei M, Davy A, Warde-Farley D, Biard A, Courville A, Bengio Y, Pal C, Jodoin P-M, Larochelle H. Brain tumor segmentation with deep neural networks. Med Image Anal. 2017;35:18&#x2013;31. doi: 10.1016/j.media.2016.05.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.media.2016.05.004</ArticleId>
            <ArticleId IdType="pubmed">27310171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang S, Yuan Y. Object detection based on convolutional neural network, CS231n Stanford Final Writeup. Available at http://cs231n.stanford.edu/reports/2015/pdfs/CS231n_final_writeup_sjtang.pdf. Accessed June 02, 2017</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">30058506</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>09</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1478-9523</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>17</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Palliative &amp; supportive care</Title>
          <ISOAbbreviation>Palliat Support Care</ISOAbbreviation>
        </Journal>
        <ArticleTitle>State of advance care planning research: A descriptive overview of systematic reviews.</ArticleTitle>
        <Pagination>
          <StartPage>234</StartPage>
          <EndPage>244</EndPage>
          <MedlinePgn>234-244</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1017/S1478951518000500</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To provide an overview of the current state of research of advance care planning (ACP), highlighting most studied topics, publication time, quality of studies and reported outcomes, and to identify gaps to improve ACP receptivity, utilization, implementation, and outcomes.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">Cochrane methodology for conducting overviews of systematic reviews. Study quality was assessed using a modified version of the Assessing the Methodological Quality of Systematic Reviews tool. The following databases were searched from inception to April 2017: MEDLINE, EBM Reviews, Cochrane Reviews, CINAHL, Global Health, PsycINFO, and EMBASE. Searches were supplemented with gray literature and manual searches.</AbstractText>
          <AbstractText Label="RESULT" NlmCategory="RESULTS">Eighty systematic reviews, covering 1,662 single articles, show that ACP-related research focuses on nine main topics: (1) ACP as part of end-of-life or palliative care interventions, (2) care decision-making; (3) communication strategies; (4) factors influencing ACP implementation; (5) ACP for specific patient groups, (6) ACP effectiveness; (7) ACP experiences; (8) ACP cost; and (9) ACP outcome measures. The majority of this research was published since 2014, its quality ranges from moderate to low, and reports on documentation, concordance, preferences, and resource utilization outcomes.</AbstractText>
          <AbstractText Label="SIGNIFICANCE OF RESULTS" NlmCategory="CONCLUSIONS">Despite the surge of ACP research, there are major knowledge gaps about ACP initiation, timeliness, optimal content, and impact because of the low quality and fragmentation of the available evidence. Research has mostly focused on discrete aspects within ACP instead of using a holistic evaluative approach that takes into account its intricate working mechanisms, the effects of systems and contexts, and the impacts on multilevel stakeholders. Higher quality studies and innovative interventions are needed to develop effective ACP programs and address research gaps.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jimenez</LastName>
            <ForeName>Geronimo</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Woan Shin</ForeName>
            <Initials>WS</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NTU Institute of Health Technologies (HealthTech), Interdisciplinary Graduate School, Nanyang Technological University, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Health Services and Outcomes Research Department, National Healthcare Group, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Virk</LastName>
            <ForeName>Amrit K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Low</LastName>
            <ForeName>Chan Kee</ForeName>
            <Initials>CK</Initials>
            <AffiliationInfo>
              <Affiliation>Economics Programme, School of Social Sciences, Nanyang Technology University, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Car</LastName>
            <ForeName>Josip</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Global eHealth Unit, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ho</LastName>
            <ForeName>Andy Hau Yan</ForeName>
            <Initials>AHY</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Psychology Programme, School of Social Sciences, Nanyang Technological University, Singapore.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Palliative Care Centre for Excellence in Research and Education, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Palliat Support Care</MedlineTA>
        <NlmUniqueID>101232529</NlmUniqueID>
        <ISSNLinking>1478-9515</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Advance care planning</Keyword>
        <Keyword MajorTopicYN="N">End-of-life care</Keyword>
        <Keyword MajorTopicYN="N">Overview</Keyword>
        <Keyword MajorTopicYN="N">Palliative care</Keyword>
        <Keyword MajorTopicYN="N">Systematic reviews</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30058506</ArticleId>
        <ArticleId IdType="doi">10.1017/S1478951518000500</ArticleId>
        <ArticleId IdType="pii">S1478951518000500</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30047184</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1442-9071</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>47</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical &amp; experimental ophthalmology</Title>
          <ISOAbbreviation>Clin Exp Ophthalmol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Keratitis antimicrobial resistance surveillance program, Sydney, Australia: 2016 Annual Report.</ArticleTitle>
        <Pagination>
          <StartPage>20</StartPage>
          <EndPage>25</EndPage>
          <MedlinePgn>20-25</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ceo.13364</ELocationID>
        <Abstract>
          <AbstractText Label="IMPORTANCE">Antimicrobial resistance data from bacterial keratitis in Australia are lacking.</AbstractText>
          <AbstractText Label="BACKGROUND">Antimicrobial resistance is a global health threat. Bacterial keratitis is an ophthalmic emergency requiring immediate and effective treatment.</AbstractText>
          <AbstractText Label="DESIGN">Retrospective cohort study of bacterial isolates and antibiotic susceptibility profiles at a quaternary hospital in Sydney, Australia.</AbstractText>
          <AbstractText Label="PARTICIPANTS">Two hundred and twenty-four corneal scrapes from patients from January 1 to December 31, 2016.</AbstractText>
          <AbstractText Label="METHODS">Matrix assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry identified bacteria. The Calibrated Dichotomous Sensitivity (CDS) method determined antibiotic susceptibilities.</AbstractText>
          <AbstractText Label="MAIN OUTCOME MEASURES">Isolated organisms and antibiotic susceptibilities.</AbstractText>
          <AbstractText Label="RESULTS">One hundred and sixty-eight scrapes of 224 (75%) were culture positive. One hundred and thirty-one patients had a single organism isolated and 21 had mixed bacterial growth. Of the 157 organisms isolated, 131 (83%) were Gram-positive and 27 (17%) Gram-negative. Of the Gram-positive organisms, 75 (57%) were coagulase-negative Staphylococci (CoNS), 15 (11%) Staphylococcus aureus (including one methicillin-resistant Staphylococcus aureus [MRSA]) and 8 (6%) Corynebacterium spp. Of the Gram-negative organisms, 15 (58%) were Pseudomonas aeruginosa. With methicillin-sensitive Staphylococcus aureus (MSSA) resistance to chloramphenicol was 21%, ciprofloxacin 7% and gentamicin 7%. With CoNS resistance to cefalotin was 9%, gentamicin 9% and ciprofloxacin 9%. With Corynebacterium spp. resistance was 40% to cefalotin, chloramphenicol 25% and ciprofloxacin 14%.</AbstractText>
          <AbstractText Label="CONCLUSIONS AND RELEVANCE">Staphyloccocus spp. and Pseudomonas spp. were the most common microorganisms isolated. There was low resistance to cefalotin and ciprofloxacin for these isolates. More than 90% of these would be covered by current therapeutic recommendations for empiric therapy in Australia.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Royal Australian and New Zealand College of Ophthalmologists.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Watson</LastName>
            <ForeName>Stephanie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sydney Eye Hospital, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cabrera-Aguas</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0001-6276-5795</Identifier>
            <AffiliationInfo>
              <Affiliation>Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sydney Eye Hospital, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khoo</LastName>
            <ForeName>Pauline</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0001-6266-306X</Identifier>
            <AffiliationInfo>
              <Affiliation>Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Sydney Eye Hospital, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pratama</LastName>
            <ForeName>Ryanbi</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>New South Wales Health Pathology East Microbiology, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gatus</LastName>
            <ForeName>Barrie J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>New South Wales Health Pathology East Microbiology, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gulholm</LastName>
            <ForeName>Trine</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>New South Wales Health Pathology East Microbiology, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El-Nasser</LastName>
            <ForeName>Jasmin</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>New South Wales Health Pathology East Microbiology, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lahra</LastName>
            <ForeName>Monica M</ForeName>
            <Initials>MM</Initials>
            <AffiliationInfo>
              <Affiliation>New South Wales Health Pathology East Microbiology, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>Clin Exp Ophthalmol</MedlineTA>
        <NlmUniqueID>100896531</NlmUniqueID>
        <ISSNLinking>1442-6404</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003315" MajorTopicYN="N">Cornea</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="Y">Drug Resistance, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015818" MajorTopicYN="N">Eye Infections, Bacterial</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007634" MajorTopicYN="N">Keratitis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014739" MajorTopicYN="N" Type="Geographic">Victoria</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antibiotic resistance</Keyword>
        <Keyword MajorTopicYN="N">bacterial keratitis</Keyword>
        <Keyword MajorTopicYN="N">corneal scrape</Keyword>
        <Keyword MajorTopicYN="N">surveillance</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30047184</ArticleId>
        <ArticleId IdType="doi">10.1111/ceo.13364</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30045974</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>07</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Role of stakeholders in Nigeria's tobacco control journey after the FCTC: lessons for tobacco control advocacy in low-income and middle-income countries.</ArticleTitle>
        <Pagination>
          <StartPage>386</StartPage>
          <EndPage>393</EndPage>
          <MedlinePgn>386-393</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054344</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">Nigeria ratified the WHO Framework Convention on Tobacco Control (FCTC) in 2005. Tobacco control advocates in Nigeria achieved some success in countering tobacco industry interference to implement the FCTC.</AbstractText>
          <AbstractText Label="METHODS">We triangulated interviews with key informants from local and international organisations who worked in Nigeria with documentation of the legislative process and Nigerian newspaper articles. Data were analysed and interpreted using the Policy Dystopia Model and WHO categories of tobacco industry interference that had been developed mostly based on experience in high-income countries.</AbstractText>
          <AbstractText Label="RESULTS">As in high-income countries, the tobacco industry continued to oppose tobacco control policies after Nigeria ratified the FCTC, including weakening Nigeria's 2015 National Tobacco Control Act. Both tobacco control advocates and industry used discursive (argument-based) and instrumental (activity-based) strategies. The industry argued self-regulation and the economic importance of tobacco. They exploited legislative procedures, used front groups and third parties to push for pro-industry changes. Advocates, with help from international organisations, mobilised prominent Nigerians and the public. Advocates pre-empted and countered the industry through traditional and social media, monitoring and exposing tobacco industry activities, and by actively engaging lawmakers and citizens during the legislative process.</AbstractText>
          <AbstractText Label="CONCLUSION">The Policy Dystopia Model and WHO categories of industry interference provide a helpful framework for understanding tobacco control debates in low/middle-income countries (LMICs) as in high-income countries. One difference in LMIC is the important role of international tobacco control advocates in supporting national tobacco control advocates. This partnership is important in pushing for FCTC-compliant legislation and countering industry activities in LMIC.</AbstractText>
          <CopyrightInformation>&#xA9; Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Egbe</LastName>
            <ForeName>Catherine O</ForeName>
            <Initials>CO</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Tobacco Control Research and Education, University of California, San Francisco, California, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Pretoria, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bialous</LastName>
            <ForeName>Stella A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Tobacco Control Research and Education, University of California, San Francisco, California, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Social and Behavioral Sciences Department, School of Nursing, and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Glantz</LastName>
            <ForeName>Stanton</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-4620-6672</Identifier>
            <AffiliationInfo>
              <Affiliation>Center for Tobacco Control Research and Education, University of California, San Francisco, California, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine (Cardiology), Cardiovascular Research Institute, Philip R. Lee Institute for Health Policy Studies, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 CA087472</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003254" MajorTopicYN="N">Consumer Advocacy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007182" MajorTopicYN="N">Income</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009524" MajorTopicYN="N">Newspapers as Topic</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011640" MajorTopicYN="N">Public Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074606" MajorTopicYN="N">Smoking Prevention</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073597" MajorTopicYN="Y">Stakeholder Participation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019460" MajorTopicYN="N">Tobacco Industry</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">advocacy</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">low/middle income country</Keyword>
        <Keyword MajorTopicYN="N">public policy</Keyword>
        <Keyword MajorTopicYN="N">tobacco industry</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: SAB has consulted with WHO and the FCTC Secretariat since the early negotiations of the FCTC. Other authors have nothing to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30045974</ArticleId>
        <ArticleId IdType="mid">NIHMS983166</ArticleId>
        <ArticleId IdType="pmc">PMC6347549</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054344</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054344</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>World Health Organization. WHO Framework Convention on Tobacco Control. Geneva, Switzerland, 2003. 
http://apps.who.int/iris/bitstream/10665/42811/1/9241591013.pdf?ua=1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farquharson K Influencing Policy Transnationally: Pro-and Anti-Tobacco Global Advocacy Networks. Aust J Publ Admin 2003;62:80&#x2013;92.</Citation>
        </Reference>
        <Reference>
          <Citation>Charoenca N, Mock J, Kungskulniti N, et al. Success counteracting tobacco company interference in Thailand: an example of FCTC implementation for low- and middleincome countries. Int J Environ Res Public Health 2012;9:1111&#x2013;34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3366603</ArticleId>
            <ArticleId IdType="pubmed">22690186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Switzerland WHO Report on the Global Tobacco Epidemic: Monitoring Tobacco Use and Prevention Policies. Geneva, 2017. 
http://apps.who.int/iris/bitstream/10665/255874/1/9789241512824-eng.pdf?ua=1. (accessed 20 Sep 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Asare BE. Tobacco Regulation in South Africa: Interest Groups and Public Policy. Afr J Polit Sci Int Relat 2009;3:99.</Citation>
        </Reference>
        <Reference>
          <Citation>Crosbie E, Sosa P, Glantz SA. The Importance of Continued Engagement During the Implementation Phase of Tobacco Control Policies in a Middle-Income Country: The Case of Costa Rica. Tob Control. 2016:tobaccocontrol-2015&#x2013;052701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4977207</ArticleId>
            <ArticleId IdType="pubmed">26856614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiilamo H, Glantz SA. Implementation of effective cigarette health warning labels among low and middle income countries: state capacity, path-dependency and tobacco industry activity. Soc Sci Med 2015;124:241&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4276461</ArticleId>
            <ArticleId IdType="pubmed">25462428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiilamo H, Glantz S. FCTC followed by accelerated implementation of tobacco advertising bans. Tob Control 2017;26:428&#x2013;33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5274612</ArticleId>
            <ArticleId IdType="pubmed">27471111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanders-Jackson AN, Song AV, Hiilamo H, et al. Effect of the Framework Convention on Tobacco Control and voluntary industry health warning labels on passage of mandated cigarette warning labels from 1965 to 2012: transition probability and event history analyses. Am J Public Health 2013;103:2041&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3795937</ArticleId>
            <ArticleId IdType="pubmed">24028248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uang R, Hiilamo H, Glantz SA. Accelerated Adoption of Smoke-Free Laws After Ratification of the World Health Organization Framework Convention on Tobacco Control. Am J Public Health 2016;106:166&#x2013;71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4689638</ArticleId>
            <ArticleId IdType="pubmed">26562125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S, Ling PM, Glantz SA. The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries. Cancer Causes Control 2012;23 Suppl 1:117&#x2013;29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3332051</ArticleId>
            <ArticleId IdType="pubmed">22370696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalra A, Bansal P, Wilson D, et al.
United States Exclusive: Documents Reveal Philip Morris&#x2019; Campaign to Subvert the World&#x2019;s Anti-Smoking Treaty. 2017. 
https://www.reuters.com/article/us-pmi-who-fctc-tobacco-exclusive/exclusive-documents-revealphilip-morris-campaign-to-subvert-the-worlds-anti-smoking-treaty-idUSKBN19Y1DN (accessed September 18, 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Gilmore AB, Fooks G, Drope J, et al. Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet 2015;385:1029&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4382920</ArticleId>
            <ArticleId IdType="pubmed">25784350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conference of the Parties to the WHO Framework Convention on Tobacco Control. Implementation of Article 5.3 of the WHO FCTC: Report by the Convention Secretariat. 2016. 
http://www.who.int/fctc/cop/cop7/FCTC_COP_7_7_EN.pdf?ua=1 (accessed 21 Sep 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Conference of the Parties to the WHO Framework Convention on Tobacco Control. Global Progress in Implementation of the WHO FCTC: Report by the Convention Secretariat. 2016. 
http://www.who.int/fctc/cop/cop7/FCTC_COP_7_4_EN.pdf?ua=1 (accessed 21 Sep 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Blecher E, Ross H. Tobacco Use in Africa: Tobacco Control through Prevention. Atlanta, GA: American Cancer Society, 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Federal Republic of Nigeria. Lagos National Tobacco Control Act. The Federal Government Printer, Nigeria: 
2015. 
http://www.tobaccocontrollaws.org/files/live/Nigeria/Nigeria%20-%20TCA%20-%20national.pdf (accessed 31 Mar 2016).</Citation>
        </Reference>
        <Reference>
          <Citation>Egbe CO, Bialous SA, Glantz SA. Avoiding &#x201C;A Massive Spin-Off Effect in West Africa and Beyond&#x201D;: The Tobacco Industry Stymies Tobacco Control in Nigeria. Nicotine Tob Res 2017;19:877&#x2013;87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6075084</ArticleId>
            <ArticleId IdType="pubmed">28199720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egbe CO, Bialous SA, Glantz S. FCTC Implementation in Nigeria: Lessons for Low and Middle-Income Countries. Nicotine Tob Res 2018:1&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6636173</ArticleId>
            <ArticleId IdType="pubmed">29660032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Environmental Rights Action/Friends of the Earth Nigeria. Shadow Report on Implementation of the Framework Convention on Tobacco Control (FCTC) Articles 5.3, 6 &amp; 13 in Nigeria
http://www.fctc.org/images/stories/reports/Nigeria%20SR.pdf (accessed 17 Jan 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>U.S. National Cancer Institute and World Health Organization. The Economics of Tobacco and Tobacco Control. National Cancer Institute Tobacco Control Monograph 21 Nih Publication No. 16-Ca-8029a Bethesda, MD: U.S: Department of Health and Human Services, National Institutes of Health, National Cancer Institute; and Geneva, CH: World Health Organization, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Ulucanlar S, Fooks GJ, Gilmore AB. The Policy Dystopia Model: An Interpretive Analysis of Tobacco Industry Political Activity. PLoS Med 2016;13:e1002125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5029800</ArticleId>
            <ArticleId IdType="pubmed">27649386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Organzation WH. Geneva, Switzerland Tobacco Industry Interference a Global Brief: WHO, 2012. 
http://apps.who.int/iris/bitstream/10665/70894/1/WHO_NMH_TFI_12.1_eng.pdf. (accessed 21 Jan 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Dedoose web application for managing, analyzing, and presenting qualitative and mixed method research data. Version 7.0.23, ed. Los Angeles, CA: SocioCultural Research Consultants, LLC, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77&#x2013;101.</Citation>
        </Reference>
        <Reference>
          <Citation>Summary of the Public Hearing on a Bill for an Act to Enact the Tobacco Smoking (Control) Bill. Held at the Federal House of Representatives, National Assembly, Abuja: 2014. Received from Campaign from Tobacco-Free Kids on September 9, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Summary of the Two-Day Public Hearing on a Bill for an Act to Amend the Tobacco Control Act, 1990 Cap T16, Laws of the Federation, and to Enact the National Tobacco Control (Ammendment) Bill, 2009. (Sb 221). Recieved from Environmental Rights Action/ Friends of the Earth Nigeria on 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Chapman S, Yach D, Saloojee Y, et al. All Africa conference on tobacco control. BMJ 1994;308:189&#x2013;91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2542529</ArticleId>
            <ArticleId IdType="pubmed">8312774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mamudu HM, Glantz SA. Civil society and the negotiation of the Framework Convention on Tobacco Control. Glob Public Health 2009;4:150&#x2013;68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2664518</ArticleId>
            <ArticleId IdType="pubmed">19333806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lambert P Interview Conducted on June 2, Egbe CO, ed. 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Franko C Interview Conducted on May 2 and 8, Egbe CO, ed. 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Ntiabang T Interview Conducted on May 8, Egbe CO, ed. 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Huber L Interview Conducted on June 1, Egbe CO, ed. 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Intersessional Consultations. 2017. 
http://www.who.int/fctc/about/whofctc_inb/consultations/en/ (accessed 20 Nov 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Gonzalez M, Green LW, Glantz SA. Through Tobacco Industry Eyes: Civil Society and the FCTC Process from Philip Morris and British American Tobacco&#x2019;s Perspectives. Tob Control 2011:tc. 2010041657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3188334</ArticleId>
            <ArticleId IdType="pubmed">21636611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oluwafemi A Interview Conducted on September 8, Egbe CO, ed. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Akinremi A Interview Conducted on June 23, Egbe CO, ed. 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Japkor P Interview Conducted on December 23, Egbe CO, ed. 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Isong E Interview Conducted on June 2, Egbe CO, ed.2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Protesters at the Nigerian National Assembly During the Public Hearing on the Tobacco Bill. Audioage. com
2014. 
http://www.audioage.com/2014/10/17/batn-at-thesenates-public-hearing-on-the-tobacco-control-bill-in-abuja/pix-2-2/ (accessed 2 Mar 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Bossle MB, Neutzling DM, Wegner D, et al. Contradictory perceptions on corporate social responsibility practices in the Brazilian tobacco industry. Latin American J. of Management for Sustainable Development 2015;2:193&#x2013;210.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Geneva, Switzerland Tobacco Industry Interference with Tobacco Control. World Health Organization; 
2008. 
http://www.who.int/tobacco/resources/publications/9789241597340.pdf (accessed 4 Mar 2016).</Citation>
        </Reference>
        <Reference>
          <Citation>McDaniel PA, Cadman B, Malone RE. African media coverage of tobacco industry corporate social responsibility initiatives. Glob Public Health 2018;13:129&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5014722</ArticleId>
            <ArticleId IdType="pubmed">26947737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezeamalu B
Nigeria Civil Society Groups Commend Governor Fashola for Signing Tobacco Bill. 2014. 
http://www.premiumtimesng.com/news/155428-civil-societygroups-commend-governor-fashola-signing-tobacco-bill.html (accessed 19 Feb 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Ochefu H Interview Conducted on January 19, Egbe CO, ed. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Nigeria NGO Tackles Senator Adedibu over Tobacco Bill. Vanguard Media Limited; 
2010. 
http://www.vanguardngr.com/ 2010/04/ngo-tackles-senator-adedibu-overtobacco-bill/ (accessed 21 Sep 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Nigeria Tobacco Firms&#x2019; Interference Biggest Threat to Control Effort. 2014. 
http://www.premiumtimesng.com/news/more-news/168216-tobacco-firms-interferencebiggest-threat-to-control-effort.html(accessed 16 Sep 2017)</Citation>
        </Reference>
        <Reference>
          <Citation>Ezeamalu B
Nigeria Group Accuses British American Tobacco of Misleading Police on Tobacco Law. 2014. 
http://www.premiumtimesng.com/news/166912-group-accusesbritish-american-tobacco-of-misleading-police-on-tobacco-law.html (accessed 18 Sep 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Jimoh A
Nigeria Csos Raise Alarm over Planned Suppression of Anti-Smoking Laws. Media Trust Limited; 
2017. 
https://www.dailytrust.com.ng/news/general/csos-raisealarm-over-planned-suppression-of-anti-smoking-laws/196818.html (accessed May 8, 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Mamora SO. A Bill for an Act to Repeal the Tobacco (Control) Act 1990 Cap. T16 Laws of the Federation and to Enact the National Tobacco Control Bill 2008 to Provide for the Regulation or Control of Production, Manufacture, Sale, Advertising, Promotion and Sponsorship of Tobacco or Tobacco Products in Nigeria and for Other Related Matters. 2017;7
https://ntcang.org/wp-content/uploads/2014/08/Bill-passed-by-6th-Assemby.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>A Bill to Provide for the Regulation and Control of Production, Manufacture, Sale, Advertising, Promotion and Sponsorship of Tobacco or Tobacco Products in Nigeria and for Other Related Matters.. 2013. 
https://ntcang.org/wp-content/uploads/2014/08/Executive-Bill.pdf (accessed 7 Feb 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Okowa IA. Senate Committee on Health Public Hearing on the National Tobacco Control Bill 2012. 2014. 
https://www.medicalworldnigeria.com/2014/10/senatecommittee-on-health-public-hearing-on-the-national-tobacco-control-bill-2012#.WU2HTBPyuUk (accessed 23 Jun 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Erameh A, Okeke A. Interview Conducted on January 19, Egbe CO, ed. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Connett D
British American Tobacco &#x2018;Bribed&#x2019; Kenyan Politician Martha Karua to Stop Action against Cigarette Smuggling. 2015. 
http://www.independent.co.uk/news/uk/crime/britishamericantobaccobribedkenyanpoliticianmarthakaruatostopactionagainstcigarettea6779236.html (accessed 18 Dec 2015).</Citation>
        </Reference>
        <Reference>
          <Citation>Ministry of Public Health and Sanitation, International Institute for Legislative Affairs Kenya. Tobacco Industry Interference in Kenya: Exposing the Tactics. 2013. 
https://ilakenya.org/wp-content/uploads/2015/10/Ti_interference_in_Kenya.pdf (accessed 4Jan 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Ailuorio PJ. News Agency of Nigeria. Nigeria Anti-Tobacco Bill Passes Second Reading at Nigeria&#x2019;s House of Reps. 2013. 
http://www.premiumtimesng.com/news/126281-anti-tobacco-bill-passes-second-reading-at-nigerias-house-of-reps.html (accessed 21 Mar 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Switzerland WHO Framework Convention on Tobacco Control: Guidelines for Implementation
World Health Organization; 
Geneva, 2013. 
https://apps.who.int/iris/bitstream/10665/80510/1/9789241505185_eng.pdf?ua=1. (accessed 15 Sep 2016).</Citation>
        </Reference>
        <Reference>
          <Citation>McDaniel PA, Intinarelli G, Malone RE. Tobacco industry issues management organizations: creating a global corporate network to undermine public health. Global Health 2008;4:1&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2265275</ArticleId>
            <ArticleId IdType="pubmed">18201375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crosbie E, Sebri&#xE9; EM, Glantz SA. Strong advocacy led to successful implementation of smokefree Mexico City. Tob Control 2011;20:64&#x2013;72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3089444</ArticleId>
            <ArticleId IdType="pubmed">21059606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drope J
Tobacco Control in Africa: People, Politics, and Policies. Anthem Press, IDRC; 
2011. 
https://www.idrc.ca/en/book/tobacco-control-africa-people-politics-and-policies (accessed 15 Nov 2016).</Citation>
        </Reference>
        <Reference>
          <Citation>Drope JM. The politics of smoke-free policies in developing countries: Lessons from Africa. CVD Prev Control 2010;5:65&#x2013;73.</Citation>
        </Reference>
        <Reference>
          <Citation>What will it take to create a tobacco-free world? Lancet 2015;385:915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25784326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crosbie E, Sebri&#xE9; EM, Glantz SA. Tobacco industry success in Costa Rica: the importance of FCTC article 5.3. Salud Publica Mex 2012;54:28&#x2013;38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3296364</ArticleId>
            <ArticleId IdType="pubmed">22286826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uang R, Crosbie E, Glantz SA. Smokefree implementation in Colombia: Monitoring, outside funding, and business support. Salud Publica Mex 2017;59:128&#x2013;36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5494994</ArticleId>
            <ArticleId IdType="pubmed">28562713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crosbie E, Sosa P, Glantz SA. Defending strong tobacco packaging and labelling regulations in Uruguay: transnational tobacco control network versus Philip Morris International. Tob Control 2017:tobaccocontrol-2017&#x2013;053690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5610601</ArticleId>
            <ArticleId IdType="pubmed">28336521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boseley S
United Kingdom Tobacco Company Launches Foundation to Stub out Smoking. Guardian News and Media Limited; 
2017. 
https://www.theguardian.com/society/2017/sep/13/tobacco-company-launches-foundation-to-stub-out-smokingphilip-morris (accessed 13 Sep 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Foundation of a Smoke-Free World. About Us. 2017. 
https://www.smokefreeworld.org/aboutus (accessed 29 Nov 2017)</Citation>
        </Reference>
        <Reference>
          <Citation>Malone RE, Chapman S, Gupta PC, et al. A &#x201C;Frank Statement&#x201D; for the 21st Century? Tob Control 2017;26:611&#x2013;2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29066592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO Statement on Philip Morris Funded Foundation for a Smoke-Free World. 2017. 
http://www.who.int/mediacentre/news/statements/2017/philip-morris-foundation/en/ (accessed 30 Sep 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Tomori O, Omaswa F, Bekure S, et al.
Preventing a Tobacco Epidemic in Africa: A Call for Effective Action to Support Health, Social. and Economic Development
2014. 
https://www.assaf.org.za/images/AfricaTobaccoControlReportFinal1.pdf (accessed 1 Oct 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Onaolapo OM. Big Tobacco Suffers Huge Setback in Nigeria: Update on Kano State Government Litigation against Tobacco Companies. Sahara Reporters
2010. 
http://saharareporters.com/2010/05/09/big-tobacco-suffers-huge-setback-nigeria-update-kano-state-government-litigation-against (accessed 15 May 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>IRIN. Govt Hits Tobacco Companies with Whopping Law Suit. Geneva, Switzerland, 2007. 
http://www.irinnews.org/news/2007/11/09/govt-hits-tobacco-companieswhopping-law-suit. (accessed 15 May 2018).</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30045973</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>07</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>Suppl 2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Analysis of Article 6 (tax and price measures to reduce the demand for tobacco products) of the WHO Framework Convention on Tobacco Control.</ArticleTitle>
        <Pagination>
          <StartPage>s97</StartPage>
          <EndPage>s103</EndPage>
          <MedlinePgn>s97-s103</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054462</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">To analyse the extent to which parties to the WHO Framework Convention on Tobacco Control (FCTC) have implemented Article 6 since the convention's entry into force.</AbstractText>
          <AbstractText Label="METHODS">Compliance was measured using nine indicators, derived from the 2016 version of the FCTC's reporting instrument's core questionnaire, and the WHO's MPOWER cigarette affordability measure. Data were collected from WHO country profiles, and the 12 country mission reports by the Impact Assessment Expert Group.</AbstractText>
          <AbstractText Label="RESULTS">The number of parties reporting any type of excise tax increased from 87% (134/154) in 2008 to 92% (160/174) in 2016. Specific excise tax systems were implemented by 36% (63/174) of FCTC ratifying countries in 2016, up from 32% (49/154) in 2008. The proportion of parties with mixed tax structures has increased from 25% (39/154) in 2008 to 32% (56/174) in 2016. The proportion of parties that levy the tax as a fully ad valorem tax has decreased from 29% (45/154) in 2008 to 24% (42/174) in 2016. Cigarettes have become less affordable in 46% (78/168), more affordable in 13% (21/168) and unchanged in terms of affordability in 41% (69/168) of parties between 2008 and 2016. The number of parties that earmark tobacco tax revenues for public health increased from 13 in 2008 to 30 in 2016. Many finance ministries are hesitant to increase the excise tax, mainly due to illicit trade concerns.</AbstractText>
          <AbstractText Label="CONCLUSION">While there has been some improvement in tobacco tax policy over time, parties should adopt stronger tax measures, despite industry opposition and threats about illicit trade. Parties should implement FCTC Article 5.3 and ratify the Protocol to Eliminate Illicit Trade in Tobacco Products.</AbstractText>
          <CopyrightInformation>&#xA9; World Health Organization [year]. Licensee BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>van Walbeek</LastName>
            <ForeName>Corne</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Economics, University of Cape Town, Rondebosch, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Southern Africa Labour and Development Research Unit, University of Cape Town, Rondebosch, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Filby</LastName>
            <ForeName>Samantha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Southern Africa Labour and Development Research Unit, University of Cape Town, Rondebosch, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003132" MajorTopicYN="N">Commerce</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074606" MajorTopicYN="Y">Smoking Prevention</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013660" MajorTopicYN="N">Taxes</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="N">Tobacco Products</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014944" MajorTopicYN="Y">World Health Organization</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">economics</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">taxation</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>24</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30045973</ArticleId>
        <ArticleId IdType="pmc">PMC6589458</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054462</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054462</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Roemer R, Taylor A, Lariviere J. Origins of the WHO Framework Convention on Tobacco Control. Am J Public Health 2005;95:936&#x2013;8. 10.2105/AJPH.2003.025908</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.2003.025908</ArticleId>
            <ArticleId IdType="pmc">PMC1449287</ArticleId>
            <ArticleId IdType="pubmed">15914812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
World Health Organization. The WHO Framework Convention on Tobacco Control. Geneva, Switzerland: World Health Organization, 2003. 
http://apps.who.int/iris/bitstream/10665/42811/1/9241591013.pdf (26 Mar 2018).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
World Health Organization Framework Convention on Tobacco Control Convention Secretariat. Parties to the WHO Framework Convention on Tobacco Control. 2018. 
http://www.who.int/fctc/cop/en/.</Citation>
        </Reference>
        <Reference>
          <Citation>Chung-Hall J, Craig L, Fong GT, et al. . Impact of the WHO Framework Convention on Tobacco Control on the Implementation and Effectiveness of Tobacco Control Measures: A Global Evidence Review. Waterloo, Ontario, Canada: ITC Project, University of Waterloo, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization Framework Convention on Tobacco Control Conference of the Parties. Impact Assessment of the WHO FCTC: Report by the Expert Group. FCTC/COP/7/6
. 2016. 
http://www.who.int/fctc/cop/cop7/FCTC_COP_7_6_EN.pdf (30 Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization Convention on Tobacco Control Conference of the Parties. Guidelines for the implementation of Article 6 of the WHO FCTC (Decision FCTC/COP6(5)). Geneva, Switzerland: World Health Organization Press, 2014. 
http://www.who.int/fctc/guidelines/adopted/Guidelines_article_6.pdf (2018, March 17).</Citation>
        </Reference>
        <Reference>
          <Citation>Jha P, Chaloupka FJ. Curbing the Epidemic: Governments and the Economics of Tobacco Control. Washington, DC: World Bank, 1999.</Citation>
        </Reference>
        <Reference>
          <Citation>
International Agency for Research on Cancer. 2011. Effectiveness of Tax and Price Policies for Tobacco Control. IARC Handbooks of Cancer Prevention, Tobacco Control. 14
Lyon, France: International Agency for Research on Cancer; 
https://www.iarc.fr/en/publications/pdfs-online/prev/handbook14/handbook14.pdf (30 Aug 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>United States National Cancer Institute and World Health Organization. The Economics of Tobacco and Tobacco Control. National Cancer Institute Tobacco Control Monograph 21. NIH Publication No. 16-CA-8029A. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; and Geneva, CH: World Health Organization., 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization Framework Convention on Tobacco Control Convention Secretariat. Global Progress Report on implementation of the WHO Framework Convention on Tobacco Control. Geneva: WHO Press, 2016. 
http://www.who.int/fctc/reporting/2016globalprogressreport.pdf (30 Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organisation. WHO Report on the Global Tobacco Epidemic. 2017. 
http://www.who.int/tobacco/global_report/en/ (19 Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Blecher EH, van Walbeek CP. An international analysis of cigarette affordability. Tob Control 2004;13:339&#x2013;46. 10.1136/tc.2003.006726</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2003.006726</ArticleId>
            <ArticleId IdType="pmc">PMC1747952</ArticleId>
            <ArticleId IdType="pubmed">15564616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blecher E. Targeting the affordability of cigarettes: a new benchmark for taxation policy in low-income and-middle-income countries. Tob Control 2010;19:325&#x2013;30. 10.1136/tc.2009.030155</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2009.030155</ArticleId>
            <ArticleId IdType="pubmed">20530141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
World Health Organisation. WHO Report on the Global Tobacco Epidemic. 2009. 
http://www.who.int/tobacco/global_report/en/ (19 Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organisation. WHO Report on the Global Tobacco Epidemic. 2011. 
http://www.who.int/tobacco/global_report/en/ (19 Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organisation. WHO Report on the Global Tobacco Epidemic. 2013. 
http://www.who.int/tobacco/global_report/en/ (19 Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organisation. WHO Report on the Global Tobacco Epidemic. 2015. 
http://www.who.int/tobacco/global_report/en/ (19 Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization Framework Convention on Tobacco Control Convention Secretariat. WHO FCTC Implementation Database. 2018. 
http://www.who.int/fctc/reporting/implement_database/en/ (30 May 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
United Nations Treaty Collection. 2018. World Health Organization Framework Convention on Tobacco Control
. Available
2018. 
https://treaties.un.org/pages/.</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization Framework Convention on Tobacco Control Convention Secretariat. Global Progress Report on implementation of the WHO Framework Convention on Tobacco Control. Geneva: WHO Press, 2014. 
http://www.who.int/fctc/reporting/2014globalprogressreport.pdf?ua=1 (30 Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Baloch A, et al. . The economics of tobacco and tobacco taxation in Pakistan. Paris: The Union, 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Chaloupka FJ, et al. . The economics of tobacco and tobacco taxation in the Philippines. Paris: The Union, 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>
Southeast Asia Initiative on Tobacco Tax of the Southeast Asian Tobacco Control Alliance. ASEAN tobacco tax report card: regional comparisons and trends. 5th ed: SEATCA, 2014. 
https://seatca.org/dmdocuments/ASEANTaxReportCard%20Sep14%20(1).pdf (11 Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Australian National Department of Health. Taxation: the history of tobacco excise arrangements in Australia since 1901: Government of Australia, 2014. 
http://www.health.gov.au/internet/main/publishing.nsf/content/tobacco-tax (2 Apr 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Thomas M.
Tobacco Excise Increase: Budget Review 2016-2017 Index. 2017. 
https://www.aph.gov.au/About_Parliament/Parliamentary_Departments/Parliamentary_Library/pubs/rp/BudgetReview201617/Tobacco (7 Apr 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Marquez PV.
Expanding the global tax base. Taxing to promote public goods: tobacco taxes. Panel session held as part of Winning the Tax Wars: Global Solutions for Developing Countries. Summary report. Washington: World Bank Group Conference, 2016. 
http://documents.worldbank.org/curated/en/820951485943150390/pdf/112347-WP-web-copy-PUBLIC.pdf (24 May 2016
11Mar 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization. Tobacco tax levels and structure: a theoretical and empirical overview: Types of taxes levied on tobacco products. Geneva Switzerland: WHO Technical Manual on Tax Administration; 
WHO Press, 2010. 
http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&amp;codcol=15&amp;codcch=786&amp;content=1 (08 May 2018).</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30043460</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1550-9613</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>38</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine</Title>
          <ISOAbbreviation>J Ultrasound Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of Noncommercial Ultrasound Gels for Use in Resource-Limited Settings.</ArticleTitle>
        <Pagination>
          <StartPage>371</StartPage>
          <EndPage>377</EndPage>
          <MedlinePgn>371-377</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/jum.14697</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Ultrasound (US) is increasingly used in settings where commercial US gel is unavailable. This study evaluated noncommercial gel recipes compared to commercial gel.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A search for US gel formulations revealed 6 recipes. Half-strength commercial gel and a modified glucomannan recipe were also tested. Nine gels, including commercial gel, were tested in Liberia and the United States. In each session, 2 physician sonologists evaluated 9 gels on 2 models, obtaining videos from the hepatorenal space with a curvilinear transducer, the cardiac parasternal long view with a phased array transducer, and the left basilic vein with a linear transducer. The sonologists and models, who were blinded to gel identity, made independent quantitative and qualitative gel evaluations comparing the test gel to commercial gel. Two physician sonologists who were blinded to the gel identities and a US operator reviewed the images and rated their quality. An analysis of variance in repeated measures was performed to test for differences in the overall score, real-time quality, and other characteristics. Post hoc pairwise comparisons to commercial gel were performed with a Tukey-Kramer adjustment. Inter- and intra-rater reliability was calculated for the image review.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Commercial gel earned a perfect score. Compared to commercial gel, xanthine gum gel scored highest, followed by half-strength commercial gel. Hot concentrated glucomannan and cold glucomannan gel were found to be significantly worse than commercial gel. No significant difference was found between images based on the gel used on the image review.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">No significant difference in image quality was found between commercial and noncommercial gels on US image review.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 by the American Institute of Ultrasound in Medicine.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vinograd</LastName>
            <ForeName>Alexandra M</ForeName>
            <Initials>AM</Initials>
            <Identifier Source="ORCID">0000-0003-0931-4842</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Emergency Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fasina</LastName>
            <ForeName>Abiola</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>US Military HIV Research Program, Bethesda, Maryland USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dean</LastName>
            <ForeName>Anthony J</ForeName>
            <Initials>AJ</Initials>
            <AffiliationInfo>
              <Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shofer</LastName>
            <ForeName>Frances</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Panebianco</LastName>
            <ForeName>Nova L</ForeName>
            <Initials>NL</Initials>
            <Identifier Source="ORCID">0000-0003-3878-0279</Identifier>
            <AffiliationInfo>
              <Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lewiss</LastName>
            <ForeName>Resa E</ForeName>
            <Initials>RE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, University of Colorado, Denver, Colorado USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Saurabh</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>State University of New York Upstate Medical University, Syracuse, New York USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rao</LastName>
            <ForeName>A K Raja</ForeName>
            <Initials>AKR</Initials>
            <AffiliationInfo>
              <Affiliation>Ashland Community Hospital, Ashland, Oregon USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Henwood</LastName>
            <ForeName>Patricia C</ForeName>
            <Initials>PC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Ultrasound Med</MedlineTA>
        <NlmUniqueID>8211547</NlmUniqueID>
        <ISSNLinking>0278-4297</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005782">Gels</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName>
          <QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005782" MajorTopicYN="N">Gels</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006295" MajorTopicYN="N">Health Resources</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName>
          <QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007988" MajorTopicYN="N" Type="Geographic">Liberia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014159" MajorTopicYN="N">Transducers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName>
          <QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">resource-limited</Keyword>
        <Keyword MajorTopicYN="N">ultrasound gel</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30043460</ArticleId>
        <ArticleId IdType="doi">10.1002/jum.14697</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30041997</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0929-6646</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>118</Volume>
            <Issue>1 Pt 2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the Formosan Medical Association = Taiwan yi zhi</Title>
          <ISOAbbreviation>J Formos Med Assoc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>First tidal volume greater than 8&#xA0;mL/kg is associated with increased mortality in complicated influenza infection with acute respiratory distress syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>378</StartPage>
          <EndPage>385</EndPage>
          <MedlinePgn>378-385</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jfma.2018.06.010</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0929-6646(17)30736-2</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUNDS" NlmCategory="BACKGROUND">Severe influenza infection causes substantial morbidity and mortality worldwide and remains an important threat to global health. This study addressed factors related to treatment outcomes in subjects of complicated influenza infection with acute respiratory distress syndrome (ARDS) during the Taiwan epidemic in the Spring of 2016.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective study conducted by Taiwan Severe Influenza Research Consortium (TSIRC), including eight tertiary referral medical centers. Patients with virology-proven influenza infection admitted to intensive care unit (ICU) between January and March 2016 were included for analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 263 patients with complicated influenza infection who fulfilled ARDS criteria; the mean age was 59.8&#xA0;&#xB1;&#xA0;14.6 (years), and 66.1% (166/263) were male. Type A influenza (77.9%, 205/263) virus was the main pathogen during this epidemic. The 30-day mortality rate was 23.2% (61/263). The mean tidal volume (V<sub>T</sub>) in the first three days after intubation was greater than 8&#xA0;mL/kg of predicted body weight (PBW). Patients whose first measured V<sub>T</sub> was &gt;8&#xA0;mL/kg PBW had an increased 30-day mortality (p&#xA0;=&#xA0;0.04, log-rank test). In a multivariate Cox proportional hazard regression model, an increase of 1&#xA0;mL/kg PBW of first V<sub>T</sub> was associated with 26.1% increase in 30-day mortality (adjusted hazard ratio 1.261, 95% confidence interval [CI] 1.072-1.484, p&#xA0;&lt;&#xA0;0.01).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">First tidal volume, shortly after intubation, greater than 8&#xA0;mL/kg PBW is an independent risk factor for mortality in complicated influenza infection with ARDS. Timely recognition of ARDS with strict adherence to protective ventilation strategy of lowering V<sub>T</sub> may be important in reducing mortality.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018. Published by Elsevier B.V.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chan</LastName>
            <ForeName>Ming-Cheng</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Central Taiwan University of Science and Technology, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chao</LastName>
            <ForeName>Wen-Cheng</ForeName>
            <Initials>WC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Shinn-Jye</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tseng</LastName>
            <ForeName>Chien-Hua</ForeName>
            <Initials>CH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Critical Care Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Hao-Chien</ForeName>
            <Initials>HC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Chest Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chien</LastName>
            <ForeName>Ying-Chun</ForeName>
            <Initials>YC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Chest Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Kuang-Yao</ForeName>
            <Initials>KY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Emergency and Critical Care Medicine, National Yang-Ming University, Taipei, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Wei-Chih</ForeName>
            <Initials>WC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perng</LastName>
            <ForeName>Wann-Cherng</ForeName>
            <Initials>WC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kao</LastName>
            <ForeName>Kuo-Chin</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Respiratory Therapy, Chang-Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Han-Chung</ForeName>
            <Initials>HC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Respiratory Therapy, Chang-Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sheu</LastName>
            <ForeName>Chau-Chyun</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Wei-An</ForeName>
            <Initials>WA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Wen-Feng</ForeName>
            <Initials>WF</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan; Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi 813, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yu-Mu</ForeName>
            <Initials>YM</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan; Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi 813, Taiwan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Slutsky</LastName>
            <ForeName>Arthur S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Keenan Research Center at the Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Canada; The Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Chieh-Liang</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Center for Quality Management, Taichung Veterans General Hospital, Taichung, Taiwan; Office of Medical Administration, Taichung Veterans General Hospital, Taichung, Taiwan. Electronic address: cljeff.wu@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>for Taiwan Severe Influenza Research Consortium (TSIRC) Investigators</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016448">Multicenter Study</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Singapore</Country>
        <MedlineTA>J Formos Med Assoc</MedlineTA>
        <NlmUniqueID>9214933</NlmUniqueID>
        <ISSNLinking>0929-6646</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName>
          <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Acute respiratory distress syndrome</Keyword>
        <Keyword MajorTopicYN="N">Influenza</Keyword>
        <Keyword MajorTopicYN="N">Tidal volume</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30041997</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jfma.2018.06.010</ArticleId>
        <ArticleId IdType="pii">S0929-6646(17)30736-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30039849</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1466-7657</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>66</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>International nursing review</Title>
          <ISOAbbreviation>Int Nurs Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A nursing shortage - a prospect of global and local policies.</ArticleTitle>
        <Pagination>
          <StartPage>9</StartPage>
          <EndPage>16</EndPage>
          <MedlinePgn>9-16</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/inr.12473</ELocationID>
        <Abstract>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">The article addresses selected determinants of the nursing shortage in Poland and other countries in the face of employee ageing.</AbstractText>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Global demographic changes have led to a systematic increase in the elderly population and a decreasing number of births, which have impacted health policy and healthcare systems in various countries. Both processes necessitate transitions in global health care. Nursing care, which has faced a human resources crisis, is a strategic area within this context.</AbstractText>
          <AbstractText Label="SOURCES OF EVIDENCE" NlmCategory="METHODS">This study is based on national listings and strategic documents for nursing policy in Poland, including Increasing average age of nurses and midwives prepared by the Polish Main Council of Nurses and Midwives, the incorporation of big data, international reports and a literature review on nursing and healthcare challenges.</AbstractText>
          <AbstractText Label="DISCUSSION/CONCLUSIONS" NlmCategory="CONCLUSIONS">This paper argues that the causes of the nursing shortage are multifaceted with no single global or local measure of its nature. An overview of the problem indicates ineffective planning and use of available nursing resources, poor recruitment or an undersupply of a new staff, and global demographic conditions. The overview highlights the fact that nursing shortages have reached a critical point for healthcare services on both the local and global levels.</AbstractText>
          <AbstractText Label="CONCLUSIONS FOR NURSING AND HEALTH POLICY" NlmCategory="UNASSIGNED">The general recommendations for nursing policy include the need to prepare and implement national social security agendas into services provided by nurses. Such a programme would include general issues: improving working and employment conditions, implementing mechanisms regulating salary and providing the possibility of lifelong learning with the incorporation of mobile and technological innovations as a sustainable solution.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 International Council of Nurses.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mar&#x107;</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Nursing and Health Sciences, Centre for Innovative Research in Medical and Natural Sciences, University of Rzesz&#xF3;w, Rzesz&#xF3;w, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bartosiewicz</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Nursing and Health Sciences, Centre for Innovative Research in Medical and Natural Sciences, University of Rzesz&#xF3;w, Rzesz&#xF3;w, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burzy&#x144;ska</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Nursing and Health Sciences, Centre for Innovative Research in Medical and Natural Sciences, University of Rzesz&#xF3;w, Rzesz&#xF3;w, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chmiel</LastName>
            <ForeName>Z</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Nursing and Health Sciences, Centre for Innovative Research in Medical and Natural Sciences, University of Rzesz&#xF3;w, Rzesz&#xF3;w, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Januszewicz</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Public Health, Centre for Innovative Research in Medical and Natural Sciences, University of Rzesz&#xF3;w, Rzesz&#xF3;w, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int Nurs Rev</MedlineTA>
        <NlmUniqueID>7808754</NlmUniqueID>
        <ISSNLinking>0020-8132</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009740" MajorTopicYN="N">Nursing Staff</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
          <QualifierName UI="Q000600" MajorTopicYN="Y">supply &amp; distribution</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010561" MajorTopicYN="N">Personnel Staffing and Scheduling</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011044" MajorTopicYN="N" Type="Geographic">Poland</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ageing</Keyword>
        <Keyword MajorTopicYN="N">Healthcare System Reform</Keyword>
        <Keyword MajorTopicYN="N">Nursing Competences</Keyword>
        <Keyword MajorTopicYN="N">Nursing Policy</Keyword>
        <Keyword MajorTopicYN="N">Nursing Regulations</Keyword>
        <Keyword MajorTopicYN="N">Nursing Roles</Keyword>
        <Keyword MajorTopicYN="N">Nursing Shortage</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30039849</ArticleId>
        <ArticleId IdType="doi">10.1111/inr.12473</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30026189</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>08</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>02</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Secondhand smoke exposure during pregnancy: a cross-sectional analysis of data from Demographic and Health Survey from 30 low-income and middle-income countries.</ArticleTitle>
        <Pagination>
          <StartPage>420</StartPage>
          <EndPage>426</EndPage>
          <MedlinePgn>420-426</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054288</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Secondhand smoke (SHS) exposure during pregnancy increases the risk of infant stillbirth, congenital malformations, low birth weight and respiratory illnesses. However, little is known about the extent of SHS exposure during pregnancy. We assessed the prevalence of SHS exposure in pregnant women in low-income and middle-income countries (LMICs).</AbstractText>
          <AbstractText Label="METHODS">We used Demographic and Health Survey data collected between 2008 and 2013 from 30 LMICs. We estimated weighted country-specific prevalence of SHS exposure among 37&#x2009;427 pregnant women. We accounted for sampling weights, clustering and stratification in the sampling methods. We also explored associations between sociodemographic variables and SHS exposure in pregnant women using pairwise multinomial regression model.</AbstractText>
          <AbstractText Label="FINDINGS">The prevalence of daily SHS exposure during pregnancy ranged from 6% (95% CI 5% to 7%) (Nigeria) to 73% (95% CI 62% to 81%) (Armenia) and was greater than active tobacco use in pregnancy across all countries studied. Being wealthier, maternal employment, higher education and urban households were associated with lower SHS exposure in full regression models. SHS exposure in pregnant women closely mirrors WHO Global Adult Tobacco Survey male active smoking patterns. Daily SHS exposure accounted for a greater population attributable fraction of stillbirths than active smoking, ranging from 1% of stillbirths (Nigeria) to 14% (Indonesia).</AbstractText>
          <AbstractText Label="INTERPRETATION">We have demonstrated that SHS exposure during pregnancy is far more common than active smoking in LMICs, accounting for more stillbirths than active smoking. Protecting pregnant women from SHS exposure should be a key strategy to improve maternal and child health.</AbstractText>
          <CopyrightInformation>&#xA9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Reece</LastName>
            <ForeName>Sian</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-4563-6972</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Health Science, University of York, York, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Morgan</LastName>
            <ForeName>Camille</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Tobacco Control Research Branch, National Cancer Institute, Rockville, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parascandola</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Tobacco Control Research Branch, National Cancer Institute, Rockville, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siddiqi</LastName>
            <ForeName>Kamran</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Science, University of York, York, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>13007</GrantID>
            <Acronym>CRUK_</Acronym>
            <Agency>Cancer Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MR/J000248/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MR/M020533/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MR/P008941/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014028">Tobacco Smoke Pollution</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005191" MajorTopicYN="N">Family Characteristics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012907" MajorTopicYN="Y">Smoking</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050497" MajorTopicYN="N">Stillbirth</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014028" MajorTopicYN="Y">Tobacco Smoke Pollution</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">low/middle income country</Keyword>
        <Keyword MajorTopicYN="N">secondhand smoke</Keyword>
        <Keyword MajorTopicYN="N">surveillance and monitoring</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>8</Month>
          <Day>21</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30026189</ArticleId>
        <ArticleId IdType="mid">NIHMS1917128</ArticleId>
        <ArticleId IdType="pmc">PMC10442074</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054288</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054288</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rogers JM. Tobacco and pregnancy: overview of exposures and effects. Birth Defects Res C Embryo Today 2008;84:1&#x2013;15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18383133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cnattingius S The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine &amp; Tobacco Research 2004;6:125&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15203816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonardi-Bee J, Smyth A, Britton J, et al. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2008;93:F351&#x2013;F361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18218658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonardi-Bee J, Britton J, Venn A. Secondhand smoke and adverse fetal outcomes in nonsmoking pregnant women: a meta-analysis. Pediatrics 2011;127:734&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21382949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salmasi G, Grady R, Jones J, et al. Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol Scand 2010;89:423&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20085532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>United Nations. Sustainable development goals. 2017. 
https://sustainabledevelopment.un.org/sdgs (accessed Sep 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Caleyachetty R, Tait CA, Kengne AP, et al. Tobacco use in pregnant women: analysis of data from Demographic and Health Surveys from 54 low-income and middle-income countries. Lancet Glob Health 2014;2:e513&#x2013;e520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25304418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bloch M, Althabe F, Onyamboko M, et al. Tobacco use and secondhand smoke exposure during pregnancy: an investigative survey of women in 9 developing nations. Am J Public Health 2008;98:1833&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2636473</ArticleId>
            <ArticleId IdType="pubmed">18309125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oberg M, Woodward A, Jaakkola MS, et al.
Global estimate of the burden of disease from second-hand smoke. 2010. http://apps.who.int/iris/bitstream/10665/44426/1/9789241564076_eng.pdf (accessed 12 Jan 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Current tobacco use and secondhand smoke exposure among women of reproductive age&#x2013;14 countries, 2008&#x2013;2010. MMWR Morb Mortal Wkly Rep 2012;61:877&#x2013;82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23114255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hyss&#xE4;l&#xE4; L, Rautava P, Sillanp&#xE4;&#xE4; M, et al. Changes in the smoking and drinking habits of future fathers from the onset of their wives&#x2019; pregnancies. J Adv Nurs 1992;17:849&#x2013;54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1644981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pollak KI, Mullen PD. An exploration of the effects of partner smoking, type of social support, and stress on postpartum smoking in married women who stopped smoking during pregnancy. Psychology of Addictive Behaviors 1997;11:182&#x2013;9.</Citation>
        </Reference>
        <Reference>
          <Citation>Everett KD, Gage J, Bullock L, et al. A pilot study of smoking and associated behaviors of low-income expectant fathers. Nicotine Tob Res 2005;7:269&#x2013;76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16036284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gage JD, Everett KD, Bullock L. A review of research literature addressing male partners and smoking during pregnancy. J Obstet Gynecol Neonatal Nurs 2007;36:574&#x2013;80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17973701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oberg M, Jaakkola MS, Woodward A, et al. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 2011;377:139&#x2013;46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21112082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The DHS Program. DHS-Questionnaires. http://dhsprogram.com/What-We-Do/Survey-Types/DHS-Questionnaires.cfm (accessed Mar 2016).</Citation>
        </Reference>
        <Reference>
          <Citation>The DHS Program. DHS Model Questionnaire &#x2013; Phase 6 (2008&#x2013;2013) (French, English). http://dhsprogram.com/publications/publication-dhsq6-dhs-questionnaires-and-manuals.cfm (accessed Mar 2016).</Citation>
        </Reference>
        <Reference>
          <Citation>The DHS Program. Demographic and Health Surveys (DHS). http://www.dhsprogram.com/What-We-Do/Survey-Types/DHS.cfm (accessed Jan 2016).</Citation>
        </Reference>
        <Reference>
          <Citation>Graubard BI, Korn EL. Predictive margins with survey data. Biometrics 1999;55:652&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11318229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011;377:1331&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21496916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flegal KM, Panagiotou OA, Graubard BI. Estimating population attributable fractions to quantify the health burden of obesity. Ann Epidemiol 2015;25:201&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4383168</ArticleId>
            <ArticleId IdType="pubmed">25511307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO. WHO regional offices. 2017. 
http://www.who.int/about/regions/en/ (accessed Aug 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organisation. Tobacco and poverty: a vicious circle. Geneva
2004. 
http://www.who.int/tobacco/communications/events/wntd/2004/en/wntd2004_brochure_en.pdf (accessed Aug 27, 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Sehgal M, Rizwan SA, Krishnan A. Disease burden due to biomass cooking-fuel-related household air pollution among women in India. Glob Health Action 2014;7:25326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4221659</ArticleId>
            <ArticleId IdType="pubmed">25373414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lakshmi PV, Virdi NK, Sharma A, et al. Household air pollution and stillbirths in India: analysis of the DLHS-II National Survey. Environ Res 2013;121:17&#x2013;22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23375552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fischer F, Minnwegen M, Kaneider U, et al. Prevalence and determinants of secondhand smoke exposure among women in Bangladesh, 2011. Nicotine Tob Res 2015;17:58&#x2013;65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4832965</ArticleId>
            <ArticleId IdType="pubmed">25125322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azab M, Khabour OF, Alzoubi KH, et al. Exposure of pregnant women to waterpipe and cigarette smoke. Nicotine Tob Res 2013;15:231&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3524068</ArticleId>
            <ArticleId IdType="pubmed">22573726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Global Adult Tobacco Survey (GATS). 2015. http://gatsatlas.org/#section_read (accessed Aug 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Tobacco control country profiles. 2017. http://www.who.int/tobacco/surveillance/policy/country_profile/en/ (accessed Jan 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Guinea tobacco country profile. 2002. http://www.who.int/tobacco/media/en/Guinea.pdf (accessed Jan 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Jordan tobacco country profile. 1999. http://www.who.int/tobacco/media/en/Jordan.pdf (accessed Jan 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Tobacco control fact sheet: Tajikistan. 2016. http://www.euro.who.int/__data/assets/pdf_file/0007/337435/Tobacco-Control-Fact-Sheet-Tajikistan.pdf (accessed Jan 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Index Mundi. Mali - smoking prevalence. 2018. https://www.indexmundi.com/facts/mali/smoking-prevalence (accessed Jan 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Passey ME, Longman JM, Robinson J, et al. Smoke-free homes: what are the barriers, motivators and enablers? A qualitative systematic review and thematic synthesis. BMJ Open 2016;6:e010260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4800143</ArticleId>
            <ArticleId IdType="pubmed">26988351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Office on Smoking and Health. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General: Centers for Disease Control and Prevention, 2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20669524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quintana PJ, Matt GE, Chatfield D, et al. Wipe sampling for nicotine as a marker of thirdhand tobacco smoke contamination on surfaces in homes, cars, and hotels. Nicotine Tob Res 2013;15:1555&#x2013;63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23460657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaleta D, Polanska K, Usidame B. Smoke-free workplaces are associated with protection from second-hand smoke at homes in nigeria: evidence for population-level decisions. Biomed Res Int 2015;2015:1&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4609351</ArticleId>
            <ArticleId IdType="pubmed">26504817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pierce JP, White VM, Emery SL. What public health strategies are needed to reduce smoking initiation? Tob Control 2012;21:258&#x2013;64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22345263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy. 2013. http://www.who.int/tobacco/publications/pregnancy/guidelinestobaccosmokeexposure/en/ (accessed Aug 2017).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24649520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong VT, Dietz PM, Rolle IV, et al. Clinical interventions to reduce secondhand smoke exposure among pregnant women: a systematic review. Tob Control 2015;24:217&#x2013;23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4924528</ArticleId>
            <ArticleId IdType="pubmed">24789602</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30024353</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-1706</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global public health</Title>
          <ISOAbbreviation>Glob Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Engagement or dismissiveness? Intersecting international theory and global health.</ArticleTitle>
        <Pagination>
          <StartPage>503</StartPage>
          <EndPage>514</EndPage>
          <MedlinePgn>503-514</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2018.1500621</ELocationID>
        <Abstract>
          <AbstractText>International relations theorists and global health politics scholars largely fail to communicate with one another. We argue that drawing on insights from classic and contemporary international theory more explicitly will positively augment the study of global health politics. This paper highlights four major theoretical orientations in the international relations literature (realism, neoliberal institutionalism, constructivism, and feminism) and discusses how an understanding of these perspectives can strengthen our understanding of global health policy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Paxton</LastName>
            <ForeName>Nathan</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-7602-2842</Identifier>
            <AffiliationInfo>
              <Affiliation>a Independent Scholar , Washington, DC , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Youde</LastName>
            <ForeName>Jeremy</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-5449-1840</Identifier>
            <AffiliationInfo>
              <Affiliation>b Department of International Relations , Australian National University , Canberra , Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Public Health</MedlineTA>
        <NlmUniqueID>101256323</NlmUniqueID>
        <ISSNLinking>1744-1692</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D019513" MajorTopicYN="N">Feminism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D038622" MajorTopicYN="Y">Internationality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011057" MajorTopicYN="N">Politics</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Realism</Keyword>
        <Keyword MajorTopicYN="N">constructivism</Keyword>
        <Keyword MajorTopicYN="N">feminism</Keyword>
        <Keyword MajorTopicYN="N">international relations theory</Keyword>
        <Keyword MajorTopicYN="N">neoliberal institutionalism</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30024353</ArticleId>
        <ArticleId IdType="doi">10.1080/17441692.2018.1500621</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30019309</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1568-5608</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Inflammopharmacology</Title>
          <ISOAbbreviation>Inflammopharmacology</ISOAbbreviation>
        </Journal>
        <ArticleTitle>25-hydroxycholesterol reduces inflammation, viral load and cell death in ZIKV-infected U-87 MG glial cell line.</ArticleTitle>
        <Pagination>
          <StartPage>621</StartPage>
          <EndPage>625</EndPage>
          <MedlinePgn>621-625</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10787-018-0517-6</ELocationID>
        <Abstract>
          <AbstractText>Zika virus (ZIKV) infection is a global health issue due to its worldwide diffusion and to the related effects on neural progenitor cells with severe consequences on developing brain as well as on the central nervous system of adults. Previous studies showed that ZIKV infection induces an increment of IL1B expression in the central nervous system and also in the blood. IL-1&#x3B2; is a pro-inflammatory cytokine essential for cellular defence, tissue repair and neuroinflammation, a mechanism seen to be associated with several neuroinflammatory diseases. 25-hydroxycholesterol (25-HC) is a natural oxysterol, derived from hydroxylation of cholesterol, possessing important antiviral activity possibly correlated to its ability to alter host membrane structures. Furthermore, 25-HC is involved in the modulation of IL1B gene expression, being able to suppress IL-1&#x3B2; driven inflammation probably by blocking the activation of the SREB proteins. In our study, we analysed the antiviral action of 25-HC in ZIKV-infected U-87 MG cells, also evaluating its impact on inflammation and cell death. We demonstrated that 25-HC is able to reduce inflammation and cell death caused by ZIKV infection and also to diminish intracellular ZIKV load in U-87 MG glial cell line. Considering its antiviral activity and its ability to penetrate blood-brain barrier, 25-HC could be proposed, based on our results and literature findings, as a potential anti-ZIKV agent.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tricarico</LastName>
            <ForeName>Paola Maura</ForeName>
            <Initials>PM</Initials>
            <AffiliationInfo>
              <Affiliation>University of Trieste, Piazzale Europa 1, 34128, Trieste, Italy. tricaricopa@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Caracciolo</LastName>
            <ForeName>Ilaria</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>University of Trieste, Piazzale Europa 1, 34128, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gratton</LastName>
            <ForeName>Rossella</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Maternal and Child Health "Burlo Garofolo", Via dell' Istria 65/1, 34137, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>D'Agaro</LastName>
            <ForeName>Pierlanfranco</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>University of Trieste, Piazzale Europa 1, 34128, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Crovella</LastName>
            <ForeName>Sergio</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>University of Trieste, Piazzale Europa 1, 34128, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Maternal and Child Health "Burlo Garofolo", Via dell' Istria 65/1, 34137, Trieste, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Inflammopharmacology</MedlineTA>
        <NlmUniqueID>9112626</NlmUniqueID>
        <ISSNLinking>0925-4692</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006888">Hydroxycholesterols</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>767JTD2N31</RegistryNumber>
          <NameOfSubstance UI="C007997">25-hydroxycholesterol</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006888" MajorTopicYN="N">Hydroxycholesterols</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071243" MajorTopicYN="N">Zika Virus Infection</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">25-hydroxycholesterol</Keyword>
        <Keyword MajorTopicYN="N">Inflammation</Keyword>
        <Keyword MajorTopicYN="N">U-87 MG glial cell line</Keyword>
        <Keyword MajorTopicYN="N">ZIKV</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30019309</ArticleId>
        <ArticleId IdType="doi">10.1007/s10787-018-0517-6</ArticleId>
        <ArticleId IdType="pii">10.1007/s10787-018-0517-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Neuroimmunol. 2001 Apr 2;115(1-2):182-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11282169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Methods. 2001 Dec;25(4):402-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Novartis Found Symp. 2005;265:66-80; discussion 82-97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16050251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Neuroimmunol. 2008 Mar;195(1-2):60-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18374991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emerg Infect Dis. 2008 Aug;14(8):1232-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18680646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Viruses. 2011 Feb;3(2):160-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22049308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Hum Reprod. 2012 Jul;18(7):341-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22238372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Redox Biol. 2013 Jan 31;1:125-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24024145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Biol Chem. 2013 Dec 13;288(50):35812-23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24189069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 2014 Aug 8;345(6197):679-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25104388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sci Rep. 2014 Dec 15;4:7487</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25501851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Cardiol. 2015 Apr 1;184:255-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25726901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Neurodegener Dis. 2012 Aug;1(2):195-211</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26082912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS Pathog. 2015 Sep 14;11(9):e1005155</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26367131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med Microbiol Immunol. 2016 Jun;205(3):269-73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26702627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Aspects Med. 2016 Jun;49:23-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27086126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cell Stem Cell. 2016 Nov 3;19(5):593-598</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27545505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arq Neuropsiquiatr. 2016 Nov;74(11):937-943</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27901259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem Biophys Res Commun. 2017 Oct 28;492(4):597-602</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28153732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Immunity. 2017 Mar 21;46(3):446-456</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28314593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Infect Dis. 2017 Apr 1;64(7):914-920</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28362944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Commun. 2018 Jan 9;9(1):106</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29317641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Infect Dis. 2018 May 25;217(12):1942-1951</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29518228</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30018131</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>10</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1549-490X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>The oncologist</Title>
          <ISOAbbreviation>Oncologist</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors.</ArticleTitle>
        <Pagination>
          <StartPage>319</StartPage>
          <EndPage>326</EndPage>
          <MedlinePgn>319-326</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1634/theoncologist.2018-0117</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">The incidence of colorectal cancer (CRC) in younger patients is rising, mostly due to tumors in the descending colon and rectum. Therefore, we aimed to explore the molecular differences of left-sided CRC between younger (&#x2264;45 years) and older patients (&#x2265;65).</AbstractText>
          <AbstractText Label="SUBJECTS, MATERIALS, AND METHODS">In total, 1,126 CRC tumor samples from the splenic flexure to (and including) the rectum were examined by next-generation sequencing (NGS), immunohistochemistry, and in situ hybridization. Microsatellite instability (MSI) and tumor mutational burden (TMB) were assessed by NGS.</AbstractText>
          <AbstractText Label="RESULTS">Younger patients (<i>n</i>&#x2009;=&#x2009;350), when compared with older patients (<i>n</i>&#x2009;=&#x2009;776), showed higher mutation rates in genes associated with cancer-predisposing syndromes (e.g., Lynch syndrome), such as <i>MSH6</i> (4.8% vs. 1.2%, <i>p</i>&#x2009;=&#x2009;.005), <i>MSH2</i> (2.7% vs. 0.0%, <i>p</i>&#x2009;=&#x2009;.004), <i>POLE</i> (1.6% vs. 0.0%, <i>p</i>&#x2009;=&#x2009;.008), <i>NF1</i> (5.9% vs. 0.5%, <i>p</i>&#x2009;&lt;&#x2009;.001), <i>SMAD4</i> (14.3% vs. 8.3%, <i>p</i>&#x2009;=&#x2009;.024), and <i>BRCA2</i> (3.7% vs. 0.5%, <i>p</i>&#x2009;=&#x2009;.002). Genes involved in histone modification were also significantly more mutated: <i>KDM5C</i> (1.9% vs. 0%, <i>p</i>&#x2009;=&#x2009;.036), <i>KMT2A</i> (1.1% vs. 0%, <i>p</i>&#x2009;=&#x2009;.033), <i>KMT2C</i> (1.6% vs. 0%, <i>p</i>&#x2009;=&#x2009;.031), <i>KMT2D</i> (3.8% vs. 0.7%, <i>p</i>&#x2009;=&#x2009;.005), and <i>SETD2</i> (3.2% vs. 0.9%, <i>p</i>&#x2009;=&#x2009;.039). Finally, TMB-high (9.7% vs. 2.8%, <i>p</i>&#x2009;&lt;&#x2009;.001) and MSI-high (MSI-H; 8.1% vs. 1.9%, <i>p</i>&#x2009;=&#x2009;.009) were more frequent in younger patients.</AbstractText>
          <AbstractText Label="CONCLUSION">Our findings highlight the importance of genetic counseling and screening in younger CRC patients. MSI-H and TMB-high tumors could benefit from immune-checkpoint inhibitors, now approved for the treatment of MSI-H/deficient mismatch repair metastatic CRC patients. Finally, histone modifiers could serve as a new promising therapeutic target. With confirmatory studies, these results may influence our approach to younger adults with CRC.</AbstractText>
          <AbstractText Label="IMPLICATIONS FOR PRACTICE">The increasing rate of colorectal cancers (CRC), primarily distal tumors, among young adults poses a global health issue. This study investigates the molecular differences between younger (&#x2264;45 years old) and older (&#x2265;65) adults with left-sided CRCs. Younger patients more frequently harbor mutations in genes associated with cancer-predisposing syndromes. Higher rates of microsatellite instability-high and tumor mutational burden-high tumors occur in younger patients, who could benefit from immune-checkpoint inhibitors. Finally, histone modifiers are more frequently mutated in younger patients and could serve as a new promising therapeutic target. This study provides new insights into mutations that may guide development of novel tailored therapy in younger CRC patients.</AbstractText>
          <CopyrightInformation>&#xA9; AlphaMed Press 2018.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Puccini</LastName>
            <ForeName>Alberto</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-2492-4043</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Ospedale Policlinico San Martino, Genova, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lenz</LastName>
            <ForeName>Heinz-Josef</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marshall</LastName>
            <ForeName>John L</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arguello</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Caris Life Sciences, Phoenix, Arizona, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raghavan</LastName>
            <ForeName>Derek</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Korn</LastName>
            <ForeName>W Michael</ForeName>
            <Initials>WM</Initials>
            <AffiliationInfo>
              <Affiliation>Caris Life Sciences, Phoenix, Arizona, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weinberg</LastName>
            <ForeName>Benjamin A</ForeName>
            <Initials>BA</Initials>
            <AffiliationInfo>
              <Affiliation>Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Poorman</LastName>
            <ForeName>Kelsey</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Caris Life Sciences, Phoenix, Arizona, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Heeke</LastName>
            <ForeName>Arielle L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Philip</LastName>
            <ForeName>Philip A</ForeName>
            <Initials>PA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shields</LastName>
            <ForeName>Anthony F</ForeName>
            <Initials>AF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goldberg</LastName>
            <ForeName>Richard M</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>West Virginia University Cancer Institute, Morgantown, West Virginia, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salem</LastName>
            <ForeName>Mohamed E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA mohamed.salem@carolinashealthcare.org.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Oncologist</MedlineTA>
        <NlmUniqueID>9607837</NlmUniqueID>
        <ISSNLinking>1083-7159</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="chi">
        <AbstractText><b>&#x6458;&#x8981;</b><b><i>&#x80CC;&#x666F;&#x3002;</i></b>&#x7ED3;&#x76F4;&#x80A0;&#x764C; (CRC) &#x5728;&#x5E74;&#x8F7B;&#x60A3;&#x8005;&#x4E2D;&#x7684;&#x53D1;&#x75C5;&#x7387;&#x5448;&#x4E0A;&#x5347;&#x8D8B;&#x52BF;&#xFF0C;&#x8FD9;&#x4E3B;&#x8981;&#x662F;&#x7531;&#x4E8E;&#x964D;&#x7ED3;&#x80A0;&#x548C;&#x76F4;&#x80A0;&#x4E2D;&#x7684;&#x80BF;&#x7624;&#x6240;&#x5BFC;&#x81F4;&#x3002;&#x56E0;&#x6B64;&#xFF0C;&#x6211;&#x4EEC;&#x65E8;&#x5728;&#x63A2;&#x8BA8;&#x5E74;&#x8F7B;&#x60A3;&#x8005;(&#x2264;45 &#x5C81;)&#x4E0E;&#x5E74;&#x957F;&#x60A3;&#x8005;(&#x2265;65 &#x5C81;)&#x4E4B;&#x95F4;&#x7684;&#x5DE6;&#x4FA7; CRC &#x5206;&#x5B50;&#x5DEE;&#x5F02;&#x3002; <b><i>&#x53D7;&#x8BD5;&#x8005;&#x3001;&#x6750;&#x6599;&#x548C;&#x65B9;&#x6CD5;&#x3002;</i></b>&#x901A;&#x8FC7;&#x4E0B;&#x4E00;&#x4EE3;&#x6D4B;&#x5E8F; (NGS)&#x3001;&#x514D;&#x75AB;&#x7EC4;&#x7EC7;&#x5316;&#x5B66;&#x548C;&#x539F;&#x4F4D;&#x5206;&#x5B50;&#x6742;&#x4EA4;&#x7684;&#x65B9;&#x6CD5;&#xFF0C;&#x4E00;&#x5171;&#x5BF9; 1 126 &#x4E2A;&#x53D6;&#x6837;&#x81EA;&#x7ED3;&#x80A0;&#x813E;&#x66F2;&#x81F3;(&#x5E76;&#x5305;&#x62EC;)&#x76F4;&#x80A0;&#x7684; CRC &#x80BF;&#x7624;&#x6837;&#x672C;&#x8FDB;&#x884C;&#x4E86;&#x68C0;&#x67E5;&#x3002;&#x901A;&#x8FC7; NGS &#x5BF9;&#x5FAE;&#x536B;&#x661F;&#x4E0D;&#x7A33;&#x5B9A;&#x6027; (MSI) &#x548C;&#x80BF;&#x7624;&#x7A81;&#x53D8;&#x8D1F;&#x8377; (TMB) &#x8FDB;&#x884C;&#x4E86;&#x8BC4;&#x4F30;&#x3002; <b><i>&#x7ED3;&#x679C;&#x3002;</i></b>&#x7814;&#x7A76;&#x8868;&#x660E;&#xFF0C;&#x5E74;&#x8F7B;&#x60A3;&#x8005; (n = 350) &#x4E0E;&#x5E74;&#x957F;&#x60A3;&#x8005; (n = 776) &#x76F8;&#x6BD4;&#xFF0C;&#x764C;&#x75C7;&#x6613;&#x611F;&#x7EFC;&#x5408;&#x5F81;(&#x4F8B;&#x5982;&#x6797;&#x5947;&#x7EFC;&#x5408;&#x5F81;)&#x76F8;&#x5173;&#x7684;&#x57FA;&#x56E0;&#x7A81;&#x53D8;&#x7387;&#x8F83;&#x9AD8;&#xFF0C;&#x5982; <i>MSH6</i>(4.8% vs. 1.2%&#xFF0C;<i>p</i> = 0.005)&#x3001;<i>MSH2</i>(2.7% vs. 0.0%&#xFF0C;<i>p</i> = 0.004)&#x3001;<i>POLE</i>(1.6% vs. 0.0%&#xFF0C;<i>p</i> = 0.008)&#x3001;<i>NF1</i>(5.9% vs. 0.5%&#xFF0C;<i>p</i> &lt; 0.001)&#x3001;<i>SMAD4</i>(14.3% vs. 8.3%&#xFF0C;<i>p</i> = 0.024)&#x4EE5;&#x53CA; <i>BRCA2</i>(3.7% vs. 0.5%&#xFF0C;<i>p</i> = 0.002)&#x3002;&#x53C2;&#x4E0E;&#x7EC4;&#x86CB;&#x767D;&#x4FEE;&#x9970;&#x7684;&#x57FA;&#x56E0;&#x4E5F;&#x53D1;&#x751F;&#x4E86;&#x66F4;&#x4E3A;&#x663E;&#x8457;&#x7684;&#x7A81;&#x53D8;:<i>KDM5C</i>(1.9% vs. 0%&#xFF0C;<i>p</i> = 0.036)&#x3001;<i>KMT2A</i>(1.1% vs. 0%&#xFF0C;<i>p</i> = 0.033)&#x3001;<i>KMT2C</i>(1.6% vs. 0%&#xFF0C;<i>p</i> = 0.031)&#x3001;<i>KMT2D</i>(3.8% vs. 0.7%&#xFF0C;<i>p</i> = 0.005)&#x4EE5;&#x53CA; <i>SETD2</i>(3.2% vs. 0.9%&#xFF0C;<i>p</i> = 0.039)&#x3002;&#x6700;&#x540E;&#xFF0C;&#x5E74;&#x8F7B;&#x60A3;&#x8005;&#x51FA;&#x73B0; TMB &#x9AD8;(9.7% vs. 2.8%&#xFF0C;<i>p</i> &lt; 0.001)&#x548C; MSI &#x9AD8;(MSI&#x2010;H&#xFF1B;8.1% vs. 1.9%&#xFF0C;<i>p</i> = 0.009)&#x7684;&#x9891;&#x7387;&#x66F4;&#x9AD8;&#x3002; <b><i>&#x7ED3;&#x8BBA;&#x3002;</i></b>&#x6211;&#x4EEC;&#x7684;&#x7814;&#x7A76;&#x7ED3;&#x679C;&#x5F3A;&#x8C03;&#x4E86;&#x5728; CRC &#x5E74;&#x8F7B;&#x60A3;&#x8005;&#x4E2D;&#x5F00;&#x5C55;&#x9057;&#x4F20;&#x54A8;&#x8BE2;&#x4E0E;&#x7B5B;&#x67E5;&#x7684;&#x91CD;&#x8981;&#x6027;&#x3002;MSI&#x2010;H &#x548C; TMB &#x9AD8;&#x7684;&#x80BF;&#x7624;&#x53EF;&#x4EE5;&#x5F97;&#x76CA;&#x4E8E;&#x514D;&#x75AB;&#x68C0;&#x67E5;&#x70B9;&#x6291;&#x5236;&#x5242;&#xFF0C;&#x8BE5;&#x6291;&#x5236;&#x5242;&#x73B0;&#x5DF2;&#x83B7;&#x51C6;&#x7528;&#x4E8E;&#x6CBB;&#x7597; MSI&#x2010;H/&#x7F3A;&#x5931;&#x6027;&#x9519;&#x914D;&#x4FEE;&#x590D;&#x8F6C;&#x79FB;&#x6027; CRC &#x60A3;&#x8005;&#x3002;&#x6700;&#x540E;&#xFF0C;&#x7EC4;&#x86CB;&#x767D;&#x4FEE;&#x9970;&#x57FA;&#x56E0;&#x53EF;&#x4EE5;&#x4F5C;&#x4E3A;&#x4E00;&#x4E2A;&#x6709;&#x5E0C;&#x671B;&#x7684;&#x5168;&#x65B0;&#x6CBB;&#x7597;&#x9776;&#x70B9;&#x3002;&#x901A;&#x8FC7;&#x9A8C;&#x8BC1;&#x6027;&#x7814;&#x7A76;&#xFF0C;&#x8FD9;&#x4E9B;&#x7ED3;&#x679C;&#x53EF;&#x80FD;&#x4F1A;&#x5F71;&#x54CD;&#x6211;&#x4EEC;&#x5BF9;&#x60A3;CRC &#x7684;&#x5E74;&#x8F7B;&#x6210;&#x4EBA;&#x7684;&#x6CBB;&#x7597;&#x65B9;&#x6CD5;&#x3002; <b>&#x5BF9;&#x4E34;&#x5E8A;&#x5B9E;&#x8DF5;&#x7684;&#x63D0;&#x793A;:</b>&#x5E74;&#x8F7B;&#x6210;&#x4EBA;&#x7F79;&#x60A3;&#x7ED3;&#x76F4;&#x80A0;&#x764C; (CRC)(&#x4E3B;&#x8981;&#x662F;&#x8FDC;&#x7AEF;&#x80BF;&#x7624;)&#x7684;&#x589E;&#x957F;&#x7387;&#x5DF2;&#x6784;&#x6210;&#x5168;&#x7403;&#x6027;&#x7684;&#x5065;&#x5EB7;&#x95EE;&#x9898;&#x3002;&#x672C;&#x7814;&#x7A76;&#x8C03;&#x67E5;&#x4E86;&#x5DE6;&#x4FA7; CRC &#x5E74;&#x8F7B;&#x60A3;&#x8005;(&#x2264;45 &#x5C81;)&#x548C;&#x5E74;&#x957F;&#x60A3;&#x8005;(&#x2265;65 &#x5C81;)&#x4E4B;&#x95F4;&#x7684;&#x5206;&#x5B50;&#x5DEE;&#x5F02;&#x3002;&#x5E74;&#x8F7B;&#x60A3;&#x8005;&#x53D1;&#x751F;&#x4E0E;&#x764C;&#x75C7;&#x6613;&#x611F;&#x7EFC;&#x5408;&#x5F81;&#x76F8;&#x5173;&#x7684;&#x57FA;&#x56E0;&#x7A81;&#x53D8;&#x7684;&#x9891;&#x7387;&#x8F83;&#x9AD8;&#x3002;&#x5E74;&#x8F7B;&#x60A3;&#x8005;&#x7F79;&#x60A3;&#x5FAE;&#x536B;&#x661F;&#x4E0D;&#x7A33;&#x5B9A;&#x6027;&#x9AD8;&#x548C;&#x80BF;&#x7624;&#x7A81;&#x53D8;&#x8D1F;&#x8377;&#x9AD8;&#x7684;&#x80BF;&#x7624;&#x7684;&#x6BD4;&#x7387;&#x66F4;&#x9AD8;&#xFF0C;&#x4ED6;&#x4EEC;&#x53EF;&#x4EE5;&#x53D7;&#x76CA;&#x4E8E;&#x514D;&#x75AB;&#x68C0;&#x67E5;&#x70B9;&#x6291;&#x5236;&#x5242;&#x3002;&#x6700;&#x540E;&#xFF0C;&#x7EC4;&#x86CB;&#x767D;&#x4FEE;&#x9970;&#x57FA;&#x56E0;&#x5728;&#x5E74;&#x8F7B;&#x60A3;&#x8005;&#x4E2D;&#x53D1;&#x751F;&#x7A81;&#x53D8;&#x7684;&#x9891;&#x7387;&#x66F4;&#x9AD8;&#xFF0C;&#x53EF;&#x4EE5;&#x4F5C;&#x4E3A;&#x4E00;&#x4E2A;&#x6709;&#x5E0C;&#x671B;&#x7684;&#x5168;&#x65B0;&#x6CBB;&#x7597;&#x9776;&#x70B9;&#x3002;&#x672C;&#x7814;&#x7A76;&#x63D0;&#x51FA;&#x4E86;&#x6709;&#x5173;&#x57FA;&#x56E0;&#x7A81;&#x53D8;&#x7684;&#x5168;&#x65B0;&#x89C1;&#x89E3;&#xFF0C;&#x53EF;&#x4EE5;&#x4E3A;&#x7814;&#x53D1;&#x9488;&#x5BF9; CRC &#x5E74;&#x8F7B;&#x60A3;&#x8005;&#x7684;&#x65B0;&#x578B;&#x5B9A;&#x5236;&#x6CBB;&#x7597;&#x63D0;&#x4F9B;&#x6307;&#x5BFC;&#x3002;</AbstractText>
        <CopyrightInformation>&#xA9; AlphaMed Press 2018.</CopyrightInformation>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cancer syndromes</Keyword>
        <Keyword MajorTopicYN="N">Colorectal cancer</Keyword>
        <Keyword MajorTopicYN="N">Early&#x2010;onset</Keyword>
        <Keyword MajorTopicYN="N">Histone modifiers</Keyword>
        <Keyword MajorTopicYN="N">Microsatellite instability</Keyword>
        <Keyword MajorTopicYN="N">Tumor mutational burden</Keyword>
      </KeywordList>
      <CoiStatement>Disclosures of potential conflicts of interest may be found at the end of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30018131</ArticleId>
        <ArticleId IdType="pmc">PMC6519749</ArticleId>
        <ArticleId IdType="doi">10.1634/theoncologist.2018-0117</ArticleId>
        <ArticleId IdType="pii">theoncologist.2018-0117</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359&#x2013;E386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25220842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siegel RL, Miller KD, Fedewa SA et al. Colorectal cancer statistics, 2017. CA Cancer J Clin 2017;67:177&#x2013;193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28248415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bailey CE, Hu CY, You YN et al. Increasing disparities in the age&#x2010;related incidences of colon and rectal cancers in the United States, 1975&#x2013;2010. JAMA Surg 2015;150:17&#x2013;22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4666003</ArticleId>
            <ArticleId IdType="pubmed">25372703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weinberg BA, Marshall JL, Salem ME. The growing challenge of young adults with colorectal cancer. Oncology (Williston Park) 2017;31:381&#x2013;389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28516436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ballester V, Rashtak S, Boardman L. Clinical and molecular features of young&#x2010;onset colorectal cancer. World J Gastroenterol 2016;22:1736&#x2013;1744.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4724605</ArticleId>
            <ArticleId IdType="pubmed">26855533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stigliano V, Sanchez&#x2010;Mete L, Martayan A et al. Early&#x2010;onset colorectal cancer: A sporadic or inherited disease? World J Gastroenterol 2014;20:12420&#x2013;12430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4168075</ArticleId>
            <ArticleId IdType="pubmed">25253942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vatandoust S, Price TJ, Ullah S et al. Metastatic colorectal cancer in young adults: A study from the South Australian population&#x2010;based registry. Clin Colorectal Cancer 2016;15:32&#x2013;36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26341410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kothari N, Teer JK, Abbott AM et al. Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers. Cancer 2016;122:2828&#x2013;2835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5014625</ArticleId>
            <ArticleId IdType="pubmed">27244218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Magnani G, Furlan D, Sahnane N et al. Molecular features and methylation status in early onset (&lt;/=40 years) colorectal cancer: A population based, case&#x2010;control study. Gastroenterol Res Pract 2015;2015:132190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4629034</ArticleId>
            <ArticleId IdType="pubmed">26557847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antelo M, Balaguer F, Shia J et al. A high degree of LINE&#x2010;1 hypomethylation is a unique feature of early&#x2010;onset colorectal cancer. PLoS One 2012;7:e45357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3458035</ArticleId>
            <ArticleId IdType="pubmed">23049789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahnen DJ, Wade SW, Jones WF et al. The increasing incidence of young&#x2010;onset colorectal cancer: A call to action. Mayo Clin Proc 2014;89:216&#x2013;224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24393412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silla IO, Rueda D, Rodriguez Y et al. Early&#x2010;onset colorectal cancer: A separate subset of colorectal cancer. World J Gastroenterol 2014;20:17288&#x2013;17296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4265586</ArticleId>
            <ArticleId IdType="pubmed">25516639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pearlman R, Frankel WL, Swanson B et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early&#x2010;onset colorectal cancer. JAMA Oncol 2017;3:464&#x2013;471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5564179</ArticleId>
            <ArticleId IdType="pubmed">27978560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fidler MM, Gupta S, Soerjomataram I et al. Cancer incidence and mortality among young adults aged 20&#x2013;39 years worldwide in 2012: A population&#x2010;based study. Lancet Oncol 2017;18:1579&#x2013;1589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29111259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ben&#x2010;Ishay O, Brauner E, Peled Z et al. Diagnosis of colon cancer differs in younger versus older patients despite similar complaints. Isr Med Assoc J 2013;15:284&#x2013;287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23882892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang R, Wang MJ, Ping J. Clinicopathological features and survival outcomes of colorectal cancer in young versus elderly: A population&#x2010;based cohort study of SEER 9 registries data (1988&#x2013;2011). Medicine (Baltimore) 2015;94:e1402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4616510</ArticleId>
            <ArticleId IdType="pubmed">26334895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Q, Zhuo C, Cai G et al. Pathological features and survival outcomes of young patients with operable colon cancer: Are they homogeneous? PLoS One 2014;9:e102004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4087023</ArticleId>
            <ArticleId IdType="pubmed">25003760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heeke AC, Xiu J, Reddy SK et al. Molecular characterization of colorectal tumors in young patients compared with older patients and impact on outcome. J Clin Oncol 2016;34(suppl 4):505a.</Citation>
        </Reference>
        <Reference>
          <Citation>Abdelsattar ZM, Wong SL, Regenbogen SE et al. Colorectal cancer outcomes and treatment patterns in patients too young for average&#x2010;risk screening. Cancer 2016;122:929&#x2013;934.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4777631</ArticleId>
            <ArticleId IdType="pubmed">26808454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siegel RL, Fedewa SA, Anderson WF et al. Colorectal cancer incidence patterns in the United States, 1974. &#x2010;2013 J Natl Cancer Inst 2017;109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6059239</ArticleId>
            <ArticleId IdType="pubmed">28376186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brule SY, Jonker DJ, Karapetis CS et al. Location of colon cancer (right&#x2010;sided versus left&#x2010;sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. Eur J Cancer 2015;51:1405&#x2013;1414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25979833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loupakis F, Yang D, Yau L et al. Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst 2015;107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4565528</ArticleId>
            <ArticleId IdType="pubmed">25713148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrelli F, Tomasello G, Borgonovo K et al. Prognostic survival associated with left&#x2010;sided vs right&#x2010;sided colon cancer: A systematic review and meta&#x2010;analysis. JAMA Oncol 2016. [Epub ahead of print].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27787550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tejpar S, Stintzing S, Ciardiello F et al. Prognostic and predictive relevance of primary tumor location in patients with RAS wild&#x2010;type metastatic colorectal cancer: Retrospective analyses of the CRYSTAL and FIRE&#x2010;3 trials. JAMA Oncol 2016. [Epub ahead of print].</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7505121</ArticleId>
            <ArticleId IdType="pubmed">27722750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold D, Lueza B, Douillard JY et al. Prognostic and predictive value of primary tumour side in patients with RAS wild&#x2010;type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann Oncol 2017;28:1713&#x2013;1729.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6246616</ArticleId>
            <ArticleId IdType="pubmed">28407110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salem ME, Weinberg BA, Xiu J et al. Comparative molecular analyses of left&#x2010;sided colon, right&#x2010;sided colon, and rectal cancers. Oncotarget 2017;8:86356&#x2013;86368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5689690</ArticleId>
            <ArticleId IdType="pubmed">29156800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brennan CA, Garrett WS. Gut microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol 2016;70:395&#x2013;411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5541233</ArticleId>
            <ArticleId IdType="pubmed">27607555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le DT, Durham JN, Smith KN et al. Mismatch repair deficiency predicts response of solid tumors to PD&#x2010;1 blockade. Science 2017;357:409&#x2013;413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5576142</ArticleId>
            <ArticleId IdType="pubmed">28596308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Overman MJ, McDermott R, Leach JL et al. Nivolumab in patients with metastatic DNA mismatch repair&#x2010;deficient or microsatellite instability&#x2010;high colorectal cancer (CheckMate 142): An open&#x2010;label, multicentre, phase 2 study. Lancet Oncol 2017;18:1182&#x2013;1191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6207072</ArticleId>
            <ArticleId IdType="pubmed">28734759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawakami H, Zaanan A, Sinicrope FA. Microsatellite instability testing and its role in the management of colorectal cancer. Curr Treat Options Oncol 2015;16:30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4594190</ArticleId>
            <ArticleId IdType="pubmed">26031544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chalmers ZR, Connelly CF, Fabrizio D et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med 2017;9:34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5395719</ArticleId>
            <ArticleId IdType="pubmed">28420421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stadler ZK, Battaglin F, Middha S et al. Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next&#x2010;generation sequencing panels. J Clin Oncol 2016;34:2141&#x2013;2147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4962706</ArticleId>
            <ArticleId IdType="pubmed">27022117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gryfe R, Kim H, Hsieh ET et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342:69&#x2013;77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10631274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farrington SM, McKinley AJ, Carothers AD et al. Evidence for an age&#x2010;related influence of microsatellite instability on colorectal cancer survival. Int J Cancer 2002;98:844&#x2013;850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11948461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goel A, Nagasaka T, Spiegel J et al. Low frequency of Lynch syndrome among young patients with non&#x2010;familial colorectal cancer. Clin Gastroenterol Hepatol 2010;8:966&#x2013;971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2964436</ArticleId>
            <ArticleId IdType="pubmed">20655395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan SA, Morris M, Idrees K et al. Colorectal cancer in the very young: A comparative study of tumor markers, pathology and survival in early onset and adult onset patients. J Pediatr Surg 2016;51:1812&#x2013;1817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5312708</ArticleId>
            <ArticleId IdType="pubmed">27558481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Domingo E, Freeman&#x2010;Mills L, Rayner E et al. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: A retrospective, pooled biomarker study. Lancet Gastroenterol Hepatol 2016;1:207&#x2013;216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28404093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briggs S, Tomlinson I. Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol 2013;230:148&#x2013;153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3709119</ArticleId>
            <ArticleId IdType="pubmed">23447401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Genome Atlas Network . Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330&#x2013;337.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3401966</ArticleId>
            <ArticleId IdType="pubmed">22810696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salem ME, Puccini A, Grothey A et al. Landscape of tumor mutation load, mismatch repair deficiency, and PD&#x2010;L1 expression in a large patient cohort of gastrointestinal cancers. Mol Cancer Res 2018;16:805&#x2013;812.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6833953</ArticleId>
            <ArticleId IdType="pubmed">29523759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rizvi NA, Hellmann MD, Snyder A et al. Cancer immunology. Mutational landscape determines sensitivity to PD&#x2010;1 blockade in non&#x2010;small cell lung cancer. Science 2015;348:124&#x2013;128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4993154</ArticleId>
            <ArticleId IdType="pubmed">25765070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodman AM, Kato S, Bazhenova L et al. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol Cancer Ther 2017;16:2598&#x2013;2608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5670009</ArticleId>
            <ArticleId IdType="pubmed">28835386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Innocenti F, Ou FS, Zemla T et al. Somatic DNA mutations, MSI status, mutational load (ML): Association with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance). J Clin Oncol 2017;35(suppl 15):3504a.</Citation>
        </Reference>
        <Reference>
          <Citation>Gargalionis AN, Piperi C, Adamopoulos C et al. Histone modifications as a pathogenic mechanism of colorectal tumorigenesis. Int J Biochem Cell Biol 2012;44:1276&#x2013;1289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22583735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang T, Lin C, Zhong LL et al. Targeting histone methylation for colorectal cancer. Therap Adv Gastroenterol 2017;10:114&#x2013;131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5330608</ArticleId>
            <ArticleId IdType="pubmed">28286564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirza MR, Monk BJ, Herrstedt J et al. Niraparib maintenance therapy in platinum&#x2010;sensitive, recurrent ovarian cancer. N Engl J Med 2016;375:2154&#x2013;2164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27717299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sartore&#x2010;Bianchi A, Trusolino L, Martino C et al. Dual&#x2010;targeted therapy with trastuzumab and lapatinib in treatment&#x2010;refractory, KRAS codon 12/13 wild&#x2010;type, HER2&#x2010;positive metastatic colorectal cancer (HERACLES): A proof&#x2010;of&#x2010;concept, multicentre, open&#x2010;label, phase 2 trial. Lancet Oncol 2016;17:738&#x2013;746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27108243</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">30012377</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-2939</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>101</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of hospital infection</Title>
          <ISOAbbreviation>J Hosp Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>First Lebanese Antibiotic Awareness Week campaign: knowledge, attitudes and practices towards antibiotics.</ArticleTitle>
        <Pagination>
          <StartPage>475</StartPage>
          <EndPage>479</EndPage>
          <MedlinePgn>475-479</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jhin.2018.07.009</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0195-6701(18)30373-6</ELocationID>
        <Abstract>
          <AbstractText>Antibiotic resistance (ABR) is a major global health threat that increases the risk of treatment failure and increases medical costs. One of the most common factors contributing to the spread of ABR is self-medication. The public, as well as workers in clinical and veterinary sectors, commit false practices towards appropriate antibiotic use, favouring the spread of resistance. As such, the first Lebanese Antibiotic Awareness Week campaign was initiated with a human-centred and interactive approach. The data showed a strikingly low level of antibiotic awareness. Cooperation between relevant stakeholders, policy-makers and health actors is crucial to control and overcome the problem of ABR.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Al Omari</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al Mir</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wrayde</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Merhabi</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dhaybi</LastName>
            <ForeName>I</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jamal</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chahine</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bayaa</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tourba</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tantawi</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al Atrouni</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El Omari</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon; Laboratoire Contr&#xF4;le Qualit&#xE9; de la Chambre de Commerce, Industrie et Agriculture de Tripoli et du Nord Liban, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ayash</LastName>
            <ForeName>O</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Ordre des M&#xE9;decins du Liban - Tripoli, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeidan</LastName>
            <ForeName>N S</ForeName>
            <Initials>NS</Initials>
            <AffiliationInfo>
              <Affiliation>Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Beyrouth, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mallat</LastName>
            <ForeName>H</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dabboussi</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hamze</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon. Electronic address: mhamze@monzerhamze.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Osman</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratoire Microbiologie Sant&#xE9; et Environnement, Ecole Doctorale des Sciences et de Technologie, Facult&#xE9; de Sant&#xE9; Publique, Universit&#xE9; Libanaise, Tripoli, Lebanon.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>09</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Hosp Infect</MedlineTA>
        <NlmUniqueID>8007166</NlmUniqueID>
        <ISSNLinking>0195-6701</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004352" MajorTopicYN="Y">Drug Resistance, Microbial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017048" MajorTopicYN="N">Health Care Costs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007861" MajorTopicYN="N" Type="Geographic">Lebanon</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antibiotic awareness campaign</Keyword>
        <Keyword MajorTopicYN="N">Antibiotic awareness week</Keyword>
        <Keyword MajorTopicYN="N">Antibiotic misuse</Keyword>
        <Keyword MajorTopicYN="N">Antibiotic resistance</Keyword>
        <Keyword MajorTopicYN="N">Control of antibiotic use</Keyword>
        <Keyword MajorTopicYN="N">Lebanon</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30012377</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jhin.2018.07.009</ArticleId>
        <ArticleId IdType="pii">S0195-6701(18)30373-6</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29999412</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1931-8405</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>AIDS research and human retroviruses</Title>
          <ISOAbbreviation>AIDS Res Hum Retroviruses</ISOAbbreviation>
        </Journal>
        <ArticleTitle>HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters.</ArticleTitle>
        <Pagination>
          <StartPage>25</StartPage>
          <EndPage>32</EndPage>
          <MedlinePgn>25-32</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/AID.2018.0161</ELocationID>
        <Abstract>
          <AbstractText>HIV-1 remains a chronic viral infection of global health importance. Although HIV-1 replication can be controlled by antiretroviral therapy (ART), there is no cure due to persistence of a long-lived latent reservoir. In addition, people living with HIV-1 who are taking ART still bear signatures of persistent immune activation that include continued type 1 interferon (IFN) signaling. Paradoxically, type 1 IFN exerts a limited role on the control of chronic HIV-1. Indeed, recent reports from humanized mice suggest that type 1 IFN may partly maintain the latent reservoir. In this review, we discuss the molecular interactions between HIV-1 and the type 1 IFN signaling pathway, and examine the efficacy of type 1 IFNs in vivo. We also explore whether limited type 1 IFN manipulation may have a therapeutic role.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sugawara</LastName>
            <ForeName>Sho</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thomas</LastName>
            <ForeName>David L</ForeName>
            <Initials>DL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Balagopal</LastName>
            <ForeName>Ashwin</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 AI094189</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DA016078</GrantID>
            <Acronym>DA</Acronym>
            <Agency>NIDA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>AIDS Res Hum Retroviruses</MedlineTA>
        <NlmUniqueID>8709376</NlmUniqueID>
        <ISSNLinking>0889-2229</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016513" MajorTopicYN="N">Mice, SCID</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017735" MajorTopicYN="Y">Virus Latency</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HIV-1 pathogenesis</Keyword>
        <Keyword MajorTopicYN="N">immune activation</Keyword>
        <Keyword MajorTopicYN="N">persistent latent reservoir</Keyword>
        <Keyword MajorTopicYN="N">type 1 interferon</Keyword>
      </KeywordList>
      <CoiStatement>No competing financial interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29999412</ArticleId>
        <ArticleId IdType="pmc">PMC6343185</ArticleId>
        <ArticleId IdType="doi">10.1089/AID.2018.0161</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Montaner JS, Lima VD, Harrigan PR, et al. : Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: The &#x201C;HIV Treatment as Prevention&#x201D; experience in a Canadian setting. PLoS One 2014;9:e87872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3922718</ArticleId>
            <ArticleId IdType="pubmed">24533061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finzi D, Blankson J, Siliciano JD, et al. : Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999;5:512&#x2013;517</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10229227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei W, Guo H, Ma M, Markham R, Yu XF: Accumulation of MxB/Mx2-resistant HIV-1 capsid variants during expansion of the HIV-1 epidemic in human populations. EBioMedicine 2016;8:230&#x2013;236</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4919602</ArticleId>
            <ArticleId IdType="pubmed">27428433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ho YC, Shan L, Hosmane NN, et al. : Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 2013;155:540&#x2013;551</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3896327</ArticleId>
            <ArticleId IdType="pubmed">24243014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doyle T, Goujon C, Malim MH: HIV-1 and interferons: Who's interfering with whom? Nat Rev Microbiol 2015;13:403&#x2013;413</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7768976</ArticleId>
            <ArticleId IdType="pubmed">25915633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rustagi A, Gale M, Jr.: Innate antiviral immune signaling, viral evasion and modulation by HIV-1. J Mol Biol 2014;426:1161&#x2013;1177</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7425209</ArticleId>
            <ArticleId IdType="pubmed">24326250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veenhuis RT, Freeman ZT, Korleski J, et al. : HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells. J Clin Invest 2017;127:4352&#x2013;4364</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5707144</ArticleId>
            <ArticleId IdType="pubmed">29083319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jakobsen MR, Bak RO, Andersen A, et al. : IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci U S A 2013;110:E4571&#x2013;E4580</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3845190</ArticleId>
            <ArticleId IdType="pubmed">24154727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao D, Wu J, Wu YT, et al. : Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 2013;341:903&#x2013;906</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3860819</ArticleId>
            <ArticleId IdType="pubmed">23929945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar S, Morrison JH, Dingli D, Poeschla E: HIV-1 activation of innate immunity depends strongly on the intracellular level of TREX1 and sensing of incomplete reverse transcription products. J Virol 2018. [Epub ahead of print]; DOI: 10.1128/JVI.00001-18</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.00001-18</ArticleId>
            <ArticleId IdType="pmc">PMC6069178</ArticleId>
            <ArticleId IdType="pubmed">29769349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park SY, Waheed AA, Zhang ZR, Freed EO, Bonifacino JS: HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor. J Biol Chem 2014;289:35102&#x2013;35110</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4271200</ArticleId>
            <ArticleId IdType="pubmed">25352594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doehle BP, Chang K, Fleming L, et al. : Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells. J Virol 2012;86:8499&#x2013;8506</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3421769</ArticleId>
            <ArticleId IdType="pubmed">22647704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, Gale M, Jr.: Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J Virol 2012;86:8367&#x2013;8374</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3421752</ArticleId>
            <ArticleId IdType="pubmed">22593165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M, Jr.: Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol 2009;83:10395&#x2013;10405</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2753137</ArticleId>
            <ArticleId IdType="pubmed">19706707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM: HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 2008;373:85&#x2013;97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2312338</ArticleId>
            <ArticleId IdType="pubmed">18082865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nasr N, Maddocks S, Turville SG, et al. : HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood 2012;120:778&#x2013;788</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22677126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hotter D, Kirchhoff F, Sauter D: HIV-1 Vpu does not degrade interferon regulatory factor 3. J Virol 2013;87:7160&#x2013;7165</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3676088</ArticleId>
            <ArticleId IdType="pubmed">23552418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manganaro L, de Castro E, Maestre AM, et al. : HIV Vpu interferes with NF-kappaB activity but not with interferon regulatory factor 3. J Virol 2015;89:9781&#x2013;9790</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4577919</ArticleId>
            <ArticleId IdType="pubmed">26178989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harman AN, Nasr N, Feetham A, et al. : HIV blocks interferon induction in human dendritic cells and macrophages by dysregulation of TBK1. J Virol 2015;89:6575&#x2013;6584</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4468486</ArticleId>
            <ArticleId IdType="pubmed">25855743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasaiyaah J, Tan CP, Fletcher AJ, et al. : HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013;503:402&#x2013;405</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3928559</ArticleId>
            <ArticleId IdType="pubmed">24196705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsang J, Chain BM, Miller RF, et al. : HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS 2009;23:2255&#x2013;2263</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2873676</ArticleId>
            <ArticleId IdType="pubmed">19741482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardy GA, Sieg S, Rodriguez B, et al. : Interferon-alpha is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. PLoS One 2013;8:e56527.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3577907</ArticleId>
            <ArticleId IdType="pubmed">23437155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catalfamo M, Wilhelm C, Tcheung L, et al. : CD4 and CD8 T cell immune activation during chronic HIV infection: Roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol 2011;186:2106&#x2013;2116</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7394280</ArticleId>
            <ArticleId IdType="pubmed">21257970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sedaghat AR, German J, Teslovich TM, et al. : Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: Type I interferon-mediated disruption of T-cell dynamics. J Virol 2008;82:1870&#x2013;1883</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2258719</ArticleId>
            <ArticleId IdType="pubmed">18077723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Diwany R, Breitwieser FP, Soliman M, et al. : Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals. AIDS 2017;31:1405&#x2013;1414</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5572749</ArticleId>
            <ArticleId IdType="pubmed">28358734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Brien M, Manches O, Bhardwaj N: Plasmacytoid dendritic cells in HIV infection. Adv Exp Med Biol 2013;762:71&#x2013;107</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3713461</ArticleId>
            <ArticleId IdType="pubmed">22975872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosinger SE, Utay NS: Type I interferon: Understanding its role in HIV pathogenesis and therapy. Curr HIV/AIDS Rep 2015;12:41&#x2013;53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25662992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aiello A, Giannessi F, Percario ZA, Affabris E: The involvement of plasmacytoid cells in HIV infection and pathogenesis. Cytokine Growth Factor Rev 2018;40:77&#x2013;89</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29588163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jochems SP, Petitjean G, Kunkel D, et al. : Modulation of type I interferon-associated viral sensing during acute simian immunodeficiency virus infection in African green monkeys. J Virol 2015;89:751&#x2013;762</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4301160</ArticleId>
            <ArticleId IdType="pubmed">25355871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt B, Ashlock BM, Foster H, Fujimura SH, Levy JA: HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology 2005;343:256&#x2013;266</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16278001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lepelley A, Louis S, Sourisseau M, et al. : Innate sensing of HIV-infected cells. PLoS Pathog 2011;7:e1001284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3040675</ArticleId>
            <ArticleId IdType="pubmed">21379343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goujon C, Moncorg&#xE9; O, Bauby H, et al. : Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 2013;502:559&#x2013;562</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3808269</ArticleId>
            <ArticleId IdType="pubmed">24048477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okumura A, Lu G, Pitha-Rowe I, Pitha PM: Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A 2006;103:1440&#x2013;1445</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1360585</ArticleId>
            <ArticleId IdType="pubmed">16434471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armitage AE, Deforche K, Chang CH, et al. : APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete &#x201C;all or nothing&#x201D; phenomenon. PLoS Genet 2012;8:e1002550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3310730</ArticleId>
            <ArticleId IdType="pubmed">22457633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pollpeter D, Parsons M, Sobala AE, et al. : Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G. Nat Microbiol 2018;3:220&#x2013;233</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6014619</ArticleId>
            <ArticleId IdType="pubmed">29158605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neil SJ, Zang T, Bieniasz PD: Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008;451:425&#x2013;430</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18200009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gal&#xE3;o RP, Le Tortorec A, Pickering S, Kueck T, Neil SJ: Innate sensing of HIV-1 assembly by Tetherin induces NFkappa B-dependent proinflammatory responses. Cell Host Microbe 2012;12:633&#x2013;644</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3556742</ArticleId>
            <ArticleId IdType="pubmed">23159053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stremlau M, Perron M, Lee M, et al. : Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 2006;103:5514&#x2013;5519</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1459386</ArticleId>
            <ArticleId IdType="pubmed">16540544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lahouassa H, Daddacha W, Hofmann H, et al. : SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012;13:223&#x2013;228</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3771401</ArticleId>
            <ArticleId IdType="pubmed">22327569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Kao E, Gao X, et al. : Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 2012;491:125&#x2013;128</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3705913</ArticleId>
            <ArticleId IdType="pubmed">23000900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J&#xE4;ger S, Kim DY, Hultquist JF, et al. : Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature 2011;481:371&#x2013;375</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3310910</ArticleId>
            <ArticleId IdType="pubmed">22190037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNatt MW, Zang T, Bieniasz PD: Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog 2013;9:e1003299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3635990</ArticleId>
            <ArticleId IdType="pubmed">23633949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ranganath N, Sandstrom TS, Fadel S, C&#xF4;t&#xE9; SC, Angel JB: Type I interferon responses are impaired in latently HIV infected cells. Retrovirology 2016;13:66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5017046</ArticleId>
            <ArticleId IdType="pubmed">27613235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tough DF: Modulation of T-cell function by type I interferon. Immunol Cell Biol 2012;90:492&#x2013;497</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22391814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Bon A, Durand V, Kamphuis E, et al. : Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol 2006;176:4682&#x2013;4689</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16585561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerlach N, Schimmer S, Weiss S, Kalinke U, Dittmer U: Effects of type I interferons on Friend retrovirus infection. J Virol 2006;80:3438&#x2013;3444</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1440373</ArticleId>
            <ArticleId IdType="pubmed">16537611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moseman EA, Wu T, de la Torre JC, Schwartzberg PL, McGavern DB: Type I interferon suppresses virus-specific B cell responses by modulating CD8+ T cell differentiation. Sci Immunol 2016;1:eaah3565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5089817</ArticleId>
            <ArticleId IdType="pubmed">27812556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Bon A, Thompson C, Kamphuis E, et al. : Cutting edge: Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J Immunol 2006;176:2074&#x2013;2078</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16455962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teijaro JR, Ng C, Lee AM, et al. : Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 2013;340:207&#x2013;211</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3640797</ArticleId>
            <ArticleId IdType="pubmed">23580529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson EB, Yamada DH, Elsaesser H, et al. : Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 2013;340:202&#x2013;207</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3704950</ArticleId>
            <ArticleId IdType="pubmed">23580528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng CT, Sullivan BM, Teijaro JR, et al. : Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection. Cell Host Microbe 2015;17:653&#x2013;661</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4432251</ArticleId>
            <ArticleId IdType="pubmed">25974304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris LD, Tabb B, Sodora DL, et al. : Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 2010;84:7886&#x2013;7891</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2897601</ArticleId>
            <ArticleId IdType="pubmed">20484518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bosinger SE, Johnson ZP, Folkner KA, et al. : Intact type I Interferon production and IRF7 function in sooty mangabeys. PLoS Pathog 2013;9:e1003597.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3757038</ArticleId>
            <ArticleId IdType="pubmed">24009514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacquelin B, Mayau V, Targat B, et al. : Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009;119:3544&#x2013;3555</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2786805</ArticleId>
            <ArticleId IdType="pubmed">19959873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jochems SP, Jacquelin B, Chauveau L, et al. : Plasmacytoid dendritic cell infection and sensing capacity during pathogenic and nonpathogenic simian immunodeficiency virus infection. J Virol 2015;89:6918&#x2013;6927</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4468466</ArticleId>
            <ArticleId IdType="pubmed">25903334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandler NG, Bosinger SE, Estes JD, et al. : Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 2014;511:601&#x2013;605</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4418221</ArticleId>
            <ArticleId IdType="pubmed">25043006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carnathan D, Lawson B, Yu J, et al. : Reduced chronic lymphocyte activation following interferon alpha blockade during the acute phase of simian immunodeficiency virus infection in rhesus macaques. J Virol 2018;92:e01760-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5899190</ArticleId>
            <ArticleId IdType="pubmed">29467313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardy GA, Sieg SF, Rodriguez B, et al. : Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression. Blood 2009;113:5497&#x2013;5505</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2689050</ArticleId>
            <ArticleId IdType="pubmed">19299650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamga I, Kahi S, Develioglu L, et al. : Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. J Infect Dis 2005;192:303&#x2013;310</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15962225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kmiec D, Iyer SS, St&#xFC;rzel CM, Sauter D, Hahn BH, Kirchhoff F: Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance. MBio 2016;7:e00934-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4992969</ArticleId>
            <ArticleId IdType="pubmed">27531907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iyer SS, Bibollet-Ruche F, Sherrill-Mix S, et al. : Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness. Proc Natl Acad Sci U S A 2017;114:E590&#x2013;EE599</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5278458</ArticleId>
            <ArticleId IdType="pubmed">28069935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster TL, Wilson H, Iyer SS, et al. : Resistance of transmitted founder HIV-1 to IFITM-mediated restriction. Cell Host Microbe 2016;20:429&#x2013;442</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5075283</ArticleId>
            <ArticleId IdType="pubmed">27640936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fenton-May AE, Dibben O, Emmerich T, et al. : Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology 2013;10:146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3907080</ArticleId>
            <ArticleId IdType="pubmed">24299076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deymier MJ, Ende Z, Fenton-May AE, et al. : Heterosexual transmission of subtype C HIV-1 selects consensus-like variants without increased replicative capacity or interferon-alpha resistance. PLoS Pathog 2015;11:e1005154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4574710</ArticleId>
            <ArticleId IdType="pubmed">26378795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veazey RS, Pilch-Cooper HA, Hope TJ, et al. : Prevention of SHIV transmission by topical IFN-beta treatment. Mucosal Immunol 2016;9:1528&#x2013;1536</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4972705</ArticleId>
            <ArticleId IdType="pubmed">26838048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vanderford TH, Slichter C, Rogers KA, et al. : Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation. Blood 2012;119:5750&#x2013;5757</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3382934</ArticleId>
            <ArticleId IdType="pubmed">22550346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asmuth DM, Abel K, George MD, Dandekar S, Pollard RB, Miller CJ: Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques. J Med Primatol 2008;37:26&#x2013;30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2674790</ArticleId>
            <ArticleId IdType="pubmed">18199069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li G, Cheng M, Nunoya J, et al. : Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog 2014;10:e1004291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4117636</ArticleId>
            <ArticleId IdType="pubmed">25077616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavender KJ, Gibbert K, Peterson KE, et al. : Interferon alpha subtype-specific suppression of HIV-1 infection in vivo. J Virol 2016;90:6001&#x2013;6013</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4907223</ArticleId>
            <ArticleId IdType="pubmed">27099312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhen A, Rezek V, Youn C, et al. : Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest 2017;127:260&#x2013;268</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5199686</ArticleId>
            <ArticleId IdType="pubmed">27941243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng L, Ma J, Li J, et al. : Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest 2017;127:269&#x2013;279</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5199717</ArticleId>
            <ArticleId IdType="pubmed">27941247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng L, Yu H, Li G, et al. : Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection. JCI Insight 2017;2:94366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5470878</ArticleId>
            <ArticleId IdType="pubmed">28614789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Long BR, Stoddart CA: Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice. J Virol 2012;86:3327&#x2013;3336</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3302309</ArticleId>
            <ArticleId IdType="pubmed">22238321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asmuth DM, Murphy RL, Rosenkranz SL, et al. : Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: A phase II clinical trial. J Infect Dis 2010;201:1686&#x2013;1696</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2946345</ArticleId>
            <ArticleId IdType="pubmed">20420510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzoni L, Foulkes AS, Papasavvas E, et al. : Pegylated interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis 2013;207:213&#x2013;222</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3532820</ArticleId>
            <ArticleId IdType="pubmed">23105144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lane HC, Davey V, Kovacs JA, et al. : Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial. Ann Intern Med 1990;112:805&#x2013;811</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1971503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lane HC, Kovacs JA, Feinberg J, et al. : Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet 1988;2:1218&#x2013;1222</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2903954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manion M, Rodriguez B, Medvik K, et al. : Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. PLoS One 2012;7:e30306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3265460</ArticleId>
            <ArticleId IdType="pubmed">22291932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pillai SK, Abdel-Mohsen M, Guatelli J, et al. : Role of retroviral restriction factors in the interferon-alpha-mediated suppression of HIV-1 in vivo. Proc Natl Acad Sci U S A 2012;109:3035&#x2013;3040</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3286922</ArticleId>
            <ArticleId IdType="pubmed">22315404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. : Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004;351:438&#x2013;450</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15282351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palesch D, Bosinger SE, Mavigner M, et al. : Short-term pIFN-alpha2a treatment does not significantly reduce the viral reservoir of SIV-infected, ART-treated rhesus macaques. J Virol 2018;92:e00279-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6026735</ArticleId>
            <ArticleId IdType="pubmed">29720521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mor&#xF3;n-L&#xF3;pez S, G&#xF3;mez-Mora E, Salgado M, et al. : Short-term treatment with interferon Alfa diminishes expression of HIV-1 and reduces CD4+ T-cell activation in patients coinfected with HIV and hepatitis C virus and receiving antiretroviral therapy. J Infect Dis 2016;213:1008&#x2013;1012</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4760418</ArticleId>
            <ArticleId IdType="pubmed">26525407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strouvelle VP, Braun DL, Vongrad V, et al. : No effect of pegylated interferon-alpha on total HIV-1 DNA load in HIV-1/HCV coinfected patients. J Infect Dis 2018;217:1883&#x2013;1888</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29528417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua S, Vigano S, Tse S, et al. : Pegylated interferon-alpha-induced natural killer cell activation is associated with human immunodeficiency virus-1 DNA decline in antiretroviral therapy-treated HIV-1/hepatitis C virus-coinfected patients. Clin Infect Dis 2018;66:1910&#x2013;1917</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5982807</ArticleId>
            <ArticleId IdType="pubmed">29272392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruner KM, Murray AJ, Pollack RA, et al. : Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med 2016;22:1043&#x2013;1049</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5014606</ArticleId>
            <ArticleId IdType="pubmed">27500724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases: Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 2009;49:1335&#x2013;1374</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7477893</ArticleId>
            <ArticleId IdType="pubmed">19330875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sulkowski MS, Cooper C, Hunyady B, et al. : Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C. Nat Rev Gastroenterol Hepatol 2011;8:212&#x2013;223</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21386812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garaigorta U, Chisari FV: Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 2009;6:513&#x2013;522</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2905238</ArticleId>
            <ArticleId IdType="pubmed">20006840</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29998812</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1748-5460</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>133</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of laryngology and otology</Title>
          <ISOAbbreviation>J Laryngol Otol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Education in ear and hearing care in remote or resource-constrained environments.</ArticleTitle>
        <Pagination>
          <StartPage>3</StartPage>
          <EndPage>10</EndPage>
          <MedlinePgn>3-10</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1017/S002221511800110X</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">At the heart of surgical care needs to be the education and training of staff, particularly in the low-income and/or resource-poor setting. This is the primary means by which self-sufficiency and sustainability will ultimately be achieved. As such, training and education should be integrated into any surgical programme that is undertaken. Numerous resources are available to help provide such a goal, and an open approach to novel, inexpensive training methods is likely to be helpful in this type of setting.The need for appropriately trained audiologists in low-income countries is well recognised and clearly goes beyond providing support for ear surgery. However, where ear surgery is being undertaken, it is vital to have audiology services established in order to correctly assess patients requiring surgery, and to be able to assess and manage outcomes of surgery. The training requirements of the two specialties are therefore intimately linked.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This article highlights various methods, resources and considerations, for both otolaryngology and audiology training, which should prove a useful resource to those undertaking and organising such education, and to those staff members receiving it.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Clark</LastName>
            <ForeName>M P A</ForeName>
            <Initials>MPA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of ENT,Gloucestershire Royal Hospital,Gloucester,UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Westerberg</LastName>
            <ForeName>B D</ForeName>
            <Initials>BD</Initials>
            <AffiliationInfo>
              <Affiliation>BC Rotary Hearing and Balance Centre at St Paul's Hospital,Vancouver,Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakku</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of ENT,Mbarara University of Science and Technology,Uganda.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carling</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Kent Hearing Ltd,UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Laryngol Otol</MedlineTA>
        <NlmUniqueID>8706896</NlmUniqueID>
        <ISSNLinking>0022-2151</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001298" MajorTopicYN="N">Audiology</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004493" MajorTopicYN="N">Education</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020375" MajorTopicYN="N">Education, Distance</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006295" MajorTopicYN="N">Health Resources</DescriptorName>
          <QualifierName UI="Q000600" MajorTopicYN="Y">supply &amp; distribution</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010036" MajorTopicYN="N">Otolaryngology</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Graduate</Keyword>
        <Keyword MajorTopicYN="N">Medical</Keyword>
        <Keyword MajorTopicYN="N">Audiology</Keyword>
        <Keyword MajorTopicYN="N">Developed Countries</Keyword>
        <Keyword MajorTopicYN="N">Developing Countries</Keyword>
        <Keyword MajorTopicYN="N">Education</Keyword>
        <Keyword MajorTopicYN="N">Global Health</Keyword>
        <Keyword MajorTopicYN="N">International Cooperation</Keyword>
        <Keyword MajorTopicYN="N">Internship And Residency</Keyword>
        <Keyword MajorTopicYN="N">Otolaryngology</Keyword>
        <Keyword MajorTopicYN="N">Otologic Surgical Procedures</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29998812</ArticleId>
        <ArticleId IdType="doi">10.1017/S002221511800110X</ArticleId>
        <ArticleId IdType="pii">S002221511800110X</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29995222</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1863-2491</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of robotic surgery</Title>
          <ISOAbbreviation>J Robot Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The cost and quality of life outcomes in developing a robotic lobectomy program.</ArticleTitle>
        <Pagination>
          <StartPage>239</StartPage>
          <EndPage>243</EndPage>
          <MedlinePgn>239-243</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11701-018-0844-z</ELocationID>
        <Abstract>
          <AbstractText>The use of the robotic platform is increasingly being utilized for lung resections. Our aim was to compare outcomes of thoracoscopic (VATS) versus robotic-assisted thoracoscopic (RATS) lobectomy early in a program's adoption of robotic surgery, including perioperative outcomes, cost, and long-term quality of life. A prospective database was retrospectively reviewed for all patients undergoing minimally invasive lobectomy by either VATS or RATS techniques from 2010 to 2012. Patients' operative, post-operative complications, cost (operating room and hospital) and quality of life were compared between the two resection techniques. Long-term follow-up including assessment using the European Organization for Research and Treatment of Cancer quality of life questionnaire was documented. During the first 25 RATS lobectomies, there were 73 VATS lobectomies performed, for a total of 98 cases. There was no significant difference in cancer stage, operative time, estimated blood loss, lymph node count, or hospital length of stay. The RATS resections had significantly higher operative and total hospital cost (p&#x2009;&lt;&#x2009;0.0001 and p&#x2009;&lt;&#x2009;0.05). At a median of 65-month follow-up, 29 patients (9 robotic; 20 VATS) completed the EORTC questionnaire. The global health status and symptom scale median scores were similar to the general population and did not significantly differ between groups. While transitioning from thoracoscopic to robotic lobectomy incurs increased operative and total hospital cost, equivalent operative outcomes, length of hospitalization, and long-term quality of life can be maintained during this transition. With increasing patient and surgeon interest in robotic resection, it appears both safe and feasible to adopt this approach while maintaining outcomes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Worrell</LastName>
            <ForeName>Stephanie G</ForeName>
            <Initials>SG</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Thoracic Surgery, University of Michigan, 2120F Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan, Ann Arbor, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dedhia</LastName>
            <ForeName>Priya</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan, Ann Arbor, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gilbert</LastName>
            <ForeName>Catherine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>University of Michigan Medical School, Ann Arbor, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>James</LastName>
            <ForeName>Chrystina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>University of Michigan Medical School, Ann Arbor, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Andrew C</ForeName>
            <Initials>AC</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Thoracic Surgery, University of Michigan, 2120F Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan, Ann Arbor, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Michigan Medical School, Ann Arbor, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Jules</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Thoracic Surgery, University of Michigan, 2120F Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan, Ann Arbor, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Michigan Medical School, Ann Arbor, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reddy</LastName>
            <ForeName>Rishindra M</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Thoracic Surgery, University of Michigan, 2120F Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI, 48109, USA. reddyrm@med.umich.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, University of Michigan, Ann Arbor, USA. reddyrm@med.umich.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>University of Michigan Medical School, Ann Arbor, USA. reddyrm@med.umich.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Robot Surg</MedlineTA>
        <NlmUniqueID>101300401</NlmUniqueID>
        <ISSNLinking>1863-2483</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017721" MajorTopicYN="Y">Hospital Costs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011013" MajorTopicYN="N">Pneumonectomy</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065287" MajorTopicYN="N">Robotic Surgical Procedures</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020775" MajorTopicYN="N">Thoracic Surgery, Video-Assisted</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013906" MajorTopicYN="N">Thoracoscopy</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Health care costs</Keyword>
        <Keyword MajorTopicYN="N">Lung cancer</Keyword>
        <Keyword MajorTopicYN="N">Minimally invasive surgery</Keyword>
        <Keyword MajorTopicYN="N">Patient quality of life</Keyword>
        <Keyword MajorTopicYN="N">Robotic surgery</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29995222</ArticleId>
        <ArticleId IdType="doi">10.1007/s11701-018-0844-z</ArticleId>
        <ArticleId IdType="pii">10.1007/s11701-018-0844-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ann Thorac Surg. 2006 Feb;81(2):421-5; discussion 425-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16427825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2010 Aug 19;363(8):701-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20818872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Thorac Surg. 2011 Jun;91(6):1729-36; discussion 1736-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21529768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Thorac Surg. 2012 May;93(5):1598-604; discussion 1604-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22440364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Med Robot. 2012 Dec;8(4):448-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22991294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Cardiothorac Surg. 2012 May;1(1):77-85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23977471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thorac Cardiovasc Surg. 2014 Mar;147(3):929-37</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24210834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chest. 2014 Dec;146(6):1505-1512</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24810546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surg Endosc. 2014 Nov;28(11):3101-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24928229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Surg Educ. 2015 May-Jun;72(3):377-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25572940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Surg Res. 2016 Mar;201(1):219-25</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26850206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surg Endosc. 2017 Jan;31(1):185-192</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27139704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Thorac Surg. 2016 Sep;102(3):917-924</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27209613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thorac Dis. 2016 Jul;8(7):1798-803</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27499971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Thorac Surg. 2017 Apr;103(4):1092-1100</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28109575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Thorac Cardiovasc Surg. 2017 Sep;154(3):1065-1069</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28623099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8433390</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29986952</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Salivary cotinine concentration and carbon monoxide levels in young adults smoking midwakh in comparison with cigarette smokers.</ArticleTitle>
        <Pagination>
          <StartPage>141</StartPage>
          <EndPage>145</EndPage>
          <MedlinePgn>141-145</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2017-054202</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES">To estimate and compare the salivary cotinine levels using a semiquantitative method, called NicAlert, between three groups: non-smokers, daily smokers of cigarettes and daily smokers of midwakh, and to compare the carbon monoxide (CO) levels among these groups.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS">A total of 159 adult male volunteers aged 20 and above were included, with 54 current cigarette smokers, 52 current midwakh smokers and 53 non-smokers. Estimate of breath carbon monoxide and salivary cotinine were collected, as well as sociodemographic characteristics and details of smoking habits and second-hand smoke exposure among participants. Institutional review board approval was obtained and data were analysed using SPSS V.21 with the Kruskal-Wallis test used to obtain differences in the distribution.</AbstractText>
          <AbstractText Label="RESULTS">There was no significant difference in the median breath CO and salivary cotinine levels between cigarette and midwakh smokers. Levels of breath CO were significantly higher in cigarette and midwakh smokers as compared with non-smokers (19.5, 17.5 and 6.0, respectively, p&lt;0.05); the same relationship was observed for cotinine levels among cigarette and midwakh smokers as compared with non-smokers (4.0, 3.0 and 0.0, respectively, p&#x2264;0.05). Additionally, the values of both salivary cotinine and breath CO increased with the frequency of tobacco use.</AbstractText>
          <AbstractText Label="CONCLUSION">These are the first data that we are aware of that demonstrate that in terms of at least two key biomarkers of tobacco use, there are comparable levels of exposure between cigarettes and midwakh users, demonstrating a need for intensified attention to the use of midwakh.</AbstractText>
          <CopyrightInformation>&#xA9; Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shaikh</LastName>
            <ForeName>Rizwana Burhanuddin</ForeName>
            <Initials>RB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Community Medicine, Vydehi Institute of Medical Sciences and Research Center, Bengaluru, Karnataka, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sreedharan</LastName>
            <ForeName>Jayadevan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Community Medicine, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al Sharbatti</LastName>
            <ForeName>Shatha</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Community Medicine, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muttappallymyalil</LastName>
            <ForeName>Jayakumary</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Community Medicine, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Lily</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0001-9716-1983</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, School of Medicine, New York University, New York City, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weitzman</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, School of Medicine, New York University, New York City, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014028">Tobacco Smoke Pollution</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7U1EE4V452</RegistryNumber>
          <NameOfSubstance UI="D002248">Carbon Monoxide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>K5161X06LL</RegistryNumber>
          <NameOfSubstance UI="D003367">Cotinine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001944" MajorTopicYN="N">Breath Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002248" MajorTopicYN="N">Carbon Monoxide</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073865" MajorTopicYN="N">Cigarette Smoking</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003367" MajorTopicYN="N">Cotinine</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073868" MajorTopicYN="N">Pipe Smoking</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014028" MajorTopicYN="N">Tobacco Smoke Pollution</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cotinine</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">nicotine</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29986952</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2017-054202</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2017-054202</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29984660</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1875-6220</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Current drug discovery technologies</Title>
          <ISOAbbreviation>Curr Drug Discov Technol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.</ArticleTitle>
        <Pagination>
          <StartPage>307</StartPage>
          <EndPage>314</EndPage>
          <MedlinePgn>307-314</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2174/1570163815666180709155131</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Dengue Fever is a major threatening global health issue caused by a mosquito-borne pathogen. Even though some anti-viral drugs are now available to reduce the disease severity. Still, there is a need of better drug compound to combat with dengue fever. The NS2B/NS3 protease is a major therapeutic drug target for Insilco drug discovery.</AbstractText>
          <AbstractText Label="MATERIALS &amp; METHODS">Previously, we have performed a pharmacophore features based virtual screening studies, which has led to the identification of ZINC92615064 compound as a potent NS2B/NS3 protease inhibitor and demonstrated its potential to act as anti-dengue drug-like compound using computational approaches. In this present study, the identified lead compound ZINC92615064 has been made to undergo scaffold hopping based novel library generation, and the resulted novel library of compounds has been virtually screened on to NS2B/NS3 protease towards identifying novel proprietary scaffold of compound which is acting as a potent inhibitor for the given drug target of NS2B/NS3.</AbstractText>
          <AbstractText Label="RESULT &amp; CONCLUSION">A total of 16,847 novel designed compounds library was generated using the scaffold hopping technology based on the structure of the lead compound ZINC92615064. Out of which, compound design no. 3718 has shown the best binding potential with a predicted IC50 value of 417.13 nM along with a permissible range of ADMET properties based on its descriptor values. This NS2B/NS3 protease in complex with compound 3718 was subjected to a rigorous molecular dynamic simulation study to further validate this complex thermodynamic stability, along with the aim to reveal the underlying molecular level interactions and potential mode of action.</AbstractText>
          <CopyrightInformation>Copyright&#xA9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gurusamy</LastName>
            <ForeName>Murugaboopathi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of CSE, School of Computing, Kalasalingam Academy of Research and Education, Krishnankoil, Tamilnadu, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdul</LastName>
            <ForeName>Jainul Fathima</ForeName>
            <Initials>JF</Initials>
            <AffiliationInfo>
              <Affiliation>Research Scholar, Department of CSE, School of Computing, Kalasalingam Academy of Research and Education, Krishnankoil, Tamilnadu, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United Arab Emirates</Country>
        <MedlineTA>Curr Drug Discov Technol</MedlineTA>
        <NlmUniqueID>101157212</NlmUniqueID>
        <ISSNLinking>1570-1638</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C080102">NS2B protein, flavivirus</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D054852">Small Molecule Libraries</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.21.-</RegistryNumber>
          <NameOfSubstance UI="C504449">NS3 protease, dengue virus</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.21.-</RegistryNumber>
          <NameOfSubstance UI="D012697">Serine Endopeptidases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012697" MajorTopicYN="N">Serine Endopeptidases</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054852" MajorTopicYN="N">Small Molecule Libraries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ADMET</Keyword>
        <Keyword MajorTopicYN="N">NS2B/NS3 protease</Keyword>
        <Keyword MajorTopicYN="N">dengue</Keyword>
        <Keyword MajorTopicYN="N">drug</Keyword>
        <Keyword MajorTopicYN="N">scaffold hopping</Keyword>
        <Keyword MajorTopicYN="N">virtual screening.</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29984660</ArticleId>
        <ArticleId IdType="doi">10.2174/1570163815666180709155131</ArticleId>
        <ArticleId IdType="pii">CDDT-EPUB-91608</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29982521</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1741-3850</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of public health (Oxford, England)</Title>
          <ISOAbbreviation>J Public Health (Oxf)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Can public financing of the private sector defeat antimicrobial resistance?</ArticleTitle>
        <Pagination>
          <StartPage>422</StartPage>
          <EndPage>426</EndPage>
          <MedlinePgn>422-426</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/pubmed/fdy116</ELocationID>
        <Abstract>
          <AbstractText>Public financing to incentivise private sector innovation in antimicrobial pharmaceuticals is believed by many to be necessary to defeat growing threats from antimicrobial resistance. Large cash incentives from the public sector are said to be essential to stimulate 'normal' market forces capable of unleashing much-needed innovation. However, there is little evidence to suggest that lack of innovation in drug development is peculiar to antimicrobials or that current deficits in the supply of antimicrobials is due to unique inefficiencies in the antimicrobial market. Neither the history of drug development in general nor of antimicrobial innovation in particular supports economic interventions intended to stimulate private sector supply of new antimicrobials. On the contrary, public underwriting of the private sector, which by definition is compelled to prioritise profit, risks dire consequences for future global health.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>James</LastName>
            <ForeName>Jack E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, School of Business, Reykjav&#xED;k University, 101 Reykjav&#xED;k, Iceland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Public Health (Oxf)</MedlineTA>
        <NlmUniqueID>101188638</NlmUniqueID>
        <ISSNLinking>1741-3842</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004345" MajorTopicYN="N">Drug Industry</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004352" MajorTopicYN="Y">Drug Resistance, Microbial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005380" MajorTopicYN="Y">Financing, Government</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017149" MajorTopicYN="N">Private Sector</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">economics</Keyword>
        <Keyword MajorTopicYN="N">finance and industry</Keyword>
        <Keyword MajorTopicYN="N">infectious disease</Keyword>
        <Keyword MajorTopicYN="N">pharmaceutical industry</Keyword>
        <Keyword MajorTopicYN="N">public health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29982521</ArticleId>
        <ArticleId IdType="doi">10.1093/pubmed/fdy116</ArticleId>
        <ArticleId IdType="pii">5047932</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">29974872</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0972-9941</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>15</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Jul-Sep</Season>
            </PubDate>
          </JournalIssue>
          <Title>Journal of minimal access surgery</Title>
          <ISOAbbreviation>J Minim Access Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A standardised and simplified technique for laparoscopic resection of the splenic flexure.</ArticleTitle>
        <Pagination>
          <StartPage>268</StartPage>
          <EndPage>272</EndPage>
          <MedlinePgn>268-272</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4103/jmas.JMAS_118_18</ELocationID>
        <Abstract>
          <AbstractText>The splenic flexure is an uncommon location of colorectal cancer, being involved in 2%-3% of cases. The low chance of being engaged in resecting cancer of the splenic flexure can make it difficult for surgeons to build their learning curve and to achieve a reliable experience. As the majority of colectomies are still performed by low-volume surgeons, there is growing agreement that providing local services with adequate surgical education and training could be an effective strategy to improve outcomes and global health. Arming surgeons with simplified and easy-to-learn surgical techniques could be an important step of this strategy. A novel simplified technique for laparoscopic resection of the splenic flexure is presented, which combines laparoscopic mobilisation of the right colon with extracorporeal vascular ligation and bowel anastomosis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lotti</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Advanced Surgical Oncology Unit, Papa Giovanni Xxiii Hospital, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Poiasina</LastName>
            <ForeName>Elia</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Papa Giovanni Xxiii Hospital, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Panyor</LastName>
            <ForeName>Gabor</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Papa Giovanni Xxiii Hospital, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marini</LastName>
            <ForeName>Michele</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Papa Giovanni Xxiii Hospital, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Capponi</LastName>
            <ForeName>Michela Giulii</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Papa Giovanni Xxiii Hospital, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paderno</LastName>
            <ForeName>Nadiane</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Papa Giovanni Xxiii Hospital, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Calcagno</LastName>
            <ForeName>Pietro</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Papa Giovanni Xxiii Hospital, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Poletti</LastName>
            <ForeName>Eugenio</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Papa Giovanni Xxiii Hospital, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Campanati</LastName>
            <ForeName>Luca</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Surgery, Papa Giovanni Xxiii Hospital, Bergamo, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>India</Country>
        <MedlineTA>J Minim Access Surg</MedlineTA>
        <NlmUniqueID>101228183</NlmUniqueID>
        <ISSNLinking>1998-3921</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Colon cancer</Keyword>
        <Keyword MajorTopicYN="N">colon resection</Keyword>
        <Keyword MajorTopicYN="N">colorectal cancer</Keyword>
        <Keyword MajorTopicYN="N">laparoscopic colectomy</Keyword>
        <Keyword MajorTopicYN="N">splenic flexure</Keyword>
      </KeywordList>
      <CoiStatement>None</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29974872</ArticleId>
        <ArticleId IdType="pmc">PMC6561073</ArticleId>
        <ArticleId IdType="doi">10.4103/jmas.JMAS_118_18</ArticleId>
        <ArticleId IdType="pii">235397</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hayne D, Brown RS, McCormack M, Quinn MJ, Payne HA, Babb P, et al. Current trends in colorectal cancer: Site, incidence, mortality and survival in England and Wales. Clin Oncol (R Coll Radiol) 2001;13:448&#x2013;52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11824884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlini M, Spoletini D, Castaldi F, Giovannini C, Passaro U. Laparoscopic resection of splenic flexure tumors. Updates Surg. 2016;68:77&#x2013;83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27040272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okuda J, Yamamoto M, Tanaka K, Masubuchi S, Uchiyama K. Laparoscopic resection of transverse colon cancer at splenic flexure: Technical aspects and results. Updates Surg. 2016;68:71&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27015933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pisani Ceretti A, Maroni N, Sacchi M, Bona S, Angiolini MR, Bianchi P, et al. Laparoscopic colonic resection for splenic flexure cancer: Our experience. BMC Gastroenterol. 2015;15:76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4494171</ArticleId>
            <ArticleId IdType="pubmed">26148781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiscon V, Portale G, Migliorini G, Frigo F. Splenic flexure colon cancers: Minimally invasive treatment. Updates Surg. 2015;67:55&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25702262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roscio F, Bertoglio C, De Luca A, Frattini P, Clerici F, Scandroglio I, et al. Totally laparoscopic resection of the splenic flexure for tumor. Updates Surg. 2012;64:185&#x2013;90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22739994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ceccarelli G, Biancafarina A, Patriti A, Spaziani A, Bartoli A, Bellochi R, et al. Laparoscopic resection with intracorporeal anastomosis for colon carcinoma located in the splenic flexure. Surg Endosc. 2010;24:1784&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20044761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surgical Care and Outcomes Assessment Program (SCOAP) Collaborative. Kwon S, Billingham R, Farrokhi E, Florence M, Herzig D, et al. Adoption of laparoscopy for elective colorectal resection: A report from the surgical care and outcomes assessment program. J Am Coll Surg. 2012;214:909&#x2013;180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3397823</ArticleId>
            <ArticleId IdType="pubmed">22533998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lotti M, Capponi MG, Campanati L, Bertoli P, Palamara F, Coccolini F, et al. Laparoscopic right colectomy: Miles away or just around the corner? J Minim Access Surg. 2016;12:41&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4746974</ArticleId>
            <ArticleId IdType="pubmed">26917918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ke J, Cai J, Wen X, Wu X, He Z, Zou Y, et al. Anatomic variations of inferior mesenteric artery and left colic artery evaluated by 3-dimensional CT angiography: Insights into rectal cancer surgery &#x2013; A retrospective observational study. Int J Surg. 2017;41:106&#x2013;11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28323157</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29974615</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1445-2197</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>ANZ journal of surgery</Title>
          <ISOAbbreviation>ANZ J Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Management of primary spontaneous pneumothorax: a review.</ArticleTitle>
        <Pagination>
          <StartPage>303</StartPage>
          <EndPage>308</EndPage>
          <MedlinePgn>303-308</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.14713</ELocationID>
        <Abstract>
          <AbstractText>Primary spontaneous pneumothorax is a common problem faced by doctors in medical practice. It is a significant global health problem affecting adolescent and young adults. This article will review the etiopathology, diagnosis and current management guidelines. It aims to improve clinical practice and compliance to the complexities of procedures involved in management.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 Royal Australasian College of Surgeons.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wong</LastName>
            <ForeName>Amy</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-8983-0075</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic Surgery, Monash Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Galiabovitch</LastName>
            <ForeName>Elena</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic Surgery, Monash Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhagwat</LastName>
            <ForeName>Krishna</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiothoracic Surgery, Monash Health, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Australia</Country>
        <MedlineTA>ANZ J Surg</MedlineTA>
        <NlmUniqueID>101086634</NlmUniqueID>
        <ISSNLinking>1445-1433</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058249" MajorTopicYN="N">Birt-Hogg-Dube Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015505" MajorTopicYN="N">Chest Tubes</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004715" MajorTopicYN="N">Endometriosis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006712" MajorTopicYN="N">Homocystinuria</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008382" MajorTopicYN="N">Marfan Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019152" MajorTopicYN="N">Paracentesis</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018700" MajorTopicYN="N">Pleurodesis</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011030" MajorTopicYN="N">Pneumothorax</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013896" MajorTopicYN="N">Thoracic Diseases</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020775" MajorTopicYN="N">Thoracic Surgery, Video-Assisted</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013906" MajorTopicYN="N">Thoracoscopy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">lung/ae (adverse effects)</Keyword>
        <Keyword MajorTopicYN="N">pneumothorax/et (aetiology)</Keyword>
        <Keyword MajorTopicYN="N">video-assisted thorascopic surgery</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29974615</ArticleId>
        <ArticleId IdType="doi">10.1111/ans.14713</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29974492</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2923</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>53</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Medical education</Title>
          <ISOAbbreviation>Med Educ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The global-local tension in medical education: turning 'think global, act local' on its head?</ArticleTitle>
        <Pagination>
          <StartPage>25</StartPage>
          <EndPage>31</EndPage>
          <MedlinePgn>25-31</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/medu.13630</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT">Medical education has not been immune from forces for globalisation in the contemporary world. At the same time the social accountability of medical schools in addressing local health priorities has been emphasised. This paper explores the global-local tension in medical education through a careful selection of key overview papers.</AbstractText>
          <AbstractText Label="GLOBALISATION">Globalisation in medical education has taken two main forms: economic and altruistic. The former includes licensing curricula, recruiting internationally and establishing 'offshore' schools or campuses. Altruistic collaborations focus on the spread of learning and educational innovations. Both forms bring benefits but have been subject to critique for their differential impact and focus on educational inputs rather than outputs.</AbstractText>
          <AbstractText Label="SOCIAL ACCOUNTABILITY">Social accountability requires medical schools to direct their activities to local priorities and to serving local health systems. Adoption of the principles of social accountability compels all medical schools to ask questions of their educational programmes and graduate outcomes. However, these are globally interdependent questions and are the intent of some well-known social accountability collaborations. It is na&#xEF;ve to think that adoption of a social accountability agenda by all medical schools would necessarily reduce global health inequity. A recent Australian example shows that workforce maldistribution, for example, is resistant to even high-level intervention.</AbstractText>
          <AbstractText Label="CONCLUSIONS">It is yet too early to fully accept that 'think global, act local can be turned on its head'. There is much research to be carried out, particularly on the outcomes and impacts of medical education. Establishing cause and effect is a challenge, as is determining whether globalisation or localisation can contribute to greater global health equity. If we are ever to resolve the global-local tension in medical education, we need more evidence on the outcomes of what we do, whether globally or locally inspired.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 John Wiley &amp; Sons Ltd and The Association for the Study of Medical Education.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Prideaux</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0001-6695-2723</Identifier>
            <AffiliationInfo>
              <Affiliation>Prideaux Centre for Research in Health Professions Education, Flinders University, Adelaide, South Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Med Educ</MedlineTA>
        <NlmUniqueID>7605655</NlmUniqueID>
        <ISSNLinking>0308-0110</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Med Educ. 2019 Jan;53(1):3-5. doi: 10.1111/medu.13776.</RefSource>
          <PMID Version="1">30549096</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000533" MajorTopicYN="N">Altruism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003479" MajorTopicYN="N">Curriculum</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004501" MajorTopicYN="N">Education, Medical</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D038622" MajorTopicYN="N">Internationality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007858" MajorTopicYN="N">Learning</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010819" MajorTopicYN="Y">Physician's Role</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012941" MajorTopicYN="Y">Social Responsibility</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29974492</ArticleId>
        <ArticleId IdType="doi">10.1111/medu.13630</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29969807</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1438-8812</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>51</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Endoscopy</Title>
          <ISOAbbreviation>Endoscopy</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Prospective comparative study of endoscopic submucosal dissection and gastrectomy for early neoplastic lesions including patients' perspectives.</ArticleTitle>
        <Pagination>
          <StartPage>30</StartPage>
          <EndPage>39</EndPage>
          <MedlinePgn>30-39</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1055/a-0628-6601</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">There are no prospective studies comparing endoscopic submucosal dissection (ESD) and gastrectomy, especially evaluating patient-reported outcomes. Our aim was to compare the safety and impact on quality of life (QoL) of ESD and gastrectomy in patients with early gastric neoplasia.</AbstractText>
          <AbstractText Label="METHODS">This prospective study included consecutive patients presenting with early gastric neoplasia in a tertiary center from January 2015 to August 2016. Data collection included curative resection, adverse events (AEs), and patient-reported outcomes (questionnaires: EORTC QLQ-C30, EORTC STO-22, EQ-5D-5&#x200A;L, and Assessment of Survivor Concerns) before and after interventions (after 1 month, 3&#x200A;-&#x200A;6 months, and 1 year).</AbstractText>
          <AbstractText Label="RESULTS">254 patients with early lesions were included: 153 managed by ESD and 101 by gastrectomy, the former being significantly older and with less advanced lesions. Mean procedural time and length of stay were significantly higher in the surgery group (164 vs<i>.</i> 72 minutes and 16.3 vs<i>.</i> 3.5 days; <i>P</i>&#x200A;&lt;&#x200A;0.001). Complete resection was higher in the surgical group (99&#x200A;% vs<i>.</i> 90&#x200A;%; <i>P</i>&#x200A;=&#x200A;0.02); ESD was curative in 79&#xA0;% of patients. Severe AEs and surgical re-intervention were significantly more frequent in the gastrectomy group (21.8&#x200A;% vs. 7.8&#x200A;% and 11&#x200A;% vs<i>.</i> 1&#x200A;%, respectively). Endoscopic treatment was associated with a positive impact on global health-related QoL at 1 year (net difference&#x200A;+&#x200A;9.9; <i>P</i>&#x200A;=&#x200A;0.006), role function and symptom scales (fatigue, pain, appetite, eating restrictions, dysphagia, and body image). Concerns about recurrence did not differ between the groups.</AbstractText>
          <AbstractText Label="CONCLUSIONS">In patients with early gastric neoplasia, ESD is safer and is associated with a positive impact on health-related QoL when compared with gastrectomy, without increasing fear of recurrence and new lesions.</AbstractText>
          <CopyrightInformation>&#xA9; Georg Thieme Verlag KG Stuttgart &#xB7; New York.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lib&#xE2;nio</LastName>
            <ForeName>Diogo</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>CINTESIS - Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Braga</LastName>
            <ForeName>V&#xE2;nia</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ferraz</LastName>
            <ForeName>S&#xED;lvia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Castro</LastName>
            <ForeName>Rui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lage</LastName>
            <ForeName>Jorge</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pita</LastName>
            <ForeName>In&#xEA;s</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ribeiro</LastName>
            <ForeName>C&#xE1;tia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Surgical Oncology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abreu De Sousa</LastName>
            <ForeName>Joaquim</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Surgical Oncology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dinis-Ribeiro</LastName>
            <ForeName>M&#xE1;rio</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>CINTESIS - Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pimentel-Nunes</LastName>
            <ForeName>Pedro</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Gastroenterology Department, Instituto Portugu&#xEA;s de Oncologia do Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>CINTESIS - Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Endoscopy</MedlineTA>
        <NlmUniqueID>0215166</NlmUniqueID>
        <ISSNLinking>0013-726X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Endoscopy. 2019 Jan;51(1):106-107. doi: 10.1055/a-0806-1822.</RefSource>
          <PMID Version="1">30572363</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D061345" MajorTopicYN="N">Early Medical Intervention</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069916" MajorTopicYN="Y">Endoscopic Mucosal Resection</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005743" MajorTopicYN="Y">Gastrectomy</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010043" MajorTopicYN="N">Outcome and Process Assessment, Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011174" MajorTopicYN="N" Type="Geographic">Portugal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013274" MajorTopicYN="Y">Stomach Neoplasms</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>None</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29969807</ArticleId>
        <ArticleId IdType="doi">10.1055/a-0628-6601</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29969058</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1615-5742</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Jan-Feb</Season>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society</Title>
          <ISOAbbreviation>Pediatr Dev Pathol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Association of Maternal Prepregnancy Body Mass Index With Placental Histopathological Characteristics in Uncomplicated Term Pregnancies.</ArticleTitle>
        <Pagination>
          <StartPage>45</StartPage>
          <EndPage>52</EndPage>
          <MedlinePgn>45-52</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1093526618785838</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Prepregnancy obesity is a growing global health problem and has several risks for mother and child. The aim of this study was to systematically examine the effect of increased maternal body mass index (BMI) on placental pathology in otherwise uneventful term pregnancies.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In this analysis, we studied data of the Netherlands Amniotic Fluid study, a prospective study of women delivering in Utrecht, the Netherlands, between 2006 and 2007. We included women with uncomplicated pregnancies, vaginal delivery, and data on prepregnancy weight and height (n&#x2009;=&#x2009;382). Placental histopathology was compared between women of normal BMI (&#x2264;24.9&#x2009;kg/m<sup>2</sup>), overweight (25-29.9&#x2009;kg/m<sup>2</sup>), and obese (&#x2265;30&#x2009;kg/m<sup>2</sup>).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Increasing prepregnancy BMI was associated with heavier placentas and higher mean infant's birth weight. In addition, obesity was positively associated with high-grade chronic villitis (odds ratio [OR]: 18.1, 95% confidence interval [CI]: 1.6-205.2), accelerated villous maturation (OR: 1.1, 95% CI: 1.0-1.2), and lower incidence of placental weight below the 10th percentile for gestational age (OR: 0.5, 95% CI: 0.3-1.0). There was a substantial effect of parity on maternal, placental, and neonatal weights.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Even in uncomplicated pregnancies, maternal obesity is associated with characteristic changes in placental pathology. Further research is needed to evaluate these changes in view of later-life health of infants born to obese mothers.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Brouwers</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0003-4600-2020</Identifier>
            <AffiliationInfo>
              <Affiliation>1 Wilhelmina Children's Hospital Birth Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Franx</LastName>
            <ForeName>Arie</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>1 Wilhelmina Children's Hospital Birth Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vogelvang</LastName>
            <ForeName>Tatjana E</ForeName>
            <Initials>TE</Initials>
            <AffiliationInfo>
              <Affiliation>2 Department of Obstetrics &amp; Gynecology, Diakonessenhuis, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Houben</LastName>
            <ForeName>Michiel L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>3 Department of Pediatrics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Rijn</LastName>
            <ForeName>Bas B</ForeName>
            <Initials>BB</Initials>
            <AffiliationInfo>
              <Affiliation>1 Wilhelmina Children's Hospital Birth Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nikkels</LastName>
            <ForeName>Peter Gj</ForeName>
            <Initials>PG</Initials>
            <AffiliationInfo>
              <Affiliation>4 Department of Pathology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Dev Pathol</MedlineTA>
        <NlmUniqueID>9809673</NlmUniqueID>
        <ISSNLinking>1093-5266</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015992" MajorTopicYN="Y">Body Mass Index</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010920" MajorTopicYN="N">Placenta</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047929" MajorTopicYN="N">Term Birth</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">future health</Keyword>
        <Keyword MajorTopicYN="N">inflammation</Keyword>
        <Keyword MajorTopicYN="N">obesity</Keyword>
        <Keyword MajorTopicYN="N">placental pathology</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>2</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29969058</ArticleId>
        <ArticleId IdType="pmc">PMC6604681</ArticleId>
        <ArticleId IdType="doi">10.1177/1093526618785838</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Poston L, Caleyachetty R, Cnattingius S, et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol 2016; 4(12): 1025&#x2013;1036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27743975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307(5): 491&#x2013;497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22253363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CBS/RIVM.
Gezondheidsenqu&#xEA;te/Leefstijlmonitor. https://www.volksgezondheidenzorg.info/onderwerp/overgewicht/cijfers-context/huidige-situatie#node-overgewicht-volwassenen-naar-leeftijd.
Published 2015. Accessed June 14, 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Yogev Y, Catalano PM. Pregnancy and obesity. Obstetrics and Gynecology Clinics of North America 2009; 36(2): 285&#x2013;300, viii.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19501314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health 2007; 7: 168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1940246</ArticleId>
            <ArticleId IdType="pubmed">17650297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115(3): e290&#x2013;e296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15741354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kermack AJ, Van Rijn BB, Houghton FD, Calder PC, Cameron IT, Macklon NS. The &#x2018;Developmental Origins&#x2019; Hypothesis: relevance to the obstetrician and gynecologist. J Dev Orig Health Dis 2015; 6(5): 415&#x2013;424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26347389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB, Olsen J. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet Gynecol 2005; 106(2): 250&#x2013;259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16055572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25(8): 1175&#x2013;1182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11477502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Block T, El-Osta A. Epigenetic programming, early life nutrition and the risk of metabolic disease. Atherosclerosis 2017; 266: 31&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28950165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu MJ, Du M, Nathanielsz PW, Ford SP. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta 2010; 31(5): 387&#x2013;391.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20185176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts KA, Riley SC, Reynolds RM, et al. Placental structure and inflammation in pregnancies associated with obesity. Placenta 2011; 32(3): 247&#x2013;254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21232790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bar J, Schreiber L, Saruhanov E, Ben-Haroush A, Golan A, Kovo M. Placental histopathological findings in obese and nonobese women with complicated and uncomplicated pregnancies. Arch Gynecol Obstet 2012; 286(6): 1343&#x2013;1347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22797660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang L, Liu J, Feng L, Chen Y, Zhang J, Wang W. Maternal prepregnancy obesity is associated with higher risk of placental pathological lesions. Placenta 2014; 35(8): 563&#x2013;569.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24930988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leon-Garcia SM, Roeder HA, Nelson KK, et al. Maternal obesity and sex-specific differences in placental pathology. Placenta 2016; 38: 33&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26907380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Houben ML, Nikkels PG, van Bleek GM, et al. The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS One 2009; 4(8): e6572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2718580</ArticleId>
            <ArticleId IdType="pubmed">19668329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Houben ML, Rovers MM, Wilbrink B, et al. High concentrations of amniotic fluid proinflammatory cytokines in healthy neonates are associated with low risk of respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 2012; 31(9): 931&#x2013;934.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22699404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i&#x2013;xii, 1&#x2013;253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11234459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinar H, Sung CJ, Oyer CE, Singer DB. Reference values for singleton and twin placental weights. Pediatr Pathol Lab Med 1996; 16(6): 901&#x2013;907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9025888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med 2016; 140(7): 698&#x2013;713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27223167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veerbeek JH, Nikkels PG, Torrance HL, et al. Placental pathology in early intrauterine growth restriction associated with maternal hypertension. Placenta 2014; 35(9): 696&#x2013;701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25052232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strom-Roum EM, Tanbo TG, Eskild A. The associations of maternal body mass index with birthweight and placental weight. Does maternal diabetes matter? A population study of 106 191 pregnancies. Acta Obstet Gynecol Scand 2016; 95(10): 1162&#x2013;1170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27454190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swanson LD, Bewtra C. Increase in normal placental weights related to increase in maternal body mass index. J Matern Fetal Neonatal Med 2008; 21(2): 111&#x2013;113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18240079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace JM, Horgan GW, Bhattacharya S. Placental weight and efficiency in relation to maternal body mass index and the risk of pregnancy complications in women delivering singleton babies. Placenta 2012; 33(8): 611&#x2013;618.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22695104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alwasel SH, Abotalib Z, Aljarallah JS, et al. Secular increase in placental weight in Saudi Arabia. Placenta 2011; 32(5): 391&#x2013;394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3923651</ArticleId>
            <ArticleId IdType="pubmed">21429577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Myatt L, Maloyan A. Obesity and placental function. Semin Reprod Med 2016; 34(1): 42&#x2013;49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26734917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poston L. Maternal obesity, gestational weight gain and diet as determinants of offspring long term health. Best Pract Res Clin Endocrinol Metab 2012; 26(5): 627&#x2013;639.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22980045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elias SG, Keinan-Boker L, Peeters PH, et al. Long term consequences of the 1944-1945 Dutch famine on the insulin-like growth factor axis. Int J Cancer 2004; 108(4): 628&#x2013;630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14696131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Abeelen AF, Elias SG, Bossuyt PM, et al. Cardiovascular consequences of famine in the young. Eur Heart J 2012; 33(4): 538&#x2013;545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21868476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006; 368(9542): 1164&#x2013;1170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17011943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008; 29(3): 274&#x2013;281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4284075</ArticleId>
            <ArticleId IdType="pubmed">18262644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol 2005; 192(2): 452&#x2013;457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15695986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007; 38(10): 1439&#x2013;1446.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17889674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Redline RW, Abramowsky CR. Clinical and pathologic aspects of recurrent placental villitis. Hum Pathol 1985; 16(7): 727&#x2013;731.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4007849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tamblyn JA, Lissauer DM, Powell R, Cox P, Kilby MD. The immunological basis of villitis of unknown etiology&#x2014;review. Placenta 2013; 34(10): 846&#x2013;855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23891153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Becroft DM, Thompson JM, Mitchell EA. Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol 2005; 192(1): 264&#x2013;271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15672035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins M, McAuliffe FM, Mooney EE. Clinical associations with a placental diagnosis of delayed villous maturation: a retrospective study. Pediatr Dev Pathol 2011; 14(4): 273&#x2013;279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21329421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stallmach T, Hebisch G, Meier K, Dudenhausen JW, Vogel M. Rescue by birth: defective placental maturation and late fetal mortality. Obstet Gynecol 2001; 97(4): 505&#x2013;509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11275018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bannon AL, Waring ME, Leung K, et al. Comparison of self-reported and measured pre-pregnancy weight: implications for gestational weight gain counseling. Matern Child Health J 2017; 21(7): 1469&#x2013;1478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28155023</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29953579</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1528-1167</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60 Suppl 1</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Epilepsia</Title>
          <ISOAbbreviation>Epilepsia</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Epilepsy in Asia: Disease burden, management barriers, and challenges.</ArticleTitle>
        <Pagination>
          <StartPage>7</StartPage>
          <EndPage>21</EndPage>
          <MedlinePgn>7-21</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/epi.14458</ELocationID>
        <Abstract>
          <AbstractText>This article reviews the burden of epilepsy in Asia, the challenges faced by people with epilepsy, and the management of epilepsy. Comparison is made with other parts of the world. For this narrative review, data were collected using specified search criteria. Articles investigating the epidemiology of epilepsy, diagnosis, comorbidities and associated mortality, stigmatization, and treatment were included. Epilepsy is a global health care issue affecting up to 70 million people worldwide. Nearly 80% of people with epilepsy live in low- and middle-income countries with limited resources. People with epilepsy are prone to physical and psychological comorbidities, including anxiety and depression, which can negatively impact their quality of life. Furthermore, people with epilepsy are at higher risk of premature death than people without epilepsy. Discrimination or stigmatization of people with epilepsy is common in Asia and can affect their education, work, and marriage opportunities. Access to epilepsy treatment varies throughout Asia. Although highly advanced treatment is available in some countries, up to 90% of people with epilepsy are not adequately treated or are not treated with conventional antiepileptic therapy in resource-limited countries. People in remote areas often do not receive any epilepsy care. First-generation antiepileptic drugs (AEDs) are available, but usually only in urban areas, and second-generation AEDs are not available in all countries. Newer AEDs tend to have more favorable safety profiles than first-generation AEDs and provide options to tailor therapy for individual patients, especially those with comorbidities. Active epilepsy surgery centers are present in some countries, although epilepsy surgery is often underutilized given the number of patients who could benefit. Further epidemiologic research is needed to provide accurate epilepsy data across the Asian region. Coordinated action is warranted to improve access to treatment and care.</AbstractText>
          <CopyrightInformation>Wiley Periodicals, Inc. &#xA9; 2018 International League Against Epilepsy.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Trinka</LastName>
            <ForeName>Eugen</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0002-5950-2692</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Christian Doppler Klinik, University Hospital Paracelsus Medical University, Salzburg, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Public Health, Medical Decision Making, and Health Technology Assessment, University for Health Sciences, Medical Informatics, and Technology, Hall in Tyrol, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kwan</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Medicine and Neurology, University of Melbourne, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>ByungIn</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Inje University School of Medicine, Haeundae Paik Hospital, Busan, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dash</LastName>
            <ForeName>Amitabh</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Eisai Singapore Pte Ltd, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Epilepsia</MedlineTA>
        <NlmUniqueID>2983306R</NlmUniqueID>
        <ISSNLinking>0013-9580</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019468" MajorTopicYN="Y">Disease Management</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057545" MajorTopicYN="N">Social Stigma</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Asia</Keyword>
        <Keyword MajorTopicYN="N">antiepileptic drugs</Keyword>
        <Keyword MajorTopicYN="N">comorbidity</Keyword>
        <Keyword MajorTopicYN="N">seizures</Keyword>
        <Keyword MajorTopicYN="N">social stigma</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>2</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29953579</ArticleId>
        <ArticleId IdType="doi">10.1111/epi.14458</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29952267</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2212-3989</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Infectious disorders drug targets</Title>
          <ISOAbbreviation>Infect Disord Drug Targets</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Recent Progress on Neutralizing Antibodies against Hepatitis B Virus and its Implications.</ArticleTitle>
        <Pagination>
          <StartPage>213</StartPage>
          <EndPage>223</EndPage>
          <MedlinePgn>213-223</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2174/1871526518666180628122400</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hepatitis B virus (HBV) infection remains a global health problem. As "cure" for chronic hepatitis B is of current priority, hepatitis B immunoglobulin (HBIG) has been utilized for several decades to provide post-exposure prophylaxis. In recent years, a number of monoclonal antibodies (mAbs) targeting HBV have been developed and demonstrated with high affinity, specificity, and neutralizing potency.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">HBV neutralizing antibodies may play a potentially significant role in the search for an HBV cure. In this review, we will summarize the recent progress in developing HBV-neutralizing antibodies, describing their characteristics and potential clinical applications.</AbstractText>
          <AbstractText Label="RESULTS AND CONCLUSION" NlmCategory="CONCLUSIONS">HBV neutralizing antibodies could be a promising alternative in the prevention and treatment of HBV infection. More importantly, global collaboration and coordinated approaches are thus needed to facilitate the development of novel therapies for HBV infection.</AbstractText>
          <CopyrightInformation>Copyright&#xA9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Binbin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Central Laboratory, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wen</LastName>
            <ForeName>Yumei</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ying</LastName>
            <ForeName>Tianlei</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United Arab Emirates</Country>
        <MedlineTA>Infect Disord Drug Targets</MedlineTA>
        <NlmUniqueID>101269158</NlmUniqueID>
        <ISSNLinking>1871-5265</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D006510">Hepatitis B Antibodies</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006510" MajorTopicYN="N">Hepatitis B Antibodies</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006515" MajorTopicYN="N">Hepatitis B virus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HBV cure</Keyword>
        <Keyword MajorTopicYN="N">HbsAg</Keyword>
        <Keyword MajorTopicYN="N">Hepatitis B virus</Keyword>
        <Keyword MajorTopicYN="N">antibodies</Keyword>
        <Keyword MajorTopicYN="N">infection</Keyword>
        <Keyword MajorTopicYN="N">neutralizing antibody.</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29952267</ArticleId>
        <ArticleId IdType="doi">10.2174/1871526518666180628122400</ArticleId>
        <ArticleId IdType="pii">IDDT-EPUB-91330</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29948791</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1573-6571</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>58</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of religion and health</Title>
          <ISOAbbreviation>J Relig Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact of Hajj on Global Health Security.</ArticleTitle>
        <Pagination>
          <StartPage>289</StartPage>
          <EndPage>302</EndPage>
          <MedlinePgn>289-302</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10943-018-0648-5</ELocationID>
        <Abstract>
          <AbstractText>With the human society transfers from scattered pieces to a society as a whole and the advent of the aviation era, the occurrence of infectious diseases and their diffusion have led to international health security issues. As the world's largest and irrevocable annual transnational religious movement, the Hajj and its connection with health security concerns have caught attention since the ancient times, because a huge population from all over the world gathers in the holy city of Mecca, which has tropical arid climate. Currently, the international community and international organizations are implementing multilevel governance with respect to the health security issues of the Hajj. Relevant agencies include the World Health Organization and its regional branches, International Red Cross and Red Crescent Movement (ICRC), the Ministry of Hajj as well as the Ministry of Health of Saudi Arabia, and the public health sectors/agencies in various countries that are involved with Hajj activities. The international community has successfully held the Hajj events, even when facing the challenges brought by some viral respiratory diseases such as SARS and MERS. The Hajj has become a rare opportunity for all stakeholders to improve their capabilities in international health security governance.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Niu</LastName>
            <ForeName>Song</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Middle East Studies Institute, Shanghai International Studies University, Shanghai, China. phd_niusong@163.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Religion and China's National Security, Fudan University, Shanghai, China. phd_niusong@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Mindan</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Tongji Hospital Affiliated to the Tongji University, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>13CZJ017</GrantID>
            <Agency>National Social Science Fund of China</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Relig Health</MedlineTA>
        <NlmUniqueID>2985199R</NlmUniqueID>
        <ISSNLinking>0022-4197</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003141" MajorTopicYN="Y">Communicable Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007514" MajorTopicYN="Y">Islam</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014195" MajorTopicYN="N">Travel</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">International Health Security</Keyword>
        <Keyword MajorTopicYN="N">Islamic Hajj</Keyword>
        <Keyword MajorTopicYN="N">Red Cross and Red Crescent Societies</Keyword>
        <Keyword MajorTopicYN="N">Saudi Arabia</Keyword>
        <Keyword MajorTopicYN="N">World Health Organization</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>23</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29948791</ArticleId>
        <ArticleId IdType="pmc">PMC7088024</ArticleId>
        <ArticleId IdType="doi">10.1007/s10943-018-0648-5</ArticleId>
        <ArticleId IdType="pii">10.1007/s10943-018-0648-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29948392</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1433-7339</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</Title>
          <ISOAbbreviation>Support Care Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Couples' symptom burden in oncology care: perception of self and the other.</ArticleTitle>
        <Pagination>
          <StartPage>139</StartPage>
          <EndPage>145</EndPage>
          <MedlinePgn>139-145</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00520-018-4298-7</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The literature suggests that psychological distress and quality of life are interdependent in couples coping with cancer. The current study seeks to extend these findings to physical symptom burden, examining differences in symptom self-rating and perception of partner symptoms.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Couples were approached while waiting for an integrative oncology service. Fifty patients and their partners completed the Edmonton Symptom Assessment Scale (ESAS-FS; twelve symptoms, scores 0-10, 10 worst possible) and a Global Health measure (PROMIS10). Patient and partner each also completed the ESAS-FS as it related to their perception of the other's symptoms. ESAS distress subscales analyzed included Global (GDS), Psychosocial (PSS), and Physical (PHS). Analyses included paired t tests to examine all measures.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-eight percent of patients were female with most common cancer diagnoses of breast (22%), gastrointestinal (16%), and thoracic/H&amp;N (16%). For ESAS-FS self-ratings, patients had significantly higher physical distress than partners, with a no significant difference in psychosocial distress. For PROMIS10 self-ratings, patients reported significantly lower global health and physical health, (p's&#x2009;&lt;&#x2009;0.001); no differences were found for mental health between patients and caregivers. Patient rating of partner physical distress (PHS, p&#x2009;=&#x2009;0.01) was significantly higher than partner self-rating, with no significant difference observed in ratings for psychosocial distress. Partner rating of patient psychosocial distress (PSS, p&#x2009;&lt;&#x2009;0.001) and physical distress (PHS, p&#x2009;=&#x2009;0.001) was significantly higher than that of patient self-rating.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings suggest that both patients and partners perceive physical distress of the other higher than self; however, patients may be more sensitive to psychosocial distress in their partners.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lopez</LastName>
            <ForeName>Gabriel</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0002-3685-0280</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1414, Houston, TX, 77030, USA. gabriel.lopez@mdanderson.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Milbury</LastName>
            <ForeName>Kathrin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1414, Houston, TX, 77030, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Minxing</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yisheng</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bruera</LastName>
            <ForeName>Eduardo</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1414, Houston, TX, 77030, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cohen</LastName>
            <ForeName>Lorenzo</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Palliative, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1414, Houston, TX, 77030, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K01 AT007559</GrantID>
            <Acronym>AT</Acronym>
            <Agency>NCCIH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 CA016672</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>CA016672</GrantID>
            <Agency>National Institutes of Health</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Support Care Cancer</MedlineTA>
        <NlmUniqueID>9302957</NlmUniqueID>
        <ISSNLinking>0941-4355</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071066" MajorTopicYN="N">Patient Reported Outcome Measures</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010465" MajorTopicYN="N">Perception</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012747" MajorTopicYN="N">Sexual Partners</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Caregiver</Keyword>
        <Keyword MajorTopicYN="N">Couple communication</Keyword>
        <Keyword MajorTopicYN="N">Edmonton Symptom Assessment System</Keyword>
        <Keyword MajorTopicYN="N">Integrative oncology</Keyword>
        <Keyword MajorTopicYN="N">Patient reported outcomes</Keyword>
        <Keyword MajorTopicYN="N">Symptom burden</Keyword>
      </KeywordList>
      <CoiStatement><b>Conflict of interest</b> The authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>7</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29948392</ArticleId>
        <ArticleId IdType="mid">NIHMS1014214</ArticleId>
        <ArticleId IdType="pmc">PMC6405284</ArticleId>
        <ArticleId IdType="doi">10.1007/s00520-018-4298-7</ArticleId>
        <ArticleId IdType="pii">10.1007/s00520-018-4298-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Deshields TL, Potter P, Olsen S, Liu J (2014) The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer 22(4): 1089&#x2013;1096</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4929053</ArticleId>
            <ArticleId IdType="pubmed">24292095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim JEE, Dodd MJ, Aouizerat BE et al. (2009) A review of the prevalence and impact of multiple symptoms in oncology patients. JPSM 37(4):715&#x2013;736</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2688644</ArticleId>
            <ArticleId IdType="pubmed">19019626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girgis A, Lambert S, Johnson C et al. (2013) Physical, psychosocial, and economic burden of caring for people with cancer: a review. JOP 9(4):197&#x2013;202</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3710169</ArticleId>
            <ArticleId IdType="pubmed">23942921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulz R, Beach SR (1999) Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA 282(23): 2215&#x2013;2219</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10605972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reeve BB, Mitchell SA, Dueck AC, et al. (2014) Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 106(7)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4110472</ArticleId>
            <ArticleId IdType="pubmed">25006191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanco K, Vidal M, Joseph AA et al. (2018) Testing the feasibility of using the Edmonton Symptom Assessment System (ESAS) to assess caregiver symptom burden. Palliative and Supportive Care 16(1): 14&#x2013;22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28264740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurtz JC, Given CC et al. (1996) Concordance of cancer patient and caregiver symptom reports. Cancer Pract 4(4):185&#x2013;190</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8900759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye&#x15F;ilbalkan OU, Okgun A (2010) Patients&#x2019; self reports and caregivers&#x2019; perception of symptoms in Turkish cancer patients. Eur J Oncol Nurs 14(2):119&#x2013;124</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19822455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lobchuk MM, Kristjanson L, Degner L et al. (1997) Perceptions of symptom distress in lung cancer patients: I. Congruence between patients and primary family caregivers. J Pain Symptom Manag 14(3): 136&#x2013;146</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9291700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Litzelman K, Green PA, Yabroff KR (2016) Cancer and quality of life in spousal dyads: spillover in couples with and without cancer-related health problems. Support Care Cancer 24(2): 763&#x2013;771</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4690790</ArticleId>
            <ArticleId IdType="pubmed">26143040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milne DJ, Mulder LL, Beelen HC et al. (2006) Patients&#x2019; self-report and family caregivers&#x2019; perception of quality of life in patients with advanced cancer: how do they compare? Eur J Cancer Care (Engl) 15(2):125&#x2013;132</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16643259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nekolaichuk CL, Maguire TO, Suarez-Almazor M, Rogers WT, Bruera E (1999) Assessing the reliability of patient, nurse, and family caregiver symptom ratings in hospitalized advanced cancer patients. J Clin Oncol 17(11):3621&#x2013;3630</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10550162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silveira MJ, Given CW, Given B, Rosland AM, Piette JD (2010) Patient-caregiver concordance in symptom assessment and improvement in outcomes for patients undergoing cancer chemotherapy. Chronic Illn 6(1):46&#x2013;56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20308350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruera E, Kuehn N, Miller MJ et al. (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1714502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D (2009) Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res 18(7):873&#x2013;880</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2724630</ArticleId>
            <ArticleId IdType="pubmed">19543809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez G, McQuade J, Cohen L, Williams JT, Spelman AR, Fellman B, Li Y, Bruera E, Lee RT (2017) Integrative oncology physician consultations at a comprehensive cancer center: analysis of demographic, clinical and patient reported outcomes. J Cancer 8(3):395&#x2013;402</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5332890</ArticleId>
            <ArticleId IdType="pubmed">28261340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez G, Liu W, Milbury K, Spelman A, Wei Q, Bruera E, Cohen L (2017) The effects of oncology massage on symptom self-report for cancer patients and their caregivers. Support Care Cancer 25:3645&#x2013;3650</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC9713953</ArticleId>
            <ArticleId IdType="pubmed">28660350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yennurajalingam S, Urbauer DL, Casper KLB, Reyes-Gibby CC, Chacko R, Poulter V, Bruera E (2011) Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manag 41(1):49&#x2013;56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20739141</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29948217</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1436-6215</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>58</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>European journal of nutrition</Title>
          <ISOAbbreviation>Eur J Nutr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Iron bioavailability of four iron sources used to fortify infant cereals, using anemic weaning pigs as a model.</ArticleTitle>
        <Pagination>
          <StartPage>1911</StartPage>
          <EndPage>1922</EndPage>
          <MedlinePgn>1911-1922</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00394-018-1742-x</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Iron (Fe) deficiency anemia in young children is a global health concern which can be reduced by Fe fortification of foods. Cereal is often one of the first foods given to infants, providing adequate quantities of Fe during weaning. In this work, we have compared iron bioavailability and iron status of four iron sources used to fortify infant cereals, employing piglets as an animal model.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">The study was conducted on 36 piglets, 30 of them with induced anemia. From day 28 of life, the weaned piglets were fed with four experimental diets (n&#x2009;=&#x2009;6) each fortified with 120&#xA0;mg Fe/kg by ferrous sulfate heptahydrate (FSH), electrolytic iron (EI), ferrous fumarate (FF), or micronized dispersible ferric pyrophosphate (MDFP) for another 21&#xA0;days. In addition, one group of six anemic piglets fed with the basal diet with no iron added (Control-) and a Control+ group of non-anemic piglets (n&#x2009;=&#x2009;6) were also studied. Blood indicators of iron status were measured after depletion and during the repletion period. The Fe content in organs, hemoglobin regeneration efficiency, and relative bioavailability (RBV) was also determined.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The Fe salts adequately treated anemia in the piglets, allowing the animals to recover from the anemic state, although EI was less efficient with regard to replenishing Fe stores giving lower concentrations of plasma ferritin and iron in the spleen, liver, lung, and kidney. In addition, the RBV of EI was 88.27% with respect to the reference iron salt (FSH).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Ferrous fumarate and MDFP were equally as bioavailable as the reference salt, and were used significantly better than EI in piglets. These results contribute to extend the evidence-based results for recommending the most suitable fortificant for infant cereals.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Caballero Valc&#xE1;rcel</LastName>
            <ForeName>Ana Mar&#xED;a</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Food Science and Nutrition Department, Veterinary Faculty, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, 30100, Murcia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mart&#xED;nez Graci&#xE1;</LastName>
            <ForeName>Carmen</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-3195-825X</Identifier>
            <AffiliationInfo>
              <Affiliation>Food Science and Nutrition Department, Veterinary Faculty, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, 30100, Murcia, Spain. mamen@um.es.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mart&#xED;nez Mir&#xF3;</LastName>
            <ForeName>Silvia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Animal Production Department, Veterinary Faculty, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, 30100, Murcia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Madrid S&#xE1;nchez</LastName>
            <ForeName>Josefa</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Animal Production Department, Veterinary Faculty, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, 30100, Murcia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gonz&#xE1;lez Berm&#xFA;dez</LastName>
            <ForeName>Carlos Alberto</ForeName>
            <Initials>CA</Initials>
            <AffiliationInfo>
              <Affiliation>Food Science and Nutrition Department, Veterinary Faculty, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, 30100, Murcia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Domenech Asensi</LastName>
            <ForeName>Guillermo</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Food Science and Nutrition Department, Veterinary Faculty, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, 30100, Murcia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>L&#xF3;pez Nicol&#xE1;s</LastName>
            <ForeName>Rub&#xE9;n</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Food Science and Nutrition Department, Veterinary Faculty, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, 30100, Murcia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santaella Pascual</LastName>
            <ForeName>Marina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Food Science and Nutrition Department, Veterinary Faculty, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, 30100, Murcia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>AGL2013-40617-R</GrantID>
            <Agency>Secretar&#xED;a de Estado de Investigaci&#xF3;n, Desarrollo e Innovaci&#xF3;n</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Nutr</MedlineTA>
        <NlmUniqueID>100888704</NlmUniqueID>
        <ISSNLinking>1436-6207</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019266">Iron, Dietary</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName>
          <QualifierName UI="Q000178" MajorTopicYN="Y">diet therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001682" MajorTopicYN="N">Biological Availability</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002523" MajorTopicYN="Y">Edible Grain</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005527" MajorTopicYN="Y">Food, Fortified</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007225" MajorTopicYN="Y">Infant Food</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019266" MajorTopicYN="N">Iron, Dietary</DescriptorName>
          <QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014886" MajorTopicYN="N">Weaning</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bioavailability</Keyword>
        <Keyword MajorTopicYN="N">Iron fortification</Keyword>
        <Keyword MajorTopicYN="N">Iron salts</Keyword>
        <Keyword MajorTopicYN="N">Iron status</Keyword>
        <Keyword MajorTopicYN="N">Weaned piglets</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29948217</ArticleId>
        <ArticleId IdType="doi">10.1007/s00394-018-1742-x</ArticleId>
        <ArticleId IdType="pii">10.1007/s00394-018-1742-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Anim Sci. 1999 Aug;77(8):2135-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10461992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pediatrics. 2000 Apr;105(4):E51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10742372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Clin Nutr. 2000 Jun;71(6):1597-602</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10837304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anal Bioanal Chem. 2002 Feb;372(3):421-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11939527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Nutr. 2003 Dec;90(6):1081-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14641967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Nutr. 2004 Jan;91(1):107-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14748943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Clin Nutr. 2005 Dec;82(6):1276-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16332661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Nutr. 2006 Dec;136(12):3033-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17116716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Anim Physiol Anim Nutr (Berl). 2008 Feb;92(1):35-43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18184378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Exp Biol Med (Maywood). 2008 Jun;233(6):651-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18408137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Agric Food Chem. 2008 Jul 9;56(13):5008-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18543933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Nutr. 2008 Dec;47(8):470-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18953478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Nutr. 2009 Feb;139(2):305-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19106319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Nutr. 2009 Mar;48(2):115-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19142566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Clin Nutr. 2010 May;91(5):1423S-1429S</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20200267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Food Nutr Bull. 2010 Mar;31(1 Suppl):S7-21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20629349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Clin Nutr. 2012 Aug;96(2):309-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22760566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem J. 2013 Jan 1;449(1):69-78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22992020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nutrients. 2013 Oct 10;5(10):4022-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24152745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biol Trace Elem Res. 2015 Sep;167(1):28-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25774043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Anim Nutr. 2015;69(4):276-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26097996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Front Behav Neurosci. 2015 Oct 30;9:291</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26578919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Anim Sci Biotechnol. 2015 Nov 19;6:48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26587234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Clin Nutr. 2016 May;103(5):1252-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27053382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Clin Nutr. 1989 Jun;49(6):1274-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2729166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Vet Res. 2017 Jan 17;13(1):23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28095847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nutrients. 2017 Mar 13;9(3):null</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28335378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nutrients. 2017 Apr 04;9(4):null</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28375175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem Biophys Res Commun. 2017 Sep 2;490(4):1210-1214</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28673786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS One. 2017 Jul 13;12(7):e0181117</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28704474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Annu Rev Nutr. 1987;7:361-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3300739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vet Pathol. 1984 Nov;21(6):597-600</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6516180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nutr Rev. 1997 Jun;55(6):210-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9279057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Chem. 1997 Dec;43(12):2408-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9439462</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29912645</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2046-9055</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>39</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Paediatrics and international child health</Title>
          <ISOAbbreviation>Paediatr Int Child Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Use of a modified bubble continuous positive airway pressure (bCPAP) device for children in respiratory distress in low- and middle-income countries: a safety study.</ArticleTitle>
        <Pagination>
          <StartPage>160</StartPage>
          <EndPage>167</EndPage>
          <MedlinePgn>160-167</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/20469047.2018.1474698</ELocationID>
        <Abstract>
          <AbstractText><b>Background:</b> While bubble continuous positive airway pressure (bCPAP) is commonly used in low- and middle-income countries (LMIC) to support neonates with respiratory distress, there are limited non-invasive support options for non-neonatal children. <b>Aim</b>: To demonstrate safety of a new device designed to support children during respiratory distress in LMIC. <b>Methods:</b> A paediatric bCPAP device was designed called SEAL-bCPAP (Simplified Ear-plug Adapted-bCPAP). SEAL-bCPAP is constructed from inexpensive, easily obtainable materials. The nasal prong interface was modified from previously described neonatal bCPAP set-ups using commercial ear-plug material to improve nasal seal. A prospective interventional study was conducted to evaluate safety in children with respiratory distress treated with SEAL-bCPAP. Patients aged 30&#xA0;days to 5&#xA0;years presenting to a hospital in northern Uganda from July 2015 to June 2016 were screened. Those with moderate-severe respiratory distress and/or hypoxia despite nasal cannula oxygen were eligible for study. Enrolled patients were supported with SEAL-bCPAP until respiratory improvement or death. Complications attributable to SEAL-bCPAP were recorded. Clinical outcomes were compared with historical control pre-trial data. <b>Results</b>: Eighty-three of 87 enrolled patients were included in the final analysis. No patients had significant SEAL-bCPAP complications. Five patients had mild complications which resolved (four with nasal irritation and one with abdominal distention). Trial patients had significant (<i>p</i>&#xA0;&lt;&#xA0;0.0001) improvement in their TAL score, respiratory rate and O<sub>2</sub>sat after 2&#xA0;h of SEAL-bCPAP. Fifty-two of 64 patients (62.7%) with severe illness at Time1 did not have severe illness at Time2 (after 2&#xA0;h of SEAL-bCPAP) (<i>p</i>&#xA0;&lt;&#xA0;0.0001). Unadjusted mortality rates were 12.2% (6/49) and 9.6% (8/83), respectively, for pre-trial (historical control) and trial patients (<i>p</i>&#xA0;=&#xA0;0.64); the study was not powered to show efficacy. <b>Conclusions</b>: The SEAL-bCPAP device is safe for treatment of respiratory distress in non-neonatal children in LMIC. There is a trend toward decreased mortality that should be evaluated with adequately powered clinical trials.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bjorklund</LastName>
            <ForeName>Ashley R</ForeName>
            <Initials>AR</Initials>
            <Identifier Source="ORCID">0000-0003-2367-6444</Identifier>
            <AffiliationInfo>
              <Affiliation>a Division of Pediatric Critical Care , University of Minnesota , Minneapolis , MD , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Department of Pediatrics , Walter Reed National Military Medical Center , Bethesda , MD.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Odongkara Mpora</LastName>
            <ForeName>Beatrice</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0002-6283-9114</Identifier>
            <AffiliationInfo>
              <Affiliation>c Gulu Regional Referral Hospital , Gulu , Uganda.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Steiner</LastName>
            <ForeName>Marie E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>a Division of Pediatric Critical Care , University of Minnesota , Minneapolis , MD , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fischer</LastName>
            <ForeName>Gwenyth</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>a Division of Pediatric Critical Care , University of Minnesota , Minneapolis , MD , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Davey</LastName>
            <ForeName>Cynthia S</ForeName>
            <Initials>CS</Initials>
            <AffiliationInfo>
              <Affiliation>d Biostatistical Design and Analysis Center , University of Minnesota , Minneapolis , MN , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Slusher</LastName>
            <ForeName>Tina M</ForeName>
            <Initials>TM</Initials>
            <AffiliationInfo>
              <Affiliation>e Center for Global Pediatrics , University of Minnesota , Minneapolis , MN , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>f Department of Pediatrics , Hennepin County Medical Center , Minneapolis , MN , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>UL1 TR002494</GrantID>
            <Acronym>TR</Acronym>
            <Agency>NCATS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Paediatr Int Child Health</MedlineTA>
        <NlmUniqueID>101582666</NlmUniqueID>
        <ISSNLinking>2046-9047</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045422" MajorTopicYN="N">Continuous Positive Airway Pressure</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
          <QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014454" MajorTopicYN="N" Type="Geographic">Uganda</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ACU, acute care unit</Keyword>
        <Keyword MajorTopicYN="N">BUBBLES, bCPAP used beyond babies in low economic settings</Keyword>
        <Keyword MajorTopicYN="N">Bubble continuous positive airway pressure</Keyword>
        <Keyword MajorTopicYN="N">CPAP, continuous positive airway pressure</Keyword>
        <Keyword MajorTopicYN="N">LMIC, low- and middle-income countries</Keyword>
        <Keyword MajorTopicYN="N">OR, odds ratio</Keyword>
        <Keyword MajorTopicYN="N">Osat, oxygen saturation</Keyword>
        <Keyword MajorTopicYN="N">RR, respiratory rate</Keyword>
        <Keyword MajorTopicYN="N">SD, standard deviation</Keyword>
        <Keyword MajorTopicYN="N">SEAL-bCPAP, simplified ear-plug adapted low-cost bCPAP</Keyword>
        <Keyword MajorTopicYN="N">TAL score, modified TAL clinical score</Keyword>
        <Keyword MajorTopicYN="N">bCPAP, bubble continuous positive airway pressure</Keyword>
        <Keyword MajorTopicYN="N">child health</Keyword>
        <Keyword MajorTopicYN="N">cmHO, cm of water</Keyword>
        <Keyword MajorTopicYN="N">device innovations</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">international health</Keyword>
        <Keyword MajorTopicYN="N">low- and middle-income countries</Keyword>
        <Keyword MajorTopicYN="N">respiratory support</Keyword>
      </KeywordList>
      <CoiStatement>Disclosure statement. No potential conflict of interest was reported by the authors.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>15</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29912645</ArticleId>
        <ArticleId IdType="mid">NIHMS1056304</ArticleId>
        <ArticleId IdType="pmc">PMC6858283</ArticleId>
        <ArticleId IdType="doi">10.1080/20469047.2018.1474698</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>World Health Organization, UNICEF and Gavi Alliance. Pneumonia still responsible for one fifth of paediatric deaths, 2013.  Available from: http://www.who.int/mediacentre/news/releases/2013/world-pneumonia-day-20131112/en/#.U07twPgptN8.email</Citation>
        </Reference>
        <Reference>
          <Citation>Schluger N. Pneumonia Global Impact. The Acute Respiratory Infections Atlas. 1st ed
World Lung Foundation; 2013.  Available from: http://www.ariatlas.org/understanding_aris/pneumonia</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. MDG 4: Reduce Child mortality. 2013.  Available from: http://www.who.int/topics/millennium_development_goals/child_mortality/en</Citation>
        </Reference>
        <Reference>
          <Citation>Brett A, Sinclair DG. Use of continuous positive airway pressure in the management of community acquired pneumonia. Thorax. 1993;48:1280&#x2013;1281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC464998</ArticleId>
            <ArticleId IdType="pubmed">8303640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindner KH, Lotz P, Ahnefeld FW, et al. Continuous positive airway pressure effect on functional residual capacity, vital capacity and its subdivisions. Chest. 1987;92:66&#x2013;70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3297521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson P, Morris M, Biagas K, et al. A randomized clinical trial evaluating nasal continuous positive airway pressure for acute respiratory distress in a developing country. J Pediatr 2013;162:988&#x2013;992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23164308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slusher T, Vaucher Y, Greenwood C, et al. Newborn care In: Kamat DM, Fischer PR, editors. Textbook of global child health. Elk Grove Village, IL: American Academy of Pediatrics, 2012. p. 499.</Citation>
        </Reference>
        <Reference>
          <Citation>Rajiv PK. CPAP bedside application in the newborn. 2nd ed New Delhi: Jaypee Brothers Medical Publishers; 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Manilal-Reddy PI, Al-Jumaily AM. The use of continuous oscillating positive airway pressure (bubble CPAP) to treat neonatal respiratory disease: an engineering approach. J Med Eng 2009;33:214&#x2013;222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19340692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tagare A, Kadam S, Vaidya U, et al. Bubble CPAP versus ventilator CPAP in preterm neonates with early onset respiratory distress-a randomized controlled trial. J Trop Pediatr 2013;59:113&#x2013;119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23306407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyd J. Clinical study finds &#x201C;bubble CPAP&#x201D; boosts neonatal survival. Rice University News and Media; 
2014.  Available from: http://news.rice.edu/2014/01/29/clinical-study-finds-bubble-cpap-boosts-neonatal-survival-rates-2/</Citation>
        </Reference>
        <Reference>
          <Citation>De Klerk AM, De Klerk RK. Nasal continuous positive airway pressure and outcomes of preterm infants. J Paediatr Child Health. 2001;37:161&#x2013;167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11328472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamath BD, MacGuire ER, McClure EM, et al. Neonatal mortality from respiratory distress syndrome: lessons for the low-resource countries. Pediatrics. 2011;127:1139&#x2013;1146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC9923778</ArticleId>
            <ArticleId IdType="pubmed">21536613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawaza K, Machen HE, Brown J, et al. Efficacy of a low-cost bubble CPAP system in treatment of respiratory distress in a neonatal ward in Malawi. PLoS One. 2014;9:e86327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3906032</ArticleId>
            <ArticleId IdType="pubmed">24489715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kinikar A, Kulkarni R, Valvi C, et al. Use of indigenous bubble CPAP during swine flu pandemic in Pune, India. Indian J Pediatr 2011;78:1216&#x2013;1220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21442266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pirret AM, Sherring CL, Tai JA, et al. Local experience with the use of nasal bubble CPAP in infants with bronchiolitis admitted to a combined adult/paediatric intensive care unit. Intensive Crit Care Nurs 2005;21:314&#x2013;319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16182127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kortz TB, Herzel B, Marseille E, et al. Bubble continuous positive airway pressure in the treatment of severe paediatric pneumonia in Malawi: a cost-effectiveness analysis. BMJ Open. 2017;7:e015344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5734302</ArticleId>
            <ArticleId IdType="pubmed">28698327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jayashree M, KiranBabu HB, Singhi S, et al. Use of nasal bubble CPAP in children with hypoxemic clinical pneumonia-report from a resource limited set-up. J Trop Pediatr 2016;62:69&#x2013;74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4935781</ArticleId>
            <ArticleId IdType="pubmed">26428195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Machen HE, Mwanza ZV, Brown JK, et al. Outcomes of patients with respiratory distress treated with bubble CPAP on a pediatric ward in Malawi. J Trop Pediatr 2015;61:421&#x2013;427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26361989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walk J, Dinga P, Banda C, et al. Non-invasive ventilation with bubble CPAP is feasible and improves respiratory physiology in hospitalised Malawian children with acute respiratory failure. Paediatr Int Child Health. 2016;36:28&#x2013;33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4449832</ArticleId>
            <ArticleId IdType="pubmed">25434361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chisti MJ, Salam MA, Smith JH. Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh; an open, randomised controlled trial. Lancet. 2015;386:1057&#x2013;1065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26296950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tal A, Bavilski C, Yohai D, et al. Dexamethazone and salbutamol in the treatment of acute wheezing in infants. Pediatrics. 1983;71:13&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6129609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shete S, Nagori G, Nagori P, et al. Relation between pulse oximetry and Clinical Score in Infants with acute bronchiolitis. Natl J Physiol Pharm Pharmacol 2014;4:114&#x2013;117.</Citation>
        </Reference>
        <Reference>
          <Citation>World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310:2191&#x2013;2194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24141714</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29911285</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>04</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1661-8564</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>64</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of public health</Title>
          <ISOAbbreviation>Int J Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Towards environmental health equity in health impact assessment: innovations and opportunities.</ArticleTitle>
        <Pagination>
          <StartPage>15</StartPage>
          <EndPage>26</EndPage>
          <MedlinePgn>15-26</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00038-018-1135-1</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">As global environmental change drives inequitable health outcomes, novel health equity assessment methodologies are increasingly required. We review literatures on equity-focused HIA to clarify how equity is informing HIA practice, and to surface innovations for assessing health equity in relation to a range of exposures across geographic and temporal scales.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A narrative review of the health equity and HIA literatures analysed English articles published between 2003 and 2017 across PubMed, PubMed Central, Biomed Central and Ovid Medline. Title and abstract reviews of 849 search results yielded 89 articles receiving full text review.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Considerations of equity in HIA increased over the last 5&#xA0;years, but equity continues to be conflated with health disparities rather than their root causes (i.e. inequities). Lessons from six literatures to inform future HIA practice are described: HIA for healthy cities, climate change vulnerability assessment, cumulative health risk assessment, intersectionality-based policy analysis, corporate health impact assessment and global health impact assessment.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Academic reporting on incorporating equity in HIA practice has been limited. Nonetheless, significant methodological advancements are being made to examine the health equity implications of multiple environmental exposures.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Buse</LastName>
            <ForeName>Chris G</ForeName>
            <Initials>CG</Initials>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences, University of Northern British Columbia, Prince George, BC, Canada. chris.buse@unbc.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lai</LastName>
            <ForeName>Valerie</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cornish</LastName>
            <ForeName>Katie</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences, University of Northern British Columbia, Prince George, BC, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parkes</LastName>
            <ForeName>Margot W</ForeName>
            <Initials>MW</Initials>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences, University of Northern British Columbia, Prince George, BC, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Int J Public Health</MedlineTA>
        <NlmUniqueID>101304551</NlmUniqueID>
        <ISSNLinking>1661-8556</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069576" MajorTopicYN="Y">Health Equity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062489" MajorTopicYN="N">Health Impact Assessment</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011050" MajorTopicYN="N">Policy Making</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Environmental determinants of health</Keyword>
        <Keyword MajorTopicYN="N">Health equity</Keyword>
        <Keyword MajorTopicYN="N">Health impact assessment</Keyword>
        <Keyword MajorTopicYN="N">Impact assessment methodology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29911285</ArticleId>
        <ArticleId IdType="doi">10.1007/s00038-018-1135-1</ArticleId>
        <ArticleId IdType="pii">10.1007/s00038-018-1135-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Environ Int. 2015 Dec;85:84-95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26372694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2014 Dec 12;11(12):12896-914</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25514146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Urban Health. 2014 Aug;91(4):623-36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25047156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Global Health. 2014 Mar 10;10:13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24612523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Epidemiol Community Health. 2003 Apr;57(4):254-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12646539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS Med. 2012;9(7):e1001252</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22802732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obes Rev. 2013 Oct;14 Suppl 1:120-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24074216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2010 Nov;7(11):4037-49</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21139875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2015 May 26;12(6):5792-814</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26016437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Health Promot Int. 2015 Jun;30 Suppl 1:i71-i85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26069319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Global Health. 2016 Jun 15;12(1):27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27301248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stat Med. 2012 Sep 28;31(22):2569-75</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22969025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2014 Dec 11;11(12):12866-95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25514145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2014 Oct 24;11(11):11054-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25347193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Chiropr Med. 2006 Autumn;5(3):101-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19674681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Med J Islam Repub Iran. 2014 Aug 02;28:84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25664285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2017 Jan 26;14(2):</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28134756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Health Policy Manag. 2014 Jul 26;3(2):107-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25114950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Epidemiol. 2012 Feb;41(1):24-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22296988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ Open. 2016 Apr 04;6(4):e010339</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27044579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Environ Health Perspect. 2014 Aug;122(8):796-805</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24727499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Environ Public Health. 2014;2014:132057</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25349621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Public Health. 2016 Feb 11;16:140</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26869177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Urban Health. 2013 Oct;90 Suppl 1:14-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23001865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Urban Health. 2007 May;84(3 Suppl):i86-97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17450427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Environ Health Perspect. 2017 Feb;125(2):149-154</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27352407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perspect Public Health. 2012 Sep;132(5):216-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22991368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biomed Res Int. 2015;2015:812325</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26504832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Public Health Rep. 2013 Nov;128 Suppl 3:48-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24179279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toxicol Appl Pharmacol. 2013 Sep 15;271(3):309-23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20353796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Public Health. 2015 Oct 03;15:1009</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26433492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Environ Health Perspect. 2008 Aug;116(8):991-1000</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18709140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2011 Jul;8(7):2854-75</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21845162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Public Health Rep. 2013 Nov;128 Suppl 3:87-103</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24179284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Prev Med. 2012 Mar;42(3):203-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22341156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Equity Health. 2016 Sep 15;15(1):145</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27628650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Public Health. 2011 Dec;101 Suppl 1:S81-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21551386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2014 Sep 16;11(9):9607-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25229697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Health Serv Res. 2014 Sep 05;14:371</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25190287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Public Health Manag Pract. 2008 May-Jun;14(3):255-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18408550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Public Health. 2009 Nov;99 Suppl 3:S499-504</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19890147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Health Info Libr J. 2009 Jun;26(2):91-108</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19490148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Environ Health Perspect. 2012 Nov;120(11):1499-502</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22875311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Environ Health. 2015 Dec 14;14:93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26667475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ecohealth. 2011 Jun;8(2):137-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22231862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Health Aff (Millwood). 2011 Oct;30(10):1895-901</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21976332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Annu Rev Public Health. 2006;27:167-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16533114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2014 Aug 07;11(8):8010-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25105550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bull World Health Organ. 2003;81(6):399-403</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12894322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Epidemiol Community Health. 2002 Sep;56(9):647-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12177079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matern Child Health J. 2016 May;20(5):968-73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27013517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Public Health. 2017 May 1;27(suppl_2):56-61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26163469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Urban Health. 2010 Sep;87(5):727-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20811780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Global Health. 2017 Feb 6;13(1):7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28166801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Environ Health Perspect. 2012 Apr;120(4):A158-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22469821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glob Health Action. 2013 Jan 24;6:19239</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23364094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Urban Health. 2007 May;84(3 Suppl):i109-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17393341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Health Promot J Austr. 2009 Dec;20(3):172-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19951236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 2007 Sep 29;370(9593):1153-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17905168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Health Policy Plan. 2015 May;30(4):462-73</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24816571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMC Public Health. 2009 Apr 05;9:97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19344529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Environ Health. 2008 Nov 27;7:61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19038020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Urban Health. 2013 Oct;90 Suppl 1:105-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22644328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>New Solut. 2013;23(3):439-66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24551949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Urban Health. 2013 Oct;90 Suppl 1:129-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22714703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Urban Health. 2008 Jul;85(4):462-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18437582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Health Promot Int. 2014 Dec;29(4):621-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23449601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Equity Health. 2014 Dec 10;13:119</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25492385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Urban Health. 2012 Apr;89(2):217-31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22002303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS Med. 2012;9(6):e1001235</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22745605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Health Policy Manag. 2014 May 21;3(1):17-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24987717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int J Environ Res Public Health. 2014 Dec 25;12(1):300-21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25547399</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29911269</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1559-0291</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>187</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Applied biochemistry and biotechnology</Title>
          <ISOAbbreviation>Appl Biochem Biotechnol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Exploring the Lead Compounds for Zika Virus NS2B-NS3 Protein: an e-Pharmacophore-Based Approach.</ArticleTitle>
        <Pagination>
          <StartPage>194</StartPage>
          <EndPage>210</EndPage>
          <MedlinePgn>194-210</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12010-018-2814-3</ELocationID>
        <Abstract>
          <AbstractText>The rapid spread of the Zika virus and its association with the abnormal brain development constitute a global health emergency. With a continuing spread of the mosquito vector, the exposure is expected to accelerate in the coming years. Despite number of efforts, there is still no proper vaccine or medicine to combat this virus. Of note, the NS2B-NS3 protein is proven to be the potential target for the Zika virus therapeutics. Hence, e-pharmacophore-based drug design strategy was employed to identify potent inhibitors of NS2B-NS3 protein from ASINEX database consisting of 467,802 molecules. A 3D e-pharmacophore model was generated using PHASE module of Schr&#xF6;dinger Suite. The generated model consists of one hydrogen bond acceptor (A), two hydrogen bond donors (D), and two aromatic rings (R), ADDRR. The model was further evaluated for its ability to screen actives using enrichment analysis. Subsequently, high-throughput virtual screening protocol was employed, and the resultant hit molecules were also examined for its binding free energies and ADME properties using Prime MM-GBSA and Qikprop module of Schrodinger packages, respectively. Finally, the screened hit molecule was subjected to molecular dynamics simulation to examine its stability. Overall, the results from our analysis suggest that compound BAS 19192837 could be a potent inhibitor for the NS2B-NS3 protein of the Zika virus. It is also noteworthy to mention that our results are in good agreement with literature evidences. We hope that this result is of immense importance in designing potential drug molecules to combat the spread of Zika virus in the near future.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rohini</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamilnadu, 632014, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Agarwal</LastName>
            <ForeName>Pratika</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamilnadu, 632014, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Preethi</LastName>
            <ForeName>B</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamilnadu, 632014, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shanthi</LastName>
            <ForeName>V</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamilnadu, 632014, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramanathan</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-1613-0729</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamilnadu, 632014, India. kramanathan@vit.ac.in.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Appl Biochem Biotechnol</MedlineTA>
        <NlmUniqueID>8208561</NlmUniqueID>
        <ISSNLinking>0273-2289</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C080102">NS2B protein, flavivirus</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C060028">NS3 protein, flavivirus</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>2P299V784P</RegistryNumber>
          <NameOfSubstance UI="D007854">Lead</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.21.-</RegistryNumber>
          <NameOfSubstance UI="D012697">Serine Endopeptidases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.6.4.13</RegistryNumber>
          <NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007854" MajorTopicYN="N">Lead</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062105" MajorTopicYN="Y">Molecular Docking Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012697" MajorTopicYN="N">Serine Endopeptidases</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017361" MajorTopicYN="Y">Viral Nonstructural Proteins</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ASINEX database</Keyword>
        <Keyword MajorTopicYN="N">Enrichment analysis</Keyword>
        <Keyword MajorTopicYN="N">Molecular simulation</Keyword>
        <Keyword MajorTopicYN="N">Prime MM-GBSA</Keyword>
        <Keyword MajorTopicYN="N">Virtual screening</Keyword>
        <Keyword MajorTopicYN="N">Zika virus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29911269</ArticleId>
        <ArticleId IdType="doi">10.1007/s12010-018-2814-3</ArticleId>
        <ArticleId IdType="pii">10.1007/s12010-018-2814-3</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29908013</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2151-4658</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>71</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Arthritis care &amp; research</Title>
          <ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis.</ArticleTitle>
        <Pagination>
          <StartPage>390</StartPage>
          <EndPage>397</EndPage>
          <MedlinePgn>390-397</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.23621</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">While increased rheumatic disease activity during pregnancy has been associated with adverse pregnancy outcomes, this disease activity is typically assessed by physicians. Little is known, however, about the association between patient-reported measures of disease activity and pregnancy outcomes. The aim of our study was to evaluate this association.</AbstractText>
          <AbstractText Label="METHODS">Univariate and multivariable regression models were used to assess the relationship between patient- and physician-reported measures of disease activity and adverse pregnancy outcomes in 225 patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA). The patients were enrolled from 2008-2016 in a prospective registry at a single academic center.</AbstractText>
          <AbstractText Label="RESULTS">In women with RA, patient-reported disease activity was associated with preterm birth (odds ratio [OR] 5.9 [95% confidence interval (95% CI) 1.5, 23.9]) and gestational age in weeks (&#x3B2; = -1.5 [95% CI -2.6, -0.4]). The physician assessment of disease activity also predicted preterm (OR 2.1 [95% CI 1.2, 3.5]), small for gestational age births (OR 1.8 [95% CI 1.03, 3.1]), and gestational age in weeks (&#x3B2; = -0.6 [95% CI -0.9, -0.02]). Alternatively, in women with SLE, patient-reported disease activity measures, including the Health Assessment Questionnaire, pain, or global health measures, were not associated with adverse pregnancy outcomes. However, physician measures of SLE disease activity are associated with preterm birth (OR 2.9 [95% CI 1.3, 6.3]), cesarean delivery (OR 2.3 [95% CI 1.0, 5.3]), and preeclampsia (OR 2.8 [95% CI 1.3, 6.3]). The results did not appear to be driven by lupus nephritis or antiphospholipid syndrome.</AbstractText>
          <AbstractText Label="CONCLUSION">For women with RA, patient-reported measures of disease activity were associated with adverse pregnancy outcomes, and thus may be useful adjuncts to physician-reported measures in identifying pregnancies at greater risk. In contrast, in SLE, while physician measures of disease activity helped predict several adverse pregnancy outcomes, no patient-reported measures were associated with adverse outcomes.</AbstractText>
          <CopyrightInformation>&#xA9; 2018, American College of Rheumatology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Harris</LastName>
            <ForeName>Nathaniel</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0001-9156-5979</Identifier>
            <AffiliationInfo>
              <Affiliation>Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eudy</LastName>
            <ForeName>Amanda</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Clowse</LastName>
            <ForeName>Megan</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Duke University Medical Center, Durham, North Carolina.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA>
        <NlmUniqueID>101518086</NlmUniqueID>
        <ISSNLinking>2151-464X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071066" MajorTopicYN="Y">Patient Reported Outcome Measures</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011225" MajorTopicYN="N">Pre-Eclampsia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047928" MajorTopicYN="N">Premature Birth</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>9</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29908013</ArticleId>
        <ArticleId IdType="doi">10.1002/acr.23621</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29907914</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>07</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1525-1497</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>34</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of general internal medicine</Title>
          <ISOAbbreviation>J Gen Intern Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Asylum Seekers in a Time of Record Forced Global Displacement: the Role of Physicians.</ArticleTitle>
        <Pagination>
          <StartPage>137</StartPage>
          <EndPage>143</EndPage>
          <MedlinePgn>137-143</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11606-018-4524-5</ELocationID>
        <Abstract>
          <AbstractText>In 2016, over 65 million individuals were displaced from their homes due to human rights abuses, and 262,000 people applied for asylum in the USA. Individuals who have experienced persecution are present in many primary and specialty clinics. A medical forensic evaluation can increase the likelihood of a successful asylum case. This paper reviews the legal framework for asylum and the contribution forensic evaluations can make to this vulnerable population. Physicians without asylum expertise can help these patients by recognizing their legal right to residential protection and referring them to lawyers and physicians with expert skills. Performing forensic examinations of asylum seekers offers physicians the opportunity to collaborate with attorneys, immigration officials, and human rights experts. Clinicians who do this work find it personally and professionally rewarding, especially when they impart their expert knowledge and skills to future clinicians by involving trainees in these evaluations. Physicians who encounter refugees or asylum seekers in their roles as providers or as preceptors should have familiarity with the field of asylum medicine to enhance the comprehensive care they deliver.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McKenzie</LastName>
            <ForeName>Katherine C</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>Yale Center for Asylum Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. katherine.mckenzie@yale.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bauer</LastName>
            <ForeName>Jon</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Asylum and Human Rights Clinic, University of Connecticut School of Law, Hartford, CT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reynolds</LastName>
            <ForeName>P Preston</ForeName>
            <Initials>PP</Initials>
            <AffiliationInfo>
              <Affiliation>Division of General Medicine, Hospitalist Medicine, Geriatrics and Palliative Care, University of Virginia School of Medicine, Charlottesville, VA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Gen Intern Med</MedlineTA>
        <NlmUniqueID>8605834</NlmUniqueID>
        <ISSNLinking>0884-8734</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>J Gen Intern Med. 2019 Jan;34(1):3-4. doi: 10.1007/s11606-018-4712-3.</RefSource>
          <PMID Version="1">30350027</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006806" MajorTopicYN="N">Human Rights</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010819" MajorTopicYN="Y">Physician's Role</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012036" MajorTopicYN="N">Refugees</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035862" MajorTopicYN="N">Vulnerable Populations</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">human rights</Keyword>
        <Keyword MajorTopicYN="N">immigrant health</Keyword>
        <Keyword MajorTopicYN="N">legal issues</Keyword>
        <Keyword MajorTopicYN="N">vulnerable populations</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they do not have a conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29907914</ArticleId>
        <ArticleId IdType="pmc">PMC6318190</ArticleId>
        <ArticleId IdType="doi">10.1007/s11606-018-4524-5</ArticleId>
        <ArticleId IdType="pii">10.1007/s11606-018-4524-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>UNHCR. Global trends: forced displacement in 2016. 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Beyrer C. Pushback: the current wave of anti-homosexuality laws and impacts on health. PLoS Med. 2014;11(6):e1001658. doi: 10.1371/journal.pmed.1001658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.1001658</ArticleId>
            <ArticleId IdType="pmc">PMC4068984</ArticleId>
            <ArticleId IdType="pubmed">24959671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Devries KM, Mak JYT, Garc&#xED;a-Moreno C, Petzold M, Child JC, Falder G, et al. The global prevalence of intimate partner violence against women. Science. 2013;340(6140):1527&#x2013;8. doi: 10.1126/science.1240937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1240937</ArticleId>
            <ArticleId IdType="pubmed">23788730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Musalo K. Personal violence, public matter: evolving standards in gender-based asylum law. Harv Int Rev. 2014;36(2):45.</Citation>
        </Reference>
        <Reference>
          <Citation>Anker D, Lawrence P. &#x201C;Third generation&#x201D; gangs, warfare in Central America, and refugee law&#x2019;s political opinion ground. Immigration Briefings. 2014;14&#x2013;10:1.</Citation>
        </Reference>
        <Reference>
          <Citation>Scruggs E, Guetterman TC, Meyer AC, VanArtsdalen J, Heisler M. An absolutely necessary piece: a qualitative study of legal perspectives on medical affidavits in the asylum process. J Forensic Legal Med 44:72&#x2013;8. 10.1016/j.jflm.2016.09.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5121032</ArticleId>
            <ArticleId IdType="pubmed">27639654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lustig SL, Kureshi S, Delucchi KL, Iacopino V, Morse SC. Asylum grant rates following medical evaluations of maltreatment among political asylum applicants in the United States. J Immigr Minor Health. 2008;10(1):7&#x2013;15. doi: 10.1007/s10903-007-9056-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10903-007-9056-8</ArticleId>
            <ArticleId IdType="pubmed">17492260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prabhu M, Baranoski M. Forensic mental health professionals in the immigration process. Psychiatr Clin N Am. 2012;35(4):929&#x2013;46. doi: 10.1016/j.psc.2012.08.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psc.2012.08.012</ArticleId>
            <ArticleId IdType="pubmed">23107571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKenzie K. Medical evaluation of asylum seekers. In: Annamalai A, editor. Refugee Health Care. New York: Springer; 2014. pp. 235&#x2013;41.</Citation>
        </Reference>
        <Reference>
          <Citation>Crosby SS, Norredam M, Paasche-Orlow MK, Piwowarczyk L, Heeren T, Grodin MA. Prevalence of torture survivors among foreign-born patients presenting to an urban ambulatory care practice. J Gen Intern Med. 2006;21(7):764&#x2013;8. doi: 10.1111/j.1525-1497.2006.00488.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1525-1497.2006.00488.x</ArticleId>
            <ArticleId IdType="pmc">PMC1924712</ArticleId>
            <ArticleId IdType="pubmed">16808779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gil-Bazo M-T. Asylum as a general principle of international law. International Journal of Refugee Law. 2015;27(1):3&#x2013;28. doi: 10.1093/ijrl/eeu062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ijrl/eeu062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Universal declaration of human rights. Art. 14. United Nations; 1948.</Citation>
        </Reference>
        <Reference>
          <Citation>Convention and protocol relating to the status of refugees. Geneva: Office of the High Commissioner for Refugees; 2010.</Citation>
        </Reference>
        <Reference>
          <Citation>Convention relating to the status of refugees. Art 33(1).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12289353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Public Law 96&#x2013;212. 1980.</Citation>
        </Reference>
        <Reference>
          <Citation>Proposed refugee admissions for fiscal year 2017: report to the Congress. US Departments of State, Homeland Security and Health and Human Services; 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Immigration and Nationality Act, U.S. Code Title 8 &#xA7;&#xA7; 1158(a)(1), 1225.</Citation>
        </Reference>
        <Reference>
          <Citation>Code of Federal Regulations, Title 8 &#xA7; 208.4. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Immigration and Nationality Act US Code Title 8 &#xA7;&#xA7;1158, 1229a. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Mossaad D. Annual flow report refugees and asylees 2015. US Department of Homeland Security Office of Immigration Statistics; 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Immigration and Nationality Act, US Code Title 8 &#xA7;&#xA7; 1158&#x2013;1159. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>US Citizenship and Immigration Services. Guidance for Adjudicating Lesbian, Gay, Bisexual, Transgender and Intersex (LGBTI) Refugee and Asylum Claims. 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>US Department of Justice, Board of Immigration Appeals: Matter of A-R-C-G-; 26 I&amp;N Dec. 388 (BIA 2014). Matter of Kasinga, 21 I&amp;N Dec. 357 (BIA 1996).</Citation>
        </Reference>
        <Reference>
          <Citation>U.S. Court of Appeals: Pirir-Boc v. Holder, 750 F.3d 1077 (9th Cir. 2014); Crespin-Valladares v. Holder, 632 F.3d 117 (4th Cir. 2011). LexisNexis Legal Newsroom Immigration Law: Gang Asylum (Guatemala, Mara-18) Victory in Hartford Immigration Court, at https://www.lexisnexis.com/legalnewsroom/immigration/b/insidenews/archive/2015/03/25/gang-asylum-guatemala-mara-18-victory-in-hartford-immigration-court.aspx?Redirected=true. 2015. Accessed March 5, 2018</Citation>
        </Reference>
        <Reference>
          <Citation>Rempell S. Defining Persecution. Utah Law Review. 2013;283.</Citation>
        </Reference>
        <Reference>
          <Citation>Keller AS. Caring and advocating for victims of torture. Lancet. 2002;360(Suppl):s55&#x2013;6. doi: 10.1016/S0140-6736(02)11823-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(02)11823-X</ArticleId>
            <ArticleId IdType="pubmed">12504506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Assembly UNG. Convention Against Torture and Other Cruel, Inhuman and Degrading Punishment. 1984.</Citation>
        </Reference>
        <Reference>
          <Citation>Forrest D. Examination for the late physical after effects of torture. Journal of Clinical Forensic Medicine. 1999;6(1):4&#x2013;13. doi: 10.1016/S1353-1131(99)90169-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1353-1131(99)90169-4</ArticleId>
            <ArticleId IdType="pubmed">15335503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peel M, Iacopino V, eds. The Medical Documentation of Torture. New York: Cambridge University Press; 2002.</Citation>
        </Reference>
        <Reference>
          <Citation>Moreno A, Grodin MA. Torture and its neurological sequelae. Spinal Cord. 2002;40(5):213&#x2013;23. doi: 10.1038/sj.sc.3101284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.sc.3101284</ArticleId>
            <ArticleId IdType="pubmed">11987003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danielsen L, Rasmussen OV. Dermatological findings after alleged torture. Torture. 2006;16(2):108&#x2013;27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17251642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peel M, Iacopino V. The medical documentation of torture. London; San Francisco: Greenwich Medical Media; 2002.</Citation>
        </Reference>
        <Reference>
          <Citation>Code of Federal Regulations Title 8 &#xA7;&#xA7; 1208.16&#x2013;1208.18. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>United Nations, Office of the High Commissioner for Human Rights Istanbul Protocol: Manual on the effective investigation and documentation of torture and other cruel, inhuman or degrading treatment or punishment. United Nations, New York. 2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Physicians for Human Rights. Examining asylum seekers: a clinician&#x2019;s guide to physical and psychological evaluations of torture and ill-treatment. Cambridge, MA: Physicians for Human Rights; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Kallivayalil D. Women seeking political asylum: negotiating authority, gender and a lost home. Women &amp; Therapy. 2013;36(3&#x2013;4):319&#x2013;31. doi: 10.1080/02703149.2013.797845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02703149.2013.797845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park R, Oomen J. Context, evidence and attitude: the case for photography in medical examinations of asylum seekers in the Netherlands. Soc Sci Med. 2010;71(2):228&#x2013;35. doi: 10.1016/j.socscimed.2010.01.049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.socscimed.2010.01.049</ArticleId>
            <ArticleId IdType="pubmed">20359805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herlihy J, Scragg P, Turner S. Discrepancies in autobiographical memories&#x2014;implications for the assessment of asylum seekers: repeated interviews study. BMJ. 2002;324(7333):324&#x2013;7. doi: 10.1136/bmj.324.7333.324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.324.7333.324</ArticleId>
            <ArticleId IdType="pmc">PMC65293</ArticleId>
            <ArticleId IdType="pubmed">11834558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graessner S, Ahmad S, Merkord F. At the Side of Torture Survivors.&#xA0; Baltimore: The Johns Hopkins Press; 2001.</Citation>
        </Reference>
        <Reference>
          <Citation>Lawrance BN, Ruffer G. Adjudicating refugee and asylum status: the role of witness, expertise, and testimony. 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Yale Center for Asylum Medicine. http://medicine.yale.edu/intmed/genmed/asylum/. Accessed 5 March 2018</Citation>
        </Reference>
        <Reference>
          <Citation>Asgary RG, Metalios EE, Smith CL, Paccione GA. Evaluating asylum seekers/torture survivors in urban primary care: a collaborative approach at the Bronx Human Rights Clinic. Health Hum Rights. 2006;9(2):164&#x2013;79. doi: 10.2307/4065406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2307/4065406</ArticleId>
            <ArticleId IdType="pubmed">17265759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roth K. Giving refuge: reflections on working with asylum seekers. J Pain Symptom Manag. 2010;40(1):149&#x2013;54. doi: 10.1016/j.jpainsymman.2010.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpainsymman.2010.03.011</ArticleId>
            <ArticleId IdType="pubmed">20619217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishori R, Hannaford A, Mujawar I, Ferdowsian H, Kureshi S. &#x201C;Their stories have changed my life&#x201D;: clinicians&#x2019; reflections on their experience with and their motivation to conduct asylum evaluations. J Immigr Minor Health. 2016;18(1):210&#x2013;8. doi: 10.1007/s10903-014-0144-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10903-014-0144-2</ArticleId>
            <ArticleId IdType="pubmed">25527443</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29892089</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>11</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1530-0366</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Genetics in medicine : official journal of the American College of Medical Genetics</Title>
          <ISOAbbreviation>Genet Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Introducing medical genetics services in Ethiopia using the MiGene Family History App.</ArticleTitle>
        <Pagination>
          <StartPage>451</StartPage>
          <EndPage>458</EndPage>
          <MedlinePgn>451-458</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41436-018-0069-6</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE">Almost all low-income countries and many middle-income countries lack the capacity to deliver medical genetics services. We developed the MiGene Family History App (MFHA), which assists doctors with family history collection and population-level epidemiologic analysis. The MFHA was studied at St. Paul's Hospital in Addis Ababa, Ethiopia.</AbstractText>
          <AbstractText Label="METHODS">A needs assessment was used to assess Ethiopian physicians' experience with genetics services. The MFHA then collected patient data over a 6-month period.</AbstractText>
          <AbstractText Label="RESULTS">The majority of doctors provide genetics services, with only 16% reporting their genetics knowledge is sufficient. A total of 1699 patients from the pediatric ward (n&#x2009;=&#x2009;367), neonatal intensive care unit (NICU) (n&#x2009;=&#x2009;477), and antenatal clinic (n&#x2009;=&#x2009;855) were collected using the MFHA with a 4% incidence of a MFHA-screened condition present. The incidence was 11.7% in the pediatric ward, 3% in the NICU, and 0.5% in the antenatal clinic. Heart malformations (5.5% of patients) and trisomy 21 (4.4% of patients) were the most common conditions in the pediatric ward.</AbstractText>
          <AbstractText Label="CONCLUSION">Medical genetics services are needed in Ethiopia. As other countries increase their genetics capacity, the MFHA can provide fundamental genetics services and collect necessary epidemiologic data.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Quinonez</LastName>
            <ForeName>Shane C</ForeName>
            <Initials>SC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Communicable Diseases, Division of Genetics, Metabolism and Genomic Medicine, University of Michigan, Ann Arbor, Michigan, USA. squinon@med.umich.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yeshidinber</LastName>
            <ForeName>Abate</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Child Health, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lourie</LastName>
            <ForeName>Michael A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>University of Michigan Medical School, Ann Arbor, Michigan, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bekele</LastName>
            <ForeName>Delayehu</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mekonnen</LastName>
            <ForeName>Yemisrach</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Child Health, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nigatu</LastName>
            <ForeName>Balkachew</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Metaferia</LastName>
            <ForeName>Gesit</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Child Health, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jebessa</LastName>
            <ForeName>Solomie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Child Health, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D023362">Evaluation Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Genet Med</MedlineTA>
        <NlmUniqueID>9815831</NlmUniqueID>
        <ISSNLinking>1098-3600</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004812" MajorTopicYN="N">Epidemiologic Methods</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005002" MajorTopicYN="N" Type="Geographic">Ethiopia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D033142" MajorTopicYN="Y">Genetic Services</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008487" MajorTopicYN="Y">Medical History Taking</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020380" MajorTopicYN="N">Needs Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Community genetics</Keyword>
        <Keyword MajorTopicYN="N">Family health history</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Mobile health</Keyword>
        <Keyword MajorTopicYN="N">Noncommunicable diseases</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29892089</ArticleId>
        <ArticleId IdType="doi">10.1038/s41436-018-0069-6</ArticleId>
        <ArticleId IdType="pii">S1098-3600(21)04634-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448&#x2013;57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1201534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med. 2013;369:1336&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1109345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. The global burden of disease: 2004 update. 2008. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/ .Accessed 23 January 2018</Citation>
        </Reference>
        <Reference>
          <Citation>March of Dimes. March of Dimes global report on birth defects. January 2006:1-76. https://www.marchofdimes.org/mission/march-of-dimes-global-report-on-birth-defects.aspx .Accessed 23 January 2018</Citation>
        </Reference>
        <Reference>
          <Citation>GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1725&#x2013;74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)31575-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The Global Burden of Disease Child and Adolescent Health Collaboration, Kassebaum N, Kyu HH, et al. Child and Adolescent Health From 1990 to 2015. JAMA Pediatr . 2017;171:573&#x2013;20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapediatrics.2017.0250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christianson A, Modell B. Medical genetics in developing countries. Annu Rev Genom Hum Genet . 2004;5:219&#x2013;65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.genom.5.061903.175935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sadee W, Hartmann K, Seweryn M, et al. Missing heritability of common diseases and treatments outside the protein-coding exome. Hum Genet. 2014;133:1199&#x2013;215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00439-014-1476-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tekola-Ayele F, Rotimi CN. Translational genomics in low- and middle-income countries: opportunities and challenges. Public Health Genomics. 2015;18:1&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000433518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kingsmore SF, Lantos JD, Dinwiddie DL. Next-generation community genetics for low- and middle-income countries. Genome Med. 2012;4:25&#x2013;33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/gm324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Community genetics services: report of a WHO consultation on community genetics in low-and middle-income countries. 2011. https://apps.who.int/iris/handle/10665/44532 . Accessed 23 January 2018</Citation>
        </Reference>
        <Reference>
          <Citation>Wonkam A, Tekendo CN, Sama DJ, et al. Initiation of a medical genetics service in sub-Saharan Africa: experience of prenatal diagnosis in Cameroon. Eur J Med Genet. 2011;54:e399&#x2013;e404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejmg.2011.03.013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Makani J, Soka D, Rwezaula S, et al. Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality. Trop Med Int Health. 2015;20:184&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/tmi.12428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grosse SD, Atrash HK, Odame I, et al. The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality. Am J Prev Med. 2012;42:e101&#x2013;e103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amepre.2012.03.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galadanci N, Wudil BJ, Balogun TM, et al. Current sickle cell disease management practices in Nigeria. Int Health. 2014;6:23&#x2013;28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/inthealth/iht022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arrayed AlS. Campaign to control genetic blood diseases in Bahrain. Community Genet. 2005;8:52&#x2013;55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000083340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ. 2004;329:1134&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.329.7475.1134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Angastiniotis MA, Hadjiminas MG. Prevention of thalassaemia in Cyprus. Lancet. 1981;1:369&#x2013;71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(81)91682-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The World Bank. 2016. Ethiopia&#x2014;population and housing census 2007&#x2014;IPUMS subset. http://microdata.worldbank.org/index.php/catalog/2747 Accessed 24 February 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>The World Bank. 2016. Ethiopia. https://data.worldbank.org/country/ethiopia Accessed 24 February 2018.</Citation>
        </Reference>
        <Reference>
          <Citation>Tadesse L, Tafesse F, Hamamy H. Communities and community genetics in Ethiopia. Pan Afr Med J. 2014;18:115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.11604/pamj.2014.18.115.3172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, Bickmore T, Bowen DJ, et al. Acceptability and feasibility of a virtual counselor (VICKY) to collect family health histories. Genet Med. 2015;17:822&#x2013;30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/gim.2014.198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCandless SE, Brunger JW, Cassidy SB. The burden of genetic disease on inpatient care in a children&#x2019;s hospital. Am J Hum Genet. 2004;74:121&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/381053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walker CE, Mahede T, Davis G, et al. The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort. Genet Med. 2017;19:546&#x2013;52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/gim.2016.143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colvin L, Bower C. A retrospective population-based study of childhood hospital admissions with record linkage to a birth defects registry. BMC Pediatr . 2009;9:32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2431-9-32</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall JG, Powers EK, Mcllvaine RT, et al. The frequency and financial burden of genetic disease in a pediatric hospital. Am J Med Genet . 1978;1:417&#x2013;36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320010405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carnevale A, Hern&#xE1;ndez M, Reyes R, et al. The frequency and economic burden of genetic disease in a pediatric hospital in Mexico City. Am J Med Genet. 1985;20:665&#x2013;75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320200412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>FitzPatrick DR, Skeoch CH, Tolmie JL. Genetic aspects of admissions to a paediatric intensive care unit. Arch Dis Child. 1991;66:639&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/adc.66.5.639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoon PW, Olney RS, Khoury MJ, et al. Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study. Arch Pediatr Adolesc Med. 1997;151:1096&#x2013;103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archpedi.1997.02170480026004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ling EW, Sosuan LC, Hall JC. Congenital anomalies: an increasingly important cause of mortality and workload in a neonatal intensive care unit. Am J Perinatol . 1991;8:164&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-999369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scriver CR, Neal JL, Saginur R, et al. The frequency of genetic disease and congenital malformation among patients in a pediatric hospital. Can Med Assoc J . 1973;108:1111&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4704890</ArticleId>
            <ArticleId IdType="pmc">1941389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piel FB, Hay SI, Gupta S, et al. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10:e1001484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.1001484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He LQ, Njambi L, Nyamori JM, et al. Developing clinical cancer genetics services in resource-limited countries: the case of retinoblastoma in Kenya. Public Health Genomics. 2014;17:221&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000363645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Core Competency Working Group of the National Coalition for Health Professional Education in Genetics. Recommendations of core competencies in genetics essential for all health professionals. Genet Med. 2001;3:155&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00125817-200103000-00011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruffin MT, Nease DE, Sen A, et al. Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial. Ann Fam Med. 2011;9:3&#x2013;11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1370/afm.1197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kahn LB, Marshall JA, Baxter J, et al. Accuracy of reported family history of diabetes mellitus: results from San Luis Valley Diabetes Study. Diabetes Care. 1990;13:796&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.13.7.796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu RR, Myers RA, Hauser ER, et al. Impact of genetic testing and family health history based risk counseling on behavior change and cognitive precursors for type 2 diabetes. J Genet Couns. 2017;26:133&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10897-016-9988-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hariri S, Yoon PW, Qureshi N, et al. Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med. 2006;8:102&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.gim.0000200949.52795.df</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29886826</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1875-5453</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>20</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Current drug metabolism</Title>
          <ISOAbbreviation>Curr Drug Metab</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>15</StartPage>
          <EndPage>22</EndPage>
          <MedlinePgn>15-22</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2174/1389200219666180611083155</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diabetes, with an increased prevalence and various progressive complications, has become a significant global health challenge. The concrete mechanisms responsible for the development of diabetes still remain incompletely unknown, although substantial researches have been conducted to search for the effective therapeutic targets. This review aims to reveal the novel roles of Xenobiotic Nuclear Receptors (XNRs), including the Peroxisome Proliferator-Activated Receptor (PPAR), the Farnesoid X Receptor (FXR), the Liver X Receptor (LXR), the Pregnane X Receptor (PXR) and the Constitutive Androstane Receptor (CAR), in the development of diabetes and provide potential strategies for research and treatment of metabolic diseases.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We retrieved a large number of original data about these five XNRs and organized to focus on their recently discovered functions in diabetes and its complications.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Increasing evidences have suggested that PPAR, FXR, LXR ,PXR and CAR are involved in the development of diabetes and its complications through different mechanisms, including the regulation of glucose and lipid metabolism, insulin and inflammation response and related others.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PPAR, FXR, LXR, PXR, and CAR, as the receptors for numerous natural or synthetic compounds, may be the most effective therapeutic targets in the treatment of metabolic diseases.</AbstractText>
          <CopyrightInformation>Copyright&#xA9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pu</LastName>
            <ForeName>Shuqi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Xiaojie</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immunology, Binzhou Medical University, Yantai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Xiaoying</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology and Laboratory of Infection and Immunity, Xuzhou Medical University, Xuzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yunzhan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dai</LastName>
            <ForeName>Yunkai</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yueling</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Operating Theatre, Binzhou People's Hospital, Binzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Xiaoting</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Operating Theatre, Binzhou People's Hospital, Binzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immunology, Binzhou Medical University, Yantai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Xiaona</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Haiyong</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Otolaryngology, the Second Affiliated Hospital &amp; Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Jianhong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Ruliu</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cai</LastName>
            <ForeName>Jiazhong</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Qizhi</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immunology, Binzhou Medical University, Yantai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Ling</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Yong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>PI-WEI Institute, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Curr Drug Metab</MedlineTA>
        <NlmUniqueID>100960533</NlmUniqueID>
        <ISSNLinking>1389-2002</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000090702">Constitutive Androstane Receptor</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000071518">Liver X Receptors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D047492">Peroxisome Proliferator-Activated Receptors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000077297">Pregnane X Receptor</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015262">Xenobiotics</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0C5V0MRU6P</RegistryNumber>
          <NameOfSubstance UI="C094063">farnesoid X-activated receptor</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090702" MajorTopicYN="N">Constitutive Androstane Receptor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071518" MajorTopicYN="N">Liver X Receptors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024821" MajorTopicYN="N">Metabolic Syndrome</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047492" MajorTopicYN="N">Peroxisome Proliferator-Activated Receptors</DescriptorName>
          <QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077297" MajorTopicYN="N">Pregnane X Receptor</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015262" MajorTopicYN="N">Xenobiotics</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Constitutive Androstane Receptor (CAR)</Keyword>
        <Keyword MajorTopicYN="N">Farnesoid X Receptor (FXR)</Keyword>
        <Keyword MajorTopicYN="N">Liver X Receptor (LXR)</Keyword>
        <Keyword MajorTopicYN="N">Peroxisome Proliferator-Activated Receptor (PPAR)</Keyword>
        <Keyword MajorTopicYN="N">Pregnane X Receptor (PXR)</Keyword>
        <Keyword MajorTopicYN="N">Xenobiotic Nuclear Receptors (XNRs)</Keyword>
        <Keyword MajorTopicYN="N">diabetes.</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29886826</ArticleId>
        <ArticleId IdType="doi">10.2174/1389200219666180611083155</ArticleId>
        <ArticleId IdType="pii">CDM-EPUB-91023</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29880598</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>07</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>Suppl 2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group.</ArticleTitle>
        <Pagination>
          <StartPage>s119</StartPage>
          <EndPage>s128</EndPage>
          <MedlinePgn>s119-s128</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054389</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">To present findings of a narrative review on the implementation and effectiveness of 17 Articles of the WHO Framework Convention on Tobacco Control (FCTC) during the Treaty's first decade.</AbstractText>
          <AbstractText Label="DATA SOURCES">Published reports on global FCTC implementation; searches of four databases through June 2016; hand-search of publications/online resources; tobacco control experts.</AbstractText>
          <AbstractText Label="STUDY SELECTION">WHO Convention Secretariat global progress reports (2010, 2012, 2014); 2015 WHO report on the global tobacco epidemic; studies of social, behavioural, health, economic and/or environmental impacts of FCTC policies.</AbstractText>
          <AbstractText Label="DATA EXTRACTION">Progress in the implementation of 17 FCTC Articles was categorised (higher/intermediate/lower) by consensus. 128 studies were independently selected by multiple authors in consultation with experts.</AbstractText>
          <AbstractText Label="DATA SYNTHESIS">Implementation was highest for smoke-free laws, health warnings and education campaigns, youth access laws, and reporting/information exchange, and lowest for measures to counter industry interference, regulate tobacco product contents, promote alternative livelihoods and protect health/environment. Price/tax increases, comprehensive smoking and marketing bans, health warnings, and cessation treatment are associated with decreased tobacco consumption/health risks and increased quitting. Mass media campaigns and youth access laws prevent smoking initiation, decrease prevalence and promote cessation. There were few studies on the effectiveness of policies in several domains, including measures to prevent industry interference and regulate tobacco product contents.</AbstractText>
          <AbstractText Label="CONCLUSIONS">The FCTC has increased the implementation of measures across several policy domains, and these implementations have resulted in measurable impacts on tobacco consumption, prevalence and other outcomes. However, FCTC implementation must be accelerated, and Parties need to meet all their Treaty obligations and consider measures that exceed minimum requirements.</AbstractText>
          <CopyrightInformation>&#xA9; World Health Organization 2019. Licensee BMJ Publishing Group Limited.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chung-Hall</LastName>
            <ForeName>Janet</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Craig</LastName>
            <ForeName>Lorraine</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gravely</LastName>
            <ForeName>Shannon</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sansone</LastName>
            <ForeName>Natalie</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fong</LastName>
            <ForeName>Geoffrey T</ForeName>
            <Initials>GT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Public Health and Health Systems, Waterloo, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ontario Institute for Cancer Research, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>FDN-148477</GrantID>
            <Agency>CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D062489" MajorTopicYN="Y">Health Impact Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074606" MajorTopicYN="Y">Smoking Prevention</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014944" MajorTopicYN="Y">World Health Organization</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">prevention</Keyword>
        <Keyword MajorTopicYN="N">public policy</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: GTF has served as an expert witness on behalf of governments in litigation involving the tobacco industry.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>24</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29880598</ArticleId>
        <ArticleId IdType="pmc">PMC6589489</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054389</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054389</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1659&#x2013;724. 10.1016/S0140-6736(16)31679-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)31679-8</ArticleId>
            <ArticleId IdType="pmc">PMC5388856</ArticleId>
            <ArticleId IdType="pubmed">27733284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet 2017;389:1885&#x2013;906. 10.1016/S0140-6736(17)30819-X</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(17)30819-X</ArticleId>
            <ArticleId IdType="pmc">PMC5439023</ArticleId>
            <ArticleId IdType="pubmed">28390697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO report on the global tobacco epidemic, 2017. Monitoring tobacco use and prevention policies. Geneva: World Health Organization, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Eriksen M, Mackay J, Schluger N, et al. . The tobacco atlas. 5th edn Atlanta: American Cancer Society, 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO report on the global tobacco epidemic, 2011. Warning about the dangers of tobacco. Geneva: World Health Organization, 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO global report: mortality attributable to tobacco. Geneva: World Health Organization, 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442 10.1371/journal.pmed.0030442</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.0030442</ArticleId>
            <ArticleId IdType="pmc">PMC1664601</ArticleId>
            <ArticleId IdType="pubmed">17132052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
World Health Organization. WHO framework convention on tobacco control. 2003http://apps.who.int/iris/bitstream/10665/42811/1/9241591013.pdf?ua=1
</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. The WHO framework convention on tobacco control: an overview. Geneva: World Health Organization, 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Dubray J, Schwartz R, Chaiton M, et al. . The effect of MPOWER on smoking prevalence. Tob Control 2015;24:540&#x2013;2. 10.1136/tobaccocontrol-2014-051834</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-051834</ArticleId>
            <ArticleId IdType="pubmed">25492934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puska P. Framework convention on tobacco control: 10 years of the pioneering global health instrument. Eur J Public Health 2016;26:1 10.1093/eurpub/ckv178</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurpub/ckv178</ArticleId>
            <ArticleId IdType="pubmed">26370436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shang C, Huang J, Cheng KW, et al. . Global evidence on the association between POS advertising bans and youth smoking participation. Int J Environ Res Public Health 2016;13:306 10.3390/ijerph13030306</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijerph13030306</ArticleId>
            <ArticleId IdType="pmc">PMC4808969</ArticleId>
            <ArticleId IdType="pubmed">27005651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frazer K, Callinan JE, McHugh J, et al. . Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev 2016;2:CD005992 10.1002/14651858.CD005992.pub3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD005992.pub3</ArticleId>
            <ArticleId IdType="pmc">PMC6486282</ArticleId>
            <ArticleId IdType="pubmed">26842828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bilano V, Gilmour S, Moffiet T, et al. . Global trends and projections for tobacco use, 1990-2025: an analysis of smoking indicators from the WHO comprehensive information systems for tobacco control. Lancet 2015;385:966&#x2013;76. 10.1016/S0140-6736(15)60264-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(15)60264-1</ArticleId>
            <ArticleId IdType="pubmed">25784347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>What will it take to create a tobacco-free world? Lancet 2015;385:915 10.1016/S0140-6736(15)60512-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(15)60512-8</ArticleId>
            <ArticleId IdType="pubmed">25784326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Conference of the Parties to the WHO Framework Convention on Tobacco Control. Decision FCTC/COP6(13) Impact assessment of the WHO FCTC. 2014http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6(13)-en.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>WHO Convention Secretariat. Reporting and exchange of information (decision FCTC/COP1(14)). Synthesis of reports on implementation of the WHO framework convention on tobacco control received from parties (before 27 February 2007). Geneva: WHO Convention Secretariat, 2007.</Citation>
        </Reference>
        <Reference>
          <Citation>
WHO Convention Secretariat. Reports of the Parties received by the Convention Secretariat and progress made internationally in implementation of the Convention (Decision FCTC/COP1/(14)). 2008http://www.who.int/fctc/reporting/summary_2008_document_cop_3_14.pdf?ua=1
</Citation>
        </Reference>
        <Reference>
          <Citation>WHO Convention Secretariat. Summary report on global progress in implementation of the WHO Framework Convention on Tobacco Control. Geneva: WHO Convention Secretariat, 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO Convention Secretariat. Global progress report on the implementation of the WHO Framework Convention on Tobacco Control. Geneva: WHO Convention Secretariat, 2010.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO Convention Secretariat. Global progress report on implementation of the WHO Framework Convention on Tobacco Control. Geneva: WHO Convention Secretariat, 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO Convention Secretariat. Global progress report on implementation of the WHO Framework Convention on Tobacco Control. Geneva: WHO Convention Secretariat, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO Convention Secretariat. Global progress report on implementation of the WHO Framework Convention on Tobacco Control. Geneva: WHO Convention Secretariat, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization. Surveillance and monitoring. 2017http://www.who.int/tobacco/publications/surveillance/en/
</Citation>
        </Reference>
        <Reference>
          <Citation>Hoffman SJ, Tan C. Overview of systematic reviews on the health-related effects of government tobacco control policies. BMC Public Health 2015;15:744 10.1186/s12889-015-2041-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12889-015-2041-6</ArticleId>
            <ArticleId IdType="pmc">PMC4526291</ArticleId>
            <ArticleId IdType="pubmed">26242915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faber T, Kumar A, Mackenbach JPJ, et al. . Effect of tobacco control policies on perinatal and child health: a systematic review and meta-analysis. Lancet Public Health 2017;2:e420&#x2013;37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5592249</ArticleId>
            <ArticleId IdType="pubmed">28944313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy DT, Yuan Z, Luo Y, et al. . Seven years of progress in tobacco control: an evaluation of the effect of nations meeting the highest level MPOWER measures between 2007 and 2014. Tob Control 2018;27:50&#x2013;7. 10.1136/tobaccocontrol-2016-053381</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2016-053381</ArticleId>
            <ArticleId IdType="pmc">PMC5966723</ArticleId>
            <ArticleId IdType="pubmed">27956650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ngo A, Cheng KW, Chaloupka FJ, et al. . The effect of MPOWER scores on cigarette smoking prevalence and consumption. Prev Med 2017;105S:S10&#x2013;14. 10.1016/j.ypmed.2017.05.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ypmed.2017.05.006</ArticleId>
            <ArticleId IdType="pmc">PMC5681881</ArticleId>
            <ArticleId IdType="pubmed">28502576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gravely S, Giovino GA, Craig L, et al. . Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. Lancet Public Health 2017;2:e166&#x2013;74. 10.1016/S2468-2667(17)30045-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2468-2667(17)30045-2</ArticleId>
            <ArticleId IdType="pubmed">29253448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO Framework Convention on Tobacco Control. Impact assessment of the WHO FCTC (Decision FCTC/COP6(13)). Moscow: WHO Framework Convention on Tobacco Control, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Naslund JA, Aschbrenner KA, Araya R, et al. . Digital technology for treating and preventing mental disorders in low-income and middle-income countries: a narrative review of the literature. Lancet Psychiatry 2017;4:486&#x2013;500. 10.1016/S2215-0366(17)30096-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2215-0366(17)30096-2</ArticleId>
            <ArticleId IdType="pmc">PMC5523650</ArticleId>
            <ArticleId IdType="pubmed">28433615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collins JA, Fauser BC. Balancing the strengths of systematic and narrative reviews. Hum Reprod Update 2005;11:103&#x2013;4. 10.1093/humupd/dmh058</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humupd/dmh058</ArticleId>
            <ArticleId IdType="pubmed">15618290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO report on the global tobacco epidemic, 2015: raising taxes on tobacco. Geneva: World Health Organization, 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Uang R, Hiilamo H, Glantz SA. Accelerated adoption of smoke-free laws after ratification of the world health organization framework convention on tobacco control. Am J Public Health 2016;106:166&#x2013;71. 10.2105/AJPH.2015.302872</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.2015.302872</ArticleId>
            <ArticleId IdType="pmc">PMC4689638</ArticleId>
            <ArticleId IdType="pubmed">26562125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canadian Cancer Society. Cigarette package health warnings: international status report. 4th edn Toronto: Canadian Cancer Society, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Hiilamo H, Crosbie E, Glantz SA. The evolution of health warning labels on cigarette packs: the role of precedents, and tobacco industry strategies to block diffusion. Tob Control 2014;23:e2 10.1136/tobaccocontrol-2012-050541</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050541</ArticleId>
            <ArticleId IdType="pmc">PMC3725195</ArticleId>
            <ArticleId IdType="pubmed">23092884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO report on the global tobacco epidemic, 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization, 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Hiilamo H, Glantz SA. Implementation of effective cigarette health warning labels among low and middle income countries: state capacity, path-dependency and tobacco industry activity. Soc Sci Med 2015;124:241&#x2013;5. 10.1016/j.socscimed.2014.11.054</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.socscimed.2014.11.054</ArticleId>
            <ArticleId IdType="pmc">PMC4276461</ArticleId>
            <ArticleId IdType="pubmed">25462428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO report on the global tobacco epidemic, 2009 : implementing smoke-free environments. Geneva: World Health Organization, 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>ERC Group. World cigarettes 1 and 2: the 2007 survey. 2007.</Citation>
        </Reference>
        <Reference>
          <Citation>
Miguel-Baquilod M, Luz S, Quimbo A, et al. . 
The economics of tobacco and tobacco taxation in the Philippines. 2012https://global.tobaccofreekids.org/assets/global/pdfs/en/Philippines_tobacco_taxes_report_en.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>
John R, Pasha HA, Pasha AG, et al. . 
The economics of tobacco and tobacco taxation in Pakistan. 2013https://tobacconomics.org/wp-content/uploads/2014/05/PakistanReport_May2014.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO technical manual on tobacco tax administration. Geneva: World Health Organization, 2010.</Citation>
        </Reference>
        <Reference>
          <Citation>Dorotheo U, Ratanachena S, Ritthiphakdee B, et al. . ASEAN tobacco tax report card: regional comparisons and trends. 5th edn Bangkok, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>
Department of Finance Canada. The road to balance: creating jobs and opportunities. Economic action plan 2014. 2014http://www.budget.gc.ca/2014/docs/plan/pdf/budget2014-eng.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>
Government of New Zealand. Budget economic and fiscal update 2012. 2012http://www.treasury.govt.nz/budget/forecasts/befu2012
</Citation>
        </Reference>
        <Reference>
          <Citation>
Australian Government Department of Health. Taxation: the history of tobacco excise arrangements in Australia since 1901. 2014http://www.health.gov.au/internet/main/publishing.nsf/content/tobacco-tax
</Citation>
        </Reference>
        <Reference>
          <Citation>Willemsen MC, Nagelhout GE. Country differences and changes in focus of scientific tobacco control publications between 2000 and 2012 in Europe. Eur Addict Res 2016;22:52&#x2013;8. 10.1159/000381674</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000381674</ArticleId>
            <ArticleId IdType="pubmed">26316228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espino R, Assunta M, Kin F. Status of tobacco farming in the ASEAN region. 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>Ministry of Agrarian Development of Brazil. Tobacco growing, family farmers and diversification strategies in Brazil: current prospects and future potential for alternative crops. Technical document for the second section of the Conference of the Parties to the WHO Framework Convention on Tobacco Control. 2007.</Citation>
        </Reference>
        <Reference>
          <Citation>
WHO Convention Secretariat. FCTC implementation database: progress made in implementing Article 18. 2014http://apps.who.int/fctc/implementation/database/article/article-18/indicators/5472/reports
</Citation>
        </Reference>
        <Reference>
          <Citation>Muggli ME, Zheng A, Liberman J, et al. . Tracking the relevance of the WHO Framework Convention on Tobacco Control in legislation and litigation through the online resource, Tobacco Control Laws. Tob Control 2014;23:457&#x2013;60. 10.1136/tobaccocontrol-2012-050854</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050854</ArticleId>
            <ArticleId IdType="pubmed">23644394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong MK, Bero LA. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ 2002;325:1413&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1124865</ArticleId>
            <ArticleId IdType="pubmed">12480862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuman M, Bitton A, Glantz S. Tobacco industry strategies for influencing European Community tobacco advertising legislation. Lancet 2002;359:1323&#x2013;30. 10.1016/S0140-6736(02)08275-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(02)08275-2</ArticleId>
            <ArticleId IdType="pubmed">11965294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S, Ling PM, Glantz SA. The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries. Cancer Causes Control 2012;23(Suppl 1):117&#x2013;29. 10.1007/s10552-012-9914-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10552-012-9914-0</ArticleId>
            <ArticleId IdType="pmc">PMC3332051</ArticleId>
            <ArticleId IdType="pubmed">22370696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith KE, Savell E, Gilmore AB. What is known about tobacco industry efforts to influence tobacco tax? A systematic review of empirical studies. Tob Control 2013;22:e1 10.1136/tobaccocontrol-2011-050098</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2011-050098</ArticleId>
            <ArticleId IdType="pmc">PMC3701860</ArticleId>
            <ArticleId IdType="pubmed">22887175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Savell E, Gilmore AB, Fooks G. How does the tobacco industry attempt to influence marketing regulations? A systematic review. PLoS One 2014;9:e87389 10.1371/journal.pone.0087389</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0087389</ArticleId>
            <ArticleId IdType="pmc">PMC3914831</ArticleId>
            <ArticleId IdType="pubmed">24505286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fooks GJ, Smith J, Lee K, et al. . Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control. Global Health 2017;13:12 10.1186/s12992-017-0234-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12992-017-0234-8</ArticleId>
            <ArticleId IdType="pmc">PMC5343400</ArticleId>
            <ArticleId IdType="pubmed">28274267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gilmore AB, Rowell A, Gallus S, et al. . Towards a greater understanding of the illicit tobacco trade in Europe: a review of the PMI funded &#x2019;Project Star' report. Tob Control 2014;23:e51&#x2013;61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4078702</ArticleId>
            <ArticleId IdType="pubmed">24335339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joossens L, Gilmore AB, Stoklosa M, et al. . Assessment of the European Union&#x2019;s illicit trade agreements with the four major Transnational Tobacco Companies. Tob Control 2016;25:254&#x2013;60. 10.1136/tobaccocontrol-2014-052218</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-052218</ArticleId>
            <ArticleId IdType="pmc">PMC4853556</ArticleId>
            <ArticleId IdType="pubmed">26022741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Assunta M. Tobacco industry&#x2019;s ITGA fights FCTC implementation in the Uruguay negotiations. Tob Control 2012;21:563&#x2013;8. 10.1136/tobaccocontrol-2011-050222</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2011-050222</ArticleId>
            <ArticleId IdType="pubmed">22634569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crosbie E, Sosa P, Glantz SA. The importance of continued engagement during the implementation phase of tobacco control policies in a middle-income country: the case of Costa Rica. Tob Control 2017;26:60&#x2013;8. 10.1136/tobaccocontrol-2015-052701</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2015-052701</ArticleId>
            <ArticleId IdType="pmc">PMC4977207</ArticleId>
            <ArticleId IdType="pubmed">26856614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peeters S, Costa H, Stuckler D, et al. . The revision of the 2014 European tobacco products directive: an analysis of the tobacco industry&#x2019;s attempts to &#x2019;break the health silo'. Tob Control 2016;25:108&#x2013;17. 10.1136/tobaccocontrol-2014-051919</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-051919</ArticleId>
            <ArticleId IdType="pmc">PMC4669229</ArticleId>
            <ArticleId IdType="pubmed">25713313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fooks GJ, Gilmore AB. Corporate philanthropy, political influence, and health policy. PLoS One 2013;8:e80864 10.1371/journal.pone.0080864</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0080864</ArticleId>
            <ArticleId IdType="pmc">PMC3842338</ArticleId>
            <ArticleId IdType="pubmed">24312249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gilmore AB, Fooks G, Drope J, et al. . Exposing and addressing tobacco industry conduct in low-income and middle-income countries. Lancet 2015;385:1029&#x2013;43. 10.1016/S0140-6736(15)60312-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(15)60312-9</ArticleId>
            <ArticleId IdType="pmc">PMC4382920</ArticleId>
            <ArticleId IdType="pubmed">25784350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crosbie E, Glantz SA. Tobacco industry argues domestic trademark laws and international treaties preclude cigarette health warning labels, despite consistent legal advice that the argument is invalid. Tob Control 2014;23:e7 10.1136/tobaccocontrol-2012-050569</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050569</ArticleId>
            <ArticleId IdType="pmc">PMC3725199</ArticleId>
            <ArticleId IdType="pubmed">23179728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lencucha R. Philip Morris versus Uruguay: health governance challenged. Lancet 2010;376:852&#x2013;3. 10.1016/S0140-6736(10)61256-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(10)61256-1</ArticleId>
            <ArticleId IdType="pubmed">20833287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fooks G, Gilmore AB. International trade law, plain packaging and tobacco industry political activity: the Trans-Pacific Partnership. Tob Control 2014;23:e1 10.1136/tobaccocontrol-2012-050869</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050869</ArticleId>
            <ArticleId IdType="pmc">PMC3888632</ArticleId>
            <ArticleId IdType="pubmed">23788606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans-Reeves KA, Hatchard JL, Gilmore AB. &#x2019;It will harm business and increase illicit trade': an evaluation of the relevance, quality and transparency of evidence submitted by transnational tobacco companies to the UK consultation on standardised packaging 2012. Tob Control 2015;24:e168&#x2013;77. 10.1136/tobaccocontrol-2014-051930</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-051930</ArticleId>
            <ArticleId IdType="pmc">PMC4484371</ArticleId>
            <ArticleId IdType="pubmed">25472733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ulucanlar S, Fooks GJ, Hatchard JL, et al. . Representation and misrepresentation of scientific evidence in contemporary tobacco regulation: a review of tobacco industry submissions to the UK Government consultation on standardised packaging. PLoS Med 2014;11:e1001629 10.1371/journal.pmed.1001629</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.1001629</ArticleId>
            <ArticleId IdType="pmc">PMC3965396</ArticleId>
            <ArticleId IdType="pubmed">24667150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
World Health Organization. WHO welcomes landmark decision from Australia&#x2019;s High Court on Tobacco Plain Packaging Act. 2012http://www.who.int/mediacentre/news/statements/2012/tobacco_packaging/en/
</Citation>
        </Reference>
        <Reference>
          <Citation>
McCabe Centre for Law &amp; Cancer. Investment tribunal dismisses Philip Morris Asia&#x2019;s challenge to Australia&#x2019;s plain packaging. 2015http://untobaccocontrol.org/kh/legal-challenges/investment-tribunal-dismisses-philip-morris-asias-challenge-australias-plain-packaging/
</Citation>
        </Reference>
        <Reference>
          <Citation>High Court of Justice. British American Tobacco, Philip Morris International, JT International, Imperial Tobacco v. Secretary of State for Health. Case No: CO/2322/2015, CO/2323/2015, CO/2352/2015, CO/2601/2015, CO/2706/2015. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>
Pan American Health Organization, World Health Organization. PAHO/WHO congratulates Uruguay for successfully defending tobacco control policies against tobacco industry challenges. 2016http://www.paho.org/hq/index.php?option=com_content&amp;view=article&amp;id=12273%3Apaho-congratulates-uruguay-for-defending-tobacco-control-policies-against-tobacco-industry&amp;Itemid=1926&amp;lang=en
</Citation>
        </Reference>
        <Reference>
          <Citation>Torjesen I. Tobacco giant loses legal action over Uruguay&#x2019;s tobacco packaging rules. BMJ 2016;354:i3850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27400861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Court of Justice of the European Union. Press release No 48/16. The New EU directive on tobacco products is valid. 2016https://curia.europa.eu/jcms/upload/docs/application/pdf/2016-05/cp160048en.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Liberman J. Plainly constitutional: the upholding of plain tobacco packaging by the High Court of Australia. Am J Law Med 2013;39:361&#x2013;81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23815036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
McCabe Centre for Law &amp; Cancer. The High Court of Justice decision upholding the UK&#x2019;s standardized packaging laws: key points for other jurisdictions. 2016http://www.mccabecentre.org/blog/uk-decision.html
</Citation>
        </Reference>
        <Reference>
          <Citation>Pin&#xE9;-Abata H, McNeill A, Murray R, et al. . A survey of tobacco dependence treatment services in 121 countries. Addiction 2013;108:1476&#x2013;84. 10.1111/add.12172</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/add.12172</ArticleId>
            <ArticleId IdType="pmc">PMC3759701</ArticleId>
            <ArticleId IdType="pubmed">23451932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kruse GR, Rigotti NA, Raw M, et al. . Tobacco dependence treatment training programs: an international survey. Nicotine Tob Res 2016;18:1012&#x2013;8. 10.1093/ntr/ntv142</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntv142</ArticleId>
            <ArticleId IdType="pmc">PMC5942606</ArticleId>
            <ArticleId IdType="pubmed">26117835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Makoka D, Appau A, Lencucha R, et al. . 
Farm-level economics of tobacco production in Malawi. 2016https://www.researchgate.net/publication/305379990_Farm-Level_Economics_of_Tobacco_Production_in_Malawi
</Citation>
        </Reference>
        <Reference>
          <Citation>Magati P, Li Q, Drope J, et al. . The economics of tobacco farming in Kenya. Nairobi, Atlanta. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>
Goma F, Drope J, Zulu R, et al. . 
The economics of tobacco farming in Zambia. Lusaka, Atlanta. 2015https://www.cancer.org/content/dam/cancer-org/research/economic-and-healthy-policy/economics-tobacco-farming-zambia-presentation-version-december-2015.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Altman DG, Levine DW, Howard G, et al. . Tobacco farmers and diversification: opportunities and barriers. Tob Control 1996;5:192&#x2013;8. 10.1136/tc.5.3.192</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.5.3.192</ArticleId>
            <ArticleId IdType="pmc">PMC1759516</ArticleId>
            <ArticleId IdType="pubmed">9035353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warren CW, Erguder T, Lee J, et al. . Effect of policy changes on cigarette sales: the case of Turkey. Eur J Public Health 2012;22:712&#x2013;6. 10.1093/eurpub/ckr157</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurpub/ckr157</ArticleId>
            <ArticleId IdType="pubmed">22467758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Y&#xFC;rekli A, &#xD6;nder Z, Erk SF, et al. . 
The economics of tobacco and tobacco taxation in Turkey. 2010http://www.who.int/tobacco/en_tfi_turkey_report_feb2011.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>
Waters H, S&#xE1;enz de Miera B, Ross H, et al. . 
The economics of tobacco and tobacco taxation in Mexico. 2010https://global.tobaccofreekids.org/assets/global/pdfs/en/Mexico_tobacco_taxes_report_en.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>
Van Walbeek C.
Tobacco excise taxation in South Africa. 2003http://www.who.int/tobacco/training/success_stories/en/best_practices_south_africa_taxation.pdf?ua=1
</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization Western Pacific Region, ITC Project. Smoke-free policies in China: evidence of effectiveness and implications for action. 2015http://itcproject.org/resources/view/2159
</Citation>
        </Reference>
        <Reference>
          <Citation>Fong GT, Hyland A, Borland R, et al. . Reductions in tobacco smoke pollution and increases in support for smoke-free public places following the implementation of comprehensive smoke-free workplace legislation in the Republic of Ireland: findings from the ITC Ireland/UK Survey. Tob Control 2006;15(Suppl 3):iii51&#x2013;iii58. 10.1136/tc.2005.013649</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2005.013649</ArticleId>
            <ArticleId IdType="pmc">PMC2593063</ArticleId>
            <ArticleId IdType="pubmed">16754947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fong GT, Craig LV, Guignard R, et al. . Evaluating the effectiveness of France&#x2019;s indoor smoke-free law 1 year and 5 years after implementation: findings from the ITC France Survey. PLoS One 2013;8:e66692 10.1371/journal.pone.0066692</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0066692</ArticleId>
            <ArticleId IdType="pmc">PMC3689708</ArticleId>
            <ArticleId IdType="pubmed">23805265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooper J, Borland R, Yong HH, et al. . Compliance and support for bans on smoking in licensed venues in Australia: findings from the International Tobacco Control Four-Country Survey. Aust N Z J Public Health 2010;34:379&#x2013;85. 10.1111/j.1753-6405.2010.00570.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1753-6405.2010.00570.x</ArticleId>
            <ArticleId IdType="pmc">PMC4466907</ArticleId>
            <ArticleId IdType="pubmed">20649778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brennan E, Cameron M, Warne C, et al. . Secondhand smoke drift: examining the influence of indoor smoking bans on indoor and outdoor air quality at pubs and bars. Nicotine Tob Res 2010;12:271&#x2013;7. 10.1093/ntr/ntp204</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntp204</ArticleId>
            <ArticleId IdType="pubmed">20097839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avila-Tang E, Travers MJ, Navas-Acien A. Promoting smoke-free environments in Latin America: a comparison of methods to assess secondhand smoke exposure. Salud Publica Mex 2010;52(Suppl 2):S138&#x2013;48. 10.1590/S0036-36342010000800009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0036-36342010000800009</ArticleId>
            <ArticleId IdType="pubmed">21243184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Connolly GN, Carpenter CM, Travers MJ, et al. . How smoke-free laws improve air quality: a global study of Irish pubs. Nicotine Tob Res 2009;11:600&#x2013;5. 10.1093/ntr/ntp038</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntp038</ArticleId>
            <ArticleId IdType="pmc">PMC2688600</ArticleId>
            <ArticleId IdType="pubmed">19380381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hyland A, Travers MJ, Dresler C, et al. . A 32-country comparison of tobacco smoke derived particle levels in indoor public places. Tob Control 2008;17:159&#x2013;65. 10.1136/tc.2007.020479</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2007.020479</ArticleId>
            <ArticleId IdType="pmc">PMC5831126</ArticleId>
            <ArticleId IdType="pubmed">18303089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodman PG, Haw S, Kabir Z, et al. . Are there health benefits associated with comprehensive smoke-free laws. Int J Public Health 2009;54:367&#x2013;78. 10.1007/s00038-009-0089-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00038-009-0089-8</ArticleId>
            <ArticleId IdType="pubmed">19882106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stallings-Smith S, Zeka A, Goodman P, et al. . Reductions in cardiovascular, cerebrovascular, and respiratory mortality following the national Irish smoking ban: interrupted time-series analysis. PLoS One 2013;8:e62063 10.1371/journal.pone.0062063</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0062063</ArticleId>
            <ArticleId IdType="pmc">PMC3634756</ArticleId>
            <ArticleId IdType="pubmed">23637964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sebri&#xE9; EM, Sandoya E, Hyland A, et al. . Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke-free policy in Uruguay. Tob Control 2013;22:e16&#x2013;20. 10.1136/tobaccocontrol-2011-050134</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2011-050134</ArticleId>
            <ArticleId IdType="pmc">PMC3374906</ArticleId>
            <ArticleId IdType="pubmed">22337557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sebri&#xE9; EM, Sandoya E, Bianco E, et al. . Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke-free policy in Uruguay: experience through 2010. Tob Control 2014;23:471&#x2013;2. 10.1136/tobaccocontrol-2012-050954</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050954</ArticleId>
            <ArticleId IdType="pmc">PMC4358818</ArticleId>
            <ArticleId IdType="pubmed">25324157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pell JP, Haw S, Cobbe S, et al. . Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 2008;359:482&#x2013;91. 10.1056/NEJMsa0706740</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMsa0706740</ArticleId>
            <ArticleId IdType="pubmed">18669427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan CE, Glantz SA. Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis. Circulation 2012;126:2177&#x2013;83. 10.1161/CIRCULATIONAHA.112.121301</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.121301</ArticleId>
            <ArticleId IdType="pmc">PMC3501404</ArticleId>
            <ArticleId IdType="pubmed">23109514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Been JV, Nurmatov U, van Schayck CP, et al. . The impact of smoke-free legislation on fetal, infant and child health: a systematic review and meta-analysis protocol. BMJ Open 2013;3:e002261 10.1136/bmjopen-2012-002261</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2012-002261</ArticleId>
            <ArticleId IdType="pmc">PMC3586104</ArticleId>
            <ArticleId IdType="pubmed">23408079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fowkes FJ, Stewart MC, Fowkes FG, et al. . Scottish smoke-free legislation and trends in smoking cessation. Addiction 2008;103:1888&#x2013;95. 10.1111/j.1360-0443.2008.02350.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1360-0443.2008.02350.x</ArticleId>
            <ArticleId IdType="pubmed">19032538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gravely S, Fong GT, Driezen P, et al. . The impact of the 2009/2010 enhancement of cigarette health warning labels in Uruguay: longitudinal findings from the International Tobacco Control (ITC) Uruguay Survey. Tob Control 2016;25:89&#x2013;95. 10.1136/tobaccocontrol-2014-051742</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-051742</ArticleId>
            <ArticleId IdType="pmc">PMC4618260</ArticleId>
            <ArticleId IdType="pubmed">25512431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammond D. Health warning messages on tobacco products: a review. Tob Control 2011;20:327&#x2013;37. 10.1136/tc.2010.037630</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2010.037630</ArticleId>
            <ArticleId IdType="pubmed">21606180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammond D, Fong GT, McDonald PW, et al. . Impact of the graphic Canadian warning labels on adult smoking behaviour. Tob Control 2003;12:391&#x2013;5. 10.1136/tc.12.4.391</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.12.4.391</ArticleId>
            <ArticleId IdType="pmc">PMC1747800</ArticleId>
            <ArticleId IdType="pubmed">14660774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammond D, McDonald PW, Fong GT, et al. . The impact of cigarette warning labels and smoke-free bylaws on smoking cessation: evidence from former smokers. Can J Public Health 2004;95:201&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6976079</ArticleId>
            <ArticleId IdType="pubmed">15191132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammond D, Reid JL, Driezen P, et al. . Pictorial health warnings on cigarette packs in the United States: an experimental evaluation of the proposed FDA warnings. Nicotine Tob Res 2013;15:93&#x2013;102. 10.1093/ntr/nts094</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/nts094</ArticleId>
            <ArticleId IdType="pmc">PMC3524059</ArticleId>
            <ArticleId IdType="pubmed">22505660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J, Chaloupka FJ, Fong GT. Cigarette graphic warning labels and smoking prevalence in Canada: a critical examination and reformulation of the FDA regulatory impact analysis. Tob Control 2014;23(Suppl 1):i7&#x2013;12. 10.1136/tobaccocontrol-2013-051170</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2013-051170</ArticleId>
            <ArticleId IdType="pmc">PMC4254709</ArticleId>
            <ArticleId IdType="pubmed">24218057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammond D, Fong GT, McNeill A, et al. . Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control 2006;15(Suppl 3):iii19&#x2013;25. 10.1136/tc.2005.012294</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2005.012294</ArticleId>
            <ArticleId IdType="pmc">PMC2593056</ArticleId>
            <ArticleId IdType="pubmed">16754942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borland R, Wilson N, Fong GT, et al. . Impact of graphic and text warnings on cigarette packs: findings from four countries over five years. Tob Control 2009;18:358&#x2013;64. 10.1136/tc.2008.028043</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2008.028043</ArticleId>
            <ArticleId IdType="pmc">PMC4527864</ArticleId>
            <ArticleId IdType="pubmed">19561362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
ITC Project. FCTC Article 11 tobacco warning labels: evidence and recommendations from the ITC Project. 2009http://www.itcproject.org/files/ITC_Tobacco_Labels_Bro_V3.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Fathelrahman AI, Li L, Borland R, et al. . Stronger pack warnings predict quitting more than weaker ones: finding from the ITC Malaysia and Thailand surveys. Tob Induc Dis 2013;11:20 10.1186/1617-9625-11-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1617-9625-11-20</ArticleId>
            <ArticleId IdType="pmc">PMC3848583</ArticleId>
            <ArticleId IdType="pubmed">24330614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiosi JJ, Andes L, Asma S, et al. . Warning about the harms of tobacco use in 22 countries: findings from a cross-sectional household survey. Tob Control 2016;25:393&#x2013;401. 10.1136/tobaccocontrol-2014-052047</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-052047</ArticleId>
            <ArticleId IdType="pubmed">25953532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller CL, Hill DJ, Quester PG, et al. . Impact on the Australian quitline of new graphic cigarette pack warnings including the Quitline number. Tob Control 2009;18:235&#x2013;7. 10.1136/tc.2008.028290</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2008.028290</ArticleId>
            <ArticleId IdType="pmc">PMC2679186</ArticleId>
            <ArticleId IdType="pubmed">19211613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J, Grigg M. New Zealand: new graphic warnings encourage registrations with the quitline. Tob Control 2009;18:72 10.1136/tc.2008.027649</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2008.027649</ArticleId>
            <ArticleId IdType="pubmed">19168492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson N, Li J, Hoek J, et al. . Long-term benefit of increasing the prominence of a quitline number on cigarette packaging: 3 years of Quitline call data. N Z Med J 2010;123:109&#x2013;11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20927170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
British Heart Foundation, ITC Project. Standardised packaging for tobacco products. 2014http://www.itcproject.org/files/ITC_British_Heart_FoundationA4-v8-web-Final-18Dec2014.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>
Hammond D.
Standardized packaging of tobacco products: evidence review. Prepared on behalf of the Irish Department of Health. 2014http://health.gov.ie/wp-content/uploads/2014/06/2014-Ireland-Plain-Pack-Main-Report-Final-Report-July-26.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>
Chantler S.
Standardised packaging of tobacco. Report of the independent review undertaken by Sir Cyril Chantler. 2014https://www.kcl.ac.uk/health/10035-TSO-2901853-Chantler-Review-ACCESSIBLE.PDF
</Citation>
        </Reference>
        <Reference>
          <Citation>
Moodie C, Stead M, Bauld L, et al. . 
Plain tobacco packaging: a systematic review. 2012http://phrc.lshtm.ac.uk/papers/PHRC_006_Final_Report.pdf
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23902856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wakefield M, Coomber K, Zacher M, et al. . Australian adult smokers' responses to plain packaging with larger graphic health warnings 1&#x2005;year after implementation: results from a national cross-sectional tracking survey. Tob Control 2015;24:ii17&#x2013;25. 10.1136/tobaccocontrol-2014-052050</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-052050</ArticleId>
            <ArticleId IdType="pmc">PMC4401339</ArticleId>
            <ArticleId IdType="pubmed">28407606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yong HH, Borland R, Hammond D, et al. . Smokers' reactions to the new larger health warning labels on plain cigarette packs in Australia: findings from the ITC Australia project. Tob Control 2016;25:181&#x2013;7. 10.1136/tobaccocontrol-2014-051979</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-051979</ArticleId>
            <ArticleId IdType="pmc">PMC4601932</ArticleId>
            <ArticleId IdType="pubmed">25700365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunlop SM, Dobbins T, Young JM, et al. . Impact of Australia&#x2019;s introduction of tobacco plain packs on adult smokers' pack-related perceptions and responses: results from a continuous tracking survey. BMJ Open 2014;4:e005836 10.1136/bmjopen-2014-005836</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2014-005836</ArticleId>
            <ArticleId IdType="pmc">PMC4275762</ArticleId>
            <ArticleId IdType="pubmed">25524542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durkin S, Brennan E, Coomber K, et al. . Short-term changes in quitting-related cognitions and behaviours after the implementation of plain packaging with larger health warnings: findings from a national cohort study with Australian adult smokers. Tob Control 2015;24:ii26&#x2013;32. 10.1136/tobaccocontrol-2014-052058</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2014-052058</ArticleId>
            <ArticleId IdType="pmc">PMC4392190</ArticleId>
            <ArticleId IdType="pubmed">28407608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young JM, Stacey I, Dobbins TA, et al. . Association between tobacco plain packaging and Quitline calls: a population-based, interrupted time-series analysis. Med J Aust 2014;200:29&#x2013;32. 10.5694/mja13.11070</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5694/mja13.11070</ArticleId>
            <ArticleId IdType="pubmed">24438415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Australian Department of Health. Post-implementation review tobacco plain packaging 2016. 2016http://ris.pmc.gov.au/2016/02/26/tobacco-plain-packaging/
</Citation>
        </Reference>
        <Reference>
          <Citation>Kmietowicz Z. Australia sees large fall in smoking after introduction of standardised packs. BMJ 2014;349:g4689 10.1136/bmj.g4689</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.g4689</ArticleId>
            <ArticleId IdType="pubmed">25035288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
ITC Project. ITC Uruguay national report. Findings from the Wave 1 to 4 Surveys (2006-2012). 2014http://www.itcproject.org/resources/view/1698
</Citation>
        </Reference>
        <Reference>
          <Citation>
ITC Project. ITC Canada national report: findings from the Wave 1 to 8 Surveys (2002- 2011). 2013http://www.itcproject.org/resources/view/1533.</Citation>
        </Reference>
        <Reference>
          <Citation>Caixeta R, Sinha D, Khoury R, et al. . Adult awareness of tobacco advertising, promotion, and sponsorship--14 countries. MMWR Morb Mortal Wkly Rep 2012;61:365&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22622091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris F, MacKintosh AM, Anderson S, et al. . Effects of the 2003 advertising/promotion ban in the United Kingdom on awareness of tobacco marketing: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control 2006;15(Suppl 3):iii26&#x2013;33. 10.1136/tc.2005.013110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2005.013110</ArticleId>
            <ArticleId IdType="pmc">PMC2593060</ArticleId>
            <ArticleId IdType="pubmed">16754943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kasza KA, Hyland AJ, Brown A, et al. . The effectiveness of tobacco marketing regulations on reducing smokers' exposure to advertising and promotion: findings from the International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health 2011;8:321&#x2013;40. 10.3390/ijerph8020321</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijerph8020321</ArticleId>
            <ArticleId IdType="pmc">PMC3084464</ArticleId>
            <ArticleId IdType="pubmed">21556189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li L, Yong HH, Borland R, et al. . Reported awareness of tobacco advertising and promotion in China compared to Thailand, Australia and the USA. Tob Control 2009;18:222&#x2013;7. 10.1136/tc.2008.027037</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2008.027037</ArticleId>
            <ArticleId IdType="pmc">PMC2679187</ArticleId>
            <ArticleId IdType="pubmed">19332425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNeill A, Lewis S, Quinn C, et al. . Evaluation of the removal of point-of-sale tobacco displays in Ireland. Tob Control 2011;20:137&#x2013;43. 10.1136/tc.2010.038141</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2010.038141</ArticleId>
            <ArticleId IdType="pubmed">21088060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saffer H, Chaloupka F. The effect of tobacco advertising bans on tobacco consumption. J Health Econ 2000;19:1117&#x2013;37. 10.1016/S0167-6296(00)00054-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0167-6296(00)00054-0</ArticleId>
            <ArticleId IdType="pubmed">11186847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blecher E. The impact of tobacco advertising bans on consumption in developing countries. J Health Econ 2008;27:930&#x2013;42. 10.1016/j.jhealeco.2008.02.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhealeco.2008.02.010</ArticleId>
            <ArticleId IdType="pubmed">18440661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saffer H. Tobacco advertising and promotion Tobacco control in developing countries. Oxford: Oxford University, 2000.</Citation>
        </Reference>
        <Reference>
          <Citation>
National Cancer Institute. The role of the media in promoting and reducing tobacco use: smoking and tobacco control monograph No. 19. NIH Pub. No. 07-6242. 2008https://cancercontrol.cancer.gov/brp/tcrb/monographs/19/m19_complete.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Paynter J, Edwards R. The impact of tobacco promotion at the point of sale: a systematic review. Nicotine Tob Res 2009;11:25&#x2013;35. 10.1093/ntr/ntn002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntn002</ArticleId>
            <ArticleId IdType="pubmed">19246438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spanopoulos D, Britton J, McNeill A, et al. . Tobacco display and brand communication at the point of sale: implications for adolescent smoking behaviour. Tob Control 2014;23:64&#x2013;9. 10.1136/tobaccocontrol-2012-050765</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050765</ArticleId>
            <ArticleId IdType="pmc">PMC3888631</ArticleId>
            <ArticleId IdType="pubmed">23449398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheffels J, Lavik R. Out of sight, out of mind? Removal of point-of-sale tobacco displays in Norway. Tob Control 2013;22:e37&#x2013;42. 10.1136/tobaccocontrol-2011-050341</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2011-050341</ArticleId>
            <ArticleId IdType="pmc">PMC3731079</ArticleId>
            <ArticleId IdType="pubmed">22678299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>West R, Raw M, McNeill A, et al. . Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction 2015;110:1388&#x2013;403. 10.1111/add.12998</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/add.12998</ArticleId>
            <ArticleId IdType="pmc">PMC4737108</ArticleId>
            <ArticleId IdType="pubmed">26031929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carson KV, Verbiest ME, Crone MR, et al. . Training health professionals in smoking cessation. Cochrane Database Syst Rev 2012:CD000214 10.1002/14651858.CD000214.pub2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD000214.pub2</ArticleId>
            <ArticleId IdType="pmc">PMC10088066</ArticleId>
            <ArticleId IdType="pubmed">22592671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warren CW, Jones NR, Chauvin J, et al. . Tobacco use and cessation counselling: cross-country. Data from the Global Health Professions Student Survey (GHPSS), 2005-7. Tob Control 2008;17:238&#x2013;47. 10.1136/tc.2007.023895</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2007.023895</ArticleId>
            <ArticleId IdType="pubmed">18474539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooper J, Borland R, Yong HH. Australian smokers increasingly use help to quit, but number of attempts remains stable: findings from the International Tobacco Control Study 2002-09. Aust N Z J Public Health 2011;35:368&#x2013;76. 10.1111/j.1753-6405.2011.00733.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1753-6405.2011.00733.x</ArticleId>
            <ArticleId IdType="pmc">PMC4678149</ArticleId>
            <ArticleId IdType="pubmed">21806733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kasza KA, Hyland AJ, Borland R, et al. . Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction 2013;108:193&#x2013;202. 10.1111/j.1360-0443.2012.04009.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1360-0443.2012.04009.x</ArticleId>
            <ArticleId IdType="pmc">PMC3500450</ArticleId>
            <ArticleId IdType="pubmed">22891869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ossip-Klein DJ, McIntosh S. Quitlines in North America: evidence base and applications. Am J Med Sci 2003;326:201&#x2013;5. 10.1097/00000441-200310000-00010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000441-200310000-00010</ArticleId>
            <ArticleId IdType="pubmed">14557735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stead LF, Hartmann-Boyce J, Perera R, et al. . Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2013:CD002850 10.1002/14651858.CD002850.pub3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD002850.pub3</ArticleId>
            <ArticleId IdType="pubmed">23934971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson CM, Zhu SH. Tobacco quitlines: looking back and looking ahead. Tob Control 2007;16(Suppl 1):i81&#x2013;6. 10.1136/tc.2007.020701</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2007.020701</ArticleId>
            <ArticleId IdType="pmc">PMC2598521</ArticleId>
            <ArticleId IdType="pubmed">18048638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller CL, Wakefield M, Roberts L. Uptake and effectiveness of the Australian telephone Quitline service in the context of a mass media campaign. Tob Control 2003;12(Suppl 2):53ii&#x2013;8. 10.1136/tc.12.suppl_2.ii53</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.12.suppl_2.ii53</ArticleId>
            <ArticleId IdType="pmc">PMC1766110</ArticleId>
            <ArticleId IdType="pubmed">12878774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdullah ASM, Lam T-H, Chan SSC, et al. . Which smokers use the smoking cessation Quitline in Hong Kong. and how effective is the Quitline? Tob Control 2004;13:415&#x2013;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1747959</ArticleId>
            <ArticleId IdType="pubmed">15564628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bauld L, Bell K, McCullough L, et al. . The effectiveness of NHS smoking cessation services: a systematic review. J Public Health 2010;32:71&#x2013;82. 10.1093/pubmed/fdp074</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/pubmed/fdp074</ArticleId>
            <ArticleId IdType="pubmed">19638397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dobbie F, Hiscock R, Leonardi-Bee J, et al. . Evaluating Long-term Outcomes of NHS Stop Smoking Services (ELONS): a prospective cohort study. Health Technol Assess 2015;19:1&#x2013;156. 10.3310/hta19950</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3310/hta19950</ArticleId>
            <ArticleId IdType="pmc">PMC4781027</ArticleId>
            <ArticleId IdType="pubmed">26565129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullen KA, Manuel DG, Hawken SJ, et al. . Effectiveness of a hospital-initiated smoking cessation programme: 2-year health and healthcare outcomes. Tob Control 2017;26:293&#x2013;9. 10.1136/tobaccocontrol-2015-052728</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2015-052728</ArticleId>
            <ArticleId IdType="pmc">PMC5543264</ArticleId>
            <ArticleId IdType="pubmed">27225016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gibson JE, Murray RL, Borland R, et al. . The impact of the United Kingdom&#x2019;s national smoking cessation strategy on quit attempts and use of cessation services: findings from the International Tobacco Control Four Country Survey. Nicotine Tob Res 2010;12(Suppl):S64&#x2013;71. 10.1093/ntr/ntq119</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntq119</ArticleId>
            <ArticleId IdType="pmc">PMC2948139</ArticleId>
            <ArticleId IdType="pubmed">20889483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferguson J, Bauld L, Chesterman J, et al. . The English smoking treatment services: one-year outcomes. Addiction 2005;100(Suppl 2):59&#x2013;69. 10.1111/j.1360-0443.2005.01028.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1360-0443.2005.01028.x</ArticleId>
            <ArticleId IdType="pubmed">15755262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judge K, Bauld L, Chesterman J, et al. . The English smoking treatment services: short-term outcomes. Addiction 2005;100(Suppl 2):46&#x2013;58. 10.1111/j.1360-0443.2005.01027.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1360-0443.2005.01027.x</ArticleId>
            <ArticleId IdType="pubmed">15844289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brose LS, West R, McDermott MS, et al. . What makes for an effective stop-smoking service? Thorax 2011;66:924&#x2013;6. 10.1136/thoraxjnl-2011-200251</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thoraxjnl-2011-200251</ArticleId>
            <ArticleId IdType="pubmed">21709164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>West R, DiMarino ME, Gitchell J, et al. . Impact of UK policy initiatives on use of medicines to aid smoking cessation. Tob Control 2005;14:166&#x2013;71. 10.1136/tc.2004.008649</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.2004.008649</ArticleId>
            <ArticleId IdType="pmc">PMC1748027</ArticleId>
            <ArticleId IdType="pubmed">15923466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bauer UE, Johnson TM, Hopkins RS, et al. . Changes in youth cigarette use and intentions following implementation of a tobacco control program: findings from the Florida Youth Tobacco Survey, 1998-2000. JAMA 2000;284:723&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10927781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niederdeppe J, Farrelly MC, Haviland ML. Confirming "truth": more evidence of a successful tobacco countermarketing campaign in Florida. Am J Public Health 2004;94:255&#x2013;7. 10.2105/AJPH.94.2.255</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.94.2.255</ArticleId>
            <ArticleId IdType="pmc">PMC1448237</ArticleId>
            <ArticleId IdType="pubmed">14759936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weiss JW, Cen S, Schuster DV, et al. . Longitudinal effects of pro-tobacco and anti-tobacco messages on adolescent smoking susceptibility. Nicotine Tob Res 2006;8:455&#x2013;65. 10.1080/14622200600670454</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14622200600670454</ArticleId>
            <ArticleId IdType="pubmed">16801303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brinn MP, Carson KV, Esterman AJ, et al. . Mass media interventions for preventing smoking in young people. Cochrane Database Syst Rev 2010:CD001006 10.1002/14651858.CD001006.pub2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD001006.pub2</ArticleId>
            <ArticleId IdType="pubmed">21069667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flynn BS, Worden JK, Secker-Walker RH, et al. . Mass media and school interventions for cigarette smoking prevention: effects 2 years after completion. Am J Public Health 1994;84:1148&#x2013;50. 10.2105/AJPH.84.7.1148</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.84.7.1148</ArticleId>
            <ArticleId IdType="pmc">PMC1614753</ArticleId>
            <ArticleId IdType="pubmed">8017542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farrelly MC, Davis KC, Haviland ML, et al. . Evidence of a dose-response relationship between "truth" antismoking ads and youth smoking prevalence. Am J Public Health 2005;95:425&#x2013;31. 10.2105/AJPH.2004.049692</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.2004.049692</ArticleId>
            <ArticleId IdType="pmc">PMC1449196</ArticleId>
            <ArticleId IdType="pubmed">15727971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wakefield M, Chaloupka F. Effectiveness of comprehensive tobacco control programmes in reducing teenage smoking in the USA. Tob Control 2000;9:177&#x2013;86. 10.1136/tc.9.2.177</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.9.2.177</ArticleId>
            <ArticleId IdType="pmc">PMC1748334</ArticleId>
            <ArticleId IdType="pubmed">10841854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldman LK, Glantz SA. Evaluation of antismoking advertising campaigns. JAMA 1998;279:772&#x2013;7. 10.1001/jama.279.10.772</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.279.10.772</ArticleId>
            <ArticleId IdType="pubmed">9508154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siegel M, Biener L. The impact of an antismoking media campaign on progression to established smoking: results of a longitudinal youth study. Am J Public Health 2000;90:380&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1446163</ArticleId>
            <ArticleId IdType="pubmed">10705855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emery S, Wakefield MA, Terry-McElrath Y, et al. . Televised state-sponsored antitobacco advertising and youth smoking beliefs and behavior in the United States, 1999-2000. Arch Pediatr Adolesc Med 2005;159:639 10.1001/archpedi.159.7.639</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archpedi.159.7.639</ArticleId>
            <ArticleId IdType="pubmed">15996997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sly DF, Heald GR, Ray S. The Florida "truth" anti-tobacco media evaluation: design, first year results, and implications for planning future state media evaluations. Tob Control 2001;10:9&#x2013;15. 10.1136/tc.10.1.9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.10.1.9</ArticleId>
            <ArticleId IdType="pmc">PMC1763974</ArticleId>
            <ArticleId IdType="pubmed">11226354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farrelly MC, Healton CG, Davis KC, et al. . Getting to the truth: evaluating national tobacco countermarketing campaigns. Am J Public Health 2002;92:901&#x2013;7. 10.2105/AJPH.92.6.901</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.92.6.901</ArticleId>
            <ArticleId IdType="pmc">PMC1447480</ArticleId>
            <ArticleId IdType="pubmed">12036775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Popham WJ, Potter LD, Bal DG, et al. . Do anti-smoking media campaigns help smokers quit? Public Health Rep 1993;108:510&#x2013;3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1403416</ArticleId>
            <ArticleId IdType="pubmed">8341788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White V, Tan N, Wakefield M, et al. . Do adult focused anti-smoking campaigns have an impact on adolescents? The case of the Australian National Tobacco Campaign. Tob Control 2003;12(Suppl 2):23ii&#x2013;9. 10.1136/tc.12.suppl_2.ii23</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.12.suppl_2.ii23</ArticleId>
            <ArticleId IdType="pmc">PMC1766099</ArticleId>
            <ArticleId IdType="pubmed">12878770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang P, Alo C, Satterwhite D, et al. . Usual sources of cigarettes for middle and high school students--Texas, 1998-1999. MMWR Morb Mortal Wkly Rep 2002;51:900&#x2013;1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12418543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levinson AH, Mickiewicz T. Reducing underage cigarette sales in an isolated community: the effect on adolescent cigarette supplies. Prev Med 2007;45:447&#x2013;53. 10.1016/j.ypmed.2007.07.034</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ypmed.2007.07.034</ArticleId>
            <ArticleId IdType="pubmed">17804046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tutt D, Bauer L, Difranza J. Restricting the retail supply of tobacco to minors. J Public Health Policy 2009;30:68&#x2013;82. 10.1057/jphp.2008.44</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1057/jphp.2008.44</ArticleId>
            <ArticleId IdType="pubmed">19367302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verdonk-Kleinjan WM, Knibbe RA, Bieleman B, et al. . The tobacco sales ban and tobacco purchases by adolescents: a general population study in The Netherlands. Eur J Public Health 2008;18:498&#x2013;503. 10.1093/eurpub/ckn054</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurpub/ckn054</ArticleId>
            <ArticleId IdType="pubmed">18579576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jason LA, Ji PY, Anes MD, et al. . Active enforcement of cigarette control laws in the prevention of cigarette sales to minors. JAMA 1991;266:3159&#x2013;61. 10.1001/jama.1991.03470220075030</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.1991.03470220075030</ArticleId>
            <ArticleId IdType="pubmed">1956104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiFranza JR, Carlson RP, Caisse RE. Reducing youth access to tobacco. Tob Control 1992;1:58 10.1136/tc.1.1.58a</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.1.1.58a</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staff M, March L, Brnabic A, et al. . Can non-prosecutory enforcement of public health legislation reduce smoking among high school students? Aust N Z J Public Health 1998;22:332&#x2013;5. 10.1111/j.1467-842X.1998.tb01387.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1467-842X.1998.tb01387.x</ArticleId>
            <ArticleId IdType="pubmed">9629818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gendall P, Hoek J, Marsh L, et al. . Youth tobacco access: trends and policy implications. BMJ Open 2014;4:e004631 10.1136/bmjopen-2013-004631</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2013-004631</ArticleId>
            <ArticleId IdType="pmc">PMC3996823</ArticleId>
            <ArticleId IdType="pubmed">24742976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friend K, Carmona M, Wilbur P, et al. . Youths' social sources of cigarettes: the limits of youth-access policies. Contemp Drug Probl 2001;28:507&#x2013;26. 10.1177/009145090102800309</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/009145090102800309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lantz PM, Jacobson PD, Warner KE, et al. . Investing in youth tobacco control: a review of smoking prevention and control strategies. Tob Control 2000;9:47&#x2013;63. 10.1136/tc.9.1.47</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tc.9.1.47</ArticleId>
            <ArticleId IdType="pmc">PMC1748282</ArticleId>
            <ArticleId IdType="pubmed">10691758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
HM Revenue &amp; Customs, Border Force. Tackling illicit tobacco: From leaf to light. 2015https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/418732/Tackling_illicit_tobacco_-_From_leaf_to_light__2015_.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Joossens L, Raw M. How can cigarette smuggling be reduced? BMJ 2000;321:947&#x2013;50. 10.1136/bmj.321.7266.947</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.321.7266.947</ArticleId>
            <ArticleId IdType="pmc">PMC1118741</ArticleId>
            <ArticleId IdType="pubmed">11030690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Joossens L.
Report on smuggling control in Spain. 2003http://www.who.int/tobacco/training/en/bestpracticesreportonsmugglingcontrolspain.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Akhter F, Buckles D, Tito R. Breaking the dependency on tobacco production: transition strategies for Bangladesh : Leppan W, Lecours N, Buckles D, Tobacco control and tobacco farming: separating myth from reality. London: Anthem Press, 2014:141&#x2013;88.</Citation>
        </Reference>
        <Reference>
          <Citation>Li VC, Wang Q, Xia N, et al. . Tobacco crop substitution: pilot effort in China. Am J Public Health 2012;102:1660&#x2013;3. 10.2105/AJPH.2012.300733</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.2012.300733</ArticleId>
            <ArticleId IdType="pmc">PMC3482040</ArticleId>
            <ArticleId IdType="pubmed">22813422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kibwage J, Netondo G, Odondo A, et al. . 
Diversification of household livelihood strategies for tobacco small-holder farmers: a case study of introducing bamboo in South Nyanza region, Kenya. 2014http://www.tobaccotobamboo.org/Publications/ProjectProgressReports/TOBACCO-TO-BAMBOOFINALPROJECTTECHNICALREPORT-103765-001.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>
Kenya Tobacco Control Research Group. Bamboo as alternative crop and livelihood to smallholder tobacco farming research project. 2011http://www.tobaccotobamboo.org/index.php
</Citation>
        </Reference>
        <Reference>
          <Citation>Magati P, Kibwage J, Omondi S, et al. . A cost-benefit analysis of substituting bamboo for tobacco: a case study of smallholder tobacco farmers in South Nyanza, Kenya. Sci J Agric Res Manag 2012;2012:1&#x2013;8.</Citation>
        </Reference>
        <Reference>
          <Citation>
Keyser JC.
The costs and profitability of tobacco compared to other crops in Zimbabwe. 2002http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/281627-1095698140167/Keyser-TheCostsandProfitability-whole.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Keyser J, Lungu V. Malawi agricultural comparative advantage. 1997.</Citation>
        </Reference>
        <Reference>
          <Citation>Molla U. Economics of producing multiple rabi crops International workshop on impact of tobacco cultivation and policy advocacy for shifting to food and other agricultural crops. Dhaka, Bangladesh: Dhaka University, 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>
Vargas M, Campos R. 
Crop substitution and diversification strategies: empirical evidence from selected Brazilian municipalities. Economics of tobacco control paper no. 28. 2005http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/281627-1095698140167/VargasCropSubstitutionFinal.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Ballard T, Ehlers J, Freund E, et al. . Green tobacco sickness: occupational nicotine poisoning in tobacco workers. Arch Environ Health 1995;50:384&#x2013;9. 10.1080/00039896.1995.9935972</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00039896.1995.9935972</ArticleId>
            <ArticleId IdType="pubmed">7574894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hipke ME. Green tobacco sickness. South Med J 1993;86:989&#x2013;92. 10.1097/00007611-199309000-00002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00007611-199309000-00002</ArticleId>
            <ArticleId IdType="pubmed">8367763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gehlbach SH, Williams WA, Freeman JI. Protective clothing as a means of reducing nicotine absorption in tobacco harvesters. Arch Environ Health 1979;34:111&#x2013;4. 10.1080/00039896.1979.10667379</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00039896.1979.10667379</ArticleId>
            <ArticleId IdType="pubmed">434931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghosh SK, Gokani VN, Parikh JR, et al. . Protection against "green symptoms" from tobacco in Indian harvesters: a preliminary intervention study. Arch Environ Health 1987;42:121&#x2013;4. 10.1080/00039896.1987.9935807</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00039896.1987.9935807</ArticleId>
            <ArticleId IdType="pubmed">3579366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghosh SK, Gokani VN, Doctor PB, et al. . Intervention studies against "green symptoms" among Indian tobacco harvesters. Arch Environ Health 1991;46:316&#x2013;7. 10.1080/00039896.1991.9934396</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00039896.1991.9934396</ArticleId>
            <ArticleId IdType="pubmed">1953041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arcury TA, Quandt SA, Garcia DI, et al. . A clinic-based, case-control comparison of green tobacco sickness among minority farmworkers: clues for prevention. South Med J 2002;95:1008&#x2013;11. 10.1097/00007611-200295090-00011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00007611-200295090-00011</ArticleId>
            <ArticleId IdType="pubmed">12356099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onuki M, Yokoyama K, Kimura K, et al. . Assessment of urinary cotinine as a marker of nicotine absorption from tobacco leaves: a study on tobacco farmers in Malaysia. J Occup Health 2003;45:140&#x2013;5. 10.1539/joh.45.140</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1539/joh.45.140</ArticleId>
            <ArticleId IdType="pubmed">14646288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
McCabe Centre for Law and Cancer, Campaign for Tobacco-Free Kids. Report on WHO FCTC in legislation and litigation. 2015http://www.who.int/fctc/cop/FCTC-in-Legislation-and-Litigation-McCabe-Centre_TFK.pdf?ua=1.</Citation>
        </Reference>
        <Reference>
          <Citation>
Conference of the Parties to the WHO Framework Convention on Tobacco Control. Decision FCTC/COP7(13) measures to strengthen implementation of the convention through coordination and cooperation. 2016http://www.who.int/fctc/cop/cop7/FCTC_COP7(13)_EN.pdf?ua=1
</Citation>
        </Reference>
        <Reference>
          <Citation>
Assunta M.
Good country practices in the implementation of WHO FCTC Article 5.3 and its guidelines. Report commissioned by the Convention Secretariat. 2018http://www.who.int/fctc/publications/fctc-article-5-3-best-practices.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>
Global Center for Good Governance in Tobacco Control (GGTC). Policies and practices that protect against tobacco industry interference: a handbook on the implementation of Article 5.3 of the WHO&#x2019;s Framework Convention on Tobacco Control (WHO FCTC) and related actions. 2018https://seatca.org/dmdocuments/PoliciesandPracticesProtectagainstTII.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>Feliu A, Filippidis FT, Joossens L, et al. . Impact of tobacco control policies on smoking prevalence and quit ratios in 27 European Union countries from 2006 to 2014. Tob Control 2019;28:101&#x2013;9. 10.1136/tobaccocontrol-2017-054119</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2017-054119</ArticleId>
            <ArticleId IdType="pmc">PMC6317447</ArticleId>
            <ArticleId IdType="pubmed">29472445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nilan K, Raw M, McKeever TM, et al. . Progress in implementation of WHO FCTC Article 14 and its guidelines: a survey of tobacco dependence treatment provision in 142 countries. Addiction 2017;112:2023&#x2013;31. 10.1111/add.13903</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/add.13903</ArticleId>
            <ArticleId IdType="pmc">PMC5655744</ArticleId>
            <ArticleId IdType="pubmed">28600886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuipers MA, Brandhof SD, Monshouwer K, et al. . Impact of laws restricting the sale of tobacco to minors on adolescent smoking and perceived obtainability of cigarettes: an intervention-control pre-post study of 19 European Union countries. Addiction 2017;112:320&#x2013;9. 10.1111/add.13605</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/add.13605</ArticleId>
            <ArticleId IdType="pubmed">27614109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faber T, Kumar A, Mackenbach JP, et al. . Effect of tobacco control policies on perinatal and child health: a systematic review and meta-analysis. Lancet Public Health 2017;2:e420&#x2013;37. 10.1016/S2468-2667(17)30144-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2468-2667(17)30144-5</ArticleId>
            <ArticleId IdType="pmc">PMC5592249</ArticleId>
            <ArticleId IdType="pubmed">28944313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bala MM, Strzeszynski L, Topor-Madry R. Mass media interventions for smoking cessation in adults. Cochrane Database Syst Rev 2017;11:CD004704 10.1002/14651858.CD004704.pub4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD004704.pub4</ArticleId>
            <ArticleId IdType="pmc">PMC6486126</ArticleId>
            <ArticleId IdType="pubmed">29159862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noar SM, Francis DB, Bridges C, et al. . The impact of strengthening cigarette pack warnings: systematic review of longitudinal observational studies. Soc Sci Med 2016;164:118&#x2013;29. 10.1016/j.socscimed.2016.06.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.socscimed.2016.06.011</ArticleId>
            <ArticleId IdType="pmc">PMC5026824</ArticleId>
            <ArticleId IdType="pubmed">27423739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monson E, Arsenault N. Effects of enactment of legislative (public) smoking bans on voluntary home smoking restrictions: a review. Nicotine Tob Res 2017;19:141&#x2013;8. 10.1093/ntr/ntw171</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ntr/ntw171</ArticleId>
            <ArticleId IdType="pmc">PMC5234369</ArticleId>
            <ArticleId IdType="pubmed">27613902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen LN, Pullar J, Wickramasinghe KK, et al. . Evaluation of research on interventions aligned to WHO &#x2019;Best Buys' for NCDs in low-income and lower-middle-income countries: a systematic review from 1990 to 2015. BMJ Glob Health 2018;3:e000535 10.1136/bmjgh-2017-000535</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjgh-2017-000535</ArticleId>
            <ArticleId IdType="pmc">PMC5841523</ArticleId>
            <ArticleId IdType="pubmed">29527342</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29878938</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1526-7598</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>129</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Anesthesia and analgesia</Title>
          <ISOAbbreviation>Anesth Analg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cardiac Structure and Function in Morbidly Obese Parturients: An Echocardiographic Study.</ArticleTitle>
        <Pagination>
          <StartPage>444</StartPage>
          <EndPage>449</EndPage>
          <MedlinePgn>444-449</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000003554</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">The increasing prevalence of obesity worldwide is a major threat to global health. Cardiac structural and functional changes are well documented for obesity as well as for pregnancy, but there is limited literature on morbidly obese parturients. We hypothesized that there are both cardiac structural and functional differences between morbidly obese pregnant women and pregnant women of normal body mass index (BMI).</AbstractText>
          <AbstractText Label="METHODS">This prospective cross-sectional study was performed in 2 referral maternity units in Cape Town, South Africa, over a 3-month period. Forty morbidly obese pregnant women of BMI &#x2265;40 kg&#xB7;m (group O) were compared to 45 pregnant women of BMI &#x2264;30 kg&#xB7;m (group N). Cardiac structure and function were assessed by transthoracic echocardiography, according to the recommendations of the British Society of Echocardiography. The 2-sample t-test with unequal variances was used for the comparison of the mean values between the groups.</AbstractText>
          <AbstractText Label="RESULTS">Acceptable echocardiographic images were obtained in all obese women. Statistical significance was defined as P &lt; .0225 after applying the Benjamini-Hochberg correction for multiple testing. Mean (standard deviation) mean arterial pressure was higher in group O (91 [8.42] vs 84 [9.49] mm Hg, P &lt; .001). There were no between-group differences in heart rate, stroke volume, or cardiac index (84 [12] vs 79 [13] beats&#xB7;minute, P = .103; 64.4 [9.7] vs 59.5 [13.5] mL, P = .069; 2551 [474] vs 2729 [623] mL&#xB7;minute&#xB7;m, P = .156, for groups O and N, respectively). Stroke volume index was lower, and left ventricular mass was higher in group O (30.14 [4.51] vs 34.25 [7.00] mL&#xB7;m, P = .003; 152 [24] vs 115 [29] g, P &lt; .001). S' septal was lower in group O (8.43 [1.20] vs 9.25 [1.64] cm&#xB7;second, P = .012). Considering diastolic function, isovolumetric relaxation time was significantly prolonged in group O (73 [15] vs 61 [15] milliseconds, P &lt; .001). The septal tissue Doppler index E' septal was lower in group O (9.08 [1.69] vs 11.28 [3.18], P &lt; .001). There were no between-group differences in E' average (10.7 [2.3] vs 12.0 [2.7], P = .018, O versus N) or E/E' average (7.85 [1.77] vs 7.27 [1.68], P = .137, O versus N). Right ventricular E'/A' was lower in group O (1.07 [0.47] vs 1.29 [0.32], P = .016).</AbstractText>
          <AbstractText Label="CONCLUSIONS">Cardiac index did not differ between obese pregnant women and those with normal BMI. Their increased left ventricular mass and lower stroke volume index could indicate a limited adaptive reserve. Obese women had minor decreases in septal left ventricular tissue Doppler velocity, but the E/E' average values did not suggest clinically significant diastolic dysfunction.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Buddeberg</LastName>
            <ForeName>Bigna S</ForeName>
            <Initials>BS</Initials>
            <AffiliationInfo>
              <Affiliation>From the Department of Anaesthesia and Perioperative Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anaesthesia, University Hospital Basel, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fernandes</LastName>
            <ForeName>Nicole L</ForeName>
            <Initials>NL</Initials>
            <AffiliationInfo>
              <Affiliation>From the Department of Anaesthesia and Perioperative Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vorster</LastName>
            <ForeName>Adri</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>From the Department of Anaesthesia and Perioperative Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cupido</LastName>
            <ForeName>Blanche J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, University of Cape Town and Groote Schuur Hospital, Hatter Institute for Cardiovascular Research in Africa, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lombard</LastName>
            <ForeName>Carl J</ForeName>
            <Initials>CJ</Initials>
            <AffiliationInfo>
              <Affiliation>Biostatistics Unit, South African Medical Research Council, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Swanevelder</LastName>
            <ForeName>Justiaan L</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>From the Department of Anaesthesia and Perioperative Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Girard</LastName>
            <ForeName>Thierry</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anaesthesia, University Hospital Basel, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dyer</LastName>
            <ForeName>Robert A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>From the Department of Anaesthesia and Perioperative Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016448">Multicenter Study</PublicationType>
          <PublicationType UI="D064888">Observational Study</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Anesth Analg</MedlineTA>
        <NlmUniqueID>1310650</NlmUniqueID>
        <ISSNLinking>0003-2999</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000222" MajorTopicYN="N">Adaptation, Physiological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015150" MajorTopicYN="Y">Echocardiography, Doppler</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009767" MajorTopicYN="N">Obesity, Morbid</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036801" MajorTopicYN="Y">Parturition</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011249" MajorTopicYN="N">Pregnancy Complications, Cardiovascular</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013019" MajorTopicYN="N" Type="Geographic">South Africa</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016276" MajorTopicYN="Y">Ventricular Function</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016278" MajorTopicYN="N">Ventricular Function, Right</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020257" MajorTopicYN="N">Ventricular Remodeling</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29878938</ArticleId>
        <ArticleId IdType="doi">10.1213/ANE.0000000000003554</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29878100</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2025</Year>
        <Month>01</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1460-2210</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
              <Day>29</Day>
            </PubDate>
          </JournalIssue>
          <Title>European journal of orthodontics</Title>
          <ISOAbbreviation>Eur J Orthod</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The impact of temporomandibular joint arthritis on functional disability and global health in patients with juvenile idiopathic arthritis.</ArticleTitle>
        <Pagination>
          <StartPage>117</StartPage>
          <EndPage>124</EndPage>
          <MedlinePgn>117-124</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ejo/cjy034</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES">The objective of the study was to evaluate the impact of temporomandibular joint (TMJ) arthritis on the functional disability and quality of life in patients affected by juvenile idiopathic arthritis (JIA).</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS">Sixty-two consecutive patients with JIA with or without TMJ arthritis and 35 healthy control subjects were enrolled in the study. The demographic data, disease activity and clinical characteristics were obtained from all patients. The functional disability was assessed using the Italian version of the Childhood Health Assessment Questionnaire (C-HAQ). The oral health-related quality of life (OHRQoL) was assessed using the Child Perception Questionnaire (CPQ11-14). Possible determining factors of TMJ arthritis comprised demographic, disease characteristics and scores derived from questionnaires that were assessed by a uni and multivariable logistic regression analysis.</AbstractText>
          <AbstractText Label="RESULTS">Compared with patients without TMJs arthritis, JIA patients with TMJ arthritis presented higher functional disability. The multivariable logistic regression analysis performed showed that female subjects (OR = 1.5, P = 0.041), with a JIA duration over 3.9 years (OR = 2.7, P = 0.033) and presenting higher C-HAQ and CPQ11-14 scores (OR = 2.7, P = 0.012 and OR = 2.9, P = 0.015, respectively) were the greatest determining factors for TMJ arthritis.</AbstractText>
          <AbstractText Label="CONCLUSIONS">JIA patients with TMJ arthritis presented higher functional disability and lower OHRQoL scores compared with JIA patients without TMJ arthritis. TMJ arthritis was strongly associated with JIA duration and activity, especially in female patients.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press on behalf of the European Orthodontic Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Isola</LastName>
            <ForeName>Gaetano</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical, Odontostomatological, Sciences and of Morphological and Functional Images, School of Dentistry, University of Messina, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perillo</LastName>
            <ForeName>Letizia</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Multidisciplinary Department of Medical-Surgical and Dental Specialties, Second University of Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Migliorati</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthodontics, University of Genova, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matarese</LastName>
            <ForeName>Marco</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical, Odontostomatological, Sciences and of Morphological and Functional Images, School of Dentistry, University of Messina, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dalessandri</LastName>
            <ForeName>Domenico</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthodontics, School of Dentistry, University of Brescia, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grassia</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Multidisciplinary Department of Medical-Surgical and Dental Specialties, Second University of Naples, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alibrandi</LastName>
            <ForeName>Angela</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Economics, Unit of Statistical and Mathematical Sciences, University of Messina, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matarese</LastName>
            <ForeName>Giovanni</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical, Odontostomatological, Sciences and of Morphological and Functional Images, School of Dentistry, University of Messina, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>ClinicalTrials.gov</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>NCT03008681</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Eur J Orthod</MedlineTA>
        <NlmUniqueID>7909010</NlmUniqueID>
        <ISSNLinking>0141-5387</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001171" MajorTopicYN="N">Arthritis, Juvenile</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019988" MajorTopicYN="N">Children with Disabilities</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013704" MajorTopicYN="N">Temporomandibular Joint</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013705" MajorTopicYN="N">Temporomandibular Joint Disorders</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29878100</ArticleId>
        <ArticleId IdType="doi">10.1093/ejo/cjy034</ArticleId>
        <ArticleId IdType="pii">5033841</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29860671</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1557-1920</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of immigrant and minority health</Title>
          <ISOAbbreviation>J Immigr Minor Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Visual Health and Visual Healthcare Access in Refugees and Displaced Persons: A Systematic Review.</ArticleTitle>
        <Pagination>
          <StartPage>161</StartPage>
          <EndPage>174</EndPage>
          <MedlinePgn>161-174</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10903-018-0766-x</ELocationID>
        <Abstract>
          <AbstractText>Vision impairment is a significant global health concern. Still, there remains a gap in our knowledge of visual health in refugees. We conducted a systematic review of the distinctive eye care needs of refugees. We screened PubMed, EMBASE, and Web of Science through February 17, 2017 for studies that focused primarily on visual health in refugees. Risk of bias was assessed using the National Heart, Lung, and Blood Institute quality assessment tools. 26 studies were included in the final review. The prevalence of blindness ranged from 1.3 to 26.2%. Trachoma was the leading infectious cause. Only four studies assessed vision-related care. Time/location of displacement, social unrest, and sanitation impacted severity of eye disease. Refugees have unique eye care needs. Public health interventions should target eye care at every stage of displacement. Providers may use these results to inform future research and improve visual healthcare access in refugee groups.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bal</LastName>
            <ForeName>Sila</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-3951-7720</Identifier>
            <AffiliationInfo>
              <Affiliation>Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard Building 421, Philadelphia, PA, 19104, USA. silabal@mail.med.upenn.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duckles</LastName>
            <ForeName>Anne</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard Building 421, Philadelphia, PA, 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Buttenheim</LastName>
            <ForeName>Alison</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>School of Nursing, University of Pennsylvania, 3400 Civic Center Boulevard Building, Philadelphia, PA, 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Immigr Minor Health</MedlineTA>
        <NlmUniqueID>101256527</NlmUniqueID>
        <ISSNLinking>1557-1912</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001766" MajorTopicYN="N">Blindness</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020380" MajorTopicYN="N">Needs Assessment</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012036" MajorTopicYN="N">Refugees</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012499" MajorTopicYN="N">Sanitation</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014141" MajorTopicYN="N">Trachoma</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014786" MajorTopicYN="N">Vision Disorders</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Blindness refugee</Keyword>
        <Keyword MajorTopicYN="N">Refugee eye care</Keyword>
        <Keyword MajorTopicYN="N">Vision displaced persons</Keyword>
        <Keyword MajorTopicYN="N">Vision refugees</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29860671</ArticleId>
        <ArticleId IdType="doi">10.1007/s10903-018-0766-x</ArticleId>
        <ArticleId IdType="pii">10.1007/s10903-018-0766-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Br J Ophthalmol. 2001 Jun;85(6):648-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11371480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Ophthalmol. 2003 Feb;87(2):142-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12543737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>East Afr Med J. 2000 Nov;77(11):580-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12862101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Trop Paediatr. 2003 Sep;23(3):193-204</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14567835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Optom Vis Sci. 2006 Nov;83(11):803-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17106407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>East Mediterr Health J. 2007 May-Jun;13(3):580-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17687831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Ophthalmol. 1991 Jul-Sep;1(3):115-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1841666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Epidemiol. 1977 Jan;105(1):68-74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">188334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS Med. 2009 Jul 21;6(7):e1000097</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19621072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Optom Vis Sci. 2010 Dec;87(12):958-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21076356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MMWR Morb Mortal Wkly Rep. 2012 Aug 3;61(30):574-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22854626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MMWR Morb Mortal Wkly Rep. 2013 Nov 22;62(46):917-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24257200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ethiop J Health Sci. 2014 Jul;24(3):227-34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25183929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2015 Nov;122(11):2344-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26394754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Optom Vis Sci. 2016 Feb;93(2):188-93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26636398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ Case Rep. 2016 Mar 11;2016:null</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26969367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA Ophthalmol. 2016 Jul 1;134(7):778-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27196876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA Ophthalmol. 2016 Oct 1;134(10):1111-1118</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27490785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet Glob Health. 2017 Sep;5(9):e888-e897</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28779882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trop Doct. 1986 Apr;16(2):66-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3765080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Dis Child. 1986 Nov;61(11):1100-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3789790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>East Afr Med J. 1968 May;45(5):251-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5674003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Pak Med Assoc. 1982 May;32(5):130</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6811778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aust J Ophthalmol. 1983 May;11(2):119-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6870686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Ophthalmol. 1995 Apr;79(4):395-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7742298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA. 1995 Jan 18;273(3):186</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7807650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eye (Lond). 1994;8 ( Pt 1):130-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8013707</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29860233</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>Suppl 2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The impact of the WHO Framework Convention on Tobacco Control in defending legal challenges to tobacco control measures.</ArticleTitle>
        <Pagination>
          <StartPage>s113</StartPage>
          <EndPage>s118</EndPage>
          <MedlinePgn>s113-s118</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054329</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Since the WHO Framework Convention on Tobacco Control's (FCTC) entry into force, the tobacco industry has initiated litigation challenging tobacco control measures implemented by governments around the world, or supported others to initiate such litigation on its behalf. In defending their tobacco control measures against such litigation, governments have invoked their obligations and rights under the WHO FCTC. We assess the extent to which the WHO FCTC has provided legal weight to governments' defences against legal challenge.</AbstractText>
          <AbstractText Label="METHODS">We reviewed 96 court decisions concerning legal challenges to tobacco control measures, determining whether or not they cited the WHO FCTC and their outcomes. We then reviewed the cases where the WHO FCTC was cited, analysing how the WHO FCTC contributed to the resolution of the case.</AbstractText>
          <AbstractText Label="RESULTS">The WHO FCTC was cited in 45 decisions. Decisions both citing and not citing the WHO FCTC were largely decided in favour of governments, with 80% of WHO-FCTC-citing and 67% of non-WHO-FCTC-citing cases upholding the measure in its entirety and on every ground of challenge. In cases where it was cited, the WHO FCTC contributed to the resolution of the case in favour of governments by providing a legal basis for measures, demonstrating the measure's public health purpose, demonstrating the evidence in favour of a measure, demonstrating international consensus, demonstrating that a measure promotes or protects health-related human rights and demonstrating whether or not a measure is reasonable, proportionate or justifiable.</AbstractText>
          <AbstractText Label="CONCLUSIONS">The way the WHO FCTC has been cited in court decisions suggests that it has made a substantial contribution to courts' reasoning in tobacco control legal challenges and has strengthened governments' arguments in defending litigation.</AbstractText>
          <CopyrightInformation>&#xA9; World Health Organization 2018. Licensee BMJ Publishing Group Limited.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Suzanne Y</ForeName>
            <Initials>SY</Initials>
            <AffiliationInfo>
              <Affiliation>McCabe Centre for Law and Cancer, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liberman</LastName>
            <ForeName>Jonathan D</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>McCabe Centre for Law and Cancer, Melbourne, Victoria, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ricafort</LastName>
            <ForeName>Evita</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>McCabe Centre for Law and Cancer, Manila, Philippines.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074606" MajorTopicYN="N">Smoking Prevention</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019460" MajorTopicYN="N">Tobacco Industry</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014944" MajorTopicYN="Y">World Health Organization</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">human rights</Keyword>
        <Keyword MajorTopicYN="N">litigation</Keyword>
        <Keyword MajorTopicYN="N">public policy</Keyword>
        <Keyword MajorTopicYN="N">tobacco industry</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: The McCabe Centre is a WHO FCTC Knowledge Hub focusing on legal challenges to implementation of the WHO FCTC. In this role, it supports governments and others to maximise the legal weight and power of the WHO FCTC in implementing and defending tobacco control measures. Several of the cases cited in this paper were defended by lawyers who have participated in the McCabe Centre&#x2019;s Knowledge Hub activities.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>24</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29860233</ArticleId>
        <ArticleId IdType="pmc">PMC6589463</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054329</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054329</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Philip Morris Asia Limited v The Commonwealth of Australia (Award on Jurisdiction and Admissibility), PCA Case No. 2012-12 (17 Dec 2015).</Citation>
        </Reference>
        <Reference>
          <Citation>World Trade Organization. Australia &#x2014; Certain Measures Concerning Trademarks, Geographical Indications and Other Plain Packaging Requirements Applicable to Tobacco Products and Packaging, DS 434, DS435, DS441, DS458, DS467&#xA0; (pending).</Citation>
        </Reference>
        <Reference>
          <Citation>Philip Morris Brands SARL v Oriental Republic of Uruguay (Award), ICSID Case No. ARB/10/7&#xA0;(8 Jul 2016).</Citation>
        </Reference>
        <Reference>
          <Citation>Muggli ME, Zheng A, Liberman J, et al. . Tracking the relevance of the WHO Framework convention on tobacco control in legislation and litigation through the online resource, Tobacco Control Laws. Tob Control 2014;23:457&#x2013;60. 10.1136/tobaccocontrol-2012-050854</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050854</ArticleId>
            <ArticleId IdType="pubmed">23644394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steele SL, Gilmore AB, McKee M, et al. . &#x2018;The role of public law-based litigation in tobacco companies&#x2019; strategies in high-income, FCTC ratifying countries, 2004&#x2013;14&#x2019;. Journal of Public Health 2016;3:516&#x2013;21. 10.1093/pubmed/fdv068</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/pubmed/fdv068</ArticleId>
            <ArticleId IdType="pmc">PMC5072156</ArticleId>
            <ArticleId IdType="pubmed">26036703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitchell AD, Voon T. The Global Tobacco Epidemic and the Law. Cheltenham, UK: Edward Elgar, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Puig S. Tobacco Litigation in International Courts. Harv. Int. Law J 2016;56:383&#x2013;432.</Citation>
        </Reference>
        <Reference>
          <Citation>Conference of the Parties to the WHO Framework Convention on Tobacco Control. Global progress in implementation of the WHO FCTC &#x2013; a summary: Report by the Convention Secretariat, FCTC/COP/6/5. 25 Jun 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>&#xA0;World Health Organization. WHO report on the global tobacco epidemic 2017. 2017:35&#x2013;76.</Citation>
        </Reference>
        <Reference>
          <Citation>McCabe Centre for Law and Cancer and Campaign for Tobacco Free Kids. Report on WHO FCTC in Legislation and Litigation (7 August 2015). The background paper aimed to evaluate the significance of the WHO FCTC as a legal instrument more broadly, including in the drafting of legislation, in legal challenges to tobacco control measures, and in civil society public interest litigation. 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Conference of the Parties to the WHO Framework Convention on Tobacco Control. Impact assessment of the WHO FCTC: report by the expert group, FCTC/COP/7/6. 27 Jul 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>
&#xA0;Campaign for Tobacco Free Kids. Tobacco Control Laws. http://www.tobaccocontrollaws.org/ (accessed Dec 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
McCabe Centre for Law and Cancer.&#xA0;
WHO FCTC Knowledge Hub on Legal Challenges to WHO FCTC Implementation. http://www.untobaccocontrol.org/kh/legal-challenges/ (accessed Dec 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
&#xA0;Lawyers Collective and O&#x2019;Neill Institute for National and Global Health Law. Global Health and Human Rights Database. http://www.globalhealthrights.org/ (accessed Dec 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>British American Tobacco Ltd v Cabinet Secretary for the Ministry of Health, Civil Appeal No 112 of 2016. 17 February 2017 (Court of Appeal of Kenya).</Citation>
        </Reference>
        <Reference>
          <Citation>Ceylon Tobacco Company PLC v Minister of Health, CA 336/2012.&#xA0;12 May 2014 (Court of Appeal of the Democratic Socialist Republic of Sri Lanka).</Citation>
        </Reference>
        <Reference>
          <Citation>Legislative Consultation with Constitutional Division of the Supreme Court, Case No. 2012-003918. 20 Mar 2012&#xA0;(Supreme Court of Costa Rica).</Citation>
        </Reference>
        <Reference>
          <Citation>Philip Morris Norway v Health and Care Services of Norway, Civil Action No. 10-041388TVI-OTIR/02. 14 Sep 2012 (District Court of Oslo).</Citation>
        </Reference>
        <Reference>
          <Citation>R v Mader&#x2019;s Tobacco Store Ltd, 2013 NSPC 29 (Provincial Court of Nova Scotia).</Citation>
        </Reference>
        <Reference>
          <Citation>R (Sinclair Collis) v Secretary of State for Health [2011] EWCA Civ 437 (Court of Appeal of England and Wales).</Citation>
        </Reference>
        <Reference>
          <Citation>Case No. C-830/10. 20 Oct 2010 (Constitutional Court of Colombia).</Citation>
        </Reference>
        <Reference>
          <Citation>Poland v European Parliament and Council of the European Union, C-358/14, 04 May 2016&#xA0;(European Court of Justice, Second Chamber).</Citation>
        </Reference>
        <Reference>
          <Citation>R (British American Tobacco) v Secretary of State for Health [2016] EWHC 1169 (Admin) (High Court of England and Wales).</Citation>
        </Reference>
        <Reference>
          <Citation>R (British American Tobacco) v Secretary of State for Health [2016] EWCA Civ 1182 (Court of Appeal of England and Wales).</Citation>
        </Reference>
        <Reference>
          <Citation>British American Tobacco South Africa (Pty) Ltd v Minister of Health (463/2011) [2012] ZASCA 107; [2012] 3 All SA 593 (SCA), 20 Jun 2012 (Supreme Court of Appeal of South Africa).</Citation>
        </Reference>
        <Reference>
          <Citation>Canada (Attorney General) v JTI-Macdonald Corp [2007] 2 SCR 610 (Supreme Court of Canada).</Citation>
        </Reference>
        <Reference>
          <Citation>Claim of unconstitutionality filed by over 5,000 citizens against Article 3 of Law No. 28705, Docket 00032-2010-PI/TC. 19 Jul 2011&#xA0;(Constitutional Court of Peru).</Citation>
        </Reference>
        <Reference>
          <Citation>Miroslav Grcev and Stamen Filipov to the Constitutional Court, Case 261/2008-0-0. 16 Sept 2009&#xA0;(Constitutional Court of Macedonia).</Citation>
        </Reference>
        <Reference>
          <Citation>International Covenant on Economic, Social and Cultural Rights, 16 December 1966, 993 UNTS 3 (entered into force 3 January 1976).</Citation>
        </Reference>
        <Reference>
          <Citation>Case No. 2158-2009. 16 Feb 2010 (Constitutional Court of Guatemala).</Citation>
        </Reference>
        <Reference>
          <Citation>Action of Unconstitutionality Brought by Rodriguez Robles and Espinosa on behalf of British American Tobacco Panama against Executive Decree No. 611, Docket No. 192-11. 28 May 2014&#xA0; (Supreme Court of Justice of Panama).</Citation>
        </Reference>
        <Reference>
          <Citation>Philip Morris Brands SARL v&#xA0;Secretary of State, Case C-547/13. 4 May 2016&#xA0;&#xA0;(European Court of Justice, Second Chamber).</Citation>
        </Reference>
        <Reference>
          <Citation>Conference of the Parties to the WHO Framework Convention on Tobacco Control. Trade and investment issues, including agreements, and legal challenges in relation to the implementation of WHO FCTC: Report by the Convention Secretariat, FCTC/COP/7/21. 29 Jul 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Conference of the Parties to the WHO Framework Convention on Tobacco Control. Issues related to implementation of the WHO FCTC and settlement of disputes concerning the implementation or application of the Convention: Report by the Convention Secretariat, FCTC/COP/7/20. 27 Jul 2016.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29851507</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1549-7852</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>59</Volume>
            <Issue>19</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Critical reviews in food science and nutrition</Title>
          <ISOAbbreviation>Crit Rev Food Sci Nutr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dietary fat and gut microbiota: mechanisms involved in obesity control.</ArticleTitle>
        <Pagination>
          <StartPage>3045</StartPage>
          <EndPage>3053</EndPage>
          <MedlinePgn>3045-3053</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10408398.2018.1481821</ELocationID>
        <Abstract>
          <AbstractText>Obesity is a serious global health problem that is directly related to various morbidities manifestation. Intestinal dysbiosis has been implicated on obesity pathogenesis. Diet composition can alter gut microbiota, regardless of energy intake. Dietary fatty acids quality may affect gut microbiota composition, which in turn may affect host metabolic health. The mechanisms by which the different type of FFA modulate gut microbiota is yet poor elucidate and there is a lack of studies regard to this. Fatty acids may act in cell membrane, interfere with energy production, inhibit enzymatic activities, impair nutrient absorption and generate toxic compounds to cells, leading to growth inhibition or even bacterial death. The beneficial effect of the consumption of n-3 polyunsaturated fatty acids (PUFA) and conjugated linoleic acid (CLA) on microbiota, unlike n-6 PUFA and saturated fatty acids has been suggested. n-3 PUFA consumption promotes desirable changes on obese intestinal microbiota making it similar to that of normal weight individuals. More studies are needed to better understand the effect of CLA on microbiota and host health. Long term human controlled clinical trials must be conducted to allow us to understand the complex interaction between dietary fat, intestinal microbiota and obesity.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Coelho</LastName>
            <ForeName>Ol&#xED;via Gon&#xE7;alves Le&#xE3;o</ForeName>
            <Initials>OGL</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Nutri&#xE7;&#xE3;o e Sa&#xFA;de, Universidade Federal de Vi&#xE7;osa, Minas Gerais, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>C&#xE2;ndido</LastName>
            <ForeName>Fl&#xE1;via Galv&#xE3;o</ForeName>
            <Initials>FG</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Nutri&#xE7;&#xE3;o e Sa&#xFA;de, Universidade Federal de Vi&#xE7;osa, Minas Gerais, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alfenas</LastName>
            <ForeName>Rita de C&#xE1;ssia Gon&#xE7;alves</ForeName>
            <Initials>RCG</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Nutri&#xE7;&#xE3;o e Sa&#xFA;de, Universidade Federal de Vi&#xE7;osa, Minas Gerais, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Crit Rev Food Sci Nutr</MedlineTA>
        <NlmUniqueID>8914818</NlmUniqueID>
        <ISSNLinking>1040-8398</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004041">Dietary Fats</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004041" MajorTopicYN="Y">Dietary Fats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antimicrobial</Keyword>
        <Keyword MajorTopicYN="N">diet</Keyword>
        <Keyword MajorTopicYN="N">dysbiosis</Keyword>
        <Keyword MajorTopicYN="N">free fatty acids</Keyword>
        <Keyword MajorTopicYN="N">microrganims</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29851507</ArticleId>
        <ArticleId IdType="doi">10.1080/10408398.2018.1481821</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29848178</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-1706</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global public health</Title>
          <ISOAbbreviation>Glob Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Global governance and the broader determinants of health: A comparative case study of UNDP's and WTO's engagement with global health.</ArticleTitle>
        <Pagination>
          <StartPage>175</StartPage>
          <EndPage>189</EndPage>
          <MedlinePgn>175-189</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2018.1476567</ELocationID>
        <Abstract>
          <AbstractText>This comparative case study investigated how two intergovernmental organisations without formal health mandates - the United Nations Development Programme (UNDP) and the World Trade Organization (WTO) - have engaged with global health issues. Triangulating insights from key institutional documents, ten semi-structured interviews with senior officials, and scholarly books tracing the history of both organisations, the study identified an evolving and broadened engagement with global health issues in UNDP and WTO. Within WTO, the dominant view was that enhancing international trade is instrumental to improving global health, although the need to resolve tensions between public health objectives and WTO agreements was recognised. For UNDP, interviewees reported that the agency gained prominence in global health for its response to HIV/AIDS in the 1990s and early 2000s. Learning from that experience, the agency has evolved and expanded its role in two respects: it has increasingly facilitated processes to provide global normative direction for global health issues such as HIV/AIDS and access to medicines, and it has expanded its focus beyond HIV/AIDS. Overall, the study findings suggest the need for seeking greater integration among international institutions, closing key global institutional gaps, and establishing a shared global institutional space for promoting action on the broader determinants of health.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gopinathan</LastName>
            <ForeName>Unni</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Global Health, Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Global Strategy Lab, Dahdaleh Institute for Global Health Research, Faculty of Health and Osgoode Hall Law School, York University, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watts</LastName>
            <ForeName>Nick</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>University College London, Institute for Global Health, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lefebvre</LastName>
            <ForeName>Alexandre</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheung</LastName>
            <ForeName>Arthur</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Queensland, Brisbane, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoffman</LastName>
            <ForeName>Steven J</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Global Strategy Lab, Dahdaleh Institute for Global Health Research, Faculty of Health and Osgoode Hall Law School, York University, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>R&#xF8;ttingen</LastName>
            <ForeName>John-Arne</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division for Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Public Health</MedlineTA>
        <NlmUniqueID>101256323</NlmUniqueID>
        <ISSNLinking>1744-1692</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003132" MajorTopicYN="Y">Commerce</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007390" MajorTopicYN="Y">International Agencies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057766" MajorTopicYN="N">Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064890" MajorTopicYN="Y">Social Determinants of Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014480" MajorTopicYN="Y">United Nations</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Global governance</Keyword>
        <Keyword MajorTopicYN="N">United Nations Development Programme</Keyword>
        <Keyword MajorTopicYN="N">World Health Organization</Keyword>
        <Keyword MajorTopicYN="N">World Trade Organization</Keyword>
        <Keyword MajorTopicYN="N">social determinants of health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29848178</ArticleId>
        <ArticleId IdType="doi">10.1080/17441692.2018.1476567</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31435547</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2432-261X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>3</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>Spine surgery and related research</Title>
          <ISOAbbreviation>Spine Surg Relat Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Classification of Adult Spinal Deformity: Review of Current Concepts and Future Directions.</ArticleTitle>
        <Pagination>
          <StartPage>17</StartPage>
          <EndPage>26</EndPage>
          <MedlinePgn>17-26</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.22603/ssrr.2017-0100</ELocationID>
        <Abstract>
          <AbstractText>Although adult spinal deformity (ASD) has become a global health problem, the classification system and optimal surgical treatment for ASD is yet to be standardized worldwide. A significant part of the population, as high as 10%, in industrialized societies will be aged above 65 years within the next 10 years. Herein, a systematic review of the scientific literature related to the classification and treatment of ASD was conducted wherein historical to the most recent classifications of ASD were reviewed. By discussing the benefits and limitations of the previous classification systems and considering the factors affecting the clinical outcomes of surgical treatment of ASD, this article would like to propose future directions for the development of a new classification system for ASD.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dagdia</LastName>
            <ForeName>Laxmikant</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopedic Surgery, MGM Medical College and Hospital, Maharashtra, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kokabu</LastName>
            <ForeName>Terufumi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopedic Surgery, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ito</LastName>
            <ForeName>Manabu</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopedic Surgery, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Japan</Country>
        <MedlineTA>Spine Surg Relat Res</MedlineTA>
        <NlmUniqueID>101718059</NlmUniqueID>
        <ISSNLinking>2432-261X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Adult spinal deformity</Keyword>
        <Keyword MajorTopicYN="N">adult scoliosis</Keyword>
        <Keyword MajorTopicYN="N">classification</Keyword>
        <Keyword MajorTopicYN="N">review</Keyword>
      </KeywordList>
      <CoiStatement>Conflicts of Interest: The authors declare that there are no relevant conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>29</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>29</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>29</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31435547</ArticleId>
        <ArticleId IdType="pmc">PMC6690115</ArticleId>
        <ArticleId IdType="doi">10.22603/ssrr.2017-0100</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Aebi M. Correction of degenerative scoliosis of the lumbar spine. A preliminary report. ClinOrthopRelat Res. 1988 Jul;(232):80-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3383505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwab F, Benchick el-Fegoun A, Gamez L, et al. Lumbar classi&#xFB01;cation of scoliosis in the adult patient: Preliminary approach. Spine (Phila Pa 1976). 2005;30(14):1670-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16025039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carter OD, Haynes SG. Prevalence rates for scoliosis in US adults: results from the &#xFB01;rst National Health and Nutrition Examination Survey. Int J Epidemiol. 1987;16(4):537-44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3501989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perennou D, Marcelli C, Herisson C. Adult lumbar scoliosis: Epidemiologic aspects in a low-back pain population. Spine (Phila Pa 1976). 1994;19(2):123-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8153817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robin GC, Span Y, Steinberg R, et al. Scoliosis in the elderly: a follow-up study. Spine (Phila Pa 1976). 1982;7(4):355-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6215719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Francis RS. Scoliosis screening of 3,000 college-aged women. The Utah Study-Phase 2. PhysTher. 1988;68(10):1513-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3174833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwab F, Dubey A, Gamez L, et al. Adult scoliosis. Prevalence, SF-36, and nutritional parameters in an elderly volunteer population. Spine (Phila Pa 1976). 2005;30(9):1082-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15864163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aebi M. The adult scoliosis. Eur Spine J. 2005;14(10):925-48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16328223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lenke L, Edwards C, Bridwell K. The Lenke classi&#xFB01;cation of adolescent Idiopathic scoliosis: How it organizes curve patterns as a template to perform selective fusions of the spine. Spine (Phila Pa 1976). 2003;28(20):S199-207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14560193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albert TJ, Purtill J, Mesa J, et al. Study design: health outcome assessment before and after adult deformity surgery. A prospective study. Spine (Phila Pa 1976). 1995;20(18):2002-4; discussion p2005</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8578376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deyo RA, Cherkin DC, Loeser JD, et al Morbidity and mortality in association with operations on the lumbar spine. The in&#xFB02;uence of age, diagnosis, and procedure. J Bone Joint Surg Am. 1992;74(4):536-43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1583048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garbuz DS, Masri BS, Esdaile J, et al. Classi&#xFB01;cation systems in orthopedics. J Am Acad Orthop Surg. 2002;10(4):290-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15089078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simmons ED. Surgical treatment of patients with lumbar spinal stenosis with associated scoliosis. Clin Orthop Relat Res. 2001;(384):45-53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11249179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogilvie JW (1992) Adult scoliosis: evaluation and nonsurgical treatment. Instr Course Lect. 1992;41:251-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1588067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akazawa T, Kotoni T, Sakuma T, et al. Modic changes and disc degeneration of non-fused segments 27 to 45 years after Harrington instrumentation for adolescent idiopathic scoliosis: comparison to healthy controls. Spine (Phila Pa 1976). 2017. [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28767629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grevitt M, Khazim R, Webb J, et al. The short form 36 health survey questionnaire in spine surgery. J Bone Joint Surg Br. 1997;79(1):48-52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9020444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwab F, Farcy J, Bridwell K, et al. A clinical impact classification of scoliosis in the adult. Spine (Phila Pa 1976). 2006;31(18):2109-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16915098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwab F, Lafage V, Farcy J, et al. Surgical rates and operative outcome analysis in thoracolumbar and lumbar major adult scoliosis, Application of the new adult deformity classification system Spine (Phila Pa 1976). 2007;32(24):2723-30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18007252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bridwell K, Cats-BarilW, Harrast J, et al. The validity of the SRS-22 instrument in an adult spinal deformity population compared with the Oswestry and SF-12: a study of response distribution, concurrent validity, internal consistency, and reliability. Spine (Phila Pa 1976). 2005;30(4):455-61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15706344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fairbank J, Pynsent P. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25(22):2940-52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11074683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowe T, Berven SH, Schwab FJ, et al. The SRS classification for adult spinal deformity. Building on the King/Moe and Lenke classification systems. Spine (Phila Pa 1976). 2006;31(19 Suppl):S119-25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16946628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuntz C 4th, Shaffrey C, Ondra S, et al. Spine deformity: a new classification derived from neutral upright spinal alignment measurements in asymptomatic juvenile, adolescent, adult, and geriatric individuals. Neurosurgery. 2008;63(3 Suppl):25-39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18812930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nash CL Jr, Moe JH. A study of vertebral rotation. J Bone Joint Surg Am. 1969;51(2):223-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5767315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lafage V, Schwab F, Patel A, et al. Pelvic tilt and truncal inclination: two key radiographic parameters in the setting of adults with spinal deformity. Spine (Phila Pa 1976). 2009;34:E599-606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19644319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lafage V, Schwab F, Skalli W, et al. Standing balance and sagittal plane spinal deformity: analysis of spinopelvic and gravity line parameters. Spine (Phila Pa 1976). 2008;33(14):1572-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18552673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Protopsaltis TS, Schwab FJ, Bronsard N, et al. The t1 pelvic angle, a novel radiographic measure of global sagittal deformity, accounts for both spinal inclination and pelvic tilt and correlate with health-related quality of life. J Bone Joint Surg Am. 2014;96(19):1631-40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25274788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duval-Beaupere G, Schmidt C, Cosson P. A Barycentremetric study of the sagittal shape of spine and pelvis: the conditions required for an economic standing position. Ann Biomed Eng. 1992;20(4):451-62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1510296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Legaye J, Duval-Beaupere G, Hecquet J, et al. Pelvic incidence: a fundamental pelvic parameter for three-dimensional regulation of spinal sagittal curves. Eur Spine J. 1998;7(2):99-103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3611230</ArticleId>
            <ArticleId IdType="pubmed">9629932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yukawa Y, Kato F, Suda K, et al. Normative data for parameters of sagittal spinal alignment in healthy subjects: an analysis of gender specific differences and changes with aging in 626 asymptomatic individuals. Eur Spine J. 2016. [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27771788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glassman SD, Bridwell K, Dimar JR, et al. The impact of positive sagittal balance in adult spinal deformity. Spine (Phila Pa 1976). 2005;30(18):2024-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16166889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim YJ, Bridwell KH, Lance LG, et al. An analysis of sagittal spinal alignment following long adult lumbar instrumentation and fusion to L5 or S1: can we predict ideal lumbar lordosis? Spine (Phila Pa 1976). 2006;31(20):2343-52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16985463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwab FJ, Smith VA, Biserni M, et al. Adult scoliosis: a quantitative radiographic and clinical analysis. Spine (Phila Pa 1976). 2002;27(4):387-92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11840105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwab F, Ungar B, Blondel B, et al. SRS-Schwab adult spinal deformity classification: a validation study. Spine. 2012;37(12):1077-82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22045006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ascani E, Bartolozzi P, Logroscino CA, et al. Natural history of untreated idiopathic scoliosis after skeletal maturity. Spine (Phila Pa 1976). 1986;11(8):784-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3810293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briard JL, Jegou D, Cauchoix J. Adult lumbar scoliosis. Spine (Phila Pa 1976). 1979;4(6):526-32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">160085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bridwell KH, Berven S, Edwards C 2nd, et al. The problems and limitations of applying evidence-based medicine to primary surgical treatment of adult spinal deformity. Spine (Phila Pa 1976). 2007;32(19 Suppl):S135-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17728681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith JS KE, Virginie L, Shaffrey CI, et al. International Spine Study Group. Prospective multicenter assessment of perioperative and minimum two-year postoperative complication rates associated with adult spinal deformity surgery. J Neurosurg Spine. 2016;25(1):1-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26918574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carreon LY, Glassman SD, Shaffrey CI, et al. Predictors of health-related quality-of-life after complex adult spinal deformity surgery: a Scoli-RISK-1 secondary analysis. Spine Deform. 2017;5(2):139-44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28259266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yagi M, Akilah KB, Boachie-Adjei O. Incidence, risk factors and classification of proximal junctional kyphosis: surgical outcomes review of adult idiopathic scoliosis. Spine (Phila Pa 1976). 2011;36(1):E60-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21192216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HJ, Bridwell KH, Lenke LG, et al. Patients with proximal junctional kyphosis requiring revision surgery have higher postoperative lumbar lordosis and larger sagittal balance corrections. Spine (Phila Pa 1976). 2014;39(9):E576-80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24480958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim YJ, Bridwell KH, Lenke LG, et al. Proximal junctional kyphosis in adult spinal deformity after segmental posterior spinal instrumentation and fusion: minimum five-year follow-up. Spine (Phila Pa 1976). 2008;33(20):2179-84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18794759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LauD, Clark AJ, Scheer JK, et al. Proximal junctional kyphosis and failure following spinal deformity surgery: a systematic review of the literature as a background to classification development. Spine (Phila Pa 1976). 2014;39(25):2093-102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25271516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HJ, Bridwell KH, Lenke LG, et al. Proximal junctional kyphosis results in inferior SRS pain subscores in adult deformity patients. Spine (Phila Pa 1976). 2013;38(11):896-901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23232215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HJ, Lenke LG, Shaffrey CI, et al. Proximal junctional kyphosis as a distinct form of adjacent segment pathology after spinal deformity surgery. Spine (Phila Pa 1976). 2012;37(22 Suppl):S144-64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22885829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acosta FL Jr, McClendon J Jr, O'Shaughnessy BA, et al. Morbidity and mortality after spinal deformity surgery in patients 75 years and older: complications and predictive factors: clinical article. J Neurosurg Spine. 2011;15(6):667-74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21888481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yadla S, Maltenfort MG, Ratliff JK, et al. Adult scoliosis surgery outcomes: a systematic review. Neurosurg Focus. 2010;28(3):E3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20192664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lenke LG, Fehlings MG, Shaffrey CI, et al. Neurologic outcomes of complex adult spinal deformity surgery: results of the prospective, multicenter Scoli-Risk-1 study. Spine (Phila Pa 1976). 2016;41(3):204-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26866736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lafage R, Schwab F, Challier V, et al. Defining spino-pelvic alignment thresholds: should operative goals in adult spinal deformity surgery account for age? Spine (Phila Pa 1976). 2016;41(1):62-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26689395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lafage R, Schwab F, Glassman S, et al. Age-Adjusted Alignment Goals Have the Potential to Reduce PJK. Spine (Phila Pa 1976). 2017;42(17):1275-282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28263226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sethi RK, Pong RP, Leveque JC, et al. The Seattle spine team approach to adult deformity surgery: a systems-based approach to perioperative care and subsequent reduction in perioperative complication rates. Spine Deform. 2014;2(2):95-103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27927385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buchlak QD, Yanamadala V, Leveque JC, et al. Complication avoidance with pre-operative screening: insights from the Seattle spine team.Curr Rev Musculoskelet Med. 2016;9(3):316-26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4958383</ArticleId>
            <ArticleId IdType="pubmed">27260267</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29800457</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1460-2245</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>34</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Health promotion international</Title>
          <ISOAbbreviation>Health Promot Int</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sustainable development goals for health promotion: a critical frame analysis.</ArticleTitle>
        <Pagination>
          <StartPage>847</StartPage>
          <EndPage>858</EndPage>
          <MedlinePgn>847-858</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/heapro/day036</ELocationID>
        <Abstract>
          <AbstractText>The Sustainable Development Goals (SDGs) lay the foundations for supporting global health and international development work for the next 15&#x2009;years. Thirty years ago, the Ottawa Charter defined health promotion and outlined key principles for global action on health, including the importance of advocating, enabling and mediating for health equity. Advocacy underscores a human right to health and suggests political action to support its attainment. Enabling speaks to health promotion's focus on the empowerment of people and communities to take control over their health and aspirations. Mediation draws attention to the critical intersectoral partnerships required to address health and social inequities. Underpinned by this approach, the aim of this paper is to consider how key health promotion principles, namely, rights, empowerment and partnership feature (and are framed) within the SDGs and to consider how these framings may shape future directions for health promotion. To that end, a critical frame analysis of the Transforming Our World document was conducted. The analysis interrogated varying uses and meanings of partnerships, empowerment and rights (and their connections) within the SDGs. The analysis here presents three framings from the SDGs: (1) a moral code for global action on (in)equity; (2) a future orientation to address global issues yet devoid of history; and (3) a reductionist framing of health as the absence of disease. These framings raise important questions about the underpinning values of the SDGs and pathways to health equity - offering both challenges and opportunities for defining the nature and scope of health promotion.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Spencer</LastName>
            <ForeName>Grace</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Health Sciences, University of Sydney, 75 East Street, Lidcombe, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Corbin</LastName>
            <ForeName>J Hope</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health and Community Studies, Western Washington University, 516 High Street, Bellingham, WA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miedema</LastName>
            <ForeName>Esther</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Geography, Planning and International Development, Amsterdam Institute for Social Science Research, University of Amsterdam, Nieuwe Achtergracht 166 | 1018 WV Amsterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Health Promot Int</MedlineTA>
        <NlmUniqueID>9008939</NlmUniqueID>
        <ISSNLinking>0957-4824</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000079102" MajorTopicYN="N">Empowerment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069576" MajorTopicYN="N">Health Equity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006293" MajorTopicYN="Y">Health Promotion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006806" MajorTopicYN="N">Human Rights</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076502" MajorTopicYN="Y">Sustainable Development</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">empowerment</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">partnerships</Keyword>
        <Keyword MajorTopicYN="N">rights</Keyword>
        <Keyword MajorTopicYN="N">sustainable development goals</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29800457</ArticleId>
        <ArticleId IdType="doi">10.1093/heapro/day036</ArticleId>
        <ArticleId IdType="pii">5004390</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29794232</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>Suppl 1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Association between tax structure and cigarette consumption: findings from the International Tobacco Control Policy Evaluation (ITC) Project.</ArticleTitle>
        <Pagination>
          <StartPage>s31</StartPage>
          <EndPage>s36</EndPage>
          <MedlinePgn>s31-s36</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2017-054160</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Recent studies show that greater price variability and more opportunities for tax avoidance are associated with tax structures that depart from a specific uniform one. These findings indicate that tax structures other than a specific uniform one may lead to more cigarette consumption.</AbstractText>
          <AbstractText Label="OBJECTIVE">This paper aims to examine how cigarette tax structure is associated with cigarette consumption.</AbstractText>
          <AbstractText Label="METHODS">We used survey data taken from the International Tobacco Control Policy Evaluation Project in 17 countries to conduct the analysis. Self-reported cigarette consumption was aggregated to average measures for each surveyed country and wave. The effect of tax structures on cigarette consumption was estimated using generalised estimating equations after adjusting for sociodemographic characteristics, average taxes and year fixed effects.</AbstractText>
          <AbstractText Label="FINDINGS">Our study provides important empirical evidence of a relationship between tax structure and cigarette consumption. We find that a change from a specific to an ad valorem structure is associated with a 6%-11%&#x2009;higher cigarette consumption. In addition, a change from uniform to tiered structure is associated with a 34%-65%&#x2009;higher cigarette consumption. The results are consistent with existing evidence and suggest that a uniform and specific tax structure is the most effective tax structure for reducing tobacco consumption.</AbstractText>
          <CopyrightInformation>&#xA9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shang</LastName>
            <ForeName>Ce</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Health Policy Center, Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Hye Myung</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Health Policy and Administration, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chaloupka</LastName>
            <ForeName>Frank J</ForeName>
            <Initials>FJ</Initials>
            <AffiliationInfo>
              <Affiliation>Health Policy Center, Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Health Policy and Administration, School of Public Health, University of Illinois at Chicago, Chicago, Illinois, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fong</LastName>
            <ForeName>Geoffrey T</ForeName>
            <Initials>GT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychology, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Ontario Institute for Cancer Research, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thompson</LastName>
            <ForeName>Mary</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>O'Connor</LastName>
            <ForeName>Richard J</ForeName>
            <Initials>RJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cancer Prevention and Population Sciences, Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>C312/A6465</GrantID>
            <Acronym>CRUK_</Acronym>
            <Agency>Cancer Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MOP-79551</GrantID>
            <Agency>CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA090955</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01 CA138389</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>MOP-57897</GrantID>
            <Agency>CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
          <Grant>
            <GrantID>118096</GrantID>
            <Agency>CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
          <Grant>
            <GrantID>K99 AA024810</GrantID>
            <Acronym>AA</Acronym>
            <Agency>NIAAA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>C321/A11039</GrantID>
            <Acronym>CRUK_</Acronym>
            <Agency>Cancer Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>C312/A3726</GrantID>
            <Acronym>CRUK_</Acronym>
            <Agency>Cancer Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA125116</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA100362</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>C25586/A19540</GrantID>
            <Acronym>CRUK_</Acronym>
            <Agency>Cancer Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>P50 CA111236</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P01 CA200512</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>FDN-148477</GrantID>
            <Agency>CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
          <Grant>
            <GrantID>MOP-115016</GrantID>
            <Agency>CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000073865" MajorTopicYN="N">Cigarette Smoking</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003132" MajorTopicYN="N">Commerce</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D038622" MajorTopicYN="Y">Internationality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013660" MajorTopicYN="N">Taxes</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">economics</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">taxation</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>21</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29794232</ArticleId>
        <ArticleId IdType="mid">NIHMS1019726</ArticleId>
        <ArticleId IdType="pmc">PMC6702940</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2017-054160</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2017-054160</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Organization WH. WHO report on the global tobacco epidemic, 2015: raising taxes on tobacco, 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Shang C, Chaloupka FJ, Zahra N, et al. The distribution of cigarette prices under different tax structures: findings from the International Tobacco Control Policy Evaluation (ITC) Project . Tob Control 2014;23(Suppl 1):i23&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4009360</ArticleId>
            <ArticleId IdType="pubmed">23792324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaloupka FJ, Kostova D, Shang C. Cigarette excise tax structure and cigarette prices: evidence from the global adult tobacco survey and the U.S. National Adult Tobacco Survey. Nicotine Tob Res 2014;16(Suppl 1):S3&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23935181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shang C, Chaloupka FJ, Fong GT, et al. The association between tax structure and cigarette price variability: findings from the ITC Project. Tob Control 2016;24(Suppl 3):iii88&#x2013;iii93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4612523</ArticleId>
            <ArticleId IdType="pubmed">25855641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaloupka FP, Tauras R, Xu JA, et al. Cigarette excise taxation: the impact of tax structure on prices, revenues, and cigarette smoking: NBER, editor, 2010.</Citation>
        </Reference>
        <Reference>
          <Citation>Treasury USDo. Alcohol, tobacco and excise tax on firearms and ammunition.</Citation>
        </Reference>
        <Reference>
          <Citation>Organization WH. WHO technical manual on tobacco tax administration, 2010.</Citation>
        </Reference>
        <Reference>
          <Citation>Liber AC, Ross H, Ratanachena S, et al. Cigarette price level and variation in five Southeast Asian countries. Tob Control 2015;24:e137&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24500266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi K, Hennrikus D, Forster J, et al. Use of price-minimizing strategies by smokers and their effects on subsequent smoking behaviors. Nicotine Tob Res 2012;14:864&#x2013;70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22193571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Husain MJ, Kostova D, Mbulo L, et al. Changes in cigarette prices, affordability, and brand-tier consumption after a tobacco tax increase in Thailand: evidence from the global adult tobacco surveys, 2009 and 2011. Prev Med 2017;105s:S4&#x2013;S9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5711621</ArticleId>
            <ArticleId IdType="pubmed">28579499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fong GT, Cummings KM, Borland R, et al. The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control 2006;15(Suppl 3):iii3&#x2013;iii11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2593053</ArticleId>
            <ArticleId IdType="pubmed">16754944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Organization WH. WHO report on the global tobacco epidemic, 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO. Relationship between tax and price and global evidence. http://www.who.int/tobacco/economics/2_3relationshipbetweentaxprice.pdf</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29788443</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2048-7207</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>8</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
              <Day>28</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the Pediatric Infectious Diseases Society</Title>
          <ISOAbbreviation>J Pediatric Infect Dis Soc</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pediatric Infectious Diseases Meets the Future.</ArticleTitle>
        <Pagination>
          <StartPage>9</StartPage>
          <EndPage>12</EndPage>
          <MedlinePgn>9-12</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/jpids/piy042</ELocationID>
        <Abstract>
          <AbstractText>Pediatric infectious diseases physicians are dedicated to the diagnosis, prevention, and management of infections in children. As such, we play large, and important, roles in the clinical care of children from birth to late adolescence and in infection prevention, antimicrobial stewardship, research pertaining to infections, public health, international and global health, and advocacy for children's health. Furthermore, we are critical to the education of future physicians (in general), pediatricians, and infectious diseases doctors. In addition to diagnosing and treating bacterial, fungal, viral, and parasitic infections known through the ages, we have been at the forefront of meeting today's new infectious threats to children's health, which include the following: antibiotic-resistant organisms; hospital-acquired infections; global outbreaks such as Ebola, Zika, human immunodeficiency virus-acquired immune deficiency syndrome, and new strains of influenza; infections in immunocompromised children; vaccine-preventable infections; the inefficient use of medical resources; and the high cost of medical care.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gilsdorf</LastName>
            <ForeName>Janet R</ForeName>
            <Initials>JR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Michigan Medical School, Ann Arbor.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spearman</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Ohio.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Englund</LastName>
            <ForeName>Janet A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Washington, Seattle.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Tina Q</ForeName>
            <Initials>TQ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bryant</LastName>
            <ForeName>Kristina A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, University of Louisville School of Medicine, Kentucky.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016421">Editorial</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Pediatric Infect Dis Soc</MedlineTA>
        <NlmUniqueID>101586049</NlmUniqueID>
        <ISSNLinking>2048-7193</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002321" MajorTopicYN="N">Career Choice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002568" MajorTopicYN="N">Certification</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006280" MajorTopicYN="N">Health Workforce</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055552" MajorTopicYN="N">Infectious Disease Medicine</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010372" MajorTopicYN="N">Pediatrics</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">compensation</Keyword>
        <Keyword MajorTopicYN="N">job market</Keyword>
        <Keyword MajorTopicYN="N">pediatric infectious diseases</Keyword>
        <Keyword MajorTopicYN="N">pediatric subspecialist</Keyword>
        <Keyword MajorTopicYN="N">workforce</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29788443</ArticleId>
        <ArticleId IdType="doi">10.1093/jpids/piy042</ArticleId>
        <ArticleId IdType="pii">4999890</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29783887</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-1706</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global public health</Title>
          <ISOAbbreviation>Glob Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A vision for global heath diplomacy in the foreign policy process: using smart power to prevent and resolve international conflict.</ArticleTitle>
        <Pagination>
          <StartPage>147</StartPage>
          <EndPage>151</EndPage>
          <MedlinePgn>147-151</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2018.1471147</ELocationID>
        <Abstract>
          <AbstractText>In the twenty-first Century, the developed world attempts to provide global health assistance, to poorer countries - at least in part in the pursuit and maintenance of world order and stability. Rarely, however - and in most cases, then on an ad hoc basis - are related foreign policy tools deployed in combination with each other. Nonetheless, there is currently greater openness than ever before to such interdigitation. Not least this reflects the unprecedented challenges of modern political and security conditions - struggling to operate amidst a broader culture of global adverserialism, and conflict which conventional systems of intervention have struggled to successfully resolve. The problems presented in this regard by the Iraq and Afghanistan conflicts have evolved into, and been magnified by, the limited range and availability of effective responses to contemporary threats such as the Islamic State, international terrorism, jihadism, and the Syrian civil war. The risk of further contagion to even more severe world stability concerns that these situations present calls for an urgent restructuring of the way in which foreign policy processes and initiatives work, including systems of coordination and consultation between national and international agencies of defense, diplomacy, and development.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kevany</LastName>
            <ForeName>Sebastian</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>a Institute for Global Health Delivery and Diplomacy , University of California , San Francisco , CA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Public Health</MedlineTA>
        <NlmUniqueID>101256323</NlmUniqueID>
        <ISSNLinking>1744-1692</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000346" MajorTopicYN="N" Type="Geographic">Afghanistan</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000068337" MajorTopicYN="N">Armed Conflicts</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067551" MajorTopicYN="Y">Diplomacy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007493" MajorTopicYN="N" Type="Geographic">Iraq</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011209" MajorTopicYN="N">Power, Psychological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011640" MajorTopicYN="Y">Public Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">diplomacy</Keyword>
        <Keyword MajorTopicYN="N">foreign policy</Keyword>
        <Keyword MajorTopicYN="N">policy process</Keyword>
        <Keyword MajorTopicYN="N">security</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29783887</ArticleId>
        <ArticleId IdType="doi">10.1080/17441692.2018.1471147</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">29775144</PMID>
      <DateRevised>
        <Year>2024</Year>
        <Month>08</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">1933-0693</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>130</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neurosurgery</Title>
          <ISOAbbreviation>J Neurosurg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The economic consequences of neurosurgical disease in low- and middle-income countries.</ArticleTitle>
        <Pagination>
          <StartPage>1149</StartPage>
          <EndPage>1156</EndPage>
          <MedlinePgn>1149-1156</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3171/2017.12.JNS17281</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">The objective of this study was to estimate the economic consequences of neurosurgical disease in low- and middle-income countries (LMICs).</AbstractText>
          <AbstractText Label="METHODS">The authors estimated gross domestic product (GDP) losses and the broader welfare losses attributable to 5 neurosurgical disease categories in LMICs using two distinct economic models. The value of lost output (VLO) model projects annual GDP losses due to neurosurgical disease during 2015-2030, and is based on the WHO's "Projecting the Economic Cost of Ill-health" tool. The value of lost economic welfare (VLW) model estimates total welfare losses, which is based on the value of a statistical life and includes nonmarket losses such as the inherent value placed on good health, resulting from neurosurgical disease in 2015 alone.</AbstractText>
          <AbstractText Label="RESULTS">The VLO model estimates the selected neurosurgical diseases will result in $4.4 trillion (2013 US dollars, purchasing power parity) in GDP losses during 2015-2030 in the 90 included LMICs. Economic losses are projected to disproportionately affect low- and lower-middle-income countries, risking up to a 0.6% and 0.54% loss of GDP, respectively, in 2030. The VLW model evaluated 127 LMICs, and estimates that these countries experienced $3 trillion (2013 US dollars, purchasing power parity) in economic welfare losses in 2015. Regardless of the model used, the majority of the losses can be attributed to stroke and traumatic brain injury.</AbstractText>
          <AbstractText Label="CONCLUSIONS">The economic impact of neurosurgical diseases in LMICs is significant. The magnitude of economic losses due to neurosurgical diseases in LMICs provides further motivation beyond already compelling humanitarian reasons for action.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rudolfson</LastName>
            <ForeName>Niclas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>1Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2Surgery and Public Health, Department of Clinical Sciences in Lund, Lund University, Lund, Sweden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dewan</LastName>
            <ForeName>Michael C</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>1Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Kee B</ForeName>
            <Initials>KB</Initials>
            <AffiliationInfo>
              <Affiliation>1Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shrime</LastName>
            <ForeName>Mark G</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>1Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>5Department of Otology and Laryngology, Harvard Medical School; and.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meara</LastName>
            <ForeName>John G</ForeName>
            <Initials>JG</Initials>
            <AffiliationInfo>
              <Affiliation>1Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>6Department of Plastic and Reconstructive Surgery, Boston Children's Hospital, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alkire</LastName>
            <ForeName>Blake C</ForeName>
            <Initials>BC</Initials>
            <AffiliationInfo>
              <Affiliation>1Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>4Office of Global Surgery, Massachusetts Eye and Ear Infirmary.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>5Department of Otology and Laryngology, Harvard Medical School; and.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Neurosurg</MedlineTA>
        <NlmUniqueID>0253357</NlmUniqueID>
        <ISSNLinking>0022-3085</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cost of illness</Keyword>
        <Keyword MajorTopicYN="N">economics</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">neurosurgical procedures</Keyword>
        <Keyword MajorTopicYN="N">operative</Keyword>
        <Keyword MajorTopicYN="N">surgical procedures</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>2</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29775144</ArticleId>
        <ArticleId IdType="doi">10.3171/2017.12.JNS17281</ArticleId>
        <ArticleId IdType="pii">2017.12.JNS17281</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29773406</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2529-993X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Enfermedades infecciosas y microbiologia clinica (English ed.)</Title>
          <ISOAbbreviation>Enferm Infecc Microbiol Clin (Engl Ed)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Dynamics of Helicobacter pylori infection in infants during the first six months of life.</ArticleTitle>
        <Pagination>
          <StartPage>109</StartPage>
          <EndPage>111</EndPage>
          <MedlinePgn>109-111</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eimc.2018.03.016</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0213-005X(18)30177-0</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">Mainly due to the high percentage of infection and the ineffectiveness of treatments, Helicobacter pylori is a global health problem. Knowing the age at acquisition is key to preventing the infection.</AbstractText>
          <AbstractText Label="PATIENTS">Sixty-seven mothers and their respective children participated. To evaluate the presence of H. pylori, the faeces of the mother and her child were analysed using the HpSA antigen test.</AbstractText>
          <AbstractText Label="RESULTS">71.6% (48/67) of pregnant mothers were positive for H. pylori at the term of their pregnancy. In newborns, 8.96% (6/67) of them showed H. pylori colonisation/persistent infection. During the first month of life, a prevalence and incidence of infection of 23.9% and 13%, respectively, was observed.</AbstractText>
          <AbstractText Label="CONCLUSION">Overall, the results suggest that there is a high risk of H. pylori infection during the first month of life, even of the persistent type.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2018 Elsevier Espa&#xF1;a, S.L.U. and Sociedad Espa&#xF1;ola de Enfermedades Infecciosas y Microbiolog&#xED;a Cl&#xED;nica. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Merino</LastName>
            <ForeName>Jos&#xE9; S</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Microbiolog&#xED;a, Facultad de Ciencias Biol&#xF3;gicas, Universidad de Concepci&#xF3;n, Concepci&#xF3;n, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Araneda</LastName>
            <ForeName>Liliana</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Unidad de Patolog&#xED;a Cervical, Hospital las Higueras, Talcahuano, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Linco&#xF1;ir-Campos</LastName>
            <ForeName>Paulina</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Microbiolog&#xED;a, Facultad de Ciencias Biol&#xF3;gicas, Universidad de Concepci&#xF3;n, Concepci&#xF3;n, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parra</LastName>
            <ForeName>Cristian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Microbiolog&#xED;a, Facultad de Ciencias Biol&#xF3;gicas, Universidad de Concepci&#xF3;n, Concepci&#xF3;n, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>S&#xE1;ez</LastName>
            <ForeName>Katia</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Estad&#xED;stica, Facultad de Ciencias F&#xED;sicas y Matem&#xE1;ticas, Universidad de Concepci&#xF3;n, Concepci&#xF3;n, Chile.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garc&#xED;a</LastName>
            <ForeName>Apolinaria</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Microbiolog&#xED;a, Facultad de Ciencias Biol&#xF3;gicas, Universidad de Concepci&#xF3;n, Concepci&#xF3;n, Chile. Electronic address: apgarcia@udec.cl.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <Language>spa</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Din&#xE1;mica de la infecci&#xF3;n por Helicobacter pylori en lactantes durante los primeros 6 meses de vida.</VernacularTitle>
      </Article>
      <MedlineJournalInfo>
        <Country>Spain</Country>
        <MedlineTA>Enferm Infecc Microbiol Clin (Engl Ed)</MedlineTA>
        <NlmUniqueID>101777541</NlmUniqueID>
        <ISSNLinking>2529-993X</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002677" MajorTopicYN="N" Type="Geographic">Chile</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016481" MajorTopicYN="N">Helicobacter Infections</DescriptorName>
          <QualifierName UI="Q000151" MajorTopicYN="Y">congenital</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
          <QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016480" MajorTopicYN="N">Helicobacter pylori</DescriptorName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Helicobacter pylori</Keyword>
        <Keyword MajorTopicYN="N">Incidence</Keyword>
        <Keyword MajorTopicYN="N">Incidencia</Keyword>
        <Keyword MajorTopicYN="N">Newborn</Keyword>
        <Keyword MajorTopicYN="N">Persistence</Keyword>
        <Keyword MajorTopicYN="N">Persistencia</Keyword>
        <Keyword MajorTopicYN="N">Prevalence</Keyword>
        <Keyword MajorTopicYN="N">Prevalencia</Keyword>
        <Keyword MajorTopicYN="N">Reci&#xE9;n nacido</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29773406</ArticleId>
        <ArticleId IdType="doi">10.1016/j.eimc.2018.03.016</ArticleId>
        <ArticleId IdType="pii">S0213-005X(18)30177-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29743339</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Compliance with point-of-sale tobacco control policies and student tobacco use in Mumbai, India.</ArticleTitle>
        <Pagination>
          <StartPage>220</StartPage>
          <EndPage>226</EndPage>
          <MedlinePgn>220-226</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2018-054290</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">We measured how student tobacco use and psychological risk factors (intention to use and perceived ease of access to tobacco products) were associated with tobacco vendor compliance with India's Cigarettes and Other Tobacco Products Act provisions regulating the point-of-sale (POS) environment.</AbstractText>
          <AbstractText Label="METHODS">We conducted a population-based cross-sectional survey of high school students (n=1373) and tobacco vendors (n=436) in school-adjacent communities (n=26) in Mumbai, India. We used in-class self-administered questionnaires of high school students, face-to-face interviews with tobacco vendors and compliance checks of tobacco POS environments. Logistic regression models with adjustments for clustering were used to measure associations between student tobacco use, psychological risk factors and tobacco POS compliance.</AbstractText>
          <AbstractText Label="RESULTS">Compliance with POS laws was low overall and was associated with lower risk of student current tobacco use (OR 0.48, 95%&#x2009;CI 0.26 to 0.91) and current smokeless tobacco use (OR 0.40, 95%&#x2009;CI 0.21 to 0.77), when controlling for student-level and community-level tobacco use risk factors. Compliance was not associated with student intention to use tobacco (OR 0.50; 95%&#x2009;CI 0.21 to 1.18) and perceived ease of access to tobacco (OR 0.73; 95%&#x2009;CI 0.53 to 1.00).</AbstractText>
          <AbstractText Label="CONCLUSIONS">Improving vendor compliance with tobacco POS laws may reduce student tobacco use. Future studies should test strategies to improve compliance with tobacco POS laws, particularly in low-income and middle-income country settings like urban India.</AbstractText>
          <CopyrightInformation>&#xA9; Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mistry</LastName>
            <ForeName>Ritesh</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pednekar</LastName>
            <ForeName>Mangesh S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Healis Sekhsaria Institute for Public Health, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McCarthy</LastName>
            <ForeName>William J</ForeName>
            <Initials>WJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Policy and Management, University of California, Los Angeles, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Resnicow</LastName>
            <ForeName>Ken</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pimple</LastName>
            <ForeName>Sharmila A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Preventive Oncology, Tata Memorial Hospital, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hsieh</LastName>
            <ForeName>Hsing-Fang</ForeName>
            <Initials>HF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mishra</LastName>
            <ForeName>Gauravi A</ForeName>
            <Initials>GA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Prakash C</ForeName>
            <Initials>PC</Initials>
            <AffiliationInfo>
              <Affiliation>Healis Sekhsaria Institute for Public Health, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 CA201415</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013334" MajorTopicYN="N">Students</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="N">Tobacco Products</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
          <QualifierName UI="Q000600" MajorTopicYN="Y">supply &amp; distribution</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064424" MajorTopicYN="N">Tobacco Use</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adolescents</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">low/middle income country</Keyword>
        <Keyword MajorTopicYN="N">prevention</Keyword>
        <Keyword MajorTopicYN="N">public policy</Keyword>
        <Keyword MajorTopicYN="N">smokeless tobacco</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>11</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29743339</ArticleId>
        <ArticleId IdType="mid">NIHMS996006</ArticleId>
        <ArticleId IdType="pmc">PMC6411039</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2018-054290</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2018-054290</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Gajalakshmi C, Jha P, Ranson K. Global patterns of smoking and smoking-attributable mortality In: Jha P, Chaloupka F, eds. Tobacco control in developing countries. Washington D.C: Oxford University Press, 2000:9&#x2013;39.</Citation>
        </Reference>
        <Reference>
          <Citation>Jha P Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer 2009;9:655&#x2013;64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19693096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jha P, Jacob B, Gajalakshmi V, et al. A nationally representative case-control study of smoking and death in India. N Engl J Med 2008;358:1 137&#x2013;47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18272886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinha DN, Palipudi KM, Gupta PC, et al. Smokeless tobacco use: a meta-analysis of risk and attributable mortality estimates for India. Indian J Cancer 2014;51 Suppl 1:73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25526253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinha DN, Mathur N, Nazar GP, et al.; Smokeless tobacco use among youth In: Gupta PC, Arora M, Sinha D, eds. Smokeless tobacco and public health in India. New Delhi, India: Government of India, Ministry of Health and Family Welfare, 2012:343.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO. Global Youth Tobacco Survey (GYTS): India&#x2014;2009&#x2019;. World Health Organization, 2010.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO. Global Adult Tobacco Survey (GATS): India&#x2014;2016&#x2013;17&#x2019;. World Health Organization, 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>Ministry of Law and Justice. COTPA: cigarette and other tobacco products (prohibition of advertisement and regulation of trade and commerce, production, supply, and distribution) act, 2003, 2003.</Citation>
        </Reference>
        <Reference>
          <Citation>DHHS US. Preventing tobacco use among youth and young adults: a report of the Surgeon General. Washington, D.C: Dept, of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Who report on the global tobacco epidemic, 2008&#x2014;The MPOWER package. Geneva: World Health Organization, 2008.</Citation>
        </Reference>
        <Reference>
          <Citation>Paynter J, Edwards R. The impact of tobacco promotion at the point of sale: a systematic review. Nicotine Tob Res 2009; 11:25&#x2013;35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19246438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robertson L, McGee R, Marsh L, et al. A systematic review on the impact of point-of-sale tobacco promotion on smoking. Nicotine Tob Res 2015;17:2&#x2013;17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4832971</ArticleId>
            <ArticleId IdType="pubmed">25173775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robertson L, Cameron C, McGee R, et al. Point-of-sale tobacco promotion and youth smoking: a meta-analysis. Tob Control 2016;25:e83&#x2013;89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26728139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wakefield MA, Germain D, Durkin SJ. How does increasingly plainer cigarette packaging influence adult smokers&#x2019; perceptions about brand image? An experimental study. Tob Control 2008;17:416&#x2013;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2590906</ArticleId>
            <ArticleId IdType="pubmed">18827035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy DT, Friend KB. Strategies for reducing youth access to tobacco: a framework for understanding empirical findings on youth access policies. Drugs 2002;9:285&#x2013;303.</Citation>
        </Reference>
        <Reference>
          <Citation>Mistiy R, Pimple S, Mishra G, et al. Compliance with point-of-sale tobacco control policies in school-adjacent neighborhoods in Mumbai, India. Am J Health Promot 2015;30:433&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26389976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel S, Rendell H, Maudgal S, et al. Tobacco industry tactics with advertisements at the point of sale in Mumbai. Indian J Cancer 2013;50:245&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24061466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mead EL, Rimal RN, Cohen JE, et al. A two-wave observational study of compliance with youth access and tobacco advertising provisions of the Cigarettes and Other Tobacco Products Act in India. Nicotine Tob Res 2016;18:1363&#x2013;70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5942621</ArticleId>
            <ArticleId IdType="pubmed">26610937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaudhry S, Chaudhry S, Chaudhry K. Point of sale tobacco advertisements in India. Indian J Cancer 2007;44:131&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18322354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elf JL, Modi B, Stillman F, et al. Tobacco sales and marketing within 100 yards of schools in Ahmedabad City, India. Public Health 2013;127:442&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23608024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mistiy R, Pednekar M, Pimple S, et al. Banning tobacco sales and advertisements near educational institutions may reduce students&#x2019; tobacco use risk: evidence from Mumbai, India. Tob Control 2015;24:e100&#x2013;e107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23958643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiFranza JR, Celebucki CC, Moweiy PD. Measuring statewide merchant compliance with tobacco minimum age laws: the Massachusetts experience. Am J Public Health 2001;91:1124&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1446711</ArticleId>
            <ArticleId IdType="pubmed">11441743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dovell RA, Mowat DL, Dorland J, et al. Changes among retailers selling cigarettes to minors. Can J Public Health 1996;87:66&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8991749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frick RG, Klein EG, Ferketich AK, et al. Tobacco advertising and sales practices in licensed retail outlets after the Food and Drug Administration regulations. J Community Health 2012;37:963&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22197961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hern&#xE1;ndez-&#xC1;vila JE, Tirado-Ram&#xED;rez E, Santos-Luna R, et al. Use of Geographical Information Systems for billboards and points-of-sale surveillance in two Mexico cities. Salud P&#xFA;blica de M&#xE9;xico 2007;49:s241&#x2013;s246.</Citation>
        </Reference>
        <Reference>
          <Citation>Klein EG, Ferketich AK, Abdel-Rasoul M, et al. Smokeless tobacco marketing and sales practices in Appalachian Ohio following federal regulations. Nicotine Tob Res 2012;14:880&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3390545</ArticleId>
            <ArticleId IdType="pubmed">22318692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNeill A, Lewis S, Quinn C, et al. Evaluation of the removal of point-of-sale tobacco displays in Ireland. Tob Control 2011. ;20:137&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21088060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quedley M, Ng B, Sapre N, et al. In sight, in mind: retailer compliance with legislation on limiting retail tobacco displays. Nicotine Tob Res 2008;10:1347&#x2013;54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18686182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rose SW, Myers AE, D&#x2019;Angelo H, et al. Retailer adherence to Family Smoking Prevention and Tobacco Control Act, North Carolina, 2011. Prev Chronic Dis 2013; 10:E47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3617991</ArticleId>
            <ArticleId IdType="pubmed">23557638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheffels J, Lavik R. Out of sight, out of mind? Removal of point-of-sale tobacco displays in Norway. Tob Control 2013;22:e37&#x2013;42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3731079</ArticleId>
            <ArticleId IdType="pubmed">22678299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stead LF, Lancaster T. Interventions for preventing tobacco sales to minors (Review). Cochrane Database of Systematic Reviews 2008; 1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15674880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salloum RG, Nakkash RT, Myers AE, et al. Point-of-sale tobacco advertising in Beirut, Lebanon following a national advertising ban. BMC Public Health 2013;13:534.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3673907</ArticleId>
            <ArticleId IdType="pubmed">23731766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aghi M, Oswal K, Pednekar M, et al. Pictorial warnings on tobacco products at the point of sale in India. Tob Control 2012;21:450&#x2013;1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22427362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schensul JJ, Nair S, Bilgi S, et al. Availability, accessibility and promotion of smokeless tobacco in a low-income area of Mumbai. Tob Control 2013;22:324&#x2013;30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4644352</ArticleId>
            <ArticleId IdType="pubmed">22387521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yorifuji T, Tanihara S, Takao S, et al. Regional disparities in compliance with tobacco control policy in Japan: an ecological analysis. Tob Control 2011. ;20:374&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21427196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dai H, Hao J. The effects of tobacco control policies on retailer sales to minors in the USA, 2015. Tobacco Control. 2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28219976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friend KB, Lipper-Kreda S, Grube J. The impact of local U.S. tobacco policies on youth tobacco use: a critical review. Open J Prev Med 2011. ;01:34&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3244049</ArticleId>
            <ArticleId IdType="pubmed">22200035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiFranza JR, Savageau JA, Fletcher KE. Enforcement of underage sales laws as a predictor of daily smoking among adolescents: a national study. BMC Public Health 2009;9:107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2676267</ArticleId>
            <ArticleId IdType="pubmed">19374735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rigotti NA, DiFranza JR, Chang Y, et al. The effect of enforcing tobacco-sales laws on adolescents&#x2019; access to tobacco and smoking behavior. N Engl J Med 1997;337:1044&#x2013;51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9321533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lovato CY, Sabiston CM, Hadd V, et al. The impact of school smoking policies and student perceptions of enforcement on school smoking prevalence and location of smoking. Health Educ Res 2007;22:782&#x2013;93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16987941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wakefield MA, Chaloupka FJ, Kaufman NJ, et al. Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ 2000;321:333&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC27448</ArticleId>
            <ArticleId IdType="pubmed">10926588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edwards R, Ajmal A, Healey B, et al. Impact of removing point-of-sale tobacco displays: data from a New Zealand youth survey. Tob Control 2017;26:392&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27377342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunlop S, Kite J, Grunseit AC, et al. Out of sight and out of mind? Evaluating the impact of point-of-sale tobacco display bans on smoking-related beliefs and behaviors in a sample of Australian adolescents and young adults. Nicotine Tob Res 2015;17:761&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25283169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flay BR, Petraitis J, Hu FB. Psychosocial risk and protective factors for adolescent tobacco use. Nicotine Tob Res 1999; 1 Suppl 1:559&#x2013;565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11072406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desktop ArcGIS Release 10 [program], Redlands, CA: Environmental Systems Research Institute, 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>McCulloch CE, Searle SR. Generalized, linear and mixed models. New York, NY: John Wiley and Sons, 2001.</Citation>
        </Reference>
        <Reference>
          <Citation>Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods&#x2019;. Sage Publications Inc, 2002.</Citation>
        </Reference>
        <Reference>
          <Citation>Farhat J, Robb A. Applied survey data analysis using stata: The Kauffman firm survey data, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Nair S, Schensul JJ, Bilgi S, et al. Local responses to the Maharashtra gutka and pan masala ban: a report from Mumbai. Indian J Cancer 2012;49:443&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4623822</ArticleId>
            <ArticleId IdType="pubmed">23442411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pimple S, Gunjal S, Mishra GA, et al. Compliance to Gutka ban and other provisons of COTPA in Mumbai. Indian J Cancer 2014;51 Suppl 1:60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25526251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arora M, Reddy KS, Stigler MH, et al. Associations between tobacco marketing and use among urban youth in India. Am J Health Behav 2008;32:283&#x2013;94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2830491</ArticleId>
            <ArticleId IdType="pubmed">18067468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shang C, Huang J, Cheng KW, et al. Global evidence on the association between POS advertising bans and youth smoking participation. Int J Environ Res Public Health 2016;13:306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4808969</ArticleId>
            <ArticleId IdType="pubmed">27005651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whyte G, Gendall P, Hoek J. Advancing the retail endgame: public perceptions of retail policy interventions. Tob Control 2014;23:160&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23842946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jason LA, Billows WD, Schnopp-Wyatt DL, et al. Long-term findings from Woodridge in reducing illegal cigarette sales to older minors. Eval Health Prof 1996;19:3&#x2013;13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10186901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landrine H, Klonoff EA, Fritz JM. Preventing cigarette sales to minors: the need for contextual, sociocultural analysis. Prev Med 1994;23:322&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8078853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rose SW, Emery SL, Ennett S, et al. Retailer opinions about and compliance with family smoking prevention and tobacco control act point of sale provisions: a survey of tobacco retailers. BMC Public Health 2015;15:884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4567780</ArticleId>
            <ArticleId IdType="pubmed">26362769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smyth C, Freeman B, Maag A. Tobacco retail regulation: the next frontier in tobacco control? Public Health Res Pract 2015;25:e2531529.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26243488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Altman DG, Wheelis AY, McFarlane M, et al. The relationship between tobacco access and use among adolescents: a four community study. Soc Sci Med 1999;48:759&#x2013;75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10190639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forster JL, Murray DM, Wolfson M, et al. The effects of community policies to reduce youth access to tobacco. Am J Public Health 1998;88:1193&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1508321</ArticleId>
            <ArticleId IdType="pubmed">9702146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turner MM, Rimal RN, Lumby E, et al. Compliance with tobacco control policies in India: an examination of facilitators and barriers. Int J Tuberc Lung Dis 2016;20:411&#x2013;6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27046725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaine R, Russell M, Edwards R, et al. New Zealand tobacco retailers&#x2019; attitudes to selling tobacco, point-of-sale display bans and other tobacco control measures: a qualitative analysis. N Z Med J 2014;127:53&#x2013;66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24997464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peruga A, Hayes LS, Aguilera X, et al. Correlates of compliance with national comprehensive smoke-free laws. Tobacco Control. 2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29208739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panda B, Rout A, Pati S, et al. Tobacco control law enforcement and compliance in Odisha, India&#x2014;implications for tobacco control policy and practice. Asian Pac J Cancer Prev 2012;13:4631&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23167393</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29730732</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>29</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>01</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1720-8386</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>42</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of endocrinological investigation</Title>
          <ISOAbbreviation>J Endocrinol Invest</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different.</ArticleTitle>
        <Pagination>
          <StartPage>117</StartPage>
          <EndPage>128</EndPage>
          <MedlinePgn>117-128</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40618-018-0892-2</ELocationID>
        <Abstract>
          <AbstractText>The worldwide obesity epidemic continues unabated, adversely impacting upon global health and economies. People with severe obesity suffer the greatest adverse health consequences with reduced life expectancy. Currently, bariatric surgery is the most effective treatment for people with severe obesity, resulting in marked sustained weight loss, improved obesity-associated comorbidities and reduced mortality. Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), the most common bariatric procedures undertaken globally, engender weight loss and metabolic improvements by mechanisms other than restriction and malabsorption. It is now clear that a plethora of gastrointestinal (GI) tract-derived signals plays a critical role in energy and glucose regulation. SG and RYGB, which alter GI anatomy and nutrient flow, impact upon these GI signals ultimately leading to weight loss and metabolic improvements. However, whilst highly effective overall, at individual level, post-operative outcomes are highly variable, with a proportion of patients experiencing poor long-term weight loss outcome and gaining little health benefit. RYGB and SG are markedly different anatomically and thus differentially impact upon GI signalling and bodyweight regulation. Here, we review the mechanisms proposed to cause weight loss following RYGB and SG. We highlight similarities and differences between these two procedures with a focus on gut hormones, bile acids and gut microbiota. A greater understanding of these procedure-related mechanisms will allow surgical procedure choice to be tailored to the individual to maximise post-surgery health outcomes and will facilitate the discovery of non-surgical treatments for people with obesity.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pucci</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Obesity Research, Rayne Institute, University College London, London, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Weight Management and Metabolic Surgery, University College London Hospital Bariatric, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Batterham</LastName>
            <ForeName>R L</ForeName>
            <Initials>RL</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Obesity Research, Rayne Institute, University College London, London, UK. r.batterham@ucl.ac.uk.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Weight Management and Metabolic Surgery, University College London Hospital Bariatric, London, UK. r.batterham@ucl.ac.uk.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>National Institute of Health Research, University College London Hospital Biomedical Research Centre, London, UK. r.batterham@ucl.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>RP-2015-06-005</GrantID>
            <Acronym>DH_</Acronym>
            <Agency>Department of Health</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Italy</Country>
        <MedlineTA>J Endocrinol Invest</MedlineTA>
        <NlmUniqueID>7806594</NlmUniqueID>
        <ISSNLinking>0391-4097</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005743" MajorTopicYN="N">Gastrectomy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015390" MajorTopicYN="N">Gastric Bypass</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009767" MajorTopicYN="N">Obesity, Morbid</DescriptorName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bile acids</Keyword>
        <Keyword MajorTopicYN="N">Gut hormones</Keyword>
        <Keyword MajorTopicYN="N">Gut microbiota</Keyword>
        <Keyword MajorTopicYN="N">Roux-en-Y gastric bypass</Keyword>
        <Keyword MajorTopicYN="N">Sleeve gastrectomy</Keyword>
        <Keyword MajorTopicYN="N">Type 2 diabetes</Keyword>
      </KeywordList>
      <CoiStatement>CONFLICT OF INTEREST: All authors declare that they have no conflict of interest. ETHICAL APPROVAL: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. INFORMED CONSENT: Informed consent was obtained from all individual participants included in the studies performed by the authors.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>5</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29730732</ArticleId>
        <ArticleId IdType="pmc">PMC6394763</ArticleId>
        <ArticleId IdType="doi">10.1007/s40618-018-0892-2</ArticleId>
        <ArticleId IdType="pii">10.1007/s40618-018-0892-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>WHO Global health observatory (GHO) data 2016 Available from: http://www.who.int/gho/ncd/risk_factors/overweight_obesity/obesity_adults/en/</Citation>
        </Reference>
        <Reference>
          <Citation>Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3806364</ArticleId>
            <ArticleId IdType="pubmed">24149519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Makaronidis JM, Batterham RL. Potential mechanisms mediating sustained weight loss following Roux-en-Y gastric bypass and sleeve gastrectomy. Endocrinol Metab Clin North Am. 2016;45(3):539&#x2013;552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27519129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes&#x2014;5-year outcomes. N Engl J Med. 2017;376(7):641&#x2013;651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5451258</ArticleId>
            <ArticleId IdType="pubmed">28199805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial&#x2014;a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219&#x2013;234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23163728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radaelli MG, Martucci F, Perra S, et al. NAFLD/NASH in patients with type 2 diabetes and related treatment options. J Endocrinol Invest. 2017</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29189999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saber AA, Elgamal MH, McLeod MK. Bariatric surgery: the past, present, and future. Obes Surg. 2008;18(1):121&#x2013;128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18066634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Payne JH, Dewind LT, Commons RR. Metabolic observations in patients with jejunocolic shunts. Am J Surg. 1963;106:273&#x2013;289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14042557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sherman CD, Jr, May AG, Nye W, et al. Clinical and metabolic studies following bowel by-passing for obesity. Ann N Y Acad Sci. 1965;131(1):614&#x2013;622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5216995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg. 2014;24(8):1126&#x2013;1135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25008469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mason EE, Ito C. Gastric bypass in obesity. Surg Clin N Am. 1967;47(6):1345&#x2013;1351.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6073761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279&#x2013;2289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5562777</ArticleId>
            <ArticleId IdType="pubmed">28405878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning S, Pucci A, Carter NC, et al. Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Endosc. 2015;29(6):1484&#x2013;1491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4422859</ArticleId>
            <ArticleId IdType="pubmed">25239175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pucci A, Tymoszuk U, Cheung WH, et al. Type 2 diabetes remission 2&#xA0;years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabet Med J Br Diabet Assoc. 2018;35(3):360&#x2013;367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5836992</ArticleId>
            <ArticleId IdType="pubmed">29055156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olbers T, Lonroth H, Fagevik-Olsen M, et al. Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg. 2003;13(3):364&#x2013;370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12841895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abu-Jaish W, Rosenthal RJ. Sleeve gastrectomy: a new surgical approach for morbid obesity. Expert Rev Gastroenterol Hepatol. 2010;4(1):101&#x2013;119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20136593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149(7):716&#x2013;726.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4274782</ArticleId>
            <ArticleId IdType="pubmed">24899464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015;150(10):931&#x2013;940.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4905566</ArticleId>
            <ArticleId IdType="pubmed">26132586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes&#x2013;3-year outcomes. N Engl J Med. 2014;370(21):2002&#x2013;2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5451259</ArticleId>
            <ArticleId IdType="pubmed">24679060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peterli R, Wolnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255&#x2013;265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5833546</ArticleId>
            <ArticleId IdType="pubmed">29340679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salminen P, Helmio M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y Gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241&#x2013;254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5833550</ArticleId>
            <ArticleId IdType="pubmed">29340676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ignat M, Vix M, Imad I, et al. Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg. 2017;104(3):248&#x2013;256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27901287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osland E, Yunus RM, Khan S, et al. Weight loss outcomes in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a meta-analysis and systematic review of randomized controlled trials. Surg Laparosc Endosc Percutaneous Tech. 2017;27(1):8&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28145963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013;36(8):2175&#x2013;2182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3714483</ArticleId>
            <ArticleId IdType="pubmed">23439632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miras AD, le Roux CW. Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2013;10(10):575&#x2013;584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23835488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Makaronidis JM, Batterham RL. Obesity, body weight regulation and the brain: insights from fMRI. Br J Radiol. 2018</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6223152</ArticleId>
            <ArticleId IdType="pubmed">29365284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott WR, Batterham RL. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol. 2011;301(1):R15&#x2013;R27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21474429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 2002;418(6898):650&#x2013;654.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12167864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning S, Pucci A, Batterham RL. GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery? Physiology (Bethesda, Md) 2015;30(1):50&#x2013;62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25559155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Batterham RL, Ffytche DH, Rosenthal JM, et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature. 2007;450(7166):106&#x2013;109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17934448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guida C, Stephen S, Guitton R, et al. The role of PYY in pancreatic islet physiology and surgical control of diabetes. Trends Endocrinol Metab TEM. 2017;28(8):626&#x2013;636.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28533020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pucci A, Finer N. New medications for treatment of obesity: metabolic and cardiovascular effects. Can J Cardiol. 2015;31(2):142&#x2013;152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25661549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller TD, Nogueiras R, Andermann ML, et al. Ghrelin. Mol Metab. 2015;4(6):437&#x2013;460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4443295</ArticleId>
            <ArticleId IdType="pubmed">26042199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berthoud HR. Metabolic and hedonic drives in the neural control of appetite: who is the boss? Curr Opin Neurobiol. 2011;21(6):888&#x2013;896.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3254791</ArticleId>
            <ArticleId IdType="pubmed">21981809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seeley RJ, Chambers AP, Sandoval DA. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab. 2015;21(3):369&#x2013;378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4351155</ArticleId>
            <ArticleId IdType="pubmed">25662404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009;10(3):167&#x2013;177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2739652</ArticleId>
            <ArticleId IdType="pubmed">19723493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dufer M, Horth K, Wagner R, et al. Bile acids acutely stimulate insulin secretion of mouse beta-cells via farnesoid X receptor activation and K(ATP) channel inhibition. Diabetes. 2012;61(6):1479&#x2013;1489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3357280</ArticleId>
            <ArticleId IdType="pubmed">22492528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lundasen T, Galman C, Angelin B, et al. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med. 2006;260(6):530&#x2013;536.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17116003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang S, Suh JM, Reilly SM, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med. 2015;21(2):159&#x2013;165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4320010</ArticleId>
            <ArticleId IdType="pubmed">25559344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439(7075):484&#x2013;489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16400329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki T, Aoyama J, Hashimoto M, et al. Correlation between postprandial bile acids and body fat mass in healthy normal-weight subjects. Clin Biochem. 2014;47(12):1128&#x2013;1131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24794786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007;449(7164):804&#x2013;810.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3709439</ArticleId>
            <ArticleId IdType="pubmed">17943116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez KB, Pierre JF, Chang EB. The gut microbiota: the gateway to improved metabolism. Gastroenterol Clin N Am. 2016;45(4):601&#x2013;614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5127273</ArticleId>
            <ArticleId IdType="pubmed">27837775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cummings DE. Taste and the regulation of food intake: it&#x2019;s not just about flavor. Am J Clin Nutr. 2015;102(4):717&#x2013;718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4588746</ArticleId>
            <ArticleId IdType="pubmed">26354541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piaggi P, Vinales KL, Basolo A, et al. Energy expenditure in the etiology of human obesity: spendthrift and thrifty metabolic phenotypes and energy-sensing mechanisms. J Endocrinol Invest. 2018;41(1):83&#x2013;89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5756119</ArticleId>
            <ArticleId IdType="pubmed">28741280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glicksman C, Pournaras DJ, Wright M, et al. Postprandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem. 2010;47(Pt 5):482&#x2013;484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20595403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aron-Wisnewsky J, Clement K. The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity. Curr Atheroscler Rep. 2014;16(11):454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25214424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480&#x2013;484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2677729</ArticleId>
            <ArticleId IdType="pubmed">19043404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1(6):6ra14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2894525</ArticleId>
            <ArticleId IdType="pubmed">20368178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101(44):15718&#x2013;15723.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC524219</ArticleId>
            <ArticleId IdType="pubmed">15505215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tambo A, Roshan MH, Pace NP. The microbial hypothesis: contributions of adenovirus infection and metabolic endotoxaemia to the pathogenesis of obesity. Int J Chronic Dis. 2016;2016:7030795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5143720</ArticleId>
            <ArticleId IdType="pubmed">28004036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027&#x2013;1031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17183312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkeling B, King NA, Naslund E, et al. Characterization of obese individuals who claim to detect no relationship between their eating pattern and sensations of hunger or fullness. Int J Obes (2005) 2007;31(3):435&#x2013;439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16953260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597&#x2013;1604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22029981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leibel RL, Hirsch J. Diminished energy requirements in reduced-obese patients. Metab Clin Exp. 1984;33(2):164&#x2013;170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6694559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Browning KN, Fortna SR, Hajnal A. Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones. J Physiol. 2013;591(9):2357&#x2013;2372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3650700</ArticleId>
            <ArticleId IdType="pubmed">23459752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mann T, Tomiyama AJ, Westling E, et al. Medicare&#x2019;s search for effective obesity treatments: diets are not the answer. Am Psychol. 2007;62(3):220&#x2013;233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17469900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ionut V, Bergman RN. Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol. 2011;5(5):1263&#x2013;1282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3208891</ArticleId>
            <ArticleId IdType="pubmed">22027328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92(4):704&#x2013;713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20739420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning S, Pucci A, Batterham RL. Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. J Clin Investig. 2015;125(3):939&#x2013;948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4362264</ArticleId>
            <ArticleId IdType="pubmed">25729850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dar MS, Chapman WH, 3rd, Pender JR, et al. GLP-1 response to a mixed meal: what happens 10&#xA0;years after Roux-en-Y gastric bypass (RYGB)? Obes Surg. 2012;22(7):1077&#x2013;1083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22419108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yousseif A, Emmanuel J, Karra E, et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg. 2014;24(2):241&#x2013;252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3890046</ArticleId>
            <ArticleId IdType="pubmed">23996294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346(21):1623&#x2013;1630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12023994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chandarana K, Drew ME, Emmanuel J, et al. Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humans. Gastroenterology. 2009;136(7):2115&#x2013;2126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19233179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dirksen C, Jorgensen NB, Bojsen-Moller KN, et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes (2005) 2013;37(11):1452&#x2013;1459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23419600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246(5):780&#x2013;785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17968169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Svane MS, Jorgensen NB, Bojsen-Moller KN, et al. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. Int J Obes (2005) 2016;40(11):1699&#x2013;1706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27434221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pucci A, Cheung WH, Jones J, et al. A case of severe anorexia, excessive weight loss and high peptide YY levels after sleeve gastrectomy. Endocrinol Diabetes Metab Case Rep. 2015;2015:150020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4674657</ArticleId>
            <ArticleId IdType="pubmed">26664728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao RS, Kini S. GIP and bariatric surgery. Obes Surg. 2011;21(2):244&#x2013;252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21082290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salinari S, Bertuzzi A, Asnaghi S, et al. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care. 2009;32(3):375&#x2013;380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2646012</ArticleId>
            <ArticleId IdType="pubmed">19033407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236&#x2013;242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1356398</ArticleId>
            <ArticleId IdType="pubmed">15273546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki K, Jayasena CN, Bloom SR. Obesity and appetite control. Exp Diabetes Res. 2012;2012:824305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3415214</ArticleId>
            <ArticleId IdType="pubmed">22899902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740&#x2013;748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3319900</ArticleId>
            <ArticleId IdType="pubmed">22354457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2&#xA0;weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22(7):1084&#x2013;1096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22359255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sillakivi T, Suumann J, Kirsimagi U, et al. Plasma levels of gastric biomarkers in patients after bariatric surgery: biomarkers after bariatric surgery. Hepatogastroenterology. 2013;60(128):2129&#x2013;2132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24719957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egerod KL, Engelstoft MS, Grunddal KV, et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology. 2012;153(12):5782&#x2013;5795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7958714</ArticleId>
            <ArticleId IdType="pubmed">23064014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinert RE, Peterli R, Keller S, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring, Md) 2013;21(12):E660&#x2013;E668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23804517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pournaras DJ, Glicksman C, Vincent RP, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 2012;153(8):3613&#x2013;3619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3404349</ArticleId>
            <ArticleId IdType="pubmed">22673227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmad NN, Pfalzer A. Kaplan LM (2013) Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes. 2005;37(12):1553&#x2013;1559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4157126</ArticleId>
            <ArticleId IdType="pubmed">23567924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liou AP, Paziuk M, Luevano JM, Jr, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5(178):178141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3652229</ArticleId>
            <ArticleId IdType="pubmed">23536013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509(7499):183&#x2013;188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4016120</ArticleId>
            <ArticleId IdType="pubmed">24670636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Midtvedt T, Norman A, Nygaard K. Bile acid transforming micro-organisms in rats with an intestinal blind segment. Acta Pathologica et microbiologica Scandinavica. 1969;77(1):162&#x2013;166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4904667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H, Hu C, Zhang X, et al. Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes. J Diabetes Investig. 2018;9(1):13&#x2013;20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5754516</ArticleId>
            <ArticleId IdType="pubmed">28434196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22(2):228&#x2013;238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4537510</ArticleId>
            <ArticleId IdType="pubmed">26244932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59(12):3049&#x2013;3057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2992765</ArticleId>
            <ArticleId IdType="pubmed">20876719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4554&#x2013;4561.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3063582</ArticleId>
            <ArticleId IdType="pubmed">20847294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy R, Tsai P, Jullig M, et al. Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg. 2017;27(4):917&#x2013;925.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27738970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medina DA, Pedreros JP, Turiel D, et al. Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients. PeerJ. 2017;5:e3443.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5480389</ArticleId>
            <ArticleId IdType="pubmed">28649469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Y, Liu CQ, Shan CX, et al. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: increased diversity and associations of discriminant genera with metabolic changes. Diabetes/Metab Res Rev. 2017</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27572277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cavin JB, Couvelard A, Lebtahi R, et al. Differences in alimentary glucose absorption and intestinal disposal of blood glucose after Roux-en-Y gastric bypass vs sleeve gastrectomy. Gastroenterology. 2016;150(2):454&#x2013;464.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26481855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saeidi N, Meoli L, Nestoridi E, et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science (New York, NY) 2013;341(6144):406&#x2013;410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4068965</ArticleId>
            <ArticleId IdType="pubmed">23888041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baud G, Daoudi M, Hubert T, et al. Bile diversion in Roux-en-Y gastric bypass modulates sodium-dependent glucose intestinal uptake. Cell Metab. 2016;23(3):547&#x2013;553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26924216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zakeri R, Batterham RL. Potential mechanisms underlying the effect of bariatric surgery on eating behaviour. Curr Opin Endocrinol Diabetes Obes. 2018;25(1):3&#x2013;11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29120924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berthoud HR. Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil. 2008;20(Suppl 1):64&#x2013;72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3617963</ArticleId>
            <ArticleId IdType="pubmed">18402643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berthoud HR, Shin AC, Zheng H. Obesity surgery and gut-brain communication. Physiol Behav. 2011;105(1):106&#x2013;119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3118403</ArticleId>
            <ArticleId IdType="pubmed">21315095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leibel RL, Seeley RJ, Darsow T, et al. Biologic responses to weight loss and weight regain: report from an American diabetes association research symposium. Diabetes. 2015;64(7):2299&#x2013;2309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26106187</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29724152</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-1706</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global public health</Title>
          <ISOAbbreviation>Glob Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ethical responsibilities of health research funders to advance global health justice.</ArticleTitle>
        <Pagination>
          <StartPage>80</StartPage>
          <EndPage>90</EndPage>
          <MedlinePgn>80-90</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2018.1471148</ELocationID>
        <Abstract>
          <AbstractText>Research funders from high-income countries have an ethical obligation to support health research in low and middle-income countries that promotes justice in global health. Conceptual work from bioethics proposes funders should do so through their design of grants programs, investments, and grants management. That work has begun to specify the content of funders' ethical responsibility with regards to health systems research, but it has thus far not been informed by their practice. As a first step to bridge that gap, this paper focuses on health systems research funders' design of grants programs. It aims to test the content of funders' proposed ethical responsibility against recent empirical work describing how they design their health systems research grants programs to help address global health disparities. Based on that analysis, recommendations are made for how to better articulate the content of health systems research funders' obligation. Such recommendations may be pertinent to funders of other types of international research. The paper also provides an initial picture of how well health systems research grants programs' designs may align with the ideals of global health justice.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pratt</LastName>
            <ForeName>Bridget</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0002-4934-3560</Identifier>
            <AffiliationInfo>
              <Affiliation>a Nossal Institute for Global Health and Centre for Health Equity, School of Population and Global Health , University of Melbourne , Melbourne , Australia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Department of International Health , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hyder</LastName>
            <ForeName>Adnan A</ForeName>
            <Initials>AA</Initials>
            <Identifier Source="ORCID">0000-0002-7292-577X</Identifier>
            <AffiliationInfo>
              <Affiliation>b Department of International Health , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>c Johns Hopkins Berman Institute of Bioethics , Baltimore , MD , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Public Health</MedlineTA>
        <NlmUniqueID>101256323</NlmUniqueID>
        <ISSNLinking>1744-1692</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069576" MajorTopicYN="Y">Health Equity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D028681" MajorTopicYN="Y">Moral Obligations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012109" MajorTopicYN="N">Research Support as Topic</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012935" MajorTopicYN="Y">Social Justice</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ethics</Keyword>
        <Keyword MajorTopicYN="N">donor</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">health systems research</Keyword>
        <Keyword MajorTopicYN="N">international research</Keyword>
        <Keyword MajorTopicYN="N">justice</Keyword>
        <Keyword MajorTopicYN="N">low and middle-income countries</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29724152</ArticleId>
        <ArticleId IdType="doi">10.1080/17441692.2018.1471148</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29712498</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-4303</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>56</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of asthma : official journal of the Association for the Care of Asthma</Title>
          <ISOAbbreviation>J Asthma</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of the PROMIS pediatric global health scale (PGH-7) in children with asthma.</ArticleTitle>
        <Pagination>
          <StartPage>534</StartPage>
          <EndPage>542</EndPage>
          <MedlinePgn>534-542</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/02770903.2018.1471701</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">To evaluate the reliability and validity of the PROMIS Pediatric Global Health scale, a 7-item measure of perceived physical, mental, and social health, in children with asthma.</AbstractText>
          <AbstractText Label="METHODS">From February 2014 to February 2015, convenience samples of 8-17&#xA0;year-old children (n = 182) and parents of 5-17&#xA0;year-old children (n = 328) visiting an emergency department for treatment of asthma were enrolled. The Asthma Control Test was used to characterize children as controlled versus not controlled, and the PROMIS Asthma Impact Scale was used to assess asthma symptoms' impact on functional status. We conducted longitudinal analyses among 92 children and 218 parents at 3&#xA0;weeks, and 74 children and 171 parents at 8&#xA0;weeks after enrollment.</AbstractText>
          <AbstractText Label="RESULTS">The PGH-7 reliability ranged from 0.66 to 0.81 for child-report and 0.76 to 0.82 for parent-proxy. In cross-sectional analyses, children with controlled asthma had PGH-7 scores 0.40-0.95 standard deviation units higher than those who were uncontrolled. The PGH-7 was responsive to changes in overall general health between time points, with moderate effect sizes (0.5-0.6 standard deviation units). In longitudinal analyses, PGH-7 scores were no different between those who stayed uncontrolled versus became controlled at 3&#xA0;weeks of follow-up; however, by 8&#xA0;weeks of follow-up, the differences between these groups were 0.7-0.8 standard deviation units, indicative of large effects.</AbstractText>
          <AbstractText Label="CONCLUSIONS">The PGH-7 is a reliable and valid patient-reported outcome for assessing general health among children with asthma. It is a useful complement to other asthma-specific outcome measures.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Forrest</LastName>
            <ForeName>Christopher B</ForeName>
            <Initials>CB</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Pediatrics , Perelman School of Medicine, University of Pennsylvania , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Division of General Pediatrics , Children's Hospital of Philadelphia , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zorc</LastName>
            <ForeName>Joseph J</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Pediatrics , Perelman School of Medicine, University of Pennsylvania , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>c Division of Emergency Medicine , Children's Hospital of Philadelphia , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moon</LastName>
            <ForeName>JeanHee</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Pediatrics , Perelman School of Medicine, University of Pennsylvania , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Division of General Pediatrics , Children's Hospital of Philadelphia , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pratiwadi</LastName>
            <ForeName>Ramya</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Pediatrics , Perelman School of Medicine, University of Pennsylvania , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Division of General Pediatrics , Children's Hospital of Philadelphia , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Becker</LastName>
            <ForeName>Brandon D</ForeName>
            <Initials>BD</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Pediatrics , Perelman School of Medicine, University of Pennsylvania , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Division of General Pediatrics , Children's Hospital of Philadelphia , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maltenfort</LastName>
            <ForeName>Mitchell G</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Pediatrics , Perelman School of Medicine, University of Pennsylvania , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Division of General Pediatrics , Children's Hospital of Philadelphia , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guevara</LastName>
            <ForeName>James P</ForeName>
            <Initials>JP</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Pediatrics , Perelman School of Medicine, University of Pennsylvania , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Division of General Pediatrics , Children's Hospital of Philadelphia , Philadelphia , PA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>U18 HS020508</GrantID>
            <Acronym>HS</Acronym>
            <Agency>AHRQ HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Asthma</MedlineTA>
        <NlmUniqueID>8106454</NlmUniqueID>
        <ISSNLinking>0277-0903</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006304" MajorTopicYN="Y">Health Status</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057566" MajorTopicYN="Y">Self Report</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Asthma</Keyword>
        <Keyword MajorTopicYN="N">Child</Keyword>
        <Keyword MajorTopicYN="N">Health status</Keyword>
        <Keyword MajorTopicYN="N">PROMIS: PGH-7</Keyword>
        <Keyword MajorTopicYN="N">Patient-reported outcome</Keyword>
        <Keyword MajorTopicYN="N">Quality of life</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29712498</ArticleId>
        <ArticleId IdType="doi">10.1080/02770903.2018.1471701</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29712482</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-4954</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>22</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title>
          <ISOAbbreviation>J Matern Fetal Neonatal Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Does pregnancy interval after laparoscopic sleeve gastrectomy affect maternal and perinatal outcomes?</ArticleTitle>
        <Pagination>
          <StartPage>3764</StartPage>
          <EndPage>3770</EndPage>
          <MedlinePgn>3764-3770</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/14767058.2018.1471678</ELocationID>
        <Abstract>
          <AbstractText><b>Background:</b> Obesity is a global health epidemic and is associated with many maternal and neonatal complications. Laparoscopic sleeve gastrectomy (LSG) is among the surgical treatments for obesity. The appropriate timing of pregnancy following LSG remains controversial and few studies have evaluated this public health issue. <b>Objective:</b> To evaluate the effect of pregnancy timing after LSG on maternal and perinatal outcomes. <b>Study design:</b> We performed a retrospective observational study of 23 pregnant women who underwent LSG at a tertiary hospital in Turkey. Women who became pregnant within 18 months of undergoing LSG were included in the early pregnancy after LSG group, and those who became pregnant after 18 months were included the late pregnancy after LSG group. Maternal and perinatal outcomes were evaluated, including gestational diabetes mellitus (GDM), pregnancy-associated hypertensive disorders, preterm birth, mode of delivery, small and large for gestational age births (small for gestational age (SGA), large for gestational age (LGA)), birth injury, and congenital malformations. <b>Results:</b> Body mass index (BMI) at conception was higher in the early pregnancy after LSG group than in the late pregnancy after LSG group (30.48 versus 27.25, respectively; <i>p</i>&#x2009;=&#x2009;.03). Pregnancy interval after LSG did not impact maternal-fetal complications or mode of delivery. After a 75&#x2009;g oral glucose tolerance test (OGTT) for GDM, 75% (<i>n</i>&#x2009;=&#x2009;6) of the early pregnancy group presented with early dumping syndrome, compared to only 13.3% (<i>n</i>&#x2009;=&#x2009;2) of the late pregnancy after LSG group (<i>p</i>&#x2009;=&#x2009;.009). <b>Conclusions:</b> LSG may reduce obesity-related gestational complications, such as GDM and LGA. The interval between LSG and conception did not impact maternal or neonatal outcomes. Screening for GDM can result in dumping syndrome in pregnancies after LSG.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Basbug</LastName>
            <ForeName>Alper</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-1825-9849</Identifier>
            <AffiliationInfo>
              <Affiliation>a Department of Obstetrics and Gynecology , Duzce University, Faculty of Medicine , Duzce , Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ellibe&#x15F; Kaya</LastName>
            <ForeName>A&#x15F;k&#x131;</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-1323-7416</Identifier>
            <AffiliationInfo>
              <Affiliation>a Department of Obstetrics and Gynecology , Duzce University, Faculty of Medicine , Duzce , Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dogan</LastName>
            <ForeName>Sami</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of General Surgery , Duzce University, Faculty of Medicine , Duzce , Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pehlivan</LastName>
            <ForeName>Mevlut</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of General Surgery , Duzce University, Faculty of Medicine , Duzce , Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goynumer</LastName>
            <ForeName>Gokhan</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0002-3739-6008</Identifier>
            <AffiliationInfo>
              <Affiliation>c Department of Obstetrics and Gynecology , SB Istanbul Medeniyet University Goztepe Education and Research Hospital , Istanbul , Turkey.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D064888">Observational Study</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Matern Fetal Neonatal Med</MedlineTA>
        <NlmUniqueID>101136916</NlmUniqueID>
        <ISSNLinking>1476-4954</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001721" MajorTopicYN="Y">Birth Intervals</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005743" MajorTopicYN="Y">Gastrectomy</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009767" MajorTopicYN="N">Obesity, Morbid</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010298" MajorTopicYN="N">Parity</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bariatric surgery</Keyword>
        <Keyword MajorTopicYN="N">dumping syndrome</Keyword>
        <Keyword MajorTopicYN="N">laparoscopic sleeve gastrectomy</Keyword>
        <Keyword MajorTopicYN="N">pregnancy complications</Keyword>
        <Keyword MajorTopicYN="N">pregnancy interval</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29712482</ArticleId>
        <ArticleId IdType="doi">10.1080/14767058.2018.1471678</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29703103</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1758-1001</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>56</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of clinical biochemistry</Title>
          <ISOAbbreviation>Ann Clin Biochem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The assessment of iodine status - populations, individuals and limitations.</ArticleTitle>
        <Pagination>
          <StartPage>7</StartPage>
          <EndPage>14</EndPage>
          <MedlinePgn>7-14</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/0004563218774816</ELocationID>
        <Abstract>
          <AbstractText>Iodine deficiency is a significant global health concern, and the single greatest cause of preventable cognitive impairment. It is also a growing public health concern in the UK particularly among pregnant women. Biomarkers such as urinary iodine concentration have clear utility in epidemiological studies to investigate population-level iodine status, but determination of iodine status in individuals is much more problematic with current assays. This article reviews the available biomarkers of iodine status and their relative utility at the level of both populations and individuals for the investigation of iodine deficiency and iodine excess.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wainwright</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>1 Chemical Pathology and Metabolic Medicine, Department of Laboratory Medicine, University Hospital Southampton, Southampton, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2 Current affiliation: Department of Blood Sciences, Glan Clwyd Hospital, Bodelwyddan, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cook</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>1 Chemical Pathology and Metabolic Medicine, Department of Laboratory Medicine, University Hospital Southampton, Southampton, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>05</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ann Clin Biochem</MedlineTA>
        <NlmUniqueID>0324055</NlmUniqueID>
        <ISSNLinking>0004-5632</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9679TC07X4</RegistryNumber>
          <NameOfSubstance UI="D007455">Iodine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
          <QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007455" MajorTopicYN="N">Iodine</DescriptorName>
          <QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName>
          <QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013959" MajorTopicYN="N">Thyroid Diseases</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Iodine</Keyword>
        <Keyword MajorTopicYN="N">epidemiology studies</Keyword>
        <Keyword MajorTopicYN="N">thyroid disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29703103</ArticleId>
        <ArticleId IdType="doi">10.1177/0004563218774816</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29697307</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-1706</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global public health</Title>
          <ISOAbbreviation>Glob Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>How states exerted power to create the Millennium Development Goals and how this shaped the global health agenda: Lessons for the sustainable development goals and the future of global health.</ArticleTitle>
        <Pagination>
          <StartPage>584</StartPage>
          <EndPage>599</EndPage>
          <MedlinePgn>584-599</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2018.1468474</ELocationID>
        <Abstract>
          <AbstractText>Since 2000, the eight Millennium Development Goals (MDGs) provided the framework for global development efforts transforming the field now known as global health. The MDGs both reflected and contributed to shaping a normative global health agenda. In the field of global health, the role of the state is largely considered to have diminished; however, this paper reasserts states as actors in the conceptualisation and institutionalisation of the MDGs, and illustrates how states exerted power and engaged in the MDG process. States not only sanctioned the MDGs through their heads of states endorsing the Millennium Declaration, but also acted more subtly behind the scenes supporting, enabling, and/or leveraging other actors, institutions and processes to conceptualise and legitimize the MDGs. Appreciating the MDGs' role in the conceptualisation of global health is particularly relevant as the world transitions to the MDGs' successor, the Sustainable Development Goals (SDGs). The SDGs' influence, impact and importance remains to be seen; however, to understand the future of global health and how actors, particularly states, can engage to shape the field, a deeper sense of the MDGs' legacy and how actors engaged in the past is helpful.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Marten</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-2416-2309</Identifier>
            <AffiliationInfo>
              <Affiliation>a Global Health and Development , London School of Hygiene and Tropical Medicine , London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>04</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Public Health</MedlineTA>
        <NlmUniqueID>101256323</NlmUniqueID>
        <ISSNLinking>1744-1692</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006040" MajorTopicYN="Y">Goals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011209" MajorTopicYN="Y">Power, Psychological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076502" MajorTopicYN="Y">Sustainable Development</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014480" MajorTopicYN="Y">United Nations</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Millennium Development Goals</Keyword>
        <Keyword MajorTopicYN="N">Power</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">global health governance</Keyword>
        <Keyword MajorTopicYN="N">global health policy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29697307</ArticleId>
        <ArticleId IdType="doi">10.1080/17441692.2018.1468474</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29693459</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-4303</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>56</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of asthma : official journal of the Association for the Care of Asthma</Title>
          <ISOAbbreviation>J Asthma</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluating the effectiveness of systemic corticosteroids to mitigate relapse in children assessed and treated for acute asthma: A network meta-analysis.</ArticleTitle>
        <Pagination>
          <StartPage>522</StartPage>
          <EndPage>533</EndPage>
          <MedlinePgn>522-533</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/02770903.2018.1467444</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">The objective of this systematic review was to explore the effectiveness of various systemic corticosteroid (SCS) regimens to mitigate relapse in children with asthma discharged from an acute care setting.</AbstractText>
          <AbstractText Label="DATA SOURCES">Medline, EMBASE, Global Health, International Pharmaceutical Abstracts, EMB ALL, CINAHL, SCOPUS, Proquest Dissertations and Theses Global, and LILACS were searched using controlled vocabulary and key words. Additional citations were searched via clinical trial registries, Google Scholar, bibliographies, a SCOPUS forward search of a sentinel paper, and hand searching conference abstracts.</AbstractText>
          <AbstractText Label="STUDY SELECTION">No limitations based on language, publication status, or year of publication were applied. Two independent reviewers searched to identify randomized controlled trials comparing the effectiveness of SCS regimens to prevent relapse in children following treatment for acute asthma.</AbstractText>
          <AbstractText Label="RESULTS">Fifteen studies were included. In 3 studies comparing SCS to placebo, asthma relapse was significantly reduced (RR = 0.10; 95% CI: 0.01, 0.77; I<sup>2</sup> = 0%). A network analysis identified a significant reduction in relapse in children treated with intramuscular corticosteroids (OR = 0.038; 95% CrI: 0.001, 0.397), short-course oral prednisone (OR = 0.054; 95% CrI: 0.002, 0.451), and oral dexamethasone (OR = 0.071; 95% CrI: 0.002, 0.733) compared to placebo.</AbstractText>
          <AbstractText Label="CONCLUSION">This review found evidence that SCS reduces relapse in children following treatment for acute asthma, albeit based on a limited number of studies. Additional studies are required to assess the differential effect of SCS doses and treatment duration to prevent relapse in children following discharge for acute asthma.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kirkland</LastName>
            <ForeName>Scott W</ForeName>
            <Initials>SW</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Emergency Medicine , University of Alberta , Edmonton , AB , Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vandermeer</LastName>
            <ForeName>Ben</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Pediatrics, Alberta Research Centre for Health Evidence , University of Alberta, Edmonton Clinic Health Academy , Edmonton , AB , Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Campbell</LastName>
            <ForeName>Sandy</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>c J.W. Scott Health Sciences Library , University of Alberta , Walter C. Mackenzie Health Sciences Centre, Edmonton , AB , Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Villa-Roel</LastName>
            <ForeName>Cristina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Emergency Medicine , University of Alberta , Edmonton , AB , Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Newton</LastName>
            <ForeName>Amanda</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>d Department of Pediatrics , University of Alberta , Edmonton , AB , Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ducharme</LastName>
            <ForeName>Francine M</ForeName>
            <Initials>FM</Initials>
            <AffiliationInfo>
              <Affiliation>e Departments of Pediatrics and of Social and Preventive Medicine , University of Montreal , Montreal , Quebec , Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rowe</LastName>
            <ForeName>Brian H</ForeName>
            <Initials>BH</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Emergency Medicine , University of Alberta , Edmonton , AB , Canada.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>f School of Public Health, University of Alberta , Edmonton Clinic Health Academy , Edmonton , AB , Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <Agency>CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D017418">Meta-Analysis</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Asthma</MedlineTA>
        <NlmUniqueID>8106454</NlmUniqueID>
        <ISSNLinking>0277-0903</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7S5I7G3JQL</RegistryNumber>
          <NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>VB0R961HZT</RegistryNumber>
          <NameOfSubstance UI="D011241">Prednisone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071076" MajorTopicYN="N">Network Meta-Analysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Dexamethasone</Keyword>
        <Keyword MajorTopicYN="N">emergency department</Keyword>
        <Keyword MajorTopicYN="N">prednisone</Keyword>
        <Keyword MajorTopicYN="N">randomized controlled trials</Keyword>
        <Keyword MajorTopicYN="N">systematic review</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29693459</ArticleId>
        <ArticleId IdType="doi">10.1080/02770903.2018.1467444</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29679493</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-5381</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>176</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of pharmacology</Title>
          <ISOAbbreviation>Br J Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>PPARs and pain.</ArticleTitle>
        <Pagination>
          <StartPage>1421</StartPage>
          <EndPage>1442</EndPage>
          <MedlinePgn>1421-1442</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/bph.14339</ELocationID>
        <Abstract>
          <AbstractText>Chronic pain is a common cause of disability worldwide and remains a global health and socio-economic challenge. Current analgesics are either ineffective in a significant proportion of patients with chronic pain or associated with significant adverse side effects. The PPARs, a family of nuclear hormone transcription factors, have emerged as important modulators of pain in preclinical studies and therefore a potential therapeutic target for the treatment of pain. Modulation of nociceptive processing by PPARs is likely to involve both transcription-dependent and transcription-independent mechanisms. This review presents a comprehensive overview of preclinical studies investigating the contribution of PPAR signalling to nociceptive processing in animal models of inflammatory and neuropathic pain. We examine current evidence from anatomical, molecular and pharmacological studies demonstrating a role for PPARs in pain control. We also discuss the limited evidence available from relevant clinical studies and identify areas that warrant further research. LINKED ARTICLES: This article is part of a themed section on 8<sup>th</sup> European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 The British Pharmacological Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Okine</LastName>
            <ForeName>Bright N</ForeName>
            <Initials>BN</Initials>
            <Identifier Source="ORCID">0000-0001-7797-1831</Identifier>
            <AffiliationInfo>
              <Affiliation>Pharmacology and Therapeutics, National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Pain Research, NCBES, National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gaspar</LastName>
            <ForeName>Jessica C</ForeName>
            <Initials>JC</Initials>
            <Identifier Source="ORCID">0000-0003-0227-5449</Identifier>
            <AffiliationInfo>
              <Affiliation>Pharmacology and Therapeutics, National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Pain Research, NCBES, National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Finn</LastName>
            <ForeName>David P</ForeName>
            <Initials>DP</Initials>
            <Identifier Source="ORCID">0000-0001-6186-621X</Identifier>
            <AffiliationInfo>
              <Affiliation>Pharmacology and Therapeutics, National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Pain Research, NCBES, National University of Ireland Galway, Galway, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Pharmacol</MedlineTA>
        <NlmUniqueID>7502536</NlmUniqueID>
        <ISSNLinking>0007-1188</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000700">Analgesics</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D047492">Peroxisome Proliferator-Activated Receptors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059350" MajorTopicYN="N">Chronic Pain</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009437" MajorTopicYN="N">Neuralgia</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047492" MajorTopicYN="N">Peroxisome Proliferator-Activated Receptors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29679493</ArticleId>
        <ArticleId IdType="pmc">PMC6487555</ArticleId>
        <ArticleId IdType="doi">10.1111/bph.14339</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ahern GP (2003). Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 278: 30429&#x2013;30434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12761211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alexander SPH, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD et al (2017a). The Concise Guide to PHARMACOLOGY 2017/18: Nuclear hormone receptors. Br J Pharmacol 174: S208&#x2013;S224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5650662</ArticleId>
            <ArticleId IdType="pubmed">29055032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alexander SPH, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD et al (2017b). The Concise Guide to PHARMACOLOGY 2017/18: Voltage&#x2010;gated ion channels. Br J Pharmacol 174: S160&#x2013;S194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5650668</ArticleId>
            <ArticleId IdType="pubmed">29055033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Marrion NV, Peters JA et al (2017c). The Concise Guide to PHARMACOLOGY 2017/18: G protein&#x2010;coupled receptors. Br J Pharmacol 174: S17&#x2013;S129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5650667</ArticleId>
            <ArticleId IdType="pubmed">29055040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ambrosino P, Soldovieri MV, De Maria M, Russo C, Taglialatela M (2014). Functional and biochemical interaction between PPAR&#x3B1; receptors and TRPV1 channels: potential role in PPAR&#x3B1; agonists&#x2010;mediated analgesia. Pharmacol Res 87: 113&#x2013;122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25014183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andresen SR, Bing J, Hansen RM, Biering&#x2010;Sorensen F, Johannesen IL, Hagen EM et al (2016). Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double&#x2010;blind, placebo&#x2010;controlled trial. Pain 157: 2097&#x2013;2103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27227691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aoki T (2007). Current status of carcinogenicity assessment of peroxisome proliferator&#x2010;activated receptor agonists by the US FDA and a mode&#x2010;of&#x2010;action approach to the carcinogenic potential. J Toxicol Pathol 20: 197&#x2013;202.</Citation>
        </Reference>
        <Reference>
          <Citation>Be&#x142;towski J, Racha&#x144;czyk J, W&#x142;odarczyk M (2013). Thiazolidinedione&#x2010;induced fluid retention: recent insights into the molecular mechanisms. PPAR Res 2013: 628628.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3614122</ArticleId>
            <ArticleId IdType="pubmed">23577024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benani A, Heurtaux T, Netter P, Minn A (2004). Activation of peroxisome proliferator&#x2010;activated receptor alpha in rat spinal cord after peripheral noxious stimulation. Neurosci Lett 369: 59&#x2013;63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15380308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bettoni I, Comelli F, Colombo A, Bonfanti P, Costa B (2013). Non&#x2010;neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide. CNS Neurol Disord Drug Targets 12: 34&#x2013;44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23394519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biga J, Vigreux P, Lapeyre&#x2010;Mestre M, Montastruc JL (2005). Muscular pain and hypolipidaemic drugs: a cross&#x2010;sectional study in cardiological outpatient practice. Therapie 60: 295&#x2013;297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16128273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouaboula M, Hilairet S, Marchand J, Fajas L, Fur GL, Casellas P (2005). Anandamide induced PPAR&#x3B3; transcriptional activation and 3T3&#x2010;L1 preadipocyte differentiation. Eur J Pharmacol 517: 174&#x2013;181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15987634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W (1996). Differential expression of peroxisome proliferator&#x2010;activated receptors (PPARs): tissue distribution of PPAR&#x2010;alpha, &#x2010;beta, and &#x2010;gamma in the adult rat. Endocrinology 137: 354&#x2013;366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8536636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burke NN, Hayes E, Calpin P, Kerr DM, Moriarty O, Finn DP et al (2010). Enhanced nociceptive responding in two rat models of depression is associated with alterations in monoamine levels in discrete brain regions. Neuroscience 171: 1300&#x2013;1313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20955767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Byrne FM, Cheetham S, Vickers S, Chapman V (2015). Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments. J Diabetes Res 2015: 752481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4338392</ArticleId>
            <ArticleId IdType="pubmed">25759824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Capasso R, Izzo AA, Fezza F, Pinto A, Capasso F, Mascolo N et al (2001). Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice. Br J Pharmacol 134: 945&#x2013;950.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1573032</ArticleId>
            <ArticleId IdType="pubmed">11682441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chakravarthy MV, Zhu Y, L&#xF3;pez M, Yin L, Wozniak DF, Coleman T et al (2007). Brain fatty acid synthase activates PPAR&#x3B1; to maintain energy homeostasis. J Clin Invest 117: 2539&#x2013;2552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1937501</ArticleId>
            <ArticleId IdType="pubmed">17694178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Churi SB, Abdel&#x2010;Aleem OS, Tumber KK, Scuderi&#x2010;Porter H, Taylor BK (2008). Intrathecal rosiglitazone acts at peroxisome proliferator&#x2010;activated receptor&#x2010;gamma to rapidly inhibit neuropathic pain in rats. J Pain 9: 639&#x2013;649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2556259</ArticleId>
            <ArticleId IdType="pubmed">18387855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa B, Comelli F, Bettoni I, Colleoni M, Giagnoni G (2008). The endogenous fatty acid amide, palmitoylethanolamide, has anti&#x2010;allodynic and anti&#x2010;hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPAR&#x3B3; receptors and neurotrophic factors. Pain 139: 541&#x2013;550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18602217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crisafulli C, Cuzzocrea S (2009). The role of endogenous and exogenous ligands for the peroxisome proliferator&#x2010;activated receptor alpha (PPAR&#x2010;alpha) in the regulation of inflammation in macrophages. Shock 32: 62&#x2013;73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19533851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cuzzocrea S, Bruscoli S, Mazzon E, Crisafulli C, Donato V, Di Paola R et al (2008). Peroxisome proliferator&#x2010;activated receptor&#x2010;&#x3B1; contributes to the anti&#x2010;inflammatory activity of glucocorticoids. Mol Pharmacol 73: 323&#x2013;337.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17984196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E et al (2009). Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF&#x2010;&#x3BA;B nuclear signalling in dorsal root ganglia. Eur J Pharmacol 613: 54&#x2013;59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19386271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D&#xE9;ciga&#x2010;Campos M, Ram&#xED;rez&#x2010;Mar&#xED;n PM, L&#xF3;pez&#x2010;Mu&#xF1;oz FJ (2015). Synergistic antinociceptive interaction between palmitoylethanolamide and tramadol in the mouse formalin test. Eur J Pharmacol. 765: 68&#x2013;74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26297302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Filippis D, Luongo L, Cipriano M, Palazzo E, Cinelli MP, De Novellis V et al (2011). Palmitoylethanolamide reduces granuloma&#x2010;induced hyperalgesia by modulation of mast cell activation in rats. Mol Pain 7: 3&#x2013;3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3034677</ArticleId>
            <ArticleId IdType="pubmed">21219627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Guglielmo G, Kallupi M, Scuppa G, Stopponi S, Demopulos G, Gaitanaris G et al (2014). Analgesic tolerance to morphine is regulated by PPAR&#x3B3;. Br J Pharmacol 171: 5407&#x2013;5416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4294048</ArticleId>
            <ArticleId IdType="pubmed">25048682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Novellis V, Luongo L, Guida F, Cristino L, Palazzo E, Russo R et al (2012). Effects of intra&#x2010;ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity. Eur J Pharmacol 676: 41&#x2013;50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22178921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delerive P, De Bosscher K, Vanden Berghe W, Fruchart JC, Haegeman G, Staels B (2002). DNA binding&#x2010;independent induction of I&#x3BA;B&#x3B1; gene transcription by PPAR&#x3B1;. Mol Endocrinol 16: 1029&#x2013;1039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11981037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delerive P, Fruchart JC, Staels B (2001). Peroxisome proliferator&#x2010;activated receptors in inflammation control. J Endocrinol 169: 453&#x2013;459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11375115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delerive P, Gervois P, Fruchart JC, Staels B (2000). Induction of I&#x3BA;B&#x3B1; expression as a mechanism contributing to the anti&#x2010;inflammatory activities of peroxisome proliferator&#x2010;activated receptor&#x2010;&#x3B1; activators. J Biol Chem 275: 36703&#x2013;36707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10980195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desvergne B, Wahli W (1999). Peroxisome proliferator&#x2010;activated receptors: nuclear control of metabolism. Endocr Rev 20: 649&#x2013;688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10529898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Cesare Mannelli L, D'Agostino G, Pacini A, Russo R, Zanardelli M, Ghelardini C et al (2013). Palmitoylethanolamide is a disease&#x2010;modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR&#x2010;alpha&#x2010;mediated mechanism. Mediators Inflamm 2013: 328797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3596927</ArticleId>
            <ArticleId IdType="pubmed">23533304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Cesare Mannelli L, Pacini A, Corti F, Boccella S, Luongo L, Esposito E et al (2015). Antineuropathic profile of N&#x2010;palmitoylethanolamine in a rat model of oxaliplatin&#x2010;induced neurotoxicity. PLoS ONE 10: e0128080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4454493</ArticleId>
            <ArticleId IdType="pubmed">26039098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donvito G, Bettoni I, Comelli F, Colombo A, Costa B (2015). Palmitoylethanolamide relieves pain and preserves pancreatic islet cells in a murine model of diabetes. CNS Neurol Disord Drug Targets 14: 452&#x2013;462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25921749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donvito G, Wilkerson JL, Damaj MI, Lichtman AH (2016). Palmitoylethanolamide reverses paclitaxel&#x2010;induced allodynia in mice. J Pharmacol Exp Ther 359: 310&#x2013;318.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5074488</ArticleId>
            <ArticleId IdType="pubmed">27608657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donvito G, Bagdas D, Toma W, Rahimpour E, Jackson A, Meade JA et al (2017). The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator&#x2010;activated receptor&#x2010;&#x3B1; represents a new antinociceptive signaling pathway in mice. Exp Neurol 295: 194&#x2013;201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5558428</ArticleId>
            <ArticleId IdType="pubmed">28606623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W (1992). Control of the peroxisomal beta&#x2010;oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879&#x2013;887.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1312391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Floyd JS, Barbehenn E, Lurie P, Wolfe SM (2009). Case series of liver failure associated with rosiglitazone and pioglitazone. Pharmacoepidemiol Drug Saf 18: 1238&#x2013;1243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19623674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez De Fonseca F et al (2003). Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR&#x2010;[alpha]. Nature 425: 90&#x2013;93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12955147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedland SN, Leong A, Filion KB, Genest J, Lega IC, Mottillo S et al (2012). The cardiovascular effects of peroxisome proliferator&#x2010;activated receptor agonists. Am J Med 125: 126&#x2013;133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22269613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuchs PN, Peng YB, Boyette&#x2010;Davis JA, Uhelski ML (2014). The anterior cingulate cortex and pain processing. Front Integr Neurosci 8: 35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4017137</ArticleId>
            <ArticleId IdType="pubmed">24829554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gabrielsson L, Mattsson S, Fowler CJ (2016). Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. Br J Clin Pharmacol 82: 932&#x2013;942.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5094513</ArticleId>
            <ArticleId IdType="pubmed">27220803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garg S, Deshmukh Vishwajit R, Prasoon P (2017). Possible modulation of PPAR&#x2010;&#x3B3; cascade against depression caused by neuropathic pain in rats. J Basic Clin Physiol Pharmacol 28: 593&#x2013;600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28888088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghavimi H, Charkhpour M, Ghasemi S, Mesgari M, Hamishehkar H, Hassanzadeh K et al (2015). Pioglitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in rat cerebral cortex. Pharmacol Rep 67: 78&#x2013;84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25560579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghavimi H, Hassanzadeh K, Maleki&#x2010;Dizaji N, Azarfardian A, Ghasami S, Zolali E et al (2014). Pioglitazone prevents morphine antinociception tolerance and withdrawal symptoms in rats. Naunyn Schmiedebergs Arch Pharmacol 387: 811&#x2013;821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24899385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gill N, Bijjem K, Sharma P (2013). Anti&#x2010;inflammatory and anti&#x2010;hyperalgesic effect of all&#x2010;trans retinoic acid in carrageenan&#x2010;induced paw edema in Wistar rats: involvement of peroxisome proliferator&#x2010;activated receptor&#x2010;&#x3B2;/&#x3B4; receptors. Indian J Pharmacol 45: 278&#x2013;282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3696301</ArticleId>
            <ArticleId IdType="pubmed">23833373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Green S, Tugwood JD, Issemann I (1992). The molecular mechanism of peroxisome proliferator action: a model for species differences and mechanistic risk assessment. Toxicol Lett, 64&#x2013;65 Spec No : 131&#x2013;139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1335174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griggs RB, Donahue RR, Adkins BG, Anderson KL, Thibault O, Taylor BK (2016). Pioglitazone inhibits the development of hyperalgesia and sensitization of spinal nociresponsive neurons in type 2 diabetes. J Pain 17: 359&#x2013;373.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4791042</ArticleId>
            <ArticleId IdType="pubmed">26687453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griggs RB, Donahue RR, Morgenweck J, Grace PM, Sutton A, Watkins LR et al (2015). Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPAR&#x3B3; mechanisms. Pain 156: 469&#x2013;482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4329091</ArticleId>
            <ArticleId IdType="pubmed">25599238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guida F, Luongo L, Marmo F, Romano R, Iannotta M, Napolitano F et al (2015). Palmitoylethanolamide reduces pain&#x2010;related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice. Mol Brain 8: 47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4532244</ArticleId>
            <ArticleId IdType="pubmed">26260027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harding SD, Sharman JL, Faccenda E, Southan C, Pawson AJ, Ireland S et al (2018). The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. Nucl Acids Res 46: D1091&#x2013;D1106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5753190</ArticleId>
            <ArticleId IdType="pubmed">29149325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hasegawa&#x2010;Moriyama M, Kurimoto T, Nakama M, Godai K, Kojima M, Kuwaki T et al (2013). Peroxisome proliferator&#x2010;activated receptor&#x2010;gamma agonist rosiglitazone attenuates inflammatory pain through the induction of heme oxygenase&#x2010;1 in macrophages. Pain 154: 1402&#x2013;1412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23707273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hasegawa&#x2010;Moriyama M, Ohnou T, Godai K, Kurimoto T, Nakama M, Kanmura Y (2012). Peroxisome proliferator&#x2010;activated receptor&#x2010;gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization. Biochem Biophys Res Commun 426: 76&#x2013;82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22910418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hesselink JMK, Hekker TAM (2012). Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. J Pain Res 5: 437&#x2013;442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3500919</ArticleId>
            <ArticleId IdType="pubmed">23166447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Impellizzeri D, Di Paola R, Cordaro M, Gugliandolo E, Casili G, Morittu VM et al (2016). Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of acute and chronic inflammation. Biochem Pharmacol 119: 27&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27599446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Issemann I, Green S (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645&#x2013;650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2129546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwai S, Maeda T, Kiguchi N, Kobayashi Y, Fukazawa Y, Ozaki M et al (2008). Pioglitazone attenuates tactile allodynia and microglial activation in mice with peripheral nerve injury. Drug Discov Ther 2: 353&#x2013;356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22504745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain V, Jaggi AS, Singh N (2009). Ameliorative potential of rosiglitazone in tibial and sural nerve transection&#x2010;induced painful neuropathy in rats. Pharmacol Res 59: 385&#x2013;392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19429470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jennings EM, Okine BN, Roche M, Finn DP (2014). Stress&#x2010;induced hyperalgesia. Prog Neurobiol 121: 1&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25010858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jhaveri MD, Richardson D, Robinson I, Garle MJ, Patel A, Sun Y et al (2008). Inhibition of fatty acid amide hydrolase and cyclooxygenase&#x2010;2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator&#x2010;activated receptor&#x2010;alpha in a model of inflammatory pain. Neuropharmacology 55: 85&#x2013;93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18534634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia HB, Wang XM, Qiu LL, Liu XY, Shen JC, Ji Q et al (2013). Spinal neuroimmune activation inhibited by repeated administration of pioglitazone in rats after L5 spinal nerve transection. Neurosci Lett 543: 130&#x2013;135.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23583338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia H, Xu S, Liu Q, Liu J, Xu J, Li W et al (2016). Effect of pioglitazone on neuropathic pain and spinal expression of TLR&#x2010;4 and cytokines. Exp Ther Med 12: 2644&#x2013;2650.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5038189</ArticleId>
            <ArticleId IdType="pubmed">27698768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia H, Zhu S, Ji Q, Hui K, Duan M, Xu J et al (2010). Repeated administration of pioglitazone attenuates development of hyperalgesia in a rat model of neuropathic pain. Exp Clin Psychopharmacol 18: 359&#x2013;365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20695692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loke YK, Kwok CS, Singh S (2011). Comparative cardiovascular effects of thiazolidinediones: systematic review and meta&#x2010;analysis of observational studies. BMJ 342: d1309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3230110</ArticleId>
            <ArticleId IdType="pubmed">21415101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LoVerme J, La Rana G, Russo R, Calignano A, Piomelli D (2005). The search for the palmitoylethanolamide receptor. Life Sci 77: 1685&#x2013;1698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15963531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace&#x2010;Raso G et al (2006). Rapid broad&#x2010;spectrum analgesia through activation of peroxisome proliferator&#x2010;activated receptor&#x2010;&#x3B1;. J Pharmacol Exp Ther 319: 1051&#x2013;1061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16997973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyons DN, Zhang L, Danaher RJ, Miller CS, Westlund KN (2017). PPAR&#x3B3; agonists attenuate trigeminal neuropathic pain. Clin J Pain 33: 1071&#x2013;1080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5675763</ArticleId>
            <ArticleId IdType="pubmed">28514232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyons DN, Zhang L, Pandya JD, Danaher RJ, Ma F, Miller CS et al (2018). Combination drug therapy of pioglitazone and D&#x2010;cycloserine attenuates chronic orofacial neuropathic pain and anxiety by improving mitochondrial function following trigeminal nerve injury. Clin J Pain 34: 168&#x2013;177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5701889</ArticleId>
            <ArticleId IdType="pubmed">28542026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maeda T, Kiguchi N, Kobayashi Y, Ozaki M, Kishioka S (2008). Pioglitazone attenuates tactile allodynia and thermal hyperalgesia in mice subjected to peripheral nerve injury. J Pharmacol Sci 108: 341&#x2013;347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19008646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Alboghobeish S (2017a). Systemic and local anti&#x2010;nociceptive effects of simvastatin in the rat formalin assay: role of peroxisome proliferator&#x2010;activated receptor &#x3B3; and nitric oxide. J Neurosci Res 95: 1776&#x2013;1785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28419516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Rajabi H, Pashmforoush M (2017b). Pharmacological evidence for systemic and peripheral antinociceptive activities of pioglitazone in the rat formalin test: role of PPAR&#x3B3; and nitric oxide. Eur J Pharmacol 805: 84&#x2013;92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28286124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreira DRM, Santos DS, Esp&#xED;rito Santo RFD, Santos FED, de Oliveira Filho GB, Leite ACL et al (2017). Structural improvement of new thiazolidinones compounds with antinociceptive activity in experimental chemotherapy&#x2010;induced painful neuropathy. Chem Biol Drug Des 90: 297&#x2013;307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28112878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreno S, Farioli&#x2010;Vecchioli S, Ceru MP (2004). Immunolocalization of peroxisome proliferator&#x2010;activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123: 131&#x2013;145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14667448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morgenweck J, Abdel&#x2010;Aleem OS, Mcnamara KC, Donahue RR, Badr MZ, Taylor BK (2009). Activation of peroxisome proliferator&#x2010;activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. Neuropharmacology 58: 337&#x2013;345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2813335</ArticleId>
            <ArticleId IdType="pubmed">19891980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morgenweck J, Griggs RB, Donahue RR, Zadina JE, Taylor BK (2013). PPAR&#x3B3; activation blocks development and reduces established neuropathic pain in rats. Neuropharmacology 70: 236&#x2013;246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3695821</ArticleId>
            <ArticleId IdType="pubmed">23415633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murad H, Ayuob N (2015). Co&#x2010;administration of pioglitazone improves fluoxetine's antinociceptive, neuroprotective, and antidepressant effects in chronic constriction injury in rats. Pain Physician 18: 609&#x2013;620.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26606013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Napimoga MH, Souza GR, Cunha TM, Ferrari LF, Clemente&#x2010;Napimoga JT, Parada CA et al (2007). 15d&#x2010;Prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. J Pharmacol Exp Ther 324: 313&#x2013;321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17928570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neugebauer V (2015). 15. Amygdala pain mechanisms. Handb Exp Pharmacol 227: 261&#x2013;284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4701385</ArticleId>
            <ArticleId IdType="pubmed">25846623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nissen SE, Wolski K (2007). Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New England Journal of Medicine 356: 2457&#x2013;2471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17517853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Mahony SM, Clarke G, Mckernan DP, Bravo JA, Dinan TG, Cryan JF (2013). Differential visceral nociceptive, behavioural and neurochemical responses to an immune challenge in the stress&#x2010;sensitive Wistar&#x2010;Kyoto rat strain. Behav Brain Res 253: 310&#x2013;317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23872358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okine BN, Madasu MK, Mcgowan F, Prendergast C, Gaspar JC, Harhen B et al (2016). N&#x2010;palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor&#x2010;mediated mechanism. Pain 157: 2687&#x2013;2696.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27649266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okine BN, Gaspar JC, Madasu MK, Olango WM, Harhen B, Roche M et al (2017). Characterisation of peroxisome proliferator&#x2010;activated receptor signalling in the midbrain periaqueductal grey of rats genetically prone to heightened stress, negative affect and hyperalgesia. Brain Res 1657: 185&#x2013;192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27916440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okine BN, Rea K, Olango WM, Price J, Herdman S, Madasu MK et al (2014). A role for PPAR&#x3B1; in the medial prefrontal cortex in formalin&#x2010;evoked nociceptive responding in rats. Br J Pharmacol 171: 1462&#x2013;1471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3954485</ArticleId>
            <ArticleId IdType="pubmed">24303983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okine BN, Spicer C, Millns P, Bennett A, Chapman V (2015). Systemic administration of WY&#x2010;14643, a selective synthetic agonist of peroxisome proliferator activator receptor&#x2010;alpha, alters spinal neuronal firing in a rodent model of neuropathic pain. Scand J Pain 9: 42&#x2013;48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29911649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olango WM, Finn DP (2014). Neurobiology of stress&#x2010;induced hyperalgesia. Curr Top Behav Neurosci 20: 251&#x2013;280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24850075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira AC, Bertollo CM, Rocha LT, Nascimento EB Jr, Costa KA, Coelho MM (2007). Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPARalpha, and pioglitazone, an agonist of PPARgamma. Eur J Pharmacol 561: 194&#x2013;201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17343847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Sullivan SE, Kendall DA (2010). Cannabinoid activation of peroxisome proliferator&#x2010;activated receptors: potential for modulation of inflammatory disease. Immunobiology 215: 611&#x2013;616.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19833407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paragomi P, Rahimian R, Kazemi MH, Gharedaghi MH, Khalifeh&#x2010;Soltani A, Azary S et al (2014). Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea&#x2010;predominant irritable bowel syndrome: role of nitric oxide. Clin Exp Pharmacol Physiol 41: 118&#x2013;126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24471407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park SW, Yi JH, Miranpuri G, Satriotomo I, Bowen K, Resnick DK et al (2007). Thiazolidinedione class of peroxisome proliferator&#x2010;activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther 320: 1002&#x2013;1012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17167171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pena&#x2010;dos&#x2010;Santos DR, Severino FP, Pereira SAL, Rodrigues DBR, Cunha FQ, Vieira SM et al (2009). Activation of peripheral &#x3BA;/&#x3B4; opioid receptors mediates 15&#x2010;deoxy&#x2010;&#x394;12,14&#x2010;prostaglandin J2 induced&#x2010;antinociception in rat temporomandibular joint. Neuroscience 163: 1211&#x2013;1219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19647045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pottabathini R, Kumar A, Bhatnagar A, Garg S, Ekavali E (2016). Ameliorative potential of pioglitazone and ceftriaxone alone and in combination in rat model of neuropathic pain: targeting PPAR&#xCE;3 and GLT&#x2010;1 pathways. Pharmacol Rep 68: 85&#x2013;94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26721358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rea K, Olango WM, Okine BN, Madasu MK, Mcguire IC, Coyle K et al (2014). Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype&#x2010;dependent hyper&#x2010;responsivity to noxious stimuli. Pain 155: 69&#x2013;79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24076311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz&#x2010;Medina, J. , Flores, J.A. , Tasset, I. , Tunez, I. , Valverde, O. , AND Fernandez&#x2010;Espejo, E. (2012). Alteration of neuropathic and visceral pain in female C57BL/6J mice lacking the PPAR&#x2010;&#x3B1; gene. Psychopharmacology (Berl) 222: 477&#x2013;488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22354556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russo R, Caro CD, Avagliano C, Cristiano C, La Rana G, Mattace Raso G et al (2016). Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice. Pharmacol Res 103: 279&#x2013;291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26675718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russo R, LoVerme J, La Rana G, D'Agostino G, Sasso O, Calignano A et al (2007). Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR&#x2010;alpha receptor agonist GW7647. Eur J Pharmacol 566: 117&#x2013;119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1997313</ArticleId>
            <ArticleId IdType="pubmed">17434479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sagar DR, Kendall DA, Chapman V (2008). Inhibition of fatty acid amide hydrolase produces PPAR&#x2010;alpha&#x2010;mediated analgesia in a rat model of inflammatory pain. Br J Pharmacol 155: 1297&#x2013;1306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2607214</ArticleId>
            <ArticleId IdType="pubmed">18724387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saito T, Hasegawa&#x2010;Moriyama M, Kurimoto T, Yamada T, Inada E, Kanmura Y (2016). Resolution of inflammation by resolvin D1 is essential for peroxisome proliferator&#x2010;activated receptor&#x2010;&#x3B3;&#x2010;mediated analgesia during postincisional pain development in type 2 diabetes. Anesthesiology 123: 1420&#x2013;1434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26492476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasso O, Russo R, Vitiello S, Raso GM, D'Agostino G, Iacono A et al (2012). Implication of allopregnanolone in the antinociceptive effect of N&#x2010;palmitoylethanolamide in acute or persistent pain. Pain 153: 33&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21890273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith AF, Macfie WG, Oliver MF (1970). Clofibrate, serum enzymes, and muscle pain. Br Med J 2: 86&#x2013;88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1699923</ArticleId>
            <ArticleId IdType="pubmed">5420239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP et al (1998). Activation of human aortic smooth&#x2010;muscle cells is inhibited by PPAR&#x3B1; but not by PPAR&#x3B3; activators. Nature 393: 790&#x2013;793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9655393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suard&#xED;az M, Estivill&#x2010;Torr&#xFA;s G, Goicoechea C, Bilbao A, Rodr&#xED;guez De Fonseca F (2007). Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. Pain 133: 99&#x2013;110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17449181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sunder Mudaliar MF, Chang AR, Henry RR (2003). Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications. Endocrine Practice 9: 406&#x2013;416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14583425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi Y, Hasegawa&#x2010;Moriyama M, Sakurai T, Inada E (2011). The macrophage&#x2010;mediated effects of the peroxisome proliferator&#x2010;activated receptor&#x2010;gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development. Anesth Analg 113: 398&#x2013;404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21490083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor BK, Dadia N, Yang CB, Krishnan S, Badr M (2002). Peroxisome proliferator&#x2010;activated receptor agonists inhibit inflammatory edema and hyperalgesia. Inflammation 26: 121&#x2013;127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12083418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tugwood JD, Issemann I, Anderson RG, Bundell KR, Mcpheat WL, Green S (1992). The mouse peroxisome proliferator activated receptor recognizes a response element in the 5&#x2032; flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11: 433&#x2013;439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC556472</ArticleId>
            <ArticleId IdType="pubmed">1537328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuo W, Leleu&#x2010;Chavain N, Spencer J, Sansook S, Millet R, Chavatte P (2017). Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and N&#x2010;acylethanolamine acid amidase inhibitors. J Med Chem 60: 4&#x2013;46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27766867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Eekeren ICM, Clockaerts S, Bastiaansen&#x2010;Jenniskens YM, Lubberts E, Verhaar JAN, Van Osch GJVM et al (2013). Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review. Ther Adv Musculoskelet Dis 5: 33&#x2013;44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3582306</ArticleId>
            <ArticleId IdType="pubmed">23515070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vasconcelos MAL, Royo VA, Ferreira DS, Crotti AEM, e Silva MLA, Carvalho JCT et al (2006). In vivo analgesic and anti&#x2010;inflammatory activities of ursolic acid and oleanoic acid from Miconia albicans (melastomataceae). Z Naturforsch C 61:477&#x2013;482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16989305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Zhang Q, Zhao L, Li D, Fu Z, Liang L (2014). Down&#x2010;regulation of PPAR&#x3B1; in the spinal cord contributes to augmented peripheral inflammation and inflammatory hyperalgesia in diet&#x2010;induced obese rats. Neuroscience 278: 165&#x2013;178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25135355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warden A, Truitt J, Merriman M, Ponomareva O, Jameson K, Ferguson LB et al (2016). Localization of PPAR isotypes in the adult mouse and human brain. Sci Rep 6: 27618.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4901333</ArticleId>
            <ArticleId IdType="pubmed">27283430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright MB, Bortolini M, Tadayyon M, Bopst M (2014). Minireview: challenges and opportunities in development of PPAR agonists. Mol Endocrinol 28: 1756&#x2013;1768.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5414793</ArticleId>
            <ArticleId IdType="pubmed">25148456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang L, Li L, Chen L, Li Y, Chen H, Li Y et al (2015). Potential analgesic effects of a novel N&#x2010;acylethanolamine acid amidase inhibitor F96 through PPAR&#x2010;&#x3B1;. Sci Rep 5: 13565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4550851</ArticleId>
            <ArticleId IdType="pubmed">26310614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zanardelli M, Micheli L, Cinci L, Failli P, Ghelardini C, Di Cesare Mannelli L (2014). Oxaliplatin neurotoxicity involves peroxisome alterations. PPAR&#x3B3; agonism as preventive pharmacological approach. PLoS One 9: e102758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4103888</ArticleId>
            <ArticleId IdType="pubmed">25036594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang, Y. , Song, C. , Li, H. , Hou, J. , AND Li, D. (2016). Ursolic acid prevents augmented peripheral inflammation and inflammatory hyperalgesia in high&#x2010;fat diet&#x2010;induced obese rats by restoring downregulated spinal PPAR&#x3B1;. Mol Med Rep 13: 5309&#x2013;5316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27108888</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29660081</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1745-1701</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>45</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Schizophrenia bulletin</Title>
          <ISOAbbreviation>Schizophr Bull</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Data-Driven Analysis of Functional Connectivity Reveals a Potential Auditory Verbal Hallucination Network.</ArticleTitle>
        <Pagination>
          <StartPage>415</StartPage>
          <EndPage>424</EndPage>
          <MedlinePgn>415-424</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/schbul/sby039</ELocationID>
        <Abstract>
          <AbstractText>Schizophrenia is a severe global health problem, with over half of such patients experiencing auditory verbal hallucinations (AVHs). A better understanding of the neural correlates differentiating patients experiencing AVHs from patients not experiencing AVHs and healthy controls may identify targets that lead to better treatment strategies for AVHs. Employing 2 data-driven, voxel-based measure of functional connectivity, we studied 46 patients with schizophrenia or schizoaffective disorder (28 experiencing AVHs and 18 not experiencing AVHs). Twenty healthy controls matched for age, gender, ethnicity, education level, handedness, and estimated verbal intelligence were included for comparison. The intrinsic connectivity distribution (ICD) was used to model each voxel's connectivity to the rest of the brain using a Weibull distribution. To investigate lateralization of connectivity, we used cross-hemisphere ICD, a method that separates the contribution of each hemisphere to interrogate connectivity laterality. Patients with AVHs compared with patients without AVHs exhibited significantly decreased whole-brain connectivity in the medial prefrontal cortex and posterior cingulate cortex, less lateralized connectivity in left putamen, and more lateralized connectivity in left interior frontal gyrus. Correlations with Auditory Hallucination Rating Scale (AHRS) and post hoc seed connectivity analyses revealed significantly altered network connectivity. Using the results from all analyses comparing the patient groups and correlations with AHRS, we identified a potential AVH network, consisting of 25 nodes, showing substantial overlap with the default mode network and language processing networks. This network as a whole, instead of individual nodes, may represent actionable targets for interventions.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Scheinost</LastName>
            <ForeName>Dustin</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tokoglu</LastName>
            <ForeName>Fuyuze</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hampson</LastName>
            <ForeName>Michelle</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoffman</LastName>
            <ForeName>Ralph</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Yale School of Medicine, New Haven, CT.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Constable</LastName>
            <ForeName>R Todd</ForeName>
            <Initials>RT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Yale School of Medicine, New Haven, CT.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 MH067073</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 MH073673</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Schizophr Bull</MedlineTA>
        <NlmUniqueID>0236760</NlmUniqueID>
        <ISSNLinking>0586-7614</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063132" MajorTopicYN="Y">Connectome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006212" MajorTopicYN="N">Hallucinations</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009415" MajorTopicYN="N">Nerve Net</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011699" MajorTopicYN="N">Putamen</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013067" MajorTopicYN="N">Speech Perception</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">computational psychiatry</Keyword>
        <Keyword MajorTopicYN="N">default mode network</Keyword>
        <Keyword MajorTopicYN="N">functional magnetic resonance imaging</Keyword>
        <Keyword MajorTopicYN="N">language</Keyword>
        <Keyword MajorTopicYN="N">schizophrenia</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>5</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29660081</ArticleId>
        <ArticleId IdType="pmc">PMC6403094</ArticleId>
        <ArticleId IdType="doi">10.1093/schbul/sby039</ArticleId>
        <ArticleId IdType="pii">4962163</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull. 2004;30:279&#x2013;293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15279046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andreasen NC, Flaum M. Schizophrenia: the characteristic symptoms. Schizophr Bull. 1991;17:27&#x2013;49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2047788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mueser KT, Bellack AS, Brady EU. Hallucinations in schizophrenia. Acta Psychiatr Scand. 1990;82:26&#x2013;29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2399817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ben-Zeev D, Morris S, Swendsen J, Granholm E. Predicting the occurrence, conviction, distress, and disruption of different delusional experiences in the daily life of people with schizophrenia. Schizophr Bull. 2012;38:826&#x2013;837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3406533</ArticleId>
            <ArticleId IdType="pubmed">21248277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hartley S, Barrowclough C, Haddock G. Anxiety and depression in psychosis: a systematic review of associations with positive psychotic symptoms. Acta Psychiatr Scand. 2013;128:327&#x2013;346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23379898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Dongen JD, Buck NM, van Marle HJ. The role of ideational distress in the relation between persecutory ideations and reactive aggression. Crim Behav Ment Health. 2012;22:350&#x2013;359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22936559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harkavy-Friedman JM, Kimhy D, Nelson EA, Venarde DF, Malaspina D, Mann JJ. Suicide attempts in schizophrenia: the role of command auditory hallucinations for suicide. J Clin Psychiatry. 2003;64:871&#x2013;874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12927000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong Z, &#xD6;ng&#xFC;r D, Cohen B, Ravichandran C, Noam G, Murphy B. Command hallucinations and clinical characteristics of suicidality in patients with psychotic spectrum disorders. Compr Psychiatry. 2013;54:611&#x2013;617.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23375263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ten Velden Hegelstad W, Haahr U, Larsen TK, et al. . Early detection, early symptom progression and symptomatic remission after ten years in a first episode of psychosis study. Schizophr Res. 2013;143:337&#x2013;343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23219862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodward ND, Cascio CJ. Resting-state functional connectivity in psychiatric disorders. JAMA Psychiatry. 2015;72:743&#x2013;744.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4693599</ArticleId>
            <ArticleId IdType="pubmed">26061674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fornito A, Zalesky A, Pantelis C, Bullmore ET. Schizophrenia, neuroimaging and connectomics. Neuroimage. 2012;62:2296&#x2013;2314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22387165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman RE, Hampson M. Functional connectivity studies of patients with auditory verbal hallucinations. Front Hum Neurosci. 2011;6:6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3269039</ArticleId>
            <ArticleId IdType="pubmed">22375109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alderson-Day B, McCarthy-Jones S, Fernyhough C. Hearing voices in the resting brain: a review of intrinsic functional connectivity research on auditory verbal hallucinations. Neurosci Biobehav Rev. 2015;55:78&#x2013;87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5901708</ArticleId>
            <ArticleId IdType="pubmed">25956256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shinn AK, Baker JT, Cohen BM, Ong&#xFC;r D. Functional connectivity of left Heschl&#x2019;s gyrus in vulnerability to auditory hallucinations in schizophrenia. Schizophr Res. 2013;143:260&#x2013;268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3601525</ArticleId>
            <ArticleId IdType="pubmed">23287311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman RE, Fernandez T, Pittman B, Hampson M. Elevated functional connectivity along a corticostriatal loop and the mechanism of auditory/verbal hallucinations in patients with schizophrenia. Biol Psychiatry. 2011;69:407&#x2013;414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3039042</ArticleId>
            <ArticleId IdType="pubmed">21145042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sommer IE, Clos M, Meijering AL, Diederen KM, Eickhoff SB. Resting state functional connectivity in patients with chronic hallucinations. PLoS One. 2012;7:e43516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3435327</ArticleId>
            <ArticleId IdType="pubmed">22970130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clos M, Diederen KM, Meijering AL, Sommer IE, Eickhoff SB. Aberrant connectivity of areas for decoding degraded speech in patients with auditory verbal hallucinations. Brain Struct Funct. 2014;219:581&#x2013;594.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8011946</ArticleId>
            <ArticleId IdType="pubmed">23423461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diederen KM, Neggers SF, de Weijer AD, et al. . Aberrant resting-state connectivity in non-psychotic individuals with auditory hallucinations. Psychol Med. 2013;43:1685&#x2013;1696.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23199762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf ND, Sambataro F, Vasic N, et al. . Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations. J Psychiatry Neurosci. 2011;36:366&#x2013;374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3201990</ArticleId>
            <ArticleId IdType="pubmed">21791169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vercammen A, Knegtering H, den Boer JA, Liemburg EJ, Aleman A. Auditory hallucinations in schizophrenia are associated with reduced functional connectivity of the temporo-parietal area. Biol Psychiatry. 2010;67:912&#x2013;918.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20060103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alonso-Sol&#xED;s A, Vives-Gilabert Y, Grasa E, et al. . Resting-state functional connectivity alterations in the default network of schizophrenia patients with persistent auditory verbal hallucinations. Schizophr Res. 2015;161:261&#x2013;268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25468173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jardri R, Thomas P, Delmaire C, Delion P, Pins D. The neurodynamic organization of modality-dependent hallucinations. Cereb Cortex. 2013;23:1108&#x2013;1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22535908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature Editoral. A decade for psychiatric disorders. Nature. 2010;463:9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20054363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheinost D, Lacadie C, Vohr BR, et al. . Cerebral lateralization is protective in the very prematurely born. Cereb Cortex. 2015;25:1858&#x2013;1866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4459290</ArticleId>
            <ArticleId IdType="pubmed">24451659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Constable RT, Vohr BR, Scheinost D, et al. . A left cerebellar pathway mediates language in prematurely-born young adults. Neuroimage. 2013;64:371&#x2013;378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3508203</ArticleId>
            <ArticleId IdType="pubmed">22982585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Lutterveld R, Diederen KM, Otte WM, Sommer IE. Network analysis of auditory hallucinations in nonpsychotic individuals. Hum Brain Mapp. 2014;35:1436&#x2013;1445.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6869060</ArticleId>
            <ArticleId IdType="pubmed">23426796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anticevic A, Hu S, Zhang S, et al. . Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biol Psychiatry. 2014;75:595&#x2013;605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3969771</ArticleId>
            <ArticleId IdType="pubmed">24314349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gotts SJ, Simmons WK, Milbury LA, Wallace GL, Cox RW, Martin A. Fractionation of social brain circuits in autism spectrum disorders. Brain. 2012;135:2711&#x2013;2725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3437021</ArticleId>
            <ArticleId IdType="pubmed">22791801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheinost D, Benjamin J, Lacadie CM, et al. . The intrinsic connectivity distribution: a novel contrast measure reflecting voxel level functional connectivity. Neuroimage. 2012;62:1510&#x2013;1519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3538880</ArticleId>
            <ArticleId IdType="pubmed">22659477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>First MB, Spitzer RL, Gibbon M, Williams Janet BW.. Structured Clinical Interview for DSM-5. Arlington, VA: American Psychiatric Association; 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64:663&#x2013;667.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12823080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis JM. Dose equivalence of the antipsychotic drugs. J Psychiatr Res. 1974;11:65&#x2013;69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4156792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centorrino F, Eakin M, Bahk WM, et al. . Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry. 2002;159:1932&#x2013;1935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12411232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman L, Glover GH, Krenz D, Magnotta V; FIRST BIRN. Reducing inter-scanner variability of activation in a multicenter fMRI study: role of smoothness equalization. Neuroimage. 2006;32:1656&#x2013;1668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16875843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheinost D, Papademetris X, Constable RT. The impact of image smoothness on intrinsic functional connectivity and head motion confounds. Neuroimage. 2014;95:13&#x2013;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4076413</ArticleId>
            <ArticleId IdType="pubmed">24657356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joshi A, Scheinost D, Okuda H, et al. . Unified framework for development, deployment and robust testing of neuroimaging algorithms. Neuroinformatics. 2011;9:69&#x2013;84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3066099</ArticleId>
            <ArticleId IdType="pubmed">21249532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satterthwaite TD, Elliott MA, Gerraty RT, et al. . An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data. Neuroimage. 2013;64:240&#x2013;256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3811142</ArticleId>
            <ArticleId IdType="pubmed">22926292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitchell MR, Balodis IM, Devito EE, et al. . A preliminary investigation of Stroop-related intrinsic connectivity in cocaine dependence: associations with treatment outcomes. Am J Drug Alcohol Abuse. 2013;39:392&#x2013;402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3827911</ArticleId>
            <ArticleId IdType="pubmed">24200209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheinost D, Kwon SH, Lacadie C, et al. . Alterations in anatomical covariance in the prematurely born. Cereb Cortex. 2017;27:534&#x2013;543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5939217</ArticleId>
            <ArticleId IdType="pubmed">26494796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheinost D, Shen X, Finn E, Sinha R, Constable RT, Papademetris X. Coupled Intrinsic Connectivity Distribution analysis: a method for exploratory connectivity analysis of paired FMRI data. PLoS One. 2014;9:e93544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3968179</ArticleId>
            <ArticleId IdType="pubmed">24676034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman RE, Hawkins KA, Gueorguieva R, et al. . Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry. 2003;60:49&#x2013;56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12511172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman RE, Pittman B, Constable RT, Bhagwagar Z, Hampson M. Time course of regional brain activity accompanying auditory verbal hallucinations in schizophrenia. Br J Psychiatry. 2011;198:277&#x2013;283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3065772</ArticleId>
            <ArticleId IdType="pubmed">21972276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finn ES, Shen X, Scheinost D, et al. . Functional connectome fingerprinting: identifying individuals using patterns of brain connectivity. Nat Neurosci. 2015;18:1664&#x2013;1671.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5008686</ArticleId>
            <ArticleId IdType="pubmed">26457551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rotarska-Jagiela A, van de Ven V, Oertel-Kn&#xF6;chel V, Uhlhaas PJ, Vogeley K, Linden DE. Resting-state functional network correlates of psychotic symptoms in schizophrenia. Schizophr Res. 2010;117:21&#x2013;30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20097544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorg C, Manoliu A, Neufang S, et al. . Increased intrinsic brain activity in the striatum reflects symptom dimensions in schizophrenia. Schizophr Bull. 2013;39:387&#x2013;395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3576165</ArticleId>
            <ArticleId IdType="pubmed">22241165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jardri R, Pouchet A, Pins D, Thomas P. Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis. Am J Psychiatry. 2011;168:73&#x2013;81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20952459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Northoff G, Qin P. How can the brain&#x2019;s resting state activity generate hallucinations? A &#x2018;resting state hypothesis&#x2019; of auditory verbal hallucinations. Schizophr Res. 2011;127:202&#x2013;214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21146961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shergill SS, Murray RM, McGuire PK. Auditory hallucinations: a review of psychological treatments. Schizophr Res. 1998;32:137&#x2013;150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9720119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho R, Wu W. Mechanisms of auditory verbal hallucination in schizophrenia. Front Psychiatry. 2013;4:155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3841756</ArticleId>
            <ArticleId IdType="pubmed">24348430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Northoff G. Are auditory hallucinations related to the brain&#x2019;s resting state activity? A &#x2018;Neurophenomenal Resting State Hypothesis&#x2019;. Clin Psychopharmacol Neurosci. 2014;12:189&#x2013;195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4293163</ArticleId>
            <ArticleId IdType="pubmed">25598821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buckner RL, Sepulcre J, Talukdar T, et al. . Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer&#x2019;s disease. J Neurosci. 2009;29:1860&#x2013;1873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2750039</ArticleId>
            <ArticleId IdType="pubmed">19211893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cole MW, Pathak S, Schneider W. Identifying the brain&#x2019;s most globally connected regions. Neuroimage. 2010;49:3132&#x2013;3148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19909818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Power JD, Plitt M, Laumann TO, Martin A. Sources and implications of whole-brain fMRI signals in humans. Neuroimage. 2017;146:609&#x2013;625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5321814</ArticleId>
            <ArticleId IdType="pubmed">27751941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheinost D, Finn ES, Tokoglu F, et al. . Sex differences in normal age trajectories of functional brain networks. Hum Brain Mapp. 2015;36:1524&#x2013;1535.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5522589</ArticleId>
            <ArticleId IdType="pubmed">25523617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu M, Scheinost D, Ramani R, Constable RT. Multi-modal analysis of functional connectivity and cerebral blood flow reveals shared and unique effects of propofol in large-scale brain networks. Neuroimage. 2017;148:130&#x2013;140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5410383</ArticleId>
            <ArticleId IdType="pubmed">28069540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodward ND, Karbasforoushan H, Heckers S. Thalamocortical dysconnectivity in schizophrenia. Am J Psychiatry. 2012;169:1092&#x2013;1099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3810300</ArticleId>
            <ArticleId IdType="pubmed">23032387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anticevic A, Haut K, Murray JD, et al. . Association of thalamic dysconnectivity and conversion to psychosis in youth and young adults at elevated clinical risk. JAMA Psychiatry. 2015;72:882&#x2013;891.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4892891</ArticleId>
            <ArticleId IdType="pubmed">26267151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutchison RM, Womelsdorf T, Allen EA, et al. . Dynamic functional connectivity: promise, issues, and interpretations. Neuroimage. 2013;80:360&#x2013;378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3807588</ArticleId>
            <ArticleId IdType="pubmed">23707587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson JS, Ferguson MA, Lopez-Larson M, Yurgelun-Todd D. Reproducibility of single-subject functional connectivity measurements. AJNR Am J Neuroradiol. 2011;32:548&#x2013;555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3205089</ArticleId>
            <ArticleId IdType="pubmed">21273356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laumann TO, Gordon EM, Adeyemo B, et al. . Functional system and areal organization of a highly sampled individual human brain. Neuron. 2015;87:657&#x2013;670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4642864</ArticleId>
            <ArticleId IdType="pubmed">26212711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birn RM, Molloy EK, Patriat R, et al. . The effect of scan length on the reliability of resting-state fMRI connectivity estimates. Neuroimage. 2013;83:550&#x2013;558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4104183</ArticleId>
            <ArticleId IdType="pubmed">23747458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buckner RL, Krienen FM, Yeo BT. Opportunities and limitations of intrinsic functional connectivity MRI. Nat Neurosci. 2013;16:832&#x2013;837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23799476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amad A, Cachia A, Gorwood P, et al. . The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations. Mol Psychiatry. 2014;19:184&#x2013;191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23318999</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29617166</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2327-9109</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Nov-Dec</Season>
            </PubDate>
          </JournalIssue>
          <Title>Applied neuropsychology. Adult</Title>
          <ISOAbbreviation>Appl Neuropsychol Adult</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Preoperative verbal memory problems and their clinical prognostic value in meningioma patients: A prospective study.</ArticleTitle>
        <Pagination>
          <StartPage>503</StartPage>
          <EndPage>512</EndPage>
          <MedlinePgn>503-512</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/23279095.2018.1450750</ELocationID>
        <Abstract>
          <AbstractText>This study aimed to evaluate clinical utility of The Hopkins Verbal Learning Test-Revised (HVLT-R) for assessment of preoperative memory function in meningioma patients and to investigate prognostic value of memory assessment in predicting outcomes after meningioma excision surgery. A total of 93 meningioma patients were assessed 2-3 days preoperatively using HVLT-R, and EORTC QLQ-30 and QLQ-BN20. Functional outcome at discharge was evaluated using The Glasgow Outcome Scale. A sample of 95 healthy controls was matched to patients according to age, gender, and education. Meningioma patients demonstrated impaired working memory, delayed recall and recognition, flatter learning slope, and less effective acquisition. Location of meningioma was not related to any of the studied memory scores. Patients with left sided meningiomas more often produced false positive recognitions and demonstrated worse delayed recall when compared to patients with right sided, but not bilateral meningiomas. Verbal memory impairment was not associated with perceived health status. Functional outcome at discharge was predicted by tumor side, global health status score, and HVLT-R Cumulative learning score. Cumulative verbal learning impairment was associated with greater risk for poor functional outcome, indicating that cognitive impairment has added prognostic value beyond established prognostic indicators of meningioma patients.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pranckevi&#x10D;ien&#x117;</LastName>
            <ForeName>Aist&#x117;</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-8180-3504</Identifier>
            <AffiliationInfo>
              <Affiliation>Neuroscience Institute, Lithuanian University of Health Sciences , Kaunas , Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jurkuv&#x117;nas</LastName>
            <ForeName>Vytautas</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of General Psychology, Vilnius University , Vilnius , Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deltuva</LastName>
            <ForeName>Vytenis Pranas</ForeName>
            <Initials>VP</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Institute, Lithuanian University of Health Sciences , Kaunas , Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tama&#x161;auskas</LastName>
            <ForeName>Arimantas</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Institute, Lithuanian University of Health Sciences , Kaunas , Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bunevi&#x10D;ius</LastName>
            <ForeName>Adomas</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Institute, Lithuanian University of Health Sciences , Kaunas , Lithuania.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>04</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Appl Neuropsychol Adult</MedlineTA>
        <NlmUniqueID>101584082</NlmUniqueID>
        <ISSNLinking>2327-9095</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001932" MajorTopicYN="Y">Brain Neoplasms</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008579" MajorTopicYN="Y">Meningioma</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014706" MajorTopicYN="N">Verbal Learning</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Brain tumor</Keyword>
        <Keyword MajorTopicYN="N">meningioma</Keyword>
        <Keyword MajorTopicYN="N">outcomes</Keyword>
        <Keyword MajorTopicYN="N">preoperative assessment</Keyword>
        <Keyword MajorTopicYN="N">verbal memory</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29617166</ArticleId>
        <ArticleId IdType="doi">10.1080/23279095.2018.1450750</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29608118</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>26</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-5040</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Physiotherapy theory and practice</Title>
          <ISOAbbreviation>Physiother Theory Pract</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A global health training model for teaching pediatric clinical decision making skills to Rwandan physical therapists: A case report.</ArticleTitle>
        <Pagination>
          <StartPage>891</StartPage>
          <EndPage>903</EndPage>
          <MedlinePgn>891-903</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09593985.2018.1458263</ELocationID>
        <Abstract>
          <AbstractText><b>Background and Purpose</b>: There is increasing interest among physical therapists from high-income countries to participate in education development projects in low-income countries. However, there are few examples in the literature of effective developmental models or projects. This case report describes a model for improving pediatric clinical decision making skills among Rwandan physical therapists using best practices in clinical decision making, evidence-based practice where possible, and use of the International Classification of Functioning and Disability (ICF) model. <b>Case Description</b>: A 48-hour continuing professional development course based on the pediatric section of the Advancement of Rwandan Rehabilitation Services Project (ARRSP) was presented to 66 Rwandan physical therapists in the form of classroom lectures, laboratory and case study practice, and clinical visits to the course participant's work place. Interactive teaching and learning was emphasized. <b>Outcomes</b>: Course participants completed a pre- and post-course assessment addressing course content. There was a 53% improvement in post-course assessment scores. A post-course evaluation eliciting participants' confidence in eight clinical decision making skills emphasized in course material was also administered. Comments were strongly positive (92%) for the value of clinical visits in reinforcing the participant's new clinical skills. <b>Discussion</b>: This case report documents a global health continuing professional development project that improved pediatric rehabilitation knowledge and clinical skill confidence. The project incorporated sustainability by soliciting both input and involvement of the target audience from start to finish; from the needs assessment to classroom teaching. Building on these two aspects promotes a sense of ownership and longevity.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Clark</LastName>
            <ForeName>Kathryn</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-8222-8513</Identifier>
            <AffiliationInfo>
              <Affiliation>a Medical Branch , University of Texas , Galveston , TX , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>d Health Volunteers Overseas , Washington , DC , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Whalen Smith</LastName>
            <ForeName>Cara N</ForeName>
            <Initials>CN</Initials>
            <AffiliationInfo>
              <Affiliation>b College of Medicine Government Resource Center, The Ohio State University , Columbus , OH , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>d Health Volunteers Overseas , Washington , DC , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kohls</LastName>
            <ForeName>Lori</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>c Physical Therapy Division, CHG Management Inc , Salt Lake City , UT , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>d Health Volunteers Overseas , Washington , DC , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Musabyemariya</LastName>
            <ForeName>Ines</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>d Health Volunteers Overseas , Washington , DC , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>e Heroes Day Care Center , Kigali , Rwanda.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kayonga Ntagungira</LastName>
            <ForeName>Egide</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>d Health Volunteers Overseas , Washington , DC , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>f Department of Physiotherapy , University of Rwanda College of Medicine and Health Sciences , Kigali , Rwanda.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mann</LastName>
            <ForeName>Monika</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>d Health Volunteers Overseas , Washington , DC , USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>g Department of International Health, Bloomberg School of Public Health , Johns Hopkins University.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fisher</LastName>
            <ForeName>Steve R</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>a Medical Branch , University of Texas , Galveston , TX , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>04</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Physiother Theory Pract</MedlineTA>
        <NlmUniqueID>9015520</NlmUniqueID>
        <ISSNLinking>0959-3985</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002983" MajorTopicYN="Y">Clinical Competence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000066491" MajorTopicYN="Y">Clinical Decision-Making</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004496" MajorTopicYN="Y">Education, Continuing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055317" MajorTopicYN="N">Evidence-Based Practice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010372" MajorTopicYN="N">Pediatrics</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059825" MajorTopicYN="N">Physical Therapists</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015397" MajorTopicYN="N">Program Evaluation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012432" MajorTopicYN="N" Type="Geographic">Rwanda</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Clinical decision making</Keyword>
        <Keyword MajorTopicYN="N">ICF model</Keyword>
        <Keyword MajorTopicYN="N">global health training</Keyword>
        <Keyword MajorTopicYN="N">low-income countries</Keyword>
        <Keyword MajorTopicYN="N">sustainability</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29608118</ArticleId>
        <ArticleId IdType="doi">10.1080/09593985.2018.1458263</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29571220</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>06</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1466-7657</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>66</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>International nursing review</Title>
          <ISOAbbreviation>Int Nurs Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Shaping nursing profession regulation through history - a systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>17</StartPage>
          <EndPage>29</EndPage>
          <MedlinePgn>17-29</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/inr.12449</ELocationID>
        <Abstract>
          <AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of this systematic review was to provide a critical synthesis of the factors that historically shaped the advancements of nursing regulators worldwide.</AbstractText>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">An in-depth examination of the different factors that moulded regulatory changes over time is pivotal to comprehend current issues in nursing.</AbstractText>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In the light of global health scenarios, the researchers explored the factors that historically influenced the socio-contextual circumstances upon which governments made regulatory changes.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search was performed on the following databases: PubMed, CINAHL, Scopus, OpenGrey and ScienceDirect. The review included papers from January 2000 to October 2016 published in English. The authors used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and an inductive thematic approach for synthesis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Two main themes were identified: factors underpinning current challenges and historical and contextual triggers of regulation. The first theme was composed of three aspects: education, migration and internationalization, and policy and regulation; the second theme consisted of four attributes: demographics, economics, history of registration and wars, and historical changes in nursing practice.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Factors that shaped nursing regulation were linked to changing demographics and economics, education, history of nursing registration, shifting patterns of migration and internationalization, nursing practice, policy and regulation and significant societal turns often prompted by wars.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A deeper understanding of the developments of the nursing regulatory institutions provides the foundation for portable standards that can be applied across an array of jurisdictions to guarantee a better public safety.</AbstractText>
          <AbstractText Label="IMPLICATION FOR NURSING AND HEALTH POLICY" NlmCategory="CONCLUSIONS">Understanding factors that socially, legislatively and politically have influenced the development of regulatory bodies over time helps to mould local, national and international policies that have a stronger impact on health worldwide. To achieve this, there must be effective cooperation among systems of nursing regulations globally.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 International Council of Nurses.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stievano</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Centre of Excellence for Nursing Scholarship, Ipasvi Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Caruso</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-7736-6209</Identifier>
            <AffiliationInfo>
              <Affiliation>Health Professions Research and Development Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pittella</LastName>
            <ForeName>F</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Health Professions Research and Development Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shaffer</LastName>
            <ForeName>F A</ForeName>
            <Initials>FA</Initials>
            <AffiliationInfo>
              <Affiliation>CGFNS International, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rocco</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Centre of Excellence for Nursing Scholarship, Ipasvi Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fairman</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Bio-behavioral Health Sciences, School of Nursing, University of Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Barbara Bates Center for the Study of the History of Nursing, Philadelphia, PA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>1.17.06</GrantID>
            <Agency>Centre of Excellence for Nursing Scholarship - Ipasvi Rome - Italy</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016456">Historical Article</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>03</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int Nurs Rev</MedlineTA>
        <NlmUniqueID>7808754</NlmUniqueID>
        <ISSNLinking>0020-8132</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003406" MajorTopicYN="N">Credentialing</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006676" MajorTopicYN="Y">History of Nursing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007884" MajorTopicYN="Y">Legislation, Nursing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024802" MajorTopicYN="N">Nurse's Role</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009732" MajorTopicYN="N">Nursing Care</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Credentialing</Keyword>
        <Keyword MajorTopicYN="N">Economics</Keyword>
        <Keyword MajorTopicYN="N">Globalisation</Keyword>
        <Keyword MajorTopicYN="N">History</Keyword>
        <Keyword MajorTopicYN="N">Immigration</Keyword>
        <Keyword MajorTopicYN="N">Nursing Legislation</Keyword>
        <Keyword MajorTopicYN="N">Nursing Policy</Keyword>
        <Keyword MajorTopicYN="N">Nursing Regulation</Keyword>
        <Keyword MajorTopicYN="N">Registration</Keyword>
        <Keyword MajorTopicYN="N">Systematic Reviews</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29571220</ArticleId>
        <ArticleId IdType="doi">10.1111/inr.12449</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29537338</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-1706</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global public health</Title>
          <ISOAbbreviation>Glob Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Behind the scenes: International NGOs' influence on reproductive health policy in Malawi and South Sudan.</ArticleTitle>
        <Pagination>
          <StartPage>555</StartPage>
          <EndPage>569</EndPage>
          <MedlinePgn>555-569</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2018.1446545</ELocationID>
        <Abstract>
          <AbstractText>Global health donors increasingly embrace international non-governmental organisations (INGOs) as partners, often relying on them to conduct political advocacy in recipient countries, especially in controversial policy domains like reproductive health. Although INGOs are the primary recipients of donor funding, they are expected to work through national affiliates or counterparts to enable 'locally-led' change. Using prospective policy analysis and ethnographic evidence, this paper examines how donor-funded INGOs have influenced the restrictive policy environments for safe abortion and family planning in South Sudan and Malawi. While external actors themselves emphasise the technical nature of their involvement, the paper analyses them as instrumental political actors who strategically broker alliances and resources to shape policy, often working 'behind the scenes' to manage the challenging circumstances they operate under. Consequently, their agency and power are hidden through various practices of effacement or concealment. These practices may be necessary to rationalise the tensions inherent in delivering a global programme with the goal of inducing locally-led change in a highly controversial policy domain, but they also risk inciting suspicion and foreign-national tensions.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Storeng</LastName>
            <ForeName>Katerini T</ForeName>
            <Initials>KT</Initials>
            <Identifier Source="ORCID">0000-0003-0032-7006</Identifier>
            <AffiliationInfo>
              <Affiliation>a Centre for Development and the Environment , University of Oslo , Oslo , Norway.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Department of Epidemiology and Population Health , London School of Hygiene and Tropical Medicine , London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Palmer</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Epidemiology and Population Health , London School of Hygiene and Tropical Medicine , London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Daire</LastName>
            <ForeName>Judith</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>c Curtin University , Perth , Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kloster</LastName>
            <ForeName>Maren O</ForeName>
            <Initials>MO</Initials>
            <AffiliationInfo>
              <Affiliation>a Centre for Development and the Environment , University of Oslo , Oslo , Norway.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>03</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Public Health</MedlineTA>
        <NlmUniqueID>101256323</NlmUniqueID>
        <ISSNLinking>1744-1692</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D038622" MajorTopicYN="Y">Internationality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008295" MajorTopicYN="N" Type="Geographic">Malawi</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009938" MajorTopicYN="N">Organizations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011050" MajorTopicYN="N">Policy Making</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060728" MajorTopicYN="Y">Reproductive Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000068037" MajorTopicYN="N" Type="Geographic">South Sudan</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Malawi</Keyword>
        <Keyword MajorTopicYN="N">NGOs</Keyword>
        <Keyword MajorTopicYN="N">South Sudan</Keyword>
        <Keyword MajorTopicYN="N">policy</Keyword>
        <Keyword MajorTopicYN="N">reproductive health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29537338</ArticleId>
        <ArticleId IdType="doi">10.1080/17441692.2018.1446545</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29524056</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>26</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1612-9210</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>EcoHealth</Title>
          <ISOAbbreviation>Ecohealth</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Prioritizing a One Health Approach in the Immediate Fight Against Antimicrobial Resistance.</ArticleTitle>
        <Pagination>
          <StartPage>410</StartPage>
          <EndPage>413</EndPage>
          <MedlinePgn>410-413</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10393-018-1325-6</ELocationID>
        <Abstract>
          <AbstractText>Antimicrobial resistance is a major threat to global health security. While the global community has made recent advances to mitigate the threat of antimicrobial resistance, we continue to face challenges in creating solutions and concrete actions that will yield the greatest immediate impact. To examine the critical areas in human, animal and environmental health that contribute to the emergence and spread of antimicrobial resistance, the Forum on Microbial Threats of the U.S. National Academies of Sciences, Engineering and Medicine hosted a public workshop on June 20-21, 2017 in Washington, DC. This article summarizes the final synthesis discussion that took place at the workshop on suggestions for immediate actions and implementation that are feasible and cost-effective for combating antimicrobial resistance across the One Health domains. The priorities that emerged from the participants' discussions addressed the following topics: (1) Surveillance; (2) Stewardship, Infection Prevention and Behavior Modification; (3) Basic and Applied Research and Development; and (4) Global Policy and Coordination.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ogawa</LastName>
            <ForeName>V Ayano</ForeName>
            <Initials>VA</Initials>
            <AffiliationInfo>
              <Affiliation>Forum on Microbial Threats, Health and Medicine Division, The National Academies of Sciences, Engineering, and Medicine, 500 5th St. NW, Washington, DC, 20001, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shah</LastName>
            <ForeName>Cecilia M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Forum on Microbial Threats, Health and Medicine Division, The National Academies of Sciences, Engineering, and Medicine, 500 5th St. NW, Washington, DC, 20001, USA. cshah@nas.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hughes</LastName>
            <ForeName>James M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>King</LastName>
            <ForeName>Lonnie J</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>The Ohio State University College of Veterinary Medicine, Columbus, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>03</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Ecohealth</MedlineTA>
        <NlmUniqueID>101222144</NlmUniqueID>
        <ISSNLinking>1612-9202</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073602" MajorTopicYN="N">Antimicrobial Stewardship</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017408" MajorTopicYN="N">Guidelines as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058751" MajorTopicYN="N">Livestock</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074823" MajorTopicYN="Y">One Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012106" MajorTopicYN="N">Research</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antimicrobial resistance</Keyword>
        <Keyword MajorTopicYN="N">Global health security</Keyword>
        <Keyword MajorTopicYN="N">Infectious diseases</Keyword>
        <Keyword MajorTopicYN="N">Multi-sectoral partnerships</Keyword>
        <Keyword MajorTopicYN="N">One health</Keyword>
        <Keyword MajorTopicYN="N">Surveillance</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29524056</ArticleId>
        <ArticleId IdType="doi">10.1007/s10393-018-1325-6</ArticleId>
        <ArticleId IdType="pii">10.1007/s10393-018-1325-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>JAMA. 2016 Feb 9;315(6):562-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26864410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MBio. 2016 Jun 07;7(3):</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27273824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ups J Med Sci. 2016 Aug;121(3):159-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27416324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Antimicrob Chemother. 2017 Apr 1;72(4):957-968</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27999066</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29510765</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1938-744X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Disaster medicine and public health preparedness</Title>
          <ISOAbbreviation>Disaster Med Public Health Prep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Enhancing Global Health Security: US Africa Command's Disaster Preparedness Program.</ArticleTitle>
        <Pagination>
          <StartPage>319</StartPage>
          <EndPage>329</EndPage>
          <MedlinePgn>319-329</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1017/dmp.2018.17</ELocationID>
        <Abstract>
          <AbstractText>US Africa Command's Disaster Preparedness Program (DPP), implemented by the Center for Disaster and Humanitarian Assistance Medicine, partnered with US Government agencies and international organizations to promote stability and security on the African continent by engaging with African Partner Nations' (PN) civil and military authorities to improve disaster management capabilities. From 2008 to 2015, DPP conducted disaster preparedness and response programming with 17 PNs. DPP held a series of engagements with each, including workshops, strategic planning, developing preparedness and response plans, tabletop exercises, and prioritizing disaster management capability gaps identified through the engagements. DPP partners collected data for each PN to further capacity building efforts. Thus far, 9 countries have completed military pandemic plans, 10 have developed national pandemic influenza plans, 9 have developed military support to civil authorities plans, and 11 have developed disaster management strategic work plans. There have been 20 national exercises conducted since 2009. DPP was cited as key in implementation of Ebola response plans in PNs, facilitated development of disaster management agencies in DPP PNs, and trained nearly 800 individuals. DPP enhanced PNs' ability to prepare and respond to crises, fostering relationships between international agencies, and improving civil-military coordination through both national and regional capacity building. (Disaster Med Public Health Preparedness. 2019;13:319-329).</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Morton Hamer</LastName>
            <ForeName>Melinda J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>1Center for Global Health Engagement,Uniformed Services University,Bethesda,Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reed</LastName>
            <ForeName>Paul L</ForeName>
            <Initials>PL</Initials>
            <AffiliationInfo>
              <Affiliation>1Center for Global Health Engagement,Uniformed Services University,Bethesda,Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Greulich</LastName>
            <ForeName>Jane D</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>1Center for Global Health Engagement,Uniformed Services University,Bethesda,Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beadling</LastName>
            <ForeName>Charles W</ForeName>
            <Initials>CW</Initials>
            <AffiliationInfo>
              <Affiliation>1Center for Global Health Engagement,Uniformed Services University,Bethesda,Maryland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>03</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Disaster Med Public Health Prep</MedlineTA>
        <NlmUniqueID>101297401</NlmUniqueID>
        <ISSNLinking>1935-7893</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004189" MajorTopicYN="N">Disaster Planning</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName>
          <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004190" MajorTopicYN="N">Disasters</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008889" MajorTopicYN="N">Military Personnel</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ebola response</Keyword>
        <Keyword MajorTopicYN="N">civil military</Keyword>
        <Keyword MajorTopicYN="N">disaster preparedness</Keyword>
        <Keyword MajorTopicYN="N">disaster response</Keyword>
        <Keyword MajorTopicYN="N">humanitarian aid</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29510765</ArticleId>
        <ArticleId IdType="doi">10.1017/dmp.2018.17</ArticleId>
        <ArticleId IdType="pii">S1935789318000174</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29502488</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1538-0254</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biomolecular structure &amp; dynamics</Title>
          <ISOAbbreviation>J Biomol Struct Dyn</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Identification of new benzamide inhibitor against &#x3B1;-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.</ArticleTitle>
        <Pagination>
          <StartPage>1043</StartPage>
          <EndPage>1053</EndPage>
          <MedlinePgn>1043-1053</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07391102.2018.1448303</ELocationID>
        <Abstract>
          <AbstractText>Multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis has emerged as global health threat, causing millions of deaths worldwide. Identification of new drug candidates for tuberculosis (TB) by targeting novel and less explored protein targets will be invaluable for antituberculosis drug discovery. We performed structure-based virtual screening of eMolecules database against a homology model of relatively unexplored protein target: the &#x3B1;-subunit of tryptophan synthase (&#x3B1;-TRPS) from Mycobacterium tuberculosis essential for bacterial survival. Based on physiochemical properties analysis and molecular docking, the seven candidate compounds were selected and evaluated through whole cell-based activity against the H37Rv strain of M. tuberculosis. A new Benzamide inhibitor against &#x3B1;-subunit of tryptophan synthase (&#x3B1;-TRPS) from M. tuberculosis has been identified causing 100% growth inhibition at 25&#xA0;&#x3BC;g/ml and visible bactericidal activity at 6&#xA0;&#x3BC;g/ml. This benzamide inhibitor displayed a good predicted binding score (-48.24 kcal/mol) with the &#x3B1;-TRPS binding pocket and has logP value (2.95) comparable to Rifampicin. Further refinement of docking results and evaluation of inhibitor-protein complex stability were investigated through Molecular dynamic (MD) simulations studies. Following MD simulations, Root mean square deviation, Root mean square fluctuation and secondary structure analysis confirmed that protein did not unfold and ligand stayed inside the active pocket of protein during the explored time scale. This identified benzamide inhibitor against the &#x3B1;-subunit of TRPS from M. tuberculosis could be considered as candidate for drug discovery against TB and will be further evaluated for enzyme-based inhibition in future studies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Naz</LastName>
            <ForeName>Sadia</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Chemistry , COMSATS Institute of Information Technology , Abbottabad 22060 , Pakistan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Skaggs School of Pharmacy &amp; Pharmaceutical Sciences , University of California , San Diego , CA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Farooq</LastName>
            <ForeName>Umar</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Chemistry , COMSATS Institute of Information Technology , Abbottabad 22060 , Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ali</LastName>
            <ForeName>Sajid</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>c Provincial TB Control Program, Khyber Pakhtunkhwa Hayatabad Medical Complex , Peshawar , Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarwar</LastName>
            <ForeName>Rizwana</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Chemistry , COMSATS Institute of Information Technology , Abbottabad 22060 , Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khan</LastName>
            <ForeName>Sara</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Chemistry , COMSATS Institute of Information Technology , Abbottabad 22060 , Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abagyan</LastName>
            <ForeName>Ruben</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>b Skaggs School of Pharmacy &amp; Pharmaceutical Sciences , University of California , San Diego , CA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>03</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Biomol Struct Dyn</MedlineTA>
        <NlmUniqueID>8404176</NlmUniqueID>
        <ISSNLinking>0739-1102</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001549">Benzamides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D021122">Protein Subunits</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 4.2.1.20</RegistryNumber>
          <NameOfSubstance UI="D014367">Tryptophan Synthase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001549" MajorTopicYN="N">Benzamides</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062313" MajorTopicYN="N">Databases, Pharmaceutical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057166" MajorTopicYN="N">High-Throughput Screening Assays</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056004" MajorTopicYN="Y">Molecular Dynamics Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D021122" MajorTopicYN="N">Protein Subunits</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014367" MajorTopicYN="N">Tryptophan Synthase</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">-TRPS &#x2013; alpha subunit of tryptophan synthase</Keyword>
        <Keyword MajorTopicYN="N">-subunit</Keyword>
        <Keyword MajorTopicYN="N">DMSO &#x2013; Dimethyl sulfoxide</Keyword>
        <Keyword MajorTopicYN="N">INH &#x2013; Isoniazid</Keyword>
        <Keyword MajorTopicYN="N">MD simulations</Keyword>
        <Keyword MajorTopicYN="N">MD &#x2013; Molecular dynamics</Keyword>
        <Keyword MajorTopicYN="N">MDR-TB &#x2013; Multi-drug-resistant tuberculosis</Keyword>
        <Keyword MajorTopicYN="N">MIC &#x2013; Minimum inhibitory concentration</Keyword>
        <Keyword MajorTopicYN="N">PLP &#x2013; Pyridoxal phosphate</Keyword>
        <Keyword MajorTopicYN="N">RMSD</Keyword>
        <Keyword MajorTopicYN="N">RMSD &#x2013; Root-mean-square deviation</Keyword>
        <Keyword MajorTopicYN="N">RMSF</Keyword>
        <Keyword MajorTopicYN="N">RMSF &#x2013; Root-mean-square fluctuation</Keyword>
        <Keyword MajorTopicYN="N">TB &#x2013; Tuberculosis</Keyword>
        <Keyword MajorTopicYN="N">XDR-TB &#x2013; Extensively drug-resistant tuberculosis</Keyword>
        <Keyword MajorTopicYN="N">benzamide</Keyword>
        <Keyword MajorTopicYN="N">logP &#x2013; Partition coefficient</Keyword>
        <Keyword MajorTopicYN="N">tryptophan synthase</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29502488</ArticleId>
        <ArticleId IdType="doi">10.1080/07391102.2018.1448303</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29498568</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>10</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>07</Month>
        <Day>31</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1933-0693</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>130</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neurosurgery</Title>
          <ISOAbbreviation>J Neurosurg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Quality of life following surgical treatment of lesions within the pineal region.</ArticleTitle>
        <Pagination>
          <StartPage>28</StartPage>
          <EndPage>37</EndPage>
          <MedlinePgn>28-37</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3171/2017.7.JNS17260</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">2017.7.JNS17260</ELocationID>
        <Abstract>
          <AbstractText>OBJECTIVEPineal region tumors are a rare and heterogeneous group of lesions. The optimal therapeutic approach is currently a topic of controversy, particularly in light of the potential operative risks and complications. The potential beneficial effects of surgery have already been described, but information about neurological outcome and, in particular, health-related quality of life (HRQOL) is still lacking in the literature. The aim of this study was to assess the therapeutic effect of resection of pineal region lesions, emphasizing grade of tumor resection, neurological outcome, quality of life, and the necessity of additional shunt procedures.METHODSThe authors performed a prospective study of HRQOL in 32 patients who had undergone surgical treatment of lesions in the pineal region (20 tumors and 12 cysts) between 2008 and 2014. All patients had at least 6 months of follow-up, with reexamination including standardized neurological assessment, an evaluation of dependency using the modified Rankin Scale, and an evaluation of HRQOL. The authors retrospectively examined patient charts and collected information regarding imaging studies, neurological status prior to surgery, surgical strategies used, any complications, and histological diagnoses.RESULTSIn this study, there was no surgery-associated mortality or major morbidity. Permanent minor morbidity was reported for 4 patients (13%). Comparing pre- and postoperative neurological symptoms, 75% of tumor patients had either complete resolution or improvement of preoperative symptoms; symptoms were unchanged in 10% of tumor patients and deteriorated in 15%. In patients with pineal cysts, long-term follow-up showed that 42% of patients were free of any symptoms and 58% experienced improvement of their preoperative symptoms. These outcomes were also reflected in the modified Rankin Scale scores, which demonstrated significant improvement following resection of pineal region lesions. Furthermore, significant improvements in HRQOL scores occurred in global health status, in all functional scales, and in pain, nausea and vomiting, fatigue, and insomnia (p &lt; 0.0001). Moreover, a significant reduction in the necessity for permanent shunt procedures was observed after gross-total tumor resection compared with subtotal resection (p = 0.035) of pineal cysts.CONCLUSIONSDespite potential risks, (radical) surgery is a highly effective and safe treatment option for pineal region lesions and should be considered for the majority of patients.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fedorko</LastName>
            <ForeName>Stepan</ForeName>
            <Initials>S</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zweckberger</LastName>
            <ForeName>Klaus</ForeName>
            <Initials>K</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Unterberg</LastName>
            <ForeName>Andreas W</ForeName>
            <Initials>AW</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>03</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Neurosurg</MedlineTA>
        <NlmUniqueID>0253357</NlmUniqueID>
        <ISSNLinking>0022-3085</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010870" MajorTopicYN="Y">Pineal Gland</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">EORTC = European Organisation for Research and Treatment of Cancer</Keyword>
        <Keyword MajorTopicYN="N">GTR = gross-total resection</Keyword>
        <Keyword MajorTopicYN="N">HRQOL = health-related quality of life</Keyword>
        <Keyword MajorTopicYN="N">OH = obstructive hydrocephalus</Keyword>
        <Keyword MajorTopicYN="N">PFO = patent foramen ovale</Keyword>
        <Keyword MajorTopicYN="N">QLQ-C30 = quality of life questionnaire&#x2013;core 30</Keyword>
        <Keyword MajorTopicYN="N">QOL = quality of life</Keyword>
        <Keyword MajorTopicYN="N">mRS = modified Rankin Scale</Keyword>
        <Keyword MajorTopicYN="N">neurological outcome</Keyword>
        <Keyword MajorTopicYN="N">oncology</Keyword>
        <Keyword MajorTopicYN="N">pineal region tumors</Keyword>
        <Keyword MajorTopicYN="N">quality of life</Keyword>
        <Keyword MajorTopicYN="N">resection</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>1</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>7</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29498568</ArticleId>
        <ArticleId IdType="doi">10.3171/2017.7.JNS17260</ArticleId>
        <ArticleId IdType="pii">2017.7.JNS17260</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29493468</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>10</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2212-3989</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Infectious disorders drug targets</Title>
          <ISOAbbreviation>Infect Disord Drug Targets</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Evaluation of the QuantiFERON&#xAE;-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.</ArticleTitle>
        <Pagination>
          <StartPage>141</StartPage>
          <EndPage>144</EndPage>
          <MedlinePgn>141-144</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2174/1871526518666180228164036</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mycobacterium tuberculosis remains as a vital threat to global health and its diagnosis is still complicated. Since there is no gold standard for the diagnosis of latent tuberculosis infection (LTBI), its diagnosis routinely relies on measurement of host immune responses to M. tuberculosis antigens using the Tuberculin Skin Test (TST) and Interferon-Y Release Assays (IGRAs).</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to evaluate LTBI among hospitalized children and their parents/ guardians as general populations.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A cross-sectional study comparing TST and IGRA for the diagnosis of suspected LTBI was performed in children and their guardians (as general population) in Children Medical Center, an Iranian referral hospital.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In this study, 81 patients hospitalized in CMC and 102 patient's guardians were included. A total of 57 patients (70.4%) had performed a TST and were interpreted during the study. Among them, 32 (56%) had a positive test result when a cut-off of 10 mm induration. There were fewer positive IGRA test results than positive TST results (33% versus 56%) in children. Among guardians, TST and IGRA were positive in 41% and 40% respectively. The agreement between the IGRA test and the TST among them was 0.7, while this was as slightly lower in children (0.63).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of our study indicate that the IGRA test has a higher specificity than TST, especially in children, while the frequency of positive results with both tests in adults was similar. Considering the false positive results reported with the TST, replacement of the IGRA test with TST in children is recommended.</AbstractText>
          <CopyrightInformation>Copyright&#xA9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pourakbari</LastName>
            <ForeName>Babak</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yousefi</LastName>
            <ForeName>Korosh</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahmoudi</LastName>
            <ForeName>Shima</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sadeghi</LastName>
            <ForeName>Reihaneh H</ForeName>
            <Initials>RH</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mamishi</LastName>
            <ForeName>Setareh</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D023362">Evaluation Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United Arab Emirates</Country>
        <MedlineTA>Infect Disord Drug Targets</MedlineTA>
        <NlmUniqueID>101269158</NlmUniqueID>
        <ISSNLinking>1871-5265</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011933">Reagent Kits, Diagnostic</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059425" MajorTopicYN="N">Interferon-gamma Release Tests</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055985" MajorTopicYN="N">Latent Tuberculosis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011933" MajorTopicYN="N">Reagent Kits, Diagnostic</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014374" MajorTopicYN="N">Tuberculin Test</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">IGRA</Keyword>
        <Keyword MajorTopicYN="N">Latent tuberculosis infection</Keyword>
        <Keyword MajorTopicYN="N">TST</Keyword>
        <Keyword MajorTopicYN="N">adults</Keyword>
        <Keyword MajorTopicYN="N">children</Keyword>
        <Keyword MajorTopicYN="N">mycobacterium.</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>9</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29493468</ArticleId>
        <ArticleId IdType="doi">10.2174/1871526518666180228164036</ArticleId>
        <ArticleId IdType="pii">IDDT-EPUB-88871</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29471329</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>05</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1469-994X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>04</Day>
            </PubDate>
          </JournalIssue>
          <Title>Nicotine &amp; tobacco research : official journal of the Society for Research on Nicotine and Tobacco</Title>
          <ISOAbbreviation>Nicotine Tob Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of Varenicline, Depressive Symptoms, and Region of Enrollment on Smoking Cessation in Depressed Smokers.</ArticleTitle>
        <Pagination>
          <StartPage>156</StartPage>
          <EndPage>162</EndPage>
          <MedlinePgn>156-162</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ntr/nty033</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">Despite effective treatments, relapse to smoking remains a vexing global health problem. One predictor of relapse is depressive symptoms. Medications such as varenicline reduce withdrawal-related symptoms of depression, reducing relapse. This study examined whether varenicline moderated the effect of depressive symptoms on relapse, and whether this varied by region of enrollment.</AbstractText>
          <AbstractText Label="METHODS">Adult smokers (n = 525; 37% male) with past or current, stable major depressive disorder recruited from United States (n = 255), and European (n = 270) sites participated in a randomized, double-blind cessation treatment trial including 12 weeks of varenicline or placebo, with 40-week nontreatment follow-up.</AbstractText>
          <AbstractText Label="RESULTS">Longitudinal and binary logistic regressions were used to model the probability of sustained abstinence by end of treatment and point-prevalence abstinence in follow-up. The association between depression symptoms and abstinence was moderated by intervention group at end of treatment, and by region during follow-up: more severe symptoms were associated with end-of-treatment relapse for placebo (odds ratio [OR] = 0.91, p = .003), but not varenicline (OR = 0.99, p = .568). During follow-up, increased symptoms of depression predicted greater likelihood of smoking for European (p = .009) but not US participants. Europeans were more likely to be abstinent for both outcomes (p &lt; .01).</AbstractText>
          <AbstractText Label="CONCLUSIONS">These results extend studies demonstrating varenicline is associated with less withdrawal-related depression, and suggest it aids cessation even in smokers with depressive symptoms. Findings also suggest regional differences in the relationship between depressive symptoms and cessation that may be related to differences in prevalence.</AbstractText>
          <AbstractText Label="IMPLICATIONS">This study indicates varenicline may aid cessation partially by reducing withdrawal-related symptoms of depression. It also suggests that the impact of depressive symptoms on cessation varies regionally, and that this variation may be related to differences in smoking prevalence.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Doran</LastName>
            <ForeName>Neal</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Health Sciences, University of California, San Diego.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Mental Health Care Line, Veterans Affairs San Diego Healthcare System.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dubrava</LastName>
            <ForeName>Sarah</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Pfizer, Inc New York, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Anthenelli</LastName>
            <ForeName>Robert M</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Health Sciences, University of California, San Diego.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 DA037217</GrantID>
            <Acronym>DA</Acronym>
            <Agency>NIDA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>U01 AA013641</GrantID>
            <Acronym>AA</Acronym>
            <Agency>NIAAA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AA019720</GrantID>
            <Acronym>AA</Acronym>
            <Agency>NIAAA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016448">Multicenter Study</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nicotine Tob Res</MedlineTA>
        <NlmUniqueID>9815751</NlmUniqueID>
        <ISSNLinking>1462-2203</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018722">Nicotinic Agonists</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>W6HS99O8ZO</RegistryNumber>
          <NameOfSubstance UI="D000068580">Varenicline</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018722" MajorTopicYN="N">Nicotinic Agonists</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074285" MajorTopicYN="N">Smokers</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016540" MajorTopicYN="N">Smoking Cessation</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000068580" MajorTopicYN="N">Varenicline</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>9</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>17</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29471329</ArticleId>
        <ArticleId IdType="pmc">PMC6329403</ArticleId>
        <ArticleId IdType="doi">10.1093/ntr/nty033</ArticleId>
        <ArticleId IdType="pii">4868554</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
CDC. The Health Consequences of Smoking: A Report of the Surgeon General
Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2004. 
www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/index.htm. Accessed March 6, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>CDC. Vital signs: current cigarette smoking among adults aged &gt; 18 years with mental illness&#x2014;United States, 2009&#x2013;2011. MMWR Morb Mortal Wkly Rep. 2013;62:81&#x2013;87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4604817</ArticleId>
            <ArticleId IdType="pubmed">23388551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO. WHO Report on the Global Tobacco Epidemic. Geneva: World Health Organization; 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Vital signs: current cigarette smoking among adults aged &gt; 18 years&#x2014;United States, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1227&#x2013;1232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99(1):29&#x2013;38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14678060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hitsman B, Papandonatos GD, McChargue DE et al. . Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction. 2013;108(2):294&#x2013;306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3593055</ArticleId>
            <ArticleId IdType="pubmed">23072580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kenford SL, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol. 2002;70(1):216&#x2013;227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11860048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray RP, Gerald LB, Lindgren PG, Connett JE, Rand CS, Anthonisen NR. Characteristics of participants who stop smoking and sustain abstinence for 1 and 5 years in the Lung Health Study. Prev Med. 2000;30(5):392&#x2013;400.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10845748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cinciripini PM, Robinson JD, Karam-Hage M et al. . Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA Psychiatry. 2013;70(5):522&#x2013;533.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4128024</ArticleId>
            <ArticleId IdType="pubmed">23536105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>West R, Baker CL, Cappelleri JC, Bushmakin AG. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology (Berl). 2008;197(3):371&#x2013;377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18084743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohsenow DJ, Tidey JW, Martin RA et al. . Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms. Addiction. 2017;112(10):1808&#x2013;1820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28498504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langdon KJ, Leventhal AM, Stewart S, Rosenfield D, Steeves D, Zvolensky MJ. Anhedonia and anxiety sensitivity: prospective relationships to nicotine withdrawal symptoms during smoking cessation. J Stud Alcohol Drugs. 2013;74(3):469&#x2013;478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3602362</ArticleId>
            <ArticleId IdType="pubmed">23490577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weinberger AH, Desai RA, McKee SA. Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders. Drug Alcohol Depend. 2010;108(1&#x2013;2):7&#x2013;12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2835820</ArticleId>
            <ArticleId IdType="pubmed">20006451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anthenelli RM, Morris C, Ramey TS et al. . Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med. 2013;159(6):390&#x2013;400.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24042367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warner KE, Burns DM. Hardening and the hard-core smoker: concepts, evidence, and implications. Nicotine Tob Res. 2003;5(1):37&#x2013;48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12745505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson EO, Breslau N. Is the association of smoking and depression a recent phenomenon?Nicotine Tob Res. 2006;8(2):257&#x2013;262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16766418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawrence D, Mitrou F, Zubrick SR. Non-specific psychological distress, smoking status and smoking cessation: United States national health interview survey 2005. BMC Public Health. 2011;11:256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3107796</ArticleId>
            <ArticleId IdType="pubmed">21513510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talati A, Keyes KM, Hasin DS. Changing relationships between smoking and psychiatric disorders across twentieth century birth cohorts: clinical and research implications. Mol Psychiatry. 2016;21(4):464&#x2013;471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4801658</ArticleId>
            <ArticleId IdType="pubmed">26809837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
WHO. WHO Global Report on Trends in Prevalence of Tobacco Smoking
2015. 
http://apps.who.int/iris/bitstream/10665-156262-1-9789241564922_eng.pdf. Accessed February 29, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Gallus S, Lugo A, La Vecchia C et al. . Pricing policies and control of tobacco in Europe (PPACTE) project: cross-national comparison of smoking prevalence in 18 European countries. Eur J Cancer Prev. 2014;23(3): 177&#x2013;185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24441832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fern&#xE1;ndez E, Lugo A, Clancy L, Matsuo K, La Vecchia C, Gallus S. Smoking dependence in 18 European countries: hard to maintain the hardening hypothesis. Prev Med. 2015;81:314&#x2013;319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26441299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filippidis FT, Gerovasili V, Vardavas CI, Agaku IT, Tountas Y. Determinants of use of smoking cessation aids in 27 European countries. Prev Med. 2014;65:99&#x2013;102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24832820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fiore M, Jaen C, Baker T, Bailey W, Benowitz N, Curry S.. 
Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 
2008; www.surgeongeneral.gov/initiatives/tobacco/index.html. Accessed April 2, 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>Heatherton TF, Kozlowski LT, Frecker RC, Fagerstr&#xF6;m KO. The Fagerstr&#xF6;m Test for Nicotine Dependence: a revision of the Fagerstr&#xF6;m Tolerance Questionnaire. Br J Addict. 1991;86(9):1119&#x2013;1127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1932883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chabrol H, Niezborala M, Chastan E, de Leon J. Comparison of the Heavy Smoking Index and of the Fagerstrom Test for Nicotine Dependence in a sample of 749 cigarette smokers. Addict Behav. 2005;30(7):1474&#x2013;1477.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16022945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fagan P, Pohkrel P, Herzog T et al. . Comparisons of three nicotine dependence scales in a multiethnic sample of young adult menthol and non-menthol smokers. Drug Alcohol Depend. 2015;149:203&#x2013;211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4865397</ArticleId>
            <ArticleId IdType="pubmed">25744873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382&#x2013;389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">444788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang K-Y, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13&#x2013;22.</Citation>
        </Reference>
        <Reference>
          <Citation>Blankers M, Smit ES, van der Pol P, de Vries H, Hoving C, van Laar M. The missing=smoking assumption: a fallacy in internet-based smoking cessation trials?Nicotine Tob Res. 2016;18(1):25&#x2013;33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25744969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moher D, Hopewell S, Schulz KF et al. . CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2844943</ArticleId>
            <ArticleId IdType="pubmed">20332511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheema J. Some general guidelines for choosing missing data handling methods in educational research. J Mod Appl Stat Methods. 2014;13:3.</Citation>
        </Reference>
        <Reference>
          <Citation>Diggle P, Heagerty P, Liang K-Y, Zeger S.. Analysis of Longitudinal Data. New York: Oxford University Press; 2002.</Citation>
        </Reference>
        <Reference>
          <Citation>McKee SA, Smith PH, Kaufman M, Mazure CM, Weinberger AH. Sex differences in varenicline efficacy for smoking cessation: a meta-analysis. Nicotine Tob Res. 2016;18(5):1002&#x2013;1011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5942618</ArticleId>
            <ArticleId IdType="pubmed">26446070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith PH, Kasza KA, Hyland A et al. . Gender differences in medication use and cigarette smoking cessation: results from the International tobacco control four country survey. Nicotine Tob Res. 2015;17(4):463&#x2013;472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4402353</ArticleId>
            <ArticleId IdType="pubmed">25762757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cinciripini PM, Wetter DW, Fouladi RT et al. . The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol. 2003;71(2):292&#x2013;301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12699023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burgess ES, Brown RA, Kahler CW et al. . Patterns of change in depressive symptoms during smoking cessation: who&#x2019;s at risk for relapse?J Consult Clin Psychol. 2002;70(2):356&#x2013;361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1808225</ArticleId>
            <ArticleId IdType="pubmed">11952193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiffman S, Waters AJ. Negative affect and smoking lapses: a prospective analysis. J Consult Clin Psychol. 2004;72(2):192&#x2013;201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15065954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leventhal AM, Ramsey SE, Brown RA, LaChance HR, Kahler CW. Dimensions of depressive symptoms and smoking cessation. Nicotine Tob Res. 2008;10(3):507&#x2013;517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2650807</ArticleId>
            <ArticleId IdType="pubmed">18324570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schnoll RA, Leone FT, Hitsman B. Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch. J Addict Dis. 2013;32(1):46&#x2013;52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3605741</ArticleId>
            <ArticleId IdType="pubmed">23480247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Igari M, Alexander JC, Ji Y, Qi X, Papke RL, Bruijnzeel AW. Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats. Neuropsychopharmacology. 2014;39(2): 455&#x2013;465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3870769</ArticleId>
            <ArticleId IdType="pubmed">23966067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foulds J, Russ C, Yu CR et al. . Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials. Nicotine Tob Res. 2013;15(11):1849&#x2013;1857.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23694782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patterson F, Jepson C, Strasser AA et al. . Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry. 2009;65(2):144&#x2013;149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2615779</ArticleId>
            <ArticleId IdType="pubmed">18842256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borland R, Yong HH, Balmford J et al. . Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four Country project. Nicotine Tob Res. 2010;12(suppl):S4&#x2013;S11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2948136</ArticleId>
            <ArticleId IdType="pubmed">20889479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christelis D, Sanz-de-Galdeano A. Smoking persistence across countries: a panel data analysis. J Health Econ. 2011;30(5):1077&#x2013;1093.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21802158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore K, Borland R, Yong HH et al. . Support for tobacco control interventions: Do country of origin and socioeconomic status make a difference?Int J Public Health. 2012;57(5):777&#x2013;786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3556926</ArticleId>
            <ArticleId IdType="pubmed">22714136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCann DJ, Petry NM, Bresell A, Isacsson E, Wilson E, Alexander RC. Medication nonadherence, &#x201C;professional subjects,&#x201D; and apparent placebo responders: overlapping challenges for medications development. J Clin Psychopharmacol. 2015;35(5):566&#x2013;573.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4553101</ArticleId>
            <ArticleId IdType="pubmed">26244381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Devine EG, Waters ME, Putnam M et al. . Concealment and fabrication by experienced research subjects. Clin Trials. 2013;10(6):935&#x2013;948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23867223</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29461901</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2025</Year>
        <Month>01</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1753-8165</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>44</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Informatics for health &amp; social care</Title>
          <ISOAbbreviation>Inform Health Soc Care</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Predicting treatment outcome of drug-susceptible tuberculosis patients using machine-learning models.</ArticleTitle>
        <Pagination>
          <StartPage>135</StartPage>
          <EndPage>151</EndPage>
          <MedlinePgn>135-151</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17538157.2018.1433676</ELocationID>
        <Abstract>
          <AbstractText>Tuberculosis (TB) is a deadly contagious disease and a serious global health problem. It is curable but due to its lengthy treatment process, a patient is likely to leave the treatment incomplete, leading to a more lethal, drug resistant form of disease. The World Health Organization (WHO) propagates Directly Observed Therapy Short-course (DOTS) as an effective way to stop the spread of TB in communities with a high burden. But DOTS also adds a significant burden on the financial feasibility of the program. We aim to facilitate TB programs by predicting the outcome of the treatment of a particular patient at the start of treatment so that their health workers can be utilized in a targeted and cost-effective way. The problem was modeled as a classification problem, and the outcome of treatment was predicted using state-of-art implementations of 3 machine learning algorithms. 4213 patients were evaluated, out of which 64.37% completed their treatment. Results were evaluated using 4 performance measures; accuracy, precision, sensitivity, and specificity. The models offer an improvement of more than 12% accuracy over the baseline prediction. Empirical results also revealed some insights to improve TB programs. Overall, our proposed methodology will may help teams running TB programs manage their human resources more effectively, thus saving more lives.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hussain</LastName>
            <ForeName>Owais A</ForeName>
            <Initials>OA</Initials>
            <Identifier Source="ORCID">0000-0002-5449-1867</Identifier>
            <AffiliationInfo>
              <Affiliation>a Graduate School of Science and Engineering , Karachi Institute of Economics and Technology , Karachi , Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Junejo</LastName>
            <ForeName>Khurum N</ForeName>
            <Initials>KN</Initials>
            <Identifier Source="ORCID">0000-0002-3513-5808</Identifier>
            <AffiliationInfo>
              <Affiliation>a Graduate School of Science and Engineering , Karachi Institute of Economics and Technology , Karachi , Pakistan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>02</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Inform Health Soc Care</MedlineTA>
        <NlmUniqueID>101475011</NlmUniqueID>
        <ISSNLinking>1753-8157</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003663" MajorTopicYN="N">Decision Trees</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023801" MajorTopicYN="N">Directly Observed Therapy</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074021" MajorTopicYN="N">Interatrial Block</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015233" MajorTopicYN="Y">Models, Statistical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000099059" MajorTopicYN="Y">Assessment of Medication Adherence</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Predicting tuberculosis outcome</Keyword>
        <Keyword MajorTopicYN="N">drug-susceptible tuberculosis</Keyword>
        <Keyword MajorTopicYN="N">ehealth</Keyword>
        <Keyword MajorTopicYN="N">optimization of health workers</Keyword>
        <Keyword MajorTopicYN="N">predictive analysis</Keyword>
        <Keyword MajorTopicYN="N">tuberculosis treatment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29461901</ArticleId>
        <ArticleId IdType="doi">10.1080/17538157.2018.1433676</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29461281</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1538-9804</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>42</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Jan/Feb</Season>
            </PubDate>
          </JournalIssue>
          <Title>Cancer nursing</Title>
          <ISOAbbreviation>Cancer Nurs</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Self-assessment of Goal Achievements Within a Gynecological Cancer Rehabilitation Counseling.</ArticleTitle>
        <Pagination>
          <StartPage>58</StartPage>
          <EndPage>66</EndPage>
          <MedlinePgn>58-66</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/NCC.0000000000000567</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">There is an increasing focus on patient involvement in cancer rehabilitation. Goal assessment may improve the patient's self-management of life after cancer.</AbstractText>
          <AbstractText Label="OBJECTIVE">The aim of this study was to evaluate whether (1) nurse-led supported goal setting and assessment of goal achievement were feasible in a clinical setting and (2) there was a positive association between women's goal achievement and their self-assessed global health status (GHS).</AbstractText>
          <AbstractText Label="METHODS">Women surgically treated for gynecological cancer were offered rehabilitation counseling consisting of 2 face-to-face sessions and 2 phone calls carried out by a nurse. The Goal Attainment Scale evaluated goal achievement, whereas GHS was assessed with a quality-of-life questionnaire (European Organization of Research and Treatment of Cancer Quality of Life Questionnaire Core 30).</AbstractText>
          <AbstractText Label="RESULTS">One hundred fifty-one women consented to participate; 70% of the women at the first phone call and 72% at the second phone call achieved their goals as "expected" or "more or much more than expected." Endometrial cancer patients more often achieved their goals than ovarian or cervical cancer patients. Approximately 32% of ovarian and 40% of cervical cancer patients scored their goal achievement "below expected." The patients' GHS was not associated with goal attainment measured at each phone call.</AbstractText>
          <AbstractText Label="CONCLUSION">Goal measurement is feasible in cancer rehabilitation, in both goal setting and goal achievement. Goal achievement less than expected levels in women recovering from ovarian or cervical cancer suggests a need for additional support.</AbstractText>
          <AbstractText Label="IMPLICATIONS FOR PRACTICE">This study supports goal setting and goal achievement as a feasible approach to improve cancer rehabilitation and that nursing professionals can facilitate individualized rehabilitation efforts.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Adellund Holt</LastName>
            <ForeName>Kamila</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Author Affiliations: Department of Obstetrics and Gynaecology, Odense University Hospital; and Institute of Clinical Research (Drs Holt and Jensen), and Research Unit of General Practice, Institute of Public Health, National Research Centre of Cancer Rehabilitation (Dr G. Hansen), University of Southern Denmark, Odense; and Department of Obstetrics and Gynaecology, Karolinska University Hospital, Stockholm, Sweden; and Institute of Clinical Research, University of Southern Denmark, Odense (Dr Mogensen).</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hansen</LastName>
            <ForeName>Dorte G</ForeName>
            <Initials>DG</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mogensen</LastName>
            <ForeName>Ole</ForeName>
            <Initials>O</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jensen</LastName>
            <ForeName>Pernille T</ForeName>
            <Initials>PT</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D064888">Observational Study</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer Nurs</MedlineTA>
        <NlmUniqueID>7805358</NlmUniqueID>
        <ISSNLinking>0162-220X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003376" MajorTopicYN="N">Counseling</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005833" MajorTopicYN="N">Genital Neoplasms, Female</DescriptorName>
          <QualifierName UI="Q000451" MajorTopicYN="N">nursing</QualifierName>
          <QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006040" MajorTopicYN="Y">Goals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012647" MajorTopicYN="Y">Self-Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29461281</ArticleId>
        <ArticleId IdType="doi">10.1097/NCC.0000000000000567</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29458237</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2005-9256</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>51</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cancer research and treatment</Title>
          <ISOAbbreviation>Cancer Res Treat</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01).</ArticleTitle>
        <Pagination>
          <StartPage>43</StartPage>
          <EndPage>52</EndPage>
          <MedlinePgn>43-52</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4143/crt.2017.562</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We investigated whether irinotecan plus capecitabine improved progression-free survival (PFS) compared with capecitabine alone in patients with human epidermal growth factor 2 (HER2) negative and anthracycline and taxane pretreated metastatic breast cancer (MBC).</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A total of 221 patients were randomly assigned to irinotecan (80 mg/m2, days 1 and 8) and capecitabine (1,000 mg/m2 twice a day, days 1-14) or capecitabine alone (1,250 mg/m2 twice a day, days 1-14) every 3 weeks. The primary endpoint was PFS.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no significant difference in PFS between the combination and monotherapy arm (median, 6.4 months vs. 4.7 months; hazard ratio [HR], 0.84; 95% confidence interval [CI], 0.63 to 1.11; p=0.84). In patients with triple-negative breast cancer (TNBC, n=90), the combination significantly improved PFS (median, 4.7 months vs. 2.5 months; HR, 0.58; 95% CI, 0.37 to 0.91; p=0.02). Objective response rate was numerically higher in the combination arm, though it failed to reach statistical significance (44.4% vs. 33.3%, p=0.30). Overall survival did not differ between arms (median, 20.4 months vs. 24.0 months; p=0.63). While grade 3 or 4 neutropenia was more common in the combination arm (39.6% vs 9.0%), hand-foot syndrome was more often observed in capecitabine arm. Quality of life measurements in global health status was similar. However, patients in the combination arm showed significantly worse symptom scales especially in nausea/vomiting and diarrhea.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Irinotecan plus capecitabine did not prove clinically superior to single-agent capecitabine in anthracycline- and taxane-pretreated HER2 negative MBC patients. Toxicity profiles of the two groups differed but were manageable. The role of added irinotecan in patients with TNBC remains to be elucidated.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>In Hae</ForeName>
            <Initials>IH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Internal Medicine, Center for Breast Cancer, National Cancer Center, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Im</LastName>
            <ForeName>Seock-Ah</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jung</LastName>
            <ForeName>Kyung Hae</ForeName>
            <Initials>KH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sohn</LastName>
            <ForeName>Joo Hyuk</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Yeon Hee</ForeName>
            <Initials>YH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Keun Seok</ForeName>
            <Initials>KS</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Internal Medicine, Center for Breast Cancer, National Cancer Center, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sim</LastName>
            <ForeName>Sung Hoon</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Internal Medicine, Center for Breast Cancer, National Cancer Center, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Kyong-Hwa</ForeName>
            <Initials>KH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Jee Hyun</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Oncology/Hematology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nam</LastName>
            <ForeName>Byung Ho</ForeName>
            <Initials>BH</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Clinical Trials, National Cancer Center, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Hee-Jun</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Tae-Yong</ForeName>
            <Initials>TY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Kyung-Hun</ForeName>
            <Initials>KH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Sung-Bae</ForeName>
            <Initials>SB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahn</LastName>
            <ForeName>Jin-Hee</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Oncology, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Suee</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ro</LastName>
            <ForeName>Jungsil</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Internal Medicine, Center for Breast Cancer, National Cancer Center, Goyang, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>1210530</GrantID>
            <Agency>National Cancer Center</Agency>
            <Country>Republic of Korea</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016448">Multicenter Study</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>02</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Korea (South)</Country>
        <MedlineTA>Cancer Res Treat</MedlineTA>
        <NlmUniqueID>101155137</NlmUniqueID>
        <ISSNLinking>1598-2998</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018943">Anthracyclines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001952">Bridged-Ring Compounds</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D043823">Taxoids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>1605-68-1</RegistryNumber>
          <NameOfSubstance UI="C080625">taxane</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>6804DJ8Z9U</RegistryNumber>
          <NameOfSubstance UI="D000069287">Capecitabine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7673326042</RegistryNumber>
          <NameOfSubstance UI="D000077146">Irinotecan</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018943" MajorTopicYN="N">Anthracyclines</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001952" MajorTopicYN="N">Bridged-Ring Compounds</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069287" MajorTopicYN="N">Capecitabine</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077146" MajorTopicYN="N">Irinotecan</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043823" MajorTopicYN="N">Taxoids</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Capecitabine</Keyword>
        <Keyword MajorTopicYN="N">Clinical trial</Keyword>
        <Keyword MajorTopicYN="N">Irinotecan</Keyword>
        <Keyword MajorTopicYN="N">Metastatic breast cancer</Keyword>
        <Keyword MajorTopicYN="N">Progression free survival</Keyword>
      </KeywordList>
      <CoiStatement>This study was partly funded by Shin Poong Pharmaceuticals Co.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29458237</ArticleId>
        <ArticleId IdType="pmc">PMC6333992</ArticleId>
        <ArticleId IdType="doi">10.4143/crt.2017.562</ArticleId>
        <ArticleId IdType="pii">crt.2017.562</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Cardoso F, Costa A, Norton L, Senkus E, Aapro M, Andre F, et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)dagger. Ann Oncol. 2014;25:1871&#x2013;88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4176456</ArticleId>
            <ArticleId IdType="pubmed">25234545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang JC. Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol. 2002;3:430&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12042765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pizzolato JF, Saltz LB. The camptothecins. Lancet. 2003;361:2235&#x2013;42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12842380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ichikawa W, Takahashi T, Suto K, Yamashita T, Nihei Z, Shirota Y, et al. Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. Br J Cancer. 2004;91:1245&#x2013;50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2409894</ArticleId>
            <ArticleId IdType="pubmed">15354215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Y, Shi M, Shen X, Yang C, Yang L, Zhang J. Capecitabine plus irinotecan versus 5-FU/leucovorin plus irinotecan in the treatment of colorectal cancer: a meta-analysis. Clin Colorectal Cancer. 2014;13:110&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24461997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Connor T, Rustum Y, Levine E, Creaven P. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer. Cancer Chemother Pharmacol. 2008;61:125&#x2013;31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17426973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perez EA, Hillman DW, Mailliard JA, Ingle JN, Ryan JM, Fitch TR, et al. Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both. J Clin Oncol. 2004;22:2849&#x2013;55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15254052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan WW, Hillman DW, Salim M, Northfelt DW, Anderson DM, Stella PJ, et al. N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial. Ann Oncol. 2010;21:493&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5808723</ArticleId>
            <ArticleId IdType="pubmed">19625343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stathopoulos GP, Tsavdaridis D, Malamos NA, Rigatos SK, Kosmas C, Pergantas N, et al. Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study. Cancer Chemother Pharmacol. 2005;56:487&#x2013;91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15868147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee KS, Park IH, Nam BH, Ro J. Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer. Invest New Drugs. 2013;31:152&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22562702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365&#x2013;76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8433390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, et al. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004;13:863&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15129896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jassem J, Carroll C, Ward SE, Simpson E, Hind D. The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: a systematic review. Eur J Cancer. 2009;45:2749&#x2013;58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19615886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gelmon K, Chan A, Harbeck N. The role of capecitabine in first-line treatment for patients with metastatic breast cancer. Oncologist. 2006;11 Suppl 1:42&#x2013;51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16971739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Belfiglio M, Fanizza C, Tinari N, Ficorella C, Iacobelli S, Natoli C, et al. Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer. J Cancer Res Clin Oncol. 2012;138:221&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3258394</ArticleId>
            <ArticleId IdType="pubmed">22095437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Shaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub JP, Cervantes G, et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol. 2002;20:2812&#x2013;23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12065558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albain KS, Nag SM, Calderillo-Ruiz G, Jordaan JP, Llombart AC, Pluzanska A, et al. Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment. J Clin Oncol. 2008;26:3950&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18711184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sparano JA, Vrdoljak E, Rixe O, Xu B, Manikhas A, Medina C, et al. Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol. 2010;28:3256&#x2013;63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2903325</ArticleId>
            <ArticleId IdType="pubmed">20530276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perez EA, Awada A, O'Shaughnessy J, Rugo HS, Twelves C, Im SA, et al. Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol. 2015;16:1556&#x2013;68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26482278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoch U, Staschen CM, Johnson RK, Eldon MA. Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models. Cancer Chemother Pharmacol. 2014;74:1125&#x2013;37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4236622</ArticleId>
            <ArticleId IdType="pubmed">25228368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Twelves C, Cortes J, O'Shaughnessy J, Awada A, Perez EA, Im SA, et al. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: results from the randomised phase III BEACON trial. Eur J Cancer. 2017;76:205&#x2013;15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28360015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cortes J, Rugo HS, Awada A, Twelves C, Perez EA, Im SA, et al. Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial. Breast Cancer Res Treat. 2017;165:329&#x2013;41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5543189</ArticleId>
            <ArticleId IdType="pubmed">28612225</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29429394</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1538-0254</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biomolecular structure &amp; dynamics</Title>
          <ISOAbbreviation>J Biomol Struct Dyn</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Understanding the resistance mechanism of penicillin binding protein 1a mutant against cefotaxime using molecular dynamic simulation.</ArticleTitle>
        <Pagination>
          <StartPage>741</StartPage>
          <EndPage>749</EndPage>
          <MedlinePgn>741-749</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07391102.2018.1439404</ELocationID>
        <Abstract>
          <AbstractText>Antibiotic resistance is a threatening challenge for global health, as the expansion of resistance to current antibiotics has made serious therapeutic problems. Genome mutations are key evolutionary mechanisms conferring antibiotic resistance in bacterial pathogens. For example, penicillin and cephalosporins resistance is mostly mediated by mutations in penicillin binding proteins to change the affinity of the drug. Accordingly, threonine point mutations were reported to develop antibiotic resistance in various bacterial infections including pneumococcal infections. In this study, conventional molecular dynamics simulations, umbrella sampling simulations and MM/GBSA free energy calculations were applied to figure out how the Threonine to Alanine mutation (T to A) at STMK motif affects the binding of cefotaxime to Penicillin Binding Protein 1a and to reveal the resistance mechanism induced by the T to A mutation. The results obtained from the computational methods demonstrate that the T to A mutation increases the flexibility of the binding pocket and changes its conformation, which leads to increased conformational entropy change (-T&#x394;S) and attenuates the bonds between the ligand and the receptor. In brief, our findings indicate that both of the alterations of the conformational enthalpy and entropy contribute to the T to A-induced resistance in the binding of cefotaxime into penicillin binding protein 1a.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Behmard</LastName>
            <ForeName>Esmaeil</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>a Molecular Biology Research Center, Systems Biology and Poisonings Institute , Baqiyatallah University of Medical Sciences , Tehran , Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Najafi</LastName>
            <ForeName>Ali</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>a Molecular Biology Research Center, Systems Biology and Poisonings Institute , Baqiyatallah University of Medical Sciences , Tehran , Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ahmadi</LastName>
            <ForeName>Ali</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>a Molecular Biology Research Center, Systems Biology and Poisonings Institute , Baqiyatallah University of Medical Sciences , Tehran , Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>02</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Biomol Struct Dyn</MedlineTA>
        <NlmUniqueID>8404176</NlmUniqueID>
        <ISSNLinking>0739-1102</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D046915">Penicillin-Binding Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N2GI8B1GK7</RegistryNumber>
          <NameOfSubstance UI="D002439">Cefotaxime</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002439" MajorTopicYN="N">Cefotaxime</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="Y">Drug Resistance, Bacterial</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019277" MajorTopicYN="N">Entropy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056004" MajorTopicYN="Y">Molecular Dynamics Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D046915" MajorTopicYN="N">Penicillin-Binding Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013816" MajorTopicYN="N">Thermodynamics</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">MM/GBSA</Keyword>
        <Keyword MajorTopicYN="N">antibiotic resistance</Keyword>
        <Keyword MajorTopicYN="N">penicillin binding protein</Keyword>
        <Keyword MajorTopicYN="N">umbrella sampling simulation</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29429394</ArticleId>
        <ArticleId IdType="doi">10.1080/07391102.2018.1439404</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29397576</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1365-2125</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>85</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>British journal of clinical pharmacology</Title>
          <ISOAbbreviation>Br J Clin Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India.</ArticleTitle>
        <Pagination>
          <StartPage>59</StartPage>
          <EndPage>70</EndPage>
          <MedlinePgn>59-70</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/bcp.13503</ELocationID>
        <Abstract>
          <AbstractText Label="AIMS">Rising antimicrobial resistance (AMR) is a global health crisis. India has among the highest resistance rates and antibiotic consumption internationally. Extensive use of fixed-dose combination (FDC) antibiotics and of unapproved formulations are claimed contributory factors but there has been no systematic examination of formulations or volumes sold. The aim of the present study was to investigate the regulatory approval status and sales volumes of systemic antibiotics marketed in India.</AbstractText>
          <AbstractText Label="METHODS">This was an ecological study using regulatory records in India, the UK and the US to determine the approval status in each country of systemic antibiotic FDCs and single-drug formulations (SDFs) sold in India. Pharmatrac&#xAE; sales data were used to determine the formulations and volumes sold (2007-2012), branded-product numbers and manufacturers.</AbstractText>
          <AbstractText Label="RESULTS">Of 118 systemic antibiotic FDC formulations sold in India, 43 (36%) were approved but 75 (64%) had no record of regulatory approval; four (3%) formulations were approved in the UK and/or US. Almost half of formulations (58/118; 49%) comprised dual antimicrobials, most unapproved in India (43/58; 74%), and many were pharmacologically problematic. In contrast, 80/86 (93%) SDFs were approved in India and over two-thirds in the UK and/or US. Total antibiotic sales increased by 26%, from 2056 million units (2007-08) to 2583 million units (2011-12). FDC sales rose by 38% vs. 20% for SDFs. By 2011-12, FDCs comprised one-third of sales (872 million units). Over one-third of FDCs sold (300.26 million units; 34.5%) were of unapproved formulations. Multinational companies manufactured unapproved formulations and accounted for 19% of all FDC and SDF sales annually.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Sales in India of antibiotic FDCs, including unapproved formulations, are rising. In the context of increasing AMR rates nationally and globally, unapproved antibiotic FDCs undermine India's national AMR strategy and should be banned from sale.</AbstractText>
          <CopyrightInformation>&#xA9; 2018 The British Pharmacological Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McGettigan</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0002-9757-9754</Identifier>
            <AffiliationInfo>
              <Affiliation>William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roderick</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Health and Society, Newcastle University, Newcastle upon Tyne, NE2 4AX, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kadam</LastName>
            <ForeName>Abhay</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Lakshya Society for Public Health Education and Research, Pune, Maharashtra, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pollock</LastName>
            <ForeName>Allyson</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Health and Society, Newcastle University, Newcastle upon Tyne, NE2 4AX, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>02</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Br J Clin Pharmacol</MedlineTA>
        <NlmUniqueID>7503323</NlmUniqueID>
        <ISSNLinking>0306-5251</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000600" MajorTopicYN="Y">supply &amp; distribution</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003132" MajorTopicYN="N">Commerce</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017277" MajorTopicYN="Y">Drug Approval</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="Y">Drug Resistance, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antibiotics</Keyword>
        <Keyword MajorTopicYN="N">antimicrobial resistance</Keyword>
        <Keyword MajorTopicYN="N">fixed-dose combination (FDC) formulations</Keyword>
        <Keyword MajorTopicYN="N">regulatory approval</Keyword>
        <Keyword MajorTopicYN="N">unapproved formulations</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29397576</ArticleId>
        <ArticleId IdType="pmc">PMC6303201</ArticleId>
        <ArticleId IdType="doi">10.1111/bcp.13503</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
O'Neill J.
The review on antimicrobial resistance. Tackling drug&#x2010;resistant infections globally: final report and recommendations. 19 May 2016. Available at http://amr&#x2010;review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Laxminarayan R, Matsosp P, Pant S, Brower C, Rottigen J&#x2010;A, Klugman K, et al Antimicrobials: access and sustainable effectiveness 1. Access to effective antimicrobials: a worldwide challenge. Lancet 2016; 387: 168&#x2013;175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26603918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holmes A, Moore LSP, Sundsfjord A, Stienbakk M, Regmi S, Karkey A, et al Understanding the mechanisms and drivers of antimicrobial resistance. Lancet: 2016. ; 387: 176&#x2013;187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26603922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mendelsom M, Rottingen JA, Gopinathan U, Hamer D, Wertheim H, Basnyat B, et al Maximising access to achieve appropriate human antimicrobial use in low&#x2010;income and middle&#x2010;income countries. Lancet 2016; 387: 188&#x2013;198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26603919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
World Health Organization
. Global action plan on antimicrobial resistance. Available at http://www.who.int/drugresistance/global_action_plan/en/ (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization
. List of essential medicines, India, 2011.  Available at http://apps.who.int/medicinedocs/documents/s18693en/s18693en.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>
World Health Organization
. Critically important antimicrobials for human medicine. 3rd revision, 2011.  Available at http://apps.who.int/iris/bitstream/10665/77376/1/9789241504485_eng.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell B, Levin S, et al Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 2014; 14: 742&#x2013;750.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25022435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel V, Parikh R, Nandraj S, Balasubramaniam P, Narayan K, Paul VK, et al Asssuring health coverage for all in India. Lancet 2015; 386: 2422&#x2013;2435.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26700532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Department&#x2010;Related Standing Committee on Health and Family Welfare
. 59th Report on the functioning of the Central Drugs Standard Control Organization (CDSCO). Parliament of India, New Delhi, 2012. Available at http://164.100.47.5/newcommittee/reports/englishcommittees/committee%20on%20health%20and%20family%20welfare/59.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Department&#x2010;Related Standing Committee on Health and Family Welfare
. 66th Report on action taken by the government on the recommendations/observations contained in the 59th Report on the functioning of Central Drugs Standards Control Organization (CDSCO). Parliament of India, New Delhi, 2013. Available at http://www.searchingforsafety.net/uploads/2/6/2/1/26218021/rajya_sabha_april_2013.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Chaudhury R.
Report of the Prof Ranjit Roy Chaudhury Expert Committee to formulate policy and guidelines for approval of new drugs, clinical trials and banning of drugs. Parliament of India, New Delhi, 2013.  Available at http://www.indiaenvironmentportal.org.in/files/file/clinical%20trials1.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Kokate CK. Report by the Expert Committee constituted for examination of fixed dose combinations (FDCs) permitted for manufacture for sale in the country without due approval from office of DCG&#x2010;(I) regarding. Parliament of India, New Delhi, 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Available at http://www.cdsco.nic.in/writereaddata/fdcreport10_2_2016.pdf (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Government of India
. 
Ministry of Health and FamilyWelfare
. Manufacturing and Marketing of Banned/ Unapproved Drugs. 2013. Available at http://pib.nic.in/newsite/PrintRelease.aspx?relid=101213 (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Roderick P, Mahajan R, McGettigan P, Pollock A. India should introduce a new Drugs Act. Lancet 2014; 383: 206&#x2013;209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24449942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Medicines &amp; Healthcare Products Regulatory Agency
. Co&#x2010;amoxiclav 500/125 tablets. Available at http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1515734933668.pdf (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Medicines &amp; Healthcare Products Regulatory Agency
. Septrin&#xAE; (trimethoprim + sulfamethoxazole). Available at http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1496991840650.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>
British National Formulary. Available at https://bnf.nice.org.uk/treatment-summary/antibacterials-principles-of-therapy.html (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
National Institute for Health and Care Excellence (NICE)
. Guideline NG15; August 2015. Available at https://www.nice.org.uk/guidance/NG15/chapter/1&#x2010;Recommendations#recommendations&#x2010;for&#x2010;prescribers (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016; 62: 1197&#x2013;1202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27118828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
National Centre for Disease Control, India
. National antibiotic treatment guidelines for antimicrobial use in infectious diseases. Available at http://pbhealth.gov.in/AMR_guideline7001495889.pdf (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Ministry of Health and Family Welfare, Government of India
. Antibiotic policy. Available at http://pib.nic.in/newsite/PrintRelease.aspx?relid=117474 (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta&#x2010;analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 2014; 14: 13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3897982</ArticleId>
            <ArticleId IdType="pubmed">24405683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ. Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev 2013; 26: 289&#x2013;307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3623381</ArticleId>
            <ArticleId IdType="pubmed">23554418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
All Indian Origin Chemists and Distributors
(AIOCD) Pharmasofttech, AWACS Pvt. Ltd. 2014. Available at http://www.aiocdawacs.com/ProductDetail.aspx (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Central Drugs Standard Control Organization (CDSCO)
. FDCs approved 1961&#x2013;2014. Available at http://cdsco.nic.in/writereaddata/Aprroved%20FDC%20list%20till%20november%202014.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Central Drugs Standard Control Organization (CDSCO)
. SDF list of approved drugs CDSCO. 1971&#x2013;1998. Available at http://www.cdsco.nic.in/writereaddata/1971&#x2010;98.pdf (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Central Drugs Standard Control Organization (CDSCO)
. List of approved new drug. Available at http://www.cdsco.nic.in/forms/list.aspx?lid=2034&amp;Id=11 (last accessed 31 January 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Medicines and Healthcare Products Regulatory Agency
. Medicines information: SPC &amp; PILs. Available at http://www.mhra.gov.uk/Safetyinformation/Medicinesinformation/SPCandPILs/index.htm (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
European Medicines Agency
. European public assessment reports. Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&amp;mid=WC0b01ac058001d124 (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
US Food and Drug Administration
. Orange Book: approved drug products with therapeutic equivalence evaluations. Available at https://www.accessdata.fda.gov/scripts/cder/ob/default.cfm (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Tacconelli E, Cataldo MA, Paul M, Kluytmans J, Schroeder W, Foschi F, et al STROBE&#x2010;AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship. BMJ Open 2016; 6: e010134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4762075</ArticleId>
            <ArticleId IdType="pubmed">26895985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
NHS Digital. Prescription cost analysis England
. 2012.  Available at http://www.hscic.gov.uk/catalogue/PUB10610 (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Abbott Healthcare, India
. Therapy areas. Available at http://www.abbott.in/products/therapy&#x2010;areas.html (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Mahr K, Siddiqui Z. As combination drugs engulf India, an American pharmaceutical giant profits. Reuters, 15 December 2015. Available at http://www.reuters.com/investigates/special&#x2010;report/india&#x2010;medicine&#x2010;abbott/ (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Lane EJ. India's penchant for fixed&#x2010;dose drugs a big problem. Fierce Pharma, 15 December 2015. Available at http://www.fiercepharma.com/regulatory/india&#x2010;s&#x2010;penchant&#x2010;for&#x2010;fixed&#x2010;dose&#x2010;drugs&#x2010;a&#x2010;big&#x2010;problem (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Declaration by the pharmaceutical, biotechnology and diagnostics industries on combating antimicrobial resistance, 2016.  Available at http://amr&#x2010;review.org/sites/default/files/Industry_Declaration_on_Combating_Antimicrobial_Resistance_UPDATED%20SIGNATORIES_MAY_2016.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Kokate CK. Report of expert committee on fixed dose combinations (FDCs) licensed by SLAs for manufacture without approval of DCG(I), applications of which have been received by CDSCO. Available at http://www.cdsco.nic.in/writereaddata/fdcexpert%2019.1.2016.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Kokate CK. Report of expert committee on applications of fixed dose combinations (FDCs) received by CDSCO for proving safety and efficacy categorised under category &#x2018;a&#x2019;. Available at http://www.cdsco.nic.in/writereaddata/fdc16.04.2015.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Government of India
, 
Ministry of Health and Family Welfare
. The Gazette of India. No 608. New Delhi. 10th March 2016. Available at http://www.cdsco.nic.in/writereaddata/GSR705E.pdf (last accessed 31 January 2018).</Citation>
        </Reference>
        <Reference>
          <Citation>
Jain A.
Delhi High Court reverses ban on combination drugs. The Hindu, 2 December 2016. Available at http://www.thehindu.com/news/national/article16735149.ece. (last accessed 21 November 2017)</Citation>
        </Reference>
        <Reference>
          <Citation>
Rautray S, Raghavan P. Government need not consult statutory board to ban combo drugs: Supreme Court. Economic Times Healthworld. Available at https://health.economictimes.indiatimes.com/news/policy/government&#x2010;need&#x2010;not&#x2010;consult&#x2010;statutory&#x2010;board&#x2010;to&#x2010;ban&#x2010;combo&#x2010;drugs&#x2010;supreme&#x2010;court/61664489 (last accessed 6 December 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>
Press Information Bureau. Government of India, 22 June 2016 Available at http://pib.nic.in/newsite/erelease.aspx?relid=146413 (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Holloway KA, Rosella L, Henry D. The impact of WHO essential medicines policies on inappropriate use of antibiotics. PLoS ONE 2016; 11: e0152020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4803297</ArticleId>
            <ArticleId IdType="pubmed">27002977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Government of India, Ministry of Health and Family Welfare
. National action plan on antimicrobial resistance 2017&#x2013;2021. Available at http://cseindia.org/userfiles/inap_amr_20170420.pdf (last accessed 21 November 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Dar OA, Hasan R, Schlundt J, Harbarth S, Caleo G, Dar FK, et al Exploring the evidence base for national and regional policy interventions to combat resistance. Lancet 2016; 387: 285&#x2013;295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26603921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ardal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, et al International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet 2016; 387: 296&#x2013;307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26603920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
IMS Health Midas Pharmaceutical Sales Data. Available at http://www.imshealth.com/en/solution&#x2010;areas/technology&#x2010;and&#x2010;applications/offerings/midas (last accessed 21 November 2017).</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29383944</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-3799</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>28</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical nursing research</Title>
          <ISOAbbreviation>Clin Nurs Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Effects of a Culturally Tailored, Patient-Centered Psychosocial Intervention in South Korean Cancer Survivors.</ArticleTitle>
        <Pagination>
          <StartPage>931</StartPage>
          <EndPage>946</EndPage>
          <MedlinePgn>931-946</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1054773818755836</ELocationID>
        <Abstract>
          <AbstractText>This study aimed to develop a culturally tailored, patient-centered psychosocial intervention program and to investigate the effects of the program on health-related quality of life, sleep disturbance, and depression in cancer survivors. This was a one-group pretest and posttest design. A total of 19 cancer survivors participated in the program. The program was designed to have an 8-week duration with one class per week. Every class was composed of a 90-min education session and a 90-min exercise. Among the health-related quality of life subscales, the scores of global health status/quality of life, physical functioning, and emotional functioning at posttest were statistically increased than those at pretest. Fatigue scores significantly decreased, whereas no changes were observed in sleep disturbance or depression scores. The findings of this study suggested that a culturally tailored, patient-centered psychosocial intervention could be applied in clinical settings to improve health-related quality of life in cancer survivors.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Dohun</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Chungbuk National University, Cheongju-si, South Korea.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Chungbuk National University Hospital, Cheongju-si, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Sun Ju</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Seoul National University, Seoul, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Hyun Ok</ForeName>
            <Initials>HO</Initials>
            <AffiliationInfo>
              <Affiliation>Cheong Ju Medical Center, Cheongju-si, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Seung Hee</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Chungbuk National University Hospital, Cheongju-si, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>01</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Nurs Res</MedlineTA>
        <NlmUniqueID>9208508</NlmUniqueID>
        <ISSNLinking>1054-7738</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073116" MajorTopicYN="N">Cancer Survivors</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054521" MajorTopicYN="Y">Cultural Competency</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018802" MajorTopicYN="Y">Patient-Centered Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012893" MajorTopicYN="N">Sleep Wake Disorders</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cancer</Keyword>
        <Keyword MajorTopicYN="N">health-related quality of life</Keyword>
        <Keyword MajorTopicYN="N">program</Keyword>
        <Keyword MajorTopicYN="N">survivors</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29383944</ArticleId>
        <ArticleId IdType="doi">10.1177/1054773818755836</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29382243</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1464-5165</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>13</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Disability and rehabilitation</Title>
          <ISOAbbreviation>Disabil Rehabil</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Development of an exercise intervention as part of rehabilitation in a glioblastoma multiforme survivor during irradiation treatment: a case report.</ArticleTitle>
        <Pagination>
          <StartPage>1608</StartPage>
          <EndPage>1614</EndPage>
          <MedlinePgn>1608-1614</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09638288.2018.1432707</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION">This case report describes the rationale and development of an exercise intervention in a patient with glioblastoma multiforme (GBM ) and discusses potential relations of observed effects in functional performance and quality of life (QOL).</AbstractText>
          <AbstractText Label="METHODS">A 54-year-old GBM survivor completed a supervised six-week exercise intervention during irradiation treatment beginning 42&#x2009;d after resection. Exercise modalities of cardiorespiratory, resistance, and balance training were designed on generic recommendations of various cancer populations and literature review.</AbstractText>
          <AbstractText Label="RESULTS">Our case attended all possible sessions without experiencing adverse effects, and improved in aerobe power (24%), muscle strength (0-38%), standing balance (71%), walking ability (9%), and QOL domains of "Global Health Status/QoL" and "Physical functioning."</AbstractText>
          <AbstractText Label="CONCLUSIONS">Based on this single case, exercise rehabilitation has the ability to maintain or improve functional performance and QOL domains even during heavy treatments. It also implies that patients with GBM are capable and may be willing to participate in exercise rehabilitation if supervised by physical therapists. Implications for rehabilitation The use of exercise as part of rehabilitation still needs attention in strong methodology studies of patients with gliomas. Exercise rehabilitation may maintain or even improve functional performance and QOL domains during medical treatment regimens. Functional independent patients with GBM are capable to comply with generic exercise recommendations and may be willing to participate in exercise rehabilitation if supervised by physical therapists.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hansen</LastName>
            <ForeName>Anders</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Sports Science and Clinical Biomechanics , University of Southern Denmark , Odense , Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b OPEN, Odense Patient Data Explorative Network, Odense University Hospital , Odense , Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>S&#xF8;gaard</LastName>
            <ForeName>Karen</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Sports Science and Clinical Biomechanics , University of Southern Denmark , Odense , Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>c Occupational and Environmental Medicine , Odense University Hospital , Odense , Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Minet</LastName>
            <ForeName>Lisbeth Rosenbek</ForeName>
            <Initials>LR</Initials>
            <AffiliationInfo>
              <Affiliation>d Department of Clinical Research, Research Unit of Rehabilitation , University of Southern Denmark , Odense , Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>e Research Centre, University College Lillebaelt , Odense , Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>01</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Disabil Rehabil</MedlineTA>
        <NlmUniqueID>9207179</NlmUniqueID>
        <ISSNLinking>0963-8288</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005081" MajorTopicYN="N">Exercise Therapy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005909" MajorTopicYN="Y">Glioblastoma</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName>
          <QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076604" MajorTopicYN="Y">Physical Functional Performance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000072797" MajorTopicYN="N">Walking Speed</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Brain tumour</Keyword>
        <Keyword MajorTopicYN="N">outpatient rehabilitation</Keyword>
        <Keyword MajorTopicYN="N">physical therapy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29382243</ArticleId>
        <ArticleId IdType="doi">10.1080/09638288.2018.1432707</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29366628</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1096-3634</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>89</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Seminars in cell &amp; developmental biology</Title>
          <ISOAbbreviation>Semin Cell Dev Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Organ-specific mechanisms linking innate and adaptive antifungal immunity.</ArticleTitle>
        <Pagination>
          <StartPage>78</StartPage>
          <EndPage>90</EndPage>
          <MedlinePgn>78-90</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semcdb.2018.01.008</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S1084-9521(17)30173-8</ELocationID>
        <Abstract>
          <AbstractText>Fungal infections remain a significant global health problem in humans. Fungi infect millions of people worldwide and cause from acute superficial infections to life-threatening systemic disease to chronic illnesses. Trying to decipher the complex innate and adaptive immune mechanisms that protect humans from pathogenic fungi is therefore a key research goal that may lead to immune-based therapeutic strategies and improved patient outcomes. In this review, we summarize how the cells and molecules of the innate immune system activate the adaptive immune system to elicit long-term immunity to fungi. We present current knowledge and exciting new advances in the context of organ-specific immunity, outlining the tissue-specific tropisms for the major pathogenic fungi of humans, the antifungal functions of tissue-resident myeloid cells, and the adaptive immune responses required to protect specific organs from fungal challenge.</AbstractText>
          <CopyrightInformation>Published by Elsevier Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Drummond</LastName>
            <ForeName>Rebecca A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: rebecca.drummond@nih.gov.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lionakis</LastName>
            <ForeName>Michail S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: lionakism@niaid.nih.gov.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>Z99 AI999999</GrantID>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>ZIA AI001175-01</GrantID>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>ZIA AI001175-02</GrantID>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Semin Cell Dev Biol</MedlineTA>
        <NlmUniqueID>9607332</NlmUniqueID>
        <ISSNLinking>1084-9521</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D056704" MajorTopicYN="N">Adaptive Immunity</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000935" MajorTopicYN="N">Antifungal Agents</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005658" MajorTopicYN="N">Fungi</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009181" MajorTopicYN="N">Mycoses</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Alveolar macrophage</Keyword>
        <Keyword MajorTopicYN="N">Card9</Keyword>
        <Keyword MajorTopicYN="N">Fungi</Keyword>
        <Keyword MajorTopicYN="N">Kupffer</Keyword>
        <Keyword MajorTopicYN="N">Langerhans</Keyword>
        <Keyword MajorTopicYN="N">Microglia</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29366628</ArticleId>
        <ArticleId IdType="mid">NIHMS937069</ArticleId>
        <ArticleId IdType="pmc">PMC6054575</ArticleId>
        <ArticleId IdType="doi">10.1016/j.semcdb.2018.01.008</ArticleId>
        <ArticleId IdType="pii">S1084-9521(17)30173-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ginhoux F, Guilliams M. Tissue-Resident Macrophage Ontogeny and Homeostasis. Immunity. 2016;44:439&#x2013;449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26982352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drummond RA, Collar AL, Swamydas M, Rodriguez CA, Lim JK, Mendez LM, Fink DL, Hsu AP, Zhai B, Karauzum H, Mikelis CM, Rose SR, Ferre EMN, Yockey L, Lemberg K, Kuehn HS, Rosenzweig SD, Lin X, Chittiboina P, Datta SK, Belhorn TH, Weimer ET, Hernandez ML, Hohl TM, Kuhns DB, Lionakis MS. CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System. PLoS Pathog. 2015;11:e1005293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4683065</ArticleId>
            <ArticleId IdType="pubmed">26679537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heymann F, Peusquens J, Ludwig-Portugall I, Kohlhepp M, Ergen C, Niemietz P, Martin C, van Rooijen N, Ochando JC, Randolph GJ, Luedde T, Ginhoux F, Kurts C, Trautwein C, Tacke F. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology. 2015;62:279&#x2013;291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25810240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden Killers: Human Fungal Infections. Sci Transl Med. 2012;4:165rv13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23253612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clinical Infectious Diseases. 2017;64:134&#x2013;140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5215215</ArticleId>
            <ArticleId IdType="pubmed">27988485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panackal AA, Wuest SC, Lin Y-C, Wu T, Zhang N, Kosa P, Komori M, Blake A, Browne SK, Rosen LB, Hagen F, Meis J, Levitz SM, Quezado M, Hammoud D, Bennett JE, Bielekova B, Williamson PR. Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis. PLOS Pathogens. 2015;11:e1004884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4447450</ArticleId>
            <ArticleId IdType="pubmed">26020932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aguirre K, Crowe J, Haas A, Smith J. Resistance to Cryptococcus neoformans infection in the absence of CD4(+) T cells. Medical Mycology. 2004;42:15&#x2013;25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14982110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohatgi S, Pirofski LA. Host immunity to Cryptococcus neoformans. Future Microbiol. 2015;10:565&#x2013;581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4523559</ArticleId>
            <ArticleId IdType="pubmed">25865194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brandt ME, Warnock DW. Epidemiology, Clinical Manifestations, and Therapy of Infections Caused by Dematiaceous Fungi. J Chemother. 2003;15:36&#x2013;47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14708965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lionakis MS, Dunleavy K, Roschewski M, Widemann BC, Butman JA, Schmitz R, Yang Y, Cole DE, Melani C, Higham CS, Desai JV, Ceribelli M, Chen L, Thomas CJ, Little RF, Gea-Banacloche J, Bhaumik S, Stetler-Stevenson M, Pittaluga S, Jaffe ES, Heiss J, Lucas N, Steinberg SM, Staudt LM, Wilson WH. Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma. Cancer Cell. 2017;31:833&#x2013;843.e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5571650</ArticleId>
            <ArticleId IdType="pubmed">28552327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rieber N, Gazendam RP, Freeman AF, Hsu AP, Collar AL, Sugui JA, Drummond RA, Rongkavilit C, Hoffman K, Henderson C, Clark L, Mezger M, Swamydas M, Engeholm M, Sch&#xFC;le R, Neumayer B, Ebel F, Mikelis CM, Pittaluga S, Prasad VK, Singh A, Milner JD, Williams KW, Lim JK, Kwon-Chung KJ, Holland SM, Hartl D, Kuijpers TW, Lionakis MS. Extrapulmonary Aspergillus infection in patients with CARD9 deficiency. JCI Insight. 2016;1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5070961</ArticleId>
            <ArticleId IdType="pubmed">27777981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginhoux F, Prinz M. Origin of Microglia: Current Concepts and Past Controversies. Cold Spring Harbor Perspectives in Biology. 2015</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4526747</ArticleId>
            <ArticleId IdType="pubmed">26134003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>R&#xE9;u P, Khosravi A, Bernard S, Mold JE, Salehpour M, Alkass K, Perl S, Tisdale J, Possnert G, Druid H, Fris&#xE9;n J. The Lifespan and Turnover of Microglia in the Human Brain. Cell Reports. 2017;20:779&#x2013;784.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5540680</ArticleId>
            <ArticleId IdType="pubmed">28746864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blasi E, Mazzolla R, Barluzzi R, Bistoni F. MICROGLIAL CELL-MEDIATED ANTICANDIDA ACTIVITY - TEMPERATURE, IONS, PROTEIN-KINASE-C AS CRUCIAL ELEMENTS. J Neuroimmunol. 1991;34:53&#x2013;60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1894734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barluzzi R, Brozzetti A, Delfino D, Bistoni F, Blasi E. Role of the capsule in microglial cell-Cryptococcus neoformans interaction: impairment of antifungal activity but not of secretory functions. Medical Mycology. 1998;36:189&#x2013;197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9776834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Preissler J, Grosche A, Lede V, Le Duc D, Krugel K, Matyash V, Szulzewsky F, Kallendrusch S, Immig K, Kettenmann H, Bechmann I, Schoneberg T, Schulz A. Altered Microglial Phagocytosis in GPR34-Deficient Mice. Glia. 2015;63:206&#x2013;215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25142016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song XY, Tanaka S, Cox D, Lee SC. Fc gamma receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction. J Leukoc Biol. 2004;75:1147&#x2013;1155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14982949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adami C, Sorci G, Blasi E, Agneletti AL, Bistoni F, Donato R. S100B expression in and effects on microglia. Glia. 2001;33:131&#x2013;142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11180510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardison SE, Herrera G, Young ML, Hole CR, Wozniak KL, Wormley FL. Protective Immunity against Pulmonary Cryptococcosis Is Associated with STAT1-Mediated Classical Macrophage Activation. J Immunol. 2012;189:4060&#x2013;4068.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3466339</ArticleId>
            <ArticleId IdType="pubmed">22984078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987&#x2013;991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27459405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Redwine JM, Buchmeier MJ, Evans CF. In Vivo Expression of Major Histocompatibility Complex Molecules on Oligodendrocytes and Neurons during Viral Infection. The American Journal of Pathology. 2001;159:1219&#x2013;1224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1850521</ArticleId>
            <ArticleId IdType="pubmed">11583948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aguirre K, Miller S. MHC class II-positive perivascular microglial cells mediate resistance to Cryptococcus neoformans brain infection. Glia. 2002;39:184&#x2013;188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12112369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sa Q, Ochiai E, Tiwari A, Perkins S, Mullins J, Gehman M, Huckle W, Eyestone WH, Saunders TL, Shelton BJ, Suzuki Y. Cutting Edge: IFN-&#x3B3; Produced by Brain-Resident Cells Is Crucial To Control Cerebral Infection with Toxoplasma gondii. The Journal of Immunology. 2015</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4520543</ArticleId>
            <ArticleId IdType="pubmed">26091720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drummond RA, Lionakis MS. Mechanistic insights into the role of C-type lectin receptor/CARD9 signaling in human antifungal immunity. Front Cell Infect Microbiol. 2016;6 doi: 10.3389/fcimb.2016.00039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2016.00039</ArticleId>
            <ArticleId IdType="pmc">PMC4820464</ArticleId>
            <ArticleId IdType="pubmed">27092298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cornely OA, Bangard C, Jaspers NI. Hepatosplenic candidiasis. Clinical Liver Disease. 2015;6:47&#x2013;50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6490647</ArticleId>
            <ArticleId IdType="pubmed">31040987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rihana NA, Kandula M, Velez A, Dahal K, Neill EB. Histoplasmosis Presenting as Granulomatous Hepatitis: Case Report and Review of the Literature. Case Reports in Medicine. 2014;2014:4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4070324</ArticleId>
            <ArticleId IdType="pubmed">25013413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17:306&#x2013;321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28317925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lionakis MS, Lim JK, Lee CCR, Murphy PM. Organ-Specific Innate Immune Responses in a Mouse Model of Invasive Candidiasis. J Innate Immun. 2011;3:180&#x2013;199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3072204</ArticleId>
            <ArticleId IdType="pubmed">21063074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Redmond HP, Shou J, Gallagher HJ, Kelly CJ, Daly JM. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. The Journal of Immunology. 1993;150:3427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8385685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jawhara S, Pluskota E, Verbovetskiy D, Skomorovska-Prokvolit O, Plow EF, Soloviev DA. Integrin &#x3B1;X&#x3B2;2 Is a Leukocyte Receptor for Candida albicans and Is Essential for Protection against Fungal Infections. The Journal of Immunology. 2012;189:2468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3424400</ArticleId>
            <ArticleId IdType="pubmed">22844116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>&#xD8;verland G, Stuest&#xF8;l JF, Dahle MK, Myhre AE, Netea MG, Verweij P, Yndestad A, Aukrust P, Kullberg BJ, Warris A, Wang JE, Aasen AO. Cytokine Responses to Fungal Pathogens in Kupffer Cells are Toll-like Receptor 4 Independent and Mediated by Tyrosine Kinases. Scandinavian Journal of Immunology. 2005;62:148&#x2013;154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16101821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krueger PD, Kim TS, Sung S-SJ, Braciale TJ, Hahn YS. Liver-Resident CD103+ Dendritic Cells Prime Antiviral CD8+ T Cells In Situ. The Journal of Immunology. 2015;194:3213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4369411</ArticleId>
            <ArticleId IdType="pubmed">25712214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelly A, Fahey R, Fletcher JM, Keogh C, Carroll AG, Siddachari R, Geoghegan J, Hegarty JE, Ryan EJ, O&#x2019;Farrelly C. CD141+ myeloid dendritic cells are enriched in healthy human liver. Journal of Hepatology. 2014;60:135&#x2013;142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23968887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parker JC, McCloskey JJ, Knauer KA. Pathobiologic features of human candidiasis - common deep mycosis of brain, heart and kidney in altered host. Am J Clin Pathol. 1976;65:991&#x2013;1000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">779443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacCallum DM. Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model. Fems Yeast Research. 2009;9:1111&#x2013;1122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2784217</ArticleId>
            <ArticleId IdType="pubmed">19845042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lionakis MS, Swamydas M, Fischer BG, Plantinga TS, Johnson MD, Jaeger M, Green NM, Masedunskas A, Weigert R, Mikelis C, Wan W, Lee C-CR, Lim JK, Rivollier A, Yang JC, Laird GM, Wheeler RT, Alexander BD, Perfect JR, Gao J-L, Kullberg B-J, Netea MG, Murphy PM. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J Clin Invest. 2013;123:5035&#x2013;5051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3859390</ArticleId>
            <ArticleId IdType="pubmed">24177428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spellberg B, Johnston D, Phan QT, Edwards JE, French SW, Ibrahim AS, Filler SG. Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis. Infect Immun. 2003;71:5756&#x2013;5764.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC201094</ArticleId>
            <ArticleId IdType="pubmed">14500497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ngo LY, Kasahara S, Kumasaka DK, Knoblaugh SE, Jhingran A, Hohl TM. Inflammatory Monocytes Mediate Early and Organ-Specific Innate Defense During Systemic Candidiasis. Journal of Infectious Diseases. 2014;209:109&#x2013;119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3864383</ArticleId>
            <ArticleId IdType="pubmed">23922372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lionakis MS, Fischer BG, Lim JK, Swamydas M, Wan W, Richard Lee C-C, Cohen JI, Scheinberg P, Gao J-L, Murphy PM. Chemokine Receptor Ccr1 Drives Neutrophil-Mediated Kidney Immunopathology and Mortality in Invasive Candidiasis. PLoS Pathog. 2012;8:e1002865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3420964</ArticleId>
            <ArticleId IdType="pubmed">22916017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soos TJ, Sims TN, Barisoni L, Lin K, Littman DR, Dustin ML, Nelson PJ. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 2006;70:591&#x2013;596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16760907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stamatiades Efstathios G, Tremblay M-E, Bohm M, Crozet L, Bisht K, Kao D, Coelho C, Fan X, Yewdell William T, Davidson A, Heeger Peter S, Diebold S, Nimmerjahn F, Geissmann F. Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages. Cell. 2016;166:991&#x2013;1003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4983224</ArticleId>
            <ArticleId IdType="pubmed">27477514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gottschalk C, Kurts C. The Debate about Dendritic Cells and Macrophages in the Kidney. Frontiers in Immunology. 2015;6:435.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4556034</ArticleId>
            <ArticleId IdType="pubmed">26388867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rogers NM, Ferenbach DA, Isenberg JS, Thomson AW, Hughes J. Dendritic cells and macrophages in the kidney: a spectrum of good and evil. Nat Rev Nephrol. 2014;10:625&#x2013;643.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4922410</ArticleId>
            <ArticleId IdType="pubmed">25266210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawakami T, Lichtnekert J, Thompson LJ, Karna P, Bouabe H, Hohl TM, Heinecke JW, Ziegler SF, Nelson PJ, Duffield JS. Resident Renal Mononuclear Phagocytes Comprise Five Discrete Populations with Distinct Phenotypes and Functions. The Journal of Immunology. 2013;191:3358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3808972</ArticleId>
            <ArticleId IdType="pubmed">23956422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferenbach D, Hughes J. Macrophages and dendritic cells: what is the difference? Kidney Int. 2008;74:5&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18560360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kr&#xFC;ger T, Benke D, Eitner F, Lang A, Wirtz M, Hamilton-Williams EE, Engel D, Giese B, M&#xFC;ller-Newen G, Floege J, Kurts C. Identification and Functional Characterization of Dendritic Cells in the Healthy Murine Kidney and in Experimental Glomerulonephritis. Journal of the American Society of Nephrology. 2004;15:613&#x2013;621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14978163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gury-BenAri M, Thaiss Christoph A, Serafini N, Winter Deborah R, Giladi A, Lara-Astiaso D, Levy M, Salame Tomer M, Weiner A, David E, Shapiro H, Dori-Bachash M, Pevsner-Fischer M, Lorenzo-Vivas E, Keren-Shaul H, Paul F, Harmelin A, Eberl G, Itzkovitz S, Tanay A, Di Santo James P, Elinav E, Amit I. The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome. Cell. 2016;166:1231&#x2013;1246.e13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27545347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE, Hammerich L, Panzer U, Kaden S, Quaggin SE, Floege J, Gr&#xF6;ne H-J, Kurts C. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest. 2009;119:1286&#x2013;1297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2673875</ArticleId>
            <ArticleId IdType="pubmed">19381017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabb H. The T cell as a bridge between innate and adaptive immune systems: Implications for the kidney. Kidney Int. 2002;61:1935&#x2013;1946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12028434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hochheiser K, Heuser C, Krause TA, Teteris S, Ilias A, Weisheit C, Hoss F, Tittel AP, Knolle PA, Panzer U, Engel DR, Tharaux P-L, Kurts C. Exclusive CX(3)CR1 dependence of kidney DCs impacts glomerulonephritis progression. The Journal of Clinical Investigation. 2013;123:4242&#x2013;4254.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3784547</ArticleId>
            <ArticleId IdType="pubmed">23999431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitney PG, B&#xE4;r E, Osorio F, Rogers NC, Schraml BU, Deddouche S, LeibundGut-Landmann S, Reis e Sousa C. Syk Signaling in Dendritic Cells Orchestrates Innate Resistance to Systemic Fungal Infection. PLoS Pathog. 2014;10:e1004276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4102599</ArticleId>
            <ArticleId IdType="pubmed">25033445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Break TJ, Hoffman KW, Swamydas M, Lee C-CR, Lim JK, Lionakis MS. Batf3-dependent CD103(+) dendritic cell accumulation is dispensable for mucosal and systemic antifungal host defense. Virulence. 2016;7:826&#x2013;835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5029292</ArticleId>
            <ArticleId IdType="pubmed">27191829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collar AL, Swamydas M, O&#x2019;Hayre M, Sajib MS, Hoffman KW, Singh SP, Mourad A, Johnson MD, Ferre EMN, Farber JM, Lim JK, Mikelis CM, Gutkind JS, Lionakis MS. The Homozygous CX3CR1-M280 Mutation Impairs Human Monocyte Survival. JCI Insight. 2018 In Press.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5821174</ArticleId>
            <ArticleId IdType="pubmed">29415879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dominguez-Andres J, Feo-Lucas L, de la Escalera MM, Gonzalez L, Lopez-Bravo M, Ardavin C. Inflammatory Ly6C(high) Monocytes Protect against Candidiasis through IL-15-Driven NK Cell/Neutrophil Activation. Immunity. 2017;46:1059-+.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28636955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romani L, Mencacci A, Grohmann U, Mocci S, Mosci P, Puccetti P, Bistoni F. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med. 1992;176:19&#x2013;25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2119284</ArticleId>
            <ArticleId IdType="pubmed">1535368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Q, Lu J, Li Q, Wang C, Wang XM, Lee VWS, Wang C, Nguyen H, Zheng G, Zhao Y, Alexander SI, Wang Y, Harris DCH. CD103+ Dendritic Cells Elicit CD8+ T Cell Responses to Accelerate Kidney Injury in Adriamycin Nephropathy. Journal of the American Society of Nephrology. 2016;27:1344&#x2013;1360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4849820</ArticleId>
            <ArticleId IdType="pubmed">26376858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evers BDG, Engel DR, B&#xF6;hner AMC, Tittel AP, Krause TA, Heuser C, Garbi N, Kastenm&#xFC;ller W, Mack M, Tiegs G, Panzer U, Boor P, Ludwig-Portugall I, Kurts C. CD103+ Kidney Dendritic Cells Protect against Crescentic GN by Maintaining IL- 10&#x2013;Producing Regulatory T Cells. Journal of the American Society of Nephrology. 2016;27:3368&#x2013;3382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5084885</ArticleId>
            <ArticleId IdType="pubmed">27036736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones-Carson J, Vazquez-Torres A, Warner T, Balish E. Disparate Requirement for T Cells in Resistance to Mucosal and Acute Systemic Candidiasis. Infect Immun. 2000;68:2363&#x2013;2365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC97429</ArticleId>
            <ArticleId IdType="pubmed">10722645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drummond RA, Wallace C, Reid DM, Way SS, Kaplan DH, Brown GD. Cutting Edge: Failure of Antigen-Specific CD4(+) T Cell Recruitment to the Kidney during Systemic Candidiasis. J Immunol. 2014;193:5381&#x2013;5385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4238746</ArticleId>
            <ArticleId IdType="pubmed">25344471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldman DL, Davis J, Bommarito F, Shao X, Casadevall A. Enhanced Allergic Inflammation and Airway Responsiveness in Rats with Chronic Cryptococcus neoformans Infection: Potential Role for Fungal Pulmonary Infection in the Pathogenesis of Asthma. J Infect Dis. 2006;193:1178&#x2013;1186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16544260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hadebe S, Kirstein F, Fierens K, Chen K, Drummond RA, Vautier S, Sajaniemi S, Murray G, Williams DL, Redelinghuys P, Reinhart TA, Fallert Junecko BA, Kolls JK, Lambrecht BN, Brombacher F, Brown GD. Microbial Ligand Costimulation Drives Neutrophilic Steroid-Refractory Asthma. PLoS One. 2015;10:e0134219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4532492</ArticleId>
            <ArticleId IdType="pubmed">26261989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Overton NL, Simpson A, Bowyer P, Denning DW. Genetic susceptibility to severe asthma with fungal sensitization. International Journal of Immunogenetics. 2017 n/an/a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28371335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams C, Ranjendran R, Ramage G. Pathogenesis of Fungal Infections in Cystic Fibrosis. Current Fungal Infection Reports. 2016;10:163&#x2013;169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5155017</ArticleId>
            <ArticleId IdType="pubmed">28035247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol. 2014;14:81&#x2013;93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24445666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paine R, Preston AM, Wilcoxen S, Jin H, Siu BB, Morris SB, Reed JA, Ross G, Whitsett JA, Beck JM. Granulocyte-Macrophage Colony-Stimulating Factor in the Innate Immune Response to Pneumocystis carinii Pneumonia in Mice. The Journal of Immunology. 2000;164:2602.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10679099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steele C, Marrero L, Swain S, Harmsen AG, Zheng MQ, Brown GD, Gordon S, Shellito JE, Kolls JK. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp muris involves molecular recognition by the dectin-1 beta-glucan receptor. J Exp Med. 2003;198:1677&#x2013;1688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2194130</ArticleId>
            <ArticleId IdType="pubmed">14657220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Philippe B, Ibrahim-Granet O, Pr&#xE9;vost MC, Gougerot-Pocidalo MA, Sanchez Perez M, Van der Meeren A, Latg&#xE9; JP. Killing of Aspergillus fumigatus by Alveolar Macrophages Is Mediated by Reactive Oxidant Intermediates. Infect Immun. 2003;71:3034&#x2013;3042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC155721</ArticleId>
            <ArticleId IdType="pubmed">12761080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhatia S, Fei M, Yarlagadda M, Qi Z, Akira S, Saijo S, Iwakura Y, van Rooijen N, Gibson GA, St Croix CM, Ray A, Ray P. Rapid Host Defense against Aspergillus fumigatus Involves Alveolar Macrophages with a Predominance of Alternatively Activated Phenotype. PLoS One. 2011;6:e15943.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3016416</ArticleId>
            <ArticleId IdType="pubmed">21246055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rocco NM, Carmen JC, Klein BS. Blastomyces dermatitidis Yeast Cells Inhibit Nitric Oxide Production by Alveolar Macrophage Inducible Nitric Oxide Synthase. Infect Immun. 2011;79:2385&#x2013;2395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3125838</ArticleId>
            <ArticleId IdType="pubmed">21444664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kopf M, Schneider C, Nobs SP. The development and function of lung-resident macrophages and dendritic cells. Nat Immunol. 2015;16:36&#x2013;44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25521683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plantinga M, Guilliams M, Vanheerswynghels M, Deswarte K, Branco-Madeira F, Toussaint W, Vanhoutte L, Neyt K, Killeen N, Malissen B, Hammad H, Lambrecht Bart N. Conventional and Monocyte-Derived CD11b+ Dendritic Cells Initiate and Maintain T Helper 2 Cell-Mediated Immunity to House Dust Mite Allergen. Immunity. 2013;38:322&#x2013;335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23352232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho Adrian W, See P, Shin A, Wasan Pavandip S, Hoeffel G, Malleret B, Heiseke A, Chew S, Jardine L, Purvis Harriet A, Hilkens Catharien M, Tam J, Poidinger M, Stanley ER, Krug Anne B, Renia L, Sivasankar B, Ng Lai G, Collin M, Ricciardi-Castagnoli P, Honda K, Haniffa M, Ginhoux F. IRF4 Transcription Factor-Dependent CD11b(+) Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses. Immunity. 2013;38:970&#x2013;983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3666057</ArticleId>
            <ArticleId IdType="pubmed">23706669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Prooyen N, Henderson CA, Hocking Murray D, Sil A. CD103+ Conventional Dendritic Cells Are Critical for TLR7/9-Dependent Host Defense against Histoplasma capsulatum, an Endemic Fungal Pathogen of Humans. PLOS Pathogens. 2016;12:e1005749.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4961300</ArticleId>
            <ArticleId IdType="pubmed">27459510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espinosa V, Jhingran A, Dutta O, Kasahara S, Donnelly R, Du P, Rosenfeld J, Leiner I, Chen C-C, Ron Y, Hohl TM, Rivera A. Inflammatory Monocytes Orchestrate Innate Antifungal Immunity in the Lung. PLOS Pathogens. 2014;10:e1003940.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3930594</ArticleId>
            <ArticleId IdType="pubmed">24586155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hohl TM, Rivera A, Lipuma L, Gallegos A, Shi C, Mack M, Pamer EG. Inflammatory Monocytes Facilitate Adaptive CD4 T Cell Responses during Respiratory Fungal Infection. Cell host &amp; microbe. 2009;6:470&#x2013;481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2785497</ArticleId>
            <ArticleId IdType="pubmed">19917501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu J, Flaczyk A, Neal LM, Fa Z, Eastman AJ, Malachowski AN, Cheng D, Moore BB, Curtis JL, Osterholzer JJ, Olszewski MA. Scavenger Receptor MARCO Orchestrates Early Defenses and Contributes to Fungal Containment during Cryptococcal Infection. The Journal of Immunology. 2017</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5423401</ArticleId>
            <ArticleId IdType="pubmed">28298522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez N, Ketheesan N, West K, Vallerskog T, Kornfeld H. Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages From Diabetic Mice. The Journal of Infectious Diseases. 2016;214:1629&#x2013;1637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5144731</ArticleId>
            <ArticleId IdType="pubmed">27630197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sterkel Alana K, Lorenzini Jenna L, Fites JS, Subramanian Vignesh K, Sullivan Thomas D, Wuthrich M, Brandhorst T, Hernandez-Santos N, Deepe George S, Klein Bruce S. Fungal Mimicry of a Mammalian Aminopeptidase Disables Innate Immunity and Promotes Pathogenicity. Cell Host &amp; Microbe. 2016;19:361&#x2013;374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5088612</ArticleId>
            <ArticleId IdType="pubmed">26922990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>W&#xFC;thrich M, Ersland K, Sullivan T, Galles K, Klein Bruce S. Fungi Subvert Vaccine T Cell Priming at the Respiratory Mucosa by Preventing Chemokine-Induced Influx of Inflammatory Monocytes. Immunity. 2012;36:680&#x2013;692.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3334432</ArticleId>
            <ArticleId IdType="pubmed">22483803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>W&#xFC;thrich M, Gern B, Hung CY, Ersland K, Rocco N, Pick-Jacobs J, Galles K, Filutowicz H, Warner T, Evans M, Cole G, Klein B. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest. 2011;121:554&#x2013;568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3026727</ArticleId>
            <ArticleId IdType="pubmed">21206087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Werner JL, Gessner MA, Lilly LM, Nelson MP, Metz AE, Horn D, Dunaway CW, Deshane J, Chaplin DD, Weaver CT, Brown GD, Steele C. Neutrophils Produce Interleukin 17A (IL-17A) in a Dectin-1-and IL-23-Dependent Manner during Invasive Fungal Infection. Infect Immun. 2011;79:3966&#x2013;3977.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3187263</ArticleId>
            <ArticleId IdType="pubmed">21807912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, Schwiebert LM, Faro-Trindade I, Brown GD, Steele C. Requisite Role for the Dectin-1 beta-Glucan Receptor in Pulmonary Defense against Aspergillus fumigatus. J Immunol. 2009;182:4938&#x2013;4946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3434356</ArticleId>
            <ArticleId IdType="pubmed">19342673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivera A, Hohl TM, Collins N, Leiner I, Gallegos A, Saijo S, Coward JW, Iwakura Y, Pamer EG. Dectin-1 diversifies Aspergillus fumigatus&#x2013;specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J Exp Med. 2011;208:369&#x2013;381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3039849</ArticleId>
            <ArticleId IdType="pubmed">21242294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gringhuis SI, Wevers BA, Kaptein TM, van Capel TMM, Theelen B, Boekhout T, de Jong EC, Geijtenbeek TBH. Selective C-Rel Activation via Malt1 Controls Anti-Fungal Th17 Immunity by Dectin-1 and Dectin-2. Plos Pathog. 2011;7 Article No: e1001259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3024268</ArticleId>
            <ArticleId IdType="pubmed">21283787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, Koenen HJPM, Cheng S-C, Joosten I, van den Berg WB, Williams DL, van der Meer JWM, Joosten LAB, Netea MG. The Macrophage Mannose Receptor Induces IL-17 in Response to Candida albicans. Cell Host Microbe. 2009;5:329&#x2013;340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19380112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, LeBert V, Hung CY, Galles K, Saijo S, Lin X, Cole GT, Klein BS, W&#xFC;thrich M. C-Type Lectin Receptors Differentially Induce Th17 Cells and Vaccine Immunity to the Endemic Mycosis of North America. The Journal of Immunology. 2014;192:1107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3910401</ArticleId>
            <ArticleId IdType="pubmed">24391211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dan JM, Kelly RM, Lee CK, Levitz SM. Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect Immun. 2008;76:2362&#x2013;2367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2423054</ArticleId>
            <ArticleId IdType="pubmed">18391001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drummond RA, Saijo S, Iwakura Y, Brown GD. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol. 2011;41:276&#x2013;281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3434674</ArticleId>
            <ArticleId IdType="pubmed">21267996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamoto H, Nakamura Y, Sato K, Takahashi Y, Nomura T, Miyasaka T, Ishii K, Hara H, Yamamoto N, Kanno E, Iwakura Y, Kawakami K. Defect of CARD9 Leads to Impaired Accumulation of Gamma Interferon-Producing Memory Phenotype T Cells in Lungs and Increased Susceptibility to Pulmonary Infection with Cryptococcus neoformans. Infect Immun. 2014;82:1606&#x2013;1615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3993402</ArticleId>
            <ArticleId IdType="pubmed">24470469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lionakis MS, Netea MG, Holland SM. Mendelian Genetics of Human Susceptibility to Fungal Infection. Cold Spring Harbor Perspect Med. 2014;4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4031953</ArticleId>
            <ArticleId IdType="pubmed">24890837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>L&#xE9;vy R, Okada S, B&#xE9;ziat V, Moriya K, Liu C, Chai LYA, Migaud M, Hauck F, Al Ali A, Cyrus C, Vatte C, Patiroglu T, Unal E, Ferneiny M, Hyakuna N, Nepesov S, Oleastro M, Ikinciogullari A, Dogu F, Asano T, Ohara O, Yun L, Della Mina E, Bronnimann D, Itan Y, Gothe F, Bustamante J, Boisson-Dupuis S, Tahuil N, Aytekin C, Salhi A, Al Muhsen S, Kobayashi M, Toubiana J, Abel L, Li X, Camcioglu Y, Celmeli F, Klein C, AlKhater SA, Casanova J-L, Puel A. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proceedings of the National Academy of Sciences. 2016;113:E8277&#x2013;E8285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5187691</ArticleId>
            <ArticleId IdType="pubmed">27930337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jhingran A, Kasahara S, Shepardson KM, Junecko BAF, Heung LJ, Kumasaka DK, Knoblaugh SE, Lin X, Kazmierczak BI, Reinhart TA, Cramer RA, Hohl TM. Compartment-Specific and Sequential Role of MyD88 and CARD9 in Chemokine Induction and Innate Defense during Respiratory Fungal Infection. PLoS Pathog. 2015;11:e1004589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4306481</ArticleId>
            <ArticleId IdType="pubmed">25621893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito T, Wang Y-H, Duramad O, Hori T, Delespesse GJ, Watanabe N, Qin FX-F, Yao Z, Cao W, Liu Y-J. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. The Journal of Experimental Medicine. 2005;202:1213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2213234</ArticleId>
            <ArticleId IdType="pubmed">16275760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ying S, O&#x2019;Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, Robinson D, Zhang G, Zhao J, Lee TH, Corrigan C. Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity. The Journal of Immunology. 2005;174:8183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15944327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, Schoenfeld D, Nomicos E, Park M, Kong HH, Segre JA. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498:367&#x2013;370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3711185</ArticleId>
            <ArticleId IdType="pubmed">23698366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clinics in Dermatology. 2007;25:606&#x2013;615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18021899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Jong MAWP, Vriend LEM, Theelen B, Taylor ME, Fluitsma D, Boekhout T, Geijtenbeek TBH. C-type lectin Langerin is a &#x3B2;-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Molecular Immunology. 2010;47:1216&#x2013;1225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2837148</ArticleId>
            <ArticleId IdType="pubmed">20097424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stingl G, Br&#xFC;ggen M-C, V&#xE1;zquez-Strauss M . Intramural Sequencing Ctr NIH. Innate and Adaptive Components of the Cutaneous Immune Barrier: The Central Role of Dendritic Cells. In: Gaspari AA, Tyring SK, Kaplan DH, editors. Clinical and Basic Immunodermatology. Springer International Publishing; Cham: 2017. pp. 1&#x2013;10.</Citation>
        </Reference>
        <Reference>
          <Citation>Igyarto BZ, Haley K, Ortner D, Bobr A, Gerami-Nejad M, Edelson BT, Zurawski SM, Malissen B, Zurawski G, Berman J, Kaplan DH. Skin-Resident Murine Dendritic Cell Subsets Promote Distinct and Opposing Antigen-Specific T Helper Cell Responses. Immunity. 2011;35:260&#x2013;272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3163010</ArticleId>
            <ArticleId IdType="pubmed">21782478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. IL-23 and IL-17A, but Not IL-12 and IL-22, Are Required for Optimal Skin Host Defense against Candida albicans. Journal of immunology (Baltimore, Md: 1950) 2010;185:5453&#x2013;5462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3076054</ArticleId>
            <ArticleId IdType="pubmed">20921529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashem Sakeen W, Igy&#xE1;rt&#xF3; Botond Z, Gerami-Nejad M, Kumamoto Y, Mohammed J, Jarrett E, Drummond Rebecca A, Zurawski Sandra M, Zurawski G, Berman J, Iwasaki A, Brown Gordon D, Kaplan Daniel H. Candida albicans Morphology and Dendritic Cell Subsets Determine T Helper Cell Differentiation. Immunity. 2015;42:356&#x2013;366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4343045</ArticleId>
            <ArticleId IdType="pubmed">25680275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scholz F, Naik S, Sutterwala FS, Kaplan DH. Langerhans Cells Suppress CD49a+ NK Cell&#x2013;Mediated Skin Inflammation. The Journal of Immunology. 2015;195:2335&#x2013;2342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4546924</ArticleId>
            <ArticleId IdType="pubmed">26209621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng H, Jiang X, Chen Y, Sojka DK, Wei H, Gao X, Sun R, Yokoyama WM, Tian Z. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. The Journal of Clinical Investigation. 2013;123:1444&#x2013;1456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3613925</ArticleId>
            <ArticleId IdType="pubmed">23524967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashem Sakeen W, Riedl Maureen S, Yao C, Honda Christopher N, Vulchanova L, Kaplan Daniel H. Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity. Immunity. 2015;43:515&#x2013;526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4607048</ArticleId>
            <ArticleId IdType="pubmed">26377898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naik S, Bouladoux N, Linehan JL, Han S-J, Harrison OJ, Wilhelm C, Conlan S, Himmelfarb S, Byrd AL, Deming C, Quinones M, Brenchley JM, Kong HH, Tussiwand R, Murphy KM, Merad M, Segre JA, Belkaid Y. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature. 2015;520:104&#x2013;108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4667810</ArticleId>
            <ArticleId IdType="pubmed">25539086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohammed J, Beura LK, Bobr A, Astry B, Chicoine B, Kashem SW, Welty NE, Igyarto BZ, Wijeyesinghe S, Thompson EA, Matte C, Bartholin L, Kaplan A, Sheppard D, Bridges AG, Shlomchik WD, Masopust D, Kaplan DH. Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-[beta] Nat Immunol. 2016;17:414&#x2013;421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5135085</ArticleId>
            <ArticleId IdType="pubmed">26901152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashem SW, Kaplan DH. Skin Immunity to Candida albicans. Trends in Immunology. 2016;37:440&#x2013;450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4931795</ArticleId>
            <ArticleId IdType="pubmed">27178391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lanternier F, Pathan S, Vincent QB, Liu L, Cypowyj S, Prando C, Migaud M, Taibi L, Ammar-Khodja A, Boudghene Stambouli O, Guellil B, Jacobs F, Goffard J-C, Schepers K, del Marmol V, Boussofara L, Denguezli M, Larif M, Bachelez H, Michel L, Lefranc G, Hay R, Jouvion G, Chretien F, Fraitag S, Bougnoux M-E, Boudia M, Abel L, Lortholary O, Casanova J-L, Picard C, Grimbacher B, Puel A. Deep Dermatophytosis and Inherited CARD9 Deficiency. N Engl J Med. 2013;369:1704&#x2013;1714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4084693</ArticleId>
            <ArticleId IdType="pubmed">24131138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu W, Zhang R, Wang X, Song Y, Liu Z, Han W, Li R. Impairment of Immune Response against Dematiaceous Fungi in Card9 Knockout Mice. Mycopathologia. 2016:1&#x2013;12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27421992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yasukawa S, Miyazaki Y, Yoshii C, Nakaya M, Ozaki N, Toda S, Kuroda E, Ishibashi K-i, Yasuda T, Natsuaki Y, Mi-ichi F, Iizasa Ei, Nakahara T, Yamazaki M, Kabashima K, Iwakura Y, Takai T, Saito T, Kurosaki T, Malissen B, Ohno N, Furue M, Yoshida H, Hara H. An ITAM-Syk-CARD9 signalling axis triggers contact hypersensitivity by stimulating IL-1 production in dendritic cells. Nature Communications. 2014;5:3755.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24806599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kostarnoy AV, Gancheva PG, Lepenies B, Tukhvatulin AI, Dzharullaeva AS, Polyakov NB, Grumov DA, Egorova DA, Kulibin AY, Bobrov MA, Malolina EA, Zykin PA, Soloviev AI, Riabenko E, Maltseva DV, Sakharov DA, Tonevitsky AG, Verkhovskaya LV, Logunov DY, Naroditsky BS, Gintsburg AL. Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate. Proceedings of the National Academy of Sciences. 2017</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5380039</ArticleId>
            <ArticleId IdType="pubmed">28292894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Da Gl&#xF3;ria Sousa M, Reid DM, Schweighoffer E, Tybulewicz V, Ruland J, Langhorne J, Yamasaki S, Taylor PR, Almeida SR, Brown GD. Restoration of Pattern Recognition Receptor Costimulation to Treat Chromoblastomycosis, a Chronic Fungal Infection of the Skin. Cell Host Microbe. 2011;9:436&#x2013;443.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3098964</ArticleId>
            <ArticleId IdType="pubmed">21575914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Sousa MdGT, Belda JW, Spina R, Lota PR, Valente NS, Brown GD, Criado PR, Benard G. Topical Application of Imiquimod as a Treatment for Chromoblastomycosis. Clinical Infectious Diseases. 2014;58:1734&#x2013;1737.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4036686</ArticleId>
            <ArticleId IdType="pubmed">24633683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Auclair S, Liu F, Hu H. Loss of immune control in HIV-infected patients: how does mucosal candidiasis occur? Future Microbiol. 2016;12:5&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27922753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova J-L. Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity. Science. 2011</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3070042</ArticleId>
            <ArticleId IdType="pubmed">21350122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferre EMN, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB, Break TJ, Gu W, Hunsberger S, Browne SK, Hsu AP, Rampertaap S, Swamydas M, Collar AL, Kong HH, Lee C-CR, Chascsa D, Simcox T, Pham A, Bondici A, Natarajan M, Monsale J, Kleiner DE, Quezado M, Alevizos I, Moutsopoulos NM, Yockey L, Frein C, Soldatos A, Calvo KR, Adjemian J, Similuk MN, Lang DM, Stone KD, Uzel G, Kopp JB, Bishop RJ, Holland SM, Olivier KN, Fleisher TA, Heller T, Winer KK, Lionakis MS. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5004733</ArticleId>
            <ArticleId IdType="pubmed">27588307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hern&#xE1;ndez-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, Gaffen SL. Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 2013;6:900&#x2013;910.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3608691</ArticleId>
            <ArticleId IdType="pubmed">23250275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dutzan N, Abusleme L, Bridgeman H, Greenwell-Wild T, Zangerle-Murray T, Fife ME, Bouladoux N, Linley H, Brenchley L, Wemyss K, Calderon G, Hong B-Y, Break TJ, Bowdish DME, Lionakis MS, Jones SA, Trinchieri G, Diaz PI, Belkaid Y, Konkel JE, Moutsopoulos NM. On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier. Immunity. 2017;46:133&#x2013;147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5263257</ArticleId>
            <ArticleId IdType="pubmed">28087239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009;206:299&#x2013;311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2646568</ArticleId>
            <ArticleId IdType="pubmed">19204111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conti HR, Peterson AC, Brane L, Huppler AR, Hern&#xE1;ndez-Santos N, Whibley N, Garg AV, Simpson-Abelson MR, Gibson GA, Mamo AJ, Osborne LC, Bishu S, Ghilardi N, Siebenlist U, Watkins SC, Artis D, McGeachy MJ, Gaffen SL. Oral-resident natural Th17 cells and &#x3B3;&#x3B4; T cells control opportunistic Candida albicans infections. The Journal of Experimental Medicine. 2014;211:2075&#x2013;2084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4172215</ArticleId>
            <ArticleId IdType="pubmed">25200028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verma AH, Richardson JP, Zhou C, Coleman BM, Moyes DL, Ho J, Huppler AR, Ramani K, McGeachy MJ, Mufazalov IA, Waisman A, Kane LP, Biswas PS, Hube B, Naglik JR, Gaffen SL. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Science Immunology. 2017;2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5881387</ArticleId>
            <ArticleId IdType="pubmed">29101209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gladiator A, Wangler N, Trautwein-Weidner K, LeibundGut-Landmann S. Cutting Edge: IL-17-Secreting Innate Lymphoid Cells Are Essential for Host Defense against Fungal Infection. J Immunol. 2013;190:521&#x2013;525.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23255360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Li RA, Edgerton M, Gaffen SL. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol. 2011;4:448&#x2013;455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3119375</ArticleId>
            <ArticleId IdType="pubmed">21346738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bishu S, Hern&#xE1;ndez-Santos N, Simpson-Abelson MR, Huppler AR, Conti HR, Ghilardi N, Mamo AJ, Gaffen SL. The Adaptor CARD9 Is Required for Adaptive but Not Innate Immunity to Oral Mucosal Candida albicans Infections. Infect Immun. 2014;82:1173&#x2013;1180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3958019</ArticleId>
            <ArticleId IdType="pubmed">24379290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trautwein-Weidner K, Gladiator A, Kirchner FR, Becattini S, R&#xFC;licke T, Sallusto F, LeibundGut-Landmann S. Antigen-Specific Th17 Cells Are Primed by Distinct and Complementary Dendritic Cell Subsets in Oropharyngeal Candidiasis. PLoS Pathog. 2015;11:e1005164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4591991</ArticleId>
            <ArticleId IdType="pubmed">26431538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moyes DL, Wilson D, Richardson JP, Mogavero S, Tang SX, Wernecke J, H&#xF6;fs S, Gratacap RL, Robbins J, Runglall M, Murciano C, Blagojevic M, Thavaraj S, F&#xF6;rster TM, Hebecker B, Kasper L, Vizcay G, Iancu SI, Kichik N, H&#xE4;der A, Kurzai O, Luo T, Kr&#xFC;ger T, Kniemeyer O, Cota E, Bader O, Wheeler RT, Gutsmann T, Hube B, Naglik JR. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature advance online publication. 2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4851236</ArticleId>
            <ArticleId IdType="pubmed">27027296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Altmeier S, Toska A, Sparber F, Teijeira A, Halin C, LeibundGut-Landmann S. IL-1 Coordinates the Neutrophil Response to C. albicans in the Oral Mucosa. PLOS Pathogens. 2016;12:e1005882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5025078</ArticleId>
            <ArticleId IdType="pubmed">27632536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trautwein-Weidner K, Gladiator A, Nur S, Diethelm P, LeibundGut-Landmann S. IL-17-mediated antifungal defense in the oral mucosa is independent of neutrophils. Mucosal Immunol. 2015;8:221&#x2013;231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25005360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Vivier E. Innate lymphoid cells - a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13:145&#x2013;149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23348417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M, Levy E, Dusseaux M, Meyssonnier V, Premel V, Ngo C, Riteau B, Duban L, Robert D, Rottman M, Soudais C, Lantz O. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol. 2010;11:701&#x2013;708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20581831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Y, Rae W, Ramakrishnan KA, Barcenas-Morales G, D&#xF6;ffinger R, Eren E, Faust SN, Ottensmeier CH, Williams AP. Mucosal-Associated Invariant T (MAIT) Cells Are Impaired in Th17 Associated Primary and Secondary Immunodeficiencies. PLoS One. 2016;11:e0155059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4864289</ArticleId>
            <ArticleId IdType="pubmed">27167980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson RP, Ives ML, Rao G, Lau A, Payne K, Kobayashi M, Arkwright PD, Peake J, Wong M, Adelstein S, Smart JM, French MA, Fulcher DA, Picard C, Bustamante J, Boisson-Dupuis S, Gray P, Stepensky P, Warnatz K, Freeman AF, Rossjohn J, McCluskey J, Holland SM, Casanova J-L, Uzel G, Ma CS, Tangye SG, Deenick EK. STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function. The Journal of Experimental Medicine. 2015;212:855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4451129</ArticleId>
            <ArticleId IdType="pubmed">25941256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nature reviews Immunology. 2014;14:405&#x2013;416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4332855</ArticleId>
            <ArticleId IdType="pubmed">24854590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffmann C, Dollive S, Grunberg S, Chen J, Li H, Wu GD, Lewis JD, Bushman FD. Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents. PLoS One. 2013;8:e66019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3684604</ArticleId>
            <ArticleId IdType="pubmed">23799070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Angebault C, Djossou F, Ab&#xE9;lanet S, Permal E, Ben Soltana M, Diancourt L, Bouchier C, Woerther P-L, Catzeflis F, Andremont A, d&#x2019;Enfert C, Bougnoux M-E. Candida albicans Is Not Always the Preferential Yeast Colonizing Humans: A Study in Wayampi Amerindians. The Journal of Infectious Diseases. 2013;208:1705&#x2013;1716.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23904289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffmann TW, Pham H-P, Bridonneau C, Aubry C, Lamas B, Martin-Gallausiaux C, Moroldo M, Rainteau D, Lapaque N, Six A, Richard ML, Fargier E, Le Guern M-E, Langella P, Sokol H. Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. ISME J. 2015</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4737937</ArticleId>
            <ArticleId IdType="pubmed">26218241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pande K, Chen C, Noble SM. Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism. Nat Genet. 2013;45:1088&#x2013;1091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3758371</ArticleId>
            <ArticleId IdType="pubmed">23892606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X, Simms-Waldrip TR, Xie Y, Hooper LV, Koh AY. Activation of HIF-1[alpha] and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med advance online publication. 2015</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4496259</ArticleId>
            <ArticleId IdType="pubmed">26053625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vautier S, Drummond RA, Chen K, Murray GI, Kadosh D, Brown AJP, Gow NAR, MacCallum DM, Kolls JK, Brown GD. Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity. Cellular Microbiology. 2014 n/a-n/a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4409086</ArticleId>
            <ArticleId IdType="pubmed">25346172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Odds FC, Davidson AD, Jacobsen MD, Tavanti A, Whyte JA, Kibbler CC, Ellis DH, Maiden MCJ, Shaw DJ, Gow NAR. Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J Clin Microbiol. 2006;44:3647&#x2013;3658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1594753</ArticleId>
            <ArticleId IdType="pubmed">17021093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koh AY, K&#xF6;hler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal Damage and Neutropenia Are Required for Candida albicans Dissemination. PLoS Pathog. 2008;4:e35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2242836</ArticleId>
            <ArticleId IdType="pubmed">18282097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chehoud CAB, Albenberg LGDO, Judge CAB, Hoffmann CP, Grunberg SBA, Bittinger KP, Baldassano RNMD, Lewis JDMD, Bushman FDP, Wu GDMD. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4509842</ArticleId>
            <ArticleId IdType="pubmed">26083617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis James D, Chen Eric Z, Baldassano Robert N, Otley Anthony R, Griffiths Anne M, Lee D, Bittinger K, Bailey A, Friedman Elliot S, Hoffmann C, Albenberg L, Sinha R, Compher C, Gilroy E, Nessel L, Grant A, Chehoud C, Li H, Wu Gary D, Bushman Frederic D. Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn&#x2019;s Disease. Cell Host &amp; Microbe. 2015;18:489&#x2013;500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4633303</ArticleId>
            <ArticleId IdType="pubmed">26468751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milling S, Yrlid U, Cerovic V, MacPherson G. Subsets of migrating intestinal dendritic cells. Immunol Rev. 2010;234:259&#x2013;267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20193024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14:667&#x2013;685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25234148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Persson Emma K, Uronen-Hansson H, Semmrich M, Rivollier A, H&#xE4;gerbrand K, Marsal J, Gudjonsson S, H&#xE5;kansson U, Reizis B, Kotarsky K, Agace William W. IRF4 Transcription-Factor-Dependent CD103+CD11b+ Dendritic Cells Drive Mucosal T Helper 17 Cell Differentiation. Immunity. 2013;38:958&#x2013;969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23664832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welty NE, Staley C, Ghilardi N, Sadowsky MJ, Igy&#xE1;rt&#xF3; BZ, Kaplan DH. Intestinal lamina propria dendritic cells maintain T cell homeostasis but do not affect commensalism. J Exp Med. 2013;210:2011&#x2013;2024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3782055</ArticleId>
            <ArticleId IdType="pubmed">24019552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cerovic V, Houston SA, Scott CL, Aumeunier A, Yrlid U, Mowat AM, Milling SWF. Intestinal CD103- dendritic cells migrate in lymph and prime effector T cells. Mucosal Immunol. 2013;6:104&#x2013;113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22718260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott CL, Bain CC, Wright PB, Sichien D, Kotarsky K, Persson EK, Luda K, Guilliams M, Lambrecht BN, Agace WW, Milling SW, Mowat AM. CCR2+CD103- intestinal dendritic cells develop from DC-committed precursors and induce interleukin-17 production by T cells. Mucosal Immunol. 2015;8:327&#x2013;339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4270738</ArticleId>
            <ArticleId IdType="pubmed">25138666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drummond RA, Dambuza IM, Vautier S, Taylor JA, Reid DM, Bain CC, Underhill DM, Masopust D, Kaplan DH, Brown GD. CD4+ T-cell survival in the GI tract requires dectin-1 during fungal infection. Mucosal Immunol. 2015 doi: 10.1038/mi.2015.79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mi.2015.79</ArticleId>
            <ArticleId IdType="pmc">PMC4677461</ArticleId>
            <ArticleId IdType="pubmed">26349660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vautier S, Drummond RA, Redelinghuys P, Murray GI, MacCallum DM, Brown GD. Dectin-1 Is not required for controlling Candida albicans colonization of the gastrointestinal tract. Infect Immun. 2012;80:4216&#x2013;4222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3497410</ArticleId>
            <ArticleId IdType="pubmed">22988015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S, Brown GD. Dectin-1 is required for &#x3B2;-glucan recognition and control of fungal infection. Nat Immunol. 2007;8:31&#x2013;38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1888731</ArticleId>
            <ArticleId IdType="pubmed">17159984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iliev ID, Funari VA, Taylor KD, Quoclinh N, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, Rotter JI, Wang HL, McGovern DPB, Brown GD, Underhill DM. Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis. Science. 2012;336:1314&#x2013;1317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3432565</ArticleId>
            <ArticleId IdType="pubmed">22674328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang T, Pan D, Zhou Z, You Y, Jiang C, Zhao X, Lin X. Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut. PLoS Pathog. 2016;12:e1005662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4900642</ArticleId>
            <ArticleId IdType="pubmed">27280399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wheeler Matthew L, Limon Jose J, Bar Agnieszka S, Leal Christian A, Gargus M, Tang J, Brown J, Funari Vincent A, Wang Hanlin L, Crother Timothy R, Arditi M, Underhill David M, Iliev Iliyan D. Immunological Consequences of Intestinal Fungal Dysbiosis. Cell Host &amp; Microbe. 19:865&#x2013;873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4900921</ArticleId>
            <ArticleId IdType="pubmed">27237365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, Zhang CK, Boucher G, Ripke S, Ellinghaus D, Burtt N, Fennell T, Kirby A, Latiano A, Goyette P, Green T, Halfvarson J, Haritunians T, Korn JM, Kuruvilla F, Lagace C, Neale B, Lo KS, Schumm P, Torkvist L, Dubinsky MC, Brant SR, Silverberg MS, Duerr RH, Altshuler D, Gabriel S, Lettre G, Franke A, D&#x2019;Amato M, McGovern DPB, Cho JH, Rioux JD, Xavier RJ, Daly MJ K. Natl Inst Diabet Digestive, B. United Kingdom Inflammatory, and D. Int Inflammatory Bowel. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet. 2011;43:1066-U50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3378381</ArticleId>
            <ArticleId IdType="pubmed">21983784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Z, Conway Kara L, Heath Robert J, Rush Jason S, Leshchiner Elizaveta S, Ramirez-Ortiz Zaida G, Nedelsky Natalia B, Huang H, Ng A, Gardet A, Cheng S-C, Shamji Alykhan F, Rioux John D, Wijmenga C, Netea Mihai G, Means Terry K, Daly Mark J, Xavier Ramnik J. Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation. Immunity. 2015;43:715&#x2013;726.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4672733</ArticleId>
            <ArticleId IdType="pubmed">26488816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sokol H, Conway KL, Zhang M, Choi M, Morin B, Cao Z, Villablanca EJ, Li C, Wijmenga C, Yun SH, Shi HN, Xavier RJ. Card9 Mediates Intestinal Epithelial Cell Restitution, T-Helper 17 Responses, and Control of Bacterial Infection in Mice. Gastroenterology. 2013;145:591&#x2013;601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3781941</ArticleId>
            <ArticleId IdType="pubmed">23732773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamas B, Richard ML, Leducq V, Pham H-P, Michel M-L, Da Costa G, Bridonneau C, Jegou S, Hoffmann TW, Natividad JM, Brot L, Taleb S, Couturier-Maillard A, Nion-Larmurier I, Merabtene F, Seksik P, Bourrier A, Cosnes J, Ryffel B, Beaugerie L, Launay J-M, Langella P, Xavier RJ, Sokol H. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med advance online publication. 2016</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5087285</ArticleId>
            <ArticleId IdType="pubmed">27158904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lanternier F, Mahdaviani SA, Barbati E, Chaussade H, Koumar Y, Levy R, Denis B, Brunel A-S, Martin S, Loop M, Peeters J, de Selys A, Vanclaire J, Vermylen C, Nassogne M-C, Chatzis O, Liu L, Migaud M, Pedergnana V, Desoubeaux G, Jouvion G, Chretien F, Darazam IA, Sch&#xE4;ffer AA, Netea MG, De Bruycker JJ, Bernard L, Reynes J, Amazrine N, Abel L, Van der Linden D, Harrison T, Picard C, Lortholary O, Mansouri D, Casanova J-L, Puel A. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species&#x2013;induced meningoencephalitis, colitis, or both. J Allergy Clin Immunol. 2015;135:1558&#x2013;1568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4831587</ArticleId>
            <ArticleId IdType="pubmed">25702837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, Tardif MR, Sathaliyawala T, Kubota M, Farber DL, Collman RG, Shaked A, Fouser LA, Weiner DB, Tessier PA, Friedman JR, Kiyono H, Bushman FD, Chang K-M, Artis D. Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria. Science. 2012;336:1321&#x2013;1325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3659421</ArticleId>
            <ArticleId IdType="pubmed">22674331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y, Merad M. Microbiota-Dependent Crosstalk Between Macrophages and ILC3 Promotes Intestinal Homeostasis. Science. 2014;343</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4291125</ArticleId>
            <ArticleId IdType="pubmed">24625929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hepworth MR, Fung TC, Masur SH, Kelsen JR, McConnell FM, Dubrot J, Withers DR, Hugues S, Farrar MA, Reith W, Eberl G, Baldassano RN, Laufer TM, Elson CO, Sonnenberg GF. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria&#x2013;specific CD4+ T cells. Science. 2015;348:1031&#x2013;1035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4449822</ArticleId>
            <ArticleId IdType="pubmed">25908663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crellin NK, Trifari S, Kaplan CD, Satoh-Takayama N, Di Santo JP, Spits H. Regulation of Cytokine Secretion in Human CD127+ LTi-like Innate Lymphoid Cells by Toll-like Receptor 2. Immunity. 2010;33:752&#x2013;764.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21055975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor PR, Roy S, Meszaros EC, Sun Y, Howell SJ, Malemud CJ, Pearlman E. JAK/STAT regulation of Aspergillus fumigatus corneal infections and IL-6/23-stimulated neutrophil, IL-17, elastase, and MMP9 activity. J Leukoc Biol. 2016;100:213&#x2013;222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4946614</ArticleId>
            <ArticleId IdType="pubmed">27034404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>St Leger AJ, Desai JV, Drummond RA, Kugadas A, Almaghrabi F, Silver P, Raychaudhuri K, Gadjeva M, Iwakura Y, Lionakis MS, Caspi RR. An Ocular Commensal Protects against Corneal Infection by Driving an Interleukin-17 Response from Mucosal &#x3B3;&#x3B4; T Cells. Immunity. 47:148&#x2013;158.e5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5553552</ArticleId>
            <ArticleId IdType="pubmed">28709803</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29297762</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-9767</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global health promotion</Title>
          <ISOAbbreviation>Glob Health Promot</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Healthy China 2030, a breakthrough for improving health.</ArticleTitle>
        <Pagination>
          <StartPage>96</StartPage>
          <EndPage>99</EndPage>
          <MedlinePgn>96-99</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1757975917743533</ELocationID>
        <Abstract>
          <AbstractText>China has the largest population in the world, and its health levels have greatly affected the healthy development of the population of the world. Healthy China 2030 is a breakthrough for ensuring that the Chinese population have access to health, through advocating the whole society's participation in the concept of "Health for All, and All for Health." The plan puts forward five strategies such as popularizing healthy life, optimizing the health service, improving health protection, building a healthy environment, and developing healthy industry, from the perspectives of health effects of personal life and behavior, health care and security, production, and the living environment. As a national guide for public health promotion, we briefly describe the main intentions of Healthy China 2030, and give some commentaries from a health promotion perspective.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tan</LastName>
            <ForeName>Xiaodong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Wuhan University, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yanan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Wuhan University, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shao</LastName>
            <ForeName>Haiyan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Wuhan University, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>01</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Health Promot</MedlineTA>
        <NlmUniqueID>101497462</NlmUniqueID>
        <ISSNLinking>1757-9759</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006293" MajorTopicYN="Y">Health Promotion</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">global health/globalization</Keyword>
        <Keyword MajorTopicYN="N">health promotion</Keyword>
        <Keyword MajorTopicYN="N">healthy cities/healthy communities</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>1</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29297762</ArticleId>
        <ArticleId IdType="doi">10.1177/1757975917743533</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29280418</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>27</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-8305</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Nutritional neuroscience</Title>
          <ISOAbbreviation>Nutr Neurosci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Comparative effect of <i>Camellia sinensis</i> teas on object recognition test deficit and metabolic changes induced by cafeteria diet.</ArticleTitle>
        <Pagination>
          <StartPage>531</StartPage>
          <EndPage>540</EndPage>
          <MedlinePgn>531-540</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/1028415X.2017.1418726</ELocationID>
        <Abstract>
          <AbstractText><b>Objectives:</b> Consumption of high-fat and high-sugar diets in Western countries has increased significantly causing major global health problems including metabolic syndrome and obesity. In addition, studies have suggested that obesity can lead to learning and memory deficits. In this context, the use of natural compounds with low costs, minor side effects and increased antioxidant activity, such as teas, could reduce the damages induced by obesity. We investigated the effect of white, green, red, and black teas (<i>Camellia sinensis</i>) and their possible neuroprotective mechanisms in an experimental obesity model induced by a cafeteria diet (CD). <b>Methods:</b> Female Swiss mice (20-30&#x2005;g) were used; they received a normal diet or a hypercaloric diet (CD) during 8 weeks. Concomitantly, some mice received orally white, green, red, or black teas (1% dose) or water. <b>Results:</b> The mice subjected to CD showed weight gain, body fat accumulation, increased glucose, cholesterol, and triglycerides, associated to recognition memory deficits and increased reactive species (RS) levels and acetylcholinesterase (AChE) activity in the hippocampus. All teas significantly reduced AChE activity and partially reduced fat accumulation. Green and red teas reduced memory deficit. White, green, and black teas reduced RS levels, while only green and black tea reduced plasma triglyceride levels. <b>Discussion:</b> According to the results obtained it is possible to conclude that green tea was better than other teas in reducing effects of the CD model, being able to protect a greater number of parameters.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Soares</LastName>
            <ForeName>Melina Bucco</ForeName>
            <Initials>MB</Initials>
            <AffiliationInfo>
              <Affiliation>a Laborat&#xF3;rio de Biotecnologia da Reprodu&#xE7;&#xE3;o (Biotech), Campus Uruguaiana, Universidade Federal do Pampa , CEP 97500-970 , Uruguaiana , RS , Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramalho</LastName>
            <ForeName>Juliana Bernera</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>a Laborat&#xF3;rio de Biotecnologia da Reprodu&#xE7;&#xE3;o (Biotech), Campus Uruguaiana, Universidade Federal do Pampa , CEP 97500-970 , Uruguaiana , RS , Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Izaguirry</LastName>
            <ForeName>Aryele Pinto</ForeName>
            <Initials>AP</Initials>
            <AffiliationInfo>
              <Affiliation>a Laborat&#xF3;rio de Biotecnologia da Reprodu&#xE7;&#xE3;o (Biotech), Campus Uruguaiana, Universidade Federal do Pampa , CEP 97500-970 , Uruguaiana , RS , Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pavin</LastName>
            <ForeName>Natasha Frasson</ForeName>
            <Initials>NF</Initials>
            <AffiliationInfo>
              <Affiliation>a Laborat&#xF3;rio de Biotecnologia da Reprodu&#xE7;&#xE3;o (Biotech), Campus Uruguaiana, Universidade Federal do Pampa , CEP 97500-970 , Uruguaiana , RS , Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spiazzi</LastName>
            <ForeName>Cristiano Chiapinotto</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>a Laborat&#xF3;rio de Biotecnologia da Reprodu&#xE7;&#xE3;o (Biotech), Campus Uruguaiana, Universidade Federal do Pampa , CEP 97500-970 , Uruguaiana , RS , Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Schimidt</LastName>
            <ForeName>Helen Lidiane</ForeName>
            <Initials>HL</Initials>
            <AffiliationInfo>
              <Affiliation>b Applied Neuromechanics Research Group, Federal University of Pampa , CEP 97500-970 Uruguaiana , RS , Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mello-Carpes</LastName>
            <ForeName>P&#xE2;mela Billig</ForeName>
            <Initials>PB</Initials>
            <AffiliationInfo>
              <Affiliation>c Physiology Research Group, Federal University of Pampa , CEP 97500-970 Uruguaiana, RS , Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santos</LastName>
            <ForeName>Francielli Weber</ForeName>
            <Initials>FW</Initials>
            <AffiliationInfo>
              <Affiliation>a Laborat&#xF3;rio de Biotecnologia da Reprodu&#xE7;&#xE3;o (Biotech), Campus Uruguaiana, Universidade Federal do Pampa , CEP 97500-970 , Uruguaiana , RS , Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Nutr Neurosci</MedlineTA>
        <NlmUniqueID>100892202</NlmUniqueID>
        <ISSNLinking>1028-415X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D013662">Tea</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 1.15.1.1</RegistryNumber>
          <NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.1.7</RegistryNumber>
          <NameOfSubstance UI="D000110">Acetylcholinesterase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000110" MajorTopicYN="N">Acetylcholinesterase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D028241" MajorTopicYN="Y">Camellia sinensis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059305" MajorTopicYN="N">Diet, High-Fat</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D021641" MajorTopicYN="N">Recognition, Psychology</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013662" MajorTopicYN="Y">Tea</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Black tea</Keyword>
        <Keyword MajorTopicYN="N">Cafeteria diet</Keyword>
        <Keyword MajorTopicYN="N">Green tea</Keyword>
        <Keyword MajorTopicYN="N">Memory deficits</Keyword>
        <Keyword MajorTopicYN="N">Oxidative stress</Keyword>
        <Keyword MajorTopicYN="N">Red tea</Keyword>
        <Keyword MajorTopicYN="N">White tea</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29280418</ArticleId>
        <ArticleId IdType="doi">10.1080/1028415X.2017.1418726</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29255953</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-5546</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>25</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Science and engineering ethics</Title>
          <ISOAbbreviation>Sci Eng Ethics</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Synthetic Biology and the Translational Imperative.</ArticleTitle>
        <Pagination>
          <StartPage>33</StartPage>
          <EndPage>52</EndPage>
          <MedlinePgn>33-52</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11948-017-0011-3</ELocationID>
        <Abstract>
          <AbstractText>Advances at the interface between the biological sciences and engineering are giving rise to emerging research fields such as synthetic biology. Harnessing the potential of synthetic biology requires timely and adequate translation into clinical practice. However, the translational research enterprise is currently facing fundamental obstacles that slow down the transition of scientific discoveries from the laboratory to the patient bedside. These obstacles including scarce financial resources and deficiency of organizational and logistic settings are widely discussed as primary impediments to translational research. In addition, a number of socio-ethical considerations inherent in translational research need to be addressed. As the translational capacity of synthetic biology is tightly linked to its social acceptance and ethical approval, ethical limitations may-together with financial and organizational problems-be co-determinants of suboptimal translation. Therefore, an early assessment of such limitations will contribute to proactively favor successful translation and prevent the promising potential of synthetic biology from remaining under-expressed. Through the discussion of two case-specific inventions in synthetic biology and their associated ethical implications, we illustrate the socio-ethical challenges ahead in the process of implementing synthetic biology into clinical practice. Since reducing the translational lag is essential for delivering the benefits of basic biomedical research to society at large and promoting global health, we advocate a moral obligation to accelerating translational research: the "translational imperative."</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Heidari Feidt</LastName>
            <ForeName>Raheleh</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Biomedical Ethics, Universit&#xE4;t Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ienca</LastName>
            <ForeName>Marcello</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Biomedical Ethics, Universit&#xE4;t Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Health Ethics &amp; Policy Lab, Department of Health Sciences and Technology (D-HEST), ETH Z&#xFC;rich, Auf der Mauer 17, 8001, Zurich, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Elger</LastName>
            <ForeName>Bernice Simone</ForeName>
            <Initials>BS</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Biomedical Ethics, Universit&#xE4;t Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Legal Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Folcher</LastName>
            <ForeName>Marc</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-3544-0554</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biosystems Science and Engineering (D-BSSE), ETH Z&#xFC;rich, Mattenstrasse 26, 4058, Basel, Switzerland. marc.folcher@bsse.ethz.ch.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Sci Eng Ethics</MedlineTA>
        <NlmUniqueID>9516228</NlmUniqueID>
        <ISSNLinking>1353-3452</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>Sci Eng Ethics. 2019 Feb;25(1):53. doi: 10.1007/s11948-018-0019-3.</RefSource>
          <PMID Version="1">29368114</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001675" MajorTopicYN="N">Bioethics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062069" MajorTopicYN="N">Inventions</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058615" MajorTopicYN="N">Synthetic Biology</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057170" MajorTopicYN="N">Translational Research, Biomedical</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">First-in-human trials</Keyword>
        <Keyword MajorTopicYN="N">Synthetic biology</Keyword>
        <Keyword MajorTopicYN="N">Translational imperative</Keyword>
        <Keyword MajorTopicYN="N">Translational research</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29255953</ArticleId>
        <ArticleId IdType="doi">10.1007/s11948-017-0011-3</ArticleId>
        <ArticleId IdType="pii">10.1007/s11948-017-0011-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Med Ethics. 2001 Jun;27(3):148-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11417019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>FASEB J. 2001 Nov;15(13):2303-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11689456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Med. 2002 Sep;8(9):909</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12205440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Law Med Ethics. 2002 Fall;30(3):381-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12497698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA. 2003 Mar 12;289(10):1278-87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12633190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 2003 Apr 24;422(6934):835-47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12695777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radiat Res. 2003 Jul;160(1):1-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12816517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 2003 Oct 3;302(5642):63-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14526066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8414-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15159530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 2005 Jan 8;330(7482):79-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15637370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Med. 2005 Jul;11(7):705-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16015353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychophysiology. 2006 Nov;43(6):517-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17076808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA. 2007 Jan 24;297(4):403-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17244837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Treat Res. 2007;132:219-29</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17305025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dev World Bioeth. 2007 Dec;7(3):128-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18021117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genet Med. 2007 Oct;9(10):665-74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18073579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Rev Genet. 2008 Mar;9(3):239-44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18278058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA. 2008 May 21;299(19):2319-21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18492974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Bioeth. 2008 Mar;8(3):43-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18570103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Bioeth. 2008 Mar;8(3):62-4; discussion W1-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18570109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 2008 Sep 5;321(5894):1298-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18772421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 2008 Sep 12;321(5895):1443</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18787148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Rev Mol Cell Biol. 2009 Jun;10(6):410-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19461664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Infect Immun. 2010 Feb;78(2):563-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20038540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acad Med. 2010 Mar;85(3):463-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20182119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Med Ethics. 2010 Apr;36(4):207-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20338930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Biotechnol. 2010 Apr;28(4):355-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20351688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sci Transl Med. 2010 May 5;2(30):30cm16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20445199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS Negl Trop Dis. 2010 May 25;4(5):e718</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20520793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Bioeth. 2010 Aug;10(8):19-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20694901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Ist Super Sanita. 2011;47(1):72-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21430343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Transl Sci. 2011 Jun;4(3):153-62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21707944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J R Soc Med. 2011 Dec;104(12):510-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22179294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayo Clin Proc. 2012 Mar;87(3):268-79</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22325364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS Biol. 2013;11(4):e1001530</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23565062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Genomics. 2013 Mar;14(1):11-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23997647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18150-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24127594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Rev Mol Cell Biol. 2014 Apr;15(4):289-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24622617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Commun. 2014 Nov 11;5:5392</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25386727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Opin Biotechnol. 2015 Dec;35:37-45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25679308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J R Soc Interface. 2015 May 6;12(106):null</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25808341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Health Econ. 2016 May;47:20-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26928437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sci Eng Ethics. 2017 Apr;23(2):351-363</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27325413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 2016 Dec 9;354(6317):1296-1301</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27940875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sci Transl Med. 2017 Apr 26;9(387):</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28446682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Med Philos. 1994 Feb;19(1):23-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8201288</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29254426</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2023</Year>
        <Month>09</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-6887</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>31</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of aging and health</Title>
          <ISOAbbreviation>J Aging Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Economic Adversity Transitions From Childhood to Older Adulthood Are Differentially Associated With Later-Life Physical Performance Measures in Men and Women in Middle and High-Income Sites.</ArticleTitle>
        <Pagination>
          <StartPage>509</StartPage>
          <EndPage>527</EndPage>
          <MedlinePgn>509-527</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/0898264317736846</ELocationID>
        <Abstract>
          <AbstractText><b>Objective:</b> This study examines the relationship between economic adversity transitions from childhood to older adulthood and older adulthood physical performance among 1,998 community-dwelling older adults from five demographically diverse sites from middle and high-income countries. <b>Method:</b> The principal exposure variable was economic adversity transition. No adversity encompassed not experiencing poverty in both childhood and older adulthood, improved described having only experienced poverty in childhood, worsened captured having experienced poverty in older adulthood, and severe is having experienced poverty in both childhood and older adulthood. The short physical performance battery (SPPB) was used for outcome measures. Analyses of the continuous SPPB score used linear regression, while analysis of a binary outcome (SPPB &lt; 8 vs. &#x2265;8) used Poisson regression models with robust error variance, both adjusting for sex, education, and site location. <b>Result:</b> In sex-stratified models, the SPPB &lt; 8 prevalence rate ratio (PRR) was higher for the severe (PRR: 2.80, 95% confidence interval [CI] = [1.70, 4.61]), worsened (PRR: 2.40, 95% CI = [1.41, 4.09]), and improved (PRR: 1.82, 95% CI = [1.11, 3.01]) groups, compared with those with no adversity in childhood or as adults, but only for females. <b>Discussion:</b> Findings from this study indicate that persistent economic adversity has a negative effect on older adult physical performance, especially among women.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hwang</LastName>
            <ForeName>Phoebe W</ForeName>
            <Initials>PW</Initials>
            <AffiliationInfo>
              <Affiliation>University of Hawai'i at M&#x101;noa, Honolulu, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dos Santos Gomes</LastName>
            <ForeName>Cristiano</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Rio Grande do Norte, Natal, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Auais</LastName>
            <ForeName>Mohammad</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Queen's University, Kingston, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Braun</LastName>
            <ForeName>Kathryn L</ForeName>
            <Initials>KL</Initials>
            <AffiliationInfo>
              <Affiliation>University of Hawai'i at M&#x101;noa, Honolulu, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guralnik</LastName>
            <ForeName>Jack M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>University of Maryland School of Medicine, Baltimore, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pirkle</LastName>
            <ForeName>Catherine M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>University of Hawai'i at M&#x101;noa, Honolulu, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>U54 MD007584</GrantID>
            <Acronym>MD</Acronym>
            <Agency>NIMHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>U54 MD007601</GrantID>
            <Acronym>MD</Acronym>
            <Agency>NIMHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Aging Health</MedlineTA>
        <NlmUniqueID>8912686</NlmUniqueID>
        <ISSNLinking>0898-2643</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019049" MajorTopicYN="N">Developed Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054624" MajorTopicYN="Y">Health Status Disparities</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076604" MajorTopicYN="Y">Physical Functional Performance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011203" MajorTopicYN="N">Poverty</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">gerontology</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">life course adversity</Keyword>
        <Keyword MajorTopicYN="N">life course epidemiology</Keyword>
        <Keyword MajorTopicYN="N">physical performance</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of Conflicting Interests. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29254426</ArticleId>
        <ArticleId IdType="mid">NIHMS983860</ArticleId>
        <ArticleId IdType="pmc">PMC6087498</ArticleId>
        <ArticleId IdType="doi">10.1177/0898264317736846</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Barros AJD, &amp; Hirakata VN (2003). Alternatives for logistic regression in cross-sectional studies: An empirical comparison of models that directly estimate the prevalence ratio. BMC Medical Research Methodology, 3, Article 21. doi:10.1186/1471-2288-3-21</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2288-3-21</ArticleId>
            <ArticleId IdType="pmc">PMC521200</ArticleId>
            <ArticleId IdType="pubmed">14567763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ben-Shlomo Y, &amp; Kuh D (2002). A life course approach to chronic disease epidemiology: Conceptual models, empirical challenges and interdisciplinary perspectives. International Journal of Epidemiology, 31, 285&#x2013;293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11980781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>C&#xE2;mara SMA, Pirkle C, Moreira MA, Vieira MCA, Vafaei A, &amp; Maciel &#xC1;CC (2015). Early maternal age and multiparity are associated to poor physical performance in middle-aged women from Northeast Brazil: A cross-sectional community based study. BMC Women&#x2019;s Health, 15, Article 56. doi:10.1186/s12905-015-0214-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12905-015-0214-1</ArticleId>
            <ArticleId IdType="pmc">PMC4526418</ArticleId>
            <ArticleId IdType="pubmed">26243283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cawthorne A (2008). The straight facts on women in poverty. Center for American Progress. Retrieved from https://cdn.americanprogressaction.org/wp-content/uploads/issues/2008/10/pdf/women_poverty.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Crimmins EM, Kim JK, &amp; Seeman TE (2009). Poverty and biological risk: The earlier &#x201C;aging&#x201D; of the poor. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, A, 64, 286&#x2013;292. doi:10.1093/gerona/gln010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/gerona/gln010</ArticleId>
            <ArticleId IdType="pmc">PMC2655037</ArticleId>
            <ArticleId IdType="pubmed">19196637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>da Concei&#xE7;&#xE3;o Chagas de Almeida M, &amp; Aquino EM (2009). The role of education level in the intergenerational pattern of adolescent pregnancy in Brazil. International Perspectives on Sexual and Reproductive Health, 35, 139&#x2013;146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19805019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Albuquerque Sousa ACP, Guerra RO, Tu MT, Phillips SP, Guralnik JM, &amp; Zunzunegui M-V (2014). Lifecourse adversity and physical performance across countries among men and women aged 65&#x2013;74. PLoS ONE, 9(8), e102299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4125146</ArticleId>
            <ArticleId IdType="pubmed">25101981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Y&#xE9;benes MJG, Otero A, Zunzunegui MV, Rodr&#xED;guez-Laso A, S&#xE1;nchez-S&#xE1;nchez F, &amp; Del Ser T (2003). Validation of a short cognitive tool for the screening of dementia in elderly people with low educational level. International Journal of Geriatric Psychiatry, 18, 925&#x2013;936.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14533125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Entwisle DR, Alexander KL, Olson LS, &amp; Ross K (1999). Paid work in early adolescence: Developmental and ethnic patterns. The Journal of Early Adolescence, 19, 363&#x2013;388.</Citation>
        </Reference>
        <Reference>
          <Citation>Evans GW, Chen E, Miller G, &amp; Seeman T (2012). How poverty gets under the skin: A life course perspective. Retrieved from http://www.oxfordhand-books.com/view/10.1093/oxfordhb/9780199769100.001.0001/oxfordhb-9780199769100-e-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordhb/9780199769100.001.0001/oxfordhb-9780199769100-e-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukagawa NK, Brown M, Sinacore DR, &amp; Host HH (1995). The relationship of strength to function in the older adult. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, A, 50(Special Issue), 55&#x2013;59. doi:10.1093/gerona/50A.Special_Issue.55</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/gerona/50A.Special_Issue.55</ArticleId>
            <ArticleId IdType="pubmed">7493219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Functional Decline in Older Adults&#x2014;American Family Physician. (n.d.). Retrieved from http://www.aafp.org/afp/2013/0915/p388.html</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3955056</ArticleId>
            <ArticleId IdType="pubmed">24134046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galobardes B, Lynch JW, &amp; Smith GD (2004). Childhood socioeconomic circumstances and cause-specific mortality in adulthood: Systematic review and interpretation. Epidemiologic Reviews, 26, 7&#x2013;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15234944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glasier A, G&#xFC;lmezoglu AM, Schmid GP, Moreno CG, &amp; Van Look PF (2006). Sexual and reproductive health: A matter of life and death. The Lancet, 368, 1595&#x2013;1607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17084760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grundy E, &amp; Sloggett A (2003). Health inequalities in the older population: The role of personal capital, social resources and socio-economic circumstances. Social Science &amp; Medicine, 56, 935&#x2013;947. doi:10.1016/S0277-9536(02)00093-X</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0277-9536(02)00093-X</ArticleId>
            <ArticleId IdType="pubmed">12593868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guilley E, Bopp M, Faeh D, &amp; Paccaud F (2010). Socioeconomic gradients in mortality in the oldest old: A review. Archives of Gerontology and Geriatrics, 51, e37&#x2013;e40. doi:10.1016/j.archger.2009.12.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.archger.2009.12.009</ArticleId>
            <ArticleId IdType="pubmed">20071040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guralnik JM, Simonsick E, Ferrucci L, Glynn RJ, Berkman LF, Blazer Dan G, &#x2026;Wallace RB (1994). A short physical performance batter assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, A, 49, 85&#x2013;94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8126356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haas S (2008). Trajectories of functional health: The &#x201C;long arm&#x201D; of childhood health and socioeconomic factors. Social Science &amp; Medicine, 66, 849&#x2013;861. doi:10.1016/j.socscimed.2007.11.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.socscimed.2007.11.004</ArticleId>
            <ArticleId IdType="pubmed">18158208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardy R, Lawlor DA, Black S, Mishra GD, &amp; Kuh D (2009). Age at birth of first child and coronary heart disease risk factors at age 53 years in men and women: British birth cohort study. Journal of Epidemiology and Community Health, 63, 99&#x2013;105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2613438</ArticleId>
            <ArticleId IdType="pubmed">18782806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harper C, Marcus R, &amp; Moore K (2003). Enduring poverty and the conditions of childhood: Lifecourse and intergenerational poverty transmissions. World Development, 31, 535&#x2013;554. doi:10.1016/S0305-750X(03)00010-X</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0305-750X(03)00010-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernandez DC, &amp; Pressler E (2014). Accumulation of childhood poverty on young adult overweight or obese status: Race/ethnicity and gender disparities. Journal of Epidemiology and Community Health, 68, 478&#x2013;484. doi:10.1136/jech-2013-203062</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jech-2013-203062</ArticleId>
            <ArticleId IdType="pubmed">24391207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiernan KE (1997). Becoming a young parent: A longitudinal study of associated factors. British Journal of Sociology, 48, 406&#x2013;428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9372635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuh D, &amp; Ben-Shlomo Y (Eds.). (1997). A life course approach to chronic disease epidemiology. Oxford, UK: Oxford University Press.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11980781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuh D, Hardy R, Langenberg C, Richards M, &amp; Wadsworth ME (2002). Mortality in adults aged 26&#x2013;54 years related to socioeconomic conditions in childhood and adulthood: Post war birth cohort study. British Medical Journal, 325, 1076&#x2013;1080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC131184</ArticleId>
            <ArticleId IdType="pubmed">12424168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leon DA, &amp; Walt G (2001). Poverty, inequality, and health: An international perspective. Oxford University Press.</Citation>
        </Reference>
        <Reference>
          <Citation>Lif EF, Brannstrom L, Vinnerljung B, &amp; Hjern A (2016). Childhood adversities and later economic hardship among Swedish child welfare clients Cumulative bcw167.</Citation>
        </Reference>
        <Reference>
          <Citation>LIFE Study Investigators, Pahor M, Blair SN, Espeland M, Fielding R, Gill TM, Guralnik JM, &#x2026; Studenski S (2006). Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 61, 1157&#x2013;1165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17167156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lynch JW, Kaplan GA, &amp; Shema SJ (1997). Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning. New England Journal of Medicine, 337, 1889&#x2013;1895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9407157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marmot M (2005). Social determinants of health inequalities. The Lancet, 365, 1099&#x2013;1104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15781105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mechakra-Tahiri SD, Freeman EE, Haddad S, Samson E, &amp; Zunzunegui M-V (2012). The gender gap in mobility: A global cross-sectional study. BMC Public Health, 12, Article 598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3506530</ArticleId>
            <ArticleId IdType="pubmed">22856611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra GD, Cooper R, &amp; Kuh D (2010). A life course approach to reproductive health: Theory and methods. Maturitas, 65, 92&#x2013;97. doi:10.1016/j.maturitas.2009.12.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.maturitas.2009.12.009</ArticleId>
            <ArticleId IdType="pmc">PMC3504662</ArticleId>
            <ArticleId IdType="pubmed">20079587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szklo M, &amp; Nieto J (2012). Epidemiology: Beyond the Basics (3rd ed.). Burlington, MA: Jones &amp; Bartlett.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. (2015). Gender. Fact Sheet N 403. Retrieved from www.who.int/mediacentre/factsheets/fs403/en/</Citation>
        </Reference>
        <Reference>
          <Citation>Yeung WJ, &amp; Hofferth SL (1998). Family adaptations to income and job loss in the US. Journal of Family and Economic Issues, 19, 255&#x2013;283.</Citation>
        </Reference>
        <Reference>
          <Citation>Zunzunegui MV, Alvarado BE, Guerra R, Gomez JF, Ylli A, Guralnik JM, &amp; International Mobility in Aging Study Research Group. (2015). The mobility gap between older men and women: The embodiment of gender. Archives of Gerontology and Geriatrics, 61, 140&#x2013;148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26113021</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29239235</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1464-5165</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Disability and rehabilitation</Title>
          <ISOAbbreviation>Disabil Rehabil</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Assessing self-reported disability in a low-literate population with chronic low back pain: cross-cultural adaptation and psychometric testing of Igbo Roland Morris disability questionnaire.</ArticleTitle>
        <Pagination>
          <StartPage>948</StartPage>
          <EndPage>957</EndPage>
          <MedlinePgn>948-957</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09638288.2017.1416185</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE">Cross-culturally adapt and validate the Igbo Roland Morris Disability Questionnaire.</AbstractText>
          <AbstractText Label="METHOD">Cross-cultural adaptation, test-retest, and cross-sectional psychometric testing. Roland Morris Disability Questionnaire was forward and back translated by clinical/non-clinical translators. An expert committee appraised the translations. Twelve participants with chronic low back pain pre-tested the measure in a rural Nigerian community. Internal consistency using Cronbach's alpha; test-retest reliability using intra-class correlation coefficient and Bland-Altman plot; and minimal detectable change were investigated in a convenient sample of 50 people with chronic low back pain in rural and urban Nigeria. Pearson's correlation analyses using the eleven-point box scale and back performance scale, and exploratory factor analysis were used to examine construct validity in a random sample of 200 adults with chronic low back pain in rural Nigeria. Ceiling and floor effects were investigated in the two samples.</AbstractText>
          <AbstractText Label="RESULTS">Modifications gave the option of interviewer-administration and reflected Nigerian social context. The measure had excellent internal consistency (&#x3B1;&#x2009;=&#x2009;0.91) and intraclass correlation coefficient (ICC =0.84), moderately high correlations (r&#x2009;&gt;&#x2009;0.6) with performance-based disability and pain intensity, and a predominant uni-dimensional structure, with no ceiling or floor effects.</AbstractText>
          <AbstractText Label="CONCLUSIONS">Igbo Roland Morris Disability Questionnaire is a valid and reliable measure of pain-related disability. Implications for rehabilitation Low back pain is the leading cause of years lived with disability worldwide, and is particularly prevalent in rural Nigeria, but there are no self-report measures to assess its impact due to low literacy rates. This study describes the cross-cultural adaptation and validation of a core self-report back pain specific disability measure in a low-literate Nigerian population. The Igbo Roland Morris Disability Questionnaire is a reliable and valid measure of self-reported disability in Igbo populations as indicated by excellent internal consistency (&#x3B1;&#x2009;=&#x2009;0.91) and intra-class correlation coefficient (ICC =0.84), moderately high correlations (r&#x2009;&gt;&#x2009;0.6) with performance-based disability and pain intensity that supports a pain-related disability construct, a predominant one factor structure with no ceiling or floor effects. The measure will be useful for researchers and clinicians examining the factors associated with low back pain disability or the effects of interventions on low back pain disability in this culture. This measure will support global health initiatives concurrently involving people from several cultures or countries, and may inform cross-cultural disability research in other populations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Igwesi-Chidobe</LastName>
            <ForeName>Chinonso N</ForeName>
            <Initials>CN</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Medical Rehabilitation, Faculty of Health Sciences and Technology, College of Medicine , University of Nigeria (Enugu Campus) , Enugu State , Nigeria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>b Department of Physiotherapy, School of population health sciences , faculty of life sciences and medicine, King's College London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Obiekwe</LastName>
            <ForeName>Chinwe</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>c Department of Physiotherapy , University of Nigeria Teaching Hospital , Enugu State , Nigeria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sorinola</LastName>
            <ForeName>Isaac O</ForeName>
            <Initials>IO</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Physiotherapy, School of population health sciences , faculty of life sciences and medicine, King's College London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Godfrey</LastName>
            <ForeName>Emma L</ForeName>
            <Initials>EL</Initials>
            <AffiliationInfo>
              <Affiliation>b Department of Physiotherapy, School of population health sciences , faculty of life sciences and medicine, King's College London , UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>d Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience , King's College London , London , UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Disabil Rehabil</MedlineTA>
        <NlmUniqueID>9207179</NlmUniqueID>
        <ISSNLinking>0963-8288</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003431" MajorTopicYN="N">Cross-Cultural Comparison</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059026" MajorTopicYN="Y">Diagnostic Self Evaluation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004185" MajorTopicYN="N">Disability Evaluation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067010" MajorTopicYN="N">Literacy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017116" MajorTopicYN="Y">Low Back Pain</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011594" MajorTopicYN="Y">Psychometrics</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057566" MajorTopicYN="Y">Self Report</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cross-cultural research</Keyword>
        <Keyword MajorTopicYN="N">cross-cultural adaptation</Keyword>
        <Keyword MajorTopicYN="N">interviewer-administration</Keyword>
        <Keyword MajorTopicYN="N">low back pain</Keyword>
        <Keyword MajorTopicYN="N">psychometric testing</Keyword>
        <Keyword MajorTopicYN="N">self-reported disability</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29239235</ArticleId>
        <ArticleId IdType="doi">10.1080/09638288.2017.1416185</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29235401</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-1706</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global public health</Title>
          <ISOAbbreviation>Glob Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>What do human rights bring to discussions of power and politics in health policy and systems?</ArticleTitle>
        <Pagination>
          <StartPage>489</StartPage>
          <EndPage>502</EndPage>
          <MedlinePgn>489-502</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/17441692.2017.1405457</ELocationID>
        <Abstract>
          <AbstractText>Scholarly interrogations of power and politics are not endemic to the disciplines primarily tasked with exploring health policy and planning in the domestic or global domains. Scholars in these domains have come late to investigating power, prompted in part by the growing focus in domestic and global health research on the intersections between governance, globalization and health inequities. Recent prominent reports in this area increasingly point to human rights as important norms capable of responding in part to power differentials that sustain and exacerbate health inequities. Yet human rights law is not traditionally incorporated into health policy scholarship or education, despite offering important normative and strategic frameworks for public and global health, with distinctive contributions in relation to identifying and challenging certain forms of power disparity. This paper overviews two of these reports and how they see power functioning to sustain health inequities. It then turns to investigate what human rights and the right to health in particular may offer in addressing and challenging power in the health policy context.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Forman</LastName>
            <ForeName>Lisa</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>a Dalla Lana School of Public Health , University of Toronto , Ontario , Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Public Health</MedlineTA>
        <NlmUniqueID>101256323</NlmUniqueID>
        <ISSNLinking>1744-1692</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003695" MajorTopicYN="Y">Delivery of Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054625" MajorTopicYN="N">Healthcare Disparities</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006806" MajorTopicYN="Y">Human Rights</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011057" MajorTopicYN="Y">Politics</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Human rights</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">health policy</Keyword>
        <Keyword MajorTopicYN="N">power</Keyword>
        <Keyword MajorTopicYN="N">right to health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29235401</ArticleId>
        <ArticleId IdType="doi">10.1080/17441692.2017.1405457</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29212379</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2025</Year>
        <Month>01</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1464-5165</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Disability and rehabilitation</Title>
          <ISOAbbreviation>Disabil Rehabil</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Provision of rehabilitation services for children with disabilities living in low- and middle-income countries: a scoping review.</ArticleTitle>
        <Pagination>
          <StartPage>861</StartPage>
          <EndPage>868</EndPage>
          <MedlinePgn>861-868</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09638288.2017.1411982</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">Childhood disability is a growing global health priority. The purpose of this scoping review was to identify and summarize rehabilitation interventions used to support children with disabilities in low- and middle-income countries.</AbstractText>
          <AbstractText Label="METHODS">This scoping review involved a systematic search of electronic databases using a combination of subject headings and/or keywords related to child disability, rehabilitation, and low- and middle-income countries. Charting involved an iterative process whereby the full text of articles meeting the inclusion criteria were abstracted using a charting form. Data were charted according to pre-selected and emerging characteristics deemed relevant to the scoping review's purpose.</AbstractText>
          <AbstractText Label="RESULTS">Eighty-one articles were included in the final analysis. Forty-three articles explored the use of screening and/or diagnostic tools in identifying children with disabilities in low and middle income countries, and 38 articles evaluated rehabilitation services for these children.</AbstractText>
          <AbstractText Label="CONCLUSIONS">A number of rehabilitation strategies are available that have the potential to improve the identification of and outcomes for children with disabilities in low and middle income countries. Future research ought to advance the development, implementation, and evaluation of training programs for non-rehabilitation specialists (e.g., doctors, nurses, and teachers), non-specialist community members (e.g., community health workers), and caregivers in the area of rehabilitation, and evaluate the effectiveness of rehabilitation interventions in improving participatory outcomes and quality of life for children with disabilities. Implications for Rehabilitation Additional research is needed to understand the influence of rehabilitation on personal factors (e.g., self-efficacy and quality of life) and participation for children with disabilities. There is limited availability of experienced rehabilitation service providers, especially in rural areas, warranting additional research into the development and evaluation of non-specialist training programs, and the integration of rehabilitation concepts across health workforce education programs. Researchers from low and middle income countries appear to be underrepresented in published rehabilitation research, indicating a need to further promote the inclusion of this group through community-based participatory research.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Magnusson</LastName>
            <ForeName>Dawn</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Physical Medicine and Rehabilitation , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sweeney</LastName>
            <ForeName>Frank</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>b Division of Biokinesiology and Physical Therapy , University of Southern California , Los Angeles , CA , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Landry</LastName>
            <ForeName>Michel</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>c Department of Orthopaedic Surgery , Duke University , Durham , NC , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000098583">Scoping Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Disabil Rehabil</MedlineTA>
        <NlmUniqueID>9207179</NlmUniqueID>
        <ISSNLinking>0963-8288</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002658" MajorTopicYN="Y">Developmental Disabilities</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019988" MajorTopicYN="Y">Children with Disabilities</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020380" MajorTopicYN="N">Needs Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012046" MajorTopicYN="N">Rehabilitation</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Child</Keyword>
        <Keyword MajorTopicYN="N">developmental disability</Keyword>
        <Keyword MajorTopicYN="N">global south</Keyword>
        <Keyword MajorTopicYN="N">intervention</Keyword>
        <Keyword MajorTopicYN="N">therapy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29212379</ArticleId>
        <ArticleId IdType="doi">10.1080/09638288.2017.1411982</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29199493</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-4954</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title>
          <ISOAbbreviation>J Matern Fetal Neonatal Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementation.</ArticleTitle>
        <Pagination>
          <StartPage>1541</StartPage>
          <EndPage>1546</EndPage>
          <MedlinePgn>1541-1546</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/14767058.2017.1406475</ELocationID>
        <Abstract>
          <AbstractText>Pertussis remains a serious global health issue in infants aged less than 6 months. Neonates and young infants have the highest risk of developing pertussis as they are too young to be vaccinated and thus are more likely to develop more severe pertussis-related complications, including death. Protecting this vulnerable age population from pertussis is considered a main priority in many national health programs. Two vaccine strategies exist to protect infants from pertussis: "cocooning" and maternal vaccination during pregnancy. The latter is the more recent and preferred strategy, which protects newborns by passive transplacental transfer of pertussis antibodies. We review the reported evidence on the safety, effectiveness, timing and implementation of this antenatal immunization strategy.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lumbreras Areta</LastName>
            <ForeName>Marina</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Obstetrics and Gynecology , Geneva University Hospitals and Faculty of Medicine , Geneva , Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eberhardt</LastName>
            <ForeName>Christiane Sigrid</ForeName>
            <Initials>CS</Initials>
            <AffiliationInfo>
              <Affiliation>b Centre for Vaccinology and Neonatal Immunology, Department of Pathology-Immunology , University of Geneva , Geneva , Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>c Department of Neonatology and Pediatric Intensive Care , Children's Hospital of Geneva , Geneva , Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siegrist</LastName>
            <ForeName>Claire-Anne</ForeName>
            <Initials>CA</Initials>
            <AffiliationInfo>
              <Affiliation>b Centre for Vaccinology and Neonatal Immunology, Department of Pathology-Immunology , University of Geneva , Geneva , Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>d Department of Pediatrics , Children's Hospital of Geneva , Geneva , Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martinez de Tejada</LastName>
            <ForeName>Bego&#xF1;a</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>a Department of Obstetrics and Gynecology , Geneva University Hospitals and Faculty of Medicine , Geneva , Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Matern Fetal Neonatal Med</MedlineTA>
        <NlmUniqueID>101136916</NlmUniqueID>
        <ISSNLinking>1476-4954</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D022681">Diphtheria-Tetanus-acellular Pertussis Vaccines</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022681" MajorTopicYN="N">Diphtheria-Tetanus-acellular Pertussis Vaccines</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007232" MajorTopicYN="N">Infant, Newborn, Diseases</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008431" MajorTopicYN="Y">Maternal-Fetal Exchange</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014917" MajorTopicYN="N">Whooping Cough</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Immunization</Keyword>
        <Keyword MajorTopicYN="N">maternal</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
        <Keyword MajorTopicYN="N">safety</Keyword>
        <Keyword MajorTopicYN="N">vaccination</Keyword>
        <Keyword MajorTopicYN="N">whooping cough</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29199493</ArticleId>
        <ArticleId IdType="doi">10.1080/14767058.2017.1406475</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29187122</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-9767</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global health promotion</Title>
          <ISOAbbreviation>Glob Health Promot</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Social determinants of cancer incidence and mortality around the world: an ecological study.</ArticleTitle>
        <Pagination>
          <StartPage>41</StartPage>
          <EndPage>49</EndPage>
          <MedlinePgn>41-49</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1757975916686913</ELocationID>
        <Abstract>
          <AbstractText>Cancer continues to be a leading cause of mortality and morbidity the world over. While the incidence of cancer is projected to increase by 70% over the next two decades, some research findings suggest a disproportionate distribution of new cancer cases and attendant fatalities across certain regions of the world, with poor and lower income countries worse affected at a time when advances in cancer research, medical technology, and drug development are giving rise to better cancer survival in developed countries. In this study, the role of selected social determinants of health in gauging cancer outcomes relative to incidence across various countries in different regions of the world was explored. The results indicated that the education index, income index, Gini coefficient, availability of cancer control policies and programs, as well as health system performance have an association with and are good predictors of the mortality to incidence ratio (MIR) of lung, breast, cervical, and colorectal cancers. In other words, populations with better education, higher incomes and lower inequalities, active cancer control policies and programs and high performing health systems have better cancer outcomes as reflected in lower MIRs relative to other populations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McDaniel</LastName>
            <ForeName>Justin T</ForeName>
            <Initials>JT</Initials>
            <AffiliationInfo>
              <Affiliation>1 International Center for Community Health Promotion and Education, Robinson, IL, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2 Charleston Southern University, Charleston, SC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nuhu</LastName>
            <ForeName>Kaamel</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>1 International Center for Community Health Promotion and Education, Robinson, IL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ruiz</LastName>
            <ForeName>Juan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>1 International Center for Community Health Promotion and Education, Robinson, IL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alorbi</LastName>
            <ForeName>Genevieve</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>1 International Center for Community Health Promotion and Education, Robinson, IL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>03</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Health Promot</MedlineTA>
        <NlmUniqueID>101497462</NlmUniqueID>
        <ISSNLinking>1757-9759</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006293" MajorTopicYN="N">Health Promotion</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064890" MajorTopicYN="N">Social Determinants of Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">equity</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">globalization</Keyword>
        <Keyword MajorTopicYN="N">social justice</Keyword>
        <Keyword MajorTopicYN="N">socioeconomic status</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29187122</ArticleId>
        <ArticleId IdType="doi">10.1177/1757975916686913</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29129454</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-2518</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Vaccine</Title>
          <ISOAbbreviation>Vaccine</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Announcing the publication of the WHO immunological basis for immunization series module on pertussis vaccines.</ArticleTitle>
        <Pagination>
          <StartPage>217</StartPage>
          <EndPage>218</EndPage>
          <MedlinePgn>217-218</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2017.10.110</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0264-410X(17)31542-6</ELocationID>
        <Abstract>
          <AbstractText>In 2017, the World Health Organization (WHO) published an updated document aimed at facilitating the understanding of the immunological basis of pertussis vaccines and their use. The document "The Immunological Basis for Immunization Series: Pertussis Vaccines" is freely available on the WHO website. The main purpose of the module is to provide national immunization managers and vaccination professionals with an overview of the scientific basis of vaccination against pertussis and the immunological basis for the WHO position on pertussis vaccines. The Immunological Basis for Immunization Series was initially developed in 1993. Since then the series was regularly updated and extended. They reflect the biological differences in immune responses to the individual pathogens and the differing strategies employed to create the best possible level of protection that can be provided by vaccination. We invite the immunization community to use these references, and we hope the updated pertussis vaccine module will be a valuable resource.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2017. Published by Elsevier Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <CollectiveName>World Health Organization</CollectiveName>
            <AffiliationInfo>
              <Affiliation>IVB Department, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Vaccine</MedlineTA>
        <NlmUniqueID>8406899</NlmUniqueID>
        <ISSNLinking>0264-410X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010567">Pertussis Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001886" MajorTopicYN="N">Bordetella pertussis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007115" MajorTopicYN="Y">Immunization Schedule</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010567" MajorTopicYN="N">Pertussis Vaccine</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014917" MajorTopicYN="N">Whooping Cough</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014944" MajorTopicYN="Y">World Health Organization</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bordetella pertussis</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Pertussis vaccines</Keyword>
        <Keyword MajorTopicYN="N">Vaccine immunology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29129454</ArticleId>
        <ArticleId IdType="doi">10.1016/j.vaccine.2017.10.110</ArticleId>
        <ArticleId IdType="pii">S0264-410X(17)31542-6</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29125391</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-9767</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global health promotion</Title>
          <ISOAbbreviation>Glob Health Promot</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Five Ways to Wellbeing: holistic narratives of public health programme participants.</ArticleTitle>
        <Pagination>
          <StartPage>71</StartPage>
          <EndPage>79</EndPage>
          <MedlinePgn>71-79</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1757975917732352</ELocationID>
        <Abstract>
          <AbstractText>This paper reports on a study which formed part of a qualitative process evaluation of a wellbeing programme in North West England. The study used the biographic narrative interpretive method (BNIM) to undertake and analyse data from interviews with six participants from diverse projects within the programme. This generated rich case studies and spotlighted cross-case commonalities, building understanding of how the programme achieved its effects. We present findings using the Five Ways to Wellbeing framework, presenting one abridged 'case' and summarising cross-cutting themes. We explore how BNIM gives insight into the psychosocial complexity of wellbeing, building understanding of its holistic and dynamic nature, and then highlight the flexibility, resonance and widespread appeal of Five Ways to Wellbeing. In concluding, we argue that by enabling participants to tell their own stories of participation in the different projects, we gain a more authentic understanding of the 'whole' story of how involvement has affected wellbeing. Such approaches are crucial as wellbeing becomes a central concept in global health policy and promotion.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Farrier</LastName>
            <ForeName>Alan</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>University of Central Lancashire, School of Community Health and Midwifery, Preston, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dooris</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>University of Central Lancashire, School of Community Health and Midwifery, Preston, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Froggett</LastName>
            <ForeName>Lynn</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>University of Central Lancashire, School of Social Work, Care and Community, Preston, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Health Promot</MedlineTA>
        <NlmUniqueID>101497462</NlmUniqueID>
        <ISSNLinking>1757-9759</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001364" MajorTopicYN="Y">Awareness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006240" MajorTopicYN="N">Happiness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006694" MajorTopicYN="N">Holistic Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007398" MajorTopicYN="Y">Interpersonal Relations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007858" MajorTopicYN="Y">Learning</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D033262" MajorTopicYN="N">Narration</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010990" MajorTopicYN="N">Pleasure-Pain Principle</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058992" MajorTopicYN="Y">Social Participation</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">case study</Keyword>
        <Keyword MajorTopicYN="N">evaluation</Keyword>
        <Keyword MajorTopicYN="N">healthy cities/healthy communities</Keyword>
        <Keyword MajorTopicYN="N">public health</Keyword>
        <Keyword MajorTopicYN="N">qualitative</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29125391</ArticleId>
        <ArticleId IdType="doi">10.1177/1757975917732352</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29110590</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>07</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1875-533X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Current medicinal chemistry</Title>
          <ISOAbbreviation>Curr Med Chem</ISOAbbreviation>
        </Journal>
        <ArticleTitle>New Strategy on Antimicrobial-resistance: Inhibitors of DNA Replication Enzymes.</ArticleTitle>
        <Pagination>
          <StartPage>1761</StartPage>
          <EndPage>1787</EndPage>
          <MedlinePgn>1761-1787</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2174/0929867324666171106160326</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antimicrobial resistance is found in all microorganisms and has become one of the biggest threats to global health. New antimicrobials with different action mechanisms are effective weapons to fight against antibiotic-resistance.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This review aims to find potential drugs which can be further developed into clinic practice and provide clues for developing more effective antimicrobials.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">DNA replication universally exists in all living organisms and is a complicated process in which multiple enzymes are involved in. Enzymes in bacterial DNA replication of initiation and elongation phases bring abundant targets for antimicrobial development as they are conserved and indispensable. In this review, enzyme inhibitors of DNA helicase, DNA primase, topoisomerases, DNA polymerase and DNA ligase were discussed. Special attentions were paid to structures, activities and action modes of these enzyme inhibitors.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among these enzymes, type II topoisomerase is the most validated target with abundant inhibitors. For type II topoisomerase inhibitors (excluding quinolones), NBTIs and benzimidazole urea derivatives are the most promising inhibitors because of their good antimicrobial activity and physicochemical properties. Simultaneously, DNA gyrase targeted drugs are particularly attractive in the treatment of tuberculosis as DNA gyrase is the sole type II topoisomerase in Mycobacterium tuberculosis. Relatively, exploitation of antimicrobial inhibitors of the other DNA replication enzymes are primeval, in which inhibitors of topo III are even blank so far.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This review demonstrates that inhibitors of DNA replication enzymes are abundant, diverse and promising, many of which can be developed into antimicrobials to deal with antibioticresistance.</AbstractText>
          <CopyrightInformation>Copyright&#xA9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yi</LastName>
            <ForeName>Lanhua</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food Science and Engineering, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>L&#xFC;</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>College of Food Science and Engineering, Northwest A&amp;F University, Yangling, Shaanxi Province 712100, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United Arab Emirates</Country>
        <MedlineTA>Curr Med Chem</MedlineTA>
        <NlmUniqueID>9440157</NlmUniqueID>
        <ISSNLinking>0929-8673</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019384">Nucleic Acid Synthesis Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D059005">Topoisomerase II Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.7.-</RegistryNumber>
          <NameOfSubstance UI="D019915">DNA Primase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.6.4.-</RegistryNumber>
          <NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 6.5.1.-</RegistryNumber>
          <NameOfSubstance UI="D011088">DNA Ligases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011088" MajorTopicYN="N">DNA Ligases</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019915" MajorTopicYN="N">DNA Primase</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004352" MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019384" MajorTopicYN="N">Nucleic Acid Synthesis Inhibitors</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059005" MajorTopicYN="N">Topoisomerase II Inhibitors</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antimicrobials</Keyword>
        <Keyword MajorTopicYN="N">DNA replication</Keyword>
        <Keyword MajorTopicYN="N">action mode</Keyword>
        <Keyword MajorTopicYN="N">activity</Keyword>
        <Keyword MajorTopicYN="N">antimicrobial resistance</Keyword>
        <Keyword MajorTopicYN="N">inhibitors.</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29110590</ArticleId>
        <ArticleId IdType="doi">10.2174/0929867324666171106160326</ArticleId>
        <ArticleId IdType="pii">CMC-EPUB-86712</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29095381</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1535-1815</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <Issue>9</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pediatric emergency care</Title>
          <ISOAbbreviation>Pediatr Emerg Care</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ventricular Tachycardia Induced by Propafenone Intoxication in a Pediatric Patient.</ArticleTitle>
        <Pagination>
          <StartPage>e164</StartPage>
          <EndPage>e168</EndPage>
          <MedlinePgn>e164-e168</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/PEC.0000000000001346</ELocationID>
        <Abstract>
          <AbstractText>Unintentional poisonings are a global health problem frequently resulting in hospital admissions. Propafenone is a class 1C antiarrhythmic drug used in the second-line management of supraventricular and ventricular arrhythmias and, when unintentionally ingested, can lead to severe and life-threatening poisoning. We describe a case of a 3-year-old male patient unintentionally ingesting 300 mg (20 mg/kg) of propafenone and presenting with ventricular tachycardia with QT prolongation. Two boli of intravenous hypertonic sodium bicarbonate (total amount of 3 mEq/kg), followed by 3-hours continuous infusion of 1 mEq kg h sodium bicarbonate, were able to restore the clinical conditions of the patient. With this case report, we aim to highlight the existing challenge in the therapeutic management of propafenone intoxication that finds intravenous hypertonic bicarbonate to be a useful tool also in pediatric population.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Rosa</LastName>
            <ForeName>Margherita</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>From the Emergency Department, Santobono Pediatric Hospital, Naples.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pappacoda</LastName>
            <ForeName>Serena</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>From the Emergency Department, Santobono Pediatric Hospital, Naples.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>D&#x2BC;Anna</LastName>
            <ForeName>Carolina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>From the Emergency Department, Santobono Pediatric Hospital, Naples.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Mita</LastName>
            <ForeName>Onorina</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>From the Emergency Department, Santobono Pediatric Hospital, Naples.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ponticiello</LastName>
            <ForeName>Eduardo</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>From the Emergency Department, Santobono Pediatric Hospital, Naples.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marzuillo</LastName>
            <ForeName>Pierluigi</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Woman, Child and of General and Specialized Surgery, Universit&#xE0; degli Studi della Campania "Luigi Vanvitelli," Via Luigi De Crecchio 2, Napoli, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tipo</LastName>
            <ForeName>Vincenzo</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>From the Emergency Department, Santobono Pediatric Hospital, Naples.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pediatr Emerg Care</MedlineTA>
        <NlmUniqueID>8507560</NlmUniqueID>
        <ISSNLinking>0749-5161</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>68IQX3T69U</RegistryNumber>
          <NameOfSubstance UI="D011405">Propafenone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>8MDF5V39QO</RegistryNumber>
          <NameOfSubstance UI="D017693">Sodium Bicarbonate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000506" MajorTopicYN="Y">poisoning</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011405" MajorTopicYN="N">Propafenone</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000506" MajorTopicYN="Y">poisoning</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017693" MajorTopicYN="N">Sodium Bicarbonate</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017180" MajorTopicYN="N">Tachycardia, Ventricular</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29095381</ArticleId>
        <ArticleId IdType="doi">10.1097/PEC.0000000000001346</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">29081237</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1469-2910</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Anthropology &amp; medicine</Title>
          <ISOAbbreviation>Anthropol Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Universal classifications, national approaches and specific situations: a comparative study on the conceptualization of nodding syndrome in Uganda and Tanzania.</ArticleTitle>
        <Pagination>
          <StartPage>177</StartPage>
          <EndPage>196</EndPage>
          <MedlinePgn>177-196</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13648470.2017.1361652</ELocationID>
        <Abstract>
          <AbstractText>This paper presents a comparative study on conceptualizations of the poorly understood nodding syndrome (NS) in Uganda and Tanzania. NS has been constructed as a biomedical category to serve global health discourse as well as national contexts of managing the condition. The paper looks into the shifting meanings and conceptualizations of NS in the affected areas of Kitgum (UG) and Mahenge (TZ) district. The perceived universality of biomedical classifications is problematized as conflicting with the specific contexts of <i>lucluc</i> and <i>kifafa cha kusinzia</i>. Reconciliation proves to be challenging, poignantly evoking the cultural construction as such of any medical condition.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>van Bemmel</LastName>
            <ForeName>Karin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of African Languages and Cultures, Ghent University , Ghent , Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van der Weegen</LastName>
            <ForeName>Kim</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cultural Anthropology, Utrecht University , Utrecht , Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>30</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Anthropol Med</MedlineTA>
        <NlmUniqueID>9709920</NlmUniqueID>
        <ISSNLinking>1364-8470</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060432" MajorTopicYN="N">Anthropology, Medical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064128" MajorTopicYN="Y">Nodding Syndrome</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013636" MajorTopicYN="N" Type="Geographic">Tanzania</DescriptorName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014454" MajorTopicYN="N" Type="Geographic">Uganda</DescriptorName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Nodding syndrome</Keyword>
        <Keyword MajorTopicYN="N">Tanzania</Keyword>
        <Keyword MajorTopicYN="N">Uganda</Keyword>
        <Keyword MajorTopicYN="N">conceptualization</Keyword>
        <Keyword MajorTopicYN="N">medical anthropology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29081237</ArticleId>
        <ArticleId IdType="doi">10.1080/13648470.2017.1361652</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">29020703</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>09</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1439-4421</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>81</Volume>
            <Issue>8-09</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))</Title>
          <ISOAbbreviation>Gesundheitswesen</ISOAbbreviation>
        </Journal>
        <ArticleTitle>[Public Health Education in Health-Related Study Programs in Germany: Perspectives from Course Coordinators].</ArticleTitle>
        <Pagination>
          <StartPage>599</StartPage>
          <EndPage>605</EndPage>
          <MedlinePgn>599-605</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0043-116940</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Public health education in Germany takes place in public health courses and in health-related study courses. We aim to provide data and knowledge on structure and content of health-related study courses and on cooperation between universities and/or Universities of Applied Sciences.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted an online-based cross-sectional study (01.6. - 15.9.2015), involving 93 universities and Universities of Applied Sciences in Germany. Herewith we addressed 351 study course coordinators. We included course coordinators from universities and Universities of Applied Sciences who were members of the German Association of Social Medicine and Prevention (DGSMP) or in the Association Universities for Health (HOGE).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">104 course coordinators responded to the survey (43% men, 57% women). Among others, global health and environmental health are primarily taught in public health courses; ethics and psychology primarily in health-related study courses. Financial support for teaching and research is highly needed at universities and at universities of applied sciences. Furthermore, there is a high need of cooperation between institutions. Additionally, course coordinators from universities of applied sciences indicated a need for cooperative doctoral programs.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In Germany, competence criteria for teaching public health are missing. Additionally, cooperation between study courses needs to be developed further.</AbstractText>
          <CopyrightInformation>&#xA9; Georg Thieme Verlag KG Stuttgart &#xB7; New York.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lindert</LastName>
            <ForeName>Jutta</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Fachbereich Soziale Arbeit und Gesundheit, Hochschule Emden-Leer, Emden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wehrwein</LastName>
            <ForeName>Annette</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Fachbereich Soziale Arbeit und Gesundheit, Hochschule Emden-Leer, Emden.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Klemperer</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Fachbereich Soziale Arbeit und Gesundheit, Ostbayerische Technische Hochschule Regensburg, Regensburg.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Walter</LastName>
            <ForeName>Ulla</ForeName>
            <Initials>U</Initials>
            <AffiliationInfo>
              <Affiliation>Institut f&#xFC;r Epidemiologie, Sozialmedizin und Gesundheitssystemforschung, Medizinische Hochschule Hannover, Hannover.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>ger</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>Lehre von Public Health in gesundheitsbezogenen Studieng&#xE4;ngen in Deutschland: die Sicht von Studiengangsverantwortlichen.</VernacularTitle>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Gesundheitswesen</MedlineTA>
        <NlmUniqueID>9204210</NlmUniqueID>
        <ISSNLinking>0941-3790</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003479" MajorTopicYN="N">Curriculum</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006266" MajorTopicYN="Y">Health Education</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014495" MajorTopicYN="Y">Universities</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText Label="HINTERGRUND" NlmCategory="UNASSIGNED">Inhalte von Public Health werden in Deutschland in gesundheitsbezogenen Studieng&#xE4;ngen an Hochschulen und Universit&#xE4;ten gelehrt. Ziel dieser Studie war es, Daten zur Lehre und zur Kooperation von Lehrenden von Public Health in gesundheitsbezogenen Studieng&#xE4;ngen in Deutschland zur Verf&#xFC;gung zu stellen.</AbstractText>
        <AbstractText Label="METHODE" NlmCategory="METHODS">Eine Querschnittsuntersuchung wurde online-basiert vom 01.06. bis 15.09.2015 an 93 Hochschulen/Universit&#xE4;ten in Deutschland mit 351 Studiengangsverantwortlichen aus gesundheitsbezogenen Studieng&#xE4;ngen durchgef&#xFC;hrt. Einbezogen wurden Public Health Studieng&#xE4;nge und gesundheitsbezogene Studieng&#xE4;nge, deren Hochschulen bzw. Universit&#xE4;ten entweder Mitglied in der &#x201E;Deutschen Gesellschaft f&#xFC;r Sozialmedizin und Pr&#xE4;vention&#x201C; (DGSMP) oder in der Gesellschaft &#x201E;Hochschulen f&#xFC;r Gesundheit&#x201C; (HOGE) sind. Teilgenommen an dieser Studie haben N=104 Studiengangsverantwortliche (43% M&#xE4;nner, 57% Frauen). In Public Health Studieng&#xE4;ngen wurden &#x201E;Global Health&#x201C; und &#x201E;Umwelt und Gesundheit&#x201C; als Studieninhalte h&#xE4;ufiger als in gesundheitsbezogenen Studieng&#xE4;ngen benannt; in gesundheitsbezogenen Studieng&#xE4;ngen wurden h&#xE4;ufiger &#x201E;Ethik&#x201C; und &#x201E;Gesundheitspsychologie&#x201C; als Lehrinhalte benannt. Finanzielle Unterst&#xFC;tzungen durch die Hochschulen/ Universit&#xE4;ten sowie strukturierte Partnerschaften zwischen Hochschulen und/ oder Universit&#xE4;ten werden von Lehrenden an Hochschulen (36%) und an Universit&#xE4;ten (40%) gew&#xFC;nscht. Lehrende an Hochschulen w&#xFC;nschen dar&#xFC;ber hinaus Promotionspartnerschaften.</AbstractText>
        <AbstractText Label="SCHLUSSFOLGERUNG" NlmCategory="UNASSIGNED">Bisher gibt es in Deutschland keine einheitlichen fachlichen Qualit&#xE4;tskriterien f&#xFC;r Absolvierende von Public Health bzw. gesundheitsbezogenen Studieng&#xE4;ngen. Zudem gibt es nach Aussage der Studiengangsverantwortlichen dieser Studieng&#xE4;nge wenig Kooperation zwischen Lehrenden der Public Health bzw. der gesundheitsbezogenen Studieng&#xE4;nge.</AbstractText>
        <CopyrightInformation>&#xA9; Georg Thieme Verlag KG Stuttgart &#xB7; New York.</CopyrightInformation>
      </OtherAbstract>
      <CoiStatement>Die Autoren geben an, dass kein Interessenkonflikt besteht.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29020703</ArticleId>
        <ArticleId IdType="doi">10.1055/s-0043-116940</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">28929421</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1559-0267</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>57</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical reviews in allergy &amp; immunology</Title>
          <ISOAbbreviation>Clin Rev Allergy Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Immunotherapy of Food Allergy: a Comprehensive Review.</ArticleTitle>
        <Pagination>
          <StartPage>55</StartPage>
          <EndPage>73</EndPage>
          <MedlinePgn>55-73</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12016-017-8647-y</ELocationID>
        <Abstract>
          <AbstractText>Food allergy imposes a severe global health burden, and thus, there is a dire need for safe and effective treatments. Allergen-specific immunotherapy (AIT) is currently the only approach to restore immune tolerance through administrating increasing doses of allergen extracts. Unfortunately, the development of AIT for food allergies has been impeded by the frequent anaphylactic side effects during the course of treatment. The emergence of component-resolved diagnosis has greatly improved our ability to identify causative allergens and revolutionized the design of AIT. Molecular features such as IgE-binding epitopes and T cell epitopes have been elucidated in most major food allergens, inspiring the use of multiple strategies to manipulate the allergens and design safer alternatives to AIT. Although these allergen-modifying approaches are currently restricted to preclinical characterization and animal studies, the employment of these strategies has certainly paved the way for improving the safety of existing AIT. A safe and effective AIT for food allergy is not far beyond reach.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wai</LastName>
            <ForeName>Christine Y Y</ForeName>
            <Initials>CYY</Initials>
            <AffiliationInfo>
              <Affiliation>Simon F.S. Li Marine Science Laboratory, School of Life Sciences, The Chinese University of Hong Kong, Room 201A, Science Park Road, Shatin, N.T., Hong Kong, SAR, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leung</LastName>
            <ForeName>Nicki Y H</ForeName>
            <Initials>NYH</Initials>
            <AffiliationInfo>
              <Affiliation>Simon F.S. Li Marine Science Laboratory, School of Life Sciences, The Chinese University of Hong Kong, Room 201A, Science Park Road, Shatin, N.T., Hong Kong, SAR, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leung</LastName>
            <ForeName>Patrick S C</ForeName>
            <Initials>PSC</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology/Allergy, School of Medicine, University of California, Davis, CA, 95616, USA. psleung@ucdavis.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, Suite 6510, Davis, CA, 95616, USA. psleung@ucdavis.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chu</LastName>
            <ForeName>Ka Hou</ForeName>
            <Initials>KH</Initials>
            <AffiliationInfo>
              <Affiliation>Simon F.S. Li Marine Science Laboratory, School of Life Sciences, The Chinese University of Hong Kong, Room 201A, Science Park Road, Shatin, N.T., Hong Kong, SAR, China. kahouchu@cuhk.edu.hk.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>02130206</GrantID>
            <Agency>Health and Medical Research Fund</Agency>
            <Country/>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Clin Rev Allergy Immunol</MedlineTA>
        <NlmUniqueID>9504368</NlmUniqueID>
        <ISSNLinking>1080-0549</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000485">Allergens</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>37341-29-0</RegistryNumber>
          <NameOfSubstance UI="D007073">Immunoglobulin E</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000485" MajorTopicYN="N">Allergens</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000707" MajorTopicYN="N">Anaphylaxis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003888" MajorTopicYN="N">Desensitization, Immunologic</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018984" MajorTopicYN="N">Epitopes, T-Lymphocyte</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005512" MajorTopicYN="N">Food Hypersensitivity</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007108" MajorTopicYN="N">Immune Tolerance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007073" MajorTopicYN="N">Immunoglobulin E</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Conjugated allergens</Keyword>
        <Keyword MajorTopicYN="N">Hypoallergen</Keyword>
        <Keyword MajorTopicYN="N">Mimotope</Keyword>
        <Keyword MajorTopicYN="N">Omalizumab</Keyword>
        <Keyword MajorTopicYN="N">T cell epitope</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>9</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>9</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28929421</ArticleId>
        <ArticleId IdType="doi">10.1007/s12016-017-8647-y</ArticleId>
        <ArticleId IdType="pii">10.1007/s12016-017-8647-y</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 1999 Aug;119(4):247-58</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10474029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 1999 Aug;119(4):265-74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10474031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2000 Sep;106(3):579-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10984381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2000 Oct;30(10):1403-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10998016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Immunol. 2000 Nov 1;165(9):4773-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11045997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>FASEB J. 2000 Nov;14(14):2177-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11053238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biosci Biotechnol Biochem. 2001 Feb;65(2):285-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11302160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):70-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11306930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):395-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11307026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>FEBS Lett. 2001 Jul 27;502(1-2):46-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11478946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Immunol Rev. 2001 Aug;182:207-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11722636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2002 Jan;127(1):27-37</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11893851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Immunol. 2002 May 1;168(9):4576-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11971005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Exp Med. 2002 Jun 3;195(11):1499-505</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12045248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2002;57 Suppl 72:84-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12144562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2002;57 Suppl 72:88-93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12144563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Immunol. 2003 Jan 1;170(1):445-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12496430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aliment Pharmacol Ther. 2003 Feb;17(3):459-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12562461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Immunol. 2003 May;33(5):1205-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12731045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CMAJ. 2003 May 13;168(10):1279-85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12743075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biosci Biotechnol Biochem. 2003 Apr;67(4):712-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12784609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2003 Jun;111(6):1406-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12789247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2003 Jul;112(1):141-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12847491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2003 Sep;112(3):599-605</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13679821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Protein Eng. 2003 Oct;16(10):747-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14600204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2003 Nov;58(11):1144-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14616125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2004 Jan;113(1):141-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14713920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 1992 Aug;90(2):256-62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1500630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 1992 Jun;47(3):218-29</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1510234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2004 May;113(5):821-30; quiz 831</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15131562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2004 Sep;59(9):980-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15291907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2004 Dec;114(6):1294-300</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15577826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2004 Dec;114(6):1410-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15577846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Nutr Food Res. 2004 Oct;48(5):356-62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15672475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Immunol. 2005 Jun;115(3):302-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15893698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Immunol. 2006 Mar;43(9):1454-61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16150491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Nutr Food Res. 2005 Oct;49(10):963-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16189800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2005 Oct;116(4):893-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16210066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2005 Nov;116(5):1073-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16275379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Nutr Food Res. 2006 Jan;50(1):18-23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16288502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rev Allergy Immunol. 2006 Feb;30(1):61-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16461997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Invest. 2006 Mar;116(3):833-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16498503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2006 Mar;36(3):303-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16499640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc Natl Acad Sci U S A. 2006 May 16;103(20):7783-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16672373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2006 Oct;61(10):1238-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16942579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2006 Oct;118(4):915-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17030246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 2006 Nov 17;314(5802):1157-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17110582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2007 Feb;119(2):507-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17125821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2007 Jan;119(1):199-205</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17208602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2007 Apr;119(4):944-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17292955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Immunol. 2007 May 15;178(10):6290-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17475857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2007;144(1):23-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17496423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2007 Jul;120(1):76-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17531298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Exp Med. 2007 Aug 6;204(8):1757-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17620361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Immunol. 2007 Oct 15;179(8):5309-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17911617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2008 Feb;121(2):368-374.e1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18036651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2008 Feb;121(2):343-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18158176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2008;146(2):91-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18204275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pediatr Allergy Immunol. 2008 Aug;19(5):399-407</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18221468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Immunol. 2008 Apr;45(8):2269-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18242709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2008 Apr;63(4):479-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18315737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Allergy Asthma Immunol. 2008 Mar;100(3):283-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18429351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2008;147(4):305-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18617750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Nutr Food Res. 2008 Nov;52 Suppl 2:S262-71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18686294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2008 Oct;122(4):795-802</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18760458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>G Ital Dermatol Venereol. 2008 Apr;143(2):95-104</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18833036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2008 Nov;122(5):977-983.e1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18851876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2008 Dec;122(6):1154-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18951617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem Biophys Res Commun. 2009 Jan 9;378(2):203-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19022223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Immunol. 2009 Feb;46(4):722-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19054565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2009 Jun;64(6):876-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19183164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2009 Aug;64(8):1218-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19226304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Agric Food Chem. 2009 Mar 25;57(6):2241-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19231857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2009 Apr;123(4):735-46; quiz 747-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19348912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2009 Jul;124(1):100-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19356790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2009 Jul;124(1):114-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19523674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2009 Aug;124(2):292-300, 300.e1-97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19577283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2009 Sep;39(9):1427-37</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19624524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2009 Sep;124(3):610-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19665770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2009 Oct;124(4):771-8.e5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19665774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2009 Nov;124(5):997-1002</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19733905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2010 Apr;40(4):650-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19958367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2010 Apr;40(4):668-78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20082619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergol Int. 2010 Jun;59(2):175-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20179418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2010;153(1):1-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20357479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Immunology. 2010 Jul;130(3):319-28</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20408898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2010 May;125(5):1165-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20451043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2010 Jun;125(6):1279-1285.e9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20466413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nat Med. 2010 Oct;16(10):1128-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20835248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Allergy Asthma Immunol. 2010 Nov;105(5):376-81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21055664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2011 Mar;127(3):608-15.e1-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21093025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Agric Food Chem. 2011 Jan 12;59(1):458-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21142203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2011 Jan;127(1):18-27; quiz 28-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21211639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Investig Allergol Clin Immunol. 2010;20(6):514-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21243936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2011 Mar;127(3):640-6.e1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21281959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2011 Mar;127(3):654-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21377034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2011 Apr;127(4):990-7.e1-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21377717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Immunol. 2011 May 15;186(10):5629-37</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21490160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Top Microbiol Immunol. 2011;352:107-19</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21567311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2011 Nov;128(5):1022-30.e1-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21571358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2011 Oct;41(10):1346-59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21623967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Immunol. 2011 Sep;48(15-16):1983-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21784530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2011 Dec;128(6):1340-1348.e12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21872305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2012 Jan;67(1):74-82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21950267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18049-54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22006331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Agric Food Chem. 2011 Dec 28;59(24):13195-202</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22106958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Dev Immunol. 2012;2012:623474</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22110534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2012;157(4):323-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22123204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2012 Feb;129(2):448-55, 455.e1-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22130425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Transl Allergy. 2012 Mar 09;2(1):5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22409908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Food Chem Toxicol. 2012 Aug;50(8):2675-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22449541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Invest. 2012 May;122(5):1700-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22523067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS One. 2012;7(5):e37156</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22629361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2012 Sep;130(3):716-23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22795369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2012 Jul 19;367(3):233-43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22808958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acta Paediatr. 2013 Feb;102(2):172-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22897785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Transl Allergy. 2012 Nov 12;2(1):22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23140259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2012 Dec;42(12):1801-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23181796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2013 Jan;131(1):213-21.e1-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23199607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arthritis Res Ther. 2012 Nov 30;14(6):228</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23210525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rev Allergy Immunol. 2014 Jun;46(3):225-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23229594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rev Allergy Immunol. 2014 Jun;46(3):180-97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23242979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2013 Jan;131(1):14-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23265693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2013 Jan;131(1):119-27.e1-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23265698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Allergy Organ J. 2010 Apr;3(4):57-161</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23268426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2013 Jan;43(1):116-27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23278886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2013 Jun;43(6):684-97</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23711131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pediatr Allergy Immunol. 2013 Aug;24(5):450-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23773122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2013 Jul;43(7):811-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23786287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2013 Oct;132(4):906-11.e1-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23791510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2013 Sep;132(3):737-739.e6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23806635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Methods. 2014 Mar 1;66(1):34-43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23911839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Methods. 2014 Mar 1;66(1):22-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23954566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Curr Opin Immunol. 2013 Dec;25(6):781-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23972904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Nutr Food Res. 2014 Feb;58(2):394-404</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23983060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hum Immunol. 2013 Dec;74(12):1542-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23993987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pediatr Allergy Immunol. 2013 Nov;24(7):656-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24028387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Nutr Food Res. 2014 Feb;58(2):405-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24124125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 2014 Mar;69(3):338-47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24354793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2014 Feb;133(2):291-307; quiz 308</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24388012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 2014 Apr 12;383(9925):1297-304</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24485709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ACS Nano. 2014 Mar 25;8(3):2148-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24559284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2014 Feb;133(2):500-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24636474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2014 Jun;44(6):867-81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24666588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Agric Food Chem. 2014 Jul 23;62(29):7010-21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24758688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2014;163(4):292-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24777233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rev Allergy Immunol. 2015 Oct;49(2):203-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24870065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2015 Feb;45(2):368-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25077670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PLoS One. 2014 Nov 03;9(11):e111649</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25365343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastroenterology. 2015 May;148(6):1132-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25633563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gastroenterology. 2015 May;148(6):1120-31.e4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25680669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):532-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25725940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2015;166(1):41-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25765512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2015 Jun;45(6):1015-26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25900315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Expert Rev Mol Diagn. 2015;15(7):895-906</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25975845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy Asthma Proc. 2015 May-Jun;36(3):185-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25976435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2015 Jul;136(1):125-134.e12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25985925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2015 Nov;136(5):1295-301.e1-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26037551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rev Allergy Immunol. 2016 Feb;50(1):84-96</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26048266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rev Allergy Immunol. 2016 Apr;50(2):175-88</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26054822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2015;167(1):29-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26112225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2015 Dec;136(6):1601-1606</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26194541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cell Mol Immunol. 2017 Mar;14(3):308-318</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26364917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2016 Apr;137(4):1103-1110.e11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26581915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Exp Allergy. 2016 Mar;46(3):491-503</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26610061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mol Immunol. 2016 Mar;71:152-160</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26897338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2016 Jun;137(6):1681-1696</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27090934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2016 Aug;138(2):536-543.e4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27130858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 1989 May;83(5):900-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2715549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2017 Jan;139(1):189-201.e4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27417020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2017 Mar;139(3):873-881.e8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27609658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Invest. 2016 Oct 3;126(10):4030-4044</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27643438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2017 Jun;139(6):1897-1905.e1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27876628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 2017 Oct;140(4):1043-1053.e8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28414061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 2017;174(2):86-96</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29065408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Allergy. 1973 Sep;3(3):255-61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4778072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Appl Immunol. 1969;36(1):152-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4980287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Appl Immunol. 1970;38(5):536-48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4986154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem Biophys Res Commun. 1993 Nov 15;196(3):1086-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7504464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Invest. 1995 Oct;96(4):1715-21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7560062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 1995 Jul 13;376(6536):177-80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7603570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plant Cell. 1995 Jul;7(7):945-56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7640527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Immunol. 1993 Nov 15;151(10):5354-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7693809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Int Arch Allergy Immunol. 1994 Sep;105(1):49-55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7916224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 1994 Nov;94(5):882-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7963157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 1994 Jun;93(6):1047-59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8006309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 1996 Nov;98(5 Pt 1):954-61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8939159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Biochem. 1997 Apr 15;245(2):334-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9151961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arch Biochem Biophys. 1997 Jun 15;342(2):244-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9186485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 1997 Jun;99(6 Pt 1):744-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9215240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):67-74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9449503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Biol Chem. 1998 May 29;273(22):13753-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9593717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Allergy Clin Immunol. 1998 Jul;102(1):127-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9679856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>FASEB J. 1998 Dec;12(15):1635-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9837853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allergy. 1998 Nov;53(11):1013-22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9860234</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">28832243</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>10</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-9767</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global health promotion</Title>
          <ISOAbbreviation>Glob Health Promot</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A systematic review of portable electronic technology for health education in resource-limited settings.</ArticleTitle>
        <Pagination>
          <StartPage>70</StartPage>
          <EndPage>81</EndPage>
          <MedlinePgn>70-81</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1757975917715035</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE">The objective of this study is to conduct a systematic review of the literature of how portable electronic technologies with offline functionality are perceived and used to provide health education in resource-limited settings.</AbstractText>
          <AbstractText Label="METHODS">Three reviewers evaluated articles and performed a bibliography search to identify studies describing health education delivered by portable electronic device with offline functionality in low- or middle-income countries. Data extracted included: study population; study design and type of analysis; type of technology used; method of use; setting of technology use; impact on caregivers, patients, or overall health outcomes; and reported limitations.</AbstractText>
          <AbstractText Label="RESULTS">Searches yielded 5514 unique titles. Out of 75 critically reviewed full-text articles, 10 met inclusion criteria. Study locations included Botswana, Peru, Kenya, Thailand, Nigeria, India, Ghana, and Tanzania. Topics addressed included: development of healthcare worker training modules, clinical decision support tools, patient education tools, perceptions and usability of portable electronic technology, and comparisons of technologies and/or mobile applications. Studies primarily looked at the assessment of developed educational modules on trainee health knowledge, perceptions and usability of technology, and comparisons of technologies. Overall, studies reported positive results for portable electronic device-based health education, frequently reporting increased provider/patient knowledge, improved patient outcomes in both quality of care and management, increased provider comfort level with technology, and an environment characterized by increased levels of technology-based, informal learning situations. Negative assessments included high investment costs, lack of technical support, and fear of device theft.</AbstractText>
          <AbstractText Label="CONCLUSIONS">While the research is limited, portable electronic educational resources present promising avenues to increase access to effective health education in resource-limited settings, contingent on the development of culturally adapted and functional materials to be used on such devices.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>McHenry</LastName>
            <ForeName>Megan S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>1. Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2. Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fischer</LastName>
            <ForeName>Lydia J</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>1. Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2. Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chun</LastName>
            <ForeName>Yeona</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>1. Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vreeman</LastName>
            <ForeName>Rachel C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>1. Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>2. Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>3. Moi University, College of Health Sciences, School of Medicine, Department of Child Health and Paediatrics, Eldoret, Kenya.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>08</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Health Promot</MedlineTA>
        <NlmUniqueID>101497462</NlmUniqueID>
        <ISSNLinking>1757-9759</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001902" MajorTopicYN="N" Type="Geographic">Botswana</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002983" MajorTopicYN="N">Clinical Competence</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006266" MajorTopicYN="N">Health Education</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
          <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName>
          <QualifierName UI="Q000193" MajorTopicYN="Y">education</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006295" MajorTopicYN="Y">Health Resources</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007630" MajorTopicYN="N" Type="Geographic">Kenya</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010568" MajorTopicYN="N" Type="Geographic">Peru</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011204" MajorTopicYN="N">Poverty Areas</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013636" MajorTopicYN="N" Type="Geographic">Tanzania</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013785" MajorTopicYN="N" Type="Geographic">Thailand</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">community-based research / participatory research</Keyword>
        <Keyword MajorTopicYN="N">e-health</Keyword>
        <Keyword MajorTopicYN="N">education (including health education)</Keyword>
        <Keyword MajorTopicYN="N">global health / globalization</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28832243</ArticleId>
        <ArticleId IdType="doi">10.1177/1757975917715035</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">28786746</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>27</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-9767</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global health promotion</Title>
          <ISOAbbreviation>Glob Health Promot</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Happier countries, longer lives: an ecological study on the relationship between subjective sense of well-being and life expectancy.</ArticleTitle>
        <Pagination>
          <StartPage>36</StartPage>
          <EndPage>40</EndPage>
          <MedlinePgn>36-40</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1757975917714035</ELocationID>
        <Abstract>
          <AbstractText>The relationship between sense of well-being and longevity is not well-established across populations of varying levels of socioeconomic status. We sought to examine the relationship between happiness, or subjective sense of well-being and life expectancy using data from 151 countries. This analysis is based on the 2012 Happy Planet Index project conducted by the Center of Well-Being of the New Economics Foundation, based in the United Kingdom. Well-being data for each country were taken from responses to the 'Ladder of Life' question in the 2012 Gallup World Poll in which participants were asked to rate their quality of life on a scale from 1 (worst possible life) to 10 (best possible life). Life expectancy and gross domestic product data were taken from the 2011 United Nations records. Ecological footprint data were taken from Global Footprint Network records. Subjective sense of well-being was highly correlated with life expectancy (Pearson correlation <i>r</i> = 0.71, <i>p</i> &lt; 0.0001). In a multivariable linear regression model adjusted for gross domestic product, ecological footprint, and population, each 1 unit of the well-being scale was associated with an increase in life expectancy of 4.0 years (95% confidence interval = 2.7-5.3). In conclusion, better sense of well-being has a strong relationship with life expectancy regardless of economic status or population size, suggesting that governments should foster happiness in order to support long-living populations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Evans</LastName>
            <ForeName>Grahame F</ForeName>
            <Initials>GF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Soliman</LastName>
            <ForeName>Elsayed Z</ForeName>
            <Initials>EZ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>08</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Health Promot</MedlineTA>
        <NlmUniqueID>101497462</NlmUniqueID>
        <ISSNLinking>1757-9759</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058572" MajorTopicYN="N">Carbon Footprint</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019049" MajorTopicYN="N">Developed Countries</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059026" MajorTopicYN="N">Diagnostic Self Evaluation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017753" MajorTopicYN="N">Ecosystem</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005843" MajorTopicYN="N">Geography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006240" MajorTopicYN="Y">Happiness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008017" MajorTopicYN="Y">Life Expectancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012647" MajorTopicYN="N">Self-Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012923" MajorTopicYN="N">Social Class</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ecological studies</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">happiness</Keyword>
        <Keyword MajorTopicYN="N">quality of life</Keyword>
        <Keyword MajorTopicYN="N">subjective well-being</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>8</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28786746</ArticleId>
        <ArticleId IdType="doi">10.1177/1757975917714035</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">28704137</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>11</Month>
        <Day>27</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-9767</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Global health promotion</Title>
          <ISOAbbreviation>Glob Health Promot</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Uruguayan secondary school students speak up about tobacco: results from focus group discussions in and around Montevideo.</ArticleTitle>
        <Pagination>
          <StartPage>15</StartPage>
          <EndPage>24</EndPage>
          <MedlinePgn>15-24</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1757975917703302</ELocationID>
        <Abstract>
          <AbstractText>This qualitative research study investigated intrapersonal, interpersonal, and environmental factors that shape young adolescent tobacco use behaviors in Uruguay. Focus groups were conducted in the summer of 2012 and fall of 2013 in four secondary schools in Montevideo, Uruguay, including two private schools and two public schools. A total of four focus groups were led in each school, composed of 4-6 students each, 16 focus groups in total. Data analysis utilized NVivo software and included deductive and inductive content analysis. Overwhelmingly, students reported that the onset of smoking occurred in the second year of secondary school. The primary intrapersonal factors that were found to be universal among respondents identified that smoking was a performance in groups, to garner attention from their peers. Students interviewed most often stated that the greatest interpersonal factors for smoking were to look older, as a rite of passage, and for group membership. Environmental factors cited most often indicate that they smoked during unsupervised time, either at night or around the short Uruguayan school day. Focus group interviews revealed that adolescents had easy access to cigarettes for purchase through small family owned grocery stores, even though laws exist preventing the sale of cigarettes to minors. Few differences were cited between strata related to cigarette use in adolescents. The differences that do exist are most apparent across gender, though there were a few observed differences when stratified by public and private school. Findings from this study indicate that key factors across ecological levels (intrapersonal, interpersonal, and environmental) should be taken into consideration when designing tobacco prevention programs for youth in Uruguay. A multiple-component approach which addresses risk factors at all of these levels, implemented in schools, may be particularly well-suited to this setting.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peterson</LastName>
            <ForeName>Erin</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>1. University of Texas Health Science Center - School of Public Health, Austin Regional Campus, Austin, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harrell</LastName>
            <ForeName>Melissa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>1. University of Texas Health Science Center - School of Public Health, Austin Regional Campus, Austin, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Springer</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>1. University of Texas Health Science Center - School of Public Health, Austin Regional Campus, Austin, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Medina</LastName>
            <ForeName>Jos&#xE9;</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>1. University of Texas Health Science Center - School of Public Health, Austin Regional Campus, Austin, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martinez</LastName>
            <ForeName>Luc&#xED;a</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>2. Centro de Investigaci&#xF3;n de la Epidemia de Tabaquismo, Montevideo, Uruguay.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Perry</LastName>
            <ForeName>Cheryl</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>1. University of Texas Health Science Center - School of Public Health, Austin Regional Campus, Austin, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Estol</LastName>
            <ForeName>Diego</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>2. Centro de Investigaci&#xF3;n de la Epidemia de Tabaquismo, Montevideo, Uruguay.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 DA035157</GrantID>
            <Acronym>DA</Acronym>
            <Agency>NIDA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>07</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Glob Health Promot</MedlineTA>
        <NlmUniqueID>101497462</NlmUniqueID>
        <ISSNLinking>1757-9759</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014028">Tobacco Smoke Pollution</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000294" MajorTopicYN="Y">Adolescent Behavior</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010379" MajorTopicYN="N">Peer Group</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012574" MajorTopicYN="N">Schools</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013334" MajorTopicYN="Y">Students</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="N">Tobacco Products</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014028" MajorTopicYN="N">Tobacco Smoke Pollution</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014583" MajorTopicYN="N" Type="Geographic">Uruguay</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adolescents &amp; youth</Keyword>
        <Keyword MajorTopicYN="N">gender</Keyword>
        <Keyword MajorTopicYN="N">global health/globalization</Keyword>
        <Keyword MajorTopicYN="N">health promotion</Keyword>
        <Keyword MajorTopicYN="N">public health</Keyword>
        <Keyword MajorTopicYN="N">qualitative</Keyword>
        <Keyword MajorTopicYN="N">socioeconomic status</Keyword>
        <Keyword MajorTopicYN="N">tobacco</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of Conflicting Interests. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>7</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>7</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28704137</ArticleId>
        <ArticleId IdType="mid">NIHMS926952</ArticleId>
        <ArticleId IdType="pmc">PMC5748367</ArticleId>
        <ArticleId IdType="doi">10.1177/1757975917703302</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Blanco-Marquizo A, Goja B, Peruga A, Jones MR, Yuan J, Samet JM, et al. Reduction of secondhand tobacco smoke in public places following national smoke-free legislation in Uruguay. Tob Control. 2010;19:231&#x2013;234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20501496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abascal W, Esteves E, Goja B, Gonzalez Mora F, Lorenzo A, Sica A, et al. Tobacco control campaign in Uruguay: a population-based trend analysis. Lancet. 2012;380:1575&#x2013;1582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22981904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grana R, Benowitz N, Glantz SA. Background Paper on E-cigarettes (Electronic Nicotine Delivery Systems) San Francisco, CA: Center for Tobacco Control Research and Education; 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Global health observatory data repository. Geneva: World Health Organization; 2016.  [accessed 20 November 2016].  Available from:  apps.who.int/ghodata.</Citation>
        </Reference>
        <Reference>
          <Citation>NPR. Philip Morris sues Uruguay over graphic cigarette packaging. NPR; 2015.  [accessed 8 March 2016].  Available from:  http://www.npr.org/sections/goatsandsoda/2014/09/15/345540221/philip-morris-sues-uruguay-over-graphic-cigarette-packaging.</Citation>
        </Reference>
        <Reference>
          <Citation>Davies W.  Michael Bloomberg fights Big Tobacco in Uruguay. BBC News; 2015.  [accessed 8 March 2016].  Available from:  http://www.bbc.com/news/world-latin-america-32199250.</Citation>
        </Reference>
        <Reference>
          <Citation>Castaldi M, Esposito A. Phillip Morris loses tough-on-tobacco lawsuit in Uruguay.  [accessed 9 September 2016];Reuters. 2016  Available from:  http://www.reuters.com/article/us-pmi-uruguay-lawsuit-idUSKCN0ZO2LZ.</Citation>
        </Reference>
        <Reference>
          <Citation>Junta Nacional de Drogas y Observatorio Uruguayo de Drogas. Sexta Encuesta Nacional sobre Consumo de Drogas en Estudiantes de Ense&#xF1;anza Media. Uruguay: Junta Nacional de Drogas y Observatorio Uruguayo de Drogas; 2014.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. WHO report on the global tobacco epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013.  [accessed 9 September 2016].  Available from:  http://www.who.int/tobacco/global_report/2013/en/</Citation>
        </Reference>
        <Reference>
          <Citation>National Institute on Drug Abuse. Tobacco/nicotine. Bethesda, MD: National Institute on Drug Abuse; 2014.  [accessed 23 February 2016].  Available from:  https://www.drugabuse.gov/drugs-abuse/tobacco-nicotine.</Citation>
        </Reference>
        <Reference>
          <Citation>Olivera G.  Uruguay (ages 13&#x2013;15) global youth tobacco survey (GYTS) fact sheet. Pan American Health Organization; 2007.  [accessed 19 July 2016].  Available from:  http://www1.paho.org/hq/dmdocuments/2010/2007%20Uruguay%20GYTS%20Factsheet%20(Ages%2013-15).pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>McDaniel PA, Smith EA, Malone RE. The tobacco endgame: a qualitative review and synthesis. Tob Control. 2016;25:594&#x2013;604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5036259</ArticleId>
            <ArticleId IdType="pubmed">26320149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauer PA, Akiba M, Wilkerson SB, Apthorp HS, Snow D, Martin-Glenn ML. Out-of-school-time programs: a meta-analysis of effects for at-risk students. Rev Edu Res. 2006;76:275&#x2013;313.</Citation>
        </Reference>
        <Reference>
          <Citation>Menezes AM, Hallal PC, Horta BL. Early determinants of smoking in adolescence: a prospective birth cohort study. Cadernos Sa&#xFA;de P&#xFA;blica. 2007;23:347&#x2013;354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17221084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greene K, Banerjee SC. Examining unsupervised time with peers and the role of association with delinquent peers on adolescent smoking. Nicotine Tob Res. 2009;11:371&#x2013;380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7297257</ArticleId>
            <ArticleId IdType="pubmed">19307446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durlak JA, Weissberg RP. The Impact of After-School Programs that Promote Personal and Social Skills. Chicago, IL: Collaborative for Academic, Social, and Emotional Learning (NJ1); 2007.</Citation>
        </Reference>
        <Reference>
          <Citation>US Department of Health and Human Services, Public Health Service, Office of the Surgeon General. Preventing Tobacco use among Youth and Young Adults: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Lule E, Rosen JE, Sing S. Adolescent health programs. In: Jamison DT, Breman JG, Measham AR, editors. Disease Control Priorities in Developing Countries. 2. Washington, DC: The International Bank for Reconstruction and Development, The World Bank, Oxford University; 2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21250309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>EDC: Learning Transforms Lives. HHD&#x2019;s youth tobacco control initiative in Latin America. HHD; 2005.  [accessed 9 September 2016].  Available from:  http://hhd.org/resources/story/hhds-youth-tobacco-control-initiative-latin-america.</Citation>
        </Reference>
        <Reference>
          <Citation>Malcon MC, Menezes AMB, Assun&#xE7;&#xE3;o MCF, Neutzling MB, Challal P. Efetividade de uma interven&#xE7;&#xE3;o educacional em tabagismo entre adolescentes escolares. Rev Bras Epidemiol. 2011;14:63&#x2013;72.</Citation>
        </Reference>
        <Reference>
          <Citation>Gaete J, Ort&#xFA;zar C, Zitko P, Montgomery A, Araya R. Influence of school-related factors on smoking among Chilean adolescents: a cross-sectional multilevel study. BMC Pediatr. 2016;16:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4901418</ArticleId>
            <ArticleId IdType="pubmed">27282769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez ZM, Opaleye ES, Martins SS, Ahluwalia JS, Noto AR. Adolescent gender differences in the determinants of tobacco smoking: a cross sectional survey among high school students in S&#xE3;o Paulo. BMC Public Health. 2010;10:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3004838</ArticleId>
            <ArticleId IdType="pubmed">21129177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horner P, Grogan-Kaylor A, Delva J, Bares CB, Andrade F, Castillo M. The association of family and peer factors with tobacco, alcohol, and marijuana use among Chilean adolescents in neighborhood context. Subst Abuse Rehabil. 2011;2:163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3249750</ArticleId>
            <ArticleId IdType="pubmed">22224067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lorenzo-Blanco EI, Bares C, Delva J. Correlates of Chilean adolescents&#x2019; negative attitudes toward cigarettes: the role of gender, peer, parental, and environmental factors. Nicotine Tob Res. 2012;14:142&#x2013;152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3276218</ArticleId>
            <ArticleId IdType="pubmed">22157230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozer EJ, Fernald LCH. Alcohol and tobacco use among rural Mexican adolescents: Individual, familial, and community level factors. J Adolesc Health. 2008;43:498&#x2013;505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18848679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry CL, Stigler MH, Arora M, Reddy KS. Prevention in translation: tobacco use prevention in India. Health Promot Pract. 2008;9:378&#x2013;386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16861597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry CL. Creating health behavior change: how to develop community-wide programs for youth. Thousand Oaks, CA: Sage; 1999.</Citation>
        </Reference>
        <Reference>
          <Citation>NIH. International Tobacco and Health Research and Capacity Building Program (TOBAC) Bethesda, MD: Fogarty International Center; 2015.  [accessed 16 February 2016].  Available from:  http://www.fic.nih.gov/programs/Pages/tobacco.aspx.</Citation>
        </Reference>
        <Reference>
          <Citation>Redmond R, Curtis E. Focus groups: principles and process. Nurse Res. 2009;16:57&#x2013;69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19425401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McAlister AL, Perry CL, Parcel GS. How individuals, environments, and health behaviors interact. Health Behav. 2008:169.</Citation>
        </Reference>
        <Reference>
          <Citation>Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice. Hoboken, NJ: John Wiley &amp; Sons; 2008.</Citation>
        </Reference>
        <Reference>
          <Citation>QSR International. NVivo Qualitative Data Analysis Software. 10. QSR International Pty Ltd; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Leech NL, Onwuegbuzie AJ. Beyond constant comparison qualitative data analysis: using NVivo. School Psychol Quart. 2011;26:70.</Citation>
        </Reference>
        <Reference>
          <Citation>Onwuegbuzie AJ, Dickinson WB, Leech NL, Zoran AG. A qualitative framework for collecting and analyzing data in focus group research. Int J Qual Methods. 2009;8:1&#x2013;21.</Citation>
        </Reference>
        <Reference>
          <Citation>US Department of Health and Human Services, Office of Adolescent Health. Risk &amp; Protective Factors. US Department of Health and Human Services, Office of Adolescent Health; 2016.  [accessed 9 September 2016].  Available from:  http://www.hhs.gov/ash/oah/adolescent-health-topics/substance-abuse/tobacco/risk-and-protective-factors.html.</Citation>
        </Reference>
        <Reference>
          <Citation>Menezes AM, Goncalves H, Anselmi L, Hallal PC, Araujo CL. Smoking in early adolescence: evidence from the 1993 Pelotas (Brazil) Birth Cohort Study. J Adolesc Health. 2006;39:669&#x2013;677.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17046503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ussery EN. Master&#x2019;s thesis/doctoral dissertation. The University of Texas School of Public Health; 2015. Investigating the relation between physical activity and cigarette smoking: a longitudinal analysis from the United States and a pilot test of a structured afterschool program in Uruguay.</Citation>
        </Reference>
        <Reference>
          <Citation>Guilamo-Ramos V, Dittus P, Holloway I, Bouris A, Crossett L. An integrated framework for the analysis of adolescent cigarette smoking in middle school Latino youth. Youth Soc. 2011;43:193&#x2013;224.</Citation>
        </Reference>
        <Reference>
          <Citation>Pallonen UE, Prochaska JO, Velicer WF, Prokhorov AV, Smith NF. Stages of acquisition and cessation for adolescent smoking: an empirical integration. Addict Behav. 1998;23:303&#x2013;324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9668929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cortes M, Schiaffino A, Marti M, Fernandez E. Cognitive factors associated with smoking initiation in adolescents. Gac Sanit. 2005;19:36&#x2013;44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15745667</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">28535285</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1758-5341</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>59</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Gerontologist</Title>
          <ISOAbbreviation>Gerontologist</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Delayed Hospital Discharges of Older Patients: A Systematic Review on Prevalence and Costs.</ArticleTitle>
        <Pagination>
          <StartPage>e86</StartPage>
          <EndPage>e97</EndPage>
          <MedlinePgn>e86-e97</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/geront/gnx028</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE OF THE STUDY">To determine the prevalence of delayed discharges of elderly inpatients and associated costs.</AbstractText>
          <AbstractText Label="DESIGN AND METHODS">We searched Medline, Embase, Global Health, CAB Abstracts, Econlit, Web of Knowledge, EBSCO - CINAHL, The Cochrane Library, Health Management Information Consortium, and SCIE - Social Care Online for evidence published between 1990 and 2015 on number of days or proportion of delayed discharges for elderly inpatients in acute hospitals. Descriptive and regression analyses were conducted. Data on proportions of delayed discharges were pooled using a random effects logistic model and the association of relevant factors was assessed. Mean costs of delayed discharge were calculated in USD adjusted for Purchasing Power Parity (PPP).</AbstractText>
          <AbstractText Label="RESULTS">Of 64 studies included, 52 (81.3%) reported delayed discharges as proportions of total hospital stay and 9 (14.1%) estimated the respective costs for these delays. Proportions of delayed discharges varied widely, from 1.6% to 91.3% with a weighted mean of 22.8%. This variation was also seen in studies from the same country, for example, in the United Kingdom, they ranged between 1.6% and 60.0%. No factor was found to be significantly associated with delays. The mean costs of delayed discharge also varied widely (between 142 and 31,935 USD PPP adjusted), reflecting the variability in mean days of delay per patient.</AbstractText>
          <AbstractText Label="IMPLICATIONS">Delayed discharges occur in most countries and the associated costs are significant. However, the variability in prevalence of delayed discharges and available data on costs limit our knowledge of the full impact of delayed discharges. A standardization of methods is necessary to allow comparisons to be made, and additional studies are required-preferably by disease area-to determine the postdischarge needs of specific patient groups and the estimated costs of delays.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2017. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Landeiro</LastName>
            <ForeName>Filipa</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roberts</LastName>
            <ForeName>Kenny</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gray</LastName>
            <ForeName>Alastair Mcintosh</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leal</LastName>
            <ForeName>Jos&#xE9;</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Gerontologist</MedlineTA>
        <NlmUniqueID>0375327</NlmUniqueID>
        <ISSNLinking>0016-9013</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017048" MajorTopicYN="Y">Health Care Costs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Costs</Keyword>
        <Keyword MajorTopicYN="N">Delayed discharge</Keyword>
        <Keyword MajorTopicYN="N">Older people</Keyword>
        <Keyword MajorTopicYN="N">Prevalence</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2016</Year>
          <Month>9</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28535285</ArticleId>
        <ArticleId IdType="doi">10.1093/geront/gnx028</ArticleId>
        <ArticleId IdType="pii">3850587</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">28353120</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1573-0387</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>52</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of the history of biology</Title>
          <ISOAbbreviation>J Hist Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Molecular Basis of Evolution and Disease: A Cold War Alliance.</ArticleTitle>
        <Pagination>
          <StartPage>325</StartPage>
          <EndPage>346</EndPage>
          <MedlinePgn>325-346</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10739-017-9476-9</ELocationID>
        <Abstract>
          <AbstractText>This paper extends previous arguments against the assumption that the study of variation at the molecular level was instigated with a view to solving an internal conflict between the balance and classical schools of population genetics. It does so by focusing on the intersection of basic research in protein chemistry and the molecular approach to disease with the enactment of global health campaigns during the Cold War period. The paper connects advances in research on protein structure and function as reflected in Christian Anfinsen's The molecular basis of evolution, with a political reading of Emil&#xE9; Zuckerkandl and Linus Pauling's identification of molecular disease and evolution. Beyond atomic fallout, these advances constituted a rationale for the promotion of genetic surveys of human populations in the Third World, in connection with international health programs. Light is shed not only on the experimental roots of the molecular challenge but on the broader geopolitical context where the rising role of biomedicine and public health (particularly the malaria eradication campaigns) had an impact on evolutionary biology.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Su&#xE1;rez-D&#xED;az</LastName>
            <ForeName>Edna</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Departamento de Biolog&#xED;a Evolutiva, Facultad de Ciencias, Universidad Nacional Aut&#xF3;noma de M&#xE9;xico (UNAM), Av. Universidad 3000 Copilco, Coyoac&#xE1;n, 04510, Mexico City, Mexico. ednasuarez@ciencias.unam.mx.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>152879</GrantID>
            <Agency>Consejo Nacional de Ciencia y Tecnolog&#xED;a (MX)</Agency>
            <Country>International</Country>
          </Grant>
          <Grant>
            <GrantID>IN400314</GrantID>
            <Agency>Programa de Apoyo a Proyectos de Investigaci&#xF3;n e Innovaci&#xF3;n Tecnol&#xF3;gica (UNAM)</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>J Hist Biol</MedlineTA>
        <NlmUniqueID>0202503</NlmUniqueID>
        <ISSNLinking>0022-5010</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>J Hist Biol. 2019 Jun;52(2):347. doi: 10.1007/s10739-017-9479-6.</RefSource>
          <PMID Version="1">28493180</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Christian Anfinsen</Keyword>
        <Keyword MajorTopicYN="N">Emil&#xE9; Zuckerkandl</Keyword>
        <Keyword MajorTopicYN="N">G6PD deficiencies</Keyword>
        <Keyword MajorTopicYN="N">Linus Pauling</Keyword>
        <Keyword MajorTopicYN="N">Malaria eradication campaigns</Keyword>
        <Keyword MajorTopicYN="N">Medical chemistry</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28353120</ArticleId>
        <ArticleId IdType="doi">10.1007/s10739-017-9476-9</ArticleId>
        <ArticleId IdType="pii">10.1007/s10739-017-9476-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hist Philos Life Sci. 1998;20(2):189-214</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10326332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 1999 Nov 19;286(5444):1488-90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10610548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 1972 Fall;5(2):205-57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11610121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 1996 Fall;29(3):361-86</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11618362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 1998 Spring;31(1):85-111</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11619919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 1998 Summer;31(2):155-78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11620303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 1992 Summer;25(2):231-55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11623042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 1992 Spring;25(1):1-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11623198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 1999 Autumn;32(2):321-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11624208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 1994 Spring;27(1):21-59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11639258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Med Genet. 2002 Aug 30;115(2):83-93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12400054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biophys Chem. 2003;100(1-3):109-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12646356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 1956 Sep 14;124(3220):484-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13360274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 1956 Oct 13;178(4537):792-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13369537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Am Med Assoc. 1957 Oct 19;165(7):835-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13462859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc Natl Acad Sci U S A. 1961 Sep 15;47:1309-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13683522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc Natl Acad Sci U S A. 1963 Oct;50:672-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14077496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Hum Genet. 1965 Mar;17:179-87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14262135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hist Philos Life Sci. 2002;24(3-4):441-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15045833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Science. 1949 Nov 25;110(2865):543-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15395398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 2006 Winter;39(4):707-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17575956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 2007 Spring;40(1):147-77</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17993170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 2008 Fall;41(3):473-528</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19244721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 2009 Fall;42(3):495-527</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20027785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 2010 Winter;43(4):623-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20665074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 2010 Winter;43(4):697-725</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20665076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stud Hist Philos Biol Biomed Sci. 2014 Sep;47 Pt A:97-107</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24954151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stud Hist Philos Biol Biomed Sci. 2014 Sep;47 Pt A:108-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25022488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hist Biol. 2014 Fall;47(3):443-78</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25574534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochim Biophys Acta. 1989;1000:197-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2673366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proc R Soc Lond B Biol Sci. 1966 Mar 22;164(995):298-310</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4379519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 1968 Feb 17;217(5129):624-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5637732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Phys Anthropol. 1969 May;30(3):349-54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5791013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Theor Biol. 1965 Mar;8(2):357-66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5876245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nature. 1966 May 21;210(5038):811-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5958448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genetics. 1966 Aug;54(2):577-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5968642</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">27681061</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1758-1087</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of medical biography</Title>
          <ISOAbbreviation>J Med Biogr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Denis Burkitt: A legacy of global health.</ArticleTitle>
        <Pagination>
          <StartPage>4</StartPage>
          <EndPage>8</EndPage>
          <MedlinePgn>4-8</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/0967772016658785</ELocationID>
        <Abstract>
          <AbstractText>When first described in 1958, Burkitt lymphoma was considered by many to be an African curiosity. However, over the next few decades, over 10,000 publications on Burkitt lymphoma would influence many facets of oncology research including immunology, molecular genetics, chemotherapy, and viral oncology. At the time of discovery, its distribution in equatorial Africa was unique; it was where a child was born and lived, and not what race they were, that conveyed the greatest incidence risk. Its association with Epstein-Barr virus brought attention to the possibility that oncogenesis may be influenced by viruses. The influence that Burkitt lymphoma had on furthering oncology is far-reaching, and it is fitting that the physician credited with bringing attention to this disease was himself broad in his influence. Denis Burkitt was a humanitarian surgeon whose work was not limited to Burkitt lymphoma: he instigated a plan to rid an entire Ugandan district of yaws, he designed and created affordable orthopaedic equipment that could be locally produced in Kampala, and he was an early advocate of a high fiber diet. The following article will examine the biography of Denis Burkitt, with a focus on how he was able to further oncology and global health.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Esau</LastName>
            <ForeName>Daniel</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D019215">Biography</PublicationType>
          <PublicationType UI="D016456">Historical Article</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>09</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Med Biogr</MedlineTA>
        <NlmUniqueID>9308895</NlmUniqueID>
        <ISSNLinking>0967-7720</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002051" MajorTopicYN="N">Burkitt Lymphoma</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008495" MajorTopicYN="N">Medical Oncology</DescriptorName>
          <QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014454" MajorTopicYN="N" Type="Geographic">Uganda</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <PersonalNameSubjectList>
        <PersonalNameSubject>
          <LastName>Burkitt</LastName>
          <ForeName>Denis</ForeName>
          <Initials>D</Initials>
        </PersonalNameSubject>
      </PersonalNameSubjectList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Burkitt</Keyword>
        <Keyword MajorTopicYN="N">Burkitt lymphoma</Keyword>
        <Keyword MajorTopicYN="N">Uganda</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">oncology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>9</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>9</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27681061</ArticleId>
        <ArticleId IdType="doi">10.1177/0967772016658785</ArticleId>
        <ArticleId IdType="pii">0967772016658785</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">27112506</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">1552-6518</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>34</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Mar</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of interpersonal violence</Title>
          <ISOAbbreviation>J Interpers Violence</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intimate Partner Violence Among Older Portuguese Immigrant Women in Canada.</ArticleTitle>
        <Pagination>
          <StartPage>961</StartPage>
          <EndPage>979</EndPage>
          <MedlinePgn>961-979</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">0886260516646101</ELocationID>
        <Abstract>
          <AbstractText>One third of the immigrant population around the world is made up of women. Of these women, many belong to the Portuguese community. Immigrants account for more than one in five Canadians. The Portuguese older immigrant women living in Canada are vulnerable to be victims of intimate partner violence (IPV), which is a prevalent and important global health issue that affects differently diverse groups. There are few available researches regarding IPV on this population. The objective of this study is to understand how Portuguese older immigrant women living in Canada experience IPV. This is a qualitative study with a social phenomenological focus. Alfred Schutz's motivation theory was used to analyze the impulses that led older women to face IPV. The data were collected from July to October 2013 in the Greater Toronto Area. Ten women 60 years or older were included in the study. The participants perceived themselves as being victimized by their current or ex partners. They are unhappy and suffer from a variety of health problems, which they related to their experience of IPV. These factors, along with participants' personal beliefs, and their legal situations as immigrants in Canada, made them act, either in a way that would try to maintain their relationships, or tried to escape the violent situation. IPV is a complex phenomenon, with different perceptions surrounding it. The experiences of the older immigrant women showed that ending the marriage is not always a possibility to them because of cultural issues and their immigrant status in Canada. Some women wish help and support to improve their relationships.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2016.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Souto</LastName>
            <ForeName>Rafaella Queiroga</ForeName>
            <Initials>RQ</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Pernambuco, Recife, Brazil rafaellaqueiroga7@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guruge</LastName>
            <ForeName>Sepali</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Ryerson University, Toronto, Ontario, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Merighi</LastName>
            <ForeName>Miriam Aparecida Barbosa</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>University of Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Jesus</LastName>
            <ForeName>Maria Cristina Pinto</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>University of Sao Paulo, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2016</Year>
          <Month>04</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>J Interpers Violence</MedlineTA>
        <NlmUniqueID>8700910</NlmUniqueID>
        <ISSNLinking>0886-2605</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">battered women</Keyword>
        <Keyword MajorTopicYN="N">community violence</Keyword>
        <Keyword MajorTopicYN="N">domestic violence</Keyword>
        <Keyword MajorTopicYN="N">elder abuse</Keyword>
        <Keyword MajorTopicYN="N">violent offenders</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27112506</ArticleId>
        <ArticleId IdType="doi">10.1177/0886260516646101</ArticleId>
        <ArticleId IdType="pii">0886260516646101</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
